id sid tid token lemma pos aji-51 1 1 _ _ PUNCT aji-51 2 1 _ _ PUNCT aji-51 3 1 _ _ PUNCT aji-51 4 1 _ _ PUNCT aji-51 5 1 _ _ PUNCT aji-51 6 1 _ _ PUNCT aji-51 7 1 _ _ PUNCT aji-51 8 1 _ _ PUNCT aji-51 9 1 _ _ PUNCT aji-51 10 1 _ _ PUNCT aji-51 11 1 _ _ PUNCT aji-51 12 1 _ _ PUNCT aji-51 13 1 _ _ PUNCT aji-51 14 1 _ _ PUNCT aji-51 15 1 _ _ PUNCT aji-51 16 1 _ _ PUNCT aji-51 17 1 _ _ PUNCT aji-51 18 1 _ _ PUNCT aji-51 19 1 _ _ PUNCT aji-51 20 1 _ _ PUNCT aji-51 21 1 _ _ PUNCT aji-51 22 1 _ _ PUNCT aji-51 23 1 _ _ PUNCT aji-51 24 1 _ _ PUNCT aji-51 25 1 _ _ PUNCT aji-51 26 1 _ _ PUNCT aji-51 27 1 _ _ PUNCT aji-51 28 1 _ _ PUNCT aji-51 29 1 _ _ PUNCT aji-51 30 1 _ _ PUNCT aji-51 31 1 _ _ PUNCT aji-51 32 1 _ _ PUNCT aji-51 33 1 _ _ PUNCT aji-51 34 1 _ _ PUNCT aji-51 35 1 _ _ PUNCT aji-51 36 1 _ _ PUNCT aji-51 37 1 _ _ PUNCT aji-51 38 1 _ _ PUNCT aji-51 39 1 _ _ PUNCT aji-51 40 1 _ _ PUNCT aji-51 41 1 _ _ PUNCT aji-51 42 1 _ _ PUNCT aji-51 43 1 _ _ PUNCT aji-51 44 1 _ _ PUNCT aji-51 45 1 _ _ PUNCT aji-51 46 1 _ _ PUNCT aji-51 47 1 _ _ PUNCT aji-51 48 1 _ _ PUNCT aji-51 49 1 _ _ PUNCT aji-51 50 1 _ _ PUNCT aji-51 51 1 _ _ PUNCT aji-51 52 1 _ _ PUNCT aji-51 53 1 _ _ PUNCT aji-51 54 1 _ _ PUNCT aji-51 55 1 _ _ PUNCT aji-51 56 1 _ _ PUNCT aji-51 57 1 _ _ PUNCT aji-51 58 1 _ _ PUNCT aji-51 59 1 _ _ PUNCT aji-51 60 1 _ _ PUNCT aji-51 61 1 _ _ PUNCT aji-51 62 1 _ _ PUNCT aji-51 63 1 _ _ PUNCT aji-51 64 1 _ _ PUNCT aji-51 65 1 _ _ PUNCT aji-51 66 1 _ _ PUNCT aji-51 67 1 _ _ PUNCT aji-51 68 1 _ _ PUNCT aji-51 69 1 _ _ PUNCT aji-51 70 1 _ _ PUNCT aji-51 71 1 _ _ PUNCT aji-51 72 1 _ _ PUNCT aji-51 73 1 _ _ PUNCT aji-51 74 1 _ _ PUNCT aji-51 75 1 _ _ PUNCT aji-51 76 1 _ _ PUNCT aji-51 77 1 _ _ PUNCT aji-51 78 1 _ _ PUNCT aji-51 79 1 _ _ PUNCT aji-51 80 1 _ _ PUNCT aji-51 81 1 _ _ PUNCT aji-51 82 1 _ _ PUNCT aji-51 83 1 _ _ PUNCT aji-51 84 1 _ _ PUNCT aji-51 85 1 _ _ PUNCT aji-51 86 1 _ _ PUNCT aji-51 87 1 _ _ PUNCT aji-51 88 1 _ _ PUNCT aji-51 89 1 _ _ PUNCT aji-51 90 1 _ _ PUNCT aji-51 91 1 _ _ PUNCT aji-51 92 1 _ _ PUNCT aji-51 93 1 _ _ PUNCT aji-51 94 1 _ _ PUNCT aji-51 95 1 _ _ PUNCT aji-51 96 1 _ _ PUNCT aji-51 97 1 _ _ PUNCT aji-51 98 1 _ _ PUNCT aji-51 99 1 _ _ PUNCT aji-51 100 1 _ _ PUNCT aji-51 101 1 _ _ PUNCT aji-51 102 1 # # NOUN aji-51 102 2 clinical clinical ADJ aji-51 102 3 immunologist immunologist NOUN aji-51 102 4 ; ; PUNCT aji-51 102 5 * * PUNCT aji-51 102 6 corresponding correspond VERB aji-51 102 7 author author NOUN aji-51 102 8 : : PUNCT aji-51 102 9 e e NOUN aji-51 102 10 - - NOUN aji-51 102 11 mail mail NOUN aji-51 102 12 : : PUNCT aji-51 102 13 drstoff@imofny.org drstoff@imofny.org ADJ aji-51 102 14 , , PUNCT aji-51 102 15 jessestoff@gmail.com jessestoff@gmail.com PROPN aji-51 102 16 asian asian ADJ aji-51 102 17 journal journal NOUN aji-51 102 18 of of ADP aji-51 102 19 immunology immunology NOUN aji-51 102 20 5(1 5(1 NUM aji-51 102 21 ): ): PUNCT aji-51 102 22 1 1 NUM aji-51 102 23 - - SYM aji-51 102 24 39 39 NUM aji-51 102 25 , , PUNCT aji-51 102 26 2022 2022 NUM aji-51 102 27 ; ; PUNCT aji-51 102 28 article article NOUN aji-51 102 29 no.aji.77967 no.aji.77967 VERB aji-51 102 30 a a DET aji-51 102 31 multimodal multimodal ADJ aji-51 102 32 strategic strategic ADJ aji-51 102 33 approach approach NOUN aji-51 102 34 to to ADP aji-51 102 35 integrative integrative ADJ aji-51 102 36 oncology oncology NOUN aji-51 102 37 jesse jesse PROPN aji-51 102 38 a. a. PROPN aji-51 102 39 stoff stoff PROPN aji-51 103 1 a a DET aji-51 103 2 * * PROPN aji-51 103 3 # # NOUN aji-51 103 4 a a DET aji-51 103 5 integrative integrative ADJ aji-51 103 6 medicine medicine NOUN aji-51 103 7 of of ADP aji-51 103 8 new new PROPN aji-51 103 9 york york PROPN aji-51 103 10 , , PUNCT aji-51 103 11 520 520 NUM aji-51 103 12 franklin franklin PROPN aji-51 103 13 ave ave PROPN aji-51 103 14 suite suite PROPN aji-51 103 15 230 230 NUM aji-51 103 16 garden garden NOUN aji-51 103 17 city city NOUN aji-51 103 18 , , PUNCT aji-51 103 19 ny-11530 ny-11530 PROPN aji-51 103 20 , , PUNCT aji-51 103 21 usa usa PROPN aji-51 103 22 . . PROPN aji-51 103 23 author author PROPN aji-51 103 24 ’s ’s PART aji-51 103 25 contribution contribution NOUN aji-51 103 26 the the DET aji-51 103 27 sole sole ADJ aji-51 103 28 author author NOUN aji-51 103 29 designed design VERB aji-51 103 30 , , PUNCT aji-51 103 31 analysed analyse VERB aji-51 103 32 , , PUNCT aji-51 103 33 interpreted interpret VERB aji-51 103 34 and and CCONJ aji-51 103 35 prepared prepare VERB aji-51 103 36 the the DET aji-51 103 37 manuscript manuscript NOUN aji-51 103 38 . . PUNCT aji-51 104 1 article article NOUN aji-51 104 2 information information PROPN aji-51 104 3 editor(s editor(s PROPN aji-51 104 4 ): ): PUNCT aji-51 104 5 ( ( PUNCT aji-51 104 6 1 1 X aji-51 104 7 ) ) PUNCT aji-51 104 8 dr dr PROPN aji-51 104 9 . . PROPN aji-51 104 10 wagner wagner PROPN aji-51 104 11 loyola loyola PROPN aji-51 104 12 , , PUNCT aji-51 104 13 brazilian brazilian ADJ aji-51 104 14 agricultural agricultural ADJ aji-51 104 15 research research NOUN aji-51 104 16 corporation corporation PROPN aji-51 104 17 , , PUNCT aji-51 104 18 concordia concordia PROPN aji-51 104 19 . . PUNCT aji-51 105 1 reviewers reviewer NOUN aji-51 105 2 : : PUNCT aji-51 105 3 ( ( PUNCT aji-51 105 4 1 1 X aji-51 105 5 ) ) PUNCT aji-51 105 6 yue yue PROPN aji-51 105 7 jia jia PROPN aji-51 105 8 , , PUNCT aji-51 105 9 usa usa PROPN aji-51 105 10 . . PROPN aji-51 105 11 ( ( PUNCT aji-51 105 12 2 2 X aji-51 105 13 ) ) PUNCT aji-51 105 14 bhalchandra bhalchandra NOUN aji-51 105 15 mirlekar mirlekar PROPN aji-51 105 16 , , PUNCT aji-51 105 17 university university PROPN aji-51 105 18 of of ADP aji-51 105 19 north north PROPN aji-51 105 20 carolina carolina PROPN aji-51 105 21 at at ADP aji-51 105 22 chapel chapel PROPN aji-51 105 23 hill hill PROPN aji-51 105 24 , , PUNCT aji-51 105 25 usa usa PROPN aji-51 105 26 . . PROPN aji-51 105 27 complete complete ADJ aji-51 105 28 peer peer NOUN aji-51 105 29 review review NOUN aji-51 105 30 history history NOUN aji-51 105 31 , , PUNCT aji-51 105 32 details detail NOUN aji-51 105 33 of of ADP aji-51 105 34 the the DET aji-51 105 35 editor(s editor(s NOUN aji-51 105 36 ) ) PUNCT aji-51 105 37 , , PUNCT aji-51 105 38 reviewers reviewer NOUN aji-51 105 39 and and CCONJ aji-51 105 40 additional additional ADJ aji-51 105 41 reviewers reviewer NOUN aji-51 105 42 are be AUX aji-51 105 43 available available ADJ aji-51 105 44 here here ADV aji-51 105 45 : : PUNCT aji-51 105 46 https://www.sdiarticle5.com/review-history/77967 https://www.sdiarticle5.com/review-history/77967 PROPN aji-51 105 47 received receive VERB aji-51 105 48 10 10 NUM aji-51 105 49 october october NOUN aji-51 105 50 2021 2021 NUM aji-51 105 51 accepted accept VERB aji-51 105 52 13 13 NUM aji-51 105 53 december december PROPN aji-51 105 54 2021 2021 NUM aji-51 105 55 published publish VERB aji-51 105 56 15 15 NUM aji-51 105 57 january january PROPN aji-51 105 58 2022 2022 NUM aji-51 105 59 abstract abstract ADV aji-51 105 60 the the DET aji-51 105 61 term term NOUN aji-51 105 62 “ " PUNCT aji-51 105 63 integrative integrative ADJ aji-51 105 64 oncology oncology NOUN aji-51 105 65 ” " PUNCT aji-51 105 66 can can AUX aji-51 105 67 mean mean VERB aji-51 105 68 particular particular ADJ aji-51 105 69 things thing NOUN aji-51 105 70 to to ADP aji-51 105 71 different different ADJ aji-51 105 72 audiences audience NOUN aji-51 105 73 . . PUNCT aji-51 106 1 for for ADP aji-51 106 2 the the DET aji-51 106 3 purposes purpose NOUN aji-51 106 4 of of ADP aji-51 106 5 this this DET aji-51 106 6 article article NOUN aji-51 106 7 , , PUNCT aji-51 106 8 i i PRON aji-51 106 9 intend intend VERB aji-51 106 10 it it PRON aji-51 106 11 to to PART aji-51 106 12 mean mean VERB aji-51 106 13 the the DET aji-51 106 14 simultaneous simultaneous ADJ aji-51 106 15 use use NOUN aji-51 106 16 of of ADP aji-51 106 17 multiple multiple ADJ aji-51 106 18 anti anti ADJ aji-51 106 19 - - ADJ aji-51 106 20 cancer cancer ADJ aji-51 106 21 strategies strategy NOUN aji-51 106 22 that that PRON aji-51 106 23 can can AUX aji-51 106 24 have have VERB aji-51 106 25 a a DET aji-51 106 26 synergistic synergistic ADJ aji-51 106 27 effect effect NOUN aji-51 106 28 against against ADP aji-51 106 29 the the DET aji-51 106 30 tumor tumor NOUN aji-51 106 31 , , PUNCT aji-51 106 32 its its PRON aji-51 106 33 microenvironment microenvironment NOUN aji-51 106 34 , , PUNCT aji-51 106 35 and and CCONJ aji-51 106 36 its its PRON aji-51 106 37 propensity propensity NOUN aji-51 106 38 to to PART aji-51 106 39 metastasize metastasize VERB aji-51 106 40 . . PUNCT aji-51 107 1 thereby thereby ADV aji-51 107 2 , , PUNCT aji-51 107 3 having have VERB aji-51 107 4 a a DET aji-51 107 5 maximum maximum ADJ aji-51 107 6 impact impact NOUN aji-51 107 7 against against ADP aji-51 107 8 the the DET aji-51 107 9 cancer cancer NOUN aji-51 107 10 with with ADP aji-51 107 11 a a DET aji-51 107 12 minimum minimum NOUN aji-51 107 13 of of ADP aji-51 107 14 side side NOUN aji-51 107 15 effects effect NOUN aji-51 107 16 for for SCONJ aji-51 107 17 the the DET aji-51 107 18 patient patient NOUN aji-51 107 19 to to PART aji-51 107 20 endure endure VERB aji-51 107 21 . . PUNCT aji-51 108 1 as as SCONJ aji-51 108 2 noted note VERB aji-51 108 3 in in ADP aji-51 108 4 the the DET aji-51 108 5 references reference NOUN aji-51 108 6 , , PUNCT aji-51 108 7 this this DET aji-51 108 8 paper paper NOUN aji-51 108 9 briefly briefly NOUN aji-51 108 10 describes describe VERB aji-51 108 11 the the DET aji-51 108 12 five five NUM aji-51 108 13 prevailing prevail VERB aji-51 108 14 evidence evidence NOUN aji-51 108 15 - - PUNCT aji-51 108 16 based base VERB aji-51 108 17 systematic systematic ADJ aji-51 108 18 approaches approach NOUN aji-51 108 19 in in ADP aji-51 108 20 use use NOUN aji-51 108 21 today today NOUN aji-51 108 22 . . PUNCT aji-51 109 1 each each PRON aji-51 109 2 of of ADP aji-51 109 3 these these DET aji-51 109 4 approaches approach NOUN aji-51 109 5 has have VERB aji-51 109 6 varying vary VERB aji-51 109 7 degrees degree NOUN aji-51 109 8 of of ADP aji-51 109 9 effectiveness effectiveness NOUN aji-51 109 10 which which PRON aji-51 109 11 , , PUNCT aji-51 109 12 in in ADP aji-51 109 13 my my PRON aji-51 109 14 experience experience NOUN aji-51 109 15 , , PUNCT aji-51 109 16 when when SCONJ aji-51 109 17 clinically clinically ADV aji-51 109 18 integrated integrate VERB aji-51 109 19 , , PUNCT aji-51 109 20 produces produce VERB aji-51 109 21 exponentially exponentially ADV aji-51 109 22 better well ADJ aji-51 109 23 efficacy efficacy NOUN aji-51 109 24 , , PUNCT aji-51 109 25 hence hence ADV aji-51 109 26 shifting shift VERB aji-51 109 27 progression progression NOUN aji-51 109 28 - - PUNCT aji-51 109 29 free free ADJ aji-51 109 30 survival survival NOUN aji-51 109 31 into into ADP aji-51 109 32 the the DET aji-51 109 33 possibility possibility NOUN aji-51 109 34 of of ADP aji-51 109 35 increased increase VERB aji-51 109 36 overall overall ADJ aji-51 109 37 survival survival NOUN aji-51 109 38 and and CCONJ aji-51 109 39 a a DET aji-51 109 40 durable durable ADJ aji-51 109 41 remission remission NOUN aji-51 109 42 . . PUNCT aji-51 110 1 this this DET aji-51 110 2 paper paper NOUN aji-51 110 3 is be AUX aji-51 110 4 an an DET aji-51 110 5 attempt attempt NOUN aji-51 110 6 to to PART aji-51 110 7 offer offer VERB aji-51 110 8 some some DET aji-51 110 9 perspective perspective NOUN aji-51 110 10 of of ADP aji-51 110 11 how how SCONJ aji-51 110 12 to to PART aji-51 110 13 apply apply VERB aji-51 110 14 these these DET aji-51 110 15 disparate disparate ADJ aji-51 110 16 methodologies methodology NOUN aji-51 110 17 so so SCONJ aji-51 110 18 that that SCONJ aji-51 110 19 they they PRON aji-51 110 20 may may AUX aji-51 110 21 be be AUX aji-51 110 22 more more ADV aji-51 110 23 effectively effectively ADV aji-51 110 24 integrated integrate VERB aji-51 110 25 , , PUNCT aji-51 110 26 resulting result VERB aji-51 110 27 in in ADP aji-51 110 28 consistently consistently ADV aji-51 110 29 better well ADJ aji-51 110 30 clinical clinical ADJ aji-51 110 31 responses response NOUN aji-51 110 32 . . PUNCT aji-51 111 1 keywords keyword NOUN aji-51 111 2 : : PUNCT aji-51 111 3 integrative integrative ADJ aji-51 111 4 oncology oncology NOUN aji-51 111 5 ; ; PUNCT aji-51 111 6 oncology oncology NOUN aji-51 111 7 ; ; PUNCT aji-51 111 8 multimodal multimodal NOUN aji-51 111 9 strategic strategic ADJ aji-51 111 10 ; ; PUNCT aji-51 111 11 cancer cancer NOUN aji-51 111 12 . . PUNCT aji-51 112 1 1 1 X aji-51 112 2 . . X aji-51 112 3 introduction introduction NOUN aji-51 112 4 cancer cancer NOUN aji-51 112 5 , , PUNCT aji-51 112 6 as as ADP aji-51 112 7 a a DET aji-51 112 8 disease disease NOUN aji-51 112 9 of of ADP aji-51 112 10 our our PRON aji-51 112 11 time time NOUN aji-51 112 12 , , PUNCT aji-51 112 13 has have AUX aji-51 112 14 been be AUX aji-51 112 15 described describe VERB aji-51 112 16 as as ADP aji-51 112 17 a a DET aji-51 112 18 “ " PUNCT aji-51 112 19 wound wound NOUN aji-51 112 20 that that PRON aji-51 112 21 does do AUX aji-51 112 22 not not PART aji-51 112 23 heal heal VERB aji-51 112 24 ” " PUNCT aji-51 113 1 [ [ X aji-51 113 2 1 1 NUM aji-51 113 3 ] ] PUNCT aji-51 113 4 because because SCONJ aji-51 113 5 it it PRON aji-51 113 6 has have VERB aji-51 113 7 a a DET aji-51 113 8 multitude multitude NOUN aji-51 113 9 of of ADP aji-51 113 10 biochemical biochemical ADJ aji-51 113 11 dysfunctions dysfunction NOUN aji-51 113 12 at at ADP aji-51 113 13 its its PRON aji-51 113 14 core core NOUN aji-51 113 15 . . PUNCT aji-51 114 1 however however ADV aji-51 114 2 , , PUNCT aji-51 114 3 in in ADP aji-51 114 4 order order NOUN aji-51 114 5 for for SCONJ aji-51 114 6 these these DET aji-51 114 7 genetically genetically ADV aji-51 114 8 and and CCONJ aji-51 114 9 phenotypically phenotypically ADV aji-51 114 10 abnormal abnormal ADJ aji-51 114 11 cells cell NOUN aji-51 114 12 to to PART aji-51 114 13 survive survive VERB aji-51 114 14 and and CCONJ aji-51 114 15 thrive thrive VERB aji-51 114 16 , , PUNCT aji-51 114 17 the the DET aji-51 114 18 watchdog watchdog NOUN aji-51 114 19 of of ADP aji-51 114 20 the the DET aji-51 114 21 review review NOUN aji-51 114 22 article article NOUN aji-51 114 23 stoff stoff PROPN aji-51 114 24 ; ; PUNCT aji-51 114 25 aji aji PROPN aji-51 114 26 , , PUNCT aji-51 114 27 5(1 5(1 NUM aji-51 114 28 ): ): PUNCT aji-51 114 29 1 1 NUM aji-51 114 30 - - SYM aji-51 114 31 39 39 NUM aji-51 114 32 , , PUNCT aji-51 114 33 2022 2022 NUM aji-51 114 34 ; ; PUNCT aji-51 114 35 article article NOUN aji-51 114 36 no.aji.77967 no.aji.77967 NOUN aji-51 114 37 2 2 NUM aji-51 114 38 body body NOUN aji-51 114 39 , , PUNCT aji-51 114 40 the the DET aji-51 114 41 immune immune ADJ aji-51 114 42 system system NOUN aji-51 114 43 , , PUNCT aji-51 114 44 must must AUX aji-51 114 45 itself itself PRON aji-51 114 46 be be AUX aji-51 114 47 suffering suffer VERB aji-51 114 48 from from ADP aji-51 114 49 a a DET aji-51 114 50 number number NOUN aji-51 114 51 of of ADP aji-51 114 52 serious serious ADJ aji-51 114 53 areas area NOUN aji-51 114 54 of of ADP aji-51 114 55 structural structural ADJ aji-51 114 56 and and CCONJ aji-51 114 57 functional functional ADJ aji-51 114 58 damage damage NOUN aji-51 114 59 . . PUNCT aji-51 115 1 from from ADP aji-51 115 2 a a DET aji-51 115 3 perspective perspective NOUN aji-51 115 4 of of ADP aji-51 115 5 ten ten NUM aji-51 115 6 thousand thousand NUM aji-51 115 7 feet foot NOUN aji-51 115 8 , , PUNCT aji-51 115 9 there there PRON aji-51 115 10 are be VERB aji-51 115 11 two two NUM aji-51 115 12 basic basic ADJ aji-51 115 13 characteristics characteristic NOUN aji-51 115 14 of of ADP aji-51 115 15 cancer cancer NOUN aji-51 115 16 : : PUNCT aji-51 115 17 genetic genetic ADJ aji-51 115 18 instability instability NOUN aji-51 115 19 and and CCONJ aji-51 115 20 the the DET aji-51 115 21 propensity propensity NOUN aji-51 115 22 to to PART aji-51 115 23 metastasize metastasize VERB aji-51 115 24 . . PUNCT aji-51 116 1 from from ADP aji-51 116 2 those those DET aji-51 116 3 two two NUM aji-51 116 4 basic basic ADJ aji-51 116 5 observational observational ADJ aji-51 116 6 characteristics characteristic NOUN aji-51 116 7 , , PUNCT aji-51 116 8 the the DET aji-51 116 9 hallmarks hallmark NOUN aji-51 116 10 of of ADP aji-51 116 11 cancer cancer NOUN aji-51 116 12 were be AUX aji-51 116 13 derived derive VERB aji-51 116 14 by by ADP aji-51 116 15 drs dr NOUN aji-51 116 16 . . PUNCT aji-51 117 1 hanahan hanahan PROPN aji-51 117 2 and and CCONJ aji-51 117 3 weinberg weinberg PROPN aji-51 117 4 in in ADP aji-51 117 5 2000 2000 NUM aji-51 117 6 as as SCONJ aji-51 117 7 follows follow VERB aji-51 117 8 : : PUNCT aji-51 117 9     SPACE aji-51 117 10 self self NOUN aji-51 117 11 - - PUNCT aji-51 117 12 sufficiency sufficiency NOUN aji-51 117 13 in in ADP aji-51 117 14 growth growth NOUN aji-51 117 15 signals signal NOUN aji-51 117 16 . . PUNCT aji-51 118 1 insensitivity insensitivity NOUN aji-51 118 2 to to PART aji-51 118 3 antigrowth antigrowth VERB aji-51 118 4 signals signal NOUN aji-51 118 5 . . PUNCT aji-51 119 1 evading evade VERB aji-51 119 2 apoptosis apoptosis NOUN aji-51 119 3 , , PUNCT aji-51 119 4 limitless limitless ADJ aji-51 119 5 replicative replicative ADJ aji-51 119 6 potential potential NOUN aji-51 119 7 , , PUNCT aji-51 119 8 sustained sustained ADJ aji-51 119 9 angiogenesis angiogenesis NOUN aji-51 119 10 , , PUNCT aji-51 119 11 tissue tissue NOUN aji-51 119 12 invasion invasion NOUN aji-51 119 13 and and CCONJ aji-51 119 14 metastasis metastasis NOUN aji-51 119 15 . . PUNCT aji-51 120 1 and and CCONJ aji-51 120 2 then then ADV aji-51 120 3 the the DET aji-51 120 4 following follow VERB aji-51 120 5 were be AUX aji-51 120 6 added add VERB aji-51 120 7 in in ADP aji-51 120 8 2011 2011 NUM aji-51 120 9 : : PUNCT aji-51 120 10     SPACE aji-51 120 11 deregulating deregulate VERB aji-51 120 12 cellular cellular ADJ aji-51 120 13 energetics energetic NOUN aji-51 120 14 , , PUNCT aji-51 120 15 avoiding avoid VERB aji-51 120 16 immune immune ADJ aji-51 120 17 destruction destruction NOUN aji-51 120 18 , , PUNCT aji-51 120 19 genome genome NOUN aji-51 120 20 instability instability NOUN aji-51 120 21 and and CCONJ aji-51 120 22 mutation mutation NOUN aji-51 120 23 , , PUNCT aji-51 120 24 tumor tumor NOUN aji-51 120 25 - - PUNCT aji-51 120 26 promoting promote VERB aji-51 120 27 inflammation inflammation NOUN aji-51 120 28 [ [ X aji-51 120 29 2,3 2,3 NUM aji-51 120 30 ] ] PUNCT aji-51 120 31 . . PUNCT aji-51 121 1 based base VERB aji-51 121 2 upon upon SCONJ aji-51 121 3 the the DET aji-51 121 4 characteristics characteristic NOUN aji-51 121 5 of of ADP aji-51 121 6 the the DET aji-51 121 7 cancer cancer NOUN aji-51 121 8 , , PUNCT aji-51 121 9 there there PRON aji-51 121 10 are be VERB aji-51 121 11 five five NUM aji-51 121 12 common common ADJ aji-51 121 13 office office NOUN aji-51 121 14 - - PUNCT aji-51 121 15 based base VERB aji-51 121 16 / / SYM aji-51 121 17 out out ADP aji-51 121 18 - - PUNCT aji-51 121 19 patient patient NOUN aji-51 121 20 strategies strategy NOUN aji-51 121 21 that that PRON aji-51 121 22 we we PRON aji-51 121 23 can can AUX aji-51 121 24 employ employ VERB aji-51 121 25 . . PUNCT aji-51 122 1 each each PRON aji-51 122 2 of of ADP aji-51 122 3 these these DET aji-51 122 4 strategies strategy NOUN aji-51 122 5 is be AUX aji-51 122 6 made make VERB aji-51 122 7 up up ADP aji-51 122 8 of of ADP aji-51 122 9 a a DET aji-51 122 10 number number NOUN aji-51 122 11 of of ADP aji-51 122 12 tactics tactic NOUN aji-51 122 13 based base VERB aji-51 122 14 upon upon SCONJ aji-51 122 15 the the DET aji-51 122 16 unique unique ADJ aji-51 122 17 expressed express VERB aji-51 122 18 characteristics characteristic NOUN aji-51 122 19 of of ADP aji-51 122 20 the the DET aji-51 122 21 target target NOUN aji-51 122 22 cancer cancer NOUN aji-51 122 23 and and CCONJ aji-51 122 24 the the DET aji-51 122 25 physiological physiological ADJ aji-51 122 26 individuality individuality NOUN aji-51 122 27 of of ADP aji-51 122 28 the the DET aji-51 122 29 patient patient NOUN aji-51 122 30 . . PUNCT aji-51 123 1 those those DET aji-51 123 2 five five NUM aji-51 123 3 strategies strategy NOUN aji-51 123 4 are be AUX aji-51 123 5 first first ADJ aji-51 123 6 , , PUNCT aji-51 123 7 to to PART aji-51 123 8 balance balance VERB aji-51 123 9 and and CCONJ aji-51 123 10 normalize normalize VERB aji-51 123 11 the the DET aji-51 123 12 metabolism metabolism NOUN aji-51 123 13 of of ADP aji-51 123 14 the the DET aji-51 123 15 patient patient NOUN aji-51 123 16 while while SCONJ aji-51 123 17 inhibiting inhibit VERB aji-51 123 18 the the DET aji-51 123 19 physiology physiology NOUN aji-51 123 20 of of ADP aji-51 123 21 the the DET aji-51 123 22 cancer cancer NOUN aji-51 123 23 . . PUNCT aji-51 124 1 second second ADJ aji-51 124 2 , , PUNCT aji-51 124 3 to to PART aji-51 124 4 identify identify VERB aji-51 124 5 and and CCONJ aji-51 124 6 seek seek VERB aji-51 124 7 to to PART aji-51 124 8 repair repair VERB aji-51 124 9 areas area NOUN aji-51 124 10 of of ADP aji-51 124 11 damage damage NOUN aji-51 124 12 within within ADP aji-51 124 13 the the DET aji-51 124 14 structure structure NOUN aji-51 124 15 and and CCONJ aji-51 124 16 function function NOUN aji-51 124 17 of of ADP aji-51 124 18 the the DET aji-51 124 19 immune immune ADJ aji-51 124 20 system system NOUN aji-51 124 21 . . PUNCT aji-51 125 1 third third ADJ aji-51 125 2 , , PUNCT aji-51 125 3 to to PART aji-51 125 4 identify identify VERB aji-51 125 5 actionable actionable ADJ aji-51 125 6 genetic genetic ADJ aji-51 125 7 and and CCONJ aji-51 125 8 protein protein NOUN aji-51 125 9 mutations mutation NOUN aji-51 125 10 that that PRON aji-51 125 11 are be AUX aji-51 125 12 driving drive VERB aji-51 125 13 the the DET aji-51 125 14 cancer cancer NOUN aji-51 125 15 and and CCONJ aji-51 125 16 address address VERB aji-51 125 17 them they PRON aji-51 125 18 . . PUNCT aji-51 126 1 forth forth ADV aji-51 126 2 , , PUNCT aji-51 126 3 to to PART aji-51 126 4 employ employ VERB aji-51 126 5 agents agent NOUN aji-51 126 6 that that PRON aji-51 126 7 can can AUX aji-51 126 8 inhibit inhibit VERB aji-51 126 9 , , PUNCT aji-51 126 10 suppress suppress ADJ aji-51 126 11 , , PUNCT aji-51 126 12 or or CCONJ aji-51 126 13 destroy destroy VERB aji-51 126 14 the the DET aji-51 126 15 root root NOUN aji-51 126 16 of of ADP aji-51 126 17 the the DET aji-51 126 18 problem problem NOUN aji-51 126 19 , , PUNCT aji-51 126 20 the the DET aji-51 126 21 cancer cancer NOUN aji-51 126 22 stem stem NOUN aji-51 126 23 cells cell NOUN aji-51 126 24 . . PUNCT aji-51 127 1 and and CCONJ aji-51 127 2 fifth fifth ADJ aji-51 127 3 , , PUNCT aji-51 127 4 to to PART aji-51 127 5 directly directly ADV aji-51 127 6 attack attack VERB aji-51 127 7 the the DET aji-51 127 8 cancer cancer NOUN aji-51 127 9 with with ADP aji-51 127 10 cytotoxic cytotoxic ADJ aji-51 127 11 ( ( PUNCT aji-51 127 12 chemotherapeutic chemotherapeutic ADJ aji-51 127 13 ) ) PUNCT aji-51 127 14 agents agent NOUN aji-51 127 15 and and CCONJ aji-51 127 16 radiation radiation NOUN aji-51 127 17 therapy therapy NOUN aji-51 127 18 . . PUNCT aji-51 128 1 utilizing utilize VERB aji-51 128 2 agents agent NOUN aji-51 128 3 that that PRON aji-51 128 4 can can AUX aji-51 128 5 decisively decisively ADV aji-51 128 6 accomplish accomplish VERB aji-51 128 7 one one NUM aji-51 128 8 of of ADP aji-51 128 9 these these DET aji-51 128 10 strategies strategy NOUN aji-51 128 11 or or CCONJ aji-51 128 12 that that PRON aji-51 128 13 can can AUX aji-51 128 14 engage engage VERB aji-51 128 15 and and CCONJ aji-51 128 16 strike strike VERB aji-51 128 17 two two NUM aji-51 128 18 or or CCONJ aji-51 128 19 more more ADJ aji-51 128 20 of of ADP aji-51 128 21 these these DET aji-51 128 22 objectives objective NOUN aji-51 128 23 with with ADP aji-51 128 24 less less ADJ aji-51 128 25 toxicity toxicity NOUN aji-51 128 26 can can AUX aji-51 128 27 lead lead VERB aji-51 128 28 to to ADP aji-51 128 29 greater great ADJ aji-51 128 30 quality quality NOUN aji-51 128 31 and and CCONJ aji-51 128 32 quantity quantity NOUN aji-51 128 33 of of ADP aji-51 128 34 life life NOUN aji-51 128 35 for for ADP aji-51 128 36 our our PRON aji-51 128 37 patients patient NOUN aji-51 128 38 . . PUNCT aji-51 129 1 2 2 X aji-51 129 2 . . X aji-51 129 3 metabolic metabolic NOUN aji-51 129 4 approach approach NOUN aji-51 129 5 2.1 2.1 NUM aji-51 129 6 biochemical biochemical ADJ aji-51 129 7 support support NOUN aji-51 129 8 of of ADP aji-51 129 9 the the DET aji-51 129 10 patient patient ADJ aji-51 129 11 milieu milieu NOUN aji-51 129 12 metabolic metabolic NOUN aji-51 129 13 targeting target VERB aji-51 129 14 is be AUX aji-51 129 15 the the DET aji-51 129 16 first first ADJ aji-51 129 17 anti anti ADJ aji-51 129 18 - - ADJ aji-51 129 19 cancer cancer ADJ aji-51 129 20 strategy strategy NOUN aji-51 129 21 because because SCONJ aji-51 129 22 it it PRON aji-51 129 23 lays lay VERB aji-51 129 24 the the DET aji-51 129 25 foundation foundation NOUN aji-51 129 26 for for ADP aji-51 129 27 the the DET aji-51 129 28 improved improved ADJ aji-51 129 29 response response NOUN aji-51 129 30 for for ADP aji-51 129 31 all all PRON aji-51 129 32 of of ADP aji-51 129 33 the the DET aji-51 129 34 other other ADJ aji-51 129 35 strategies strategy NOUN aji-51 129 36 that that PRON aji-51 129 37 follow follow VERB aji-51 129 38 . . PUNCT aji-51 130 1 in in ADP aji-51 130 2 1498 1498 NUM aji-51 130 3 , , PUNCT aji-51 130 4 albrecht albrecht PROPN aji-51 130 5 durer durer PROPN aji-51 130 6 created create VERB aji-51 130 7 the the DET aji-51 130 8 famous famous ADJ aji-51 130 9 woodcut woodcut NOUN aji-51 130 10 entitled entitle VERB aji-51 130 11 “ " PUNCT aji-51 130 12 the the DET aji-51 130 13 four four NUM aji-51 130 14 horsemen horseman NOUN aji-51 130 15 , , PUNCT aji-51 130 16 from from ADP aji-51 130 17 the the DET aji-51 130 18 apocalypse apocalypse NOUN aji-51 130 19 ” " PUNCT aji-51 130 20 which which PRON aji-51 130 21 , , PUNCT aji-51 130 22 in in ADP aji-51 130 23 a a DET aji-51 130 24 sense sense NOUN aji-51 130 25 , , PUNCT aji-51 130 26 foreshadowed foreshadow VERB aji-51 130 27 the the DET aji-51 130 28 epidemic epidemic NOUN aji-51 130 29 of of ADP aji-51 130 30 severe severe ADJ aji-51 130 31 and and CCONJ aji-51 130 32 chronic chronic ADJ aji-51 130 33 diseases disease NOUN aji-51 130 34 that that PRON aji-51 130 35 we we PRON aji-51 130 36 now now ADV aji-51 130 37 face face VERB aji-51 130 38 . . PUNCT aji-51 131 1 from from ADP aji-51 131 2 a a DET aji-51 131 3 metabolic metabolic NOUN aji-51 131 4 , , PUNCT aji-51 131 5 thousand thousand NUM aji-51 131 6 - - PUNCT aji-51 131 7 foot foot NOUN aji-51 131 8 perspective perspective NOUN aji-51 131 9 , , PUNCT aji-51 131 10 there there PRON aji-51 131 11 are be VERB aji-51 131 12 four four NUM aji-51 131 13 major major ADJ aji-51 131 14 processes process NOUN aji-51 131 15 that that PRON aji-51 131 16 are be AUX aji-51 131 17 common common ADJ aji-51 131 18 pathways pathway NOUN aji-51 131 19 for for ADP aji-51 131 20 the the DET aji-51 131 21 initiation initiation NOUN aji-51 131 22 and and CCONJ aji-51 131 23 promotion promotion NOUN aji-51 131 24 of of ADP aji-51 131 25 cancer cancer NOUN aji-51 131 26 . . PUNCT aji-51 132 1 each each PRON aji-51 132 2 of of ADP aji-51 132 3 which which PRON aji-51 132 4 should should AUX aji-51 132 5 be be AUX aji-51 132 6 assessed assess VERB aji-51 132 7 for for ADP aji-51 132 8 every every DET aji-51 132 9 patient patient NOUN aji-51 132 10 : : PUNCT aji-51 132 11 glycation glycation NOUN aji-51 132 12 ; ; PUNCT aji-51 132 13 which which PRON aji-51 132 14 can can AUX aji-51 132 15 be be AUX aji-51 132 16 easily easily ADV aji-51 132 17 measured measure VERB aji-51 132 18 with with ADP aji-51 132 19 blood blood NOUN aji-51 132 20 sugar sugar NOUN aji-51 132 21 , , PUNCT aji-51 132 22 hemoglobin hemoglobin NOUN aji-51 132 23 a1c a1c PROPN aji-51 132 24 , , PUNCT aji-51 132 25 and and CCONJ aji-51 132 26 glycomark glycomark NOUN aji-51 132 27 ; ; PUNCT aji-51 132 28 inflammation inflammation NOUN aji-51 132 29 ; ; PUNCT aji-51 132 30 for for ADP aji-51 132 31 which which PRON aji-51 132 32 there there PRON aji-51 132 33 are be VERB aji-51 132 34 a a DET aji-51 132 35 myriad myriad NOUN aji-51 132 36 of of ADP aji-51 132 37 markers marker NOUN aji-51 132 38 including include VERB aji-51 132 39 esr esr PROPN aji-51 132 40 , , PUNCT aji-51 132 41 crp crp PROPN aji-51 132 42 , , PUNCT aji-51 132 43 plasma plasma NOUN aji-51 132 44 viscosity viscosity NOUN aji-51 132 45 , , PUNCT aji-51 132 46 adiponectin adiponectin NOUN aji-51 132 47 , , PUNCT aji-51 132 48 monocyte monocyte NOUN aji-51 132 49 chemoattractant chemoattractant NOUN aji-51 132 50 protein protein NOUN aji-51 132 51 1 1 NUM aji-51 132 52 ( ( PUNCT aji-51 132 53 mcp-1 mcp-1 NOUN aji-51 132 54 ) ) PUNCT aji-51 132 55 , , PUNCT aji-51 132 56 cd40 cd40 PROPN aji-51 132 57 ligand ligand NOUN aji-51 132 58 and and CCONJ aji-51 132 59 lipoprotein lipoprotein ADJ aji-51 132 60 - - PUNCT aji-51 132 61 associated associate VERB aji-51 132 62 phospholipase phospholipase NOUN aji-51 132 63 a(2 a(2 PROPN aji-51 132 64 ) ) PUNCT aji-51 132 65 ( ( PUNCT aji-51 132 66 lp lp NOUN aji-51 132 67 - - NOUN aji-51 132 68 pla(2 pla(2 NOUN aji-51 132 69 ) ) PUNCT aji-51 132 70 ) ) PUNCT aji-51 132 71 , , PUNCT aji-51 132 72 and and CCONJ aji-51 132 73 ferritin ferritin ADJ aji-51 132 74 to to ADP aji-51 132 75 name name NOUN aji-51 132 76 but but CCONJ aji-51 132 77 a a DET aji-51 132 78 few few ADJ aji-51 132 79 ; ; PUNCT aji-51 132 80 methylation methylation NOUN aji-51 132 81 ; ; PUNCT aji-51 132 82 which which PRON aji-51 132 83 can can AUX aji-51 132 84 be be AUX aji-51 132 85 watched watch VERB aji-51 132 86 with with ADP aji-51 132 87 homocysteine homocysteine ADJ aji-51 132 88 levels level NOUN aji-51 132 89 ; ; PUNCT aji-51 132 90 and and CCONJ aji-51 132 91 finally finally ADV aji-51 132 92 , , PUNCT aji-51 132 93 we we PRON aji-51 132 94 come come VERB aji-51 132 95 to to ADP aji-51 132 96 oxidation oxidation NOUN aji-51 132 97 ; ; PUNCT aji-51 132 98 which which PRON aji-51 132 99 is be AUX aji-51 132 100 largely largely ADV aji-51 132 101 reflected reflect VERB aji-51 132 102 in in ADP aji-51 132 103 levels level NOUN aji-51 132 104 of of ADP aji-51 132 105 lipid lipid NOUN aji-51 132 106 peroxides peroxide NOUN aji-51 132 107 and and CCONJ aji-51 132 108 oxidized oxidize VERB aji-51 132 109 ldl ldl NOUN aji-51 132 110 . . PUNCT aji-51 133 1 current current ADJ aji-51 133 2 research research NOUN aji-51 133 3 demonstrates demonstrate VERB aji-51 133 4 that that SCONJ aji-51 133 5 cancer cancer NOUN aji-51 133 6 is be AUX aji-51 133 7 largely largely ADV aji-51 133 8 a a DET aji-51 133 9 metabolic metabolic NOUN aji-51 133 10 disease disease NOUN aji-51 133 11 involving involve VERB aji-51 133 12 disturbances disturbance NOUN aji-51 133 13 in in ADP aji-51 133 14 energy energy NOUN aji-51 133 15 production production NOUN aji-51 133 16 ( ( PUNCT aji-51 133 17 deregulating deregulate VERB aji-51 133 18 cellular cellular ADJ aji-51 133 19 energetics energetic NOUN aji-51 133 20 ) ) PUNCT aji-51 133 21 through through ADP aji-51 133 22 a a DET aji-51 133 23 shift shift NOUN aji-51 133 24 from from ADP aji-51 133 25 respiration respiration NOUN aji-51 133 26 to to ADP aji-51 133 27 fermentation fermentation NOUN aji-51 133 28 , , PUNCT aji-51 133 29 but but CCONJ aji-51 133 30 this this PRON aji-51 133 31 is be AUX aji-51 133 32 not not PART aji-51 133 33 the the DET aji-51 133 34 only only ADJ aji-51 133 35 aberrant aberrant ADJ aji-51 133 36 energy energy NOUN aji-51 133 37 pathway pathway NOUN aji-51 133 38 that that SCONJ aji-51 133 39 cancer cancer NOUN aji-51 133 40 cells cell NOUN aji-51 133 41 can can AUX aji-51 133 42 utilize utilize VERB aji-51 133 43 . . PUNCT aji-51 134 1 the the DET aji-51 134 2 genomic genomic ADJ aji-51 134 3 instability instability NOUN aji-51 134 4 observed observe VERB aji-51 134 5 in in ADP aji-51 134 6 tumor tumor NOUN aji-51 134 7 cells cell NOUN aji-51 134 8 , , PUNCT aji-51 134 9 leading lead VERB aji-51 134 10 to to ADP aji-51 134 11 the the DET aji-51 134 12 other other ADJ aji-51 134 13 recognized recognize VERB aji-51 134 14 hallmarks hallmark NOUN aji-51 134 15 of of ADP aji-51 134 16 cancer cancer NOUN aji-51 134 17 listed list VERB aji-51 134 18 above above ADV aji-51 134 19 , , PUNCT aji-51 134 20 is be AUX aji-51 134 21 now now ADV aji-51 134 22 considered consider VERB aji-51 134 23 downstream downstream ADJ aji-51 134 24 epiphenomena epiphenomena PROPN aji-51 134 25 of of ADP aji-51 134 26 the the DET aji-51 134 27 initial initial ADJ aji-51 134 28 disturbance disturbance NOUN aji-51 134 29 of of ADP aji-51 134 30 cellular cellular ADJ aji-51 134 31 energy energy NOUN aji-51 134 32 metabolism metabolism NOUN aji-51 134 33 which which PRON aji-51 134 34 is be AUX aji-51 134 35 often often ADV aji-51 134 36 caused cause VERB aji-51 134 37 by by ADP aji-51 134 38 a a DET aji-51 134 39 toxin toxin NOUN aji-51 135 1 [ [ X aji-51 135 2 4 4 NUM aji-51 135 3 ] ] PUNCT aji-51 135 4 . . PUNCT aji-51 136 1 the the DET aji-51 136 2 disturbances disturbance NOUN aji-51 136 3 in in ADP aji-51 136 4 tumor tumor NOUN aji-51 136 5 cell cell NOUN aji-51 136 6 energy energy NOUN aji-51 136 7 metabolism metabolism NOUN aji-51 136 8 can can AUX aji-51 136 9 be be AUX aji-51 136 10 linked link VERB aji-51 136 11 to to ADP aji-51 136 12 demonstrated demonstrate VERB aji-51 136 13 abnormalities abnormality NOUN aji-51 136 14 in in ADP aji-51 136 15 the the DET aji-51 136 16 structure structure NOUN aji-51 136 17 and and CCONJ aji-51 136 18 function function NOUN aji-51 136 19 of of ADP aji-51 136 20 and and CCONJ aji-51 136 21 within within ADP aji-51 136 22 the the DET aji-51 136 23 mitochondria mitochondria NOUN aji-51 137 1 [ [ X aji-51 137 2 5 5 NUM aji-51 137 3 - - SYM aji-51 137 4 7 7 NUM aji-51 137 5 ] ] PUNCT aji-51 137 6 . . PUNCT aji-51 138 1 extrapolating extrapolate VERB aji-51 138 2 upon upon SCONJ aji-51 138 3 this this DET aji-51 138 4 research research NOUN aji-51 138 5 we we PRON aji-51 138 6 come come VERB aji-51 138 7 to to ADP aji-51 138 8 several several ADJ aji-51 138 9 conclusions conclusion NOUN aji-51 138 10 for for ADP aji-51 138 11 therapeutic therapeutic ADJ aji-51 138 12 intervention intervention NOUN aji-51 138 13 . . PUNCT aji-51 139 1 glycation glycation NOUN aji-51 139 2 starts start VERB aji-51 139 3 with with ADP aji-51 139 4 diet diet PROPN aji-51 139 5 . . PUNCT aji-51 140 1 diet diet PROPN aji-51 140 2 has have AUX aji-51 140 3 been be AUX aji-51 140 4 recognized recognize VERB aji-51 140 5 and and CCONJ aji-51 140 6 is be AUX aji-51 140 7 now now ADV aji-51 140 8 accepted accept VERB aji-51 140 9 by by ADP aji-51 140 10 mainstream mainstream NOUN aji-51 140 11 medicine medicine NOUN aji-51 140 12 as as ADP aji-51 140 13 a a DET aji-51 140 14 viable viable ADJ aji-51 140 15 strategy strategy NOUN aji-51 140 16 for for ADP aji-51 140 17 minimizing minimize VERB aji-51 140 18 the the DET aji-51 140 19 risk risk NOUN aji-51 140 20 of of ADP aji-51 140 21 getting get VERB aji-51 140 22 cancer cancer NOUN aji-51 141 1 [ [ X aji-51 141 2 8 8 NUM aji-51 141 3 - - SYM aji-51 141 4 10 10 NUM aji-51 141 5 ] ] PUNCT aji-51 141 6 . . PUNCT aji-51 142 1 furthermore furthermore ADV aji-51 142 2 , , PUNCT aji-51 142 3 “ " PUNCT aji-51 142 4 a a DET aji-51 142 5 higher high ADJ aji-51 142 6 frequency frequency NOUN aji-51 142 7 of of ADP aji-51 142 8 organic organic ADJ aji-51 142 9 food food NOUN aji-51 142 10 consumption consumption NOUN aji-51 142 11 was be AUX aji-51 142 12 associated associate VERB aji-51 142 13 with with ADP aji-51 142 14 a a DET aji-51 142 15 reduced reduced ADJ aji-51 142 16 risk risk NOUN aji-51 142 17 of of ADP aji-51 142 18 cancer cancer NOUN aji-51 142 19 ” " PUNCT aji-51 143 1 [ [ X aji-51 143 2 11 11 NUM aji-51 143 3 ] ] PUNCT aji-51 143 4 . . PUNCT aji-51 144 1 a a DET aji-51 144 2 proper proper ADJ aji-51 144 3 diet diet NOUN aji-51 144 4 can can AUX aji-51 144 5 address address VERB aji-51 144 6 issues issue NOUN aji-51 144 7 of of ADP aji-51 144 8 nutritional nutritional ADJ aji-51 144 9 deficiency deficiency NOUN aji-51 144 10 and and CCONJ aji-51 144 11 some some DET aji-51 144 12 toxin toxin NOUN aji-51 144 13 exposure exposure NOUN aji-51 144 14 while while SCONJ aji-51 144 15 supplying supply VERB aji-51 144 16 necessary necessary ADJ aji-51 144 17 anti anti NOUN aji-51 144 18 - - NOUN aji-51 144 19 oxidants oxidant NOUN aji-51 144 20 and and CCONJ aji-51 144 21 helping help VERB aji-51 144 22 to to PART aji-51 144 23 manage manage VERB aji-51 144 24 glycation glycation NOUN aji-51 144 25 ( ( PUNCT aji-51 144 26 while while SCONJ aji-51 144 27 hopefully hopefully ADV aji-51 144 28 being be AUX aji-51 144 29 delicious delicious ADJ aji-51 144 30 ) ) PUNCT aji-51 144 31 . . PUNCT aji-51 145 1 when when SCONJ aji-51 145 2 we we PRON aji-51 145 3 apply apply VERB aji-51 145 4 a a DET aji-51 145 5 dietary dietary ADJ aji-51 145 6 strategy strategy NOUN aji-51 145 7 to to ADP aji-51 145 8 someone someone PRON aji-51 145 9 with with ADP aji-51 145 10 cancer cancer NOUN aji-51 145 11 , , PUNCT aji-51 145 12 while while SCONJ aji-51 145 13 recognizing recognize VERB aji-51 145 14 the the DET aji-51 145 15 dysregulated dysregulated ADJ aji-51 145 16 metabolic metabolic ADJ aji-51 145 17 mitochondrial mitochondrial ADJ aji-51 145 18 foundation foundation NOUN aji-51 145 19 of of ADP aji-51 145 20 the the DET aji-51 145 21 tumors tumor NOUN aji-51 145 22 , , PUNCT aji-51 145 23 we we PRON aji-51 145 24 come come VERB aji-51 145 25 to to ADP aji-51 145 26 a a DET aji-51 145 27 low low ADJ aji-51 145 28 carbohydrate carbohydrate NOUN aji-51 145 29 / / SYM aji-51 145 30 ketogenic ketogenic ADJ aji-51 145 31 diet diet NOUN aji-51 145 32 . . PUNCT aji-51 146 1 because because SCONJ aji-51 146 2 cancer cancer NOUN aji-51 146 3 is be AUX aji-51 146 4 biochemically biochemically ADV aji-51 146 5 dependant dependant ADJ aji-51 146 6 upon upon SCONJ aji-51 146 7 sugar sugar NOUN aji-51 146 8 to to PART aji-51 146 9 maintain maintain VERB aji-51 146 10 its its PRON aji-51 146 11 fermentation fermentation NOUN aji-51 146 12 metabolism metabolism NOUN aji-51 146 13 , , PUNCT aji-51 146 14 depriving deprive VERB aji-51 146 15 it it PRON aji-51 146 16 as as ADV aji-51 146 17 much much ADV aji-51 146 18 as as ADP aji-51 146 19 possible possible ADJ aji-51 146 20 , , PUNCT aji-51 146 21 of of ADP aji-51 146 22 sugar sugar NOUN aji-51 146 23 will will AUX aji-51 146 24 further far ADV aji-51 146 25 destabilize destabilize VERB aji-51 146 26 the the DET aji-51 146 27 cancer cancer NOUN aji-51 146 28 cells cell NOUN aji-51 146 29 making make VERB aji-51 146 30 it it PRON aji-51 146 31 easier easy ADJ aji-51 146 32 to to PART aji-51 146 33 trigger trigger VERB aji-51 146 34 apoptosis apoptosis NOUN aji-51 146 35 , , PUNCT aji-51 146 36 with with ADP aji-51 146 37 the the DET aji-51 146 38 addition addition NOUN aji-51 146 39 of of ADP aji-51 146 40 other other ADJ aji-51 146 41 therapeutic therapeutic ADJ aji-51 146 42 agents agent NOUN aji-51 146 43 [ [ X aji-51 146 44 12,13 12,13 NUM aji-51 146 45 ] ] PUNCT aji-51 146 46 . . PUNCT aji-51 147 1 one one NUM aji-51 147 2 of of ADP aji-51 147 3 those those DET aji-51 147 4 therapeutic therapeutic ADJ aji-51 147 5 agents agent NOUN aji-51 147 6 is be AUX aji-51 147 7 metformin metformin NOUN aji-51 147 8 . . PUNCT aji-51 148 1 in in ADP aji-51 148 2 addition addition NOUN aji-51 148 3 to to ADP aji-51 148 4 stoff stoff PROPN aji-51 148 5 ; ; PUNCT aji-51 148 6 aji aji PROPN aji-51 148 7 , , PUNCT aji-51 148 8 5(1 5(1 NUM aji-51 148 9 ): ): PUNCT aji-51 148 10 1 1 NUM aji-51 148 11 - - SYM aji-51 148 12 39 39 NUM aji-51 148 13 , , PUNCT aji-51 148 14 2022 2022 NUM aji-51 148 15 ; ; PUNCT aji-51 148 16 article article NOUN aji-51 148 17 no.aji.77967 no.aji.77967 NOUN aji-51 148 18 3 3 NUM aji-51 148 19 lowering lower VERB aji-51 148 20 blood blood NOUN aji-51 148 21 sugar sugar NOUN aji-51 148 22 levels level NOUN aji-51 148 23 and and CCONJ aji-51 148 24 thus thus ADV aji-51 148 25 minimizing minimize VERB aji-51 148 26 the the DET aji-51 148 27 fuel fuel NOUN aji-51 148 28 source source NOUN aji-51 148 29 for for ADP aji-51 148 30 cancer cancer NOUN aji-51 148 31 cells cell NOUN aji-51 148 32 , , PUNCT aji-51 148 33 metformin metformin NOUN aji-51 148 34 interferes interfere VERB aji-51 148 35 directly directly ADV aji-51 148 36 with with ADP aji-51 148 37 cell cell NOUN aji-51 148 38 proliferation proliferation NOUN aji-51 148 39 and and CCONJ aji-51 148 40 supports support VERB aji-51 148 41 apoptosis apoptosis NOUN aji-51 148 42 in in ADP aji-51 148 43 a a DET aji-51 148 44 non non ADJ aji-51 148 45 - - ADJ aji-51 148 46 insulin insulin ADJ aji-51 148 47 - - PUNCT aji-51 148 48 mediated mediate VERB aji-51 148 49 manner manner NOUN aji-51 148 50 . . PUNCT aji-51 149 1 accumulated accumulate VERB aji-51 149 2 research research NOUN aji-51 149 3 and and CCONJ aji-51 149 4 clinical clinical ADJ aji-51 149 5 evidence evidence NOUN aji-51 149 6 suggest suggest VERB aji-51 149 7 that that SCONJ aji-51 149 8 metformin metformin NOUN aji-51 149 9 exerts exert VERB aji-51 149 10 its its PRON aji-51 149 11 positive positive ADJ aji-51 149 12 effect effect NOUN aji-51 149 13 on on ADP aji-51 149 14 the the DET aji-51 149 15 clinical clinical ADJ aji-51 149 16 course course NOUN aji-51 149 17 of of ADP aji-51 149 18 neoplastic neoplastic ADJ aji-51 149 19 diseases disease NOUN aji-51 149 20 , , PUNCT aji-51 149 21 primarily primarily ADV aji-51 149 22 through through ADP aji-51 149 23 the the DET aji-51 149 24 stimulation stimulation NOUN aji-51 149 25 of of ADP aji-51 149 26 5 5 NUM aji-51 149 27 ' ' PART aji-51 149 28 amp amp NOUN aji-51 149 29 - - PUNCT aji-51 149 30 activated activate VERB aji-51 149 31 protein protein NOUN aji-51 149 32 kinase kinase NOUN aji-51 149 33 ( ( PUNCT aji-51 149 34 ampk ampk PROPN aji-51 149 35 ) ) PUNCT aji-51 149 36 in in ADP aji-51 149 37 association association NOUN aji-51 149 38 with with ADP aji-51 149 39 the the DET aji-51 149 40 upstream upstream ADJ aji-51 149 41 liver liver PROPN aji-51 149 42 kinase kinase PROPN aji-51 149 43 b1 b1 PROPN aji-51 149 44 ( ( PUNCT aji-51 149 45 lkb1 lkb1 PROPN aji-51 149 46 ) ) PUNCT aji-51 150 1 [ [ X aji-51 150 2 14,15 14,15 NUM aji-51 150 3 ] ] PUNCT aji-51 150 4 . . PUNCT aji-51 151 1 ampk ampk NOUN aji-51 151 2 is be AUX aji-51 151 3 a a DET aji-51 151 4 key key ADJ aji-51 151 5 cellular cellular ADJ aji-51 151 6 energy energy NOUN aji-51 151 7 sensor sensor NOUN aji-51 151 8 , , PUNCT aji-51 151 9 activation activation NOUN aji-51 151 10 of of ADP aji-51 151 11 which which PRON aji-51 151 12 by by ADP aji-51 151 13 metformin metformin NOUN aji-51 151 14 leads lead VERB aji-51 151 15 to to ADP aji-51 151 16 suppression suppression NOUN aji-51 151 17 of of ADP aji-51 151 18 energy energy NOUN aji-51 151 19 - - PUNCT aji-51 151 20 consuming consume VERB aji-51 151 21 processes process NOUN aji-51 151 22 such such ADJ aji-51 151 23 as as ADP aji-51 151 24 gluconeogenesis gluconeogenesis NOUN aji-51 151 25 [ [ X aji-51 151 26 16,17 16,17 NUM aji-51 151 27 ] ] PUNCT aji-51 151 28 . . PUNCT aji-51 152 1 in in ADP aji-51 152 2 carcinoma carcinoma NOUN aji-51 152 3 cells cell NOUN aji-51 152 4 , , PUNCT aji-51 152 5 the the DET aji-51 152 6 stimulation stimulation NOUN aji-51 152 7 of of ADP aji-51 152 8 ampk ampk NOUN aji-51 152 9 , , PUNCT aji-51 152 10 mediated mediate VERB aji-51 152 11 by by ADP aji-51 152 12 metformin metformin NOUN aji-51 152 13 , , PUNCT aji-51 152 14 resulted result VERB aji-51 152 15 in in ADP aji-51 152 16 the the DET aji-51 152 17 inhibition inhibition NOUN aji-51 152 18 of of ADP aji-51 152 19 the the DET aji-51 152 20 mtor mtor NOUN aji-51 152 21 / / SYM aji-51 152 22 ribosomal ribosomal PROPN aji-51 152 23 s6 s6 PROPN aji-51 152 24 kinase kinase PROPN aji-51 152 25 pathway pathway NOUN aji-51 152 26 and and CCONJ aji-51 152 27 thus thus ADV aji-51 152 28 inhibition inhibition NOUN aji-51 152 29 of of ADP aji-51 152 30 the the DET aji-51 152 31 pathological pathological ADJ aji-51 152 32 cell cell NOUN aji-51 152 33 cycle cycle NOUN aji-51 152 34 progression progression NOUN aji-51 152 35 , , PUNCT aji-51 152 36 cell cell NOUN aji-51 152 37 growth growth NOUN aji-51 152 38 , , PUNCT aji-51 152 39 and and CCONJ aji-51 152 40 angiogenesis angiogenesis NOUN aji-51 153 1 [ [ X aji-51 153 2 18,19 18,19 NUM aji-51 153 3 ] ] PUNCT aji-51 153 4 . . PUNCT aji-51 154 1 this this PRON aji-51 154 2 is be AUX aji-51 154 3 a a DET aji-51 154 4 particularly particularly ADV aji-51 154 5 important important ADJ aji-51 154 6 effect effect NOUN aji-51 154 7 when when SCONJ aji-51 154 8 there there PRON aji-51 154 9 is be VERB aji-51 154 10 a a DET aji-51 154 11 mutation mutation NOUN aji-51 154 12 of of ADP aji-51 154 13 phosphatase phosphatase NOUN aji-51 154 14 and and CCONJ aji-51 154 15 tensin tensin PROPN aji-51 154 16 homolog homolog PROPN aji-51 154 17 ( ( PUNCT aji-51 154 18 pten pten NOUN aji-51 154 19 ) ) PUNCT aji-51 154 20 which which PRON aji-51 154 21 would would AUX aji-51 154 22 normally normally ADV aji-51 154 23 downregulate downregulate VERB aji-51 154 24 this this DET aji-51 154 25 pathway pathway NOUN aji-51 155 1 [ [ X aji-51 155 2 20 20 NUM aji-51 155 3 ] ] PUNCT aji-51 155 4 . . PUNCT aji-51 156 1 inflammation inflammation NOUN aji-51 156 2 is be AUX aji-51 156 3 another another DET aji-51 156 4 metabolic metabolic NOUN aji-51 156 5 pathway pathway NOUN aji-51 156 6 that that PRON aji-51 156 7 drives drive VERB aji-51 156 8 cancer cancer NOUN aji-51 156 9 , , PUNCT aji-51 156 10 therefore therefore ADV aji-51 156 11 , , PUNCT aji-51 156 12 anti anti ADJ aji-51 156 13 - - ADJ aji-51 156 14 inflammatory inflammatory ADJ aji-51 156 15 strategies strategy NOUN aji-51 156 16 are be AUX aji-51 156 17 of of ADP aji-51 156 18 critical critical ADJ aji-51 156 19 importance importance NOUN aji-51 156 20 against against ADP aji-51 156 21 cancer cancer NOUN aji-51 156 22 [ [ X aji-51 156 23 21 21 NUM aji-51 156 24 ] ] PUNCT aji-51 156 25 . . PUNCT aji-51 157 1 inflammation inflammation NOUN aji-51 157 2 results result VERB aji-51 157 3 from from ADP aji-51 157 4 or or CCONJ aji-51 157 5 is be AUX aji-51 157 6 triggered trigger VERB aji-51 157 7 by by ADP aji-51 157 8 virtually virtually ADV aji-51 157 9 every every DET aji-51 157 10 disease disease NOUN aji-51 157 11 known know VERB aji-51 157 12 to to ADP aji-51 157 13 man man VERB aji-51 157 14 and and CCONJ aji-51 157 15 has have VERB aji-51 157 16 cellular cellular ADJ aji-51 157 17 pathways pathway NOUN aji-51 157 18 , , PUNCT aji-51 157 19 plasma plasma NOUN aji-51 157 20 cascades cascade NOUN aji-51 157 21 , , PUNCT aji-51 157 22 and and CCONJ aji-51 157 23 acute acute ADJ aji-51 157 24 and and CCONJ aji-51 157 25 chronic chronic ADJ aji-51 157 26 markers marker NOUN aji-51 157 27 . . PUNCT aji-51 158 1 some some PRON aji-51 158 2 of of ADP aji-51 158 3 the the DET aji-51 158 4 markers marker NOUN aji-51 158 5 associated associate VERB aji-51 158 6 with with ADP aji-51 158 7 cancer cancer NOUN aji-51 158 8 include include VERB aji-51 158 9 crp crp PROPN aji-51 158 10 , , PUNCT aji-51 158 11 il-6 il-6 PRON aji-51 158 12 , , PUNCT aji-51 158 13 il-8 il-8 NOUN aji-51 158 14 , , PUNCT aji-51 158 15 and and CCONJ aji-51 158 16 tnf tnf PROPN aji-51 158 17 - - PUNCT aji-51 158 18 alpha alpha NOUN aji-51 158 19 . . PUNCT aji-51 159 1 inflammation inflammation NOUN aji-51 159 2 can can AUX aji-51 159 3 stimulate stimulate VERB aji-51 159 4 cancer cancer NOUN aji-51 159 5 stem stem NOUN aji-51 159 6 cells cell NOUN aji-51 159 7 as as ADV aji-51 159 8 well well ADV aji-51 159 9 as as ADP aji-51 159 10 more more ADV aji-51 159 11 mature mature ADJ aji-51 159 12 tumor tumor NOUN aji-51 159 13 cells cell NOUN aji-51 159 14 , , PUNCT aji-51 159 15 triggering trigger VERB aji-51 159 16 disease disease NOUN aji-51 159 17 progression progression NOUN aji-51 159 18 . . PUNCT aji-51 160 1 inflammation inflammation NOUN aji-51 160 2 is be AUX aji-51 160 3 a a DET aji-51 160 4 defense defense NOUN aji-51 160 5 mechanism mechanism NOUN aji-51 160 6 that that PRON aji-51 160 7 serves serve VERB aji-51 160 8 to to PART aji-51 160 9 protect protect VERB aji-51 160 10 us we PRON aji-51 160 11 from from ADP aji-51 160 12 acute acute ADJ aji-51 160 13 inflammatory inflammatory ADJ aji-51 160 14 illnesses illness NOUN aji-51 160 15 ( ( PUNCT aji-51 160 16 infections infection NOUN aji-51 160 17 ) ) PUNCT aji-51 160 18 and and CCONJ aji-51 160 19 injuries injury NOUN aji-51 160 20 that that SCONJ aji-51 160 21 historically historically ADV aji-51 160 22 , , PUNCT aji-51 160 23 from from ADP aji-51 160 24 an an DET aji-51 160 25 evolutionary evolutionary ADJ aji-51 160 26 point point NOUN aji-51 160 27 of of ADP aji-51 160 28 view view NOUN aji-51 160 29 , , PUNCT aji-51 160 30 were be AUX aji-51 160 31 the the DET aji-51 160 32 main main ADJ aji-51 160 33 causes cause NOUN aji-51 160 34 of of ADP aji-51 160 35 death death NOUN aji-51 160 36 . . PUNCT aji-51 161 1 inflammatory inflammatory ADJ aji-51 161 2 proteins protein NOUN aji-51 161 3 activate activate VERB aji-51 161 4 the the DET aji-51 161 5 th2 th2 PROPN aji-51 161 6 pathway pathway NOUN aji-51 161 7 which which PRON aji-51 161 8 generates generate VERB aji-51 161 9 more more ADJ aji-51 161 10 inflammation inflammation NOUN aji-51 161 11 . . PUNCT aji-51 162 1 in in ADP aji-51 162 2 doing do VERB aji-51 162 3 so so ADV aji-51 162 4 , , PUNCT aji-51 162 5 in in ADP aji-51 162 6 an an DET aji-51 162 7 apparent apparent ADJ aji-51 162 8 effort effort NOUN aji-51 162 9 to to PART aji-51 162 10 focus focus VERB aji-51 162 11 and and CCONJ aji-51 162 12 conserve conserve VERB aji-51 162 13 resources resource NOUN aji-51 162 14 , , PUNCT aji-51 162 15 when when SCONJ aji-51 162 16 the the DET aji-51 162 17 th2 th2 PROPN aji-51 162 18 pathway pathway NOUN aji-51 162 19 becomes becomes AUX aji-51 162 20 chronically chronically ADV aji-51 162 21 stimulated stimulate VERB aji-51 162 22 by by ADP aji-51 162 23 infection infection NOUN aji-51 162 24 , , PUNCT aji-51 162 25 vaccinations vaccination NOUN aji-51 162 26 , , PUNCT aji-51 162 27 nutritional nutritional ADJ aji-51 162 28 deficiency deficiency NOUN aji-51 162 29 , , PUNCT aji-51 162 30 sugar sugar NOUN aji-51 162 31 , , PUNCT aji-51 162 32 alcohol alcohol NOUN aji-51 162 33 , , PUNCT aji-51 162 34 trauma trauma NOUN aji-51 162 35 , , PUNCT aji-51 162 36 stress stress NOUN aji-51 162 37 , , PUNCT aji-51 162 38 or or CCONJ aji-51 162 39 toxins toxin NOUN aji-51 162 40 , , PUNCT aji-51 162 41 it it PRON aji-51 162 42 suppresses suppress VERB aji-51 162 43 the the DET aji-51 162 44 th1 th1 NOUN aji-51 162 45 pathway pathway NOUN aji-51 162 46 which which PRON aji-51 162 47 is be AUX aji-51 162 48 a a DET aji-51 162 49 critical critical ADJ aji-51 162 50 pathway pathway NOUN aji-51 162 51 of of ADP aji-51 162 52 the the DET aji-51 162 53 immune immune ADJ aji-51 162 54 system system NOUN aji-51 162 55 , , PUNCT aji-51 162 56 needed need VERB aji-51 162 57 to to PART aji-51 162 58 protect protect VERB aji-51 162 59 us we PRON aji-51 162 60 from from ADP aji-51 162 61 , , PUNCT aji-51 162 62 and and CCONJ aji-51 162 63 fight fight VERB aji-51 162 64 cancer cancer NOUN aji-51 162 65 . . PUNCT aji-51 163 1 cimetidine cimetidine PROPN aji-51 163 2 can can AUX aji-51 163 3 help help VERB aji-51 163 4 to to PART aji-51 163 5 restore restore VERB aji-51 163 6 the the DET aji-51 163 7 th1 th1 PROPN aji-51 163 8 / / SYM aji-51 163 9 th2 th2 PROPN aji-51 163 10 balance balance NOUN aji-51 163 11 and and CCONJ aji-51 163 12 overcome overcome VERB aji-51 163 13 pro pro ADJ aji-51 163 14 - - ADJ aji-51 163 15 inflammatory inflammatory ADJ aji-51 163 16 th2 th2 PROPN aji-51 163 17 dominance dominance NOUN aji-51 164 1 [ [ X aji-51 164 2 22 22 NUM aji-51 164 3 ] ] PUNCT aji-51 164 4 . . PUNCT aji-51 165 1 activation activation NOUN aji-51 165 2 of of ADP aji-51 165 3 the the DET aji-51 165 4 th1 th1 NOUN aji-51 165 5 pathway pathway NOUN aji-51 165 6 and and CCONJ aji-51 165 7 its its PRON aji-51 165 8 downstream downstream ADJ aji-51 165 9 effector effector NOUN aji-51 165 10 cells cell NOUN aji-51 165 11 results result VERB aji-51 165 12 in in ADP aji-51 165 13 the the DET aji-51 165 14 production production NOUN aji-51 165 15 of of ADP aji-51 165 16 reactive reactive ADJ aji-51 165 17 oxygen oxygen NOUN aji-51 165 18 species specie NOUN aji-51 165 19 ( ( PUNCT aji-51 165 20 ros ros PROPN aji-51 165 21 ) ) PUNCT aji-51 165 22 . . PUNCT aji-51 166 1 which which PRON aji-51 166 2 are be AUX aji-51 166 3 inflammatory inflammatory ADJ aji-51 166 4 molecules molecule NOUN aji-51 166 5 that that PRON aji-51 166 6 act act VERB aji-51 166 7 locally locally ADV aji-51 166 8 to to PART aji-51 166 9 kill kill VERB aji-51 166 10 cancer cancer NOUN aji-51 166 11 cells cell NOUN aji-51 166 12 , , PUNCT aji-51 166 13 so so SCONJ aji-51 166 14 we we PRON aji-51 166 15 do do AUX aji-51 166 16 n’t not PART aji-51 166 17 want want VERB aji-51 166 18 to to PART aji-51 166 19 negate negate VERB aji-51 166 20 all all DET aji-51 166 21 inflammatory inflammatory ADJ aji-51 166 22 responses response NOUN aji-51 166 23 [ [ X aji-51 166 24 23 23 NUM aji-51 166 25 ] ] PUNCT aji-51 166 26 . . PUNCT aji-51 167 1 an an DET aji-51 167 2 important important ADJ aji-51 167 3 enzyme enzyme NOUN aji-51 167 4 for for ADP aji-51 167 5 the the DET aji-51 167 6 inflammatory inflammatory ADJ aji-51 167 7 response response NOUN aji-51 167 8 is be AUX aji-51 167 9 cyclooxygenase cyclooxygenase NOUN aji-51 167 10 ( ( PUNCT aji-51 167 11 cox cox PROPN aji-51 167 12 ) ) PUNCT aji-51 167 13 , , PUNCT aji-51 167 14 which which PRON aji-51 167 15 is be AUX aji-51 167 16 critical critical ADJ aji-51 167 17 for for ADP aji-51 167 18 the the DET aji-51 167 19 conversion conversion NOUN aji-51 167 20 of of ADP aji-51 167 21 arachidonic arachidonic ADJ aji-51 167 22 acid acid NOUN aji-51 167 23 to to ADP aji-51 167 24 prostaglandins prostaglandin NOUN aji-51 167 25 and and CCONJ aji-51 167 26 other other ADJ aji-51 167 27 eicosanoids eicosanoid NOUN aji-51 167 28 . . PUNCT aji-51 168 1 it it PRON aji-51 168 2 exists exist VERB aji-51 168 3 as as SCONJ aji-51 168 4 two two NUM aji-51 168 5 isoforms isoform NOUN aji-51 168 6 : : PUNCT aji-51 168 7 cox-1 cox-1 X aji-51 168 8 and and CCONJ aji-51 168 9 cox-2 cox-2 NUM aji-51 168 10 ; ; PUNCT aji-51 168 11 cox-1 cox-1 PUNCT aji-51 168 12 is be AUX aji-51 168 13 constitutively constitutively ADV aji-51 168 14 expressed express VERB aji-51 168 15 whereas whereas SCONJ aji-51 168 16 cox-2 cox-2 ADV aji-51 168 17 is be AUX aji-51 168 18 a a DET aji-51 168 19 highly highly ADV aji-51 168 20 inducible inducible ADJ aji-51 168 21 gene gene NOUN aji-51 168 22 that that PRON aji-51 168 23 is be AUX aji-51 168 24 activated activate VERB aji-51 168 25 by by ADP aji-51 168 26 cytokines cytokine NOUN aji-51 168 27 , , PUNCT aji-51 168 28 growth growth NOUN aji-51 168 29 factors factor NOUN aji-51 168 30 , , PUNCT aji-51 168 31 phorbol phorbol ADJ aji-51 168 32 esters ester NOUN aji-51 168 33 , , PUNCT aji-51 168 34 oncogens oncogen NOUN aji-51 168 35 , , PUNCT aji-51 168 36 and and CCONJ aji-51 168 37 chemical chemical NOUN aji-51 168 38 carcinogens carcinogen NOUN aji-51 168 39 . . PUNCT aji-51 169 1 cox-2 cox-2 NOUN aji-51 169 2 plays play VERB aji-51 169 3 a a DET aji-51 169 4 key key ADJ aji-51 169 5 role role NOUN aji-51 169 6 in in ADP aji-51 169 7 carcinogenesis carcinogenesis NOUN aji-51 169 8 as as SCONJ aji-51 169 9 has have AUX aji-51 169 10 been be AUX aji-51 169 11 demonstrated demonstrate VERB aji-51 169 12 in in ADP aji-51 169 13 numerous numerous ADJ aji-51 169 14 cancer cancer NOUN aji-51 169 15 cell cell NOUN aji-51 169 16 types type NOUN aji-51 169 17 . . PUNCT aji-51 170 1 multiple multiple ADJ aji-51 170 2 pathways pathway NOUN aji-51 170 3 have have AUX aji-51 170 4 been be AUX aji-51 170 5 proposed propose VERB aji-51 170 6 to to PART aji-51 170 7 explain explain VERB aji-51 170 8 how how SCONJ aji-51 170 9 increased increase VERB aji-51 170 10 cox-2 cox-2 ADJ aji-51 170 11 expression expression NOUN aji-51 170 12 might might AUX aji-51 170 13 contribute contribute VERB aji-51 170 14 to to ADP aji-51 170 15 carcinogenesis carcinogenesis NOUN aji-51 170 16 including include VERB aji-51 170 17 elevated elevate VERB aji-51 170 18 bcl-2 bcl-2 VERB aji-51 170 19 protein protein NOUN aji-51 170 20 levels level NOUN aji-51 170 21 and and CCONJ aji-51 170 22 inhibition inhibition NOUN aji-51 170 23 of of ADP aji-51 170 24 apoptosis apoptosis NOUN aji-51 170 25 , , PUNCT aji-51 170 26 increased increased ADJ aji-51 170 27 angiogenesis angiogenesis NOUN aji-51 170 28 , , PUNCT aji-51 170 29 and and CCONJ aji-51 170 30 enhanced enhance VERB aji-51 170 31 metastatic metastatic ADJ aji-51 170 32 activity activity NOUN aji-51 170 33 . . PUNCT aji-51 171 1 suppressing suppress VERB aji-51 171 2 cox-2 cox-2 ADJ aji-51 171 3 activity activity NOUN aji-51 171 4 , , PUNCT aji-51 171 5 or or CCONJ aji-51 171 6 at at ADP aji-51 171 7 least least ADJ aji-51 171 8 not not PART aji-51 171 9 stimulating stimulate VERB aji-51 171 10 it it PRON aji-51 171 11 , , PUNCT aji-51 171 12 which which PRON aji-51 171 13 many many ADJ aji-51 171 14 chemotherapeutic chemotherapeutic ADJ aji-51 171 15 agents agent NOUN aji-51 171 16 do do VERB aji-51 171 17 , , PUNCT aji-51 171 18 is be AUX aji-51 171 19 an an DET aji-51 171 20 important important ADJ aji-51 171 21 part part NOUN aji-51 171 22 of of ADP aji-51 171 23 any any DET aji-51 171 24 anticancer anticancer NOUN aji-51 171 25 strategy strategy NOUN aji-51 171 26 . . PUNCT aji-51 172 1 many many ADJ aji-51 172 2 agents agent NOUN aji-51 172 3 have have AUX aji-51 172 4 been be AUX aji-51 172 5 identified identify VERB aji-51 172 6 that that PRON aji-51 172 7 suppress suppress VERB aji-51 172 8 cox-2 cox-2 ADJ aji-51 172 9 activity activity NOUN aji-51 172 10 , , PUNCT aji-51 172 11 which which PRON aji-51 172 12 can can AUX aji-51 172 13 be be AUX aji-51 172 14 assayed assay VERB aji-51 172 15 in in ADP aji-51 172 16 vitro vitro X aji-51 172 17 and and CCONJ aji-51 172 18 is be AUX aji-51 172 19 reflected reflect VERB aji-51 172 20 clinically clinically ADV aji-51 172 21 in in ADP aji-51 172 22 decreased decrease VERB aji-51 172 23 levels level NOUN aji-51 172 24 of of ADP aji-51 172 25 crp crp PROPN aji-51 172 26 , , PUNCT aji-51 172 27 interleukin6 interleukin6 PROPN aji-51 172 28 ( ( PUNCT aji-51 172 29 il-6 il-6 NUM aji-51 172 30 ) ) PUNCT aji-51 172 31 , , PUNCT aji-51 172 32 p p NOUN aji-51 172 33 - - PUNCT aji-51 172 34 selectin selectin NOUN aji-51 172 35 , , PUNCT aji-51 172 36 matrix matrix NOUN aji-51 172 37 metalloproteinase-9 metalloproteinase-9 NUM aji-51 172 38 ( ( PUNCT aji-51 172 39 mmp-9 mmp-9 NUM aji-51 172 40 ) ) PUNCT aji-51 172 41 , , PUNCT aji-51 172 42 tumor tumor NOUN aji-51 172 43 necrosis necrosis NOUN aji-51 172 44 factor factor NOUN aji-51 172 45 ( ( PUNCT aji-51 172 46 tnf tnf PROPN aji-51 172 47 - - PUNCT aji-51 172 48 α α NOUN aji-51 172 49 ) ) PUNCT aji-51 172 50 , , PUNCT aji-51 172 51 and and CCONJ aji-51 172 52 other other ADJ aji-51 172 53 inflammatory inflammatory ADJ aji-51 172 54 markers marker NOUN aji-51 172 55 . . PUNCT aji-51 173 1 some some PRON aji-51 173 2 of of ADP aji-51 173 3 the the DET aji-51 173 4 antiinflammatory antiinflammatory NOUN aji-51 173 5 agents agent NOUN aji-51 173 6 that that PRON aji-51 173 7 are be AUX aji-51 173 8 helpful helpful ADJ aji-51 173 9 against against ADP aji-51 173 10 cancer cancer NOUN aji-51 173 11 include include VERB aji-51 173 12 celecoxib celecoxib NOUN aji-51 173 13 , , PUNCT aji-51 173 14 fish fish NOUN aji-51 173 15 oil oil NOUN aji-51 173 16 , , PUNCT aji-51 173 17 ( ( PUNCT aji-51 173 18 eicosapentaenoic eicosapentaenoic ADJ aji-51 173 19 acid acid NOUN aji-51 173 20 ( ( PUNCT aji-51 173 21 epa epa PROPN aji-51 173 22 ) ) PUNCT aji-51 173 23 and and CCONJ aji-51 173 24 docosahexaenoic docosahexaenoic ADJ aji-51 173 25 acid acid NOUN aji-51 173 26 ( ( PUNCT aji-51 173 27 dha dha PROPN aji-51 173 28 ) ) PUNCT aji-51 173 29 ) ) PUNCT aji-51 173 30 , , PUNCT aji-51 173 31 white white ADJ aji-51 173 32 willow willow NOUN aji-51 173 33 tree tree NOUN aji-51 173 34 , , PUNCT aji-51 173 35 curcumin curcumin NOUN aji-51 173 36 , , PUNCT aji-51 173 37 green green ADJ aji-51 173 38 tea tea NOUN aji-51 173 39 , , PUNCT aji-51 173 40 pycnogenol pycnogenol NOUN aji-51 173 41 , , PUNCT aji-51 173 42 boswellia boswellia PROPN aji-51 173 43 , , PUNCT aji-51 173 44 resveratrol resveratrol NOUN aji-51 173 45 , , PUNCT aji-51 173 46 cats cat NOUN aji-51 173 47 claw claw NOUN aji-51 173 48 , , PUNCT aji-51 173 49 and and CCONJ aji-51 173 50 capsaicin capsaicin NOUN aji-51 173 51 to to PART aji-51 173 52 name name VERB aji-51 173 53 just just ADV aji-51 173 54 a a DET aji-51 173 55 few few ADJ aji-51 173 56 of of ADP aji-51 173 57 the the DET aji-51 173 58 most most ADV aji-51 173 59 common common ADJ aji-51 173 60 medicaments[24 medicaments[24 NOUN aji-51 173 61 - - PUNCT aji-51 173 62 49 49 NUM aji-51 173 63 ] ] PUNCT aji-51 173 64 . . PUNCT aji-51 174 1 methylation methylation NOUN aji-51 174 2 seems seem VERB aji-51 174 3 to to PART aji-51 174 4 still still ADV aji-51 174 5 be be AUX aji-51 174 6 incompletely incompletely ADV aji-51 174 7 understood understand VERB aji-51 174 8 when when SCONJ aji-51 174 9 it it PRON aji-51 174 10 comes come VERB aji-51 174 11 to to ADP aji-51 174 12 cancer cancer NOUN aji-51 174 13 . . PUNCT aji-51 175 1 on on ADP aji-51 175 2 the the DET aji-51 175 3 one one NUM aji-51 175 4 hand hand NOUN aji-51 175 5 , , PUNCT aji-51 175 6 people people NOUN aji-51 175 7 with with ADP aji-51 175 8 the the DET aji-51 175 9 fairly fairly ADV aji-51 175 10 common common ADJ aji-51 175 11 methylenetetrahydrofolate methylenetetrahydrofolate ADJ aji-51 175 12 reductase reductase NOUN aji-51 175 13 ( ( PUNCT aji-51 175 14 mthfr mthfr NOUN aji-51 175 15 ) ) PUNCT aji-51 175 16 mutation mutation NOUN aji-51 175 17 are be AUX aji-51 175 18 at at ADP aji-51 175 19 a a DET aji-51 175 20 higher high ADJ aji-51 175 21 risk risk NOUN aji-51 175 22 of of ADP aji-51 175 23 getting get VERB aji-51 175 24 certain certain ADJ aji-51 175 25 ( ( PUNCT aji-51 175 26 and and CCONJ aji-51 175 27 maybe maybe ADV aji-51 175 28 all all DET aji-51 175 29 ) ) PUNCT aji-51 175 30 cancers cancer NOUN aji-51 175 31 [ [ X aji-51 175 32 50 50 NUM aji-51 175 33 ] ] PUNCT aji-51 175 34 . . PUNCT aji-51 176 1 this this PRON aji-51 176 2 makes make VERB aji-51 176 3 sense sense NOUN aji-51 176 4 because because SCONJ aji-51 176 5 that that DET aji-51 176 6 gene gene NOUN aji-51 176 7 affects affect VERB aji-51 176 8 some some PRON aji-51 176 9 of of ADP aji-51 176 10 the the DET aji-51 176 11 liver liver NOUN aji-51 176 12 detox detox NOUN aji-51 176 13 pathways pathway NOUN aji-51 176 14 and and CCONJ aji-51 176 15 when when SCONJ aji-51 176 16 it it PRON aji-51 176 17 is be AUX aji-51 176 18 n’t not PART aji-51 176 19 working work VERB aji-51 176 20 well well INTJ aji-51 176 21 it it PRON aji-51 176 22 can can AUX aji-51 176 23 lead lead VERB aji-51 176 24 to to ADP aji-51 176 25 known know VERB aji-51 176 26 increased increase VERB aji-51 176 27 risks risk NOUN aji-51 176 28 for for ADP aji-51 176 29 cardiovascular cardiovascular ADJ aji-51 176 30 heart heart NOUN aji-51 176 31 disease disease NOUN aji-51 176 32 , , PUNCT aji-51 176 33 leukemia leukemia NOUN aji-51 176 34 , , PUNCT aji-51 176 35 breast breast NOUN aji-51 176 36 cancer cancer NOUN aji-51 176 37 , , PUNCT aji-51 176 38 colon colon NOUN aji-51 176 39 cancer cancer NOUN aji-51 176 40 , , PUNCT aji-51 176 41 and and CCONJ aji-51 176 42 many many ADJ aji-51 176 43 other other ADJ aji-51 176 44 illnesses illness NOUN aji-51 176 45 [ [ X aji-51 176 46 51 51 NUM aji-51 176 47 ] ] PUNCT aji-51 176 48 . . PUNCT aji-51 177 1 the the DET aji-51 177 2 mutation mutation NOUN aji-51 177 3 can can AUX aji-51 177 4 be be AUX aji-51 177 5 tested test VERB aji-51 177 6 for for ADP aji-51 177 7 and and CCONJ aji-51 177 8 some some PRON aji-51 177 9 of of ADP aji-51 177 10 its its PRON aji-51 177 11 effects effect NOUN aji-51 177 12 monitored monitor VERB aji-51 177 13 with with ADP aji-51 177 14 homocysteine homocysteine ADJ aji-51 177 15 blood blood NOUN aji-51 177 16 levels level NOUN aji-51 177 17 . . PUNCT aji-51 178 1 many many ADJ aji-51 178 2 of of ADP aji-51 178 3 the the DET aji-51 178 4 negative negative ADJ aji-51 178 5 effects effect NOUN aji-51 178 6 can can AUX aji-51 178 7 be be AUX aji-51 178 8 bypassed bypass VERB aji-51 178 9 with with ADP aji-51 178 10 methylated methylate VERB aji-51 178 11 b b NOUN aji-51 178 12 vitamins vitamin NOUN aji-51 178 13 . . PUNCT aji-51 179 1 on on ADP aji-51 179 2 the the DET aji-51 179 3 other other ADJ aji-51 179 4 hand hand NOUN aji-51 179 5 , , PUNCT aji-51 179 6 gene gene NOUN aji-51 179 7 expression expression NOUN aji-51 179 8 can can AUX aji-51 179 9 be be AUX aji-51 179 10 significantly significantly ADV aji-51 179 11 modulated modulate VERB aji-51 179 12 by by ADP aji-51 179 13 alterations alteration NOUN aji-51 179 14 in in ADP aji-51 179 15 dna dna PROPN aji-51 179 16 methylation methylation NOUN aji-51 179 17 patterns pattern NOUN aji-51 179 18 . . PUNCT aji-51 180 1 methylation methylation NOUN aji-51 180 2 within within ADP aji-51 180 3 the the DET aji-51 180 4 promoter promoter NOUN aji-51 180 5 regions region NOUN aji-51 180 6 of of ADP aji-51 180 7 tumor tumor NOUN aji-51 180 8 suppressor suppressor NOUN aji-51 180 9 genes gene NOUN aji-51 180 10 causes cause VERB aji-51 180 11 their their PRON aji-51 180 12 silencing silencing NOUN aji-51 180 13 , , PUNCT aji-51 180 14 and and CCONJ aji-51 180 15 methylation methylation NOUN aji-51 180 16 within within ADP aji-51 180 17 the the DET aji-51 180 18 gene gene NOUN aji-51 180 19 itself itself PRON aji-51 180 20 can can AUX aji-51 180 21 induce induce VERB aji-51 180 22 mutational mutational ADJ aji-51 180 23 events event NOUN aji-51 180 24 . . PUNCT aji-51 181 1 these these DET aji-51 181 2 mechanisms mechanism NOUN aji-51 181 3 may may AUX aji-51 181 4 play play VERB aji-51 181 5 a a DET aji-51 181 6 fundamental fundamental ADJ aji-51 181 7 role role NOUN aji-51 181 8 in in ADP aji-51 181 9 precipitating precipitate VERB aji-51 181 10 the the DET aji-51 181 11 development development NOUN aji-51 181 12 of of ADP aji-51 181 13 a a DET aji-51 181 14 large large ADJ aji-51 181 15 and and CCONJ aji-51 181 16 diverse diverse ADJ aji-51 181 17 number number NOUN aji-51 181 18 of of ADP aji-51 181 19 stoff stoff PROPN aji-51 181 20 ; ; PUNCT aji-51 181 21 aji aji PROPN aji-51 181 22 , , PUNCT aji-51 181 23 5(1 5(1 NUM aji-51 181 24 ): ): PUNCT aji-51 181 25 1 1 NUM aji-51 181 26 - - SYM aji-51 181 27 39 39 NUM aji-51 181 28 , , PUNCT aji-51 181 29 2022 2022 NUM aji-51 181 30 ; ; PUNCT aji-51 181 31 article article NOUN aji-51 181 32 no.aji.77967 no.aji.77967 ADJ aji-51 181 33 4 4 NUM aji-51 181 34 human human ADJ aji-51 181 35 cancers[52 cancers[52 NOUN aji-51 181 36 ] ] PUNCT aji-51 181 37 . . PUNCT aji-51 182 1 it it PRON aji-51 182 2 is be AUX aji-51 182 3 important important ADJ aji-51 182 4 to to PART aji-51 182 5 monitor monitor VERB aji-51 182 6 homocysteine homocysteine NOUN aji-51 182 7 and and CCONJ aji-51 182 8 b b NOUN aji-51 182 9 vitamin vitamin NOUN aji-51 182 10 levels level NOUN aji-51 182 11 while while SCONJ aji-51 182 12 treating treat VERB aji-51 182 13 people people NOUN aji-51 182 14 with with ADP aji-51 182 15 cancer cancer NOUN aji-51 182 16 , , PUNCT aji-51 182 17 because because SCONJ aji-51 182 18 overshooting overshoot VERB aji-51 182 19 your your PRON aji-51 182 20 mark mark NOUN aji-51 182 21 may may AUX aji-51 182 22 make make VERB aji-51 182 23 some some DET aji-51 182 24 cancers cancer NOUN aji-51 182 25 worse bad ADJ aji-51 182 26 [ [ X aji-51 182 27 53 53 NUM aji-51 182 28 ] ] PUNCT aji-51 182 29 . . PUNCT aji-51 183 1 when when SCONJ aji-51 183 2 a a DET aji-51 183 3 woman woman NOUN aji-51 183 4 is be AUX aji-51 183 5 pregnant pregnant ADJ aji-51 183 6 we we PRON aji-51 183 7 give give AUX aji-51 183 8 prenatal prenatal ADJ aji-51 183 9 vitamins vitamin NOUN aji-51 183 10 which which PRON aji-51 183 11 are be AUX aji-51 183 12 largely largely ADV aji-51 183 13 b b X aji-51 183 14 vitamins vitamin NOUN aji-51 183 15 to to PART aji-51 183 16 stimulate stimulate VERB aji-51 183 17 the the DET aji-51 183 18 cell cell NOUN aji-51 183 19 growth growth NOUN aji-51 183 20 of of ADP aji-51 183 21 the the DET aji-51 183 22 fetus fetus NOUN aji-51 183 23 , , PUNCT aji-51 183 24 and and CCONJ aji-51 183 25 when when SCONJ aji-51 183 26 you you PRON aji-51 183 27 ’re ’re AUX aji-51 183 28 fighting fight VERB aji-51 183 29 cancer cancer NOUN aji-51 183 30 you you PRON aji-51 183 31 do do AUX aji-51 183 32 n’t not PART aji-51 183 33 want want VERB aji-51 183 34 to to PART aji-51 183 35 do do VERB aji-51 183 36 that that PRON aji-51 183 37 . . PUNCT aji-51 184 1 however however ADV aji-51 184 2 , , PUNCT aji-51 184 3 it it PRON aji-51 184 4 is be AUX aji-51 184 5 important important ADJ aji-51 184 6 to to PART aji-51 184 7 note note VERB aji-51 184 8 that that SCONJ aji-51 184 9 , , PUNCT aji-51 184 10 b b X aji-51 184 11 vitamin vitamin NOUN aji-51 184 12 deficiencies deficiency NOUN aji-51 184 13 will will AUX aji-51 184 14 inhibit inhibit VERB aji-51 184 15 many many ADJ aji-51 184 16 immune immune ADJ aji-51 184 17 functions function NOUN aji-51 184 18 that that PRON aji-51 184 19 are be AUX aji-51 184 20 desperately desperately ADV aji-51 184 21 needed need VERB aji-51 184 22 for for ADP aji-51 184 23 the the DET aji-51 184 24 fight fight NOUN aji-51 184 25 [ [ X aji-51 184 26 54 54 NUM aji-51 184 27 ] ] PUNCT aji-51 184 28 . . PUNCT aji-51 185 1 nothing nothing PRON aji-51 185 2 about about ADP aji-51 185 3 fighting fight VERB aji-51 185 4 cancer cancer NOUN aji-51 185 5 is be AUX aji-51 185 6 easy easy ADJ aji-51 185 7 , , PUNCT aji-51 185 8 getting get VERB aji-51 185 9 biochemical biochemical ADJ aji-51 185 10 moieties moiety NOUN aji-51 185 11 to to ADP aji-51 185 12 and and CCONJ aji-51 185 13 maintaining maintain VERB aji-51 185 14 them they PRON aji-51 185 15 within within ADP aji-51 185 16 the the DET aji-51 185 17 normal normal ADJ aji-51 185 18 range range NOUN aji-51 185 19 is be AUX aji-51 185 20 a a DET aji-51 185 21 safe safe ADJ aji-51 185 22 bet bet NOUN aji-51 185 23 , , PUNCT aji-51 185 24 from from ADP aji-51 185 25 a a DET aji-51 185 26 metabolic metabolic NOUN aji-51 185 27 perspective perspective NOUN aji-51 185 28 . . PUNCT aji-51 186 1 oxidation oxidation NOUN aji-51 186 2 , , PUNCT aji-51 186 3 like like ADP aji-51 186 4 the the DET aji-51 186 5 rest rest NOUN aji-51 186 6 of of ADP aji-51 186 7 metabolic metabolic NOUN aji-51 186 8 activity activity NOUN aji-51 186 9 , , PUNCT aji-51 186 10 is be AUX aji-51 186 11 also also ADV aji-51 186 12 a a DET aji-51 186 13 bit bit NOUN aji-51 186 14 of of ADP aji-51 186 15 a a DET aji-51 186 16 double double ADJ aji-51 186 17 - - PUNCT aji-51 186 18 edged edge VERB aji-51 186 19 sword sword NOUN aji-51 186 20 when when SCONJ aji-51 186 21 it it PRON aji-51 186 22 comes come VERB aji-51 186 23 to to ADP aji-51 186 24 cancer cancer NOUN aji-51 186 25 . . PUNCT aji-51 187 1 oxidative oxidative ADJ aji-51 187 2 stress stress NOUN aji-51 187 3 is be AUX aji-51 187 4 caused cause VERB aji-51 187 5 by by ADP aji-51 187 6 many many ADJ aji-51 187 7 things thing NOUN aji-51 187 8 including include VERB aji-51 187 9 ; ; PUNCT aji-51 187 10 obesity obesity NOUN aji-51 187 11 , , PUNCT aji-51 187 12 high high ADJ aji-51 187 13 fat fat ADJ aji-51 187 14 diet diet NOUN aji-51 187 15 , , PUNCT aji-51 187 16 sugar sugar NOUN aji-51 187 17 , , PUNCT aji-51 187 18 the the DET aji-51 187 19 chemicals chemical NOUN aji-51 187 20 in in ADP aji-51 187 21 processed process VERB aji-51 187 22 foods food NOUN aji-51 187 23 , , PUNCT aji-51 187 24 radiation radiation NOUN aji-51 187 25 , , PUNCT aji-51 187 26 smoking smoking NOUN aji-51 187 27 , , PUNCT aji-51 187 28 alcohol alcohol NOUN aji-51 187 29 , , PUNCT aji-51 187 30 covid-19 covid-19 PROPN aji-51 187 31 , , PUNCT aji-51 187 32 environmental environmental ADJ aji-51 187 33 pollution pollution NOUN aji-51 187 34 and and CCONJ aji-51 187 35 chemicals chemical NOUN aji-51 187 36 , , PUNCT aji-51 187 37 etc etc X aji-51 187 38 . . X aji-51 187 39 , , PUNCT aji-51 187 40 etc etc X aji-51 187 41 . . X aji-51 187 42 , , PUNCT aji-51 187 43 etc etc X aji-51 187 44 .. .. X aji-51 187 45 (i.e (i.e X aji-51 187 46 . . PUNCT aji-51 188 1 life life NOUN aji-51 188 2 ) ) PUNCT aji-51 189 1 [ [ X aji-51 189 2 55 55 NUM aji-51 189 3 ] ] PUNCT aji-51 189 4 . . PUNCT aji-51 190 1 damage damage NOUN aji-51 190 2 from from ADP aji-51 190 3 oxidative oxidative ADJ aji-51 190 4 stress stress NOUN aji-51 190 5 occurs occur VERB aji-51 190 6 when when SCONJ aji-51 190 7 the the DET aji-51 190 8 cells cell NOUN aji-51 190 9 and and CCONJ aji-51 190 10 tissues tissue NOUN aji-51 190 11 are be AUX aji-51 190 12 unable unable ADJ aji-51 190 13 to to PART aji-51 190 14 keep keep VERB aji-51 190 15 up up ADP aji-51 190 16 with with ADP aji-51 190 17 harm harm NOUN aji-51 190 18 done do VERB aji-51 190 19 by by ADP aji-51 190 20 the the DET aji-51 190 21 free free ADJ aji-51 190 22 radicals radical NOUN aji-51 190 23 that that PRON aji-51 190 24 are be AUX aji-51 190 25 generated generate VERB aji-51 190 26 from from ADP aji-51 190 27 the the DET aji-51 190 28 above above NOUN aji-51 190 29 , , PUNCT aji-51 190 30 and and CCONJ aji-51 190 31 other other ADJ aji-51 190 32 causes cause NOUN aji-51 190 33 . . PUNCT aji-51 191 1 a a DET aji-51 191 2 free free ADJ aji-51 191 3 radical radical NOUN aji-51 191 4 is be AUX aji-51 191 5 an an DET aji-51 191 6 atom atom NOUN aji-51 191 7 , , PUNCT aji-51 191 8 molecule molecule NOUN aji-51 191 9 , , PUNCT aji-51 191 10 or or CCONJ aji-51 191 11 ion ion NOUN aji-51 191 12 that that PRON aji-51 191 13 has have VERB aji-51 191 14 an an DET aji-51 191 15 unpaired unpaired ADJ aji-51 191 16 valence valence NOUN aji-51 191 17 electron electron NOUN aji-51 191 18 that that PRON aji-51 191 19 can can AUX aji-51 191 20 bind bind VERB aji-51 191 21 to to ADP aji-51 191 22 , , PUNCT aji-51 191 23 and and CCONJ aji-51 191 24 damage damage NOUN aji-51 191 25 , , PUNCT aji-51 191 26 dna dna NOUN aji-51 191 27 and and CCONJ aji-51 191 28 messenger messenger NOUN aji-51 191 29 molecules molecule NOUN aji-51 191 30 but but CCONJ aji-51 191 31 is be AUX aji-51 191 32 normally normally ADV aji-51 191 33 kept keep VERB aji-51 191 34 in in ADP aji-51 191 35 check check NOUN aji-51 191 36 by by ADP aji-51 191 37 the the DET aji-51 191 38 body body NOUN aji-51 191 39 ’s ’s PART aji-51 191 40 store store NOUN aji-51 191 41 of of ADP aji-51 191 42 anti anti NOUN aji-51 191 43 - - NOUN aji-51 191 44 oxidants oxidant NOUN aji-51 191 45 . . PUNCT aji-51 192 1 this this DET aji-51 192 2 damage damage NOUN aji-51 192 3 is be AUX aji-51 192 4 carcinogenic carcinogenic ADJ aji-51 192 5 . . PUNCT aji-51 193 1 anti anti NOUN aji-51 193 2 - - NOUN aji-51 193 3 oxidants oxidant NOUN aji-51 193 4 can can AUX aji-51 193 5 mitigate mitigate VERB aji-51 193 6 oxidative oxidative ADJ aji-51 193 7 stress stress NOUN aji-51 193 8 and and CCONJ aji-51 193 9 are be AUX aji-51 193 10 found find VERB aji-51 193 11 in in ADP aji-51 193 12 vegetables vegetable NOUN aji-51 193 13 such such ADJ aji-51 193 14 as as ADP aji-51 193 15 broccoli broccoli NOUN aji-51 193 16 , , PUNCT aji-51 193 17 spinach spinach NOUN aji-51 193 18 , , PUNCT aji-51 193 19 carrots carrot NOUN aji-51 193 20 , , PUNCT aji-51 193 21 cabbage cabbage NOUN aji-51 193 22 , , PUNCT aji-51 193 23 and and CCONJ aji-51 193 24 vitamins vitamin NOUN aji-51 193 25 c c X aji-51 193 26 , , PUNCT aji-51 193 27 e e NOUN aji-51 193 28 , , PUNCT aji-51 193 29 d d PROPN aji-51 193 30 , , PUNCT aji-51 193 31 a a PRON aji-51 193 32 , , PUNCT aji-51 193 33 etc etc X aji-51 193 34 . . X aji-51 193 35 , , PUNCT aji-51 193 36 etc etc X aji-51 193 37 . . X aji-51 193 38 , , PUNCT aji-51 193 39 etc etc X aji-51 193 40 ... ... X aji-51 193 41 uncontrolled uncontrolled ADJ aji-51 193 42 oxidative oxidative ADJ aji-51 193 43 stress stress NOUN aji-51 193 44 can can AUX aji-51 193 45 activate activate VERB aji-51 193 46 a a DET aji-51 193 47 variety variety NOUN aji-51 193 48 of of ADP aji-51 193 49 transcription transcription NOUN aji-51 193 50 factors factor NOUN aji-51 193 51 including include VERB aji-51 193 52 nuclear nuclear ADJ aji-51 193 53 factor factor NOUN aji-51 193 54 kappa kappa ADJ aji-51 193 55 - - ADJ aji-51 193 56 light light ADJ aji-51 193 57 - - PUNCT aji-51 193 58 chainenhancer chainenhancer NOUN aji-51 193 59 of of ADP aji-51 193 60 activated activate VERB aji-51 193 61 b b PROPN aji-51 193 62 cells cell NOUN aji-51 193 63 ( ( PUNCT aji-51 193 64 nf nf NOUN aji-51 193 65 - - PUNCT aji-51 193 66 κb κb NOUN aji-51 193 67 ) ) PUNCT aji-51 193 68 , , PUNCT aji-51 193 69 activator activator NOUN aji-51 193 70 protein protein NOUN aji-51 193 71 1 1 NUM aji-51 193 72 ( ( PUNCT aji-51 193 73 ap-1 ap-1 NOUN aji-51 193 74 ) ) PUNCT aji-51 193 75 , , PUNCT aji-51 193 76 tumor tumor NOUN aji-51 193 77 protein protein NOUN aji-51 193 78 53 53 NUM aji-51 193 79 ( ( PUNCT aji-51 193 80 p53 p53 NOUN aji-51 193 81 ) ) PUNCT aji-51 193 82 , , PUNCT aji-51 193 83 hypoxia hypoxia NOUN aji-51 193 84 - - PUNCT aji-51 193 85 inducible inducible ADJ aji-51 193 86 factor-1a factor-1a ADJ aji-51 193 87 ( ( PUNCT aji-51 193 88 hif-1α hif-1α NOUN aji-51 193 89 ) ) PUNCT aji-51 193 90 , , PUNCT aji-51 193 91 peroxisome peroxisome VERB aji-51 193 92 proliferatoractivated proliferatoractivate VERB aji-51 193 93 receptor receptor NOUN aji-51 193 94 gamma gamma NOUN aji-51 193 95 ( ( PUNCT aji-51 193 96 ppar ppar NOUN aji-51 193 97 - - PUNCT aji-51 193 98 γ γ NOUN aji-51 193 99 ) ) PUNCT aji-51 193 100 , , PUNCT aji-51 193 101 β β NOUN aji-51 193 102 - - ADJ aji-51 193 103 catenin catenin ADJ aji-51 193 104 / / SYM aji-51 193 105 wnt wnt PROPN aji-51 193 106 , , PUNCT aji-51 193 107 and and CCONJ aji-51 193 108 nuclear nuclear ADJ aji-51 193 109 factor factor NOUN aji-51 193 110 erythroid erythroid NOUN aji-51 193 111 2 2 NUM aji-51 193 112 – – PUNCT aji-51 193 113 related relate VERB aji-51 193 114 factor factor NOUN aji-51 193 115 2 2 NUM aji-51 193 116 ( ( PUNCT aji-51 193 117 nrf2 nrf2 PROPN aji-51 193 118 ) ) PUNCT aji-51 193 119 . . PUNCT aji-51 194 1 activation activation NOUN aji-51 194 2 of of ADP aji-51 194 3 these these DET aji-51 194 4 transcription transcription NOUN aji-51 194 5 factors factor NOUN aji-51 194 6 can can AUX aji-51 194 7 lead lead VERB aji-51 194 8 to to ADP aji-51 194 9 the the DET aji-51 194 10 expression expression NOUN aji-51 194 11 of of ADP aji-51 194 12 over over ADP aji-51 194 13 500 500 NUM aji-51 194 14 different different ADJ aji-51 194 15 genes gene NOUN aji-51 194 16 , , PUNCT aji-51 194 17 including include VERB aji-51 194 18 those those PRON aji-51 194 19 for for ADP aji-51 194 20 growth growth NOUN aji-51 194 21 factors factor NOUN aji-51 194 22 , , PUNCT aji-51 194 23 inflammatory inflammatory ADJ aji-51 194 24 cytokines cytokine NOUN aji-51 194 25 , , PUNCT aji-51 194 26 chemokines chemokine NOUN aji-51 194 27 , , PUNCT aji-51 194 28 and and CCONJ aji-51 194 29 cell cell NOUN aji-51 194 30 cycle cycle NOUN aji-51 194 31 regulatory regulatory ADJ aji-51 194 32 molecules molecule NOUN aji-51 194 33 . . PUNCT aji-51 195 1 activation activation NOUN aji-51 195 2 of of ADP aji-51 195 3 these these DET aji-51 195 4 molecules molecule NOUN aji-51 195 5 by by ADP aji-51 195 6 oxidative oxidative ADJ aji-51 195 7 stress stress NOUN aji-51 195 8 stimulates stimulate VERB aji-51 195 9 inflammatory inflammatory ADJ aji-51 195 10 pathways pathway NOUN aji-51 195 11 leading lead VERB aji-51 195 12 to to ADP aji-51 195 13 the the DET aji-51 195 14 transformation transformation NOUN aji-51 195 15 of of ADP aji-51 195 16 a a DET aji-51 195 17 normal normal ADJ aji-51 195 18 cell cell NOUN aji-51 195 19 to to ADP aji-51 195 20 a a DET aji-51 195 21 tumor tumor NOUN aji-51 195 22 cell cell NOUN aji-51 195 23 , , PUNCT aji-51 195 24 increases increase VERB aji-51 195 25 tumor tumor NOUN aji-51 195 26 cell cell NOUN aji-51 195 27 survival survival NOUN aji-51 195 28 , , PUNCT aji-51 195 29 proliferation proliferation NOUN aji-51 195 30 , , PUNCT aji-51 195 31 chemoresistance chemoresistance NOUN aji-51 195 32 , , PUNCT aji-51 195 33 radioresistance radioresistance NOUN aji-51 195 34 , , PUNCT aji-51 195 35 invasion invasion NOUN aji-51 195 36 , , PUNCT aji-51 195 37 angiogenesis angiogenesis NOUN aji-51 195 38 and and CCONJ aji-51 195 39 supports support VERB aji-51 195 40 cancer cancer NOUN aji-51 195 41 stem stem NOUN aji-51 195 42 cell cell NOUN aji-51 195 43 survival survival NOUN aji-51 195 44 [ [ X aji-51 195 45 56 56 NUM aji-51 195 46 ] ] PUNCT aji-51 195 47 . . PUNCT aji-51 196 1 on on ADP aji-51 196 2 the the DET aji-51 196 3 other other ADJ aji-51 196 4 side side NOUN aji-51 196 5 of of ADP aji-51 196 6 the the DET aji-51 196 7 sword sword NOUN aji-51 196 8 , , PUNCT aji-51 196 9 the the DET aji-51 196 10 production production NOUN aji-51 196 11 of of ADP aji-51 196 12 oxidative oxidative ADJ aji-51 196 13 reactive reactive ADJ aji-51 196 14 oxygen oxygen NOUN aji-51 196 15 species specie NOUN aji-51 196 16 ( ( PUNCT aji-51 196 17 ros ros PROPN aji-51 196 18 ) ) PUNCT aji-51 196 19 is be AUX aji-51 196 20 required require VERB aji-51 196 21 for for ADP aji-51 196 22 the the DET aji-51 196 23 function function NOUN aji-51 196 24 of of ADP aji-51 196 25 another another DET aji-51 196 26 major major ADJ aji-51 196 27 effector effector NOUN aji-51 196 28 of of ADP aji-51 196 29 the the DET aji-51 196 30 innate innate ADJ aji-51 196 31 immune immune ADJ aji-51 196 32 system system NOUN aji-51 196 33 , , PUNCT aji-51 196 34 natural natural ADJ aji-51 196 35 killer killer NOUN aji-51 196 36 ( ( PUNCT aji-51 196 37 nk nk PROPN aji-51 196 38 ) ) PUNCT aji-51 196 39 cells cell NOUN aji-51 196 40 — — PUNCT aji-51 196 41 hydroxyl hydroxyl NOUN aji-51 196 42 radical radical ADJ aji-51 196 43 production production NOUN aji-51 196 44 is be AUX aji-51 196 45 responsible responsible ADJ aji-51 196 46 for for ADP aji-51 196 47 nk nk PROPN aji-51 196 48 cells cell NOUN aji-51 196 49 - - PUNCT aji-51 196 50 mediated mediate VERB aji-51 196 51 cytolysis cytolysis NOUN aji-51 196 52 , , PUNCT aji-51 196 53 by by ADP aji-51 196 54 promoting promote VERB aji-51 196 55 the the DET aji-51 196 56 secretion secretion NOUN aji-51 196 57 of of ADP aji-51 196 58 cytotoxic cytotoxic ADJ aji-51 196 59 factors factor NOUN aji-51 196 60 from from ADP aji-51 196 61 nk nk PROPN aji-51 196 62 cells cell NOUN aji-51 196 63 granules granule NOUN aji-51 196 64 [ [ PUNCT aji-51 196 65 57 57 NUM aji-51 196 66 - - SYM aji-51 196 67 62 62 NUM aji-51 196 68 ] ] PUNCT aji-51 196 69 . . PUNCT aji-51 197 1 ros ros PROPN aji-51 197 2 can can AUX aji-51 197 3 promote promote VERB aji-51 197 4 carcinogenesis carcinogenesis NOUN aji-51 197 5 by by ADP aji-51 197 6 inducing induce VERB aji-51 197 7 genetic genetic ADJ aji-51 197 8 mutations mutation NOUN aji-51 197 9 , , PUNCT aji-51 197 10 activating activate VERB aji-51 197 11 oncogenes oncogene NOUN aji-51 197 12 , , PUNCT aji-51 197 13 and and CCONJ aji-51 197 14 raising raise VERB aji-51 197 15 oxidative oxidative ADJ aji-51 197 16 stress stress NOUN aji-51 197 17 , , PUNCT aji-51 197 18 which which PRON aji-51 197 19 can can AUX aji-51 197 20 stimulate stimulate VERB aji-51 197 21 cell cell NOUN aji-51 197 22 proliferation proliferation NOUN aji-51 197 23 , , PUNCT aji-51 197 24 survival survival NOUN aji-51 197 25 , , PUNCT aji-51 197 26 and and CCONJ aji-51 197 27 reduce reduce VERB aji-51 197 28 apoptosis apoptosis NOUN aji-51 197 29 . . PUNCT aji-51 198 1 over over ADP aji-51 198 2 the the DET aji-51 198 3 past past ADJ aji-51 198 4 few few ADJ aji-51 198 5 decades decade NOUN aji-51 198 6 , , PUNCT aji-51 198 7 natural natural ADJ aji-51 198 8 compounds compound NOUN aji-51 198 9 have have AUX aji-51 198 10 attracted attract VERB aji-51 198 11 attention attention NOUN aji-51 198 12 as as ADP aji-51 198 13 potential potential ADJ aji-51 198 14 cancer cancer NOUN aji-51 198 15 therapies therapy NOUN aji-51 198 16 because because SCONJ aji-51 198 17 of of ADP aji-51 198 18 their their PRON aji-51 198 19 ability ability NOUN aji-51 198 20 to to PART aji-51 198 21 maintain maintain VERB aji-51 198 22 cellular cellular ADJ aji-51 198 23 redox redox ADJ aji-51 198 24 homeostasis homeostasis NOUN aji-51 198 25 with with ADP aji-51 198 26 minimal minimal ADJ aji-51 198 27 toxicity toxicity NOUN aji-51 198 28 . . PUNCT aji-51 199 1 research research NOUN aji-51 199 2 and and CCONJ aji-51 199 3 clinical clinical ADJ aji-51 199 4 studies study NOUN aji-51 199 5 show show VERB aji-51 199 6 that that SCONJ aji-51 199 7 bioactive bioactive VERB aji-51 199 8 dietary dietary ADJ aji-51 199 9 polyphenols polyphenol NOUN aji-51 199 10 exert exert VERB aji-51 199 11 antitumor antitumor PROPN aji-51 199 12 effects effect NOUN aji-51 199 13 by by ADP aji-51 199 14 inducing induce VERB aji-51 199 15 ros ros PROPN aji-51 199 16 - - PUNCT aji-51 199 17 mediated mediate VERB aji-51 199 18 cytotoxicity cytotoxicity NOUN aji-51 199 19 in in ADP aji-51 199 20 cancer cancer NOUN aji-51 199 21 cells cell NOUN aji-51 199 22 . . PUNCT aji-51 200 1 these these DET aji-51 200 2 bioactive bioactive ADJ aji-51 200 3 compounds compound NOUN aji-51 200 4 also also ADV aji-51 200 5 regulate regulate VERB aji-51 200 6 cell cell NOUN aji-51 200 7 proliferation proliferation NOUN aji-51 200 8 , , PUNCT aji-51 200 9 survival survival NOUN aji-51 200 10 , , PUNCT aji-51 200 11 and and CCONJ aji-51 200 12 apoptotic apoptotic ADJ aji-51 200 13 and and CCONJ aji-51 200 14 antiapoptotic antiapoptotic ADJ aji-51 200 15 signaling signal VERB aji-51 200 16 pathways pathway NOUN aji-51 200 17 [ [ X aji-51 200 18 63 63 NUM aji-51 200 19 ] ] PUNCT aji-51 200 20 . . PUNCT aji-51 201 1 amongst amongst ADP aji-51 201 2 many many ADJ aji-51 201 3 other other ADJ aji-51 201 4 examples example NOUN aji-51 201 5 , , PUNCT aji-51 201 6 this this PRON aji-51 201 7 is be AUX aji-51 201 8 demonstrated demonstrate VERB aji-51 201 9 in in ADP aji-51 201 10 the the DET aji-51 201 11 ability ability NOUN aji-51 201 12 of of ADP aji-51 201 13 aronia aronia NOUN aji-51 201 14 melanocarpa melanocarpa X aji-51 201 15 to to PART aji-51 201 16 increase increase VERB aji-51 201 17 the the DET aji-51 201 18 expression expression NOUN aji-51 201 19 and and CCONJ aji-51 201 20 activity activity NOUN aji-51 201 21 of of ADP aji-51 201 22 p53 p53 NOUN aji-51 201 23 and and CCONJ aji-51 201 24 p73 p73 NOUN aji-51 201 25 that that PRON aji-51 201 26 leads lead VERB aji-51 201 27 to to ADP aji-51 201 28 the the DET aji-51 201 29 down down NOUN aji-51 201 30 - - PUNCT aji-51 201 31 regulation regulation NOUN aji-51 201 32 of of ADP aji-51 201 33 the the DET aji-51 201 34 expression expression NOUN aji-51 201 35 of of ADP aji-51 201 36 cyclin cyclin PROPN aji-51 201 37 b1 b1 PROPN aji-51 201 38 , , PUNCT aji-51 201 39 which which PRON aji-51 201 40 contributes contribute VERB aji-51 201 41 to to ADP aji-51 201 42 the the DET aji-51 201 43 cell cell NOUN aji-51 201 44 cycle cycle NOUN aji-51 201 45 arrest arrest NOUN aji-51 201 46 of of ADP aji-51 201 47 cancer cancer NOUN aji-51 201 48 cells cell NOUN aji-51 201 49 [ [ X aji-51 201 50 64 64 NUM aji-51 201 51 - - SYM aji-51 201 52 66 66 NUM aji-51 201 53 ] ] PUNCT aji-51 201 54 . . PUNCT aji-51 202 1 some some DET aji-51 202 2 commonly commonly ADV aji-51 202 3 used use VERB aji-51 202 4 anti anti ADJ aji-51 202 5 - - ADJ aji-51 202 6 cancer cancer ADJ aji-51 202 7 agents agent NOUN aji-51 202 8 include include VERB aji-51 202 9 : : PUNCT aji-51 202 10 glycation glycation NOUN aji-51 202 11 metformin metformin NOUN aji-51 202 12 [ [ X aji-51 202 13 67,68 67,68 NUM aji-51 202 14 ] ] X aji-51 202 15 berberine berberine NOUN aji-51 203 1 [ [ X aji-51 203 2 69,70 69,70 NOUN aji-51 203 3 ] ] PUNCT aji-51 203 4 azadirachta azadirachta VERB aji-51 203 5 indica indica PROPN aji-51 203 6 ( ( PUNCT aji-51 203 7 neem neem NOUN aji-51 203 8 ) ) PUNCT aji-51 204 1 [ [ X aji-51 204 2 71,72 71,72 X aji-51 204 3 ] ] X aji-51 204 4 inflammation inflammation ADJ aji-51 204 5 celebrex celebrex PROPN aji-51 205 1 [ [ X aji-51 205 2 73 73 NUM aji-51 205 3 ] ] PUNCT aji-51 205 4 curcumin curcumin NOUN aji-51 206 1 [ [ X aji-51 206 2 74,75 74,75 NUM aji-51 206 3 ] ] X aji-51 206 4 grape grape NOUN aji-51 206 5 seed seed NOUN aji-51 206 6 extract extract NOUN aji-51 206 7 [ [ X aji-51 206 8 76,77 76,77 NOUN aji-51 206 9 ] ] X aji-51 206 10 cimetidine cimetidine NOUN aji-51 207 1 [ [ X aji-51 207 2 78 78 NUM aji-51 207 3 ] ] X aji-51 207 4 viscum viscum NOUN aji-51 207 5 [ [ X aji-51 207 6 79 79 NUM aji-51 207 7 ] ] PUNCT aji-51 207 8 methylation methylation NOUN aji-51 207 9 decitabine decitabine NOUN aji-51 208 1 [ [ X aji-51 208 2 80 80 NUM aji-51 208 3 ] ] PUNCT aji-51 208 4 egcg egcg NOUN aji-51 208 5 [ [ X aji-51 208 6 81 81 NUM aji-51 208 7 ] ] PUNCT aji-51 208 8 oxidation oxidation NOUN aji-51 208 9 dmso dmso NOUN aji-51 208 10 [ [ X aji-51 208 11 82 82 NUM aji-51 208 12 ] ] X aji-51 208 13 raloxifene raloxifene NOUN aji-51 209 1 [ [ X aji-51 209 2 83 83 NUM aji-51 209 3 ] ] X aji-51 209 4 vitamin vitamin NOUN aji-51 209 5 c c NOUN aji-51 209 6 and and CCONJ aji-51 209 7 many many ADJ aji-51 209 8 other other ADJ aji-51 209 9 vitamins vitamin NOUN aji-51 209 10 and and CCONJ aji-51 209 11 minerals mineral NOUN aji-51 209 12 [ [ X aji-51 209 13 84 84 NUM aji-51 209 14 ] ] SYM aji-51 209 15 2.2 2.2 NUM aji-51 209 16 biochemical biochemical ADJ aji-51 209 17 targets target NOUN aji-51 209 18 of of ADP aji-51 209 19 the the DET aji-51 209 20 tumor tumor NOUN aji-51 209 21 : : PUNCT aji-51 209 22 the the DET aji-51 209 23 micro micro NOUN aji-51 209 24 - - NOUN aji-51 209 25 environment environment VERB aji-51 209 26 a a DET aji-51 209 27 closer close ADJ aji-51 209 28 look look NOUN aji-51 209 29 at at ADP aji-51 209 30 the the DET aji-51 209 31 cancer cancer NOUN aji-51 209 32 itself itself PRON aji-51 209 33 demonstrates demonstrate VERB aji-51 209 34 that that SCONJ aji-51 209 35 by by ADP aji-51 209 36 corrupting corrupt VERB aji-51 209 37 and and CCONJ aji-51 209 38 recruiting recruit VERB aji-51 209 39 non non ADJ aji-51 209 40 - - ADJ aji-51 209 41 malignant malignant ADJ aji-51 209 42 cells cell NOUN aji-51 209 43 in in ADP aji-51 209 44 the the DET aji-51 209 45 area area NOUN aji-51 209 46 , , PUNCT aji-51 209 47 the the DET aji-51 209 48 tumor tumor NOUN aji-51 209 49 has have AUX aji-51 209 50 created create VERB aji-51 209 51 its its PRON aji-51 209 52 own own ADJ aji-51 209 53 biochemical biochemical ADJ aji-51 209 54 tumor tumor NOUN aji-51 209 55 microenvironment microenvironment NOUN aji-51 209 56 ( ( PUNCT aji-51 209 57 tme tme PROPN aji-51 209 58 ) ) PUNCT aji-51 209 59 stoff stoff PROPN aji-51 209 60 ; ; PUNCT aji-51 209 61 aji aji PROPN aji-51 209 62 , , PUNCT aji-51 209 63 5(1 5(1 NUM aji-51 209 64 ): ): PUNCT aji-51 209 65 1 1 NUM aji-51 209 66 - - SYM aji-51 209 67 39 39 NUM aji-51 209 68 , , PUNCT aji-51 209 69 2022 2022 NUM aji-51 209 70 ; ; PUNCT aji-51 209 71 article article NOUN aji-51 209 72 no.aji.77967 no.aji.77967 PROPN aji-51 209 73 5 5 NUM aji-51 209 74 suitable suitable ADJ aji-51 209 75 for for ADP aji-51 209 76 its its PRON aji-51 209 77 self self NOUN aji-51 209 78 - - PUNCT aji-51 209 79 protection protection NOUN aji-51 209 80 and and CCONJ aji-51 209 81 propagation propagation NOUN aji-51 209 82 [ [ X aji-51 209 83 85 85 NUM aji-51 209 84 ] ] PUNCT aji-51 209 85 . . PUNCT aji-51 210 1 many many ADJ aji-51 210 2 different different ADJ aji-51 210 3 cell cell NOUN aji-51 210 4 types type NOUN aji-51 210 5 , , PUNCT aji-51 210 6 besides besides SCONJ aji-51 210 7 the the DET aji-51 210 8 cancer cancer NOUN aji-51 210 9 , , PUNCT aji-51 210 10 can can AUX aji-51 210 11 be be AUX aji-51 210 12 found find VERB aji-51 210 13 in in ADP aji-51 210 14 the the DET aji-51 210 15 tme tme NOUN aji-51 210 16 including include VERB aji-51 210 17 ; ; PUNCT aji-51 210 18 adipocytes adipocyte NOUN aji-51 210 19 , , PUNCT aji-51 210 20 fibroblasts fibroblast NOUN aji-51 210 21 , , PUNCT aji-51 210 22 dendritic dendritic ADJ aji-51 210 23 cells cell NOUN aji-51 210 24 , , PUNCT aji-51 210 25 lymphocytic lymphocytic ADJ aji-51 210 26 endothelial endothelial ADJ aji-51 210 27 cells cell NOUN aji-51 210 28 , , PUNCT aji-51 210 29 myeloid myeloid NOUN aji-51 210 30 - - PUNCT aji-51 210 31 derived derive VERB aji-51 210 32 suppressor suppressor NOUN aji-51 210 33 cells cell NOUN aji-51 210 34 , , PUNCT aji-51 210 35 pericytes pericyte NOUN aji-51 210 36 , , PUNCT aji-51 210 37 tumor tumor NOUN aji-51 210 38 - - PUNCT aji-51 210 39 associated associate VERB aji-51 210 40 macrophages macrophage NOUN aji-51 210 41 , , PUNCT aji-51 210 42 tumor tumor NOUN aji-51 210 43 - - PUNCT aji-51 210 44 associated associate VERB aji-51 210 45 neutrophils neutrophil NOUN aji-51 210 46 , , PUNCT aji-51 210 47 and and CCONJ aji-51 210 48 vascular vascular ADJ aji-51 210 49 endothelial endothelial ADJ aji-51 210 50 cells cell NOUN aji-51 210 51 , , PUNCT aji-51 210 52 to to PART aji-51 210 53 name name VERB aji-51 210 54 but but CCONJ aji-51 210 55 a a DET aji-51 210 56 few few ADJ aji-51 211 1 [ [ X aji-51 211 2 86 86 NUM aji-51 211 3 ] ] PUNCT aji-51 211 4 . . PUNCT aji-51 212 1 other other ADJ aji-51 212 2 cells cell NOUN aji-51 212 3 to to PART aji-51 212 4 be be AUX aji-51 212 5 found find VERB aji-51 212 6 in in ADP aji-51 212 7 tme tme NOUN aji-51 212 8 include include VERB aji-51 212 9 t t NOUN aji-51 212 10 - - PUNCT aji-51 212 11 cells cell NOUN aji-51 212 12 , , PUNCT aji-51 212 13 nk nk PROPN aji-51 212 14 cells cell NOUN aji-51 212 15 , , PUNCT aji-51 212 16 nkt nkt NOUN aji-51 212 17 cells cell NOUN aji-51 212 18 , , PUNCT aji-51 212 19 and and CCONJ aji-51 212 20 some some DET aji-51 212 21 b b NOUN aji-51 212 22 - - PUNCT aji-51 212 23 cells cell NOUN aji-51 212 24 that that PRON aji-51 212 25 are be AUX aji-51 212 26 there there ADV aji-51 212 27 to to PART aji-51 212 28 fight fight VERB aji-51 212 29 the the DET aji-51 212 30 good good ADJ aji-51 212 31 fight fight NOUN aji-51 212 32 . . PUNCT aji-51 213 1 dendritic dendritic ADJ aji-51 213 2 cells cell NOUN aji-51 213 3 and and CCONJ aji-51 213 4 macrophages macrophage NOUN aji-51 213 5 found find VERB aji-51 213 6 just just ADV aji-51 213 7 outside outside ADV aji-51 213 8 of of ADP aji-51 213 9 the the DET aji-51 213 10 tme tme NOUN aji-51 213 11 are be AUX aji-51 213 12 also also ADV aji-51 213 13 engaged engage VERB aji-51 213 14 in in ADP aji-51 213 15 the the DET aji-51 213 16 battle battle NOUN aji-51 213 17 against against ADP aji-51 213 18 the the DET aji-51 213 19 cancer cancer NOUN aji-51 213 20 , , PUNCT aji-51 213 21 but but CCONJ aji-51 213 22 if if SCONJ aji-51 213 23 consumed consume VERB aji-51 213 24 by by ADP aji-51 213 25 the the DET aji-51 213 26 tumor tumor NOUN aji-51 213 27 , , PUNCT aji-51 213 28 seem seem VERB aji-51 213 29 to to PART aji-51 213 30 become become VERB aji-51 213 31 corrupted corrupted ADJ aji-51 213 32 and and CCONJ aji-51 213 33 aid aid NOUN aji-51 213 34 in in ADP aji-51 213 35 its its PRON aji-51 213 36 survival survival NOUN aji-51 213 37 [ [ X aji-51 213 38 87 87 NUM aji-51 213 39 ] ] PUNCT aji-51 213 40 . . PUNCT aji-51 214 1 the the DET aji-51 214 2 dynamic dynamic ADJ aji-51 214 3 interactions interaction NOUN aji-51 214 4 of of ADP aji-51 214 5 the the DET aji-51 214 6 cancer cancer NOUN aji-51 214 7 cells cell NOUN aji-51 214 8 with with ADP aji-51 214 9 the the DET aji-51 214 10 stromal stromal ADJ aji-51 214 11 cells cell NOUN aji-51 214 12 ( ( PUNCT aji-51 214 13 cellular cellular ADJ aji-51 214 14 part part NOUN aji-51 214 15 ) ) PUNCT aji-51 214 16 and and CCONJ aji-51 214 17 extracellular extracellular ADJ aji-51 214 18 matrix matrix NOUN aji-51 214 19 ( ( PUNCT aji-51 214 20 ecm ecm NOUN aji-51 214 21 ) ) PUNCT aji-51 214 22 components component NOUN aji-51 214 23 ( ( PUNCT aji-51 214 24 non non ADJ aji-51 214 25 - - ADJ aji-51 214 26 cellular cellular ADJ aji-51 214 27 structures structure NOUN aji-51 214 28 ) ) PUNCT aji-51 214 29 are be AUX aji-51 214 30 essential essential ADJ aji-51 214 31 for for ADP aji-51 214 32 stimulating stimulate VERB aji-51 214 33 the the DET aji-51 214 34 multiple multiple ADJ aji-51 214 35 cell cell NOUN aji-51 214 36 lines line NOUN aji-51 214 37 of of ADP aji-51 214 38 the the DET aji-51 214 39 cancer cancer NOUN aji-51 214 40 , , PUNCT aji-51 214 41 as as ADV aji-51 214 42 well well ADV aji-51 214 43 as as ADP aji-51 214 44 its its PRON aji-51 214 45 clonal clonal ADJ aji-51 214 46 evolution evolution NOUN aji-51 214 47 and and CCONJ aji-51 214 48 propensity propensity NOUN aji-51 214 49 to to PART aji-51 214 50 develop develop VERB aji-51 214 51 multidrug multidrug NOUN aji-51 214 52 resistance resistance NOUN aji-51 214 53 , , PUNCT aji-51 214 54 resulting result VERB aji-51 214 55 in in ADP aji-51 214 56 cancer cancer NOUN aji-51 214 57 cell cell NOUN aji-51 214 58 progression progression NOUN aji-51 214 59 and and CCONJ aji-51 214 60 metastasis metastasis PRON aji-51 214 61 [ [ X aji-51 214 62 88 88 NUM aji-51 214 63 ] ] PUNCT aji-51 214 64 . . PUNCT aji-51 215 1 the the DET aji-51 215 2 ecm ecm PROPN aji-51 215 3 holds hold VERB aji-51 215 4 cells cell NOUN aji-51 215 5 , , PUNCT aji-51 215 6 tissues tissue NOUN aji-51 215 7 , , PUNCT aji-51 215 8 and and CCONJ aji-51 215 9 organs organ NOUN aji-51 215 10 together together ADV aji-51 215 11 and and CCONJ aji-51 215 12 maintains maintain VERB aji-51 215 13 the the DET aji-51 215 14 three three NUM aji-51 215 15 - - PUNCT aji-51 215 16 dimensional dimensional ADJ aji-51 215 17 structure structure NOUN aji-51 215 18 of of ADP aji-51 215 19 the the DET aji-51 215 20 body body NOUN aji-51 215 21 . . PUNCT aji-51 216 1 for for SCONJ aji-51 216 2 a a DET aji-51 216 3 cancer cancer NOUN aji-51 216 4 cell cell NOUN aji-51 216 5 to to PART aji-51 216 6 metastasize metastasize VERB aji-51 216 7 from from ADP aji-51 216 8 the the DET aji-51 216 9 primary primary ADJ aji-51 216 10 tumor tumor NOUN aji-51 216 11 to to ADP aji-51 216 12 other other ADJ aji-51 216 13 organs organ NOUN aji-51 216 14 , , PUNCT aji-51 216 15 it it PRON aji-51 216 16 must must AUX aji-51 216 17 locally locally ADV aji-51 216 18 degrade degrade VERB aji-51 216 19 the the DET aji-51 216 20 ecm ecm PROPN aji-51 216 21 components component NOUN aji-51 216 22 that that PRON aji-51 216 23 are be AUX aji-51 216 24 the the DET aji-51 216 25 physical physical ADJ aji-51 216 26 barriers barrier NOUN aji-51 216 27 to to ADP aji-51 216 28 cell cell NOUN aji-51 216 29 motility motility NOUN aji-51 216 30 . . PUNCT aji-51 217 1 cancer cancer NOUN aji-51 217 2 cells cell NOUN aji-51 217 3 build build VERB aji-51 217 4 , , PUNCT aji-51 217 5 shape shape NOUN aji-51 217 6 , , PUNCT aji-51 217 7 and and CCONJ aji-51 217 8 recruit recruit NOUN aji-51 217 9 support support NOUN aji-51 217 10 for for ADP aji-51 217 11 their their PRON aji-51 217 12 tme tme NOUN aji-51 217 13 through through ADP aji-51 217 14 the the DET aji-51 217 15 release release NOUN aji-51 217 16 of of ADP aji-51 217 17 many many ADJ aji-51 217 18 different different ADJ aji-51 217 19 types type NOUN aji-51 217 20 of of ADP aji-51 217 21 molecules molecule NOUN aji-51 217 22 including include VERB aji-51 217 23 ; ; PUNCT aji-51 217 24 matrix matrix NOUN aji-51 217 25 remodeling remodeling NOUN aji-51 217 26 enzymes enzyme NOUN aji-51 217 27 , , PUNCT aji-51 217 28 mediators mediator NOUN aji-51 217 29 of of ADP aji-51 217 30 inflammation inflammation NOUN aji-51 217 31 ( ( PUNCT aji-51 217 32 which which PRON aji-51 217 33 can can AUX aji-51 217 34 stimulate stimulate VERB aji-51 217 35 the the DET aji-51 217 36 activity activity NOUN aji-51 217 37 of of ADP aji-51 217 38 the the DET aji-51 217 39 matrix matrix NOUN aji-51 217 40 metalloproteinases metalloproteinase NOUN aji-51 217 41 ) ) PUNCT aji-51 217 42 , , PUNCT aji-51 217 43 cytokines cytokine NOUN aji-51 217 44 , , PUNCT aji-51 217 45 cellfree cellfree ADJ aji-51 217 46 dna dna NOUN aji-51 217 47 ( ( PUNCT aji-51 217 48 cfdna cfdna PROPN aji-51 217 49 , , PUNCT aji-51 217 50 which which PRON aji-51 217 51 we we PRON aji-51 217 52 can can AUX aji-51 217 53 now now ADV aji-51 217 54 test test VERB aji-51 217 55 for for ADP aji-51 217 56 [ [ X aji-51 217 57 89 89 NUM aji-51 217 58 ] ] PUNCT aji-51 217 59 chemokines chemokine NOUN aji-51 217 60 , , PUNCT aji-51 217 61 growth growth NOUN aji-51 217 62 factors factor NOUN aji-51 217 63 , , PUNCT aji-51 217 64 exosomes exosome NOUN aji-51 217 65 , , PUNCT aji-51 217 66 and and CCONJ aji-51 217 67 can can AUX aji-51 217 68 facilitate facilitate VERB aji-51 217 69 horizontal horizontal ADJ aji-51 217 70 gene gene NOUN aji-51 217 71 transfer transfer NOUN aji-51 217 72 [ [ X aji-51 217 73 90 90 NUM aji-51 217 74 ] ] PUNCT aji-51 217 75 . . PUNCT aji-51 218 1 the the DET aji-51 218 2 reciprocal reciprocal ADJ aji-51 218 3 and and CCONJ aji-51 218 4 self self NOUN aji-51 218 5 - - PUNCT aji-51 218 6 supporting support VERB aji-51 218 7 cell cell NOUN aji-51 218 8 - - PUNCT aji-51 218 9 cell cell NOUN aji-51 218 10 / / SYM aji-51 218 11 ecm ecm NOUN aji-51 218 12 interaction interaction NOUN aji-51 218 13 forces force VERB aji-51 218 14 the the DET aji-51 218 15 expression expression NOUN aji-51 218 16 of of ADP aji-51 218 17 new new ADJ aji-51 218 18 phenotypes phenotype NOUN aji-51 218 19 of of ADP aji-51 218 20 non non ADJ aji-51 218 21 - - ADJ aji-51 218 22 cancer cancer ADJ aji-51 218 23 cells cell NOUN aji-51 218 24 that that PRON aji-51 218 25 promotes promote VERB aji-51 218 26 the the DET aji-51 218 27 development development NOUN aji-51 218 28 and and CCONJ aji-51 218 29 invasion invasion NOUN aji-51 218 30 of of ADP aji-51 218 31 the the DET aji-51 218 32 cancer cancer NOUN aji-51 218 33 at at ADP aji-51 218 34 large large ADJ aji-51 218 35 [ [ X aji-51 218 36 91 91 NUM aji-51 218 37 ] ] PUNCT aji-51 218 38 . . PUNCT aji-51 219 1 trying try VERB aji-51 219 2 to to PART aji-51 219 3 bring bring VERB aji-51 219 4 order order NOUN aji-51 219 5 back back ADV aji-51 219 6 to to ADP aji-51 219 7 such such DET aji-51 219 8 a a DET aji-51 219 9 maelstrom maelstrom NOUN aji-51 219 10 is be AUX aji-51 219 11 the the DET aji-51 219 12 focus focus NOUN aji-51 219 13 of of ADP aji-51 219 14 a a DET aji-51 219 15 great great ADJ aji-51 219 16 deal deal NOUN aji-51 219 17 of of ADP aji-51 219 18 research research NOUN aji-51 219 19 at at ADP aji-51 219 20 this this DET aji-51 219 21 time time NOUN aji-51 219 22 as as SCONJ aji-51 219 23 it it PRON aji-51 219 24 is be AUX aji-51 219 25 an an DET aji-51 219 26 important important ADJ aji-51 219 27 piece piece NOUN aji-51 219 28 of of ADP aji-51 219 29 a a DET aji-51 219 30 durable durable ADJ aji-51 219 31 remission remission NOUN aji-51 219 32 . . PUNCT aji-51 220 1 targeting target VERB aji-51 220 2 the the DET aji-51 220 3 tme tme NOUN aji-51 220 4 has have AUX aji-51 220 5 proven prove VERB aji-51 220 6 to to PART aji-51 220 7 be be AUX aji-51 220 8 no no DET aji-51 220 9 easy easy ADJ aji-51 220 10 feat feat NOUN aji-51 220 11 and and CCONJ aji-51 220 12 has have AUX aji-51 220 13 been be AUX aji-51 220 14 based base VERB aji-51 220 15 upon upon SCONJ aji-51 220 16 trying try VERB aji-51 220 17 to to PART aji-51 220 18 undermine undermine VERB aji-51 220 19 the the DET aji-51 220 20 major major ADJ aji-51 220 21 components component NOUN aji-51 220 22 of of ADP aji-51 220 23 it it PRON aji-51 220 24 . . PUNCT aji-51 221 1 starting start VERB aji-51 221 2 with with ADP aji-51 221 3 the the DET aji-51 221 4 milieu milieu NOUN aji-51 221 5 itself itself PRON aji-51 221 6 , , PUNCT aji-51 221 7 it it PRON aji-51 221 8 has have AUX aji-51 221 9 long long ADV aji-51 221 10 been be AUX aji-51 221 11 noted note VERB aji-51 221 12 that that SCONJ aji-51 221 13 the the DET aji-51 221 14 tme tme NOUN aji-51 221 15 is be AUX aji-51 221 16 more more ADV aji-51 221 17 acidic acidic ADJ aji-51 221 18 than than ADP aji-51 221 19 normal normal ADJ aji-51 221 20 tissue tissue NOUN aji-51 221 21 in in ADP aji-51 221 22 the the DET aji-51 221 23 local local ADJ aji-51 221 24 area area NOUN aji-51 221 25 , , PUNCT aji-51 221 26 while while SCONJ aji-51 221 27 the the DET aji-51 221 28 intracellular intracellular ADJ aji-51 221 29 ph ph NOUN aji-51 221 30 is be AUX aji-51 221 31 often often ADV aji-51 221 32 more more ADJ aji-51 221 33 alkaline alkaline NOUN aji-51 222 1 [ [ X aji-51 222 2 92 92 NUM aji-51 222 3 ] ] PUNCT aji-51 222 4 . . PUNCT aji-51 223 1 however however ADV aji-51 223 2 , , PUNCT aji-51 223 3 just just ADV aji-51 223 4 trying try VERB aji-51 223 5 to to PART aji-51 223 6 inject inject VERB aji-51 223 7 the the DET aji-51 223 8 tme tme NOUN aji-51 223 9 with with ADP aji-51 223 10 sodium sodium NOUN aji-51 223 11 bicarbonate bicarbonate NOUN aji-51 223 12 does do AUX aji-51 223 13 not not PART aji-51 223 14 seem seem VERB aji-51 223 15 to to PART aji-51 223 16 be be AUX aji-51 223 17 a a DET aji-51 223 18 reliably reliably ADV aji-51 223 19 effective effective ADJ aji-51 223 20 treatment treatment NOUN aji-51 223 21 because because SCONJ aji-51 223 22 the the DET aji-51 223 23 active active ADJ aji-51 223 24 biological biological ADJ aji-51 223 25 processes process NOUN aji-51 223 26 that that PRON aji-51 223 27 created create VERB aji-51 223 28 the the DET aji-51 223 29 abnormal abnormal ADJ aji-51 223 30 gradient gradient NOUN aji-51 223 31 , , PUNCT aji-51 223 32 to to PART aji-51 223 33 begin begin VERB aji-51 223 34 with with ADP aji-51 223 35 , , PUNCT aji-51 223 36 will will AUX aji-51 223 37 rebound rebound VERB aji-51 223 38 and and CCONJ aji-51 223 39 increase increase VERB aji-51 223 40 its its PRON aji-51 223 41 level level NOUN aji-51 223 42 of of ADP aji-51 223 43 activity activity NOUN aji-51 223 44 to to PART aji-51 223 45 re re VERB aji-51 223 46 - - VERB aji-51 223 47 establish establish VERB aji-51 223 48 its its PRON aji-51 223 49 supportive supportive ADJ aji-51 223 50 environment environment NOUN aji-51 223 51 . . PUNCT aji-51 224 1 combining combine VERB aji-51 224 2 sodium sodium NOUN aji-51 224 3 bicarb bicarb NOUN aji-51 224 4 with with ADP aji-51 224 5 cytotoxic cytotoxic ADJ aji-51 224 6 agents agent NOUN aji-51 224 7 seems seem VERB aji-51 224 8 to to PART aji-51 224 9 offer offer VERB aji-51 224 10 a a DET aji-51 224 11 better well ADJ aji-51 224 12 strategy strategy NOUN aji-51 225 1 [ [ X aji-51 225 2 93,94 93,94 NUM aji-51 225 3 ] ] PUNCT aji-51 225 4 . . PUNCT aji-51 226 1 changing change VERB aji-51 226 2 the the DET aji-51 226 3 electrochemical electrochemical ADJ aji-51 226 4 gradient gradient NOUN aji-51 226 5 of of ADP aji-51 226 6 the the DET aji-51 226 7 tme tme NOUN aji-51 226 8 , , PUNCT aji-51 226 9 and and CCONJ aji-51 226 10 thus thus ADV aji-51 226 11 the the DET aji-51 226 12 ph ph NOUN aji-51 226 13 , , PUNCT aji-51 226 14 with with ADP aji-51 226 15 an an DET aji-51 226 16 electrical electrical ADJ aji-51 226 17 current current NOUN aji-51 226 18 has have AUX aji-51 226 19 also also ADV aji-51 226 20 shown show VERB aji-51 226 21 to to PART aji-51 226 22 be be AUX aji-51 226 23 effective effective ADJ aji-51 226 24 in in ADP aji-51 226 25 some some DET aji-51 226 26 cases case NOUN aji-51 226 27 [ [ X aji-51 226 28 95 95 NUM aji-51 226 29 - - SYM aji-51 226 30 97 97 NUM aji-51 226 31 ] ] PUNCT aji-51 226 32 . . PUNCT aji-51 227 1 another another DET aji-51 227 2 strategy strategy NOUN aji-51 227 3 that that PRON aji-51 227 4 targets target VERB aji-51 227 5 the the DET aji-51 227 6 tme tme NOUN aji-51 227 7 is be AUX aji-51 227 8 to to PART aji-51 227 9 inhibit inhibit VERB aji-51 227 10 the the DET aji-51 227 11 matrix matrix NOUN aji-51 227 12 metalloproteinases(mmps metalloproteinases(mmp NOUN aji-51 227 13 ) ) PUNCT aji-51 227 14 that that PRON aji-51 227 15 degrade degrade VERB aji-51 227 16 the the DET aji-51 227 17 extracellular extracellular ADJ aji-51 227 18 matrix matrix NOUN aji-51 227 19 ( ( PUNCT aji-51 227 20 ecm ecm NOUN aji-51 227 21 ) ) PUNCT aji-51 227 22 components component NOUN aji-51 227 23 that that PRON aji-51 227 24 then then ADV aji-51 227 25 allows allow VERB aji-51 227 26 for for ADP aji-51 227 27 local local ADJ aji-51 227 28 metastasis metastasis NOUN aji-51 227 29 . . PUNCT aji-51 228 1 research research NOUN aji-51 228 2 has have AUX aji-51 228 3 identified identify VERB aji-51 228 4 many many ADJ aji-51 228 5 substances substance NOUN aji-51 228 6 that that PRON aji-51 228 7 can can AUX aji-51 228 8 inhibit inhibit VERB aji-51 228 9 these these DET aji-51 228 10 mmp mmp PROPN aji-51 228 11 ’s ’s PART aji-51 228 12 . . PUNCT aji-51 229 1 resveratrol resveratrol NOUN aji-51 229 2 , , PUNCT aji-51 229 3 a a DET aji-51 229 4 polyphenol polyphenol NOUN aji-51 229 5 present present NOUN aji-51 229 6 in in ADP aji-51 229 7 various various ADJ aji-51 229 8 plants plant NOUN aji-51 229 9 , , PUNCT aji-51 229 10 food food NOUN aji-51 229 11 products product NOUN aji-51 229 12 , , PUNCT aji-51 229 13 red red ADJ aji-51 229 14 wine wine NOUN aji-51 229 15 , , PUNCT aji-51 229 16 and and CCONJ aji-51 229 17 grapes grape NOUN aji-51 229 18 , , PUNCT aji-51 229 19 has have AUX aji-51 229 20 been be AUX aji-51 229 21 demonstrated demonstrate VERB aji-51 229 22 to to PART aji-51 229 23 suppress suppress VERB aji-51 229 24 mmp-2 mmp-2 NUM aji-51 229 25 and and CCONJ aji-51 229 26 mmp-9 mmp-9 NOUN aji-51 229 27 [ [ X aji-51 229 28 98 98 NUM aji-51 229 29 ] ] PUNCT aji-51 229 30 . . PUNCT aji-51 230 1 additionally additionally ADV aji-51 230 2 , , PUNCT aji-51 230 3 resveratrol resveratrol NOUN aji-51 230 4 can can AUX aji-51 230 5 inhibit inhibit VERB aji-51 230 6 the the DET aji-51 230 7 expression expression NOUN aji-51 230 8 of of ADP aji-51 230 9 vascular vascular ADJ aji-51 230 10 endothelial endothelial ADJ aji-51 230 11 growth growth NOUN aji-51 230 12 factor factor NOUN aji-51 230 13 ( ( PUNCT aji-51 230 14 vegf vegf PROPN aji-51 230 15 ) ) PUNCT aji-51 230 16 and and CCONJ aji-51 230 17 act act VERB aji-51 230 18 as as ADP aji-51 230 19 an an DET aji-51 230 20 anti anti ADJ aji-51 230 21 - - ADJ aji-51 230 22 inflammatory inflammatory ADJ aji-51 230 23 agent agent NOUN aji-51 230 24 [ [ X aji-51 230 25 99 99 NUM aji-51 230 26 ] ] PUNCT aji-51 230 27 . . PUNCT aji-51 231 1 agents agent NOUN aji-51 231 2 derived derive VERB aji-51 231 3 from from ADP aji-51 231 4 marine marine ADJ aji-51 231 5 sources source NOUN aji-51 231 6 have have AUX aji-51 231 7 also also ADV aji-51 231 8 been be AUX aji-51 231 9 found find VERB aji-51 231 10 to to PART aji-51 231 11 inhibit inhibit VERB aji-51 231 12 mmp mmp PROPN aji-51 231 13 ’s ’s PART aji-51 231 14 including include VERB aji-51 231 15 various various ADJ aji-51 231 16 plant plant NOUN aji-51 231 17 and and CCONJ aji-51 231 18 animal animal NOUN aji-51 231 19 sources source NOUN aji-51 231 20 of of ADP aji-51 231 21 saccharoids saccharoid NOUN aji-51 231 22 , , PUNCT aji-51 231 23 flavonoids flavonoid NOUN aji-51 231 24 , , PUNCT aji-51 231 25 polyphones polyphone NOUN aji-51 231 26 , , PUNCT aji-51 231 27 and and CCONJ aji-51 231 28 fatty fatty NOUN aji-51 231 29 acids acid NOUN aji-51 231 30 but but CCONJ aji-51 231 31 thus thus ADV aji-51 231 32 far far ADV aji-51 231 33 , , PUNCT aji-51 231 34 few few ADJ aji-51 231 35 have have AUX aji-51 231 36 been be AUX aji-51 231 37 shown show VERB aji-51 231 38 to to PART aji-51 231 39 be be AUX aji-51 231 40 reliably reliably ADV aji-51 231 41 clinically clinically ADV aji-51 231 42 effective effective ADJ aji-51 231 43 [ [ X aji-51 231 44 100 100 NUM aji-51 231 45 ] ] PUNCT aji-51 231 46 . . PUNCT aji-51 232 1 one one NUM aji-51 232 2 agent agent NOUN aji-51 232 3 that that PRON aji-51 232 4 did do AUX aji-51 232 5 make make VERB aji-51 232 6 it it PRON aji-51 232 7 into into ADP aji-51 232 8 clinical clinical ADJ aji-51 232 9 trials trial NOUN aji-51 232 10 was be AUX aji-51 232 11 ae-941 ae-941 PROPN aji-51 232 12 / / SYM aji-51 232 13 neovastat neovastat NOUN aji-51 232 14 . . PUNCT aji-51 233 1 according accord VERB aji-51 233 2 to to ADP aji-51 233 3 the the DET aji-51 233 4 national national PROPN aji-51 233 5 cancer cancer PROPN aji-51 233 6 institute institute PROPN aji-51 233 7 , , PUNCT aji-51 233 8 “ " PUNCT aji-51 233 9 shark shark NOUN aji-51 233 10 cartilage cartilage NOUN aji-51 233 11 extract extract NOUN aji-51 233 12 , , PUNCT aji-51 233 13 ae-941 ae-941 X aji-51 233 14 competitively competitively ADV aji-51 233 15 inhibits inhibit VERB aji-51 233 16 the the DET aji-51 233 17 binding binding NOUN aji-51 233 18 of of ADP aji-51 233 19 pro pro ADJ aji-51 233 20 - - ADJ aji-51 233 21 angiogenic angiogenic ADJ aji-51 233 22 vascular vascular ADJ aji-51 233 23 endothelial endothelial NOUN aji-51 233 24 growth growth NOUN aji-51 233 25 factor factor NOUN aji-51 233 26 ( ( PUNCT aji-51 233 27 vegf vegf PROPN aji-51 233 28 ) ) PUNCT aji-51 233 29 to to ADP aji-51 233 30 its its PRON aji-51 233 31 cell cell NOUN aji-51 233 32 receptor receptor NOUN aji-51 233 33 , , PUNCT aji-51 233 34 thereby thereby ADV aji-51 233 35 inhibiting inhibit VERB aji-51 233 36 endothelial endothelial ADJ aji-51 233 37 cell cell NOUN aji-51 233 38 proliferation proliferation NOUN aji-51 233 39 ” " PUNCT aji-51 233 40 . . PUNCT aji-51 234 1 this this DET aji-51 234 2 agent agent NOUN aji-51 234 3 also also ADV aji-51 234 4 inhibits inhibit VERB aji-51 234 5 matrix matrix NOUN aji-51 234 6 metalloproteinases metalloproteinase NOUN aji-51 234 7 ( ( PUNCT aji-51 234 8 mmps mmp NOUN aji-51 234 9 ) ) PUNCT aji-51 234 10 , , PUNCT aji-51 234 11 but but CCONJ aji-51 234 12 at at ADP aji-51 234 13 this this DET aji-51 234 14 time time NOUN aji-51 234 15 , , PUNCT aji-51 234 16 there there PRON aji-51 234 17 are be VERB aji-51 234 18 no no DET aji-51 234 19 clinical clinical ADJ aji-51 234 20 studies study NOUN aji-51 234 21 involving involve VERB aji-51 234 22 its its PRON aji-51 234 23 use use NOUN aji-51 234 24 [ [ X aji-51 234 25 101 101 NUM aji-51 234 26 ] ] PUNCT aji-51 234 27 . . PUNCT aji-51 235 1 chlorella chlorella NOUN aji-51 235 2 , , PUNCT aji-51 235 3 a a DET aji-51 235 4 protein protein NOUN aji-51 235 5 extract extract NOUN aji-51 235 6 from from ADP aji-51 235 7 algae algae NOUN aji-51 235 8 has have AUX aji-51 235 9 also also ADV aji-51 235 10 been be AUX aji-51 235 11 shown show VERB aji-51 235 12 to to PART aji-51 235 13 have have VERB aji-51 235 14 mmp mmp PROPN aji-51 235 15 ’s ’s PART aji-51 235 16 inhibitory inhibitory ADJ aji-51 235 17 properties property NOUN aji-51 235 18 [ [ X aji-51 235 19 102 102 NUM aji-51 235 20 ] ] PUNCT aji-51 235 21 . . PUNCT aji-51 236 1 tissue tissue NOUN aji-51 236 2 inhibitors inhibitor NOUN aji-51 236 3 of of ADP aji-51 236 4 metalloproteinases metalloproteinase NOUN aji-51 236 5 ( ( PUNCT aji-51 236 6 timp timp NOUN aji-51 236 7 ’s ’s PART aji-51 236 8 ) ) PUNCT aji-51 236 9 naturally naturally ADV aji-51 236 10 impede impede VERB aji-51 236 11 the the DET aji-51 236 12 activity activity NOUN aji-51 236 13 of of ADP aji-51 236 14 the the DET aji-51 236 15 mmp mmp PROPN aji-51 236 16 ’s ’s PART aji-51 236 17 and and CCONJ aji-51 236 18 its its PRON aji-51 236 19 the the DET aji-51 236 20 imbalance imbalance NOUN aji-51 236 21 between between ADP aji-51 236 22 the the DET aji-51 236 23 activation activation NOUN aji-51 236 24 and and CCONJ aji-51 236 25 inhibition inhibition NOUN aji-51 236 26 of of ADP aji-51 236 27 them they PRON aji-51 236 28 that that PRON aji-51 236 29 is be AUX aji-51 236 30 largely largely ADV aji-51 236 31 responsible responsible ADJ aji-51 236 32 for for ADP aji-51 236 33 the the DET aji-51 236 34 progression progression NOUN aji-51 236 35 of of ADP aji-51 236 36 a a DET aji-51 236 37 tumor tumor NOUN aji-51 236 38 ’s ’s PART aji-51 236 39 growth growth NOUN aji-51 236 40 [ [ X aji-51 236 41 103 103 NUM aji-51 236 42 ] ] PUNCT aji-51 236 43 . . PUNCT aji-51 237 1 other other ADJ aji-51 237 2 polyphenols polyphenol NOUN aji-51 237 3 that that PRON aji-51 237 4 can can AUX aji-51 237 5 inhibit inhibit VERB aji-51 237 6 the the DET aji-51 237 7 mmp mmp PROPN aji-51 237 8 ’s ’s PART aji-51 237 9 are be AUX aji-51 237 10 quercetin quercetin NOUN aji-51 237 11 , , PUNCT aji-51 237 12 epigallocatechin epigallocatechin PROPN aji-51 237 13 gallate gallate PROPN aji-51 237 14 , , PUNCT aji-51 237 15 and and CCONJ aji-51 237 16 curcumin curcumin NOUN aji-51 237 17 . . PUNCT aji-51 238 1 they they PRON aji-51 238 2 act act VERB aji-51 238 3 as as ADP aji-51 238 4 dynamic dynamic ADJ aji-51 238 5 antioxidants antioxidant NOUN aji-51 238 6 , , PUNCT aji-51 238 7 and and CCONJ aji-51 238 8 are be AUX aji-51 238 9 able able ADJ aji-51 238 10 to to PART aji-51 238 11 interact interact VERB aji-51 238 12 with with ADP aji-51 238 13 cell cell NOUN aji-51 238 14 - - PUNCT aji-51 238 15 signaling signal VERB aji-51 238 16 pathways pathway NOUN aji-51 238 17 , , PUNCT aji-51 238 18 modulating modulate VERB aji-51 238 19 gene gene NOUN aji-51 238 20 expression expression NOUN aji-51 238 21 in in ADP aji-51 238 22 three three NUM aji-51 238 23 different different ADJ aji-51 238 24 ways way NOUN aji-51 238 25 : : PUNCT aji-51 238 26 i i NOUN aji-51 238 27 ) ) PUNCT aji-51 238 28 influencing influence VERB aji-51 238 29 the the DET aji-51 238 30 activity activity NOUN aji-51 238 31 of of ADP aji-51 238 32 transcription transcription NOUN aji-51 238 33 factors factor NOUN aji-51 238 34 , , PUNCT aji-51 238 35 ii ii NOUN aji-51 238 36 ) ) PUNCT aji-51 238 37 epigenetically epigenetically ADV aji-51 238 38 , , PUNCT aji-51 238 39 modulating modulate VERB aji-51 238 40 micrornas microrna NOUN aji-51 238 41 , , PUNCT aji-51 238 42 and and CCONJ aji-51 238 43 iii iii X aji-51 238 44 ) ) PUNCT aji-51 238 45 having have VERB aji-51 238 46 an an DET aji-51 238 47 anti anti ADJ aji-51 238 48 - - ADJ aji-51 238 49 inflammatory inflammatory ADJ aji-51 238 50 effect effect NOUN aji-51 238 51 , , PUNCT aji-51 238 52 all all PRON aji-51 238 53 of of ADP aji-51 238 54 these these DET aji-51 238 55 actions action NOUN aji-51 238 56 serve serve VERB aji-51 238 57 to to ADP aji-51 238 58 down down ADV aji-51 238 59 - - PUNCT aji-51 238 60 regulate regulate VERB aji-51 238 61 mmp mmp PROPN aji-51 238 62 activity activity NOUN aji-51 238 63 [ [ X aji-51 238 64 104 104 NUM aji-51 238 65 ] ] PUNCT aji-51 238 66 . . PUNCT aji-51 239 1 combining combine VERB aji-51 239 2 polyphenols polyphenol NOUN aji-51 239 3 with with ADP aji-51 239 4 amino amino ADJ aji-51 239 5 acids acid NOUN aji-51 239 6 that that PRON aji-51 239 7 are be AUX aji-51 239 8 used use VERB aji-51 239 9 in in ADP aji-51 239 10 the the DET aji-51 239 11 production production NOUN aji-51 239 12 of of ADP aji-51 239 13 the the DET aji-51 239 14 ecm ecm NOUN aji-51 239 15 along along ADP aji-51 239 16 with with ADP aji-51 239 17 vitamin vitamin NOUN aji-51 239 18 c c NOUN aji-51 239 19 which which PRON aji-51 239 20 , , PUNCT aji-51 239 21 too too ADV aji-51 239 22 , , PUNCT aji-51 239 23 is be AUX aji-51 239 24 critical critical ADJ aji-51 239 25 for for ADP aji-51 239 26 ecm ecm NOUN aji-51 239 27 support support NOUN aji-51 239 28 , , PUNCT aji-51 239 29 has have AUX aji-51 239 30 been be AUX aji-51 239 31 shown show VERB aji-51 239 32 to to PART aji-51 239 33 be be AUX aji-51 239 34 an an DET aji-51 239 35 effective effective ADJ aji-51 239 36 strategy strategy NOUN aji-51 239 37 for for ADP aji-51 239 38 slowing slow VERB aji-51 239 39 the the DET aji-51 239 40 progression progression NOUN aji-51 239 41 of of ADP aji-51 239 42 tumors tumor NOUN aji-51 239 43 . . PUNCT aji-51 240 1 their their PRON aji-51 240 2 combined combined ADJ aji-51 240 3 anti anti ADJ aji-51 240 4 - - ADJ aji-51 240 5 cancer cancer ADJ aji-51 240 6 effects effect NOUN aji-51 240 7 include include VERB aji-51 240 8 stoff stoff PROPN aji-51 240 9 ; ; PUNCT aji-51 240 10 aji aji PROPN aji-51 240 11 , , PUNCT aji-51 240 12 5(1 5(1 NUM aji-51 240 13 ): ): PUNCT aji-51 240 14 1 1 NUM aji-51 240 15 - - SYM aji-51 240 16 39 39 NUM aji-51 240 17 , , PUNCT aji-51 240 18 2022 2022 NUM aji-51 240 19 ; ; PUNCT aji-51 240 20 article article NOUN aji-51 240 21 no.aji.77967 no.aji.77967 VERB aji-51 240 22 6 6 NUM aji-51 240 23 inhibition inhibition NOUN aji-51 240 24 of of ADP aji-51 240 25 : : PUNCT aji-51 240 26 metastasis metastasis NOUN aji-51 240 27 , , PUNCT aji-51 240 28 tumor tumor NOUN aji-51 240 29 cell cell NOUN aji-51 240 30 growth growth NOUN aji-51 240 31 , , PUNCT aji-51 240 32 matrix matrix NOUN aji-51 240 33 metalloproteinase metalloproteinase NOUN aji-51 240 34 secretion secretion NOUN aji-51 240 35 and and CCONJ aji-51 240 36 activity activity NOUN aji-51 240 37 , , PUNCT aji-51 240 38 local local ADJ aji-51 240 39 invasion invasion NOUN aji-51 240 40 , , PUNCT aji-51 240 41 angiogenesis angiogenesis NOUN aji-51 240 42 , , PUNCT aji-51 240 43 as as ADV aji-51 240 44 well well ADV aji-51 240 45 as as ADP aji-51 240 46 induction induction NOUN aji-51 240 47 of of ADP aji-51 240 48 apoptosis apoptosis NOUN aji-51 240 49 of of ADP aji-51 240 50 the the DET aji-51 240 51 cancer cancer NOUN aji-51 240 52 cells cell NOUN aji-51 240 53 [ [ X aji-51 240 54 105 105 NUM aji-51 240 55 - - SYM aji-51 240 56 108 108 NUM aji-51 240 57 ] ] PUNCT aji-51 240 58 . . PUNCT aji-51 241 1 this this DET aji-51 241 2 combination combination NOUN aji-51 241 3 has have AUX aji-51 241 4 been be AUX aji-51 241 5 effective effective ADJ aji-51 241 6 both both CCONJ aji-51 241 7 in in ADP aji-51 241 8 vitro vitro X aji-51 241 9 and and CCONJ aji-51 241 10 in in ADP aji-51 241 11 vivo vivo NOUN aji-51 241 12 against against ADP aji-51 241 13 many many ADJ aji-51 241 14 different different ADJ aji-51 241 15 cancers cancer NOUN aji-51 241 16 and and CCONJ aji-51 241 17 cancer cancer NOUN aji-51 241 18 cell cell NOUN aji-51 241 19 lines line NOUN aji-51 241 20 including include VERB aji-51 241 21 ovarian ovarian ADJ aji-51 241 22 , , PUNCT aji-51 241 23 melanoma melanoma ADJ aji-51 241 24 , , PUNCT aji-51 241 25 squamous squamous ADJ aji-51 241 26 cell cell NOUN aji-51 241 27 , , PUNCT aji-51 241 28 and and CCONJ aji-51 241 29 others other NOUN aji-51 241 30 in in ADP aji-51 241 31 a a DET aji-51 241 32 dose dose NOUN aji-51 241 33 - - PUNCT aji-51 241 34 dependant dependant ADJ aji-51 241 35 curve curve NOUN aji-51 241 36 [ [ X aji-51 241 37 109 109 NUM aji-51 241 38 ] ] PUNCT aji-51 241 39 . . PUNCT aji-51 242 1 a a DET aji-51 242 2 chief chief ADJ aji-51 242 3 problem problem NOUN aji-51 242 4 for for ADP aji-51 242 5 the the DET aji-51 242 6 use use NOUN aji-51 242 7 of of ADP aji-51 242 8 polyphenolic polyphenolic ADJ aji-51 242 9 compounds compound NOUN aji-51 242 10 against against ADP aji-51 242 11 cancer cancer NOUN aji-51 242 12 is be AUX aji-51 242 13 their their PRON aji-51 242 14 low low ADJ aji-51 242 15 bioavailability bioavailability NOUN aji-51 242 16 [ [ X aji-51 242 17 110 110 NUM aji-51 242 18 ] ] PUNCT aji-51 242 19 . . PUNCT aji-51 243 1 different different ADJ aji-51 243 2 types type NOUN aji-51 243 3 of of ADP aji-51 243 4 formulations formulation NOUN aji-51 243 5 have have AUX aji-51 243 6 been be AUX aji-51 243 7 designed design VERB aji-51 243 8 to to PART aji-51 243 9 address address VERB aji-51 243 10 this this DET aji-51 243 11 issue issue NOUN aji-51 243 12 , , PUNCT aji-51 243 13 nanonization nanonization NOUN aji-51 243 14 being be AUX aji-51 243 15 one one NUM aji-51 243 16 of of ADP aji-51 243 17 the the DET aji-51 243 18 most most ADV aji-51 243 19 notable notable ADJ aji-51 243 20 approaches approach NOUN aji-51 243 21 among among ADP aji-51 243 22 them they PRON aji-51 243 23 . . PUNCT aji-51 244 1 variations variation NOUN aji-51 244 2 of of ADP aji-51 244 3 nanoformulations nanoformulation NOUN aji-51 244 4 are be AUX aji-51 244 5 designed design VERB aji-51 244 6 to to PART aji-51 244 7 be be AUX aji-51 244 8 effectively effectively ADV aji-51 244 9 transported transport VERB aji-51 244 10 through through ADP aji-51 244 11 the the DET aji-51 244 12 relevant relevant ADJ aji-51 244 13 biological biological ADJ aji-51 244 14 barriers barrier NOUN aji-51 244 15 to to ADP aji-51 244 16 the the DET aji-51 244 17 targeted target VERB aji-51 244 18 organs organ NOUN aji-51 244 19 , , PUNCT aji-51 244 20 tissues tissue NOUN aji-51 244 21 , , PUNCT aji-51 244 22 and and CCONJ aji-51 244 23 cells cell NOUN aji-51 244 24 . . PUNCT aji-51 245 1 research research NOUN aji-51 245 2 on on ADP aji-51 245 3 natural natural ADJ aji-51 245 4 polyphenols polyphenol NOUN aji-51 245 5 as as SCONJ aji-51 245 6 bioactive bioactive NOUN aji-51 245 7 agents agent NOUN aji-51 245 8 include include VERB aji-51 245 9 : : PUNCT aji-51 245 10 resveratrol resveratrol NOUN aji-51 245 11 , , PUNCT aji-51 245 12 curcumin curcumin NOUN aji-51 245 13 , , PUNCT aji-51 245 14 quercetin quercetin NOUN aji-51 245 15 , , PUNCT aji-51 245 16 epigallocatechin-3 epigallocatechin-3 PROPN aji-51 245 17 - - NOUN aji-51 245 18 gallate gallate NOUN aji-51 245 19 , , PUNCT aji-51 245 20 chrysin chrysin PROPN aji-51 245 21 , , PUNCT aji-51 245 22 baicalein baicalein PROPN aji-51 245 23 , , PUNCT aji-51 245 24 luteolin luteolin PROPN aji-51 245 25 , , PUNCT aji-51 245 26 honokiol honokiol NOUN aji-51 245 27 , , PUNCT aji-51 245 28 silibinin silibinin NOUN aji-51 245 29 , , PUNCT aji-51 245 30 and and CCONJ aji-51 245 31 coumarin coumarin NOUN aji-51 245 32 derivatives derivative NOUN aji-51 245 33 , , PUNCT aji-51 245 34 which which PRON aji-51 245 35 have have AUX aji-51 245 36 shown show VERB aji-51 245 37 efficacy efficacy NOUN aji-51 245 38 in in ADP aji-51 245 39 a a DET aji-51 245 40 dose dose NOUN aji-51 245 41 - - PUNCT aji-51 245 42 dependent dependent ADJ aji-51 245 43 manner manner NOUN aji-51 245 44 and and CCONJ aji-51 245 45 may may AUX aji-51 245 46 result result VERB aji-51 245 47 in in ADP aji-51 245 48 better well ADJ aji-51 245 49 treatments treatment NOUN aji-51 245 50 of of ADP aji-51 245 51 cancer cancer NOUN aji-51 245 52 [ [ X aji-51 245 53 111 111 NUM aji-51 245 54 ] ] PUNCT aji-51 245 55 . . PUNCT aji-51 246 1 the the DET aji-51 246 2 tumor tumor NOUN aji-51 246 3 microenvironment microenvironment NOUN aji-51 246 4 , , PUNCT aji-51 246 5 created create VERB aji-51 246 6 by by ADP aji-51 246 7 the the DET aji-51 246 8 cancer cancer NOUN aji-51 246 9 , , PUNCT aji-51 246 10 further far ADV aji-51 246 11 supports support VERB aji-51 246 12 its its PRON aji-51 246 13 dysfunctional dysfunctional ADJ aji-51 246 14 growth growth NOUN aji-51 246 15 and and CCONJ aji-51 246 16 ability ability NOUN aji-51 246 17 to to PART aji-51 246 18 metastasize metastasize VERB aji-51 246 19 through through ADP aji-51 246 20 epigenetic epigenetic ADJ aji-51 246 21 changes change NOUN aji-51 246 22 . . PUNCT aji-51 247 1 epigenetic epigenetic ADJ aji-51 247 2 changes change NOUN aji-51 247 3 are be AUX aji-51 247 4 heritable heritable ADJ aji-51 247 5 but but CCONJ aji-51 247 6 , , PUNCT aji-51 247 7 unlike unlike ADP aji-51 247 8 genetic genetic ADJ aji-51 247 9 nucleotide nucleotide NOUN aji-51 247 10 modification modification NOUN aji-51 247 11 , , PUNCT aji-51 247 12 are be AUX aji-51 247 13 reversible reversible ADJ aji-51 247 14 and and CCONJ aji-51 247 15 therefore therefore ADV aji-51 247 16 targetable targetable ADJ aji-51 247 17 as as ADP aji-51 247 18 part part NOUN aji-51 247 19 of of ADP aji-51 247 20 an an DET aji-51 247 21 oncolytic oncolytic ADJ aji-51 247 22 therapy therapy NOUN aji-51 247 23 . . PUNCT aji-51 248 1 a a DET aji-51 248 2 variety variety NOUN aji-51 248 3 of of ADP aji-51 248 4 epigenetic epigenetic ADJ aji-51 248 5 mechanisms mechanism NOUN aji-51 248 6 have have AUX aji-51 248 7 been be AUX aji-51 248 8 identified identify VERB aji-51 248 9 that that PRON aji-51 248 10 can can AUX aji-51 248 11 induce induce VERB aji-51 248 12 and/or and/or CCONJ aji-51 248 13 support support VERB aji-51 248 14 a a DET aji-51 248 15 cancer cancer NOUN aji-51 248 16 , , PUNCT aji-51 248 17 such such ADJ aji-51 248 18 as as ADP aji-51 248 19 : : PUNCT aji-51 248 20 silencing silence VERB aji-51 248 21 of of ADP aji-51 248 22 tumor tumor NOUN aji-51 248 23 suppressor suppressor NOUN aji-51 248 24 genes gene NOUN aji-51 248 25 , , PUNCT aji-51 248 26 activation activation NOUN aji-51 248 27 of of ADP aji-51 248 28 oncogenes oncogene NOUN aji-51 248 29 by by ADP aji-51 248 30 altered alter VERB aji-51 248 31 cytosine cytosine NOUN aji-51 248 32 phosphorus phosphorus NOUN aji-51 248 33 guanine guanine NOUN aji-51 248 34 ( ( PUNCT aji-51 248 35 cpg cpg NOUN aji-51 248 36 ) ) PUNCT aji-51 248 37 island island NOUN aji-51 248 38 methylation methylation NOUN aji-51 248 39 patterns pattern NOUN aji-51 248 40 , , PUNCT aji-51 248 41 histone histone NOUN aji-51 248 42 modifications modification NOUN aji-51 248 43 , , PUNCT aji-51 248 44 and and CCONJ aji-51 248 45 dysregulation dysregulation NOUN aji-51 248 46 of of ADP aji-51 248 47 dna dna NOUN aji-51 248 48 binding bind VERB aji-51 248 49 proteins protein NOUN aji-51 248 50 . . PUNCT aji-51 249 1 a a DET aji-51 249 2 quick quick ADJ aji-51 249 3 search search NOUN aji-51 249 4 in in ADP aji-51 249 5 https://www.ncbi.nlm.nih.gov/pmc https://www.ncbi.nlm.nih.gov/pmc NOUN aji-51 249 6 for for ADP aji-51 249 7 “ " PUNCT aji-51 249 8 epigenetic epigenetic ADJ aji-51 249 9 toxins toxin NOUN aji-51 249 10 and and CCONJ aji-51 249 11 human human ADJ aji-51 249 12 cancers cancer NOUN aji-51 249 13 ” " PUNCT aji-51 249 14 will will AUX aji-51 249 15 yield yield VERB aji-51 249 16 thousands thousand NOUN aji-51 249 17 of of ADP aji-51 249 18 articles article NOUN aji-51 249 19 about about ADP aji-51 249 20 substances substance NOUN aji-51 249 21 both both CCONJ aji-51 249 22 natural natural ADJ aji-51 249 23 and and CCONJ aji-51 249 24 synthetic synthetic NOUN aji-51 249 25 that that PRON aji-51 249 26 can can AUX aji-51 249 27 create create VERB aji-51 249 28 such such ADJ aji-51 249 29 changes change NOUN aji-51 249 30 [ [ X aji-51 249 31 112 112 NUM aji-51 249 32 ] ] PUNCT aji-51 249 33 . . PUNCT aji-51 250 1 not not PART aji-51 250 2 only only ADV aji-51 250 3 are be AUX aji-51 250 4 the the DET aji-51 250 5 epigenetic epigenetic ADJ aji-51 250 6 changes change NOUN aji-51 250 7 potential potential ADJ aji-51 250 8 targets target NOUN aji-51 250 9 for for ADP aji-51 250 10 treatment treatment NOUN aji-51 250 11 , , PUNCT aji-51 250 12 but but CCONJ aji-51 250 13 their their PRON aji-51 250 14 inducers inducer NOUN aji-51 250 15 are be AUX aji-51 250 16 as as ADV aji-51 250 17 well well ADV aji-51 250 18 [ [ X aji-51 250 19 113,114 113,114 NUM aji-51 250 20 ] ] PUNCT aji-51 250 21 . . PUNCT aji-51 251 1 the the DET aji-51 251 2 tme tme NOUN aji-51 251 3 creates create VERB aji-51 251 4 and and CCONJ aji-51 251 5 supports support VERB aji-51 251 6 epigenetic epigenetic ADJ aji-51 251 7 biochemical biochemical ADJ aji-51 251 8 reactions reaction NOUN aji-51 251 9 that that PRON aji-51 251 10 dynamically dynamically ADV aji-51 251 11 regulate regulate VERB aji-51 251 12 dna dna NOUN aji-51 251 13 expression expression NOUN aji-51 251 14 . . PUNCT aji-51 252 1 nucleotide nucleotide NOUN aji-51 252 2 methylation methylation NOUN aji-51 252 3 and and CCONJ aji-51 252 4 histone histone NOUN aji-51 252 5 modification modification NOUN aji-51 252 6 induce induce VERB aji-51 252 7 the the DET aji-51 252 8 dysregulation dysregulation NOUN aji-51 252 9 of of ADP aji-51 252 10 genes gene NOUN aji-51 252 11 related relate VERB aji-51 252 12 to to ADP aji-51 252 13 proliferation proliferation NOUN aji-51 252 14 , , PUNCT aji-51 252 15 apoptosis apoptosis NOUN aji-51 252 16 , , PUNCT aji-51 252 17 and and CCONJ aji-51 252 18 metastasis metastasis NOUN aji-51 252 19 [ [ X aji-51 252 20 115 115 NUM aji-51 252 21 ] ] PUNCT aji-51 252 22 . . PUNCT aji-51 253 1 dna dna PROPN aji-51 253 2 methylation methylation NOUN aji-51 253 3 is be AUX aji-51 253 4 strongly strongly ADV aji-51 253 5 associated associate VERB aji-51 253 6 with with ADP aji-51 253 7 the the DET aji-51 253 8 repression repression NOUN aji-51 253 9 of of ADP aji-51 253 10 transcription transcription NOUN aji-51 253 11 of of ADP aji-51 253 12 tumor tumor NOUN aji-51 253 13 suppressor suppressor NOUN aji-51 253 14 genes gene NOUN aji-51 253 15 through through ADP aji-51 253 16 adding add VERB aji-51 253 17 a a DET aji-51 253 18 methyl methyl NOUN aji-51 253 19 group group NOUN aji-51 253 20 by by ADP aji-51 253 21 dna dna PROPN aji-51 253 22 methyltransferases methyltransferase NOUN aji-51 253 23 ( ( PUNCT aji-51 253 24 dnmts dnmt VERB aji-51 253 25 ) ) PUNCT aji-51 254 1 [ [ X aji-51 254 2 116 116 NUM aji-51 254 3 ] ] PUNCT aji-51 254 4 . . PUNCT aji-51 255 1 other other ADJ aji-51 255 2 reactions reaction NOUN aji-51 255 3 by by ADP aji-51 255 4 histone histone NOUN aji-51 255 5 deacetylases deacetylase NOUN aji-51 255 6 ( ( PUNCT aji-51 255 7 hdacs hdac NOUN aji-51 255 8 ) ) PUNCT aji-51 255 9 contribute contribute VERB aji-51 255 10 to to ADP aji-51 255 11 transcriptional transcriptional ADJ aji-51 255 12 repression repression NOUN aji-51 255 13 by by ADP aji-51 255 14 removing remove VERB aji-51 255 15 the the DET aji-51 255 16 acetyl acetyl NOUN aji-51 255 17 group group NOUN aji-51 255 18 at at ADP aji-51 255 19 lysine lysine NOUN aji-51 255 20 residues residue NOUN aji-51 255 21 leading lead VERB aji-51 255 22 to to ADP aji-51 255 23 tumorigenesis tumorigenesis NOUN aji-51 255 24 , , PUNCT aji-51 255 25 as as ADP aji-51 255 26 a a DET aji-51 255 27 result result NOUN aji-51 255 28 of of ADP aji-51 255 29 the the DET aji-51 255 30 research research NOUN aji-51 255 31 , , PUNCT aji-51 255 32 both both DET aji-51 255 33 biochemical biochemical ADJ aji-51 255 34 pathways pathway NOUN aji-51 255 35 have have AUX aji-51 255 36 become become VERB aji-51 255 37 the the DET aji-51 255 38 focus focus NOUN aji-51 255 39 of of ADP aji-51 255 40 intense intense ADJ aji-51 255 41 research research NOUN aji-51 255 42 to to PART aji-51 255 43 develop develop VERB aji-51 255 44 dnmt dnmt NOUN aji-51 255 45 and and CCONJ aji-51 255 46 hdac hdac VERB aji-51 255 47 inhibitors inhibitor NOUN aji-51 255 48 [ [ X aji-51 255 49 117 117 NUM aji-51 255 50 ] ] PUNCT aji-51 255 51 . . PUNCT aji-51 256 1 histone histone NOUN aji-51 256 2 acetyltransferases acetyltransferase NOUN aji-51 256 3 ( ( PUNCT aji-51 256 4 hat hat NOUN aji-51 256 5 ) ) PUNCT aji-51 256 6 , , PUNCT aji-51 256 7 erasers eraser NOUN aji-51 256 8 ( ( PUNCT aji-51 256 9 histone histone NOUN aji-51 256 10 demethylases demethylase NOUN aji-51 256 11 ( ( PUNCT aji-51 256 12 hdm hdm PROPN aji-51 256 13 ) ) PUNCT aji-51 256 14 and and CCONJ aji-51 256 15 histone histone NOUN aji-51 256 16 methylases methylase NOUN aji-51 256 17 ( ( PUNCT aji-51 256 18 hmt hmt NOUN aji-51 256 19 ) ) PUNCT aji-51 256 20 have have AUX aji-51 256 21 also also ADV aji-51 256 22 become become VERB aji-51 256 23 epigenetic epigenetic ADJ aji-51 256 24 targets target NOUN aji-51 256 25 of of ADP aji-51 256 26 research research NOUN aji-51 256 27 [ [ X aji-51 256 28 118 118 NUM aji-51 256 29 ] ] PUNCT aji-51 256 30 . . PUNCT aji-51 257 1 some some DET aji-51 257 2 drugs drug NOUN aji-51 257 3 are be AUX aji-51 257 4 currently currently ADV aji-51 257 5 available available ADJ aji-51 257 6 and and CCONJ aji-51 257 7 used use VERB aji-51 257 8 for for ADP aji-51 257 9 their their PRON aji-51 257 10 epigenetic epigenetic ADJ aji-51 257 11 effects effect NOUN aji-51 257 12 such such ADJ aji-51 257 13 as as ADP aji-51 257 14 decitabine decitabine NOUN aji-51 257 15 , , PUNCT aji-51 257 16 which which PRON aji-51 257 17 can can AUX aji-51 257 18 prevent prevent VERB aji-51 257 19 dna dna NOUN aji-51 257 20 remethylation remethylation NOUN aji-51 257 21 and and CCONJ aji-51 257 22 re re NOUN aji-51 257 23 - - VERB aji-51 257 24 activate activate VERB aji-51 257 25 silenced silence VERB aji-51 257 26 suppressor suppressor NOUN aji-51 257 27 genes gene NOUN aji-51 257 28 [ [ X aji-51 257 29 119 119 NUM aji-51 257 30 ] ] PUNCT aji-51 257 31 . . PUNCT aji-51 258 1 azacitidine azacitidine PROPN aji-51 258 2 is be AUX aji-51 258 3 considered consider VERB aji-51 258 4 a a DET aji-51 258 5 global global ADJ aji-51 258 6 dnmt dnmt NOUN aji-51 258 7 inhibitor inhibitor NOUN aji-51 258 8 and and CCONJ aji-51 258 9 upon upon SCONJ aji-51 258 10 treatment treatment NOUN aji-51 258 11 of of ADP aji-51 258 12 breast breast NOUN aji-51 258 13 cancer cancer NOUN aji-51 258 14 cells cell NOUN aji-51 258 15 , , PUNCT aji-51 258 16 dna dna PROPN aji-51 258 17 re re NOUN aji-51 258 18 - - NOUN aji-51 258 19 methylation methylation NOUN aji-51 258 20 was be AUX aji-51 258 21 inhibited inhibit VERB aji-51 258 22 for for ADP aji-51 258 23 23 23 NUM aji-51 258 24 out out ADP aji-51 258 25 of of ADP aji-51 258 26 26 26 NUM aji-51 258 27 tested test VERB aji-51 258 28 hypermethylated hypermethylate VERB aji-51 258 29 genes gene NOUN aji-51 258 30 , , PUNCT aji-51 258 31 allowing allow VERB aji-51 258 32 5 5 NUM aji-51 258 33 tumor tumor NOUN aji-51 258 34 suppressor suppressor NOUN aji-51 258 35 genes gene NOUN aji-51 258 36 to to PART aji-51 258 37 be be AUX aji-51 258 38 reexpressed reexpresse VERB aji-51 258 39 [ [ X aji-51 258 40 120 120 NUM aji-51 258 41 ] ] PUNCT aji-51 258 42 . . PUNCT aji-51 259 1 the the DET aji-51 259 2 problem problem NOUN aji-51 259 3 with with ADP aji-51 259 4 these these PRON aji-51 259 5 and and CCONJ aji-51 259 6 the the DET aji-51 259 7 many many ADJ aji-51 259 8 other other ADJ aji-51 259 9 drugs drug NOUN aji-51 259 10 , , PUNCT aji-51 259 11 thus thus ADV aji-51 259 12 far far ADV aji-51 259 13 developed develop VERB aji-51 259 14 for for ADP aji-51 259 15 their their PRON aji-51 259 16 epigenetic epigenetic ADJ aji-51 259 17 effects effect NOUN aji-51 259 18 , , PUNCT aji-51 259 19 are be AUX aji-51 259 20 the the DET aji-51 259 21 unintended unintended ADJ aji-51 259 22 consequences consequence NOUN aji-51 259 23 ( ( PUNCT aji-51 259 24 side side NOUN aji-51 259 25 effects effect NOUN aji-51 259 26 ) ) PUNCT aji-51 259 27 on on ADP aji-51 259 28 normal normal ADJ aji-51 259 29 , , PUNCT aji-51 259 30 healthy healthy ADJ aji-51 259 31 cells cell NOUN aji-51 259 32 elsewhere elsewhere ADV aji-51 259 33 in in ADP aji-51 259 34 the the DET aji-51 259 35 body body NOUN aji-51 259 36 . . PUNCT aji-51 260 1 reducing reduce VERB aji-51 260 2 and and CCONJ aji-51 260 3 pulsing pulse VERB aji-51 260 4 the the DET aji-51 260 5 doses dose NOUN aji-51 260 6 given give VERB aji-51 260 7 has have AUX aji-51 260 8 helped help VERB aji-51 260 9 somewhat somewhat ADV aji-51 260 10 to to PART aji-51 260 11 reduce reduce VERB aji-51 260 12 the the DET aji-51 260 13 side side NOUN aji-51 260 14 effects effect NOUN aji-51 260 15 while while SCONJ aji-51 260 16 maintaining maintain VERB aji-51 260 17 efficacy efficacy NOUN aji-51 260 18 [ [ X aji-51 260 19 121 121 NUM aji-51 260 20 ] ] PUNCT aji-51 260 21 . . PUNCT aji-51 261 1 the the DET aji-51 261 2 tactics tactic NOUN aji-51 261 3 for for ADP aji-51 261 4 targeting target VERB aji-51 261 5 the the DET aji-51 261 6 tme tme NOUN aji-51 261 7 have have VERB aji-51 261 8 a a DET aji-51 261 9 certain certain ADJ aji-51 261 10 amount amount NOUN aji-51 261 11 of of ADP aji-51 261 12 overlap overlap NOUN aji-51 261 13 with with ADP aji-51 261 14 those those PRON aji-51 261 15 that that PRON aji-51 261 16 seek seek VERB aji-51 261 17 the the DET aji-51 261 18 destruction destruction NOUN aji-51 261 19 of of ADP aji-51 261 20 the the DET aji-51 261 21 cancer cancer NOUN aji-51 261 22 stem stem NOUN aji-51 261 23 cells cell NOUN aji-51 261 24 because because SCONJ aji-51 261 25 they they PRON aji-51 261 26 are be AUX aji-51 261 27 the the DET aji-51 261 28 major major ADJ aji-51 261 29 architects architect NOUN aji-51 261 30 of of ADP aji-51 261 31 their their PRON aji-51 261 32 immediate immediate ADJ aji-51 261 33 environment environment NOUN aji-51 261 34 . . PUNCT aji-51 262 1 however however ADV aji-51 262 2 , , PUNCT aji-51 262 3 the the DET aji-51 262 4 chief chief ADJ aji-51 262 5 goal goal NOUN aji-51 262 6 of of ADP aji-51 262 7 an an DET aji-51 262 8 antimetabolic antimetabolic ADJ aji-51 262 9 cancer cancer NOUN aji-51 262 10 therapy therapy NOUN aji-51 262 11 is be AUX aji-51 262 12 to to PART aji-51 262 13 disrupt disrupt VERB aji-51 262 14 the the DET aji-51 262 15 energy energy NOUN aji-51 262 16 production production NOUN aji-51 262 17 pathways pathway NOUN aji-51 262 18 that that PRON aji-51 262 19 support support VERB aji-51 262 20 the the DET aji-51 262 21 cancer cancer NOUN aji-51 262 22 cells cell NOUN aji-51 262 23 . . PUNCT aji-51 263 1 for for ADP aji-51 263 2 example example NOUN aji-51 263 3 , , PUNCT aji-51 263 4 enox2 enox2 PROPN aji-51 263 5 is be AUX aji-51 263 6 a a DET aji-51 263 7 gene gene NOUN aji-51 263 8 located locate VERB aji-51 263 9 on on ADP aji-51 263 10 the the DET aji-51 263 11 long long ADJ aji-51 263 12 arm arm NOUN aji-51 263 13 of of ADP aji-51 263 14 the the DET aji-51 263 15 x x NOUN aji-51 263 16 chromosome chromosome NOUN aji-51 263 17 and and CCONJ aji-51 263 18 encodes encode NOUN aji-51 263 19 for for ADP aji-51 263 20 the the DET aji-51 263 21 ecto ecto PROPN aji-51 263 22 - - ADJ aji-51 263 23 nox nox ADJ aji-51 263 24 protein protein NOUN aji-51 263 25 . . PUNCT aji-51 264 1 it it PRON aji-51 264 2 is be AUX aji-51 264 3 a a DET aji-51 264 4 member member NOUN aji-51 264 5 of of ADP aji-51 264 6 the the DET aji-51 264 7 nox nox NOUN aji-51 264 8 family family NOUN aji-51 264 9 of of ADP aji-51 264 10 nadph nadph ADJ aji-51 264 11 oxidases oxidase NOUN aji-51 264 12 which which PRON aji-51 264 13 are be AUX aji-51 264 14 important important ADJ aji-51 264 15 for for ADP aji-51 264 16 energy energy NOUN aji-51 264 17 production production NOUN aji-51 264 18 and and CCONJ aji-51 264 19 the the DET aji-51 264 20 growth growth NOUN aji-51 264 21 of of ADP aji-51 264 22 the the DET aji-51 264 23 cell cell NOUN aji-51 264 24 . . PUNCT aji-51 265 1 tumor tumor NOUN aji-51 265 2 - - PUNCT aji-51 265 3 associated associate VERB aji-51 265 4 nadh nadh NOUN aji-51 265 5 oxidase oxidase NOUN aji-51 265 6 ( ( PUNCT aji-51 265 7 tnox tnox NOUN aji-51 265 8 ) ) PUNCT aji-51 265 9 , , PUNCT aji-51 265 10 has have AUX aji-51 265 11 been be AUX aji-51 265 12 identified identify VERB aji-51 265 13 as as ADP aji-51 265 14 a a DET aji-51 265 15 target target NOUN aji-51 265 16 for for ADP aji-51 265 17 lowdose lowdose ADJ aji-51 265 18 cell cell NOUN aji-51 265 19 killing killing NOUN aji-51 265 20 ( ( PUNCT aji-51 265 21 apoptosis apoptosis NOUN aji-51 265 22 ) ) PUNCT aji-51 265 23 of of ADP aji-51 265 24 cancer cancer NOUN aji-51 265 25 cells cell NOUN aji-51 265 26 by by ADP aji-51 265 27 green green ADJ aji-51 265 28 tea tea NOUN aji-51 265 29 catechins catechin NOUN aji-51 265 30 and and CCONJ aji-51 265 31 capsicum capsicum NOUN aji-51 265 32 vanilloid vanilloid NOUN aji-51 265 33 combinations combination NOUN aji-51 265 34 [ [ PUNCT aji-51 265 35 122 122 NUM aji-51 265 36 - - SYM aji-51 265 37 125 125 NUM aji-51 265 38 ] ] PUNCT aji-51 265 39 . . PUNCT aji-51 266 1 this this DET aji-51 266 2 protein protein NOUN aji-51 266 3 is be AUX aji-51 266 4 uniquely uniquely ADV aji-51 266 5 associated associate VERB aji-51 266 6 with with ADP aji-51 266 7 all all DET aji-51 266 8 forms form NOUN aji-51 266 9 of of ADP aji-51 266 10 cancer cancer NOUN aji-51 266 11 and and CCONJ aji-51 266 12 is be AUX aji-51 266 13 absent absent ADJ aji-51 266 14 from from ADP aji-51 266 15 normal normal ADJ aji-51 266 16 cells cell NOUN aji-51 266 17 and and CCONJ aji-51 266 18 tissues tissue NOUN aji-51 266 19 . . PUNCT aji-51 267 1 another another DET aji-51 267 2 anticancer anticancer NOUN aji-51 267 3 metabolic metabolic NOUN aji-51 267 4 strategy strategy NOUN aji-51 267 5 is be AUX aji-51 267 6 to to PART aji-51 267 7 use use VERB aji-51 267 8 the the DET aji-51 267 9 combination combination NOUN aji-51 267 10 of of ADP aji-51 267 11 two two NUM aji-51 267 12 nutraceuticals nutraceutical NOUN aji-51 267 13 : : PUNCT aji-51 267 14 lipoic lipoic ADJ aji-51 267 15 acid acid NOUN aji-51 267 16 and and CCONJ aji-51 267 17 calcium calcium NOUN aji-51 267 18 hydroxycitrate hydroxycitrate NOUN aji-51 267 19 , , PUNCT aji-51 267 20 which which PRON aji-51 267 21 target target VERB aji-51 267 22 two two NUM aji-51 267 23 cancer cancer NOUN aji-51 267 24 energy energy NOUN aji-51 267 25 enzymes enzyme NOUN aji-51 267 26 atp atp PROPN aji-51 267 27 citrate citrate NOUN aji-51 267 28 lyase lyase NOUN aji-51 267 29 and and CCONJ aji-51 267 30 pyruvate pyruvate NOUN aji-51 267 31 dehydrogenase dehydrogenase NOUN aji-51 267 32 kinase kinase PROPN aji-51 267 33 . . PUNCT aji-51 268 1 experimentally experimentally ADV aji-51 268 2 , , PUNCT aji-51 268 3 this this DET aji-51 268 4 treatment treatment NOUN aji-51 268 5 was be AUX aji-51 268 6 as as ADV aji-51 268 7 efficient efficient ADJ aji-51 268 8 as as ADP aji-51 268 9 chemotherapy chemotherapy NOUN aji-51 268 10 in in ADP aji-51 268 11 the the DET aji-51 268 12 mouse mouse NOUN aji-51 268 13 cancer cancer NOUN aji-51 268 14 models model NOUN aji-51 268 15 that that PRON aji-51 268 16 were be AUX aji-51 268 17 tested test VERB aji-51 268 18 [ [ X aji-51 268 19 126,127 126,127 NUM aji-51 268 20 ] ] PUNCT aji-51 268 21 . . PUNCT aji-51 269 1 clinically clinically ADV aji-51 269 2 , , PUNCT aji-51 269 3 in in ADP aji-51 269 4 combination combination NOUN aji-51 269 5 with with ADP aji-51 269 6 lowdose lowdose ADJ aji-51 269 7 naltrexone naltrexone NOUN aji-51 269 8 , , PUNCT aji-51 269 9 this this DET aji-51 269 10 anti anti ADJ aji-51 269 11 - - ADJ aji-51 269 12 metabolic metabolic ADJ aji-51 269 13 tactic tactic NOUN aji-51 269 14 has have AUX aji-51 269 15 also also ADV aji-51 269 16 been be AUX aji-51 269 17 effective effective ADJ aji-51 269 18 even even ADV aji-51 269 19 against against ADP aji-51 269 20 advanced advanced ADJ aji-51 269 21 chemo chemo NOUN aji-51 269 22 - - PUNCT aji-51 269 23 resistant resistant ADJ aji-51 269 24 carcinomas carcinoma NOUN aji-51 270 1 [ [ X aji-51 270 2 128 128 NUM aji-51 270 3 , , PUNCT aji-51 270 4 129 129 NUM aji-51 270 5 ] ] PUNCT aji-51 270 6 . . PUNCT aji-51 271 1 stoff stoff PROPN aji-51 271 2 ; ; PUNCT aji-51 271 3 aji aji PROPN aji-51 271 4 , , PUNCT aji-51 271 5 5(1 5(1 NUM aji-51 271 6 ): ): PUNCT aji-51 271 7 1 1 NUM aji-51 271 8 - - SYM aji-51 271 9 39 39 NUM aji-51 271 10 , , PUNCT aji-51 271 11 2022 2022 NUM aji-51 271 12 ; ; PUNCT aji-51 271 13 article article NOUN aji-51 271 14 no.aji.77967 no.aji.77967 VERB aji-51 271 15 7 7 NUM aji-51 271 16 2.3 2.3 NUM aji-51 271 17 genetic genetic ADJ aji-51 271 18 molecular molecular NOUN aji-51 271 19 targeting target VERB aji-51 271 20 targeting target VERB aji-51 271 21 the the DET aji-51 271 22 abnormal abnormal ADJ aji-51 271 23 genetics genetic NOUN aji-51 271 24 of of ADP aji-51 271 25 cancer cancer NOUN aji-51 271 26 is be AUX aji-51 271 27 the the DET aji-51 271 28 second second ADJ aji-51 271 29 anti anti ADJ aji-51 271 30 - - ADJ aji-51 271 31 cancer cancer ADJ aji-51 271 32 strategy strategy NOUN aji-51 271 33 . . PUNCT aji-51 272 1 before before SCONJ aji-51 272 2 we we PRON aji-51 272 3 even even ADV aji-51 272 4 begin begin VERB aji-51 272 5 to to PART aji-51 272 6 specifically specifically ADV aji-51 272 7 target target VERB aji-51 272 8 aberrant aberrant ADJ aji-51 272 9 genetics genetic NOUN aji-51 272 10 , , PUNCT aji-51 272 11 there there PRON aji-51 272 12 are be VERB aji-51 272 13 therapies therapy NOUN aji-51 272 14 that that PRON aji-51 272 15 can can AUX aji-51 272 16 be be AUX aji-51 272 17 instituted institute VERB aji-51 272 18 for for ADP aji-51 272 19 generally generally ADV aji-51 272 20 stabilizing stabilize VERB aji-51 272 21 genes gene NOUN aji-51 272 22 which which PRON aji-51 272 23 buys buy VERB aji-51 272 24 time time NOUN aji-51 272 25 for for ADP aji-51 272 26 more more ADV aji-51 272 27 definitive definitive ADJ aji-51 272 28 testing testing NOUN aji-51 272 29 that that PRON aji-51 272 30 allows allow VERB aji-51 272 31 for for ADP aji-51 272 32 precise precise ADJ aji-51 272 33 targeting targeting NOUN aji-51 272 34 of of ADP aji-51 272 35 the the DET aji-51 272 36 cancer cancer NOUN aji-51 272 37 genome genome NOUN aji-51 272 38 . . PUNCT aji-51 273 1 each each PRON aji-51 273 2 of of ADP aji-51 273 3 these these DET aji-51 273 4 agents agent NOUN aji-51 273 5 has have VERB aji-51 273 6 a a DET aji-51 273 7 multitude multitude NOUN aji-51 273 8 of of ADP aji-51 273 9 beneficial beneficial ADJ aji-51 273 10 effects effect NOUN aji-51 273 11 , , PUNCT aji-51 273 12 but but CCONJ aji-51 273 13 chief chief NOUN aji-51 273 14 among among ADP aji-51 273 15 them they PRON aji-51 273 16 is be AUX aji-51 273 17 their their PRON aji-51 273 18 ability ability NOUN aji-51 273 19 to to PART aji-51 273 20 stabilize stabilize VERB aji-51 273 21 aberrant aberrant ADJ aji-51 273 22 genetics genetic NOUN aji-51 273 23 , , PUNCT aji-51 273 24 creating create VERB aji-51 273 25 the the DET aji-51 273 26 time time NOUN aji-51 273 27 and and CCONJ aji-51 273 28 opportunity opportunity NOUN aji-51 273 29 for for ADP aji-51 273 30 an an DET aji-51 273 31 integrative integrative ADJ aji-51 273 32 anticancer anticancer NOUN aji-51 273 33 strategy strategy NOUN aji-51 273 34 . . PUNCT aji-51 274 1 during during ADP aji-51 274 2 the the DET aji-51 274 3 course course NOUN aji-51 274 4 of of ADP aji-51 274 5 oncogenesis oncogenesis NOUN aji-51 274 6 and and CCONJ aji-51 274 7 tumor tumor NOUN aji-51 274 8 progression progression NOUN aji-51 274 9 , , PUNCT aji-51 274 10 cancer cancer NOUN aji-51 274 11 cells cell NOUN aji-51 274 12 constitutively constitutively ADV aji-51 274 13 upregulate upregulate VERB aji-51 274 14 signaling signal VERB aji-51 274 15 pathways pathway NOUN aji-51 274 16 relevant relevant ADJ aji-51 274 17 to to ADP aji-51 274 18 cell cell NOUN aji-51 274 19 proliferation proliferation NOUN aji-51 274 20 as as ADP aji-51 274 21 a a DET aji-51 274 22 result result NOUN aji-51 274 23 of of ADP aji-51 274 24 any any DET aji-51 274 25 number number NOUN aji-51 274 26 of of ADP aji-51 274 27 genetic genetic ADJ aji-51 274 28 mutations mutation NOUN aji-51 274 29 . . PUNCT aji-51 275 1 it it PRON aji-51 275 2 is be AUX aji-51 275 3 that that DET aji-51 275 4 genetic genetic ADJ aji-51 275 5 instability instability NOUN aji-51 275 6 that that PRON aji-51 275 7 leads lead VERB aji-51 275 8 to to ADP aji-51 275 9 cancer cancer NOUN aji-51 275 10 cells cell NOUN aji-51 275 11 acting act VERB aji-51 275 12 as as ADP aji-51 275 13 cancer cancer NOUN aji-51 275 14 in in ADP aji-51 275 15 the the DET aji-51 275 16 first first ADJ aji-51 275 17 place place NOUN aji-51 275 18 , , PUNCT aji-51 275 19 and and CCONJ aji-51 275 20 it it PRON aji-51 275 21 is be AUX aji-51 275 22 those those DET aji-51 275 23 unstable unstable ADJ aji-51 275 24 mutations mutation NOUN aji-51 275 25 that that PRON aji-51 275 26 account account VERB aji-51 275 27 for for ADP aji-51 275 28 the the DET aji-51 275 29 multiple multiple ADJ aji-51 275 30 cell cell NOUN aji-51 275 31 lines line NOUN aji-51 275 32 that that PRON aji-51 275 33 compose compose VERB aji-51 275 34 every every DET aji-51 275 35 tumor tumor NOUN aji-51 275 36 . . PUNCT aji-51 276 1 many many ADJ aji-51 276 2 agents agent NOUN aji-51 276 3 have have AUX aji-51 276 4 been be AUX aji-51 276 5 identified identify VERB aji-51 276 6 that that PRON aji-51 276 7 can can AUX aji-51 276 8 aid aid VERB aji-51 276 9 in in ADP aji-51 276 10 cell cell NOUN aji-51 276 11 differentiation differentiation NOUN aji-51 276 12 and and CCONJ aji-51 276 13 reversion reversion NOUN aji-51 276 14 back back ADV aji-51 276 15 to to ADP aji-51 276 16 a a DET aji-51 276 17 phenotypically phenotypically ADV aji-51 276 18 normal normal ADJ aji-51 276 19 cell cell NOUN aji-51 276 20 type type NOUN aji-51 276 21 [ [ X aji-51 276 22 130 130 NUM aji-51 276 23 ] ] PUNCT aji-51 276 24 . . PUNCT aji-51 277 1 some some PRON aji-51 277 2 of of ADP aji-51 277 3 them they PRON aji-51 277 4 are be AUX aji-51 277 5 considered consider VERB aji-51 277 6 as as SCONJ aji-51 277 7 follows follow VERB aji-51 277 8 . . PUNCT aji-51 278 1 first first ADV aji-51 278 2 on on ADP aji-51 278 3 our our PRON aji-51 278 4 list list NOUN aji-51 278 5 of of ADP aji-51 278 6 genetic genetic ADJ aji-51 278 7 stabilizers stabilizer NOUN aji-51 278 8 is be AUX aji-51 278 9 dimethyl dimethyl NOUN aji-51 278 10 sulfoxide sulfoxide NOUN aji-51 278 11 . . PUNCT aji-51 279 1 dimethyl dimethyl NOUN aji-51 279 2 sulfoxide sulfoxide NOUN aji-51 279 3 ( ( PUNCT aji-51 279 4 dmso dmso NOUN aji-51 279 5 ) ) PUNCT aji-51 279 6 is be AUX aji-51 279 7 an an DET aji-51 279 8 organosulfur organosulfur NOUN aji-51 279 9 compound compound NOUN aji-51 279 10 with with ADP aji-51 279 11 polar polar ADJ aji-51 279 12 , , PUNCT aji-51 279 13 aprotic aprotic ADJ aji-51 279 14 , , PUNCT aji-51 279 15 and and CCONJ aji-51 279 16 amphiphilic amphiphilic ADJ aji-51 279 17 properties property NOUN aji-51 279 18 . . PUNCT aji-51 280 1 it it PRON aji-51 280 2 serves serve VERB aji-51 280 3 as as ADP aji-51 280 4 a a DET aji-51 280 5 solvent solvent NOUN aji-51 280 6 for for ADP aji-51 280 7 many many ADJ aji-51 280 8 polar polar ADJ aji-51 280 9 and and CCONJ aji-51 280 10 nonpolar nonpolar ADJ aji-51 280 11 molecules molecule NOUN aji-51 280 12 and and CCONJ aji-51 280 13 continues continue VERB aji-51 280 14 to to PART aji-51 280 15 be be AUX aji-51 280 16 one one NUM aji-51 280 17 of of ADP aji-51 280 18 the the DET aji-51 280 19 most most ADV aji-51 280 20 used used ADJ aji-51 280 21 solvents solvent NOUN aji-51 280 22 ( ( PUNCT aji-51 280 23 vehicle vehicle NOUN aji-51 280 24 ) ) PUNCT aji-51 280 25 in in ADP aji-51 280 26 medical medical ADJ aji-51 280 27 applications application NOUN aji-51 280 28 and and CCONJ aji-51 280 29 scientific scientific ADJ aji-51 280 30 research research NOUN aji-51 280 31 . . PUNCT aji-51 281 1 it it PRON aji-51 281 2 also also ADV aji-51 281 3 displays display VERB aji-51 281 4 a a DET aji-51 281 5 diversity diversity NOUN aji-51 281 6 of of ADP aji-51 281 7 antitumor antitumor PROPN aji-51 281 8 activities[131 activities[131 PROPN aji-51 281 9 ] ] PUNCT aji-51 281 10 . . PUNCT aji-51 282 1 previous previous ADJ aji-51 282 2 studies study NOUN aji-51 282 3 have have AUX aji-51 282 4 demonstrated demonstrate VERB aji-51 282 5 that that SCONJ aji-51 282 6 dmso dmso NOUN aji-51 282 7 can can AUX aji-51 282 8 modulate modulate VERB aji-51 282 9 ap-1 ap-1 ADP aji-51 282 10 activity activity NOUN aji-51 282 11 and and CCONJ aji-51 282 12 lead lead VERB aji-51 282 13 to to ADP aji-51 282 14 cell cell NOUN aji-51 282 15 cycle cycle NOUN aji-51 282 16 arrest arrest NOUN aji-51 282 17 at at ADP aji-51 282 18 the the DET aji-51 282 19 g1 g1 PROPN aji-51 282 20 phase phase NOUN aji-51 282 21 [ [ X aji-51 282 22 132 132 NUM aji-51 282 23 ] ] PUNCT aji-51 282 24 . . PUNCT aji-51 283 1 the the DET aji-51 283 2 fibrinolytic fibrinolytic ADJ aji-51 283 3 system system NOUN aji-51 283 4 , , PUNCT aji-51 283 5 more more ADV aji-51 283 6 appropriately appropriately ADV aji-51 283 7 referred refer VERB aji-51 283 8 to to ADP aji-51 283 9 as as SCONJ aji-51 283 10 the the DET aji-51 283 11 plasminogen plasminogen NOUN aji-51 283 12 activator activator NOUN aji-51 283 13 ( ( PUNCT aji-51 283 14 pa pa NOUN aji-51 283 15 ) ) PUNCT aji-51 283 16 system system NOUN aji-51 283 17 , , PUNCT aji-51 283 18 controls control VERB aji-51 283 19 not not PART aji-51 283 20 only only ADV aji-51 283 21 the the DET aji-51 283 22 intravascular intravascular ADJ aji-51 283 23 fibrin fibrin NOUN aji-51 283 24 deposition deposition NOUN aji-51 283 25 ( ( PUNCT aji-51 283 26 with with ADP aji-51 283 27 its its PRON aji-51 283 28 effects effect NOUN aji-51 283 29 on on ADP aji-51 283 30 cardio cardio NOUN aji-51 283 31 - - PUNCT aji-51 283 32 vascular vascular NOUN aji-51 283 33 disease disease NOUN aji-51 283 34 ) ) PUNCT aji-51 283 35 but but CCONJ aji-51 283 36 also also ADV aji-51 283 37 participates participate VERB aji-51 283 38 in in ADP aji-51 283 39 a a DET aji-51 283 40 wide wide ADJ aji-51 283 41 variety variety NOUN aji-51 283 42 of of ADP aji-51 283 43 other other ADJ aji-51 283 44 physiologic physiologic ADJ aji-51 283 45 and and CCONJ aji-51 283 46 pathologic pathologic ADJ aji-51 283 47 processes process NOUN aji-51 283 48 . . PUNCT aji-51 284 1 in in ADP aji-51 284 2 cancer cancer NOUN aji-51 284 3 , , PUNCT aji-51 284 4 the the DET aji-51 284 5 components component NOUN aji-51 284 6 of of ADP aji-51 284 7 this this DET aji-51 284 8 system system NOUN aji-51 284 9 are be AUX aji-51 284 10 involved involve VERB aji-51 284 11 in in ADP aji-51 284 12 tumor tumor NOUN aji-51 284 13 growth growth NOUN aji-51 284 14 , , PUNCT aji-51 284 15 invasion invasion NOUN aji-51 284 16 , , PUNCT aji-51 284 17 and and CCONJ aji-51 284 18 metastasis metastasis NOUN aji-51 284 19 through through ADP aji-51 284 20 their their PRON aji-51 284 21 effect effect NOUN aji-51 284 22 on on ADP aji-51 284 23 angiogenesis angiogenesis NOUN aji-51 284 24 and and CCONJ aji-51 284 25 cell cell NOUN aji-51 284 26 migration migration NOUN aji-51 284 27 , , PUNCT aji-51 284 28 by by ADP aji-51 284 29 way way NOUN aji-51 284 30 of of ADP aji-51 284 31 its its PRON aji-51 284 32 effects effect NOUN aji-51 284 33 on on ADP aji-51 284 34 the the DET aji-51 284 35 extracellular extracellular ADJ aji-51 284 36 matrix matrix NOUN aji-51 284 37 of of ADP aji-51 284 38 the the DET aji-51 284 39 tumor tumor NOUN aji-51 284 40 microenvironment microenvironment NOUN aji-51 284 41 . . PUNCT aji-51 285 1 plasminogen plasminogen NOUN aji-51 285 2 activator activator NOUN aji-51 285 3 components component NOUN aji-51 285 4 are be AUX aji-51 285 5 found find VERB aji-51 285 6 in in ADP aji-51 285 7 most most ADJ aji-51 285 8 tumors tumor NOUN aji-51 285 9 and and CCONJ aji-51 285 10 their their PRON aji-51 285 11 expression expression NOUN aji-51 285 12 signifies signify VERB aji-51 285 13 not not PART aji-51 285 14 only only ADV aji-51 285 15 their their PRON aji-51 285 16 function function NOUN aji-51 285 17 but but CCONJ aji-51 285 18 also also ADV aji-51 285 19 carries carry VERB aji-51 285 20 a a DET aji-51 285 21 prognostic prognostic ADJ aji-51 285 22 value value NOUN aji-51 285 23 . . PUNCT aji-51 286 1 their their PRON aji-51 286 2 expression expression NOUN aji-51 286 3 is be AUX aji-51 286 4 in in ADP aji-51 286 5 turn turn NOUN aji-51 286 6 modulated modulate VERB aji-51 286 7 by by ADP aji-51 286 8 cytokines cytokine NOUN aji-51 286 9 and and CCONJ aji-51 286 10 growth growth NOUN aji-51 286 11 factors factor NOUN aji-51 286 12 , , PUNCT aji-51 286 13 many many ADJ aji-51 286 14 of of ADP aji-51 286 15 which which PRON aji-51 286 16 are be AUX aji-51 286 17 up up ADV aji-51 286 18 - - PUNCT aji-51 286 19 regulated regulate VERB aji-51 286 20 in in ADP aji-51 286 21 cancer cancer NOUN aji-51 286 22 and and CCONJ aji-51 286 23 found find VERB aji-51 286 24 throughout throughout ADP aji-51 286 25 the the DET aji-51 286 26 tme tme PROPN aji-51 286 27 . . PUNCT aji-51 287 1 dmso dmso NOUN aji-51 287 2 can can AUX aji-51 287 3 inhibit inhibit VERB aji-51 287 4 the the DET aji-51 287 5 activity activity NOUN aji-51 287 6 of of ADP aji-51 287 7 pa pa PROPN aji-51 287 8 ’s ’s PART aji-51 287 9 which which PRON aji-51 287 10 helps help VERB aji-51 287 11 to to PART aji-51 287 12 stabilize stabilize VERB aji-51 287 13 the the DET aji-51 287 14 tme tme NOUN aji-51 287 15 and and CCONJ aji-51 287 16 reduce reduce VERB aji-51 287 17 the the DET aji-51 287 18 risk risk NOUN aji-51 287 19 of of ADP aji-51 287 20 metastasis metastasis NOUN aji-51 287 21 [ [ X aji-51 287 22 133 133 NUM aji-51 287 23 ] ] PUNCT aji-51 287 24 . . PUNCT aji-51 288 1 furthermore furthermore ADV aji-51 288 2 , , PUNCT aji-51 288 3 dmso dmso NOUN aji-51 288 4 can can AUX aji-51 288 5 cause cause VERB aji-51 288 6 the the DET aji-51 288 7 maturation maturation NOUN aji-51 288 8 / / SYM aji-51 288 9 differentiation differentiation NOUN aji-51 288 10 , , PUNCT aji-51 288 11 of of ADP aji-51 288 12 at at ADP aji-51 288 13 least least ADJ aji-51 288 14 some some PRON aji-51 288 15 cancers cancer NOUN aji-51 288 16 , , PUNCT aji-51 288 17 into into ADP aji-51 288 18 a a DET aji-51 288 19 benign benign NOUN aji-51 288 20 , , PUNCT aji-51 288 21 more more ADV aji-51 288 22 normal normal ADJ aji-51 288 23 cell cell NOUN aji-51 288 24 type type NOUN aji-51 288 25 [ [ X aji-51 288 26 134,135 134,135 NUM aji-51 288 27 ] ] PUNCT aji-51 288 28 . . PUNCT aji-51 289 1 vitamin vitamin NOUN aji-51 289 2 d d NOUN aji-51 289 3 is be AUX aji-51 289 4 next next ADV aji-51 289 5 on on ADP aji-51 289 6 our our PRON aji-51 289 7 list list NOUN aji-51 289 8 of of ADP aji-51 289 9 genetic genetic ADJ aji-51 289 10 stabilizers stabilizer NOUN aji-51 289 11 . . PUNCT aji-51 290 1 in in ADP aji-51 290 2 addition addition NOUN aji-51 290 3 to to ADP aji-51 290 4 enhancing enhance VERB aji-51 290 5 dna dna PROPN aji-51 290 6 repair repair NOUN aji-51 290 7 , , PUNCT aji-51 290 8 vitamin vitamin NOUN aji-51 290 9 d d NOUN aji-51 290 10 also also ADV aji-51 290 11 induces induce VERB aji-51 290 12 growth growth NOUN aji-51 290 13 arrest arrest NOUN aji-51 290 14 and and CCONJ aji-51 290 15 apoptosis apoptosis NOUN aji-51 290 16 of of ADP aji-51 290 17 tumor tumor NOUN aji-51 290 18 cells cell NOUN aji-51 290 19 and and CCONJ aji-51 290 20 their their PRON aji-51 290 21 nonneoplastic nonneoplastic ADJ aji-51 290 22 progenitors progenitor NOUN aji-51 290 23 . . PUNCT aji-51 291 1 cell cell NOUN aji-51 291 2 - - PUNCT aji-51 291 3 based base VERB aji-51 291 4 studies study NOUN aji-51 291 5 show show VERB aji-51 291 6 that that SCONJ aji-51 291 7 the the DET aji-51 291 8 active active ADJ aji-51 291 9 metabolite metabolite NOUN aji-51 291 10 1,25 1,25 NUM aji-51 291 11 dihydroxyvitamin dihydroxyvitamin NOUN aji-51 291 12 d d NOUN aji-51 291 13 is be AUX aji-51 291 14 the the DET aji-51 291 15 biologically biologically ADV aji-51 291 16 active active ADJ aji-51 291 17 form form NOUN aji-51 291 18 that that PRON aji-51 291 19 works work VERB aji-51 291 20 through through ADP aji-51 291 21 the the DET aji-51 291 22 vitamin vitamin NOUN aji-51 291 23 d d NOUN aji-51 291 24 receptor receptor NOUN aji-51 291 25 to to PART aji-51 291 26 regulate regulate VERB aji-51 291 27 gene gene NOUN aji-51 291 28 transcription transcription NOUN aji-51 291 29 . . PUNCT aji-51 292 1 vitamin vitamin NOUN aji-51 292 2 d d PROPN aji-51 292 3 ( ( PUNCT aji-51 292 4 d3 d3 PROPN aji-51 292 5 ) ) PUNCT aji-51 292 6 is be AUX aji-51 292 7 produced produce VERB aji-51 292 8 from from ADP aji-51 292 9 7dehydrocholesterol 7dehydrocholesterol PROPN aji-51 292 10 when when SCONJ aji-51 292 11 skin skin NOUN aji-51 292 12 is be AUX aji-51 292 13 directly directly ADV aji-51 292 14 exposed expose VERB aji-51 292 15 to to ADP aji-51 292 16 uvb uvb ADJ aji-51 292 17 light light NOUN aji-51 292 18 which which PRON aji-51 292 19 , , PUNCT aji-51 292 20 in in ADP aji-51 292 21 more more ADJ aji-51 292 22 northern northern ADJ aji-51 292 23 locations location NOUN aji-51 292 24 , , PUNCT aji-51 292 25 is be AUX aji-51 292 26 largely largely ADV aji-51 292 27 filtered filter VERB aji-51 292 28 out out ADP aji-51 292 29 by by ADP aji-51 292 30 the the DET aji-51 292 31 atmosphere atmosphere NOUN aji-51 292 32 . . PUNCT aji-51 293 1 vitamin vitamin NOUN aji-51 293 2 d d NOUN aji-51 293 3 is be AUX aji-51 293 4 readily readily ADV aji-51 293 5 sourced source VERB aji-51 293 6 from from ADP aji-51 293 7 various various ADJ aji-51 293 8 foods food NOUN aji-51 293 9 including include VERB aji-51 293 10 fish fish NOUN aji-51 293 11 , , PUNCT aji-51 293 12 eggs egg NOUN aji-51 293 13 , , PUNCT aji-51 293 14 caviar caviar NOUN aji-51 293 15 ( ( PUNCT aji-51 293 16 for for ADP aji-51 293 17 the the DET aji-51 293 18 gourmets gourmet NOUN aji-51 293 19 among among ADP aji-51 293 20 us we PRON aji-51 293 21 ) ) PUNCT aji-51 293 22 , , PUNCT aji-51 293 23 some some DET aji-51 293 24 mushrooms mushroom NOUN aji-51 293 25 , , PUNCT aji-51 293 26 beef beef NOUN aji-51 293 27 liver liver NOUN aji-51 293 28 , , PUNCT aji-51 293 29 and and CCONJ aji-51 293 30 cheese cheese NOUN aji-51 293 31 . . PUNCT aji-51 294 1 regardless regardless ADV aji-51 294 2 of of ADP aji-51 294 3 whether whether SCONJ aji-51 294 4 vitamin vitamin NOUN aji-51 294 5 d d NOUN aji-51 294 6 comes come VERB aji-51 294 7 from from ADP aji-51 294 8 the the DET aji-51 294 9 skin skin NOUN aji-51 294 10 or or CCONJ aji-51 294 11 the the DET aji-51 294 12 diet diet NOUN aji-51 294 13 , , PUNCT aji-51 294 14 vitamin vitamin NOUN aji-51 294 15 d3 d3 PROPN aji-51 294 16 is be AUX aji-51 294 17 transported transport VERB aji-51 294 18 through through ADP aji-51 294 19 the the DET aji-51 294 20 blood blood NOUN aji-51 294 21 by by ADP aji-51 294 22 the the DET aji-51 294 23 vitamin vitamin NOUN aji-51 294 24 d d NOUN aji-51 294 25 binding bind VERB aji-51 294 26 protein protein NOUN aji-51 294 27 ( ( PUNCT aji-51 294 28 dbp dbp PROPN aji-51 294 29 ) ) PUNCT aji-51 294 30 . . PUNCT aji-51 295 1 once once ADV aji-51 295 2 delivered deliver VERB aji-51 295 3 to to ADP aji-51 295 4 the the DET aji-51 295 5 liver liver NOUN aji-51 295 6 , , PUNCT aji-51 295 7 vitamin vitamin NOUN aji-51 295 8 d d NOUN aji-51 295 9 is be AUX aji-51 295 10 hydroxylated hydroxylate VERB aji-51 295 11 on on ADP aji-51 295 12 its its PRON aji-51 295 13 side side NOUN aji-51 295 14 chain chain NOUN aji-51 295 15 to to PART aji-51 295 16 form form VERB aji-51 295 17 25 25 NUM aji-51 295 18 hydroxyvitamin hydroxyvitamin NOUN aji-51 295 19 d d NOUN aji-51 295 20 ( ( PUNCT aji-51 295 21 25oh 25oh ADJ aji-51 295 22 d d NOUN aji-51 295 23 ) ) PUNCT aji-51 295 24 . . PUNCT aji-51 296 1 this this PRON aji-51 296 2 is be AUX aji-51 296 3 a a DET aji-51 296 4 stable stable ADJ aji-51 296 5 metabolite metabolite NOUN aji-51 296 6 whose whose DET aji-51 296 7 serum serum NOUN aji-51 296 8 levels level NOUN aji-51 296 9 are be AUX aji-51 296 10 commonly commonly ADV aji-51 296 11 used use VERB aji-51 296 12 to to PART aji-51 296 13 assess assess VERB aji-51 296 14 vitamin vitamin NOUN aji-51 296 15 d d NOUN aji-51 296 16 status status NOUN aji-51 296 17 . . PUNCT aji-51 297 1 as as SCONJ aji-51 297 2 needed need VERB aji-51 297 3 and and CCONJ aji-51 297 4 if if SCONJ aji-51 297 5 available available ADJ aji-51 297 6 , , PUNCT aji-51 297 7 d3 d3 PROPN aji-51 297 8 circulates circulate VERB aji-51 297 9 to to ADP aji-51 297 10 the the DET aji-51 297 11 kidneys kidney NOUN aji-51 297 12 which which PRON aji-51 297 13 is be AUX aji-51 297 14 the the DET aji-51 297 15 primary primary ADJ aji-51 297 16 site site NOUN aji-51 297 17 where where SCONJ aji-51 297 18 the the DET aji-51 297 19 active active ADJ aji-51 297 20 form form NOUN aji-51 297 21 of of ADP aji-51 297 22 vitamin vitamin NOUN aji-51 297 23 d d PROPN aji-51 297 24 , , PUNCT aji-51 297 25 1,25(oh)2 1,25(oh)2 PROPN aji-51 297 26 d d PROPN aji-51 297 27 , , PUNCT aji-51 297 28 is be AUX aji-51 297 29 produced produce VERB aji-51 297 30 through through ADP aji-51 297 31 the the DET aji-51 297 32 genomic genomic ADJ aji-51 297 33 actions action NOUN aji-51 297 34 of of ADP aji-51 297 35 1α,25(oh)2 1α,25(oh)2 NUM aji-51 297 36 via via ADP aji-51 297 37 the the DET aji-51 297 38 vitamin vitamin NOUN aji-51 297 39 d d NOUN aji-51 297 40 receptor receptor NOUN aji-51 297 41 ( ( PUNCT aji-51 297 42 vdr vdr NOUN aji-51 297 43 ) ) PUNCT aji-51 297 44 , , PUNCT aji-51 297 45 and and CCONJ aji-51 297 46 its its PRON aji-51 297 47 analogs analog NOUN aji-51 297 48 inhibit inhibit VERB aji-51 297 49 cell cell NOUN aji-51 297 50 cycle cycle NOUN aji-51 297 51 progression progression NOUN aji-51 297 52 and and CCONJ aji-51 297 53 tumor tumor NOUN aji-51 297 54 cell cell NOUN aji-51 297 55 growth growth NOUN aji-51 297 56 . . PUNCT aji-51 298 1 mechanisms mechanism NOUN aji-51 298 2 of of ADP aji-51 298 3 action action NOUN aji-51 298 4 range range NOUN aji-51 298 5 from from ADP aji-51 298 6 preventing prevent VERB aji-51 298 7 cell cell NOUN aji-51 298 8 proliferation proliferation NOUN aji-51 298 9 ( ( PUNCT aji-51 298 10 through through ADP aji-51 298 11 cell cell NOUN aji-51 298 12 cycle cycle NOUN aji-51 298 13 arrest arrest NOUN aji-51 298 14 ) ) PUNCT aji-51 298 15 in in ADP aji-51 298 16 cancer cancer NOUN aji-51 298 17 cells cell NOUN aji-51 298 18 to to ADP aji-51 298 19 inducing induce VERB aji-51 298 20 apoptosis apoptosis NOUN aji-51 298 21 , , PUNCT aji-51 298 22 or or CCONJ aji-51 298 23 suppressing suppress VERB aji-51 298 24 cell cell NOUN aji-51 298 25 adhesion adhesion NOUN aji-51 298 26 molecules molecule NOUN aji-51 298 27 and and CCONJ aji-51 298 28 growth growth NOUN aji-51 298 29 factors factor NOUN aji-51 298 30 that that PRON aji-51 298 31 promote promote VERB aji-51 298 32 cellular cellular ADJ aji-51 298 33 homing homing NOUN aji-51 298 34 and and CCONJ aji-51 298 35 metastasis metastasis NOUN aji-51 298 36 . . PUNCT aji-51 299 1 it it PRON aji-51 299 2 also also ADV aji-51 299 3 affords afford VERB aji-51 299 4 important important ADJ aji-51 299 5 antioxidant antioxidant ADJ aji-51 299 6 protection protection NOUN aji-51 299 7 and and CCONJ aji-51 299 8 serves serve VERB aji-51 299 9 as as ADP aji-51 299 10 an an DET aji-51 299 11 immunomodulatory immunomodulatory NOUN aji-51 299 12 for for ADP aji-51 299 13 both both CCONJ aji-51 299 14 the the DET aji-51 299 15 innate innate ADJ aji-51 299 16 and and CCONJ aji-51 299 17 adaptive adaptive ADJ aji-51 299 18 arms arm NOUN aji-51 299 19 of of ADP aji-51 299 20 the the DET aji-51 299 21 immune immune ADJ aji-51 299 22 system system NOUN aji-51 299 23 [ [ X aji-51 299 24 136 136 NUM aji-51 299 25 - - SYM aji-51 299 26 140 140 NUM aji-51 299 27 ] ] PUNCT aji-51 299 28 . . PUNCT aji-51 300 1 next next ADJ aji-51 300 2 comes come VERB aji-51 300 3 indole-3 indole-3 NOUN aji-51 300 4 - - PUNCT aji-51 300 5 carbinol carbinol NOUN aji-51 300 6 and and CCONJ aji-51 300 7 its its PRON aji-51 300 8 metabolite metabolite NOUN aji-51 300 9 3,3′-diindolylmethane 3,3′-diindolylmethane PROPN aji-51 300 10 ( ( PUNCT aji-51 300 11 dim dim NOUN aji-51 300 12 ) ) PUNCT aji-51 300 13 . . PUNCT aji-51 301 1 they they PRON aji-51 301 2 target target VERB aji-51 301 3 multiple multiple ADJ aji-51 301 4 aspects aspect NOUN aji-51 301 5 of of ADP aji-51 301 6 cancer cancer NOUN aji-51 301 7 cell cell NOUN aji-51 301 8 cycle cycle NOUN aji-51 301 9 regulation regulation NOUN aji-51 301 10 and and CCONJ aji-51 301 11 survival survival NOUN aji-51 301 12 including include VERB aji-51 301 13 akt akt PROPN aji-51 301 14 - - PUNCT aji-51 301 15 nfκb nfκb NOUN aji-51 301 16 signaling signal VERB aji-51 301 17 , , PUNCT aji-51 301 18 caspase caspase NOUN aji-51 301 19 activation activation NOUN aji-51 301 20 , , PUNCT aji-51 301 21 and and CCONJ aji-51 301 22 cyclin cyclin NOUN aji-51 301 23 - - PUNCT aji-51 301 24 dependent dependent ADJ aji-51 301 25 kinase kinase PROPN aji-51 301 26 activities activity NOUN aji-51 301 27 . . PUNCT aji-51 302 1 furthermore furthermore ADV aji-51 302 2 , , PUNCT aji-51 302 3 they they PRON aji-51 302 4 stabilize stabilize VERB aji-51 302 5 estrogen estrogen NOUN aji-51 302 6 metabolism metabolism NOUN aji-51 302 7 , , PUNCT aji-51 302 8 normalize normalize VERB aji-51 302 9 estrogen estrogen NOUN aji-51 302 10 receptor receptor NOUN aji-51 302 11 signaling signal VERB aji-51 302 12 , , PUNCT aji-51 302 13 reduce reduce VERB aji-51 302 14 endoplasmic endoplasmic ADJ aji-51 302 15 reticulum reticulum NOUN aji-51 302 16 stress stress NOUN aji-51 302 17 , , PUNCT aji-51 302 18 and and CCONJ aji-51 302 19 limit limit VERB aji-51 302 20 brca brca PROPN aji-51 302 21 gene gene NOUN aji-51 302 22 expression expression NOUN aji-51 302 23 . . PUNCT aji-51 303 1 dna dna PROPN aji-51 303 2 hypermethylation hypermethylation NOUN aji-51 303 3 is be AUX aji-51 303 4 a a DET aji-51 303 5 common common ADJ aji-51 303 6 feature feature NOUN aji-51 303 7 of of ADP aji-51 303 8 cancer cancer NOUN aji-51 303 9 genetics genetic NOUN aji-51 303 10 . . PUNCT aji-51 304 1 when when SCONJ aji-51 304 2 methylation methylation NOUN aji-51 304 3 detox detox NOUN aji-51 304 4 pathways pathway NOUN aji-51 304 5 start start VERB aji-51 304 6 to to PART aji-51 304 7 fail fail VERB aji-51 304 8 , , PUNCT aji-51 304 9 certain certain ADJ aji-51 304 10 regions region NOUN aji-51 304 11 of of ADP aji-51 304 12 the the DET aji-51 304 13 genome genome NOUN aji-51 304 14 will will AUX aji-51 304 15 accumulate accumulate VERB aji-51 304 16 too too ADV aji-51 304 17 many many ADJ aji-51 304 18 methyl methyl NOUN aji-51 304 19 groups group NOUN aji-51 304 20 , , PUNCT aji-51 304 21 such such ADJ aji-51 304 22 as as ADP aji-51 304 23 at at ADP aji-51 304 24 cpg cpg NOUN aji-51 304 25 promoter promoter NOUN aji-51 304 26 regions region NOUN aji-51 304 27 ( ( PUNCT aji-51 304 28 segments segment NOUN aji-51 304 29 of of ADP aji-51 304 30 the the DET aji-51 304 31 dna dna PROPN aji-51 304 32 involved involve VERB aji-51 304 33 in in ADP aji-51 304 34 dna dna PROPN aji-51 304 35 and and CCONJ aji-51 304 36 rna rna PROPN aji-51 304 37 stoff stoff PROPN aji-51 304 38 ; ; PUNCT aji-51 304 39 aji aji PROPN aji-51 304 40 , , PUNCT aji-51 304 41 5(1 5(1 NUM aji-51 304 42 ): ): PUNCT aji-51 304 43 1 1 NUM aji-51 304 44 - - SYM aji-51 304 45 39 39 NUM aji-51 304 46 , , PUNCT aji-51 304 47 2022 2022 NUM aji-51 304 48 ; ; PUNCT aji-51 304 49 article article NOUN aji-51 304 50 no.aji.77967 no.aji.77967 ADJ aji-51 304 51 8 8 NUM aji-51 304 52 transcription transcription NOUN aji-51 304 53 ) ) PUNCT aji-51 304 54 ; ; PUNCT aji-51 304 55 this this PRON aji-51 304 56 can can AUX aji-51 304 57 lead lead VERB aji-51 304 58 to to ADP aji-51 304 59 increased increase VERB aji-51 304 60 mutagenesis mutagenesis NOUN aji-51 304 61 and and CCONJ aji-51 304 62 eventual eventual ADJ aji-51 304 63 cancer cancer NOUN aji-51 304 64 development development NOUN aji-51 304 65 . . PUNCT aji-51 305 1 much much ADJ aji-51 305 2 research research NOUN aji-51 305 3 has have AUX aji-51 305 4 demonstrated demonstrate VERB aji-51 305 5 how how SCONJ aji-51 305 6 dim dim ADJ aji-51 305 7 reduced reduced ADJ aji-51 305 8 methylation methylation NOUN aji-51 305 9 at at ADP aji-51 305 10 5 5 NUM aji-51 305 11 cpg cpg NOUN aji-51 305 12 promoter promoter NOUN aji-51 305 13 regions region NOUN aji-51 305 14 . . PUNCT aji-51 306 1 for for ADP aji-51 306 2 example example NOUN aji-51 306 3 , , PUNCT aji-51 306 4 in in ADP aji-51 306 5 split split ADJ aji-51 306 6 population population NOUN aji-51 306 7 studies study NOUN aji-51 306 8 , , PUNCT aji-51 306 9 mice mouse NOUN aji-51 306 10 given give VERB aji-51 306 11 transgenic transgenic NOUN aji-51 306 12 adenocarcinoma adenocarcinoma NOUN aji-51 306 13 of of ADP aji-51 306 14 the the DET aji-51 306 15 mouse mouse NOUN aji-51 306 16 prostate prostate NOUN aji-51 306 17 ( ( PUNCT aji-51 306 18 tramp tramp ADJ aji-51 306 19 ) ) PUNCT aji-51 306 20 prostate prostate NOUN aji-51 306 21 cancer cancer NOUN aji-51 306 22 cells cell NOUN aji-51 306 23 were be AUX aji-51 306 24 also also ADV aji-51 306 25 given give VERB aji-51 306 26 dim dim NOUN aji-51 306 27 . . PUNCT aji-51 307 1 the the DET aji-51 307 2 mice mouse NOUN aji-51 307 3 given give VERB aji-51 307 4 the the DET aji-51 307 5 dim dim NOUN aji-51 307 6 showed show VERB aji-51 307 7 a a DET aji-51 307 8 much much ADV aji-51 307 9 lower low ADJ aji-51 307 10 incidence incidence NOUN aji-51 307 11 of of ADP aji-51 307 12 cancer cancer NOUN aji-51 307 13 and and CCONJ aji-51 307 14 metastasis metastasis NOUN aji-51 307 15 than than ADP aji-51 307 16 controls control NOUN aji-51 307 17 , , PUNCT aji-51 307 18 as as ADV aji-51 307 19 well well ADV aji-51 307 20 as as ADV aji-51 307 21 much much ADV aji-51 307 22 higher high ADJ aji-51 307 23 expression expression NOUN aji-51 307 24 of of ADP aji-51 307 25 antioxidant antioxidant NOUN aji-51 307 26 / / SYM aji-51 307 27 anticarcinogen anticarcinogen NOUN aji-51 307 28 protective protective ADJ aji-51 307 29 enzymes enzyme NOUN aji-51 307 30 nqo1 nqo1 PROPN aji-51 307 31 and and CCONJ aji-51 307 32 nfr2 nfr2 PROPN aji-51 307 33 in in ADP aji-51 307 34 prostate prostate NOUN aji-51 307 35 tissues tissue NOUN aji-51 307 36 [ [ X aji-51 307 37 141 141 NUM aji-51 307 38 - - SYM aji-51 307 39 146 146 NUM aji-51 307 40 ] ] PUNCT aji-51 307 41 . . PUNCT aji-51 308 1 curcumin curcumin PROPN aji-51 308 2 , , PUNCT aji-51 308 3 a a DET aji-51 308 4 component component NOUN aji-51 308 5 of of ADP aji-51 308 6 turmeric turmeric NOUN aji-51 308 7 ( ( PUNCT aji-51 308 8 curcuma curcuma PROPN aji-51 308 9 longa longa NOUN aji-51 308 10 ) ) PUNCT aji-51 308 11 , , PUNCT aji-51 308 12 is be AUX aji-51 308 13 a a DET aji-51 308 14 low low ADJ aji-51 308 15 molecular molecular ADJ aji-51 308 16 weight weight NOUN aji-51 308 17 molecule molecule NOUN aji-51 308 18 that that PRON aji-51 308 19 has have VERB aji-51 308 20 antiproliferative antiproliferative ADJ aji-51 308 21 activity activity NOUN aji-51 308 22 and and CCONJ aji-51 308 23 inhibits inhibit VERB aji-51 308 24 tumor tumor NOUN aji-51 308 25 initiation initiation NOUN aji-51 308 26 and and CCONJ aji-51 308 27 propagation propagation NOUN aji-51 308 28 through through ADP aji-51 308 29 a a DET aji-51 308 30 variety variety NOUN aji-51 308 31 of of ADP aji-51 308 32 pathways pathway NOUN aji-51 308 33 . . PUNCT aji-51 309 1 it it PRON aji-51 309 2 accomplishes accomplish VERB aji-51 309 3 this this PRON aji-51 309 4 through through ADP aji-51 309 5 several several ADJ aji-51 309 6 epigenetic epigenetic ADJ aji-51 309 7 effects effect NOUN aji-51 309 8 that that PRON aji-51 309 9 result result VERB aji-51 309 10 in in ADP aji-51 309 11 genetic genetic ADJ aji-51 309 12 modulation modulation NOUN aji-51 309 13 that that PRON aji-51 309 14 then then ADV aji-51 309 15 changes change VERB aji-51 309 16 the the DET aji-51 309 17 expression expression NOUN aji-51 309 18 of of ADP aji-51 309 19 several several ADJ aji-51 309 20 key key ADJ aji-51 309 21 proteins protein NOUN aji-51 309 22 , , PUNCT aji-51 309 23 some some PRON aji-51 309 24 of of ADP aji-51 309 25 which which PRON aji-51 309 26 are be AUX aji-51 309 27 the the DET aji-51 309 28 cysteine cysteine ADJ aji-51 309 29 - - PUNCT aji-51 309 30 aspartic aspartic ADJ aji-51 309 31 acid acid NOUN aji-51 309 32 proteases protease NOUN aji-51 309 33 ( ( PUNCT aji-51 309 34 caspases caspase NOUN aji-51 309 35 ) ) PUNCT aji-51 309 36 . . PUNCT aji-51 310 1 caspases caspase NOUN aji-51 310 2 are be AUX aji-51 310 3 a a DET aji-51 310 4 family family NOUN aji-51 310 5 of of ADP aji-51 310 6 enzymes enzyme NOUN aji-51 310 7 that that PRON aji-51 310 8 play play VERB aji-51 310 9 an an DET aji-51 310 10 essential essential ADJ aji-51 310 11 role role NOUN aji-51 310 12 in in ADP aji-51 310 13 apoptosis apoptosis NOUN aji-51 310 14 , , PUNCT aji-51 310 15 necrosis necrosis NOUN aji-51 310 16 , , PUNCT aji-51 310 17 and and CCONJ aji-51 310 18 inflammation inflammation NOUN aji-51 310 19 . . PUNCT aji-51 311 1 research research NOUN aji-51 311 2 demonstrates demonstrate VERB aji-51 311 3 that that SCONJ aji-51 311 4 curcumin curcumin NOUN aji-51 311 5 activates activate VERB aji-51 311 6 caspases-3 caspases-3 NUM aji-51 311 7 and and CCONJ aji-51 311 8 -8 -8 NOUN aji-51 311 9 but but CCONJ aji-51 311 10 not not PART aji-51 311 11 caspase-9 caspase-9 PROPN aji-51 311 12 , , PUNCT aji-51 311 13 indicating indicate VERB aji-51 311 14 that that SCONJ aji-51 311 15 the the DET aji-51 311 16 apoptosis apoptosis NOUN aji-51 311 17 induced induce VERB aji-51 311 18 in in ADP aji-51 311 19 cancer cancer NOUN aji-51 311 20 cells cell NOUN aji-51 311 21 occurs occur VERB aji-51 311 22 via via ADP aji-51 311 23 a a DET aji-51 311 24 membrane membrane NOUN aji-51 311 25 - - PUNCT aji-51 311 26 mediated mediate VERB aji-51 311 27 mechanism mechanism NOUN aji-51 311 28 . . PUNCT aji-51 312 1 membrane membrane NOUN aji-51 312 2 - - PUNCT aji-51 312 3 bound bind VERB aji-51 312 4 enzymes enzyme NOUN aji-51 312 5 play play VERB aji-51 312 6 other other ADJ aji-51 312 7 important important ADJ aji-51 312 8 roles role NOUN aji-51 312 9 in in ADP aji-51 312 10 the the DET aji-51 312 11 perpetuation perpetuation NOUN aji-51 312 12 of of ADP aji-51 312 13 cancer cancer NOUN aji-51 312 14 cells cell NOUN aji-51 312 15 such such ADJ aji-51 312 16 as as ADP aji-51 312 17 the the DET aji-51 312 18 ecto ecto PROPN aji-51 312 19 - - ADJ aji-51 312 20 nox nox ADJ aji-51 312 21 2 2 NUM aji-51 312 22 system system NOUN aji-51 312 23 . . PUNCT aji-51 313 1 p53 p53 NOUN aji-51 313 2 ( ( PUNCT aji-51 313 3 tp53 tp53 PROPN aji-51 313 4 ) ) PUNCT aji-51 313 5 is be AUX aji-51 313 6 a a DET aji-51 313 7 tumor tumor NOUN aji-51 313 8 suppressor suppressor NOUN aji-51 313 9 gene gene NOUN aji-51 313 10 and and CCONJ aji-51 313 11 is be AUX aji-51 313 12 responsible responsible ADJ aji-51 313 13 for for ADP aji-51 313 14 protecting protect VERB aji-51 313 15 cells cell NOUN aji-51 313 16 from from ADP aji-51 313 17 tumorigenic tumorigenic ADJ aji-51 313 18 alterations alteration NOUN aji-51 313 19 . . PUNCT aji-51 314 1 mutational mutational ADJ aji-51 314 2 inactivation inactivation NOUN aji-51 314 3 of of ADP aji-51 314 4 p53 p53 NOUN aji-51 314 5 is be AUX aji-51 314 6 frequently frequently ADV aji-51 314 7 observed observe VERB aji-51 314 8 in in ADP aji-51 314 9 many many ADJ aji-51 314 10 cancers cancer NOUN aji-51 314 11 . . PUNCT aji-51 315 1 curcumin curcumin NOUN aji-51 315 2 selectively selectively ADV aji-51 315 3 increases increase VERB aji-51 315 4 p53 p53 NOUN aji-51 315 5 expression expression NOUN aji-51 315 6 during during ADP aji-51 315 7 the the DET aji-51 315 8 g2 g2 PROPN aji-51 315 9 phase phase NOUN aji-51 315 10 of of ADP aji-51 315 11 the the DET aji-51 315 12 cell cell NOUN aji-51 315 13 cycle cycle NOUN aji-51 315 14 of of ADP aji-51 315 15 carcinoma carcinoma NOUN aji-51 315 16 cells cell NOUN aji-51 315 17 and and CCONJ aji-51 315 18 releases release VERB aji-51 315 19 cytochromes cytochrome NOUN aji-51 315 20 from from ADP aji-51 315 21 the the DET aji-51 315 22 mitochondria mitochondria NOUN aji-51 315 23 , , PUNCT aji-51 315 24 which which PRON aji-51 315 25 is be AUX aji-51 315 26 an an DET aji-51 315 27 essential essential ADJ aji-51 315 28 requirement requirement NOUN aji-51 315 29 for for ADP aji-51 315 30 then then ADV aji-51 315 31 inducing induce VERB aji-51 315 32 p53 p53 NOUN aji-51 315 33 - - PUNCT aji-51 315 34 dependent dependent ADJ aji-51 315 35 apoptosis apoptosis NOUN aji-51 315 36 in in ADP aji-51 315 37 the the DET aji-51 315 38 cancer cancer NOUN aji-51 315 39 cell cell NOUN aji-51 315 40 . . PUNCT aji-51 316 1 another another DET aji-51 316 2 protein protein NOUN aji-51 316 3 affected affect VERB aji-51 316 4 by by ADP aji-51 316 5 curcumin curcumin NOUN aji-51 316 6 is be AUX aji-51 316 7 akt akt PROPN aji-51 316 8 ( ( PUNCT aji-51 316 9 protein protein NOUN aji-51 316 10 kinase kinase PROPN aji-51 316 11 b b PROPN aji-51 316 12 ) ) PUNCT aji-51 316 13 , , PUNCT aji-51 316 14 a a DET aji-51 316 15 serine serine NOUN aji-51 316 16 / / SYM aji-51 316 17 threonine threonine ADJ aji-51 316 18 kinase kinase NOUN aji-51 316 19 . . PUNCT aji-51 317 1 it it PRON aji-51 317 2 is be AUX aji-51 317 3 a a DET aji-51 317 4 critical critical ADJ aji-51 317 5 enzyme enzyme NOUN aji-51 317 6 in in ADP aji-51 317 7 signal signal ADJ aji-51 317 8 transduction transduction NOUN aji-51 317 9 pathways pathway NOUN aji-51 317 10 involved involve VERB aji-51 317 11 in in ADP aji-51 317 12 cell cell NOUN aji-51 317 13 proliferation proliferation NOUN aji-51 317 14 , , PUNCT aji-51 317 15 apoptosis apoptosis NOUN aji-51 317 16 , , PUNCT aji-51 317 17 and and CCONJ aji-51 317 18 angiogenesis angiogenesis NOUN aji-51 317 19 . . PUNCT aji-51 318 1 curcumin curcumin PROPN aji-51 318 2 inhibited inhibit VERB aji-51 318 3 the the DET aji-51 318 4 phosphorylation phosphorylation NOUN aji-51 318 5 of of ADP aji-51 318 6 akt akt PROPN aji-51 318 7 in in ADP aji-51 318 8 a a DET aji-51 318 9 dose dose NOUN aji-51 318 10 - - PUNCT aji-51 318 11 dependent dependent ADJ aji-51 318 12 manner manner NOUN aji-51 318 13 leading lead VERB aji-51 318 14 to to ADP aji-51 318 15 another another DET aji-51 318 16 pathway pathway NOUN aji-51 318 17 of of ADP aji-51 318 18 apoptosis apoptosis NOUN aji-51 318 19 . . PUNCT aji-51 319 1 curcumin curcumin NOUN aji-51 319 2 also also ADV aji-51 319 3 induces induce VERB aji-51 319 4 the the DET aji-51 319 5 upregulation upregulation NOUN aji-51 319 6 of of ADP aji-51 319 7 carcinogen carcinogen NOUN aji-51 319 8 - - PUNCT aji-51 319 9 detoxifying detoxify VERB aji-51 319 10 enzymes enzyme NOUN aji-51 319 11 , , PUNCT aji-51 319 12 such such ADJ aji-51 319 13 as as ADP aji-51 319 14 glutathione glutathione NOUN aji-51 319 15 s s NOUN aji-51 319 16 - - NOUN aji-51 319 17 transferases transferase NOUN aji-51 319 18 , , PUNCT aji-51 319 19 which which PRON aji-51 319 20 have have VERB aji-51 319 21 antioxidation antioxidation NOUN aji-51 319 22 effects effect NOUN aji-51 319 23 and and CCONJ aji-51 319 24 suppresses suppress VERB aji-51 319 25 cyclooxygenase cyclooxygenase VERB aji-51 319 26 that that SCONJ aji-51 319 27 in in ADP aji-51 319 28 turn turn NOUN aji-51 319 29 lead lead VERB aji-51 319 30 to to ADP aji-51 319 31 the the DET aji-51 319 32 reduction reduction NOUN aji-51 319 33 of of ADP aji-51 319 34 the the DET aji-51 319 35 level level NOUN aji-51 319 36 of of ADP aji-51 319 37 inflammation inflammation NOUN aji-51 319 38 and and CCONJ aji-51 319 39 the the DET aji-51 319 40 stimulation stimulation NOUN aji-51 319 41 of of ADP aji-51 319 42 cancer cancer NOUN aji-51 319 43 stem stem NOUN aji-51 319 44 cells cell NOUN aji-51 319 45 . . PUNCT aji-51 320 1 real real ADJ aji-51 320 2 - - PUNCT aji-51 320 3 time time NOUN aji-51 320 4 animal animal NOUN aji-51 320 5 model model NOUN aji-51 320 6 studies study NOUN aji-51 320 7 have have AUX aji-51 320 8 demonstrated demonstrate VERB aji-51 320 9 that that SCONJ aji-51 320 10 curcumin curcumin NOUN aji-51 320 11 also also ADV aji-51 320 12 decreased decrease VERB aji-51 320 13 the the DET aji-51 320 14 expression expression NOUN aji-51 320 15 of of ADP aji-51 320 16 dna dna PROPN aji-51 320 17 damage damage NOUN aji-51 320 18 response response NOUN aji-51 320 19 genes gene NOUN aji-51 320 20 , , PUNCT aji-51 320 21 including include VERB aji-51 320 22 serine serine NOUN aji-51 320 23 / / SYM aji-51 320 24 threonine threonine ADJ aji-51 320 25 kinase kinase PROPN aji-51 320 26 ( ( PUNCT aji-51 320 27 atm atm PROPN aji-51 320 28 ) ) PUNCT aji-51 320 29 , , PUNCT aji-51 320 30 ataxia ataxia NOUN aji-51 320 31 telangiectasia telangiectasia NOUN aji-51 320 32 and and CCONJ aji-51 320 33 rad3related rad3related ADJ aji-51 320 34 protein protein NOUN aji-51 320 35 ( ( PUNCT aji-51 320 36 atr atr PROPN aji-51 320 37 ) ) PUNCT aji-51 320 38 , , PUNCT aji-51 320 39 breast breast NOUN aji-51 320 40 cancer cancer NOUN aji-51 320 41 1 1 NUM aji-51 320 42 ( ( PUNCT aji-51 320 43 brca1 brca1 PROPN aji-51 320 44 ) ) PUNCT aji-51 320 45 , , PUNCT aji-51 320 46 14 14 NUM aji-51 320 47 - - SYM aji-51 320 48 3 3 NUM aji-51 320 49 - - PUNCT aji-51 320 50 3σ 3σ NUM aji-51 320 51 , , PUNCT aji-51 320 52 dna dna NOUN aji-51 320 53 - - PUNCT aji-51 320 54 dependent dependent ADJ aji-51 320 55 protein protein NOUN aji-51 320 56 kinase kinase NOUN aji-51 320 57 ( ( PUNCT aji-51 320 58 dnapk dnapk NOUN aji-51 320 59 ) ) PUNCT aji-51 320 60 , , PUNCT aji-51 320 61 and and CCONJ aji-51 320 62 o6 o6 ADJ aji-51 320 63 - - PUNCT aji-51 320 64 methylguanine methylguanine NOUN aji-51 320 65 - - PUNCT aji-51 320 66 dna dna NOUN aji-51 320 67 methyltransferase methyltransferase NOUN aji-51 320 68 ( ( PUNCT aji-51 320 69 mgmt mgmt PROPN aji-51 320 70 ) ) PUNCT aji-51 320 71 ; ; PUNCT aji-51 320 72 thus thus ADV aji-51 320 73 , , PUNCT aji-51 320 74 the the DET aji-51 320 75 reduction reduction NOUN aji-51 320 76 of of ADP aji-51 320 77 a a DET aji-51 320 78 dna dna PROPN aji-51 320 79 damage damage NOUN aji-51 320 80 response response NOUN aji-51 320 81 is be AUX aji-51 320 82 but but CCONJ aji-51 320 83 a a DET aji-51 320 84 part part NOUN aji-51 320 85 of of ADP aji-51 320 86 the the DET aji-51 320 87 reason reason NOUN aji-51 320 88 for for ADP aji-51 320 89 curcumin curcumin NOUN aji-51 320 90 - - PUNCT aji-51 320 91 induced induce VERB aji-51 320 92 growth growth NOUN aji-51 320 93 inhibition inhibition NOUN aji-51 320 94 of of ADP aji-51 320 95 cancer cancer NOUN aji-51 320 96 cells cell NOUN aji-51 320 97 [ [ X aji-51 320 98 147 147 NUM aji-51 320 99 - - SYM aji-51 320 100 149 149 NUM aji-51 320 101 ] ] PUNCT aji-51 320 102 . . PUNCT aji-51 321 1 sulforaphane sulforaphane NOUN aji-51 321 2 ( ( PUNCT aji-51 321 3 sfn sfn PROPN aji-51 321 4 ) ) PUNCT aji-51 321 5 is be AUX aji-51 321 6 an an DET aji-51 321 7 isothiocyanate isothiocyanate NOUN aji-51 321 8 found find VERB aji-51 321 9 in in ADP aji-51 321 10 cruciferous cruciferous ADJ aji-51 321 11 vegetables vegetable NOUN aji-51 321 12 such such ADJ aji-51 321 13 as as ADP aji-51 321 14 broccoli broccoli NOUN aji-51 321 15 , , PUNCT aji-51 321 16 brussel brussel NOUN aji-51 321 17 sprouts sprout NOUN aji-51 321 18 , , PUNCT aji-51 321 19 cauliflower cauliflower NOUN aji-51 321 20 , , PUNCT aji-51 321 21 and and CCONJ aji-51 321 22 cabbage cabbage NOUN aji-51 321 23 . . PUNCT aji-51 322 1 experimentally experimentally ADV aji-51 322 2 , , PUNCT aji-51 322 3 in in ADP aji-51 322 4 cell cell NOUN aji-51 322 5 cultures culture NOUN aji-51 322 6 and and CCONJ aji-51 322 7 animal animal NOUN aji-51 322 8 models model NOUN aji-51 322 9 , , PUNCT aji-51 322 10 sfn sfn PROPN aji-51 322 11 was be AUX aji-51 322 12 shown show VERB aji-51 322 13 to to PART aji-51 322 14 be be AUX aji-51 322 15 a a DET aji-51 322 16 highly highly ADV aji-51 322 17 effective effective ADJ aji-51 322 18 chemoprotective chemoprotective ADJ aji-51 322 19 against against ADP aji-51 322 20 carcinogen carcinogen NOUN aji-51 322 21 - - PUNCT aji-51 322 22 induced induced ADJ aji-51 322 23 , , PUNCT aji-51 322 24 and and CCONJ aji-51 322 25 genetic genetic ADJ aji-51 322 26 animal animal NOUN aji-51 322 27 cancer cancer NOUN aji-51 322 28 models model NOUN aji-51 322 29 , , PUNCT aji-51 322 30 as as ADV aji-51 322 31 well well ADV aji-51 322 32 as as ADP aji-51 322 33 in in ADP aji-51 322 34 xenograft xenograft NOUN aji-51 322 35 transplant transplant NOUN aji-51 322 36 models model NOUN aji-51 322 37 of of ADP aji-51 322 38 cancer cancer NOUN aji-51 322 39 . . PUNCT aji-51 323 1 the the DET aji-51 323 2 early early ADJ aji-51 323 3 research research NOUN aji-51 323 4 focused focus VERB aji-51 323 5 on on ADP aji-51 323 6 the the DET aji-51 323 7 detoxification detoxification NOUN aji-51 323 8 ability ability NOUN aji-51 323 9 of of ADP aji-51 323 10 sfn sfn NOUN aji-51 323 11 to to PART aji-51 323 12 induce induce VERB aji-51 323 13 phase phase NOUN aji-51 323 14 2 2 NUM aji-51 323 15 enzyme enzyme NOUN aji-51 323 16 pathways pathway NOUN aji-51 323 17 . . PUNCT aji-51 324 1 later later ADJ aji-51 324 2 studies study NOUN aji-51 324 3 showed show VERB aji-51 324 4 that that SCONJ aji-51 324 5 sfn sfn PROPN aji-51 324 6 could could AUX aji-51 324 7 cause cause VERB aji-51 324 8 cancer cancer NOUN aji-51 324 9 cells cell NOUN aji-51 324 10 to to PART aji-51 324 11 enter enter VERB aji-51 324 12 g2 g2 PROPN aji-51 324 13 / / SYM aji-51 324 14 m m PROPN aji-51 324 15 phase phase NOUN aji-51 324 16 arrest arrest NOUN aji-51 324 17 and and CCONJ aji-51 324 18 result result VERB aji-51 324 19 in in ADP aji-51 324 20 apoptotic apoptotic ADJ aji-51 324 21 cell cell NOUN aji-51 324 22 death death NOUN aji-51 324 23 , , PUNCT aji-51 324 24 with with ADP aji-51 324 25 the the DET aji-51 324 26 latter latter ADJ aji-51 324 27 being be AUX aji-51 324 28 evidenced evidence VERB aji-51 324 29 by by ADP aji-51 324 30 caspase caspase NOUN aji-51 324 31 - - PUNCT aji-51 324 32 mediated mediate VERB aji-51 324 33 cleavage cleavage NOUN aji-51 324 34 of of ADP aji-51 324 35 poly(adp poly(adp NOUN aji-51 324 36 - - PUNCT aji-51 324 37 ribose ribose NOUN aji-51 324 38 ) ) PUNCT aji-51 324 39 polymerase polymerase NOUN aji-51 324 40 and and CCONJ aji-51 324 41 increased increase VERB aji-51 324 42 release release NOUN aji-51 324 43 of of ADP aji-51 324 44 histone histone NOUN aji-51 324 45 - - PUNCT aji-51 324 46 associated associate VERB aji-51 324 47 dna dna NOUN aji-51 324 48 fragments fragment NOUN aji-51 324 49 from from ADP aji-51 324 50 the the DET aji-51 324 51 tumor tumor NOUN aji-51 324 52 downstream downstream NOUN aji-51 324 53 . . PUNCT aji-51 325 1 furthermore furthermore ADV aji-51 325 2 , , PUNCT aji-51 325 3 it it PRON aji-51 325 4 leads lead VERB aji-51 325 5 to to ADP aji-51 325 6 the the DET aji-51 325 7 transcriptional transcriptional ADJ aji-51 325 8 activation activation NOUN aji-51 325 9 of of ADP aji-51 325 10 genes gene NOUN aji-51 325 11 including include VERB aji-51 325 12 tumor tumor NOUN aji-51 325 13 suppressor suppressor NOUN aji-51 325 14 genes gene NOUN aji-51 325 15 . . PUNCT aji-51 326 1 the the DET aji-51 326 2 effect effect NOUN aji-51 326 3 on on ADP aji-51 326 4 cancer cancer NOUN aji-51 326 5 genetics genetic NOUN aji-51 326 6 is be AUX aji-51 326 7 profound profound ADJ aji-51 326 8 and and CCONJ aji-51 326 9 therapeutically therapeutically ADV aji-51 326 10 beneficial beneficial ADJ aji-51 326 11 [ [ X aji-51 326 12 150 150 NUM aji-51 326 13 - - SYM aji-51 326 14 153 153 NUM aji-51 326 15 ] ] PUNCT aji-51 326 16 . . PUNCT aji-51 327 1 fish fish NOUN aji-51 327 2 oil oil NOUN aji-51 327 3 rounds round VERB aji-51 327 4 out out ADP aji-51 327 5 our our PRON aji-51 327 6 list list NOUN aji-51 327 7 of of ADP aji-51 327 8 top top ADJ aji-51 327 9 genetic genetic ADJ aji-51 327 10 stabilizing stabilizing NOUN aji-51 327 11 supplements supplement NOUN aji-51 327 12 . . PUNCT aji-51 328 1 one one NUM aji-51 328 2 of of ADP aji-51 328 3 many many ADJ aji-51 328 4 changes change NOUN aji-51 328 5 that that PRON aji-51 328 6 occur occur VERB aji-51 328 7 to to ADP aji-51 328 8 the the DET aji-51 328 9 cancer cancer NOUN aji-51 328 10 cell cell NOUN aji-51 328 11 ’s ’s PART aji-51 328 12 biochemistry biochemistry NOUN aji-51 328 13 and and CCONJ aji-51 328 14 genetics genetic NOUN aji-51 328 15 is be AUX aji-51 328 16 in in ADP aji-51 328 17 the the DET aji-51 328 18 production production NOUN aji-51 328 19 , , PUNCT aji-51 328 20 metabolism metabolism NOUN aji-51 328 21 , , PUNCT aji-51 328 22 and and CCONJ aji-51 328 23 expression expression NOUN aji-51 328 24 of of ADP aji-51 328 25 micrornas microrna NOUN aji-51 328 26 ( ( PUNCT aji-51 328 27 mirnas mirna NOUN aji-51 328 28 ) ) PUNCT aji-51 328 29 . . PUNCT aji-51 329 1 first first ADV aji-51 329 2 discovered discover VERB aji-51 329 3 in in ADP aji-51 329 4 the the DET aji-51 329 5 early early ADJ aji-51 329 6 1990s 1990 NOUN aji-51 329 7 , , PUNCT aji-51 329 8 their their PRON aji-51 329 9 importance importance NOUN aji-51 329 10 as as ADP aji-51 329 11 a a DET aji-51 329 12 distinct distinct ADJ aji-51 329 13 class class NOUN aji-51 329 14 of of ADP aji-51 329 15 biological biological ADJ aji-51 329 16 regulators regulator NOUN aji-51 329 17 was be AUX aji-51 329 18 not not PART aji-51 329 19 appreciated appreciate VERB aji-51 329 20 for for ADP aji-51 329 21 another another DET aji-51 329 22 decade decade NOUN aji-51 329 23 . . PUNCT aji-51 330 1 micrornas microrna NOUN aji-51 330 2 ( ( PUNCT aji-51 330 3 mirnas mirna NOUN aji-51 330 4 ) ) PUNCT aji-51 330 5 are be AUX aji-51 330 6 short short ADJ aji-51 330 7 molecules molecule NOUN aji-51 330 8 , , PUNCT aji-51 330 9 just just ADV aji-51 330 10 21–25 21–25 NUM aji-51 330 11 nucleotides nucleotide NOUN aji-51 330 12 long long ADV aji-51 330 13 , , PUNCT aji-51 330 14 but but CCONJ aji-51 330 15 can can AUX aji-51 330 16 have have VERB aji-51 330 17 powerful powerful ADJ aji-51 330 18 effects effect NOUN aji-51 330 19 on on ADP aji-51 330 20 gene gene NOUN aji-51 330 21 expression expression NOUN aji-51 330 22 . . PUNCT aji-51 331 1 more more ADJ aji-51 331 2 than than ADP aji-51 331 3 2000 2000 NUM aji-51 331 4 mirnas mirna NOUN aji-51 331 5 have have AUX aji-51 331 6 been be AUX aji-51 331 7 identified identify VERB aji-51 331 8 including include VERB aji-51 331 9 many many ADJ aji-51 331 10 specific specific ADJ aji-51 331 11 mirnas mirna NOUN aji-51 331 12 that that PRON aji-51 331 13 have have AUX aji-51 331 14 been be AUX aji-51 331 15 found find VERB aji-51 331 16 to to PART aji-51 331 17 be be AUX aji-51 331 18 associated associate VERB aji-51 331 19 with with ADP aji-51 331 20 cancer cancer NOUN aji-51 331 21 and and CCONJ aji-51 331 22 the the DET aji-51 331 23 risk risk NOUN aji-51 331 24 of of ADP aji-51 331 25 metastasis metastasis NOUN aji-51 331 26 . . PUNCT aji-51 332 1 the the DET aji-51 332 2 identification identification NOUN aji-51 332 3 of of ADP aji-51 332 4 circulating circulate VERB aji-51 332 5 mirna mirna PROPN aji-51 332 6 specific specific NOUN aji-51 332 7 to to ADP aji-51 332 8 metastatic metastatic ADJ aji-51 332 9 cancer cancer NOUN aji-51 332 10 presents present VERB aji-51 332 11 a a DET aji-51 332 12 unique unique ADJ aji-51 332 13 opportunity opportunity NOUN aji-51 332 14 for for ADP aji-51 332 15 early early ADJ aji-51 332 16 disease disease NOUN aji-51 332 17 identification identification NOUN aji-51 332 18 and and CCONJ aji-51 332 19 for for ADP aji-51 332 20 monitoring monitor VERB aji-51 332 21 disease disease NOUN aji-51 332 22 burden burden NOUN aji-51 332 23 as as ADP aji-51 332 24 a a DET aji-51 332 25 circulating circulate VERB aji-51 332 26 biomarker biomarker NOUN aji-51 332 27 . . PUNCT aji-51 333 1 for for ADP aji-51 333 2 example example NOUN aji-51 333 3 , , PUNCT aji-51 333 4 abnormal abnormal ADJ aji-51 333 5 activation activation NOUN aji-51 333 6 of of ADP aji-51 333 7 some some DET aji-51 333 8 mirnas mirna NOUN aji-51 333 9 found find VERB aji-51 333 10 in in ADP aji-51 333 11 the the DET aji-51 333 12 blood blood NOUN aji-51 333 13 , , PUNCT aji-51 333 14 let-151a let-151a PROPN aji-51 333 15 , , PUNCT aji-51 333 16 mir-21 mir-21 PROPN aji-51 333 17 , , PUNCT aji-51 333 18 mir-155 mir-155 NOUN aji-51 333 19 , , PUNCT aji-51 333 20 mir-,145 mir-,145 PROPN aji-51 333 21 mir-18a mir-18a NUM aji-51 333 22 , , PUNCT aji-51 333 23 and and CCONJ aji-51 333 24 mir-16 mir-16 PROPN aji-51 333 25 , , PUNCT aji-51 333 26 as as ADV aji-51 333 27 well well ADV aji-51 333 28 as as ADP aji-51 333 29 tissue tissue NOUN aji-51 333 30 - - PUNCT aji-51 333 31 specific specific ADJ aji-51 333 32 mirnas mirna NOUN aji-51 333 33 , , PUNCT aji-51 333 34 mir-182 mir-182 NOUN aji-51 333 35 , , PUNCT aji-51 333 36 mir-145 mir-145 NOUN aji-51 333 37 , , PUNCT aji-51 333 38 mir mir PROPN aji-51 333 39 stoff stoff PROPN aji-51 333 40 ; ; PUNCT aji-51 333 41 aji aji PROPN aji-51 333 42 , , PUNCT aji-51 333 43 5(1 5(1 NUM aji-51 333 44 ): ): PUNCT aji-51 333 45 1 1 NUM aji-51 333 46 - - SYM aji-51 333 47 39 39 NUM aji-51 333 48 , , PUNCT aji-51 333 49 2022 2022 NUM aji-51 333 50 ; ; PUNCT aji-51 333 51 article article NOUN aji-51 333 52 no.aji.77967 no.aji.77967 PROPN aji-51 333 53 9 9 NUM aji-51 333 54 21 21 NUM aji-51 333 55 , , PUNCT aji-51 333 56 mir-155/154 mir-155/154 PROPN aji-51 333 57 , , PUNCT aji-51 333 58 mir-203 mir-203 NOUN aji-51 333 59 , , PUNCT aji-51 333 60 mir-213 mir-213 NOUN aji-51 333 61 , , PUNCT aji-51 333 62 and and CCONJ aji-51 333 63 mir-7 mir-7 ADV aji-51 333 64 , , PUNCT aji-51 333 65 are be AUX aji-51 333 66 often often ADV aji-51 333 67 found find VERB aji-51 333 68 in in ADP aji-51 333 69 patients patient NOUN aji-51 333 70 affected affect VERB aji-51 333 71 by by ADP aji-51 333 72 breast breast NOUN aji-51 333 73 cancer cancer NOUN aji-51 333 74 . . PUNCT aji-51 334 1 furthermore furthermore ADV aji-51 334 2 , , PUNCT aji-51 334 3 there there PRON aji-51 334 4 is be VERB aji-51 334 5 a a DET aji-51 334 6 growing grow VERB aji-51 334 7 body body NOUN aji-51 334 8 of of ADP aji-51 334 9 evidence evidence NOUN aji-51 334 10 on on ADP aji-51 334 11 the the DET aji-51 334 12 value value NOUN aji-51 334 13 of of ADP aji-51 334 14 mirnas mirna NOUN aji-51 334 15 associated associate VERB aji-51 334 16 with with ADP aji-51 334 17 the the DET aji-51 334 18 development development NOUN aji-51 334 19 of of ADP aji-51 334 20 drug drug NOUN aji-51 334 21 resistance resistance NOUN aji-51 334 22 , , PUNCT aji-51 334 23 suggesting suggest VERB aji-51 334 24 their their PRON aji-51 334 25 values value NOUN aji-51 334 26 , , PUNCT aji-51 334 27 once once ADV aji-51 334 28 targeted target VERB aji-51 334 29 , , PUNCT aji-51 334 30 as as ADP aji-51 334 31 a a DET aji-51 334 32 potential potential ADJ aji-51 334 33 approach approach NOUN aji-51 334 34 to to ADP aji-51 334 35 overcoming overcome VERB aji-51 334 36 chemoresistance chemoresistance NOUN aji-51 334 37 . . PUNCT aji-51 335 1 mirnas mirna NOUN aji-51 335 2 that that PRON aji-51 335 3 are be AUX aji-51 335 4 absorbed absorb VERB aji-51 335 5 into into ADP aji-51 335 6 our our PRON aji-51 335 7 bloodstream bloodstream NOUN aji-51 335 8 from from ADP aji-51 335 9 genetically genetically ADV aji-51 335 10 modified modify VERB aji-51 335 11 organism organism NOUN aji-51 335 12 ( ( PUNCT aji-51 335 13 gmo gmo PROPN aji-51 335 14 ) ) PUNCT aji-51 335 15 foods food NOUN aji-51 335 16 are be AUX aji-51 335 17 currently currently ADV aji-51 335 18 being be AUX aji-51 335 19 studied study VERB aji-51 335 20 for for ADP aji-51 335 21 their their PRON aji-51 335 22 oncogenic oncogenic ADJ aji-51 335 23 potential potential NOUN aji-51 335 24 , , PUNCT aji-51 335 25 as as SCONJ aji-51 335 26 they they PRON aji-51 335 27 are be AUX aji-51 335 28 normally normally ADV aji-51 335 29 foreign foreign ADJ aji-51 335 30 to to ADP aji-51 335 31 human human ADJ aji-51 335 32 biology biology NOUN aji-51 335 33 . . PUNCT aji-51 336 1 fish fish NOUN aji-51 336 2 oil oil NOUN aji-51 336 3 can can AUX aji-51 336 4 modulate modulate VERB aji-51 336 5 the the DET aji-51 336 6 expression expression NOUN aji-51 336 7 of of ADP aji-51 336 8 the the DET aji-51 336 9 mirnas mirna NOUN aji-51 336 10 which which PRON aji-51 336 11 can can AUX aji-51 336 12 significantly significantly ADV aji-51 336 13 reduce reduce VERB aji-51 336 14 the the DET aji-51 336 15 risk risk NOUN aji-51 336 16 of of ADP aji-51 336 17 metastasis metastasis NOUN aji-51 336 18 while while SCONJ aji-51 336 19 having have VERB aji-51 336 20 many many ADJ aji-51 336 21 other other ADJ aji-51 336 22 anticancer anticancer NOUN aji-51 336 23 effects effect NOUN aji-51 336 24 [ [ X aji-51 336 25 154159 154159 NUM aji-51 336 26 ] ] PUNCT aji-51 336 27 . . PUNCT aji-51 337 1 the the DET aji-51 337 2 science science NOUN aji-51 337 3 of of ADP aji-51 337 4 genetics genetic NOUN aji-51 337 5 studies study NOUN aji-51 337 6 the the DET aji-51 337 7 genes gene NOUN aji-51 337 8 that that PRON aji-51 337 9 make make VERB aji-51 337 10 up up ADP aji-51 337 11 our our PRON aji-51 337 12 chromosomes chromosome NOUN aji-51 337 13 , , PUNCT aji-51 337 14 which which PRON aji-51 337 15 lead lead VERB aji-51 337 16 to to ADP aji-51 337 17 inherited inherit VERB aji-51 337 18 characteristics characteristic NOUN aji-51 337 19 ; ; PUNCT aji-51 337 20 think think VERB aji-51 337 21 gregor gregor PROPN aji-51 337 22 mendle mendle PROPN aji-51 337 23 and and CCONJ aji-51 337 24 his his PRON aji-51 337 25 peas pea NOUN aji-51 337 26 . . PUNCT aji-51 338 1 genomics genomic NOUN aji-51 338 2 is be AUX aji-51 338 3 the the DET aji-51 338 4 study study NOUN aji-51 338 5 of of ADP aji-51 338 6 large large ADJ aji-51 338 7 groups group NOUN aji-51 338 8 of of ADP aji-51 338 9 genes gene NOUN aji-51 338 10 or or CCONJ aji-51 338 11 even even ADV aji-51 338 12 the the DET aji-51 338 13 entire entire ADJ aji-51 338 14 genome genome NOUN aji-51 338 15 , , PUNCT aji-51 338 16 looking look VERB aji-51 338 17 for for ADP aji-51 338 18 mutations mutation NOUN aji-51 338 19 , , PUNCT aji-51 338 20 fusions fusion NOUN aji-51 338 21 , , PUNCT aji-51 338 22 deletions deletion NOUN aji-51 338 23 , , PUNCT aji-51 338 24 loss loss NOUN aji-51 338 25 of of ADP aji-51 338 26 heterozygosity heterozygosity NOUN aji-51 338 27 , , PUNCT aji-51 338 28 etc etc X aji-51 338 29 . . X aji-51 338 30 variations variation NOUN aji-51 338 31 and and CCONJ aji-51 338 32 alterations alteration NOUN aji-51 338 33 that that PRON aji-51 338 34 lead lead VERB aji-51 338 35 to to ADP aji-51 338 36 the the DET aji-51 338 37 expression expression NOUN aji-51 338 38 of of ADP aji-51 338 39 cancer cancer NOUN aji-51 338 40 . . PUNCT aji-51 339 1 aberrations aberration NOUN aji-51 339 2 of of ADP aji-51 339 3 the the DET aji-51 339 4 genome genome NOUN aji-51 339 5 lead lead NOUN aji-51 339 6 to to ADP aji-51 339 7 the the DET aji-51 339 8 transcription transcription NOUN aji-51 339 9 of of ADP aji-51 339 10 the the DET aji-51 339 11 faulty faulty ADJ aji-51 339 12 gene gene NOUN aji-51 339 13 into into ADP aji-51 339 14 a a DET aji-51 339 15 messenger messenger NOUN aji-51 339 16 rna rna NOUN aji-51 339 17 ( ( PUNCT aji-51 339 18 mrna mrna PROPN aji-51 339 19 ) ) PUNCT aji-51 339 20 molecule molecule NOUN aji-51 339 21 , , PUNCT aji-51 339 22 that that PRON aji-51 339 23 leaves leave VERB aji-51 339 24 the the DET aji-51 339 25 cell cell NOUN aji-51 339 26 nucleus nucleus NOUN aji-51 339 27 and and CCONJ aji-51 339 28 enters enter VERB aji-51 339 29 the the DET aji-51 339 30 cytoplasm cytoplasm NOUN aji-51 339 31 , , PUNCT aji-51 339 32 where where SCONJ aji-51 339 33 it it PRON aji-51 339 34 directs direct VERB aji-51 339 35 the the DET aji-51 339 36 synthesis synthesis NOUN aji-51 339 37 of of ADP aji-51 339 38 the the DET aji-51 339 39 protein protein NOUN aji-51 339 40 for for ADP aji-51 339 41 which which PRON aji-51 339 42 it it PRON aji-51 339 43 encodes encode VERB aji-51 339 44 . . PUNCT aji-51 340 1 abnormal abnormal ADJ aji-51 340 2 genes gene NOUN aji-51 340 3 lead lead VERB aji-51 340 4 to to ADP aji-51 340 5 abnormal abnormal ADJ aji-51 340 6 proteins protein NOUN aji-51 340 7 . . PUNCT aji-51 341 1 the the DET aji-51 341 2 study study NOUN aji-51 341 3 of of ADP aji-51 341 4 proteins protein NOUN aji-51 341 5 is be AUX aji-51 341 6 called call VERB aji-51 341 7 proteomics proteomic NOUN aji-51 341 8 ; ; PUNCT aji-51 341 9 it it PRON aji-51 341 10 ’s ’ VERB aji-51 341 11 primarily primarily ADV aji-51 341 12 the the DET aji-51 341 13 functional functional ADJ aji-51 341 14 proteins protein NOUN aji-51 341 15 , , PUNCT aji-51 341 16 which which PRON aji-51 341 17 includes include VERB aji-51 341 18 enzyme enzyme NOUN aji-51 341 19 activities activity NOUN aji-51 341 20 , , PUNCT aji-51 341 21 as as ADV aji-51 341 22 well well ADV aji-51 341 23 as as ADP aji-51 341 24 protein protein NOUN aji-51 341 25 / / SYM aji-51 341 26 protein protein NOUN aji-51 341 27 interactions interaction NOUN aji-51 341 28 ( ( PUNCT aji-51 341 29 such such ADJ aji-51 341 30 as as ADP aji-51 341 31 immune immune ADJ aji-51 341 32 receptor receptor NOUN aji-51 341 33 sites site NOUN aji-51 341 34 ) ) PUNCT aji-51 341 35 and and CCONJ aji-51 341 36 post post ADJ aji-51 341 37 - - ADJ aji-51 341 38 translational translational ADJ aji-51 341 39 modifications modification NOUN aji-51 341 40 of of ADP aji-51 341 41 the the DET aji-51 341 42 proteins protein NOUN aji-51 341 43 that that PRON aji-51 341 44 are be AUX aji-51 341 45 of of ADP aji-51 341 46 the the DET aji-51 341 47 most most ADJ aji-51 341 48 interest interest NOUN aji-51 341 49 because because SCONJ aji-51 341 50 they they PRON aji-51 341 51 are be AUX aji-51 341 52 the the DET aji-51 341 53 most most ADV aji-51 341 54 antigenic antigenic ADJ aji-51 341 55 and and CCONJ aji-51 341 56 hence hence ADV aji-51 341 57 the the DET aji-51 341 58 most most ADV aji-51 341 59 targetable targetable ADJ aji-51 341 60 / / SYM aji-51 341 61 treatable treatable ADJ aji-51 341 62 . . PUNCT aji-51 342 1 the the DET aji-51 342 2 sciences science NOUN aji-51 342 3 of of ADP aji-51 342 4 genomics genomic NOUN aji-51 342 5 and and CCONJ aji-51 342 6 proteomics proteomic NOUN aji-51 342 7 have have AUX aji-51 342 8 opened open VERB aji-51 342 9 the the DET aji-51 342 10 door door NOUN aji-51 342 11 to to ADP aji-51 342 12 what what PRON aji-51 342 13 is be AUX aji-51 342 14 being be AUX aji-51 342 15 referred refer VERB aji-51 342 16 to to ADP aji-51 342 17 as as ADP aji-51 342 18 “ " PUNCT aji-51 342 19 precision precision NOUN aji-51 342 20 medicine medicine NOUN aji-51 342 21 ” " PUNCT aji-51 343 1 [ [ X aji-51 343 2 160 160 NUM aji-51 343 3 ] ] X aji-51 343 4 . . PUNCT aji-51 344 1 precision precision NOUN aji-51 344 2 medicine medicine NOUN aji-51 344 3 is be AUX aji-51 344 4 " " PUNCT aji-51 344 5 an an DET aji-51 344 6 emerging emerge VERB aji-51 344 7 approach approach NOUN aji-51 344 8 for for ADP aji-51 344 9 disease disease NOUN aji-51 344 10 treatment treatment NOUN aji-51 344 11 and and CCONJ aji-51 344 12 prevention prevention NOUN aji-51 344 13 that that PRON aji-51 344 14 takes take VERB aji-51 344 15 into into ADP aji-51 344 16 account account NOUN aji-51 344 17 individual individual ADJ aji-51 344 18 variability variability NOUN aji-51 344 19 in in ADP aji-51 344 20 genes gene NOUN aji-51 344 21 , , PUNCT aji-51 344 22 environment environment NOUN aji-51 344 23 , , PUNCT aji-51 344 24 and and CCONJ aji-51 344 25 lifestyle lifestyle NOUN aji-51 344 26 for for ADP aji-51 344 27 each each DET aji-51 344 28 person person NOUN aji-51 344 29 " " PUNCT aji-51 344 30 . . PUNCT aji-51 345 1 this this DET aji-51 345 2 personalized personalized ADJ aji-51 345 3 approach approach NOUN aji-51 345 4 allows allow VERB aji-51 345 5 clinicians clinician NOUN aji-51 345 6 to to PART aji-51 345 7 predict predict VERB aji-51 345 8 more more ADV aji-51 345 9 accurately accurately ADV aji-51 345 10 which which DET aji-51 345 11 treatment treatment NOUN aji-51 345 12 is be AUX aji-51 345 13 more more ADV aji-51 345 14 likely likely ADJ aji-51 345 15 to to PART aji-51 345 16 work work VERB aji-51 345 17 for for ADP aji-51 345 18 which which DET aji-51 345 19 person person NOUN aji-51 345 20 [ [ X aji-51 345 21 161 161 NUM aji-51 345 22 ] ] PUNCT aji-51 345 23 . . PUNCT aji-51 346 1 this this PRON aji-51 346 2 is be AUX aji-51 346 3 in in ADP aji-51 346 4 contrast contrast NOUN aji-51 346 5 to to ADP aji-51 346 6 a a DET aji-51 346 7 one one NUM aji-51 346 8 - - PUNCT aji-51 346 9 size size NOUN aji-51 346 10 - - PUNCT aji-51 346 11 fits fit VERB aji-51 346 12 - - PUNCT aji-51 346 13 all all DET aji-51 346 14 approach approach NOUN aji-51 346 15 , , PUNCT aji-51 346 16 in in ADP aji-51 346 17 which which PRON aji-51 346 18 cancer cancer NOUN aji-51 346 19 treatment treatment NOUN aji-51 346 20 strategies strategy NOUN aji-51 346 21 are be AUX aji-51 346 22 developed develop VERB aji-51 346 23 for for ADP aji-51 346 24 the the DET aji-51 346 25 average average ADJ aji-51 346 26 person person NOUN aji-51 346 27 based base VERB aji-51 346 28 upon upon SCONJ aji-51 346 29 group group NOUN aji-51 346 30 clinical clinical ADJ aji-51 346 31 trials trial NOUN aji-51 346 32 ( ( PUNCT aji-51 346 33 cohorts cohort NOUN aji-51 346 34 ) ) PUNCT aji-51 346 35 , , PUNCT aji-51 346 36 with with ADP aji-51 346 37 little little ADJ aji-51 346 38 consideration consideration NOUN aji-51 346 39 for for ADP aji-51 346 40 the the DET aji-51 346 41 differences difference NOUN aji-51 346 42 between between ADP aji-51 346 43 individuals individual NOUN aji-51 346 44 . . PUNCT aji-51 347 1 precision precision NOUN aji-51 347 2 medicine medicine NOUN aji-51 347 3 works work VERB aji-51 347 4 by by ADP aji-51 347 5 profiling profile VERB aji-51 347 6 live live ADJ aji-51 347 7 or or CCONJ aji-51 347 8 preserved preserve VERB aji-51 347 9 cells cell NOUN aji-51 347 10 for for ADP aji-51 347 11 biomarkers biomarker NOUN aji-51 347 12 that that PRON aji-51 347 13 indicate indicate VERB aji-51 347 14 an an DET aji-51 347 15 abnormal abnormal ADJ aji-51 347 16 process process NOUN aji-51 347 17 , , PUNCT aji-51 347 18 gene gene NOUN aji-51 347 19 or or CCONJ aji-51 347 20 protein protein NOUN aji-51 347 21 is be AUX aji-51 347 22 present present ADJ aji-51 347 23 that that PRON aji-51 347 24 is be AUX aji-51 347 25 carcinogenic carcinogenic ADJ aji-51 347 26 and/or and/or CCONJ aji-51 347 27 cancer cancer NOUN aji-51 347 28 - - PUNCT aji-51 347 29 promoting promote VERB aji-51 347 30 [ [ X aji-51 347 31 162 162 NUM aji-51 347 32 ] ] PUNCT aji-51 347 33 . . PUNCT aji-51 348 1 cancer cancer NOUN aji-51 348 2 inhibiting inhibit VERB aji-51 348 3 genes gene NOUN aji-51 348 4 that that PRON aji-51 348 5 have have AUX aji-51 348 6 been be AUX aji-51 348 7 abnormally abnormally ADV aji-51 348 8 silenced silence VERB aji-51 348 9 are be AUX aji-51 348 10 also also ADV aji-51 348 11 tested test VERB aji-51 348 12 for for ADP aji-51 348 13 . . PUNCT aji-51 349 1 cutting cut VERB aji-51 349 2 edge edge NOUN aji-51 349 3 technologies technology NOUN aji-51 349 4 that that PRON aji-51 349 5 can can AUX aji-51 349 6 detect detect VERB aji-51 349 7 these these DET aji-51 349 8 clinically clinically ADV aji-51 349 9 useful useful ADJ aji-51 349 10 aberrations aberration NOUN aji-51 349 11 include include VERB aji-51 349 12 : : PUNCT aji-51 349 13 next next ADJ aji-51 349 14 - - PUNCT aji-51 349 15 generation generation NOUN aji-51 349 16 sequencing sequencing NOUN aji-51 349 17 ( ( PUNCT aji-51 349 18 which which PRON aji-51 349 19 allows allow VERB aji-51 349 20 for for ADP aji-51 349 21 whole whole ADJ aji-51 349 22 - - PUNCT aji-51 349 23 exome exome NOUN aji-51 349 24 dna dna NOUN aji-51 349 25 sequencing sequencing NOUN aji-51 349 26 and and CCONJ aji-51 349 27 whole whole ADJ aji-51 349 28 transcriptome transcriptome ADJ aji-51 349 29 rna rna NOUN aji-51 349 30 sequencing sequencing NOUN aji-51 349 31 ) ) PUNCT aji-51 349 32 , , PUNCT aji-51 349 33 dna dna NOUN aji-51 349 34 sequencing sequencing NOUN aji-51 349 35 ( ( PUNCT aji-51 349 36 sequence sequence NOUN aji-51 349 37 analysis analysis NOUN aji-51 349 38 reliably reliably ADV aji-51 349 39 detects detect VERB aji-51 349 40 dna dna PROPN aji-51 349 41 mutations mutation NOUN aji-51 349 42 , , PUNCT aji-51 349 43 copy copy VERB aji-51 349 44 number number NOUN aji-51 349 45 variations variation NOUN aji-51 349 46 , , PUNCT aji-51 349 47 and and CCONJ aji-51 349 48 gene gene NOUN aji-51 349 49 fusions fusion NOUN aji-51 349 50 across across ADP aji-51 349 51 the the DET aji-51 349 52 entire entire ADJ aji-51 349 53 exome exome NOUN aji-51 349 54 ) ) PUNCT aji-51 349 55 , , PUNCT aji-51 349 56 rna rna NOUN aji-51 349 57 sequencing sequencing NOUN aji-51 349 58 ( ( PUNCT aji-51 349 59 is be AUX aji-51 349 60 done do VERB aji-51 349 61 to to PART aji-51 349 62 detect detect VERB aji-51 349 63 clinically clinically ADV aji-51 349 64 relevant relevant ADJ aji-51 349 65 aberrations aberration NOUN aji-51 349 66 , , PUNCT aji-51 349 67 in in ADP aji-51 349 68 particular particular ADJ aji-51 349 69 , , PUNCT aji-51 349 70 gene gene NOUN aji-51 349 71 - - PUNCT aji-51 349 72 fusion fusion NOUN aji-51 349 73 events event NOUN aji-51 349 74 and and CCONJ aji-51 349 75 splice splice NOUN aji-51 349 76 variants variant NOUN aji-51 349 77 ) ) PUNCT aji-51 349 78 , , PUNCT aji-51 350 1 immunohistochemistry immunohistochemistry NOUN aji-51 350 2 biomarkers biomarker NOUN aji-51 350 3 , , PUNCT aji-51 350 4 in in ADP aji-51 350 5 situ situ ADJ aji-51 350 6 hybridization hybridization NOUN aji-51 350 7 ( ( PUNCT aji-51 350 8 to to PART aji-51 350 9 detect detect VERB aji-51 350 10 amplification amplification NOUN aji-51 350 11 and and CCONJ aji-51 350 12 fusion fusion NOUN aji-51 350 13 events event NOUN aji-51 350 14 ) ) PUNCT aji-51 350 15 , , PUNCT aji-51 350 16 and and CCONJ aji-51 350 17 methylation methylation NOUN aji-51 350 18 analysis analysis NOUN aji-51 350 19 . . PUNCT aji-51 351 1 when when SCONJ aji-51 351 2 evaluated evaluate VERB aji-51 351 3 as as ADP aji-51 351 4 a a DET aji-51 351 5 group group NOUN aji-51 351 6 , , PUNCT aji-51 351 7 disease disease NOUN aji-51 351 8 - - PUNCT aji-51 351 9 specific specific ADJ aji-51 351 10 lab lab NOUN aji-51 351 11 test test NOUN aji-51 351 12 panels panel NOUN aji-51 351 13 are be AUX aji-51 351 14 developed develop VERB aji-51 351 15 which which PRON aji-51 351 16 can can AUX aji-51 351 17 then then ADV aji-51 351 18 zero zero VERB aji-51 351 19 in in ADP aji-51 351 20 on on ADP aji-51 351 21 the the DET aji-51 351 22 aberrations aberration NOUN aji-51 351 23 for for ADP aji-51 351 24 any any DET aji-51 351 25 individual individual ADJ aji-51 351 26 patient patient NOUN aji-51 351 27 to to PART aji-51 351 28 improve improve VERB aji-51 351 29 the the DET aji-51 351 30 therapeutic therapeutic ADJ aji-51 351 31 response response NOUN aji-51 352 1 [ [ X aji-51 352 2 163 163 NUM aji-51 352 3 165 165 NUM aji-51 352 4 ] ] PUNCT aji-51 352 5 . . PUNCT aji-51 353 1 based base VERB aji-51 353 2 upon upon SCONJ aji-51 353 3 the the DET aji-51 353 4 biomarkers biomarker NOUN aji-51 353 5 found found AUX aji-51 353 6 , , PUNCT aji-51 353 7 clinically clinically ADV aji-51 353 8 beneficial beneficial ADJ aji-51 353 9 therapies therapy NOUN aji-51 353 10 may may AUX aji-51 353 11 be be AUX aji-51 353 12 employed employ VERB aji-51 353 13 including include VERB aji-51 353 14 the the DET aji-51 353 15 use use NOUN aji-51 353 16 of of ADP aji-51 353 17 ; ; PUNCT aji-51 353 18 hormone hormone NOUN aji-51 353 19 therapies therapy NOUN aji-51 353 20 , , PUNCT aji-51 353 21 signal signal VERB aji-51 353 22 transduction transduction NOUN aji-51 353 23 inhibitors inhibitor NOUN aji-51 353 24 , , PUNCT aji-51 353 25 gene gene NOUN aji-51 353 26 expression expression NOUN aji-51 353 27 modulators modulator NOUN aji-51 353 28 , , PUNCT aji-51 353 29 apoptosis apoptosis NOUN aji-51 353 30 inducers inducer NOUN aji-51 353 31 , , PUNCT aji-51 353 32 angiogenesis angiogenesis NOUN aji-51 353 33 inhibitors inhibitor NOUN aji-51 353 34 , , PUNCT aji-51 353 35 immunotherapies immunotherapy NOUN aji-51 353 36 , , PUNCT aji-51 353 37 and and CCONJ aji-51 353 38 toxin toxin NOUN aji-51 353 39 delivery delivery NOUN aji-51 353 40 molecules molecule NOUN aji-51 354 1 [ [ X aji-51 354 2 166,167 166,167 NUM aji-51 354 3 ] ] PUNCT aji-51 354 4 . . PUNCT aji-51 355 1 some some PRON aji-51 355 2 of of ADP aji-51 355 3 the the DET aji-51 355 4 commonly commonly ADV aji-51 355 5 used use VERB aji-51 355 6 small small ADJ aji-51 355 7 molecules molecule NOUN aji-51 355 8 include include VERB aji-51 355 9 the the DET aji-51 355 10 “ " PUNCT aji-51 355 11 nibs nib NOUN aji-51 355 12 ” " PUNCT aji-51 355 13 ( ( PUNCT aji-51 355 14 tyrosine tyrosine NOUN aji-51 355 15 - - PUNCT aji-51 355 16 kinase kinase NOUN aji-51 355 17 and and CCONJ aji-51 355 18 serine serine NOUN aji-51 355 19 / / SYM aji-51 355 20 threonine threonine ADJ aji-51 355 21 kinase kinase NOUN aji-51 355 22 inhibitors inhibitor NOUN aji-51 355 23 ) ) PUNCT aji-51 355 24 and and CCONJ aji-51 355 25 the the DET aji-51 355 26 “ " PUNCT aji-51 355 27 mabs mab NOUN aji-51 355 28 ” " PUNCT aji-51 355 29 ( ( PUNCT aji-51 355 30 monoclonal monoclonal NOUN aji-51 355 31 antibodies antibodie VERB aji-51 355 32 ) ) PUNCT aji-51 355 33 . . PUNCT aji-51 356 1 monoclonal monoclonal NOUN aji-51 356 2 antibodies antibody NOUN aji-51 356 3 have have AUX aji-51 356 4 been be AUX aji-51 356 5 developed develop VERB aji-51 356 6 to to PART aji-51 356 7 attack attack VERB aji-51 356 8 growth growth NOUN aji-51 356 9 receptors receptor NOUN aji-51 356 10 of of ADP aji-51 356 11 the the DET aji-51 356 12 cancer cancer NOUN aji-51 356 13 cells cell NOUN aji-51 356 14 , , PUNCT aji-51 356 15 growth growth NOUN aji-51 356 16 factors factor NOUN aji-51 356 17 for for ADP aji-51 356 18 new new ADJ aji-51 356 19 blood blood NOUN aji-51 356 20 vessels vessel NOUN aji-51 356 21 that that PRON aji-51 356 22 feed feed VERB aji-51 356 23 the the DET aji-51 356 24 tumor tumor NOUN aji-51 356 25 , , PUNCT aji-51 356 26 and and CCONJ aji-51 356 27 targets target NOUN aji-51 356 28 on on ADP aji-51 356 29 cells cell NOUN aji-51 356 30 of of ADP aji-51 356 31 the the DET aji-51 356 32 immune immune ADJ aji-51 356 33 system system NOUN aji-51 356 34 to to AUX aji-51 356 35 dis dis PROPN aji-51 356 36 - - PUNCT aji-51 356 37 inhibit inhibit VERB aji-51 356 38 their their PRON aji-51 356 39 activity activity NOUN aji-51 356 40 [ [ X aji-51 356 41 168 168 NUM aji-51 356 42 ] ] PUNCT aji-51 356 43 . . PUNCT aji-51 357 1 natural natural ADJ aji-51 357 2 substances substance NOUN aji-51 357 3 too too ADV aji-51 357 4 can can AUX aji-51 357 5 be be AUX aji-51 357 6 used use VERB aji-51 357 7 to to PART aji-51 357 8 target target VERB aji-51 357 9 specific specific ADJ aji-51 357 10 aberrations aberration NOUN aji-51 357 11 ; ; PUNCT aji-51 357 12 a a DET aji-51 357 13 few few ADJ aji-51 357 14 , , PUNCT aji-51 357 15 of of ADP aji-51 357 16 many many ADJ aji-51 357 17 , , PUNCT aji-51 357 18 examples example NOUN aji-51 358 1 [ [ X aji-51 358 2 169,170 169,170 NUM aji-51 358 3 ] ] X aji-51 358 4 : : PUNCT aji-51 358 5 p53 p53 NOUN aji-51 358 6 , , PUNCT aji-51 358 7 p73 p73 NOUN aji-51 358 8 aronia aronia NOUN aji-51 358 9 melanocarpa melanocarpa NOUN aji-51 359 1 [ [ X aji-51 359 2 171,172 171,172 NUM aji-51 359 3 ] ] X aji-51 359 4 vegf vegf NOUN aji-51 359 5 omega-3 omega-3 NUM aji-51 359 6 fatty fatty NOUN aji-51 359 7 acids acid NOUN aji-51 360 1 [ [ X aji-51 360 2 173 173 NUM aji-51 360 3 ] ] X aji-51 360 4 jak jak PROPN aji-51 360 5 / / SYM aji-51 360 6 stat3 stat3 NOUN aji-51 360 7 astaxanthin astaxanthin NOUN aji-51 361 1 [ [ X aji-51 361 2 174,175 174,175 NUM aji-51 361 3 ] ] X aji-51 361 4 pi3k pi3k PROPN aji-51 361 5 / / SYM aji-51 361 6 akt akt PROPN aji-51 361 7 viscum viscum VERB aji-51 361 8 alb alb PROPN aji-51 362 1 [ [ X aji-51 362 2 176 176 NUM aji-51 362 3 ] ] X aji-51 362 4 kdr kdr PROPN aji-51 362 5 artemisinin artemisinin PROPN aji-51 363 1 [ [ X aji-51 363 2 177 177 NUM aji-51 363 3 ] ] X aji-51 363 4 mmp2 mmp2 NOUN aji-51 363 5 , , PUNCT aji-51 363 6 mmp9 mmp9 PROPN aji-51 363 7 curcumin curcumin NOUN aji-51 364 1 [ [ X aji-51 364 2 178 178 NUM aji-51 364 3 ] ] PUNCT aji-51 364 4 her2 her2 PROPN aji-51 364 5 - - PUNCT aji-51 364 6 neu neu NOUN aji-51 364 7 quercetin quercetin NOUN aji-51 364 8 [ [ X aji-51 364 9 179 179 NUM aji-51 364 10 ] ] X aji-51 364 11 egfr egfr ADJ aji-51 364 12 silymarin silymarin NOUN aji-51 365 1 [ [ X aji-51 365 2 180 180 NUM aji-51 365 3 ] ] SYM aji-51 365 4 ve ve NOUN aji-51 365 5 - - PUNCT aji-51 365 6 cadherin cadherin NOUN aji-51 365 7 camellia camellia NOUN aji-51 365 8 sinensis sinensis NOUN aji-51 365 9 [ [ X aji-51 365 10 181 181 NUM aji-51 365 11 ] ] PUNCT aji-51 365 12 hif-1α hif-1α NOUN aji-51 365 13 ginseng ginseng NOUN aji-51 365 14 [ [ X aji-51 365 15 182 182 NUM aji-51 365 16 ] ] X aji-51 365 17 nf nf ADJ aji-51 365 18 - - PUNCT aji-51 365 19 κb κb NOUN aji-51 365 20 liquorice liquorice NOUN aji-51 365 21 [ [ X aji-51 365 22 183 183 NUM aji-51 365 23 ] ] PUNCT aji-51 365 24 bcl2 bcl2 NOUN aji-51 365 25 scutellaria scutellaria PROPN aji-51 365 26 baicalensis[184 baicalensis[184 PROPN aji-51 365 27 ] ] PUNCT aji-51 365 28 kras kras PROPN aji-51 365 29 coffee coffee NOUN aji-51 366 1 [ [ X aji-51 366 2 185 185 NUM aji-51 366 3 ] ] PUNCT aji-51 366 4 mcl-1 mcl-1 X aji-51 366 5 piperlongumine piperlongumine NOUN aji-51 366 6 [ [ X aji-51 366 7 186 186 NUM aji-51 366 8 ] ] PUNCT aji-51 366 9 stoff stoff PROPN aji-51 366 10 ; ; PUNCT aji-51 366 11 aji aji PROPN aji-51 366 12 , , PUNCT aji-51 366 13 5(1 5(1 NUM aji-51 366 14 ): ): PUNCT aji-51 366 15 1 1 NUM aji-51 366 16 - - SYM aji-51 366 17 39 39 NUM aji-51 366 18 , , PUNCT aji-51 366 19 2022 2022 NUM aji-51 366 20 ; ; PUNCT aji-51 366 21 article article NOUN aji-51 366 22 no.aji.77967 no.aji.77967 PROPN aji-51 366 23 10 10 NUM aji-51 366 24 2.4 2.4 NUM aji-51 366 25 immunotherapy immunotherapy NOUN aji-51 366 26 immuno immuno NOUN aji-51 366 27 - - PUNCT aji-51 366 28 therapy therapy NOUN aji-51 366 29 is be AUX aji-51 366 30 the the DET aji-51 366 31 third third ADJ aji-51 366 32 anti anti ADJ aji-51 366 33 - - ADJ aji-51 366 34 cancer cancer ADJ aji-51 366 35 strategy strategy NOUN aji-51 366 36 . . PUNCT aji-51 367 1 edward edward PROPN aji-51 367 2 jenner jenner PROPN aji-51 367 3 was be AUX aji-51 367 4 a a DET aji-51 367 5 pioneering pioneering ADJ aji-51 367 6 english english ADJ aji-51 367 7 physician physician NOUN aji-51 367 8 and and CCONJ aji-51 367 9 scientist scientist NOUN aji-51 367 10 who who PRON aji-51 367 11 improved improve VERB aji-51 367 12 the the DET aji-51 367 13 procedure procedure NOUN aji-51 367 14 of of ADP aji-51 367 15 smallpox smallpox NOUN aji-51 367 16 inoculation inoculation NOUN aji-51 367 17 to to PART aji-51 367 18 create create VERB aji-51 367 19 the the DET aji-51 367 20 smallpox smallpox NOUN aji-51 367 21 vaccine vaccine NOUN aji-51 367 22 in in ADP aji-51 367 23 1796 1796 NUM aji-51 367 24 [ [ X aji-51 367 25 187,188 187,188 NUM aji-51 367 26 ] ] PUNCT aji-51 367 27 . . PUNCT aji-51 368 1 in in ADP aji-51 368 2 the the DET aji-51 368 3 scientific scientific ADJ aji-51 368 4 fashion fashion NOUN aji-51 368 5 , , PUNCT aji-51 368 6 he he PRON aji-51 368 7 purposely purposely ADV aji-51 368 8 exposed expose VERB aji-51 368 9 people people NOUN aji-51 368 10 that that SCONJ aji-51 368 11 he he PRON aji-51 368 12 had have AUX aji-51 368 13 vaccinated vaccinate VERB aji-51 368 14 against against ADP aji-51 368 15 smallpox smallpox NOUN aji-51 368 16 to to PART aji-51 368 17 prove prove VERB aji-51 368 18 that that SCONJ aji-51 368 19 the the DET aji-51 368 20 cowpox cowpox NOUN aji-51 368 21 pus pus NOUN aji-51 368 22 that that SCONJ aji-51 368 23 he he PRON aji-51 368 24 used use VERB aji-51 368 25 did do AUX aji-51 368 26 indeed indeed ADV aji-51 368 27 confer confer VERB aji-51 368 28 protective protective ADJ aji-51 368 29 resistance resistance NOUN aji-51 368 30 . . PUNCT aji-51 369 1 although although SCONJ aji-51 369 2 others other NOUN aji-51 369 3 before before ADP aji-51 369 4 him he PRON aji-51 369 5 had have AUX aji-51 369 6 used use VERB aji-51 369 7 cowpox cowpox NOUN aji-51 369 8 to to PART aji-51 369 9 provide provide VERB aji-51 369 10 protection protection NOUN aji-51 369 11 from from ADP aji-51 369 12 smallpox smallpox NOUN aji-51 369 13 , , PUNCT aji-51 369 14 he he PRON aji-51 369 15 was be AUX aji-51 369 16 the the DET aji-51 369 17 first first ADJ aji-51 369 18 to to PART aji-51 369 19 then then ADV aji-51 369 20 demonstrate demonstrate VERB aji-51 369 21 that that SCONJ aji-51 369 22 it it PRON aji-51 369 23 did do AUX aji-51 369 24 in in ADP aji-51 369 25 fact fact NOUN aji-51 369 26 work work NOUN aji-51 369 27 and and CCONJ aji-51 369 28 that that SCONJ aji-51 369 29 the the DET aji-51 369 30 effect effect NOUN aji-51 369 31 was be AUX aji-51 369 32 reproducible reproducible ADJ aji-51 369 33 in in ADP aji-51 369 34 subsequent subsequent ADJ aji-51 369 35 patients patient NOUN aji-51 370 1 [ [ X aji-51 370 2 189 189 NUM aji-51 370 3 - - SYM aji-51 370 4 191 191 NUM aji-51 370 5 ] ] PUNCT aji-51 370 6 . . PUNCT aji-51 371 1 although although SCONJ aji-51 371 2 not not PART aji-51 371 3 understanding understand VERB aji-51 371 4 the the DET aji-51 371 5 intricacies intricacy NOUN aji-51 371 6 of of ADP aji-51 371 7 the the DET aji-51 371 8 immune immune ADJ aji-51 371 9 system system NOUN aji-51 371 10 , , PUNCT aji-51 371 11 because because SCONJ aji-51 371 12 he he PRON aji-51 371 13 applied apply VERB aji-51 371 14 the the DET aji-51 371 15 scientific scientific ADJ aji-51 371 16 method method NOUN aji-51 371 17 , , PUNCT aji-51 371 18 as as SCONJ aji-51 371 19 it it PRON aji-51 371 20 existed exist VERB aji-51 371 21 in in ADP aji-51 371 22 his his PRON aji-51 371 23 time time NOUN aji-51 371 24 , , PUNCT aji-51 371 25 he he PRON aji-51 371 26 is be AUX aji-51 371 27 referred refer VERB aji-51 371 28 to to ADP aji-51 371 29 as as ADP aji-51 371 30 the the DET aji-51 371 31 “ " PUNCT aji-51 371 32 father father NOUN aji-51 371 33 of of ADP aji-51 371 34 immunology immunology NOUN aji-51 371 35 ” " PUNCT aji-51 372 1 [ [ X aji-51 372 2 192 192 NUM aji-51 372 3 ] ] PUNCT aji-51 372 4 . . PUNCT aji-51 373 1 since since SCONJ aji-51 373 2 jenner jenner PROPN aji-51 373 3 ’s ’s PART aji-51 373 4 time time NOUN aji-51 373 5 , , PUNCT aji-51 373 6 imuno imuno NOUN aji-51 373 7 - - NOUN aji-51 373 8 therapy therapy NOUN aji-51 373 9 has have AUX aji-51 373 10 evolved evolve VERB aji-51 373 11 into into ADP aji-51 373 12 an an DET aji-51 373 13 office office NOUN aji-51 373 14 - - PUNCT aji-51 373 15 based base VERB aji-51 373 16 strategy strategy NOUN aji-51 373 17 for for ADP aji-51 373 18 which which PRON aji-51 373 19 they they PRON aji-51 373 20 write write VERB aji-51 373 21 very very ADV aji-51 373 22 thick thick ADJ aji-51 373 23 books book NOUN aji-51 373 24 and and CCONJ aji-51 373 25 , , PUNCT aji-51 373 26 in in ADP aji-51 373 27 the the DET aji-51 373 28 broadest broad ADJ aji-51 373 29 terms term NOUN aji-51 373 30 possible possible ADJ aji-51 373 31 , , PUNCT aji-51 373 32 it it PRON aji-51 373 33 is be AUX aji-51 373 34 a a DET aji-51 373 35 treatment treatment NOUN aji-51 373 36 that that PRON aji-51 373 37 uses use VERB aji-51 373 38 the the DET aji-51 373 39 immune immune ADJ aji-51 373 40 system system NOUN aji-51 373 41 , , PUNCT aji-51 373 42 in in ADP aji-51 373 43 some some DET aji-51 373 44 way way NOUN aji-51 373 45 , , PUNCT aji-51 373 46 to to PART aji-51 373 47 identify identify VERB aji-51 373 48 , , PUNCT aji-51 373 49 attack attack NOUN aji-51 373 50 , , PUNCT aji-51 373 51 and and CCONJ aji-51 373 52 destroy destroy VERB aji-51 373 53 the the DET aji-51 373 54 cancer cancer NOUN aji-51 373 55 . . PUNCT aji-51 374 1 using use VERB aji-51 374 2 the the DET aji-51 374 3 immune immune ADJ aji-51 374 4 system system NOUN aji-51 374 5 against against ADP aji-51 374 6 cancer cancer NOUN aji-51 374 7 can can AUX aji-51 374 8 be be AUX aji-51 374 9 accomplished accomplish VERB aji-51 374 10 through through ADP aji-51 374 11 active active ADJ aji-51 374 12 or or CCONJ aji-51 374 13 passive passive ADJ aji-51 374 14 pathways pathway NOUN aji-51 374 15 . . PUNCT aji-51 375 1 as as ADP aji-51 375 2 a a DET aji-51 375 3 quick quick ADJ aji-51 375 4 overview overview NOUN aji-51 375 5 , , PUNCT aji-51 375 6 there there PRON aji-51 375 7 are be VERB aji-51 375 8 over over ADV aji-51 375 9 one one NUM aji-51 375 10 hundred hundred NUM aji-51 375 11 and and CCONJ aji-51 375 12 eighty eighty NUM aji-51 375 13 - - PUNCT aji-51 375 14 seven seven NUM aji-51 375 15 cell cell NOUN aji-51 375 16 types type NOUN aji-51 375 17 identified identify VERB aji-51 375 18 within within ADP aji-51 375 19 the the DET aji-51 375 20 immune immune ADJ aji-51 375 21 system system NOUN aji-51 375 22 . . PUNCT aji-51 376 1 it it PRON aji-51 376 2 includes include VERB aji-51 376 3 the the DET aji-51 376 4 lymphatic lymphatic ADJ aji-51 376 5 system system NOUN aji-51 376 6 along along ADP aji-51 376 7 with with ADP aji-51 376 8 the the DET aji-51 376 9 bone bone NOUN aji-51 376 10 marrow marrow NOUN aji-51 376 11 , , PUNCT aji-51 376 12 spleen spleen NOUN aji-51 376 13 , , PUNCT aji-51 376 14 thymus thymus VERB aji-51 376 15 , , PUNCT aji-51 376 16 and and CCONJ aji-51 376 17 , , PUNCT aji-51 376 18 of of ADP aji-51 376 19 course course NOUN aji-51 376 20 , , PUNCT aji-51 376 21 lymph lymph NOUN aji-51 376 22 nodes node NOUN aji-51 376 23 . . PUNCT aji-51 377 1 cells cell NOUN aji-51 377 2 known know VERB aji-51 377 3 as as ADP aji-51 377 4 cd4 cd4 PROPN aji-51 377 5 t t PROPN aji-51 377 6 cells cell NOUN aji-51 377 7 are be AUX aji-51 377 8 the the DET aji-51 377 9 “ " PUNCT aji-51 377 10 apparent apparent ADJ aji-51 377 11 brains brain NOUN aji-51 377 12 ” " PUNCT aji-51 377 13 of of ADP aji-51 377 14 the the DET aji-51 377 15 immune immune ADJ aji-51 377 16 system system NOUN aji-51 377 17 and and CCONJ aji-51 377 18 they they PRON aji-51 377 19 coordinate coordinate VERB aji-51 377 20 the the DET aji-51 377 21 central central ADJ aji-51 377 22 immune immune ADJ aji-51 377 23 response response NOUN aji-51 377 24 to to ADP aji-51 377 25 any any DET aji-51 377 26 serious serious ADJ aji-51 377 27 health health NOUN aji-51 377 28 threat threat NOUN aji-51 377 29 . . PUNCT aji-51 378 1 activated activate VERB aji-51 378 2 b b PROPN aji-51 378 3 cells cell NOUN aji-51 378 4 become become VERB aji-51 378 5 plasma plasma NOUN aji-51 378 6 cells cell NOUN aji-51 378 7 and and CCONJ aji-51 378 8 , , PUNCT aji-51 378 9 in in ADP aji-51 378 10 most most ADJ aji-51 378 11 instances instance NOUN aji-51 378 12 , , PUNCT aji-51 378 13 generate generate VERB aji-51 378 14 an an DET aji-51 378 15 antibody antibody NOUN aji-51 378 16 response response NOUN aji-51 378 17 against against ADP aji-51 378 18 bacterial bacterial ADJ aji-51 378 19 and and CCONJ aji-51 378 20 viral viral ADJ aji-51 378 21 invasion invasion NOUN aji-51 378 22 . . PUNCT aji-51 379 1 lymphokine lymphokine VERB aji-51 379 2 activated activated ADJ aji-51 379 3 killer killer NOUN aji-51 379 4 cells cell NOUN aji-51 379 5 and and CCONJ aji-51 379 6 cytotoxic cytotoxic ADJ aji-51 379 7 t t NOUN aji-51 379 8 cells cell NOUN aji-51 379 9 respond respond VERB aji-51 379 10 to to ADP aji-51 379 11 viruses virus NOUN aji-51 379 12 and and CCONJ aji-51 379 13 cancer cancer NOUN aji-51 379 14 . . PUNCT aji-51 380 1 suppressor suppressor NOUN aji-51 380 2 t t PROPN aji-51 380 3 cells cell NOUN aji-51 380 4 are be AUX aji-51 380 5 used use VERB aji-51 380 6 to to PART aji-51 380 7 downregulate downregulate VERB aji-51 380 8 the the DET aji-51 380 9 actions action NOUN aji-51 380 10 of of ADP aji-51 380 11 the the DET aji-51 380 12 immune immune ADJ aji-51 380 13 system system NOUN aji-51 380 14 after after SCONJ aji-51 380 15 the the DET aji-51 380 16 threat threat NOUN aji-51 380 17 has have AUX aji-51 380 18 been be AUX aji-51 380 19 eliminated eliminate VERB aji-51 380 20 through through ADP aji-51 380 21 negative negative ADJ aji-51 380 22 feedback feedback NOUN aji-51 380 23 . . PUNCT aji-51 381 1 macrophages macrophage NOUN aji-51 381 2 are be AUX aji-51 381 3 voracious voracious ADJ aji-51 381 4 amoeboid amoeboid ADJ aji-51 381 5 - - PUNCT aji-51 381 6 like like ADJ aji-51 381 7 lymphocytes lymphocyte NOUN aji-51 381 8 that that PRON aji-51 381 9 eat eat VERB aji-51 381 10 foreign foreign ADJ aji-51 381 11 substances substance NOUN aji-51 381 12 and and CCONJ aji-51 381 13 send send VERB aji-51 381 14 a a DET aji-51 381 15 message message NOUN aji-51 381 16 back back ADV aji-51 381 17 to to ADP aji-51 381 18 the the DET aji-51 381 19 rest rest NOUN aji-51 381 20 of of ADP aji-51 381 21 the the DET aji-51 381 22 immune immune ADJ aji-51 381 23 system system NOUN aji-51 381 24 indicating indicate VERB aji-51 381 25 what what PRON aji-51 381 26 further further ADJ aji-51 381 27 immune immune ADJ aji-51 381 28 response response NOUN aji-51 381 29 is be AUX aji-51 381 30 necessary necessary ADJ aji-51 381 31 . . PUNCT aji-51 382 1 macrophages macrophage NOUN aji-51 382 2 and and CCONJ aji-51 382 3 their their PRON aji-51 382 4 cousins cousin NOUN aji-51 382 5 , , PUNCT aji-51 382 6 the the DET aji-51 382 7 dendritic dendritic ADJ aji-51 382 8 cells cell NOUN aji-51 382 9 , , PUNCT aji-51 382 10 are be AUX aji-51 382 11 involved involve VERB aji-51 382 12 in in ADP aji-51 382 13 all all DET aji-51 382 14 aspects aspect NOUN aji-51 382 15 of of ADP aji-51 382 16 the the DET aji-51 382 17 immune immune ADJ aji-51 382 18 response response NOUN aji-51 382 19 by by ADP aji-51 382 20 initially initially ADV aji-51 382 21 sending send VERB aji-51 382 22 out out ADP aji-51 382 23 the the DET aji-51 382 24 alarm alarm NOUN aji-51 382 25 that that SCONJ aji-51 382 26 something something PRON aji-51 382 27 is be AUX aji-51 382 28 amiss amiss ADJ aji-51 382 29 . . PUNCT aji-51 382 30 natural natural ADJ aji-51 382 31 killer killer NOUN aji-51 382 32 cells cell NOUN aji-51 382 33 are be AUX aji-51 382 34 preprogrammed preprogrammed ADJ aji-51 382 35 at at ADP aji-51 382 36 their their PRON aji-51 382 37 birth birth NOUN aji-51 382 38 to to PART aji-51 382 39 destroy destroy VERB aji-51 382 40 virally virally ADV aji-51 382 41 infected infect VERB aji-51 382 42 cells cell NOUN aji-51 382 43 , , PUNCT aji-51 382 44 cancer cancer NOUN aji-51 382 45 cells cell NOUN aji-51 382 46 , , PUNCT aji-51 382 47 some some DET aji-51 382 48 bacteria bacteria NOUN aji-51 382 49 , , PUNCT aji-51 382 50 and and CCONJ aji-51 382 51 parasites parasite NOUN aji-51 382 52 on on ADP aji-51 382 53 contact contact NOUN aji-51 382 54 without without ADP aji-51 382 55 the the DET aji-51 382 56 need need NOUN aji-51 382 57 for for ADP aji-51 382 58 further further ADJ aji-51 382 59 direction direction NOUN aji-51 382 60 from from ADP aji-51 382 61 the the DET aji-51 382 62 cd4 cd4 PROPN aji-51 382 63 cells cell NOUN aji-51 382 64 . . PUNCT aji-51 383 1 some some DET aji-51 383 2 mushroom mushroom NOUN aji-51 383 3 extracts extract NOUN aji-51 383 4 and and CCONJ aji-51 383 5 the the DET aji-51 383 6 bioengineered bioengineere VERB aji-51 383 7 nutraceutical nutraceutical ADJ aji-51 383 8 aie10 aie10 PROPN aji-51 383 9 tm tm PROPN aji-51 383 10 can can AUX aji-51 383 11 increase increase VERB aji-51 383 12 the the DET aji-51 383 13 concentration concentration NOUN aji-51 383 14 and and CCONJ aji-51 383 15 activity activity NOUN aji-51 383 16 of of ADP aji-51 383 17 natural natural ADJ aji-51 383 18 killer killer NOUN aji-51 383 19 cells cell NOUN aji-51 383 20 . . PUNCT aji-51 384 1 the the DET aji-51 384 2 immune immune ADJ aji-51 384 3 response response NOUN aji-51 384 4 cascade cascade NOUN aji-51 384 5 operates operate NOUN aji-51 384 6 according accord VERB aji-51 384 7 to to ADP aji-51 384 8 three three NUM aji-51 384 9 directives directive NOUN aji-51 384 10 . . PUNCT aji-51 385 1 the the DET aji-51 385 2 first first ADJ aji-51 385 3 is be AUX aji-51 385 4 to to PART aji-51 385 5 recognize recognize VERB aji-51 385 6 that that SCONJ aji-51 385 7 which which PRON aji-51 385 8 is be AUX aji-51 385 9 foreign foreign ADJ aji-51 385 10 and and CCONJ aji-51 385 11 sound sound VERB aji-51 385 12 the the DET aji-51 385 13 alarm alarm NOUN aji-51 385 14 soon soon ADV aji-51 385 15 enough enough ADV aji-51 385 16 to to PART aji-51 385 17 thwart thwart VERB aji-51 385 18 the the DET aji-51 385 19 invader invader NOUN aji-51 385 20 . . PUNCT aji-51 386 1 molecules molecule NOUN aji-51 386 2 and and CCONJ aji-51 386 3 cell cell NOUN aji-51 386 4 surfaces surface NOUN aji-51 386 5 that that PRON aji-51 386 6 are be AUX aji-51 386 7 identified identify VERB aji-51 386 8 as as ADP aji-51 386 9 foreign foreign ADJ aji-51 386 10 are be AUX aji-51 386 11 referred refer VERB aji-51 386 12 to to ADP aji-51 386 13 as as ADP aji-51 386 14 antigens antigen NOUN aji-51 386 15 and and CCONJ aji-51 386 16 have have VERB aji-51 386 17 the the DET aji-51 386 18 ability ability NOUN aji-51 386 19 to to PART aji-51 386 20 elicit elicit VERB aji-51 386 21 an an DET aji-51 386 22 immunogenic immunogenic ADJ aji-51 386 23 response response NOUN aji-51 386 24 . . PUNCT aji-51 387 1 the the DET aji-51 387 2 second second ADJ aji-51 387 3 directive directive NOUN aji-51 387 4 is be AUX aji-51 387 5 to to PART aji-51 387 6 respond respond VERB aji-51 387 7 to to ADP aji-51 387 8 the the DET aji-51 387 9 alarm alarm NOUN aji-51 387 10 with with ADP aji-51 387 11 enough enough ADJ aji-51 387 12 of of ADP aji-51 387 13 a a DET aji-51 387 14 counterattack counterattack NOUN aji-51 387 15 to to PART aji-51 387 16 effectively effectively ADV aji-51 387 17 neutralize neutralize VERB aji-51 387 18 the the DET aji-51 387 19 invader invader NOUN aji-51 387 20 quickly quickly ADV aji-51 387 21 . . PUNCT aji-51 388 1 the the DET aji-51 388 2 third third ADJ aji-51 388 3 directive directive NOUN aji-51 388 4 is be AUX aji-51 388 5 to to PART aji-51 388 6 remember remember VERB aji-51 388 7 what what PRON aji-51 388 8 happened happen VERB aji-51 388 9 so so SCONJ aji-51 388 10 that that SCONJ aji-51 388 11 if if SCONJ aji-51 388 12 the the DET aji-51 388 13 same same ADJ aji-51 388 14 situation situation NOUN aji-51 388 15 were be AUX aji-51 388 16 to to PART aji-51 388 17 arise arise VERB aji-51 388 18 again again ADV aji-51 388 19 , , PUNCT aji-51 388 20 an an DET aji-51 388 21 effective effective ADJ aji-51 388 22 response response NOUN aji-51 388 23 could could AUX aji-51 388 24 be be AUX aji-51 388 25 generated generate VERB aji-51 388 26 faster fast ADV aji-51 388 27 . . PUNCT aji-51 389 1 the the DET aji-51 389 2 length length NOUN aji-51 389 3 and and CCONJ aji-51 389 4 efficacy efficacy NOUN aji-51 389 5 of of ADP aji-51 389 6 the the DET aji-51 389 7 immune immune ADJ aji-51 389 8 response response NOUN aji-51 389 9 depends depend VERB aji-51 389 10 upon upon SCONJ aji-51 389 11 the the DET aji-51 389 12 “ " PUNCT aji-51 389 13 intactness intactness NOUN aji-51 389 14 ” " PUNCT aji-51 389 15 of of ADP aji-51 389 16 the the DET aji-51 389 17 underlying underlie VERB aji-51 389 18 biochemistry biochemistry NOUN aji-51 389 19 . . PUNCT aji-51 390 1 the the DET aji-51 390 2 immune immune ADJ aji-51 390 3 response response NOUN aji-51 390 4 cascade cascade NOUN aji-51 390 5 is be AUX aji-51 390 6 the the DET aji-51 390 7 ultimate ultimate ADJ aji-51 390 8 biological biological ADJ aji-51 390 9 information information NOUN aji-51 390 10 processing processing NOUN aji-51 390 11 and and CCONJ aji-51 390 12 transfer transfer NOUN aji-51 390 13 vehicle vehicle NOUN aji-51 390 14 designed design VERB aji-51 390 15 to to PART aji-51 390 16 define define VERB aji-51 390 17 , , PUNCT aji-51 390 18 defend defend VERB aji-51 390 19 , , PUNCT aji-51 390 20 and and CCONJ aji-51 390 21 integrate integrate VERB aji-51 390 22 oneself oneself PRON aji-51 390 23 relative relative ADJ aji-51 390 24 to to ADP aji-51 390 25 the the DET aji-51 390 26 environment environment NOUN aji-51 390 27 that that PRON aji-51 390 28 surrounds surround VERB aji-51 390 29 us we PRON aji-51 390 30 . . PUNCT aji-51 391 1 when when SCONJ aji-51 391 2 there there PRON aji-51 391 3 is be VERB aji-51 391 4 a a DET aji-51 391 5 miscommunication miscommunication NOUN aji-51 391 6 , , PUNCT aji-51 391 7 disease disease NOUN aji-51 391 8 ensues ensue VERB aji-51 391 9 due due ADJ aji-51 391 10 to to ADP aji-51 391 11 corruption corruption NOUN aji-51 391 12 , , PUNCT aji-51 391 13 misdirection misdirection NOUN aji-51 391 14 , , PUNCT aji-51 391 15 or or CCONJ aji-51 391 16 a a DET aji-51 391 17 lack lack NOUN aji-51 391 18 of of ADP aji-51 391 19 that that DET aji-51 391 20 informational informational ADJ aji-51 391 21 flow flow NOUN aji-51 391 22 . . PUNCT aji-51 392 1 active active ADJ aji-51 392 2 immune immune ADJ aji-51 392 3 therapies therapy NOUN aji-51 392 4 include include VERB aji-51 392 5 , , PUNCT aji-51 392 6 among among ADP aji-51 392 7 other other ADJ aji-51 392 8 agents agent NOUN aji-51 392 9 , , PUNCT aji-51 392 10 il-2 il-2 NUM aji-51 392 11 , , PUNCT aji-51 392 12 ifn ifn PROPN aji-51 392 13 - - PUNCT aji-51 392 14 g g NOUN aji-51 392 15 , , PUNCT aji-51 392 16 and and CCONJ aji-51 392 17 ifn ifn PROPN aji-51 392 18 - - PUNCT aji-51 392 19 a a DET aji-51 392 20 cytokines cytokine NOUN aji-51 392 21 to to PART aji-51 392 22 stimulate stimulate VERB aji-51 392 23 the the DET aji-51 392 24 th1 th1 NOUN aji-51 392 25 cells cell NOUN aji-51 392 26 , , PUNCT aji-51 392 27 pathways pathway NOUN aji-51 392 28 , , PUNCT aji-51 392 29 and and CCONJ aji-51 392 30 natural natural ADJ aji-51 392 31 killer killer NOUN aji-51 392 32 cells cell NOUN aji-51 392 33 . . PUNCT aji-51 393 1 monoclonal monoclonal NOUN aji-51 393 2 antibodies antibody NOUN aji-51 393 3 , , PUNCT aji-51 393 4 checkpoint checkpoint NOUN aji-51 393 5 inhibitors inhibitor NOUN aji-51 393 6 , , PUNCT aji-51 393 7 that that PRON aji-51 393 8 disinhibit disinhibit VERB aji-51 393 9 an an DET aji-51 393 10 immune immune ADJ aji-51 393 11 response response NOUN aji-51 393 12 are be AUX aji-51 393 13 also also ADV aji-51 393 14 an an DET aji-51 393 15 active active ADJ aji-51 393 16 immunotherapy immunotherapy NOUN aji-51 393 17 that that PRON aji-51 393 18 seems seem VERB aji-51 393 19 to to PART aji-51 393 20 be be AUX aji-51 393 21 most most ADV aji-51 393 22 effective effective ADJ aji-51 393 23 when when SCONJ aji-51 393 24 some some DET aji-51 393 25 support support NOUN aji-51 393 26 has have AUX aji-51 393 27 been be AUX aji-51 393 28 given give VERB aji-51 393 29 to to ADP aji-51 393 30 the the DET aji-51 393 31 immune immune ADJ aji-51 393 32 system system NOUN aji-51 393 33 first first ADV aji-51 393 34 . . PUNCT aji-51 394 1 other other ADJ aji-51 394 2 active active ADJ aji-51 394 3 therapies therapy NOUN aji-51 394 4 include include VERB aji-51 394 5 creating create VERB aji-51 394 6 primed prime VERB aji-51 394 7 dendritic dendritic ADJ aji-51 394 8 cells cell NOUN aji-51 394 9 ( ( PUNCT aji-51 394 10 for for ADP aji-51 394 11 example example NOUN aji-51 394 12 , , PUNCT aji-51 394 13 sipuleucel sipuleucel NOUN aji-51 394 14 - - PUNCT aji-51 394 15 t t PROPN aji-51 394 16 ( ( PUNCT aji-51 394 17 provenge provenge NOUN aji-51 394 18 ) ) PUNCT aji-51 394 19 ) ) PUNCT aji-51 394 20 and and CCONJ aji-51 394 21 natural natural ADJ aji-51 394 22 killer killer NOUN aji-51 394 23 cells cell NOUN aji-51 394 24 and and CCONJ aji-51 394 25 then then ADV aji-51 394 26 infusing infuse VERB aji-51 394 27 them they PRON aji-51 394 28 into into ADP aji-51 394 29 the the DET aji-51 394 30 patient patient NOUN aji-51 394 31 to to ADP aji-51 394 32 “ " PUNCT aji-51 394 33 patch patch VERB aji-51 394 34 ” " PUNCT aji-51 394 35 holes hole NOUN aji-51 394 36 and and CCONJ aji-51 394 37 reconstitute reconstitute VERB aji-51 394 38 an an DET aji-51 394 39 effective effective ADJ aji-51 394 40 anticancer anticancer NOUN aji-51 394 41 response response NOUN aji-51 394 42 . . PUNCT aji-51 395 1 passive passive ADJ aji-51 395 2 immunotherapies immunotherapy NOUN aji-51 395 3 include include VERB aji-51 395 4 the the DET aji-51 395 5 use use NOUN aji-51 395 6 of of ADP aji-51 395 7 infused infuse VERB aji-51 395 8 antibodies antibody NOUN aji-51 395 9 to to PART aji-51 395 10 bind bind VERB aji-51 395 11 to to ADP aji-51 395 12 cancer cancer NOUN aji-51 395 13 cells cell NOUN aji-51 395 14 . . PUNCT aji-51 396 1 then then ADV aji-51 396 2 , , PUNCT aji-51 396 3 when when SCONJ aji-51 396 4 natural natural ADJ aji-51 396 5 killer killer NOUN aji-51 396 6 cells cell NOUN aji-51 396 7 encounter encounter VERB aji-51 396 8 antibodycoated antibodycoate VERB aji-51 396 9 cells cell NOUN aji-51 396 10 , , PUNCT aji-51 396 11 the the DET aji-51 396 12 latter latter ADJ aji-51 396 13 ’s ’s NOUN aji-51 396 14 fc fc PROPN aji-51 396 15 regions region NOUN aji-51 396 16 interact interact VERB aji-51 396 17 with with ADP aji-51 396 18 their their PRON aji-51 396 19 fc fc NOUN aji-51 396 20 receptors receptor NOUN aji-51 396 21 , , PUNCT aji-51 396 22 releasing release VERB aji-51 396 23 perforin perforin NOUN aji-51 396 24 and and CCONJ aji-51 396 25 granzyme granzyme NOUN aji-51 396 26 b b PROPN aji-51 396 27 to to PART aji-51 396 28 kill kill VERB aji-51 396 29 the the DET aji-51 396 30 tumor tumor NOUN aji-51 396 31 cell cell NOUN aji-51 396 32 . . PUNCT aji-51 397 1 adoptive adoptive PROPN aji-51 397 2 t t PROPN aji-51 397 3 cell cell NOUN aji-51 397 4 therapy therapy NOUN aji-51 397 5 is be AUX aji-51 397 6 another another DET aji-51 397 7 passive passive ADJ aji-51 397 8 immunotherapy immunotherapy NOUN aji-51 397 9 . . PUNCT aji-51 398 1 several several ADJ aji-51 398 2 ways way NOUN aji-51 398 3 of of ADP aji-51 398 4 producing produce VERB aji-51 398 5 and and CCONJ aji-51 398 6 obtaining obtain VERB aji-51 398 7 tumortargeted tumortargete VERB aji-51 398 8 t t NOUN aji-51 398 9 cells cell NOUN aji-51 398 10 have have AUX aji-51 398 11 been be AUX aji-51 398 12 developed develop VERB aji-51 398 13 . . PUNCT aji-51 399 1 t t NOUN aji-51 399 2 cell cell NOUN aji-51 399 3 infiltrating infiltrate VERB aji-51 399 4 lymphocytes lymphocyte NOUN aji-51 399 5 ( ( PUNCT aji-51 399 6 tils til NOUN aji-51 399 7 ) ) PUNCT aji-51 399 8 , , PUNCT aji-51 399 9 specific specific ADJ aji-51 399 10 to to ADP aji-51 399 11 the the DET aji-51 399 12 tumor tumor NOUN aji-51 399 13 antigens antigen NOUN aji-51 399 14 , , PUNCT aji-51 399 15 can can AUX aji-51 399 16 be be AUX aji-51 399 17 removed remove VERB aji-51 399 18 from from ADP aji-51 399 19 a a DET aji-51 399 20 tumor tumor NOUN aji-51 399 21 sample sample NOUN aji-51 399 22 with with ADP aji-51 399 23 a a DET aji-51 399 24 core core NOUN aji-51 399 25 biopsy biopsy NOUN aji-51 399 26 and and CCONJ aji-51 399 27 then then ADV aji-51 399 28 purified purify VERB aji-51 399 29 with with ADP aji-51 399 30 a a DET aji-51 399 31 cell cell NOUN aji-51 399 32 separator separator NOUN aji-51 399 33 or or CCONJ aji-51 399 34 filtered filter VERB aji-51 399 35 from from ADP aji-51 399 36 the the DET aji-51 399 37 blood blood NOUN aji-51 399 38 . . PUNCT aji-51 400 1 subsequent subsequent ADJ aji-51 400 2 activation activation NOUN aji-51 400 3 with with ADP aji-51 400 4 cytokines cytokine NOUN aji-51 400 5 and and CCONJ aji-51 400 6 cell cell NOUN aji-51 400 7 culturing culturing NOUN aji-51 400 8 is be AUX aji-51 400 9 performed perform VERB aji-51 400 10 ex ex PRON aji-51 400 11 vivo vivo NOUN aji-51 400 12 , , PUNCT aji-51 400 13 and and CCONJ aji-51 400 14 then then ADV aji-51 400 15 the the DET aji-51 400 16 results result NOUN aji-51 400 17 were be AUX aji-51 400 18 reinfused reinfuse VERB aji-51 400 19 into into ADP aji-51 400 20 the the DET aji-51 400 21 patient patient NOUN aji-51 400 22 . . PUNCT aji-51 401 1 activation activation NOUN aji-51 401 2 stoff stoff PROPN aji-51 401 3 ; ; PUNCT aji-51 401 4 aji aji PROPN aji-51 401 5 , , PUNCT aji-51 401 6 5(1 5(1 NUM aji-51 401 7 ): ): PUNCT aji-51 401 8 1 1 NUM aji-51 401 9 - - SYM aji-51 401 10 39 39 NUM aji-51 401 11 , , PUNCT aji-51 401 12 2022 2022 NUM aji-51 401 13 ; ; PUNCT aji-51 401 14 article article NOUN aji-51 401 15 no.aji.77967 no.aji.77967 PROPN aji-51 401 16 11 11 NUM aji-51 401 17 can can AUX aji-51 401 18 take take VERB aji-51 401 19 place place NOUN aji-51 401 20 through through ADP aji-51 401 21 gene gene NOUN aji-51 401 22 therapy therapy NOUN aji-51 401 23 or or CCONJ aji-51 401 24 by by ADP aji-51 401 25 exposing expose VERB aji-51 401 26 the the DET aji-51 401 27 t t NOUN aji-51 401 28 cells cell NOUN aji-51 401 29 to to ADP aji-51 401 30 tumor tumor NOUN aji-51 401 31 antigens antigen NOUN aji-51 401 32 in in ADP aji-51 401 33 the the DET aji-51 401 34 presence presence NOUN aji-51 401 35 of of ADP aji-51 401 36 cytokines cytokine NOUN aji-51 401 37 . . PUNCT aji-51 402 1 tils til NOUN aji-51 402 2 can can AUX aji-51 402 3 also also ADV aji-51 402 4 be be AUX aji-51 402 5 stimulated stimulate VERB aji-51 402 6 in in ADP aji-51 402 7 vivo vivo NOUN aji-51 402 8 with with ADP aji-51 402 9 hypofractionated hypofractionate VERB aji-51 402 10 sbrt sbrt NOUN aji-51 402 11 to to PART aji-51 402 12 induce induce VERB aji-51 402 13 an an DET aji-51 402 14 abscopal abscopal ADJ aji-51 402 15 effect effect NOUN aji-51 402 16 , , PUNCT aji-51 402 17 which which PRON aji-51 402 18 when when SCONJ aji-51 402 19 achieved achieve VERB aji-51 402 20 can can AUX aji-51 402 21 have have VERB aji-51 402 22 miraculous miraculous ADJ aji-51 402 23 results result NOUN aji-51 402 24 . . PUNCT aji-51 403 1 according accord VERB aji-51 403 2 to to ADP aji-51 403 3 the the DET aji-51 403 4 national national PROPN aji-51 403 5 cancer cancer PROPN aji-51 403 6 institute institute PROPN aji-51 403 7 , , PUNCT aji-51 403 8 the the DET aji-51 403 9 abscopal abscopal ADJ aji-51 403 10 effect effect NOUN aji-51 403 11 “ " PUNCT aji-51 403 12 describes describe VERB aji-51 403 13 the the DET aji-51 403 14 shrinking shrinking NOUN aji-51 403 15 or or CCONJ aji-51 403 16 disappearance disappearance NOUN aji-51 403 17 of of ADP aji-51 403 18 tumors tumor NOUN aji-51 403 19 in in ADP aji-51 403 20 parts part NOUN aji-51 403 21 of of ADP aji-51 403 22 the the DET aji-51 403 23 body body NOUN aji-51 403 24 that that PRON aji-51 403 25 were be AUX aji-51 403 26 not not PART aji-51 403 27 the the DET aji-51 403 28 direct direct ADJ aji-51 403 29 target target NOUN aji-51 403 30 of of ADP aji-51 403 31 local local ADJ aji-51 403 32 therapy therapy NOUN aji-51 403 33 ” " PUNCT aji-51 404 1 [ [ X aji-51 404 2 193 193 NUM aji-51 404 3 ] ] PUNCT aji-51 404 4 . . PUNCT aji-51 405 1 it it PRON aji-51 405 2 was be AUX aji-51 405 3 first first ADV aji-51 405 4 described describe VERB aji-51 405 5 in in ADP aji-51 405 6 1953 1953 NUM aji-51 405 7 , , PUNCT aji-51 405 8 by by ADP aji-51 405 9 a a DET aji-51 405 10 researcher researcher NOUN aji-51 405 11 named name VERB aji-51 405 12 r. r. PROPN aji-51 405 13 h. h. PROPN aji-51 405 14 mole mole NOUN aji-51 405 15 who who PRON aji-51 405 16 demonstrated demonstrate VERB aji-51 405 17 that that SCONJ aji-51 405 18 radiation radiation NOUN aji-51 405 19 could could AUX aji-51 405 20 shrink shrink VERB aji-51 405 21 a a DET aji-51 405 22 tumor tumor NOUN aji-51 405 23 on on ADP aji-51 405 24 one one NUM aji-51 405 25 side side NOUN aji-51 405 26 of of ADP aji-51 405 27 a a DET aji-51 405 28 mouse mouse NOUN aji-51 405 29 and and CCONJ aji-51 405 30 lead lead VERB aji-51 405 31 to to ADP aji-51 405 32 the the DET aji-51 405 33 regression regression NOUN aji-51 405 34 of of ADP aji-51 405 35 an an DET aji-51 405 36 untreated untreated ADJ aji-51 405 37 tumor tumor NOUN aji-51 405 38 on on ADP aji-51 405 39 the the DET aji-51 405 40 other other ADJ aji-51 405 41 side side NOUN aji-51 405 42 of of ADP aji-51 405 43 the the DET aji-51 405 44 animal[194 animal[194 PROPN aji-51 405 45 ] ] PUNCT aji-51 405 46 . . PUNCT aji-51 406 1 he he PRON aji-51 406 2 coined coin VERB aji-51 406 3 the the DET aji-51 406 4 term term NOUN aji-51 406 5 “ " PUNCT aji-51 406 6 abscopal abscopal ADJ aji-51 406 7 effect effect NOUN aji-51 406 8 ” " PUNCT aji-51 406 9 from from ADP aji-51 406 10 the the DET aji-51 406 11 latin latin PROPN aji-51 406 12 ab ab PROPN aji-51 406 13 ( ( PUNCT aji-51 406 14 position position VERB aji-51 406 15 away away ADV aji-51 406 16 from from ADP aji-51 406 17 ) ) PUNCT aji-51 406 18 and and CCONJ aji-51 406 19 scopus scopus PROPN aji-51 406 20 ( ( PUNCT aji-51 406 21 mark mark NOUN aji-51 406 22 or or CCONJ aji-51 406 23 target target VERB aji-51 406 24 ) ) PUNCT aji-51 406 25 . . PUNCT aji-51 407 1 since since SCONJ aji-51 407 2 the the DET aji-51 407 3 phenomena phenomenon NOUN aji-51 407 4 was be AUX aji-51 407 5 first first ADV aji-51 407 6 observed observe VERB aji-51 407 7 using use VERB aji-51 407 8 radiation radiation NOUN aji-51 407 9 , , PUNCT aji-51 407 10 it it PRON aji-51 407 11 was be AUX aji-51 407 12 assumed assume VERB aji-51 407 13 that that SCONJ aji-51 407 14 that that PRON aji-51 407 15 was be AUX aji-51 407 16 the the DET aji-51 407 17 key key NOUN aji-51 407 18 to to ADP aji-51 407 19 the the DET aji-51 407 20 response response NOUN aji-51 407 21 . . PUNCT aji-51 408 1 a a DET aji-51 408 2 lot lot NOUN aji-51 408 3 of of ADP aji-51 408 4 research research NOUN aji-51 408 5 has have AUX aji-51 408 6 been be AUX aji-51 408 7 done do VERB aji-51 408 8 on on ADP aji-51 408 9 varying vary VERB aji-51 408 10 different different ADJ aji-51 408 11 parameters parameter NOUN aji-51 408 12 of of ADP aji-51 408 13 the the DET aji-51 408 14 radiation radiation NOUN aji-51 408 15 in in ADP aji-51 408 16 order order NOUN aji-51 408 17 to to PART aji-51 408 18 reliably reliably ADV aji-51 408 19 reproduce reproduce VERB aji-51 408 20 the the DET aji-51 408 21 effect effect NOUN aji-51 408 22 [ [ X aji-51 408 23 195 195 NUM aji-51 408 24 ] ] PUNCT aji-51 408 25 . . PUNCT aji-51 409 1 tumor tumor NOUN aji-51 409 2 - - PUNCT aji-51 409 3 infiltrating infiltrate VERB aji-51 409 4 lymphocytes lymphocyte NOUN aji-51 409 5 are be AUX aji-51 409 6 seen see VERB aji-51 409 7 as as ADP aji-51 409 8 an an DET aji-51 409 9 important important ADJ aji-51 409 10 part part NOUN aji-51 409 11 of of ADP aji-51 409 12 the the DET aji-51 409 13 “ " PUNCT aji-51 409 14 recipe recipe NOUN aji-51 409 15 ” " PUNCT aji-51 409 16 as as SCONJ aji-51 409 17 they they PRON aji-51 409 18 can can AUX aji-51 409 19 signal signal VERB aji-51 409 20 and and CCONJ aji-51 409 21 initiate initiate VERB aji-51 409 22 a a DET aji-51 409 23 counter counter ADJ aji-51 409 24 - - ADJ aji-51 409 25 tumor tumor ADJ aji-51 409 26 cascade cascade NOUN aji-51 409 27 and and CCONJ aji-51 409 28 bode bode VERB aji-51 409 29 well well ADV aji-51 409 30 prognostically prognostically ADV aji-51 410 1 [ [ X aji-51 410 2 196 196 NUM aji-51 410 3 ] ] PUNCT aji-51 410 4 . . PUNCT aji-51 411 1 further further ADJ aji-51 411 2 research research NOUN aji-51 411 3 has have AUX aji-51 411 4 demonstrated demonstrate VERB aji-51 411 5 that that SCONJ aji-51 411 6 cryotherapy cryotherapy NOUN aji-51 411 7 , , PUNCT aji-51 411 8 too too ADV aji-51 411 9 , , PUNCT aji-51 411 10 can can AUX aji-51 411 11 trigger trigger VERB aji-51 411 12 an an DET aji-51 411 13 abscopal abscopal ADJ aji-51 411 14 response response NOUN aji-51 411 15 [ [ X aji-51 411 16 197 197 NUM aji-51 411 17 ] ] PUNCT aji-51 411 18 . . PUNCT aji-51 412 1 in in ADP aji-51 412 2 my my PRON aji-51 412 3 experience experience NOUN aji-51 412 4 , , PUNCT aji-51 412 5 it it PRON aji-51 412 6 seems seem VERB aji-51 412 7 that that SCONJ aji-51 412 8 any any DET aji-51 412 9 locally locally ADV aji-51 412 10 applied apply VERB aji-51 412 11 treatment treatment NOUN aji-51 412 12 that that PRON aji-51 412 13 causes cause VERB aji-51 412 14 the the DET aji-51 412 15 sudden sudden ADJ aji-51 412 16 death death NOUN aji-51 412 17 of of ADP aji-51 412 18 a a DET aji-51 412 19 large large ADJ aji-51 412 20 number number NOUN aji-51 412 21 of of ADP aji-51 412 22 cancer cancer NOUN aji-51 412 23 cells cell NOUN aji-51 412 24 , , PUNCT aji-51 412 25 thus thus ADV aji-51 412 26 quickly quickly ADV aji-51 412 27 releasing release VERB aji-51 412 28 antigens antigen NOUN aji-51 412 29 , , PUNCT aji-51 412 30 without without ADP aji-51 412 31 suppressing suppress VERB aji-51 412 32 normal normal ADJ aji-51 412 33 systemic systemic ADJ aji-51 412 34 physiology physiology NOUN aji-51 412 35 ( ( PUNCT aji-51 412 36 i.e. i.e. X aji-51 412 37 the the DET aji-51 412 38 immune immune ADJ aji-51 412 39 system system NOUN aji-51 412 40 ) ) PUNCT aji-51 412 41 , , PUNCT aji-51 412 42 can can AUX aji-51 412 43 trigger trigger VERB aji-51 412 44 a a DET aji-51 412 45 cascade cascade NOUN aji-51 412 46 of of ADP aji-51 412 47 events event NOUN aji-51 412 48 that that PRON aji-51 412 49 can can AUX aji-51 412 50 lead lead VERB aji-51 412 51 to to ADP aji-51 412 52 the the DET aji-51 412 53 death death NOUN aji-51 412 54 of of ADP aji-51 412 55 tumors tumor NOUN aji-51 412 56 far far ADV aji-51 412 57 removed remove VERB aji-51 412 58 from from ADP aji-51 412 59 the the DET aji-51 412 60 point point NOUN aji-51 412 61 of of ADP aji-51 412 62 the the DET aji-51 412 63 therapy therapy NOUN aji-51 412 64 . . PUNCT aji-51 413 1 this this PRON aji-51 413 2 includes include VERB aji-51 413 3 ; ; PUNCT aji-51 413 4 radio radio NOUN aji-51 413 5 frequency frequency NOUN aji-51 413 6 ablation ablation NOUN aji-51 413 7 ( ( PUNCT aji-51 413 8 rfa rfa NOUN aji-51 413 9 ) ) PUNCT aji-51 413 10 , , PUNCT aji-51 413 11 hyperthermia hyperthermia NOUN aji-51 413 12 , , PUNCT aji-51 413 13 hi hi INTJ aji-51 413 14 frequency frequency NOUN aji-51 413 15 ultrasound ultrasound NOUN aji-51 413 16 ( ( PUNCT aji-51 413 17 hifu hifu PROPN aji-51 413 18 ) ) PUNCT aji-51 413 19 , , PUNCT aji-51 413 20 cryotherapy cryotherapy NOUN aji-51 413 21 , , PUNCT aji-51 413 22 and and CCONJ aji-51 413 23 of of ADP aji-51 413 24 course course NOUN aji-51 413 25 fractional fractional ADJ aji-51 413 26 dose dose NOUN aji-51 413 27 radiation radiation NOUN aji-51 413 28 therapy therapy NOUN aji-51 413 29 [ [ X aji-51 413 30 198 198 NUM aji-51 413 31 - - SYM aji-51 413 32 204 204 NUM aji-51 413 33 ] ] PUNCT aji-51 413 34 . . PUNCT aji-51 414 1 combining combine VERB aji-51 414 2 these these DET aji-51 414 3 “ " PUNCT aji-51 414 4 mildly mildly ADJ aji-51 414 5 ” " PUNCT aji-51 414 6 oncolytic oncolytic ADJ aji-51 414 7 therapies therapy NOUN aji-51 414 8 with with ADP aji-51 414 9 checkpoint checkpoint NOUN aji-51 414 10 inhibitors inhibitor NOUN aji-51 414 11 has have AUX aji-51 414 12 yielded yield VERB aji-51 414 13 better well ADJ aji-51 414 14 results result NOUN aji-51 414 15 [ [ X aji-51 414 16 205,206 205,206 NUM aji-51 414 17 ] ] PUNCT aji-51 414 18 . . PUNCT aji-51 415 1 the the DET aji-51 415 2 checkpoint checkpoint NOUN aji-51 415 3 inhibitors inhibitor NOUN aji-51 415 4 are be AUX aji-51 415 5 helpful helpful ADJ aji-51 415 6 only only ADV aji-51 415 7 to to ADP aji-51 415 8 the the DET aji-51 415 9 point point NOUN aji-51 415 10 that that SCONJ aji-51 415 11 the the DET aji-51 415 12 immune immune ADJ aji-51 415 13 system system NOUN aji-51 415 14 is be AUX aji-51 415 15 still still ADV aji-51 415 16 basically basically ADV aji-51 415 17 structurally structurally ADV aji-51 415 18 intact intact ADJ aji-51 415 19 and and CCONJ aji-51 415 20 functionally functionally ADV aji-51 415 21 effective effective ADJ aji-51 415 22 . . PUNCT aji-51 416 1 when when SCONJ aji-51 416 2 the the DET aji-51 416 3 principles principle NOUN aji-51 416 4 of of ADP aji-51 416 5 immune immune ADJ aji-51 416 6 reconstitution reconstitution NOUN aji-51 416 7 are be AUX aji-51 416 8 followed follow VERB aji-51 416 9 , , PUNCT aji-51 416 10 the the DET aji-51 416 11 therapeutic therapeutic ADJ aji-51 416 12 response response NOUN aji-51 416 13 can can AUX aji-51 416 14 be be AUX aji-51 416 15 much much ADV aji-51 416 16 more more ADV aji-51 416 17 beneficial beneficial ADJ aji-51 416 18 [ [ X aji-51 416 19 207 207 NUM aji-51 416 20 ] ] PUNCT aji-51 416 21 . . PUNCT aji-51 417 1 a a DET aji-51 417 2 “ " PUNCT aji-51 417 3 new new ADJ aji-51 417 4 ” " PUNCT aji-51 417 5 , , PUNCT aji-51 417 6 state state NOUN aji-51 417 7 - - PUNCT aji-51 417 8 of of ADP aji-51 417 9 - - PUNCT aji-51 417 10 the the DET aji-51 417 11 - - PUNCT aji-51 417 12 art art NOUN aji-51 417 13 , , PUNCT aji-51 417 14 passive passive ADJ aji-51 417 15 immunotherapy immunotherapy NOUN aji-51 417 16 is be AUX aji-51 417 17 the the DET aji-51 417 18 use use NOUN aji-51 417 19 of of ADP aji-51 417 20 chimeric chimeric ADJ aji-51 417 21 antigen antigen ADJ aji-51 417 22 receptors receptor NOUN aji-51 417 23 ( ( PUNCT aji-51 417 24 cars car NOUN aji-51 417 25 , , PUNCT aji-51 417 26 also also ADV aji-51 417 27 known know VERB aji-51 417 28 as as ADP aji-51 417 29 chimeric chimeric ADJ aji-51 417 30 immunoreceptors immunoreceptor NOUN aji-51 417 31 , , PUNCT aji-51 417 32 chimeric chimeric ADJ aji-51 417 33 t t NOUN aji-51 417 34 cell cell NOUN aji-51 417 35 receptors receptor NOUN aji-51 417 36 , , PUNCT aji-51 417 37 or or CCONJ aji-51 417 38 artificial artificial ADJ aji-51 417 39 t t NOUN aji-51 417 40 cell cell NOUN aji-51 417 41 receptors receptor NOUN aji-51 417 42 ) ) PUNCT aji-51 417 43 which which PRON aji-51 417 44 are be AUX aji-51 417 45 bioengineered bioengineere VERB aji-51 417 46 cell cell NOUN aji-51 417 47 receptors receptor NOUN aji-51 417 48 that that PRON aji-51 417 49 combine combine VERB aji-51 417 50 a a DET aji-51 417 51 new new ADJ aji-51 417 52 specificity specificity NOUN aji-51 417 53 with with ADP aji-51 417 54 an an DET aji-51 417 55 immune immune ADJ aji-51 417 56 cell cell NOUN aji-51 417 57 to to PART aji-51 417 58 target target VERB aji-51 417 59 cancer cancer NOUN aji-51 417 60 cells cell NOUN aji-51 417 61 . . PUNCT aji-51 418 1 essentially essentially ADV aji-51 418 2 , , PUNCT aji-51 418 3 what what PRON aji-51 418 4 is be AUX aji-51 418 5 done do VERB aji-51 418 6 is be AUX aji-51 418 7 that that PRON aji-51 418 8 specific specific ADJ aji-51 418 9 monoclonal monoclonal NOUN aji-51 418 10 antibody antibody NOUN aji-51 418 11 fractions fraction NOUN aji-51 418 12 are be AUX aji-51 418 13 grafted graft VERB aji-51 418 14 onto onto ADP aji-51 418 15 t t NOUN aji-51 418 16 cell cell NOUN aji-51 418 17 receptors receptor NOUN aji-51 418 18 . . PUNCT aji-51 419 1 the the DET aji-51 419 2 receptors receptor NOUN aji-51 419 3 are be AUX aji-51 419 4 referred refer VERB aji-51 419 5 to to ADP aji-51 419 6 as as ADP aji-51 419 7 chimeric chimeric ADJ aji-51 419 8 because because SCONJ aji-51 419 9 they they PRON aji-51 419 10 are be AUX aji-51 419 11 a a DET aji-51 419 12 fusion fusion NOUN aji-51 419 13 of of ADP aji-51 419 14 proteins protein NOUN aji-51 419 15 and and CCONJ aji-51 419 16 receptors receptor NOUN aji-51 419 17 from from ADP aji-51 419 18 different different ADJ aji-51 419 19 immune immune ADJ aji-51 419 20 sources source NOUN aji-51 419 21 . . PUNCT aji-51 420 1 car car NOUN aji-51 420 2 - - PUNCT aji-51 420 3 t t NOUN aji-51 420 4 cell cell NOUN aji-51 420 5 therapy therapy NOUN aji-51 420 6 refers refer VERB aji-51 420 7 to to ADP aji-51 420 8 an an DET aji-51 420 9 infusion infusion NOUN aji-51 420 10 of of ADP aji-51 420 11 such such ADJ aji-51 420 12 specifically specifically ADV aji-51 420 13 transformed transform VERB aji-51 420 14 cells cell NOUN aji-51 420 15 for for ADP aji-51 420 16 targeted target VERB aji-51 420 17 cancer cancer NOUN aji-51 420 18 therapy therapy NOUN aji-51 420 19 . . PUNCT aji-51 421 1 car car NOUN aji-51 421 2 - - PUNCT aji-51 421 3 t t NOUN aji-51 421 4 cells cell NOUN aji-51 421 5 destroy destroy VERB aji-51 421 6 the the DET aji-51 421 7 cancer cancer NOUN aji-51 421 8 cells cell NOUN aji-51 421 9 through through ADP aji-51 421 10 several several ADJ aji-51 421 11 mechanisms mechanism NOUN aji-51 421 12 such such ADJ aji-51 421 13 as as ADP aji-51 421 14 having have VERB aji-51 421 15 a a DET aji-51 421 16 direct direct ADJ aji-51 421 17 cytotoxic cytotoxic ADJ aji-51 421 18 effect effect NOUN aji-51 421 19 and/or and/or CCONJ aji-51 421 20 stimulating stimulate VERB aji-51 421 21 other other ADJ aji-51 421 22 cells cell NOUN aji-51 421 23 of of ADP aji-51 421 24 the the DET aji-51 421 25 immune immune ADJ aji-51 421 26 system system NOUN aji-51 421 27 through through ADP aji-51 421 28 the the DET aji-51 421 29 release release NOUN aji-51 421 30 of of ADP aji-51 421 31 various various ADJ aji-51 421 32 cytokines cytokine NOUN aji-51 421 33 and and CCONJ aji-51 421 34 growth growth NOUN aji-51 421 35 factors factor NOUN aji-51 421 36 . . PUNCT aji-51 422 1 due due ADP aji-51 422 2 to to ADP aji-51 422 3 the the DET aji-51 422 4 car car NOUN aji-51 422 5 - - PUNCT aji-51 422 6 t t NOUN aji-51 422 7 cells cell NOUN aji-51 422 8 very very ADV aji-51 422 9 narrow narrow ADJ aji-51 422 10 specificity specificity NOUN aji-51 422 11 , , PUNCT aji-51 422 12 less less ADV aji-51 422 13 prominent prominent ADJ aji-51 422 14 tumor tumor NOUN aji-51 422 15 cell cell NOUN aji-51 422 16 lines line NOUN aji-51 422 17 can can AUX aji-51 422 18 be be AUX aji-51 422 19 missed miss VERB aji-51 422 20 allowing allow VERB aji-51 422 21 for for ADP aji-51 422 22 a a DET aji-51 422 23 future future ADJ aji-51 422 24 recurrence recurrence NOUN aji-51 422 25 [ [ X aji-51 422 26 208 208 NUM aji-51 422 27 - - SYM aji-51 422 28 218 218 NUM aji-51 422 29 ] ] PUNCT aji-51 422 30 . . PUNCT aji-51 423 1 overall overall ADV aji-51 423 2 , , PUNCT aji-51 423 3 immunotherapy immunotherapy NOUN aji-51 423 4 is be AUX aji-51 423 5 designed design VERB aji-51 423 6 to to PART aji-51 423 7 correct correct VERB aji-51 423 8 , , PUNCT aji-51 423 9 stimulate stimulate VERB aji-51 423 10 , , PUNCT aji-51 423 11 direct direct ADJ aji-51 423 12 , , PUNCT aji-51 423 13 or or CCONJ aji-51 423 14 reconstitute reconstitute VERB aji-51 423 15 an an DET aji-51 423 16 effective effective ADJ aji-51 423 17 anticancer anticancer NOUN aji-51 423 18 response response NOUN aji-51 423 19 . . PUNCT aji-51 424 1 immune immune ADJ aji-51 424 2 reconstitution reconstitution NOUN aji-51 424 3 is be AUX aji-51 424 4 the the DET aji-51 424 5 evolving evolve VERB aji-51 424 6 clinical clinical ADJ aji-51 424 7 science science NOUN aji-51 424 8 of of ADP aji-51 424 9 restoring restore VERB aji-51 424 10 immune immune ADJ aji-51 424 11 competence competence NOUN aji-51 424 12 by by ADP aji-51 424 13 correcting correct VERB aji-51 424 14 biochemical biochemical ADJ aji-51 424 15 imbalances imbalance NOUN aji-51 424 16 , , PUNCT aji-51 424 17 augmenting augment VERB aji-51 424 18 cytokines cytokine NOUN aji-51 424 19 , , PUNCT aji-51 424 20 restoring restore VERB aji-51 424 21 cascade cascade NOUN aji-51 424 22 pathways pathway NOUN aji-51 424 23 , , PUNCT aji-51 424 24 and/or and/or CCONJ aji-51 424 25 implanting implant VERB aji-51 424 26 specific specific ADJ aji-51 424 27 stem stem NOUN aji-51 424 28 cells cell NOUN aji-51 424 29 to to ADP aji-51 424 30 bridge bridge NOUN aji-51 424 31 areas area NOUN aji-51 424 32 of of ADP aji-51 424 33 damage damage NOUN aji-51 424 34 . . PUNCT aji-51 425 1 all all DET aji-51 425 2 severe severe ADJ aji-51 425 3 or or CCONJ aji-51 425 4 chronic chronic ADJ aji-51 425 5 diseases disease NOUN aji-51 425 6 are be AUX aji-51 425 7 known know VERB aji-51 425 8 to to PART aji-51 425 9 have have VERB aji-51 425 10 one one NUM aji-51 425 11 or or CCONJ aji-51 425 12 more more ADV aji-51 425 13 significant significant ADJ aji-51 425 14 defects defect NOUN aji-51 425 15 in in ADP aji-51 425 16 the the DET aji-51 425 17 immune immune ADJ aji-51 425 18 system system NOUN aji-51 425 19 adversely adversely ADV aji-51 425 20 affecting affect VERB aji-51 425 21 the the DET aji-51 425 22 immunological immunological ADJ aji-51 425 23 imperatives imperative NOUN aji-51 425 24 of of ADP aji-51 425 25 recognition recognition NOUN aji-51 425 26 , , PUNCT aji-51 425 27 response response NOUN aji-51 425 28 , , PUNCT aji-51 425 29 and and CCONJ aji-51 425 30 memory memory NOUN aji-51 425 31 which which PRON aji-51 425 32 , , PUNCT aji-51 425 33 in in ADP aji-51 425 34 the the DET aji-51 425 35 case case NOUN aji-51 425 36 of of ADP aji-51 425 37 cancer cancer NOUN aji-51 425 38 , , PUNCT aji-51 425 39 leads lead VERB aji-51 425 40 to to ADP aji-51 425 41 anergy anergy NOUN aji-51 425 42 and and CCONJ aji-51 425 43 tolerance tolerance NOUN aji-51 425 44 . . PUNCT aji-51 426 1 testing test VERB aji-51 426 2 for for ADP aji-51 426 3 and and CCONJ aji-51 426 4 breaking break VERB aji-51 426 5 anergy anergy NOUN aji-51 426 6 is be AUX aji-51 426 7 the the DET aji-51 426 8 first first ADJ aji-51 426 9 step step NOUN aji-51 426 10 in in ADP aji-51 426 11 immune immune ADJ aji-51 426 12 reconstitution reconstitution NOUN aji-51 426 13 [ [ X aji-51 426 14 219 219 NUM aji-51 426 15 ] ] PUNCT aji-51 426 16 . . PUNCT aji-51 427 1 correcting correct VERB aji-51 427 2 anergy anergy NOUN aji-51 427 3 is be AUX aji-51 427 4 of of ADP aji-51 427 5 critical critical ADJ aji-51 427 6 importance importance NOUN aji-51 427 7 because because SCONJ aji-51 427 8 it it PRON aji-51 427 9 directly directly ADV aji-51 427 10 correlates correlate VERB aji-51 427 11 to to ADP aji-51 427 12 the the DET aji-51 427 13 stage stage NOUN aji-51 427 14 of of ADP aji-51 427 15 cancer cancer NOUN aji-51 427 16 : : PUNCT aji-51 427 17 over over ADP aji-51 427 18 90 90 NUM aji-51 427 19 % % NOUN aji-51 427 20 of of ADP aji-51 427 21 patients patient NOUN aji-51 427 22 with with ADP aji-51 427 23 stage stage NOUN aji-51 427 24 4 4 NUM aji-51 427 25 disease disease NOUN aji-51 427 26 are be AUX aji-51 427 27 found find VERB aji-51 427 28 to to PART aji-51 427 29 be be AUX aji-51 427 30 anergic anergic ADJ aji-51 427 31 [ [ X aji-51 427 32 220 220 NUM aji-51 427 33 ] ] PUNCT aji-51 427 34 . . PUNCT aji-51 428 1 the the DET aji-51 428 2 immune immune ADJ aji-51 428 3 system system NOUN aji-51 428 4 can can AUX aji-51 428 5 not not PART aji-51 428 6 fight fight VERB aji-51 428 7 something something PRON aji-51 428 8 that that PRON aji-51 428 9 it it PRON aji-51 428 10 does do AUX aji-51 428 11 n’t not PART aji-51 428 12 know know VERB aji-51 428 13 is be AUX aji-51 428 14 there there ADV aji-51 428 15 , , PUNCT aji-51 428 16 and and CCONJ aji-51 428 17 that that PRON aji-51 428 18 ’s ’ VERB aji-51 428 19 exactly exactly ADV aji-51 428 20 what what PRON aji-51 428 21 arises arise VERB aji-51 428 22 with with ADP aji-51 428 23 anergy anergy NOUN aji-51 428 24 . . PUNCT aji-51 429 1 anergy anergy PROPN aji-51 429 2 manifests manifest NOUN aji-51 429 3 when when SCONJ aji-51 429 4 there there PRON aji-51 429 5 is be VERB aji-51 429 6 a a DET aji-51 429 7 failure failure NOUN aji-51 429 8 of of ADP aji-51 429 9 signal signal ADJ aji-51 429 10 transmission transmission NOUN aji-51 429 11 at at ADP aji-51 429 12 any any DET aji-51 429 13 point point NOUN aji-51 429 14 in in ADP aji-51 429 15 the the DET aji-51 429 16 immune immune ADJ aji-51 429 17 response response NOUN aji-51 429 18 cascade cascade NOUN aji-51 429 19 . . PUNCT aji-51 430 1 before before SCONJ aji-51 430 2 we we PRON aji-51 430 3 can can AUX aji-51 430 4 break break VERB aji-51 430 5 anergy anergy NOUN aji-51 430 6 , , PUNCT aji-51 430 7 and and CCONJ aji-51 430 8 wake wake VERB aji-51 430 9 up up ADP aji-51 430 10 the the DET aji-51 430 11 immune immune ADJ aji-51 430 12 system system NOUN aji-51 430 13 , , PUNCT aji-51 430 14 we we PRON aji-51 430 15 must must AUX aji-51 430 16 make make VERB aji-51 430 17 sure sure ADJ aji-51 430 18 that that SCONJ aji-51 430 19 we we PRON aji-51 430 20 are be AUX aji-51 430 21 dealing deal VERB aji-51 430 22 with with ADP aji-51 430 23 true true ADJ aji-51 430 24 anergy anergy NOUN aji-51 430 25 as as SCONJ aji-51 430 26 opposed oppose VERB aji-51 430 27 to to ADP aji-51 430 28 another another DET aji-51 430 29 pathology pathology NOUN aji-51 430 30 . . PUNCT aji-51 431 1 of of ADP aji-51 431 2 historical historical ADJ aji-51 431 3 interest interest NOUN aji-51 431 4 , , PUNCT aji-51 431 5 some some DET aji-51 431 6 years year NOUN aji-51 431 7 ago ago ADV aji-51 431 8 the the DET aji-51 431 9 mérieux mérieux PROPN aji-51 431 10 company company PROPN aji-51 431 11 manufactured manufacture VERB aji-51 431 12 a a DET aji-51 431 13 skin skin NOUN aji-51 431 14 test test NOUN aji-51 431 15 called call VERB aji-51 431 16 the the DET aji-51 431 17 “ " PUNCT aji-51 431 18 multitest multit ADJ aji-51 431 19 mérieux mérieux NOUN aji-51 431 20 ” " PUNCT aji-51 431 21 or or CCONJ aji-51 431 22 “ " PUNCT aji-51 431 23 cmi cmi PROPN aji-51 431 24 multitest multit ADJ aji-51 431 25 ” " PUNCT aji-51 431 26 system system NOUN aji-51 431 27 ( ( PUNCT aji-51 431 28 istituto istituto X aji-51 431 29 merieux merieux PROPN aji-51 431 30 italia italia PROPN aji-51 431 31 , , PUNCT aji-51 431 32 rome rome PROPN aji-51 431 33 , , PUNCT aji-51 431 34 italy italy PROPN aji-51 431 35 ) ) PUNCT aji-51 431 36 . . PUNCT aji-51 432 1 it it PRON aji-51 432 2 is be AUX aji-51 432 3 used use VERB aji-51 432 4 as as ADP aji-51 432 5 a a DET aji-51 432 6 general general ADJ aji-51 432 7 test test NOUN aji-51 432 8 for for ADP aji-51 432 9 the the DET aji-51 432 10 level level NOUN aji-51 432 11 of of ADP aji-51 432 12 the the DET aji-51 432 13 cellular cellular ADJ aji-51 432 14 immune immune ADJ aji-51 432 15 response response NOUN aji-51 432 16 . . PUNCT aji-51 433 1 it it PRON aji-51 433 2 is be AUX aji-51 433 3 an an DET aji-51 433 4 intradermal intradermal ADJ aji-51 433 5 test test NOUN aji-51 433 6 of of ADP aji-51 433 7 skin skin NOUN aji-51 433 8 reactivity reactivity NOUN aji-51 433 9 ( ( PUNCT aji-51 433 10 similar similar ADJ aji-51 433 11 to to ADP aji-51 433 12 allergy allergy NOUN aji-51 433 13 tests test NOUN aji-51 433 14 ) ) PUNCT aji-51 433 15 in in ADP aji-51 433 16 which which PRON aji-51 433 17 a a DET aji-51 433 18 control control NOUN aji-51 433 19 ( ( PUNCT aji-51 433 20 glycerol glycerol NOUN aji-51 433 21 ) ) PUNCT aji-51 433 22 is be AUX aji-51 433 23 used use VERB aji-51 433 24 with with ADP aji-51 433 25 seven seven NUM aji-51 433 26 common common ADJ aji-51 433 27 antigens antigen NOUN aji-51 433 28 of of ADP aji-51 433 29 bacterial bacterial ADJ aji-51 433 30 or or CCONJ aji-51 433 31 fungal fungal ADJ aji-51 433 32 origin origin NOUN aji-51 433 33 ( ( PUNCT aji-51 433 34 tetanus tetanus NOUN aji-51 433 35 toxoid toxoid X aji-51 433 36 , , PUNCT aji-51 433 37 tuberculin tuberculin ADJ aji-51 433 38 , , PUNCT aji-51 433 39 diphtheria diphtheria NOUN aji-51 433 40 , , PUNCT aji-51 433 41 streptococcus streptococcus NOUN aji-51 433 42 , , PUNCT aji-51 433 43 candida candida PROPN aji-51 433 44 , , PUNCT aji-51 433 45 trichophyton trichophyton NOUN aji-51 433 46 , , PUNCT aji-51 433 47 and and CCONJ aji-51 433 48 proteus proteus NOUN aji-51 433 49 ) ) PUNCT aji-51 433 50 . . PUNCT aji-51 434 1 in in ADP aji-51 434 2 this this DET aji-51 434 3 test test NOUN aji-51 434 4 , , PUNCT aji-51 434 5 reactions reaction NOUN aji-51 434 6 are be AUX aji-51 434 7 categorized categorize VERB aji-51 434 8 according accord VERB aji-51 434 9 to to ADP aji-51 434 10 the the DET aji-51 434 11 number number NOUN aji-51 434 12 of of ADP aji-51 434 13 antigens antigen NOUN aji-51 434 14 provoking provoke VERB aji-51 434 15 a a DET aji-51 434 16 response response NOUN aji-51 434 17 , , PUNCT aji-51 434 18 and and CCONJ aji-51 434 19 the the DET aji-51 434 20 summed sum VERB aji-51 434 21 magnitude magnitude NOUN aji-51 434 22 of of ADP aji-51 434 23 the the DET aji-51 434 24 skin skin NOUN aji-51 434 25 response response NOUN aji-51 434 26 to to ADP aji-51 434 27 stoff stoff PROPN aji-51 434 28 ; ; PUNCT aji-51 434 29 aji aji PROPN aji-51 434 30 , , PUNCT aji-51 434 31 5(1 5(1 NUM aji-51 434 32 ): ): PUNCT aji-51 434 33 1 1 NUM aji-51 434 34 - - SYM aji-51 434 35 39 39 NUM aji-51 434 36 , , PUNCT aji-51 434 37 2022 2022 NUM aji-51 434 38 ; ; PUNCT aji-51 434 39 article article NOUN aji-51 434 40 no.aji.77967 no.aji.77967 PROPN aji-51 434 41 12 12 NUM aji-51 434 42 all all DET aji-51 434 43 seven seven NUM aji-51 434 44 antigens antigen NOUN aji-51 434 45 . . PUNCT aji-51 435 1 based base VERB aji-51 435 2 on on ADP aji-51 435 3 the the DET aji-51 435 4 chart chart NOUN aji-51 435 5 and and CCONJ aji-51 435 6 information information NOUN aji-51 435 7 supplied supply VERB aji-51 435 8 with with ADP aji-51 435 9 the the DET aji-51 435 10 simple simple ADJ aji-51 435 11 skin skin NOUN aji-51 435 12 test test NOUN aji-51 435 13 , , PUNCT aji-51 435 14 basic basic ADJ aji-51 435 15 anergy anergy NOUN aji-51 435 16 can can AUX aji-51 435 17 be be AUX aji-51 435 18 quickly quickly ADV aji-51 435 19 assessed assess VERB aji-51 435 20 and and CCONJ aji-51 435 21 quantified quantify VERB aji-51 435 22 [ [ X aji-51 435 23 221 221 NUM aji-51 435 24 ] ] PUNCT aji-51 435 25 . . PUNCT aji-51 436 1 unfortunately unfortunately ADV aji-51 436 2 , , PUNCT aji-51 436 3 this this DET aji-51 436 4 test test NOUN aji-51 436 5 can can AUX aji-51 436 6 not not PART aji-51 436 7 tell tell VERB aji-51 436 8 us we PRON aji-51 436 9 where where SCONJ aji-51 436 10 in in ADP aji-51 436 11 the the DET aji-51 436 12 recognition recognition NOUN aji-51 436 13 / / SYM aji-51 436 14 response response NOUN aji-51 436 15 chain chain NOUN aji-51 436 16 of of ADP aji-51 436 17 events event NOUN aji-51 436 18 the the DET aji-51 436 19 problem problem NOUN aji-51 436 20 lies lie VERB aji-51 436 21 . . PUNCT aji-51 437 1 however however ADV aji-51 437 2 , , PUNCT aji-51 437 3 specialized specialized ADJ aji-51 437 4 blood blood NOUN aji-51 437 5 tests test NOUN aji-51 437 6 are be AUX aji-51 437 7 now now ADV aji-51 437 8 generally generally ADV aji-51 437 9 able able ADJ aji-51 437 10 to to PART aji-51 437 11 do do VERB aji-51 437 12 that that PRON aji-51 437 13 . . PUNCT aji-51 438 1 once once ADV aji-51 438 2 this this DET aji-51 438 3 state state NOUN aji-51 438 4 of of ADP aji-51 438 5 unresponsiveness unresponsiveness NOUN aji-51 438 6 has have AUX aji-51 438 7 been be AUX aji-51 438 8 confirmed confirm VERB aji-51 438 9 , , PUNCT aji-51 438 10 the the DET aji-51 438 11 next next ADJ aji-51 438 12 step step NOUN aji-51 438 13 in in ADP aji-51 438 14 breaking break VERB aji-51 438 15 anergy anergy NOUN aji-51 438 16 is be AUX aji-51 438 17 with with ADP aji-51 438 18 an an DET aji-51 438 19 immunotherapy immunotherapy NOUN aji-51 438 20 protocol protocol NOUN aji-51 438 21 specific specific ADJ aji-51 438 22 to to ADP aji-51 438 23 the the DET aji-51 438 24 area(s area(s PROPN aji-51 438 25 ) ) PUNCT aji-51 438 26 of of ADP aji-51 438 27 immune immune ADJ aji-51 438 28 response response NOUN aji-51 438 29 dysfunction dysfunction NOUN aji-51 438 30 as as SCONJ aji-51 438 31 briefly briefly ADV aji-51 438 32 described describe VERB aji-51 438 33 above above ADV aji-51 438 34 . . PUNCT aji-51 439 1 2.5 2.5 NUM aji-51 439 2 cancer cancer NOUN aji-51 439 3 stem stem NOUN aji-51 439 4 cells cell NOUN aji-51 439 5 as as ADP aji-51 439 6 a a DET aji-51 439 7 short short ADJ aji-51 439 8 overview overview NOUN aji-51 439 9 , , PUNCT aji-51 439 10 cancer cancer NOUN aji-51 439 11 stem stem NOUN aji-51 439 12 cells cell NOUN aji-51 439 13 ( ( PUNCT aji-51 439 14 cscs cscs PROPN aji-51 439 15 ) ) PUNCT aji-51 439 16 are be AUX aji-51 439 17 cancer cancer NOUN aji-51 439 18 cells cell NOUN aji-51 439 19 ( ( PUNCT aji-51 439 20 found find VERB aji-51 439 21 within within ADP aji-51 439 22 tumors tumor NOUN aji-51 439 23 or or CCONJ aji-51 439 24 hematological hematological ADJ aji-51 439 25 cancers cancer NOUN aji-51 439 26 ) ) PUNCT aji-51 439 27 that that PRON aji-51 439 28 possess possess VERB aji-51 439 29 characteristics characteristic NOUN aji-51 439 30 associated associate VERB aji-51 439 31 with with ADP aji-51 439 32 normal normal ADJ aji-51 439 33 stem stem NOUN aji-51 439 34 cells cell NOUN aji-51 439 35 , , PUNCT aji-51 439 36 specifically specifically ADV aji-51 439 37 the the DET aji-51 439 38 ability ability NOUN aji-51 439 39 to to PART aji-51 439 40 give give VERB aji-51 439 41 rise rise NOUN aji-51 439 42 to to ADP aji-51 439 43 all all PRON aji-51 439 44 of of ADP aji-51 439 45 the the DET aji-51 439 46 heterogeneous heterogeneous ADJ aji-51 439 47 cancer cancer NOUN aji-51 439 48 cell cell NOUN aji-51 439 49 lines line NOUN aji-51 439 50 found find VERB aji-51 439 51 in in ADP aji-51 439 52 a a DET aji-51 439 53 particular particular ADJ aji-51 439 54 tumor tumor NOUN aji-51 439 55 . . PUNCT aji-51 440 1 targeting target VERB aji-51 440 2 them they PRON aji-51 440 3 is be AUX aji-51 440 4 the the DET aji-51 440 5 fourth fourth ADJ aji-51 440 6 anti anti ADJ aji-51 440 7 - - ADJ aji-51 440 8 cancer cancer ADJ aji-51 440 9 strategy strategy NOUN aji-51 440 10 . . PUNCT aji-51 441 1 until until ADP aji-51 441 2 recently recently ADV aji-51 441 3 , , PUNCT aji-51 441 4 attacking attack VERB aji-51 441 5 them they PRON aji-51 441 6 would would AUX aji-51 441 7 have have AUX aji-51 441 8 been be AUX aji-51 441 9 included include VERB aji-51 441 10 in in ADP aji-51 441 11 the the DET aji-51 441 12 general general ADJ aji-51 441 13 biochemical biochemical ADJ aji-51 441 14 targeting targeting NOUN aji-51 441 15 strategy strategy NOUN aji-51 441 16 but but CCONJ aji-51 441 17 recent recent ADJ aji-51 441 18 research research NOUN aji-51 441 19 has have AUX aji-51 441 20 shown show VERB aji-51 441 21 them they PRON aji-51 441 22 to to PART aji-51 441 23 be be AUX aji-51 441 24 a a DET aji-51 441 25 separate separate ADJ aji-51 441 26 and and CCONJ aji-51 441 27 viable viable ADJ aji-51 441 28 strategy strategy NOUN aji-51 441 29 . . PUNCT aji-51 442 1 cscs cscs PROPN aji-51 442 2 mediate mediate VERB aji-51 442 3 tumor tumor NOUN aji-51 442 4 initiation initiation NOUN aji-51 442 5 , , PUNCT aji-51 442 6 progression progression NOUN aji-51 442 7 , , PUNCT aji-51 442 8 and and CCONJ aji-51 442 9 metastasis metastasis NOUN aji-51 442 10 , , PUNCT aji-51 442 11 and and CCONJ aji-51 442 12 inhibiting inhibit VERB aji-51 442 13 them they PRON aji-51 442 14 is be AUX aji-51 442 15 an an DET aji-51 442 16 emerging emerge VERB aji-51 442 17 new new ADJ aji-51 442 18 area area NOUN aji-51 442 19 of of ADP aji-51 442 20 research research NOUN aji-51 442 21 to to PART aji-51 442 22 prevent prevent VERB aji-51 442 23 , , PUNCT aji-51 442 24 stop stop VERB aji-51 442 25 , , PUNCT aji-51 442 26 and and CCONJ aji-51 442 27 reverse reverse VERB aji-51 442 28 tumor tumor NOUN aji-51 442 29 growth growth NOUN aji-51 442 30 . . PUNCT aji-51 443 1 they they PRON aji-51 443 2 play play VERB aji-51 443 3 key key ADJ aji-51 443 4 roles role NOUN aji-51 443 5 in in ADP aji-51 443 6 tumor tumor NOUN aji-51 443 7 metastasis metastasis NOUN aji-51 443 8 , , PUNCT aji-51 443 9 drug drug NOUN aji-51 443 10 resistance resistance NOUN aji-51 443 11 , , PUNCT aji-51 443 12 and and CCONJ aji-51 443 13 cancer cancer NOUN aji-51 443 14 relapse relapse NOUN aji-51 443 15 . . PUNCT aji-51 444 1 oncologic oncologic PROPN aji-51 444 2 research research NOUN aji-51 444 3 has have AUX aji-51 444 4 established establish VERB aji-51 444 5 that that SCONJ aji-51 444 6 subpopulations subpopulation NOUN aji-51 444 7 of of ADP aji-51 444 8 cells cell NOUN aji-51 444 9 , , PUNCT aji-51 444 10 identified identify VERB aji-51 444 11 by by ADP aji-51 444 12 monoclonal monoclonal NOUN aji-51 444 13 antibodies antibody NOUN aji-51 444 14 to to ADP aji-51 444 15 specific specific ADJ aji-51 444 16 cell cell NOUN aji-51 444 17 surface surface NOUN aji-51 444 18 markers marker NOUN aji-51 444 19 , , PUNCT aji-51 444 20 behaved behave VERB aji-51 444 21 like like ADP aji-51 444 22 developmental developmental ADJ aji-51 444 23 stem stem NOUN aji-51 444 24 cells cell NOUN aji-51 444 25 in in ADP aji-51 444 26 their their PRON aji-51 444 27 capacity capacity NOUN aji-51 444 28 to to PART aji-51 444 29 regrow regrow VERB aji-51 444 30 the the DET aji-51 444 31 human human ADJ aji-51 444 32 tumors tumor NOUN aji-51 444 33 , , PUNCT aji-51 444 34 for for ADP aji-51 444 35 multiple multiple ADJ aji-51 444 36 generations generation NOUN aji-51 444 37 , , PUNCT aji-51 444 38 in in ADP aji-51 444 39 experimental experimental ADJ aji-51 444 40 immune immune NOUN aji-51 444 41 - - PUNCT aji-51 444 42 deficient deficient ADJ aji-51 444 43 animal animal NOUN aji-51 444 44 hosts host NOUN aji-51 444 45 . . PUNCT aji-51 445 1 in in ADP aji-51 445 2 all all PRON aji-51 445 3 of of ADP aji-51 445 4 the the DET aji-51 445 5 cancers cancer NOUN aji-51 445 6 studied study VERB aji-51 445 7 so so ADV aji-51 445 8 far far ADV aji-51 445 9 , , PUNCT aji-51 445 10 there there PRON aji-51 445 11 is be VERB aji-51 445 12 good good ADJ aji-51 445 13 evidence evidence NOUN aji-51 445 14 that that SCONJ aji-51 445 15 cscs cscs PROPN aji-51 445 16 are be AUX aji-51 445 17 relatively relatively ADV aji-51 445 18 resistant resistant ADJ aji-51 445 19 to to ADP aji-51 445 20 radiation radiation NOUN aji-51 445 21 therapy therapy NOUN aji-51 445 22 and and CCONJ aji-51 445 23 chemotherapy chemotherapy NOUN aji-51 445 24 because because SCONJ aji-51 445 25 of of ADP aji-51 445 26 their their PRON aji-51 445 27 slow slow ADJ aji-51 445 28 rate rate NOUN aji-51 445 29 of of ADP aji-51 445 30 growth growth NOUN aji-51 445 31 , , PUNCT aji-51 445 32 indicating indicate VERB aji-51 445 33 that that SCONJ aji-51 445 34 novel novel ADJ aji-51 445 35 csc csc VERB aji-51 445 36 - - PUNCT aji-51 445 37 targeted target VERB aji-51 445 38 therapies therapy NOUN aji-51 445 39 are be AUX aji-51 445 40 needed need VERB aji-51 445 41 . . PUNCT aji-51 446 1 several several ADJ aji-51 446 2 pathways pathway NOUN aji-51 446 3 are be AUX aji-51 446 4 promising promise VERB aji-51 446 5 targets target NOUN aji-51 446 6 against against ADP aji-51 446 7 cscs cscs NOUN aji-51 446 8 including include VERB aji-51 446 9 inducing induce VERB aji-51 446 10 their their PRON aji-51 446 11 apoptosis apoptosis NOUN aji-51 446 12 , , PUNCT aji-51 446 13 inhibiting inhibit VERB aji-51 446 14 stem stem NOUN aji-51 446 15 cell cell NOUN aji-51 446 16 self self NOUN aji-51 446 17 - - PUNCT aji-51 446 18 renewal renewal NOUN aji-51 446 19 to to ADP aji-51 446 20 either either CCONJ aji-51 446 21 stop stop VERB aji-51 446 22 their their PRON aji-51 446 23 division division NOUN aji-51 446 24 or or CCONJ aji-51 446 25 to to PART aji-51 446 26 promote promote VERB aji-51 446 27 their their PRON aji-51 446 28 differentiation differentiation NOUN aji-51 446 29 , , PUNCT aji-51 446 30 or or CCONJ aji-51 446 31 targeting target VERB aji-51 446 32 the the DET aji-51 446 33 csc csc PROPN aji-51 446 34 milieu milieu NOUN aji-51 446 35 in in ADP aji-51 446 36 the the DET aji-51 446 37 tme tme NOUN aji-51 446 38 that that PRON aji-51 446 39 supports support VERB aji-51 446 40 them they PRON aji-51 446 41 . . PUNCT aji-51 447 1 the the DET aji-51 447 2 anti anti ADJ aji-51 447 3 - - ADJ aji-51 447 4 csc csc ADJ aji-51 447 5 agents agent NOUN aji-51 447 6 are be AUX aji-51 447 7 categorized categorize VERB aji-51 447 8 under under ADP aji-51 447 9 two two NUM aji-51 447 10 broad broad ADJ aji-51 447 11 headings heading NOUN aji-51 447 12 : : PUNCT aji-51 447 13 small small ADJ aji-51 447 14 and and CCONJ aji-51 447 15 macromolecules macromolecule NOUN aji-51 447 16 with with ADP aji-51 447 17 different different ADJ aji-51 447 18 subclasses subclass NOUN aji-51 447 19 such such ADJ aji-51 447 20 as as ADP aji-51 447 21 kinase kinase PROPN aji-51 447 22 inhibitors inhibitor NOUN aji-51 447 23 and and CCONJ aji-51 447 24 polypeptides polypeptide NOUN aji-51 447 25 . . PUNCT aji-51 448 1 one one NUM aji-51 448 2 of of ADP aji-51 448 3 the the DET aji-51 448 4 first first ADJ aji-51 448 5 and and CCONJ aji-51 448 6 safest safe ADJ aji-51 448 7 agents agent NOUN aji-51 448 8 to to PART aji-51 448 9 be be AUX aji-51 448 10 recognized recognize VERB aji-51 448 11 as as ADP aji-51 448 12 a a DET aji-51 448 13 csc csc PROPN aji-51 448 14 inhibitor inhibitor NOUN aji-51 448 15 is be AUX aji-51 448 16 metformin metformin NOUN aji-51 448 17 [ [ PUNCT aji-51 448 18 222 222 NUM aji-51 448 19 - - SYM aji-51 448 20 235 235 NUM aji-51 448 21 ] ] PUNCT aji-51 448 22 . . PUNCT aji-51 449 1 tumor tumor NOUN aji-51 449 2 initiation initiation NOUN aji-51 449 3 can can AUX aji-51 449 4 either either CCONJ aji-51 449 5 be be AUX aji-51 449 6 driven drive VERB aji-51 449 7 by by ADP aji-51 449 8 transformed transform VERB aji-51 449 9 differentiated differentiated ADJ aji-51 449 10 cells cell NOUN aji-51 449 11 or or CCONJ aji-51 449 12 transformed transform VERB aji-51 449 13 tissue tissue NOUN aji-51 449 14 - - PUNCT aji-51 449 15 resident resident NOUN aji-51 449 16 stem stem NOUN aji-51 449 17 cells cell NOUN aji-51 449 18 forming form VERB aji-51 449 19 the the DET aji-51 449 20 new new ADJ aji-51 449 21 cancer cancer NOUN aji-51 449 22 stem stem NOUN aji-51 449 23 cells cell NOUN aji-51 449 24 [ [ X aji-51 449 25 236,237 236,237 NUM aji-51 449 26 ] ] PUNCT aji-51 449 27 . . PUNCT aji-51 450 1 as as SCONJ aji-51 450 2 tissue tissue NOUN aji-51 450 3 stem stem NOUN aji-51 450 4 cells cell NOUN aji-51 450 5 already already ADV aji-51 450 6 possess possess VERB aji-51 450 7 unlimited unlimited ADJ aji-51 450 8 growth growth NOUN aji-51 450 9 potential potential NOUN aji-51 450 10 , , PUNCT aji-51 450 11 it it PRON aji-51 450 12 is be AUX aji-51 450 13 believed believe VERB aji-51 450 14 that that SCONJ aji-51 450 15 the the DET aji-51 450 16 transformation transformation NOUN aji-51 450 17 into into ADP aji-51 450 18 a a DET aji-51 450 19 csc csc PROPN aji-51 450 20 requires require VERB aji-51 450 21 only only ADV aji-51 450 22 a a DET aji-51 450 23 very very ADV aji-51 450 24 small small ADJ aji-51 450 25 number number NOUN aji-51 450 26 of of ADP aji-51 450 27 genomic genomic ADJ aji-51 450 28 changes change NOUN aji-51 450 29 [ [ X aji-51 450 30 238 238 NUM aji-51 450 31 ] ] PUNCT aji-51 450 32 . . PUNCT aji-51 451 1 multiple multiple ADJ aji-51 451 2 biomarkers biomarker NOUN aji-51 451 3 that that PRON aji-51 451 4 characterize characterize VERB aji-51 451 5 cscs cscs NOUN aji-51 451 6 have have AUX aji-51 451 7 been be AUX aji-51 451 8 identified identify VERB aji-51 451 9 and and CCONJ aji-51 451 10 correlated correlate VERB aji-51 451 11 to to ADP aji-51 451 12 diagnosis diagnosis NOUN aji-51 451 13 , , PUNCT aji-51 451 14 therapy therapy NOUN aji-51 451 15 , , PUNCT aji-51 451 16 and and CCONJ aji-51 451 17 prognosis prognosis NOUN aji-51 451 18 [ [ X aji-51 451 19 239 239 NUM aji-51 451 20 ] ] PUNCT aji-51 451 21 . . PUNCT aji-51 452 1 they they PRON aji-51 452 2 have have AUX aji-51 452 3 been be AUX aji-51 452 4 shown show VERB aji-51 452 5 to to PART aji-51 452 6 display display VERB aji-51 452 7 a a DET aji-51 452 8 high high ADJ aji-51 452 9 degree degree NOUN aji-51 452 10 of of ADP aji-51 452 11 plasticity plasticity NOUN aji-51 452 12 , , PUNCT aji-51 452 13 which which PRON aji-51 452 14 changes change VERB aji-51 452 15 their their PRON aji-51 452 16 phenotypic phenotypic ADJ aji-51 452 17 and and CCONJ aji-51 452 18 functional functional ADJ aji-51 452 19 appearance appearance NOUN aji-51 452 20 making make VERB aji-51 452 21 it it PRON aji-51 452 22 harder hard ADJ aji-51 452 23 to to PART aji-51 452 24 track track VERB aji-51 452 25 them they PRON aji-51 452 26 and and CCONJ aji-51 452 27 predict predict VERB aji-51 452 28 their their PRON aji-51 452 29 activity activity NOUN aji-51 452 30 . . PUNCT aji-51 453 1 such such ADJ aji-51 453 2 shifts shift NOUN aji-51 453 3 in in ADP aji-51 453 4 their their PRON aji-51 453 5 expression expression NOUN aji-51 453 6 can can AUX aji-51 453 7 be be AUX aji-51 453 8 induced induce VERB aji-51 453 9 by by ADP aji-51 453 10 chemoand chemoand ADJ aji-51 453 11 radiation radiation NOUN aji-51 453 12 therapy therapy NOUN aji-51 453 13 as as ADV aji-51 453 14 well well ADV aji-51 453 15 as as ADP aji-51 453 16 by by ADP aji-51 453 17 senescent senescent ADJ aji-51 453 18 tumor tumor NOUN aji-51 453 19 cells cell NOUN aji-51 453 20 . . PUNCT aji-51 454 1 therapeutic therapeutic ADJ aji-51 454 2 regimens regimen NOUN aji-51 454 3 such such ADJ aji-51 454 4 as as ADP aji-51 454 5 chemoor chemoor ADJ aji-51 454 6 radiation radiation NOUN aji-51 454 7 therapy therapy NOUN aji-51 454 8 shift shift VERB aji-51 454 9 the the DET aji-51 454 10 composition composition NOUN aji-51 454 11 of of ADP aji-51 454 12 tumor tumor NOUN aji-51 454 13 cell cell NOUN aji-51 454 14 subpopulations subpopulation NOUN aji-51 454 15 changes change NOUN aji-51 454 16 by by ADP aji-51 454 17 first first ADV aji-51 454 18 killing kill VERB aji-51 454 19 some some PRON aji-51 454 20 of of ADP aji-51 454 21 the the DET aji-51 454 22 tumor tumor NOUN aji-51 454 23 cells cell NOUN aji-51 454 24 , , PUNCT aji-51 454 25 those those PRON aji-51 454 26 with with ADP aji-51 454 27 the the DET aji-51 454 28 highest high ADJ aji-51 454 29 proliferative proliferative ADJ aji-51 454 30 capacity capacity NOUN aji-51 454 31 , , PUNCT aji-51 454 32 causing cause VERB aji-51 454 33 a a DET aji-51 454 34 decrease decrease NOUN aji-51 454 35 in in ADP aji-51 454 36 tumor tumor NOUN aji-51 454 37 size size NOUN aji-51 454 38 , , PUNCT aji-51 454 39 while while SCONJ aji-51 454 40 cscs csc NOUN aji-51 454 41 which which PRON aji-51 454 42 multiply multiply VERB aji-51 454 43 at at ADP aji-51 454 44 a a DET aji-51 454 45 much much ADV aji-51 454 46 slower slow ADJ aji-51 454 47 rate rate NOUN aji-51 454 48 survive survive NOUN aji-51 454 49 . . PUNCT aji-51 455 1 instead instead ADV aji-51 455 2 of of ADP aji-51 455 3 dying die VERB aji-51 455 4 , , PUNCT aji-51 455 5 some some PRON aji-51 455 6 of of ADP aji-51 455 7 the the DET aji-51 455 8 tumor tumor NOUN aji-51 455 9 cells cell NOUN aji-51 455 10 will will AUX aji-51 455 11 become become VERB aji-51 455 12 senescent senescent ADJ aji-51 455 13 which which PRON aji-51 455 14 causes cause VERB aji-51 455 15 further further ADJ aji-51 455 16 alterations alteration NOUN aji-51 455 17 in in ADP aji-51 455 18 the the DET aji-51 455 19 tumor tumor NOUN aji-51 455 20 microenvironment microenvironment NOUN aji-51 455 21 that that PRON aji-51 455 22 better well ADV aji-51 455 23 support support VERB aji-51 455 24 the the DET aji-51 455 25 cscs cscs NOUN aji-51 455 26 [ [ X aji-51 455 27 240 240 NUM aji-51 455 28 ] ] PUNCT aji-51 455 29 . . PUNCT aji-51 456 1 the the DET aji-51 456 2 transformation transformation NOUN aji-51 456 3 to to ADP aji-51 456 4 a a DET aji-51 456 5 cancer cancer NOUN aji-51 456 6 stem stem NOUN aji-51 456 7 cell cell NOUN aji-51 456 8 can can AUX aji-51 456 9 take take VERB aji-51 456 10 place place NOUN aji-51 456 11 during during ADP aji-51 456 12 tissue tissue NOUN aji-51 456 13 regeneration regeneration NOUN aji-51 456 14 or or CCONJ aji-51 456 15 can can AUX aji-51 456 16 be be AUX aji-51 456 17 initiated initiate VERB aji-51 456 18 and/or and/or CCONJ aji-51 456 19 accelerated accelerate VERB aji-51 456 20 as as ADP aji-51 456 21 a a DET aji-51 456 22 response response NOUN aji-51 456 23 to to ADP aji-51 456 24 infections infection NOUN aji-51 456 25 , , PUNCT aji-51 456 26 toxins toxin NOUN aji-51 456 27 , , PUNCT aji-51 456 28 radiation radiation NOUN aji-51 456 29 , , PUNCT aji-51 456 30 or or CCONJ aji-51 456 31 metabolic metabolic NOUN aji-51 456 32 epigenetic epigenetic ADJ aji-51 456 33 influences influence NOUN aji-51 456 34 that that PRON aji-51 456 35 cause cause VERB aji-51 456 36 mutations mutation NOUN aji-51 456 37 [ [ X aji-51 456 38 241 241 NUM aji-51 456 39 ] ] PUNCT aji-51 456 40 . . PUNCT aji-51 457 1 during during ADP aji-51 457 2 the the DET aji-51 457 3 process process NOUN aji-51 457 4 of of ADP aji-51 457 5 transformation transformation NOUN aji-51 457 6 , , PUNCT aji-51 457 7 oncogenes oncogene NOUN aji-51 457 8 are be AUX aji-51 457 9 overexpressed overexpresse VERB aji-51 457 10 and and CCONJ aji-51 457 11 tumor tumor NOUN aji-51 457 12 suppressor suppressor NOUN aji-51 457 13 genes gene NOUN aji-51 457 14 are be AUX aji-51 457 15 inactivated inactivate VERB aji-51 457 16 , , PUNCT aji-51 457 17 hence hence ADV aji-51 457 18 promoting promote VERB aji-51 457 19 the the DET aji-51 457 20 creation creation NOUN aji-51 457 21 of of ADP aji-51 457 22 , , PUNCT aji-51 457 23 and and CCONJ aji-51 457 24 uncontrolled uncontrolled ADJ aji-51 457 25 growth growth NOUN aji-51 457 26 of of ADP aji-51 457 27 the the DET aji-51 457 28 cscs cscs PROPN aji-51 457 29 . . PUNCT aji-51 458 1 as as ADP aji-51 458 2 a a DET aji-51 458 3 consequence consequence NOUN aji-51 458 4 of of ADP aji-51 458 5 the the DET aji-51 458 6 transformative transformative ADJ aji-51 458 7 process process NOUN aji-51 458 8 , , PUNCT aji-51 458 9 the the DET aji-51 458 10 affected affected ADJ aji-51 458 11 cells cell NOUN aji-51 458 12 “ " PUNCT aji-51 458 13 de de X aji-51 458 14 - - NOUN aji-51 458 15 differentiate differentiate NOUN aji-51 458 16 ” " PUNCT aji-51 458 17 and and CCONJ aji-51 458 18 acquire acquire VERB aji-51 458 19 stem stem NOUN aji-51 458 20 cell cell NOUN aji-51 458 21 self self NOUN aji-51 458 22 - - PUNCT aji-51 458 23 renewal renewal NOUN aji-51 458 24 characteristics characteristic NOUN aji-51 458 25 forming form VERB aji-51 458 26 the the DET aji-51 458 27 nucleus nucleus NOUN aji-51 458 28 of of ADP aji-51 458 29 the the DET aji-51 458 30 cancer cancer NOUN aji-51 459 1 [ [ X aji-51 459 2 242,243 242,243 NUM aji-51 459 3 ] ] PUNCT aji-51 459 4 . . PUNCT aji-51 460 1 the the DET aji-51 460 2 mutations mutation NOUN aji-51 460 3 of of ADP aji-51 460 4 the the DET aji-51 460 5 csc csc PROPN aji-51 460 6 progeny progeny NOUN aji-51 460 7 have have VERB aji-51 460 8 a a DET aji-51 460 9 higher high ADJ aji-51 460 10 rate rate NOUN aji-51 460 11 of of ADP aji-51 460 12 replication replication NOUN aji-51 460 13 which which PRON aji-51 460 14 leads lead VERB aji-51 460 15 to to ADP aji-51 460 16 the the DET aji-51 460 17 formation formation NOUN aji-51 460 18 of of ADP aji-51 460 19 a a DET aji-51 460 20 tumor tumor NOUN aji-51 460 21 [ [ X aji-51 460 22 244 244 NUM aji-51 460 23 ] ] PUNCT aji-51 460 24 . . PUNCT aji-51 461 1 anti anti ADJ aji-51 461 2 - - ADJ aji-51 461 3 csc csc ADJ aji-51 461 4 research research NOUN aji-51 461 5 has have AUX aji-51 461 6 yielded yield VERB aji-51 461 7 some some DET aji-51 461 8 very very ADV aji-51 461 9 promising promising ADJ aji-51 461 10 therapeutic therapeutic ADJ aji-51 461 11 approaches approach NOUN aji-51 461 12 . . PUNCT aji-51 462 1 nutraceuticals nutraceutical NOUN aji-51 462 2 derived derive VERB aji-51 462 3 from from ADP aji-51 462 4 herb herb NOUN aji-51 462 5 and and CCONJ aji-51 462 6 vegetable vegetable NOUN aji-51 462 7 extracts extract NOUN aji-51 462 8 show show VERB aji-51 462 9 anti anti ADJ aji-51 462 10 - - ADJ aji-51 462 11 csc csc ADJ aji-51 462 12 activity activity NOUN aji-51 462 13 at at ADP aji-51 462 14 various various ADJ aji-51 462 15 levels level NOUN aji-51 462 16 of of ADP aji-51 462 17 clinical clinical ADJ aji-51 462 18 utility utility NOUN aji-51 462 19 . . PUNCT aji-51 463 1 cruciferous cruciferous ADJ aji-51 463 2 vegetables vegetable NOUN aji-51 463 3 belong belong VERB aji-51 463 4 to to ADP aji-51 463 5 the the DET aji-51 463 6 cruciferae cruciferae NOUN aji-51 463 7 family family NOUN aji-51 463 8 such such ADJ aji-51 463 9 as as ADP aji-51 463 10 arugula arugula NOUN aji-51 463 11 , , PUNCT aji-51 463 12 bok bok NOUN aji-51 463 13 choy choy NOUN aji-51 463 14 , , PUNCT aji-51 463 15 broccoli broccoli NOUN aji-51 463 16 , , PUNCT aji-51 463 17 broccoli broccoli NOUN aji-51 463 18 rabe rabe NOUN aji-51 463 19 , , PUNCT aji-51 463 20 brussel brussel NOUN aji-51 463 21 sprouts sprout NOUN aji-51 463 22 , , PUNCT aji-51 463 23 cabbage cabbage NOUN aji-51 463 24 , , PUNCT aji-51 463 25 and and CCONJ aji-51 463 26 others other NOUN aji-51 463 27 , , PUNCT aji-51 463 28 contain contain VERB aji-51 463 29 anti anti ADJ aji-51 463 30 - - ADJ aji-51 463 31 cancer cancer ADJ aji-51 463 32 isothiocyanates isothiocyanate NOUN aji-51 463 33 including include VERB aji-51 463 34 sulforaphane sulforaphane NOUN aji-51 463 35 , , PUNCT aji-51 463 36 that that PRON aji-51 463 37 are be AUX aji-51 463 38 enzymatically enzymatically ADV aji-51 463 39 hydrolyzed hydrolyze VERB aji-51 463 40 from from ADP aji-51 463 41 glucosinolates glucosinolate NOUN aji-51 463 42 [ [ X aji-51 463 43 245 245 NUM aji-51 463 44 ] ] PUNCT aji-51 463 45 . . PUNCT aji-51 464 1 normal normal ADJ aji-51 464 2 dietary dietary ADJ aji-51 464 3 “ " PUNCT aji-51 464 4 doses dose NOUN aji-51 464 5 ” " PUNCT aji-51 464 6 of of ADP aji-51 464 7 isothiocyanate isothiocyanate ADJ aji-51 464 8 sulforaphane sulforaphane NOUN aji-51 464 9 have have AUX aji-51 464 10 been be AUX aji-51 464 11 shown show VERB aji-51 464 12 to to PART aji-51 464 13 have have VERB aji-51 464 14 anti anti ADJ aji-51 464 15 - - ADJ aji-51 464 16 csc csc ADJ aji-51 464 17 activity activity NOUN aji-51 464 18 by by ADP aji-51 464 19 altering alter VERB aji-51 464 20 phosphorylation phosphorylation NOUN aji-51 464 21 of of ADP aji-51 464 22 several several ADJ aji-51 464 23 kinases kinase NOUN aji-51 464 24 and and CCONJ aji-51 464 25 their their PRON aji-51 464 26 substrates substrate NOUN aji-51 464 27 including include VERB aji-51 464 28 glycogen glycogen NOUN aji-51 464 29 synthase synthase NOUN aji-51 464 30 stoff stoff PROPN aji-51 464 31 ; ; PUNCT aji-51 464 32 aji aji PROPN aji-51 464 33 , , PUNCT aji-51 464 34 5(1 5(1 NUM aji-51 464 35 ): ): PUNCT aji-51 464 36 1 1 NUM aji-51 464 37 - - SYM aji-51 464 38 39 39 NUM aji-51 464 39 , , PUNCT aji-51 464 40 2022 2022 NUM aji-51 464 41 ; ; PUNCT aji-51 464 42 article article NOUN aji-51 464 43 no.aji.77967 no.aji.77967 PROPN aji-51 464 44 13 13 NUM aji-51 464 45 kinase kinase NOUN aji-51 464 46 3 3 NUM aji-51 464 47 ( ( PUNCT aji-51 464 48 gsk3 gsk3 PROPN aji-51 464 49 ) ) PUNCT aji-51 464 50 , , PUNCT aji-51 464 51 jun jun PROPN aji-51 464 52 n n CCONJ aji-51 464 53 - - PUNCT aji-51 464 54 terminal terminal ADJ aji-51 464 55 kinase kinase NOUN aji-51 464 56 ( ( PUNCT aji-51 464 57 jnk jnk PROPN aji-51 464 58 ) ) PUNCT aji-51 464 59 , , PUNCT aji-51 464 60 and and CCONJ aji-51 464 61 protein protein NOUN aji-51 464 62 kinase kinase PROPN aji-51 464 63 c c PROPN aji-51 464 64 ( ( PUNCT aji-51 464 65 pkc pkc NOUN aji-51 464 66 ) ) PUNCT aji-51 465 1 [ [ X aji-51 465 2 246 246 NUM aji-51 465 3 ] ] PUNCT aji-51 465 4 . . PUNCT aji-51 466 1 soy soy NOUN aji-51 466 2 isoflavones isoflavone NOUN aji-51 466 3 like like ADP aji-51 466 4 genistein genistein NOUN aji-51 466 5 have have AUX aji-51 466 6 been be AUX aji-51 466 7 shown show VERB aji-51 466 8 to to PART aji-51 466 9 have have VERB aji-51 466 10 a a DET aji-51 466 11 potent potent ADJ aji-51 466 12 anti anti ADJ aji-51 466 13 - - ADJ aji-51 466 14 csc csc ADJ aji-51 466 15 effect effect NOUN aji-51 466 16 by by ADP aji-51 466 17 inhibiting inhibit VERB aji-51 466 18 the the DET aji-51 466 19 phosphorylation phosphorylation NOUN aji-51 466 20 of of ADP aji-51 466 21 protein protein NOUN aji-51 466 22 kinase kinase PROPN aji-51 466 23 b b PROPN aji-51 466 24 ( ( PUNCT aji-51 466 25 akt akt PROPN aji-51 466 26 ) ) PUNCT aji-51 466 27 and and CCONJ aji-51 466 28 forkhead forkhead VERB aji-51 466 29 box box PROPN aji-51 466 30 o o PROPN aji-51 466 31 3a 3a NUM aji-51 466 32 ( ( PUNCT aji-51 466 33 foxo3a foxo3a PROPN aji-51 466 34 ) ) PUNCT aji-51 467 1 [ [ X aji-51 467 2 247 247 NUM aji-51 467 3 ] ] PUNCT aji-51 467 4 . . PUNCT aji-51 467 5 polyphenolic polyphenolic ADJ aji-51 467 6 catechins catechin NOUN aji-51 467 7 including include VERB aji-51 467 8 epigallocatechin-3 epigallocatechin-3 PROPN aji-51 467 9 - - NOUN aji-51 467 10 gallate gallate NOUN aji-51 467 11 ( ( PUNCT aji-51 467 12 egcg egcg NOUN aji-51 467 13 ) ) PUNCT aji-51 467 14 found find VERB aji-51 467 15 in in ADP aji-51 467 16 green green ADJ aji-51 467 17 tea tea NOUN aji-51 467 18 extracts extract NOUN aji-51 467 19 have have AUX aji-51 467 20 demonstrated demonstrate VERB aji-51 467 21 anti anti ADJ aji-51 467 22 - - ADJ aji-51 467 23 csc csc ADJ aji-51 467 24 activity activity NOUN aji-51 467 25 , , PUNCT aji-51 467 26 against against ADP aji-51 467 27 a a DET aji-51 467 28 variety variety NOUN aji-51 467 29 of of ADP aji-51 467 30 cancers cancer NOUN aji-51 467 31 , , PUNCT aji-51 467 32 through through ADP aji-51 467 33 its its PRON aji-51 467 34 ability ability NOUN aji-51 467 35 to to PART aji-51 467 36 inhibit inhibit VERB aji-51 467 37 nf nf ADJ aji-51 467 38 - - PUNCT aji-51 467 39 κb κb NOUN aji-51 467 40 activity activity NOUN aji-51 467 41 , , PUNCT aji-51 467 42 mitogen mitogen NOUN aji-51 467 43 - - PUNCT aji-51 467 44 activated activate VERB aji-51 467 45 protein protein NOUN aji-51 467 46 kinase kinase NOUN aji-51 467 47 ( ( PUNCT aji-51 467 48 mapk mapk NOUN aji-51 467 49 ) ) PUNCT aji-51 467 50 pathway pathway NOUN aji-51 467 51 , , PUNCT aji-51 467 52 activator activator NOUN aji-51 467 53 protein-1 protein-1 PROPN aji-51 467 54 ( ( PUNCT aji-51 467 55 ap1 ap1 PROPN aji-51 467 56 ) ) PUNCT aji-51 467 57 activity activity NOUN aji-51 467 58 , , PUNCT aji-51 467 59 and and CCONJ aji-51 467 60 egfr egfr ADV aji-51 467 61 - - PUNCT aji-51 467 62 mediated mediate VERB aji-51 467 63 downstream downstream NOUN aji-51 467 64 signaling signal VERB aji-51 467 65 pathways pathway NOUN aji-51 468 1 [ [ X aji-51 468 2 248,249 248,249 NUM aji-51 468 3 ] ] X aji-51 468 4 . . PUNCT aji-51 469 1 other other ADJ aji-51 469 2 anti anti ADJ aji-51 469 3 - - ADJ aji-51 469 4 csc csc ADJ aji-51 469 5 nutraceuticals nutraceutical NOUN aji-51 469 6 are be AUX aji-51 469 7 derived derive VERB aji-51 469 8 from from ADP aji-51 469 9 quercetin quercetin NOUN aji-51 469 10 , , PUNCT aji-51 469 11 curcumin curcumin NOUN aji-51 469 12 , , PUNCT aji-51 469 13 resveratrol resveratrol NOUN aji-51 469 14 , , PUNCT aji-51 469 15 and and CCONJ aji-51 469 16 ginger ginger NOUN aji-51 469 17 [ [ X aji-51 469 18 250 250 NUM aji-51 469 19 ] ] PUNCT aji-51 469 20 . . PUNCT aji-51 470 1 more more ADV aji-51 470 2 potent potent ADJ aji-51 470 3 anti anti ADJ aji-51 470 4 - - ADJ aji-51 470 5 csc csc ADJ aji-51 470 6 pharmaceuticals pharmaceutical NOUN aji-51 470 7 are be AUX aji-51 470 8 also also ADV aji-51 470 9 derived derive VERB aji-51 470 10 from from ADP aji-51 470 11 plant plant NOUN aji-51 470 12 sources source NOUN aji-51 470 13 . . PUNCT aji-51 471 1 taxol taxol PROPN aji-51 471 2 is be AUX aji-51 471 3 derived derive VERB aji-51 471 4 from from ADP aji-51 471 5 the the DET aji-51 471 6 bark bark NOUN aji-51 471 7 of of ADP aji-51 471 8 the the DET aji-51 471 9 pacific pacific PROPN aji-51 471 10 yew yew PROPN aji-51 471 11 tree tree NOUN aji-51 471 12 ( ( PUNCT aji-51 471 13 taxus taxus NOUN aji-51 471 14 brevifolia brevifolia NOUN aji-51 471 15 ) ) PUNCT aji-51 471 16 and and CCONJ aji-51 471 17 was be AUX aji-51 471 18 discovered discover VERB aji-51 471 19 , , PUNCT aji-51 471 20 through through ADP aji-51 471 21 a a DET aji-51 471 22 random random ADJ aji-51 471 23 screening screening NOUN aji-51 471 24 of of ADP aji-51 471 25 approximately approximately ADV aji-51 471 26 15,000 15,000 NUM aji-51 471 27 species specie NOUN aji-51 471 28 of of ADP aji-51 471 29 plants plant NOUN aji-51 471 30 , , PUNCT aji-51 471 31 to to PART aji-51 471 32 have have VERB aji-51 471 33 powerful powerful ADJ aji-51 471 34 anti anti ADJ aji-51 471 35 - - ADJ aji-51 471 36 csc csc ADJ aji-51 471 37 activity activity NOUN aji-51 471 38 against against ADP aji-51 471 39 many many ADJ aji-51 471 40 different different ADJ aji-51 471 41 cancers cancer NOUN aji-51 471 42 [ [ X aji-51 471 43 251 251 NUM aji-51 471 44 ] ] PUNCT aji-51 471 45 . . PUNCT aji-51 472 1 vinca vinca NOUN aji-51 472 2 alkaloids alkaloid NOUN aji-51 472 3 are be AUX aji-51 472 4 a a DET aji-51 472 5 group group NOUN aji-51 472 6 of of ADP aji-51 472 7 drugs drug NOUN aji-51 472 8 that that PRON aji-51 472 9 were be AUX aji-51 472 10 originally originally ADV aji-51 472 11 extracted extract VERB aji-51 472 12 from from ADP aji-51 472 13 the the DET aji-51 472 14 madagascar madagascar ADJ aji-51 472 15 periwinkle periwinkle NOUN aji-51 472 16 plant plant NOUN aji-51 472 17 , , PUNCT aji-51 472 18 catharanthus catharanthus NOUN aji-51 472 19 roseus roseus PROPN aji-51 472 20 g. g. PROPN aji-51 472 21 don don PROPN aji-51 472 22 , , PUNCT aji-51 472 23 and and CCONJ aji-51 472 24 have have VERB aji-51 472 25 anti anti ADJ aji-51 472 26 - - ADJ aji-51 472 27 csc csc ADJ aji-51 472 28 activity activity NOUN aji-51 472 29 as as ADV aji-51 472 30 well well ADV aji-51 472 31 as as ADP aji-51 472 32 cytotoxic cytotoxic ADJ aji-51 472 33 effects effect NOUN aji-51 472 34 . . PUNCT aji-51 473 1 there there PRON aji-51 473 2 are be VERB aji-51 473 3 three three NUM aji-51 473 4 major major ADJ aji-51 473 5 vinca vinca NOUN aji-51 473 6 alkaloids alkaloid NOUN aji-51 473 7 in in ADP aji-51 473 8 clinical clinical ADJ aji-51 473 9 use use NOUN aji-51 473 10 : : PUNCT aji-51 473 11 vinblastine vinblastine NOUN aji-51 473 12 ( ( PUNCT aji-51 473 13 vbl vbl PROPN aji-51 473 14 ) ) PUNCT aji-51 473 15 , , PUNCT aji-51 473 16 vinorelbine vinorelbine NOUN aji-51 473 17 ( ( PUNCT aji-51 473 18 vrl vrl PROPN aji-51 473 19 ) ) PUNCT aji-51 473 20 , , PUNCT aji-51 473 21 and and CCONJ aji-51 473 22 vincristine vincristine NOUN aji-51 473 23 ( ( PUNCT aji-51 473 24 vcr vcr NOUN aji-51 473 25 ) ) PUNCT aji-51 474 1 [ [ X aji-51 474 2 252 252 NUM aji-51 474 3 ] ] PUNCT aji-51 474 4 . . PUNCT aji-51 475 1 several several ADJ aji-51 475 2 pharmaceuticals pharmaceutical NOUN aji-51 475 3 have have AUX aji-51 475 4 been be AUX aji-51 475 5 “ " PUNCT aji-51 475 6 repurposed repurpose VERB aji-51 475 7 ” " PUNCT aji-51 475 8 as as ADP aji-51 475 9 anti anti ADJ aji-51 475 10 - - ADJ aji-51 475 11 cancer cancer ADJ aji-51 475 12 agents agent NOUN aji-51 475 13 when when SCONJ aji-51 475 14 their their PRON aji-51 475 15 anticsc anticsc ADJ aji-51 475 16 “ " PUNCT aji-51 475 17 side side NOUN aji-51 475 18 - - PUNCT aji-51 475 19 effect effect NOUN aji-51 475 20 ” " PUNCT aji-51 475 21 was be AUX aji-51 475 22 noticed notice VERB aji-51 475 23 . . PUNCT aji-51 476 1 studies study NOUN aji-51 476 2 have have AUX aji-51 476 3 demonstrated demonstrate VERB aji-51 476 4 that that SCONJ aji-51 476 5 metformins metformin NOUN aji-51 476 6 ’ ' PUNCT aji-51 476 7 anti anti ADJ aji-51 476 8 - - NOUN aji-51 476 9 cancer cancer ADJ aji-51 476 10 , , PUNCT aji-51 476 11 anticsc anticsc ADJ aji-51 476 12 effects effect NOUN aji-51 476 13 go go VERB aji-51 476 14 far far ADV aji-51 476 15 beyond beyond ADP aji-51 476 16 its its PRON aji-51 476 17 ability ability NOUN aji-51 476 18 to to PART aji-51 476 19 lower lower VERB aji-51 476 20 blood blood NOUN aji-51 476 21 sugar sugar NOUN aji-51 476 22 in in ADP aji-51 476 23 that that DET aji-51 476 24 metformin metformin NOUN aji-51 476 25 impairs impair VERB aji-51 476 26 cellular cellular ADJ aji-51 476 27 metabolism metabolism NOUN aji-51 476 28 and and CCONJ aji-51 476 29 suppresses suppress VERB aji-51 476 30 oncogenic oncogenic ADJ aji-51 476 31 signaling signal VERB aji-51 476 32 pathways pathway NOUN aji-51 476 33 , , PUNCT aji-51 476 34 including include VERB aji-51 476 35 tyrosine tyrosine PROPN aji-51 476 36 kinase kinase PROPN aji-51 476 37 receptors receptor NOUN aji-51 476 38 , , PUNCT aji-51 476 39 pi3k pi3k PROPN aji-51 476 40 / / SYM aji-51 476 41 akt akt PROPN aji-51 476 42 , , PUNCT aji-51 476 43 and and CCONJ aji-51 476 44 mtor mtor PROPN aji-51 476 45 pathways pathway NOUN aji-51 477 1 [ [ X aji-51 477 2 253 253 NUM aji-51 477 3 ] ] PUNCT aji-51 477 4 . . PUNCT aji-51 478 1 furthermore furthermore ADV aji-51 478 2 , , PUNCT aji-51 478 3 it it PRON aji-51 478 4 suppressed suppress VERB aji-51 478 5 the the DET aji-51 478 6 self self NOUN aji-51 478 7 - - PUNCT aji-51 478 8 renewal renewal NOUN aji-51 478 9 ability ability NOUN aji-51 478 10 of of ADP aji-51 478 11 cancer cancer NOUN aji-51 478 12 stem stem NOUN aji-51 478 13 cells cell NOUN aji-51 478 14 and and CCONJ aji-51 478 15 induced induce VERB aji-51 478 16 g0 g0 PROPN aji-51 478 17 / / SYM aji-51 478 18 g1 g1 PROPN aji-51 478 19 phase phase NOUN aji-51 478 20 arrest arrest NOUN aji-51 478 21 by by ADP aji-51 478 22 blocking block VERB aji-51 478 23 the the DET aji-51 478 24 activity activity NOUN aji-51 478 25 of of ADP aji-51 478 26 cyclindependent cyclindependent NOUN aji-51 478 27 kinases kinase NOUN aji-51 478 28 . . PUNCT aji-51 479 1 in in ADP aji-51 479 2 studies study NOUN aji-51 479 3 on on ADP aji-51 479 4 osteosarcoma osteosarcoma ADJ aji-51 479 5 cancer cancer NOUN aji-51 479 6 cells cell NOUN aji-51 479 7 metformin metformin NOUN aji-51 479 8 - - PUNCT aji-51 479 9 induced induce VERB aji-51 479 10 apoptosis apoptosis NOUN aji-51 479 11 through through ADP aji-51 479 12 a a DET aji-51 479 13 mitochondria mitochondria NOUN aji-51 479 14 - - PUNCT aji-51 479 15 dependent dependent ADJ aji-51 479 16 pathway pathway NOUN aji-51 479 17 , , PUNCT aji-51 479 18 leading lead VERB aji-51 479 19 to to ADP aji-51 479 20 the the DET aji-51 479 21 collapse collapse NOUN aji-51 479 22 of of ADP aji-51 479 23 the the DET aji-51 479 24 mitochondrial mitochondrial ADJ aji-51 479 25 transmembrane transmembrane NOUN aji-51 479 26 potential potential NOUN aji-51 479 27 and and CCONJ aji-51 479 28 the the DET aji-51 479 29 production production NOUN aji-51 479 30 of of ADP aji-51 479 31 oxidatively oxidatively ADV aji-51 479 32 destructive destructive ADJ aji-51 479 33 reactive reactive ADJ aji-51 479 34 oxygen oxygen NOUN aji-51 479 35 species specie NOUN aji-51 479 36 [ [ X aji-51 479 37 254 254 NUM aji-51 479 38 ] ] PUNCT aji-51 479 39 . . PUNCT aji-51 480 1 this this DET aji-51 480 2 destruction destruction NOUN aji-51 480 3 of of ADP aji-51 480 4 the the DET aji-51 480 5 already already ADV aji-51 480 6 compromised compromise VERB aji-51 480 7 mitochondria mitochondria PROPN aji-51 480 8 further far ADV aji-51 480 9 decreased decrease VERB aji-51 480 10 atp atp NOUN aji-51 480 11 synthesis synthesis NOUN aji-51 480 12 and and CCONJ aji-51 480 13 triggered trigger VERB aji-51 480 14 autophagy autophagy ADJ aji-51 480 15 cancer cancer NOUN aji-51 480 16 cell cell NOUN aji-51 480 17 death death NOUN aji-51 481 1 [ [ X aji-51 481 2 255 255 NUM aji-51 481 3 ] ] PUNCT aji-51 481 4 . . PUNCT aji-51 482 1 thus thus ADV aji-51 482 2 , , PUNCT aji-51 482 3 metformin metformin NOUN aji-51 482 4 is be AUX aji-51 482 5 an an DET aji-51 482 6 excellent excellent ADJ aji-51 482 7 addition addition NOUN aji-51 482 8 to to ADP aji-51 482 9 a a DET aji-51 482 10 metabolic metabolic NOUN aji-51 482 11 strategy strategy NOUN aji-51 482 12 in in ADP aji-51 482 13 that that SCONJ aji-51 482 14 its its PRON aji-51 482 15 activity activity NOUN aji-51 482 16 is be AUX aji-51 482 17 synergistic synergistic ADJ aji-51 482 18 with with ADP aji-51 482 19 the the DET aji-51 482 20 goals goal NOUN aji-51 482 21 of of ADP aji-51 482 22 further far ADV aji-51 482 23 degrading degrade VERB aji-51 482 24 the the DET aji-51 482 25 already already ADV aji-51 482 26 damaged damage VERB aji-51 482 27 mitochondria mitochondria NOUN aji-51 482 28 in in ADP aji-51 482 29 cscs cscs PROPN aji-51 482 30 and and CCONJ aji-51 482 31 cancer cancer NOUN aji-51 482 32 cells cell NOUN aji-51 482 33 [ [ X aji-51 482 34 256 256 NUM aji-51 482 35 ] ] PUNCT aji-51 482 36 . . PUNCT aji-51 483 1 when when SCONJ aji-51 483 2 combined combine VERB aji-51 483 3 with with ADP aji-51 483 4 a a DET aji-51 483 5 betablocker betablocker NOUN aji-51 483 6 and and CCONJ aji-51 483 7 aspirin aspirin NOUN aji-51 483 8 the the DET aji-51 483 9 anti anti PROPN aji-51 483 10 - - ADJ aji-51 483 11 csc csc ADJ aji-51 483 12 and and CCONJ aji-51 483 13 antimetastasis antimetastasis NOUN aji-51 483 14 effects effect NOUN aji-51 483 15 are be AUX aji-51 483 16 even even ADV aji-51 483 17 more more ADV aji-51 483 18 pronounced pronounced ADJ aji-51 483 19 [ [ X aji-51 483 20 257,258 257,258 NUM aji-51 483 21 ] ] PUNCT aji-51 483 22 . . PUNCT aji-51 484 1 doxycycline doxycycline NOUN aji-51 484 2 too too ADV aji-51 484 3 has have AUX aji-51 484 4 been be AUX aji-51 484 5 “ " PUNCT aji-51 484 6 re re VERB aji-51 484 7 - - VERB aji-51 484 8 purposed purposed ADJ aji-51 484 9 ” " PUNCT aji-51 484 10 for for ADP aji-51 484 11 the the DET aji-51 484 12 fight fight NOUN aji-51 484 13 against against ADP aji-51 484 14 cancer cancer NOUN aji-51 484 15 . . PUNCT aji-51 485 1 one one NUM aji-51 485 2 of of ADP aji-51 485 3 the the DET aji-51 485 4 fda fda PROPN aji-51 485 5 recognized recognize VERB aji-51 485 6 side side NOUN aji-51 485 7 effects effect NOUN aji-51 485 8 of of ADP aji-51 485 9 doxycycline doxycycline NOUN aji-51 485 10 is be AUX aji-51 485 11 the the DET aji-51 485 12 inhibition inhibition NOUN aji-51 485 13 of of ADP aji-51 485 14 mitochondrial mitochondrial ADJ aji-51 485 15 biogenesis biogenesis NOUN aji-51 485 16 . . PUNCT aji-51 486 1 currently currently ADV aji-51 486 2 , , PUNCT aji-51 486 3 in in ADP aji-51 486 4 the the DET aji-51 486 5 https://www.anticancerfund.org/en/redo-db https://www.anticancerfund.org/en/redo-db PROPN aji-51 486 6 database database NOUN aji-51 486 7 , , PUNCT aji-51 486 8 there there PRON aji-51 486 9 is be VERB aji-51 486 10 a a DET aji-51 486 11 listing listing NOUN aji-51 486 12 of of ADP aji-51 486 13 356 356 NUM aji-51 486 14 “ " PUNCT aji-51 486 15 non non ADJ aji-51 486 16 - - ADJ aji-51 486 17 cancer cancer ADJ aji-51 486 18 drugs drug NOUN aji-51 486 19 ” " PUNCT aji-51 486 20 which which PRON aji-51 486 21 have have AUX aji-51 486 22 shown show VERB aji-51 486 23 some some DET aji-51 486 24 evidence evidence NOUN aji-51 486 25 of of ADP aji-51 486 26 anticancer anticancer NOUN aji-51 486 27 activity activity NOUN aji-51 486 28 . . PUNCT aji-51 487 1 amongst amongst ADP aji-51 487 2 them they PRON aji-51 487 3 , , PUNCT aji-51 487 4 doxycycline doxycycline NOUN aji-51 487 5 is be AUX aji-51 487 6 high high ADJ aji-51 487 7 on on ADP aji-51 487 8 the the DET aji-51 487 9 list list NOUN aji-51 487 10 of of ADP aji-51 487 11 beneficial beneficial ADJ aji-51 487 12 activity activity NOUN aji-51 487 13 [ [ X aji-51 487 14 259 259 NUM aji-51 487 15 ] ] PUNCT aji-51 487 16 . . PUNCT aji-51 488 1 sorting sort VERB aji-51 488 2 them they PRON aji-51 488 3 out out ADP aji-51 488 4 into into ADP aji-51 488 5 a a DET aji-51 488 6 generally generally ADV aji-51 488 7 useful useful ADJ aji-51 488 8 algorithm algorithm NOUN aji-51 488 9 is be AUX aji-51 488 10 a a DET aji-51 488 11 research research NOUN aji-51 488 12 project project NOUN aji-51 488 13 for for ADP aji-51 488 14 watson watson NOUN aji-51 488 15 , , PUNCT aji-51 488 16 but but CCONJ aji-51 488 17 for for ADP aji-51 488 18 now now ADV aji-51 488 19 , , PUNCT aji-51 488 20 we we PRON aji-51 488 21 have have VERB aji-51 488 22 some some DET aji-51 488 23 important important ADJ aji-51 488 24 clues clue NOUN aji-51 488 25 . . PUNCT aji-51 489 1 doxycycline doxycycline NOUN aji-51 489 2 is be AUX aji-51 489 3 a a DET aji-51 489 4 known known ADJ aji-51 489 5 inhibitor inhibitor NOUN aji-51 489 6 of of ADP aji-51 489 7 the the DET aji-51 489 8 small small ADJ aji-51 489 9 mitochondrial mitochondrial ADJ aji-51 489 10 ribosome ribosome NOUN aji-51 489 11 ( ( PUNCT aji-51 489 12 28s 28 NOUN aji-51 489 13 ) ) PUNCT aji-51 489 14 and and CCONJ aji-51 489 15 , , PUNCT aji-51 489 16 as as ADP aji-51 489 17 a a DET aji-51 489 18 consequence consequence NOUN aji-51 489 19 , , PUNCT aji-51 489 20 is be AUX aji-51 489 21 an an DET aji-51 489 22 inhibitor inhibitor NOUN aji-51 489 23 of of ADP aji-51 489 24 mitochondrial mitochondrial ADJ aji-51 489 25 protein protein NOUN aji-51 489 26 translation translation NOUN aji-51 489 27 necessary necessary ADJ aji-51 489 28 for for ADP aji-51 489 29 biogenesis biogenesis NOUN aji-51 489 30 [ [ X aji-51 489 31 260 260 NUM aji-51 489 32 ] ] PUNCT aji-51 489 33 . . PUNCT aji-51 490 1 in in ADP aji-51 490 2 vitro vitro X aji-51 490 3 and and CCONJ aji-51 490 4 in in ADP aji-51 490 5 vivo vivo ADJ aji-51 490 6 evidence evidence NOUN aji-51 490 7 demonstrates demonstrate VERB aji-51 490 8 the the DET aji-51 490 9 inhibitory inhibitory ADJ aji-51 490 10 effects effect NOUN aji-51 490 11 of of ADP aji-51 490 12 doxycycline doxycycline NOUN aji-51 490 13 on on ADP aji-51 490 14 cancer cancer NOUN aji-51 490 15 growth growth NOUN aji-51 490 16 through through ADP aji-51 490 17 mitochondrial mitochondrial ADJ aji-51 490 18 destruction destruction NOUN aji-51 490 19 and and CCONJ aji-51 490 20 the the DET aji-51 490 21 consequence consequence NOUN aji-51 490 22 of of ADP aji-51 490 23 csc csc PROPN aji-51 490 24 suppression suppression NOUN aji-51 490 25 [ [ X aji-51 490 26 261 261 NUM aji-51 490 27 ] ] PUNCT aji-51 490 28 . . PUNCT aji-51 491 1 azithromycin azithromycin PROPN aji-51 491 2 inhibits inhibit VERB aji-51 491 3 the the DET aji-51 491 4 large large ADJ aji-51 491 5 mitochondrial mitochondrial ADJ aji-51 491 6 ribosome ribosome NOUN aji-51 491 7 ( ( PUNCT aji-51 491 8 39s 39s NUM aji-51 491 9 ) ) PUNCT aji-51 491 10 and and CCONJ aji-51 491 11 enhanced enhance VERB aji-51 491 12 the the DET aji-51 491 13 tumor tumor NOUN aji-51 491 14 necrosis necrosis NOUN aji-51 491 15 factor factor NOUN aji-51 491 16 - - PUNCT aji-51 491 17 related relate VERB aji-51 491 18 apoptosis apoptosis NOUN aji-51 491 19 - - PUNCT aji-51 491 20 inducing induce VERB aji-51 491 21 ligand ligand NOUN aji-51 491 22 ( ( PUNCT aji-51 491 23 trail trail NOUN aji-51 491 24 ) ) PUNCT aji-51 491 25 activity activity NOUN aji-51 491 26 , , PUNCT aji-51 491 27 which which PRON aji-51 491 28 selectively selectively ADV aji-51 491 29 targets target VERB aji-51 491 30 tumor tumor NOUN aji-51 491 31 cells cell NOUN aji-51 491 32 without without ADP aji-51 491 33 damaging damage VERB aji-51 491 34 healthy healthy ADJ aji-51 491 35 cells cell NOUN aji-51 491 36 as as ADP aji-51 491 37 an an DET aji-51 491 38 offtarget offtarget NOUN aji-51 491 39 “ " PUNCT aji-51 491 40 side side NOUN aji-51 491 41 - - PUNCT aji-51 491 42 effect effect NOUN aji-51 491 43 ” " PUNCT aji-51 491 44 [ [ X aji-51 491 45 262 262 NUM aji-51 491 46 ] ] PUNCT aji-51 491 47 . . PUNCT aji-51 492 1 together together ADV aji-51 492 2 , , PUNCT aji-51 492 3 these these DET aji-51 492 4 two two NUM aji-51 492 5 antibiotics antibiotic NOUN aji-51 492 6 have have VERB aji-51 492 7 a a DET aji-51 492 8 synergistic synergistic ADJ aji-51 492 9 , , PUNCT aji-51 492 10 anti anti ADJ aji-51 492 11 - - ADJ aji-51 492 12 metabolic metabolic ADJ aji-51 492 13 effect effect NOUN aji-51 492 14 on on ADP aji-51 492 15 cscs cscs PROPN aji-51 492 16 that that PRON aji-51 492 17 is be AUX aji-51 492 18 greater great ADJ aji-51 492 19 than than ADP aji-51 492 20 either either DET aji-51 492 21 one one NUM aji-51 492 22 alone alone ADV aji-51 492 23 . . PUNCT aji-51 493 1 we we PRON aji-51 493 2 can can AUX aji-51 493 3 add add VERB aji-51 493 4 to to ADP aji-51 493 5 the the DET aji-51 493 6 targeted target VERB aji-51 493 7 anti anti ADJ aji-51 493 8 - - ADJ aji-51 493 9 metabolic metabolic ADJ aji-51 493 10 csc csc PROPN aji-51 493 11 effect effect NOUN aji-51 493 12 with with ADP aji-51 493 13 vitamin vitamin NOUN aji-51 493 14 c c NOUN aji-51 493 15 that that PRON aji-51 493 16 , , PUNCT aji-51 493 17 in in ADP aji-51 493 18 high high ADJ aji-51 493 19 dose dose NOUN aji-51 493 20 iv iv PROPN aji-51 493 21 ’s ’s PART aji-51 493 22 ( ( PUNCT aji-51 493 23 greater great ADJ aji-51 493 24 than than ADP aji-51 493 25 15 15 NUM aji-51 493 26 grams gram NOUN aji-51 493 27 ) ) PUNCT aji-51 493 28 , , PUNCT aji-51 493 29 acts act VERB aji-51 493 30 as as ADP aji-51 493 31 a a DET aji-51 493 32 pro pro ADJ aji-51 493 33 - - ADJ aji-51 493 34 oxidant oxidant ADJ aji-51 493 35 , , PUNCT aji-51 493 36 which which PRON aji-51 493 37 can can AUX aji-51 493 38 produce produce VERB aji-51 493 39 free free ADJ aji-51 493 40 radicals radical NOUN aji-51 493 41 further far ADV aji-51 493 42 stressing stress VERB aji-51 493 43 the the DET aji-51 493 44 already already ADV aji-51 493 45 dysfunctional dysfunctional ADJ aji-51 493 46 mitochondria mitochondria NOUN aji-51 493 47 and and CCONJ aji-51 493 48 hastening hasten VERB aji-51 493 49 their their PRON aji-51 493 50 destruction destruction NOUN aji-51 493 51 [ [ X aji-51 493 52 263 263 NUM aji-51 493 53 ] ] PUNCT aji-51 493 54 . . PUNCT aji-51 494 1 this this DET aji-51 494 2 combination combination NOUN aji-51 494 3 of of ADP aji-51 494 4 antibiotics antibiotic NOUN aji-51 494 5 and and CCONJ aji-51 494 6 vitamin vitamin NOUN aji-51 494 7 c c NOUN aji-51 494 8 has have AUX aji-51 494 9 shown show VERB aji-51 494 10 efficacy efficacy NOUN aji-51 494 11 both both PRON aji-51 494 12 in in ADP aji-51 494 13 vitro vitro X aji-51 494 14 and and CCONJ aji-51 494 15 in in ADP aji-51 494 16 vivo vivo NOUN aji-51 494 17 [ [ X aji-51 494 18 264 264 NUM aji-51 494 19 ] ] PUNCT aji-51 494 20 . . PUNCT aji-51 495 1 further far ADV aji-51 495 2 compromising compromise VERB aji-51 495 3 the the DET aji-51 495 4 cscs cscs PROPN aji-51 495 5 mitochondria mitochondria NOUN aji-51 495 6 leading lead VERB aji-51 495 7 to to ADP aji-51 495 8 their their PRON aji-51 495 9 destruction destruction NOUN aji-51 495 10 , , PUNCT aji-51 495 11 seems seem VERB aji-51 495 12 to to PART aji-51 495 13 be be AUX aji-51 495 14 an an DET aji-51 495 15 important important ADJ aji-51 495 16 process process NOUN aji-51 495 17 for for ADP aji-51 495 18 stopping stop VERB aji-51 495 19 cancer cancer NOUN aji-51 495 20 . . PUNCT aji-51 496 1 a a DET aji-51 496 2 shift shift NOUN aji-51 496 3 from from ADP aji-51 496 4 respiration respiration NOUN aji-51 496 5 to to ADP aji-51 496 6 fermentation fermentation NOUN aji-51 496 7 ( ( PUNCT aji-51 496 8 glucose glucose NOUN aji-51 496 9 pathway pathway NOUN aji-51 496 10 ) ) PUNCT aji-51 496 11 is be AUX aji-51 496 12 not not PART aji-51 496 13 the the DET aji-51 496 14 only only ADJ aji-51 496 15 energy energy NOUN aji-51 496 16 production production NOUN aji-51 496 17 shift shift NOUN aji-51 496 18 that that SCONJ aji-51 496 19 cancer cancer NOUN aji-51 496 20 cells cell NOUN aji-51 496 21 , , PUNCT aji-51 496 22 and and CCONJ aji-51 496 23 in in ADP aji-51 496 24 particular particular ADJ aji-51 496 25 that that SCONJ aji-51 496 26 cscs cscs PROPN aji-51 496 27 can can AUX aji-51 496 28 use use VERB aji-51 496 29 , , PUNCT aji-51 496 30 but but CCONJ aji-51 496 31 it it PRON aji-51 496 32 does do AUX aji-51 496 33 seem seem VERB aji-51 496 34 to to PART aji-51 496 35 be be AUX aji-51 496 36 an an DET aji-51 496 37 important important ADJ aji-51 496 38 and and CCONJ aji-51 496 39 common common ADJ aji-51 496 40 one one NUM aji-51 496 41 . . PUNCT aji-51 497 1 to to ADP aji-51 497 2 an an DET aji-51 497 3 extent extent NOUN aji-51 497 4 , , PUNCT aji-51 497 5 cscs cscs PROPN aji-51 497 6 are be AUX aji-51 497 7 metabolically metabolically ADV aji-51 497 8 flexible flexible ADJ aji-51 497 9 so so SCONJ aji-51 497 10 multiple multiple ADJ aji-51 497 11 pathways pathway NOUN aji-51 497 12 may may AUX aji-51 497 13 need need VERB aji-51 497 14 to to PART aji-51 497 15 be be AUX aji-51 497 16 blocked block VERB aji-51 497 17 , , PUNCT aji-51 497 18 often often ADV aji-51 497 19 simultaneously simultaneously ADV aji-51 497 20 , , PUNCT aji-51 497 21 to to PART aji-51 497 22 minimize minimize VERB aji-51 497 23 the the DET aji-51 497 24 risk risk NOUN aji-51 497 25 of of ADP aji-51 497 26 selective selective ADJ aji-51 497 27 metabolic metabolic NOUN aji-51 497 28 escape escape NOUN aji-51 497 29 . . PUNCT aji-51 498 1 in in ADP aji-51 498 2 addition addition NOUN aji-51 498 3 to to ADP aji-51 498 4 inhibiting inhibit VERB aji-51 498 5 the the DET aji-51 498 6 major major ADJ aji-51 498 7 glucose glucose NOUN aji-51 498 8 pathway pathway NOUN aji-51 498 9 , , PUNCT aji-51 498 10 as as SCONJ aji-51 498 11 described describe VERB aji-51 498 12 above above ADV aji-51 498 13 , , PUNCT aji-51 498 14 fatty fatty ADJ aji-51 498 15 acids acid NOUN aji-51 498 16 and and CCONJ aji-51 498 17 glutamine glutamine NOUN aji-51 498 18 can can AUX aji-51 498 19 also also ADV aji-51 498 20 be be AUX aji-51 498 21 used use VERB aji-51 498 22 by by ADP aji-51 498 23 many many ADJ aji-51 498 24 cscs csc NOUN aji-51 498 25 to to PART aji-51 498 26 support support VERB aji-51 498 27 their their PRON aji-51 498 28 deranged deranged ADJ aji-51 498 29 metabolism metabolism NOUN aji-51 498 30 . . PUNCT aji-51 499 1 lipophilic lipophilic ADJ aji-51 499 2 statins statin NOUN aji-51 499 3 can can AUX aji-51 499 4 inhibit inhibit VERB aji-51 499 5 the the DET aji-51 499 6 use use NOUN aji-51 499 7 of of ADP aji-51 499 8 fatty fatty ADJ aji-51 499 9 acids acid NOUN aji-51 499 10 as as ADP aji-51 499 11 an an DET aji-51 499 12 stoff stoff NOUN aji-51 499 13 ; ; PUNCT aji-51 499 14 aji aji PROPN aji-51 499 15 , , PUNCT aji-51 499 16 5(1 5(1 NUM aji-51 499 17 ): ): PUNCT aji-51 499 18 1 1 NUM aji-51 499 19 - - SYM aji-51 499 20 39 39 NUM aji-51 499 21 , , PUNCT aji-51 499 22 2022 2022 NUM aji-51 499 23 ; ; PUNCT aji-51 499 24 article article NOUN aji-51 499 25 no.aji.77967 no.aji.77967 PROPN aji-51 499 26 14 14 NUM aji-51 499 27 energy energy NOUN aji-51 499 28 source source NOUN aji-51 499 29 for for ADP aji-51 499 30 many many ADJ aji-51 499 31 types type NOUN aji-51 499 32 of of ADP aji-51 499 33 cancer cancer NOUN aji-51 499 34 [ [ X aji-51 499 35 265 265 NUM aji-51 499 36 ] ] PUNCT aji-51 499 37 . . PUNCT aji-51 500 1 hydroxychloroquine hydroxychloroquine PROPN aji-51 500 2 blocks block VERB aji-51 500 3 cancer cancer NOUN aji-51 500 4 cells cell NOUN aji-51 500 5 ' ' PART aji-51 500 6 ability ability NOUN aji-51 500 7 to to PART aji-51 500 8 scavenge scavenge VERB aji-51 500 9 nutrients nutrient NOUN aji-51 500 10 , , PUNCT aji-51 500 11 including include VERB aji-51 500 12 glutamine glutamine NOUN aji-51 500 13 , , PUNCT aji-51 500 14 through through ADP aji-51 500 15 macropinocytosis macropinocytosis NOUN aji-51 500 16 , , PUNCT aji-51 500 17 thereby thereby ADV aji-51 500 18 closing close VERB aji-51 500 19 yet yet ADV aji-51 500 20 another another DET aji-51 500 21 pathway pathway NOUN aji-51 500 22 for for ADP aji-51 500 23 energy energy NOUN aji-51 500 24 generation generation NOUN aji-51 500 25 by by ADP aji-51 500 26 the the DET aji-51 500 27 mutated mutate VERB aji-51 500 28 cells cell NOUN aji-51 500 29 [ [ X aji-51 500 30 266 266 NUM aji-51 500 31 ] ] PUNCT aji-51 500 32 . . PUNCT aji-51 501 1 research research NOUN aji-51 501 2 on on ADP aji-51 501 3 new new ADJ aji-51 501 4 anti anti ADJ aji-51 501 5 - - ADJ aji-51 501 6 csc csc ADJ aji-51 501 7 strategies strategy NOUN aji-51 501 8 focuses focus VERB aji-51 501 9 on on ADP aji-51 501 10 their their PRON aji-51 501 11 signaling signal VERB aji-51 501 12 pathways pathway NOUN aji-51 501 13 and and CCONJ aji-51 501 14 cellular cellular ADJ aji-51 501 15 communication communication NOUN aji-51 501 16 system system NOUN aji-51 501 17 including include VERB aji-51 501 18 ; ; PUNCT aji-51 501 19 hedgehog hedgehog PROPN aji-51 501 20 , , PUNCT aji-51 501 21 wnt wnt PROPN aji-51 501 22 / / SYM aji-51 501 23 beta beta NOUN aji-51 501 24 - - PUNCT aji-51 501 25 catenin catenin NOUN aji-51 501 26 , , PUNCT aji-51 501 27 notch notch ADJ aji-51 501 28 , , PUNCT aji-51 501 29 toll toll NOUN aji-51 501 30 - - PUNCT aji-51 501 31 like like ADJ aji-51 501 32 receptor receptor NOUN aji-51 501 33 4 4 NUM aji-51 501 34 ( ( PUNCT aji-51 501 35 tlr-4 tlr-4 NUM aji-51 501 36 ) ) PUNCT aji-51 501 37 , , PUNCT aji-51 501 38 toll toll NOUN aji-51 501 39 - - PUNCT aji-51 501 40 like like ADJ aji-51 501 41 receptor receptor NOUN aji-51 501 42 9 9 NUM aji-51 501 43 ( ( PUNCT aji-51 501 44 tlr-9 tlr-9 NUM aji-51 501 45 ) ) PUNCT aji-51 501 46 , , PUNCT aji-51 501 47 integrins integrin NOUN aji-51 501 48 , , PUNCT aji-51 501 49 egfr egfr NOUN aji-51 501 50 , , PUNCT aji-51 501 51 il-1 il-1 ADP aji-51 501 52 , , PUNCT aji-51 501 53 il-6 il-6 NUM aji-51 501 54 , , PUNCT aji-51 501 55 peroxisome peroxisome VERB aji-51 501 56 proliferatoractivated proliferatoractivate VERB aji-51 501 57 receptor receptor NOUN aji-51 501 58 ( ( PUNCT aji-51 501 59 ppar ppar NOUN aji-51 501 60 ) ) PUNCT aji-51 501 61 , , PUNCT aji-51 501 62 and and CCONJ aji-51 501 63 others other NOUN aji-51 501 64 . . PUNCT aji-51 502 1 cscs cscs PROPN aji-51 502 2 and and CCONJ aji-51 502 3 tumor tumor NOUN aji-51 502 4 cells cell NOUN aji-51 502 5 , , PUNCT aji-51 502 6 like like ADP aji-51 502 7 all all DET aji-51 502 8 eukaryotic eukaryotic ADJ aji-51 502 9 cells cell NOUN aji-51 502 10 , , PUNCT aji-51 502 11 produce produce VERB aji-51 502 12 structures structure NOUN aji-51 502 13 called call VERB aji-51 502 14 exosomes exosome NOUN aji-51 502 15 in in ADP aji-51 502 16 their their PRON aji-51 502 17 endosomal endosomal ADJ aji-51 502 18 compartment compartment NOUN aji-51 502 19 [ [ X aji-51 502 20 267 267 NUM aji-51 502 21 ] ] PUNCT aji-51 502 22 . . PUNCT aji-51 503 1 they they PRON aji-51 503 2 are be AUX aji-51 503 3 approximately approximately ADV aji-51 503 4 100 100 NUM aji-51 503 5 nm nm NOUN aji-51 503 6 in in ADP aji-51 503 7 diameter diameter NOUN aji-51 503 8 and and CCONJ aji-51 503 9 are be AUX aji-51 503 10 surrounded surround VERB aji-51 503 11 by by ADP aji-51 503 12 a a DET aji-51 503 13 lipid lipid ADJ aji-51 503 14 bilayer bilayer NOUN aji-51 503 15 membrane membrane NOUN aji-51 503 16 . . PUNCT aji-51 504 1 exosomes exosome NOUN aji-51 504 2 have have AUX aji-51 504 3 been be AUX aji-51 504 4 recognized recognize VERB aji-51 504 5 as as ADP aji-51 504 6 potent potent ADJ aji-51 504 7 vehicles vehicle NOUN aji-51 504 8 of of ADP aji-51 504 9 intercellular intercellular ADJ aji-51 504 10 communication communication NOUN aji-51 504 11 due due ADP aji-51 504 12 to to ADP aji-51 504 13 their their PRON aji-51 504 14 capacity capacity NOUN aji-51 504 15 to to PART aji-51 504 16 transfer transfer VERB aji-51 504 17 proteins protein NOUN aji-51 504 18 , , PUNCT aji-51 504 19 lipids lipid NOUN aji-51 504 20 , , PUNCT aji-51 504 21 and and CCONJ aji-51 504 22 nucleic nucleic ADJ aji-51 504 23 acids acid NOUN aji-51 504 24 ; ; PUNCT aji-51 504 25 thereby thereby ADV aji-51 504 26 influencing influence VERB aji-51 504 27 various various ADJ aji-51 504 28 physiological physiological ADJ aji-51 504 29 and and CCONJ aji-51 504 30 pathological pathological ADJ aji-51 504 31 functions function NOUN aji-51 504 32 of of ADP aji-51 504 33 both both DET aji-51 504 34 recipient recipient NOUN aji-51 504 35 and and CCONJ aji-51 504 36 parent parent NOUN aji-51 504 37 cells cell NOUN aji-51 504 38 [ [ X aji-51 504 39 268 268 NUM aji-51 504 40 ] ] PUNCT aji-51 504 41 . . PUNCT aji-51 505 1 the the DET aji-51 505 2 involvement involvement NOUN aji-51 505 3 of of ADP aji-51 505 4 exosomes exosome NOUN aji-51 505 5 in in ADP aji-51 505 6 the the DET aji-51 505 7 phenotype phenotype NOUN aji-51 505 8 transformation transformation NOUN aji-51 505 9 from from ADP aji-51 505 10 non non ADJ aji-51 505 11 - - ADJ aji-51 505 12 csc csc ADJ aji-51 505 13 to to ADP aji-51 505 14 csc csc PROPN aji-51 505 15 has have AUX aji-51 505 16 been be AUX aji-51 505 17 recently recently ADV aji-51 505 18 evidenced evidence VERB aji-51 505 19 by by ADP aji-51 505 20 research research NOUN aji-51 505 21 on on ADP aji-51 505 22 the the DET aji-51 505 23 x x PUNCT aji-51 505 24 chromosome chromosome NOUN aji-51 505 25 long long ADJ aji-51 505 26 non non ADJ aji-51 505 27 - - ADJ aji-51 505 28 coding code VERB aji-51 505 29 rna rna NOUN aji-51 505 30 , , PUNCT aji-51 505 31 which which PRON aji-51 505 32 is be AUX aji-51 505 33 overexpressed overexpresse VERB aji-51 505 34 in in ADP aji-51 505 35 malignant malignant ADJ aji-51 505 36 tumor tumor NOUN aji-51 505 37 tissues tissue NOUN aji-51 505 38 and and CCONJ aji-51 505 39 activates activate VERB aji-51 505 40 toll toll NOUN aji-51 505 41 - - PUNCT aji-51 505 42 like like ADJ aji-51 505 43 receptor receptor NOUN aji-51 505 44 ( ( PUNCT aji-51 505 45 tlr tlr PROPN aji-51 505 46 ) ) PUNCT aji-51 505 47 7 7 NUM aji-51 505 48 and and CCONJ aji-51 505 49 nf nf ADJ aji-51 505 50 - - PUNCT aji-51 505 51 κb κb NOUN aji-51 505 52 inflammatory inflammatory ADJ aji-51 505 53 signaling signal VERB aji-51 505 54 [ [ X aji-51 505 55 269 269 NUM aji-51 505 56 ] ] PUNCT aji-51 505 57 . . PUNCT aji-51 506 1 exosomes exosome NOUN aji-51 506 2 have have AUX aji-51 506 3 been be AUX aji-51 506 4 reported report VERB aji-51 506 5 to to PART aji-51 506 6 interact interact VERB aji-51 506 7 with with ADP aji-51 506 8 the the DET aji-51 506 9 cells cell NOUN aji-51 506 10 of of ADP aji-51 506 11 the the DET aji-51 506 12 immune immune ADJ aji-51 506 13 system system NOUN aji-51 506 14 , , PUNCT aji-51 506 15 modulating modulate VERB aji-51 506 16 and and CCONJ aji-51 506 17 downregulating downregulate VERB aji-51 506 18 its its PRON aji-51 506 19 response response NOUN aji-51 506 20 thus thus ADV aji-51 506 21 allowing allow VERB aji-51 506 22 for for ADP aji-51 506 23 tumor tumor NOUN aji-51 506 24 progression progression NOUN aji-51 507 1 [ [ X aji-51 507 2 270 270 NUM aji-51 507 3 ] ] PUNCT aji-51 507 4 . . PUNCT aji-51 508 1 tumor tumor NOUN aji-51 508 2 - - PUNCT aji-51 508 3 derived derive VERB aji-51 508 4 exosomes exosome NOUN aji-51 508 5 ( ( PUNCT aji-51 508 6 texs texs NOUN aji-51 508 7 ) ) PUNCT aji-51 508 8 induce induce VERB aji-51 508 9 apoptosis apoptosis NOUN aji-51 508 10 of of ADP aji-51 508 11 the the DET aji-51 508 12 activated activated ADJ aji-51 508 13 cd8 cd8 PROPN aji-51 508 14 + + CCONJ aji-51 508 15 ( ( PUNCT aji-51 508 16 cluster cluster NOUN aji-51 508 17 of of ADP aji-51 508 18 differentiation differentiation NOUN aji-51 508 19 8) 8) NUM aji-51 508 20 t t NOUN aji-51 508 21 cells cell NOUN aji-51 508 22 ( ( PUNCT aji-51 508 23 which which PRON aji-51 508 24 have have VERB aji-51 508 25 an an DET aji-51 508 26 anti anti ADJ aji-51 508 27 - - ADJ aji-51 508 28 cancer cancer ADJ aji-51 508 29 surveillance surveillance NOUN aji-51 508 30 function function NOUN aji-51 508 31 ) ) PUNCT aji-51 508 32 , , PUNCT aji-51 508 33 suppress suppress VERB aji-51 508 34 natural natural ADJ aji-51 508 35 killer killer NOUN aji-51 508 36 ( ( PUNCT aji-51 508 37 nk nk PROPN aji-51 508 38 ) ) PUNCT aji-51 508 39 cell cell NOUN aji-51 508 40 activity activity NOUN aji-51 508 41 , , PUNCT aji-51 508 42 promote promote VERB aji-51 508 43 the the DET aji-51 508 44 induction induction NOUN aji-51 508 45 of of ADP aji-51 508 46 regulatory regulatory ADJ aji-51 508 47 t t NOUN aji-51 508 48 cells cell NOUN aji-51 508 49 ( ( PUNCT aji-51 508 50 tregs treg NOUN aji-51 508 51 ) ) PUNCT aji-51 508 52 and and CCONJ aji-51 508 53 myeloid myeloid NOUN aji-51 508 54 - - PUNCT aji-51 508 55 derived derive VERB aji-51 508 56 suppressor suppressor NOUN aji-51 508 57 cells cell NOUN aji-51 508 58 , , PUNCT aji-51 508 59 and and CCONJ aji-51 508 60 interfere interfere VERB aji-51 508 61 with with ADP aji-51 508 62 monocyte monocyte NOUN aji-51 508 63 differentiation differentiation NOUN aji-51 508 64 into into ADP aji-51 508 65 anti anti ADJ aji-51 508 66 - - ADJ aji-51 508 67 cancer cancer ADJ aji-51 508 68 dendritic dendritic ADJ aji-51 508 69 cells cell NOUN aji-51 508 70 [ [ X aji-51 508 71 271 271 NUM aji-51 508 72 ] ] PUNCT aji-51 508 73 . . PUNCT aji-51 509 1 while while SCONJ aji-51 509 2 texs texs NOUN aji-51 509 3 form form VERB aji-51 509 4 the the DET aji-51 509 5 immunosuppressive immunosuppressive ADJ aji-51 509 6 microenvironment microenvironment NOUN aji-51 509 7 , , PUNCT aji-51 509 8 tregderived tregderive VERB aji-51 509 9 exosomes exosome NOUN aji-51 509 10 inhibit inhibit VERB aji-51 509 11 the the DET aji-51 509 12 induction induction NOUN aji-51 509 13 of of ADP aji-51 509 14 cytotoxic cytotoxic ADJ aji-51 509 15 t t NOUN aji-51 509 16 lymphocytes lymphocyte VERB aji-51 509 17 , , PUNCT aji-51 509 18 further far ADV aji-51 509 19 allowing allow VERB aji-51 509 20 for for ADP aji-51 509 21 the the DET aji-51 509 22 growth growth NOUN aji-51 509 23 and and CCONJ aji-51 509 24 spread spread VERB aji-51 509 25 of of ADP aji-51 509 26 the the DET aji-51 509 27 tumor tumor NOUN aji-51 510 1 [ [ X aji-51 510 2 272 272 NUM aji-51 510 3 ] ] PUNCT aji-51 510 4 . . PUNCT aji-51 511 1 as as ADP aji-51 511 2 a a DET aji-51 511 3 result result NOUN aji-51 511 4 of of ADP aji-51 511 5 the the DET aji-51 511 6 research research NOUN aji-51 511 7 on on ADP aji-51 511 8 tumor tumor NOUN aji-51 511 9 cell cell NOUN aji-51 511 10 exosomes exosome NOUN aji-51 511 11 , , PUNCT aji-51 511 12 they they PRON aji-51 511 13 have have AUX aji-51 511 14 become become VERB aji-51 511 15 a a DET aji-51 511 16 promising promising ADJ aji-51 511 17 target target NOUN aji-51 511 18 for for ADP aji-51 511 19 the the DET aji-51 511 20 treatment treatment NOUN aji-51 511 21 of of ADP aji-51 511 22 cancer cancer NOUN aji-51 511 23 but but CCONJ aji-51 511 24 as as ADP aji-51 511 25 of of ADP aji-51 511 26 yet yet ADV aji-51 511 27 this this DET aji-51 511 28 therapy therapy NOUN aji-51 511 29 is be AUX aji-51 511 30 not not PART aji-51 511 31 available available ADJ aji-51 511 32 [ [ PUNCT aji-51 511 33 273 273 NUM aji-51 511 34 - - SYM aji-51 511 35 276 276 NUM aji-51 511 36 ] ] PUNCT aji-51 511 37 . . PUNCT aji-51 512 1 2.6 2.6 NUM aji-51 512 2 cytotoxic cytotoxic ADJ aji-51 512 3 cancer cancer NOUN aji-51 512 4 therapy therapy NOUN aji-51 512 5 cytotoxic cytotoxic ADJ aji-51 512 6 cancer cancer NOUN aji-51 512 7 treatments treatment NOUN aji-51 512 8 are be AUX aji-51 512 9 traditionally traditionally ADV aji-51 512 10 covered cover VERB aji-51 512 11 by by ADP aji-51 512 12 the the DET aji-51 512 13 term term NOUN aji-51 512 14 chemotherapy chemotherapy NOUN aji-51 512 15 and and CCONJ aji-51 512 16 have have AUX aji-51 512 17 come come VERB aji-51 512 18 to to PART aji-51 512 19 imply imply VERB aji-51 512 20 the the DET aji-51 512 21 use use NOUN aji-51 512 22 of of ADP aji-51 512 23 agents agent NOUN aji-51 512 24 that that PRON aji-51 512 25 act act VERB aji-51 512 26 , , PUNCT aji-51 512 27 separately separately ADV aji-51 512 28 from from ADP aji-51 512 29 the the DET aji-51 512 30 body body NOUN aji-51 512 31 at at ADP aji-51 512 32 large large ADJ aji-51 512 33 , , PUNCT aji-51 512 34 as as SCONJ aji-51 512 35 intracellular intracellular ADJ aji-51 512 36 poisons poison NOUN aji-51 512 37 to to PART aji-51 512 38 inhibit inhibit VERB aji-51 512 39 mitosis mitosis NOUN aji-51 512 40 or or CCONJ aji-51 512 41 directly directly ADV aji-51 512 42 induce induce VERB aji-51 512 43 some some DET aji-51 512 44 sort sort NOUN aji-51 512 45 of of ADP aji-51 512 46 cell cell NOUN aji-51 512 47 death death NOUN aji-51 512 48 and and CCONJ aji-51 512 49 is be AUX aji-51 512 50 the the DET aji-51 512 51 fifth fifth ADJ aji-51 512 52 anti anti ADJ aji-51 512 53 - - ADJ aji-51 512 54 cancer cancer ADJ aji-51 512 55 strategy strategy NOUN aji-51 512 56 . . PUNCT aji-51 513 1 substances substance NOUN aji-51 513 2 that that PRON aji-51 513 3 accomplish accomplish VERB aji-51 513 4 this this PRON aji-51 513 5 as as ADP aji-51 513 6 a a DET aji-51 513 7 secondary secondary ADJ aji-51 513 8 effect effect NOUN aji-51 513 9 through through ADP aji-51 513 10 blocking block VERB aji-51 513 11 extracellular extracellular ADJ aji-51 513 12 signals signal NOUN aji-51 513 13 or or CCONJ aji-51 513 14 which which PRON aji-51 513 15 act act VERB aji-51 513 16 through through ADP aji-51 513 17 a a DET aji-51 513 18 specific specific ADJ aji-51 513 19 genetic genetic ADJ aji-51 513 20 , , PUNCT aji-51 513 21 enzymatic enzymatic ADJ aji-51 513 22 , , PUNCT aji-51 513 23 or or CCONJ aji-51 513 24 hormonal hormonal ADJ aji-51 513 25 pathway pathway NOUN aji-51 513 26 are be AUX aji-51 513 27 excluded exclude VERB aji-51 513 28 from from ADP aji-51 513 29 this this DET aji-51 513 30 therapeutic therapeutic ADJ aji-51 513 31 strategy strategy NOUN aji-51 513 32 as as SCONJ aji-51 513 33 they they PRON aji-51 513 34 are be AUX aji-51 513 35 referred refer VERB aji-51 513 36 to to ADP aji-51 513 37 as as ADP aji-51 513 38 targeted target VERB aji-51 513 39 therapies therapy NOUN aji-51 513 40 and and CCONJ aji-51 513 41 elsewhere elsewhere ADV aji-51 513 42 described describe VERB aji-51 513 43 . . PUNCT aji-51 514 1 chemotherapeutic chemotherapeutic ADJ aji-51 514 2 agents agent NOUN aji-51 514 3 are be AUX aji-51 514 4 characteristically characteristically ADV aji-51 514 5 purified purify VERB aji-51 514 6 to to ADP aji-51 514 7 the the DET aji-51 514 8 point point NOUN aji-51 514 9 of of ADP aji-51 514 10 being be AUX aji-51 514 11 a a DET aji-51 514 12 chemical chemical NOUN aji-51 514 13 , , PUNCT aji-51 514 14 and and CCONJ aji-51 514 15 may may AUX aji-51 514 16 be be AUX aji-51 514 17 of of ADP aji-51 514 18 natural natural ADJ aji-51 514 19 origin origin NOUN aji-51 514 20 or or CCONJ aji-51 514 21 synthetically synthetically ADV aji-51 514 22 created create VERB aji-51 514 23 . . PUNCT aji-51 515 1 the the DET aji-51 515 2 deliberate deliberate ADJ aji-51 515 3 use use NOUN aji-51 515 4 of of ADP aji-51 515 5 natural natural ADJ aji-51 515 6 , , PUNCT aji-51 515 7 herbal herbal ADJ aji-51 515 8 source source NOUN aji-51 515 9 agents agent NOUN aji-51 515 10 began begin VERB aji-51 515 11 in in ADP aji-51 515 12 the the DET aji-51 515 13 early early ADJ aji-51 515 14 1920s 1920s NUM aji-51 515 15 , , PUNCT aji-51 515 16 including include VERB aji-51 515 17 viscum viscum ADJ aji-51 515 18 alkaloids alkaloid NOUN aji-51 515 19 and and CCONJ aji-51 515 20 lectins lectin NOUN aji-51 515 21 , , PUNCT aji-51 515 22 and and CCONJ aji-51 515 23 they they PRON aji-51 515 24 are be AUX aji-51 515 25 still still ADV aji-51 515 26 used use VERB aji-51 515 27 today today NOUN aji-51 515 28 , , PUNCT aji-51 515 29 whereas whereas SCONJ aji-51 515 30 the the DET aji-51 515 31 first first ADJ aji-51 515 32 synthetic synthetic ADJ aji-51 515 33 agent agent NOUN aji-51 515 34 , , PUNCT aji-51 515 35 nitrogen nitrogen NOUN aji-51 515 36 mustard mustard NOUN aji-51 515 37 , , PUNCT aji-51 515 38 was be AUX aji-51 515 39 “ " PUNCT aji-51 515 40 discovered discover VERB aji-51 515 41 accidentally accidentally ADV aji-51 515 42 ” " PUNCT aji-51 515 43 during during ADP aji-51 515 44 world world PROPN aji-51 515 45 war war PROPN aji-51 515 46 ii ii PROPN aji-51 515 47 when when SCONJ aji-51 515 48 it it PRON aji-51 515 49 was be AUX aji-51 515 50 observed observe VERB aji-51 515 51 that that SCONJ aji-51 515 52 it it PRON aji-51 515 53 could could AUX aji-51 515 54 shrink shrink VERB aji-51 515 55 lymphoma lymphoma NOUN aji-51 515 56 tumors tumor NOUN aji-51 515 57 in in ADP aji-51 515 58 mice mouse NOUN aji-51 515 59 . . PUNCT aji-51 516 1 a a DET aji-51 516 2 few few ADJ aji-51 516 3 years year NOUN aji-51 516 4 later later ADV aji-51 516 5 , , PUNCT aji-51 516 6 it it PRON aji-51 516 7 was be AUX aji-51 516 8 discovered discover VERB aji-51 516 9 that that SCONJ aji-51 516 10 alkaloids alkaloid NOUN aji-51 516 11 extracted extract VERB aji-51 516 12 from from ADP aji-51 516 13 the the DET aji-51 516 14 vinca vinca NOUN aji-51 516 15 rosea rosea NOUN aji-51 516 16 plant plant NOUN aji-51 516 17 were be AUX aji-51 516 18 useful useful ADJ aji-51 516 19 in in ADP aji-51 516 20 treating treat VERB aji-51 516 21 hodgkin hodgkin PROPN aji-51 516 22 ’s ’s PART aji-51 516 23 disease disease NOUN aji-51 516 24 , , PUNCT aji-51 516 25 and and CCONJ aji-51 516 26 so so ADV aji-51 516 27 a a DET aji-51 516 28 multibillion multibillion NOUN aji-51 516 29 dollar dollar NOUN aji-51 516 30 industry industry NOUN aji-51 516 31 was be AUX aji-51 516 32 birthed birth VERB aji-51 516 33 creating create VERB aji-51 516 34 and and CCONJ aji-51 516 35 extracting extract VERB aji-51 516 36 new new ADJ aji-51 516 37 substances substance NOUN aji-51 516 38 helpful helpful ADJ aji-51 516 39 in in ADP aji-51 516 40 the the DET aji-51 516 41 “ " PUNCT aji-51 516 42 war war NOUN aji-51 516 43 on on ADP aji-51 516 44 cancer cancer NOUN aji-51 516 45 ” " PUNCT aji-51 516 46 . . PUNCT aji-51 517 1 unfortunately unfortunately ADV aji-51 517 2 , , PUNCT aji-51 517 3 many many ADJ aji-51 517 4 of of ADP aji-51 517 5 these these DET aji-51 517 6 substances substance NOUN aji-51 517 7 have have VERB aji-51 517 8 similar similar ADJ aji-51 517 9 effects effect NOUN aji-51 517 10 on on ADP aji-51 517 11 healthy healthy ADJ aji-51 517 12 cells cell NOUN aji-51 517 13 , , PUNCT aji-51 517 14 thus thus ADV aji-51 517 15 creating create VERB aji-51 517 16 a a DET aji-51 517 17 multitude multitude NOUN aji-51 517 18 of of ADP aji-51 517 19 side side NOUN aji-51 517 20 effects effect NOUN aji-51 517 21 and and CCONJ aji-51 517 22 limiting limit VERB aji-51 517 23 their their PRON aji-51 517 24 usefulness usefulness NOUN aji-51 517 25 . . PUNCT aji-51 518 1 newer new ADJ aji-51 518 2 protocols protocol NOUN aji-51 518 3 that that PRON aji-51 518 4 use use VERB aji-51 518 5 lower low ADJ aji-51 518 6 doses dose NOUN aji-51 518 7 of of ADP aji-51 518 8 these these DET aji-51 518 9 agents agent NOUN aji-51 518 10 , , PUNCT aji-51 518 11 such such ADJ aji-51 518 12 as as ADP aji-51 518 13 metronomic metronomic ADJ aji-51 518 14 or or CCONJ aji-51 518 15 insulin insulin NOUN aji-51 518 16 potentiated potentiate VERB aji-51 518 17 chemotherapy chemotherapy NOUN aji-51 518 18 , , PUNCT aji-51 518 19 are be AUX aji-51 518 20 showing show VERB aji-51 518 21 good good ADJ aji-51 518 22 results result NOUN aji-51 518 23 with with ADP aji-51 518 24 far far ADV aji-51 518 25 fewer few ADJ aji-51 518 26 side side NOUN aji-51 518 27 effects effect NOUN aji-51 518 28 . . PUNCT aji-51 519 1 metronomic metronomic ADJ aji-51 519 2 , , PUNCT aji-51 519 3 low low ADJ aji-51 519 4 dose dose NOUN aji-51 519 5 chemotherapy chemotherapy NOUN aji-51 519 6 has have AUX aji-51 519 7 been be AUX aji-51 519 8 in in ADP aji-51 519 9 development development NOUN aji-51 519 10 for for ADP aji-51 519 11 two two NUM aji-51 519 12 decades decade NOUN aji-51 519 13 and and CCONJ aji-51 519 14 seems seem VERB aji-51 519 15 to to PART aji-51 519 16 act act VERB aji-51 519 17 through through ADP aji-51 519 18 several several ADJ aji-51 519 19 mechanisms mechanism NOUN aji-51 519 20 including include VERB aji-51 519 21 inhibiting inhibit VERB aji-51 519 22 the the DET aji-51 519 23 growth growth NOUN aji-51 519 24 of of ADP aji-51 519 25 new new ADJ aji-51 519 26 blood blood NOUN aji-51 519 27 vessels vessel NOUN aji-51 519 28 , , PUNCT aji-51 519 29 the the DET aji-51 519 30 restoration restoration NOUN aji-51 519 31 of of ADP aji-51 519 32 an an DET aji-51 519 33 anticancer anticancer NOUN aji-51 519 34 immune immune ADJ aji-51 519 35 response response NOUN aji-51 519 36 , , PUNCT aji-51 519 37 and and CCONJ aji-51 519 38 the the DET aji-51 519 39 induction induction NOUN aji-51 519 40 of of ADP aji-51 519 41 tumor tumor NOUN aji-51 519 42 dormancy dormancy NOUN aji-51 519 43 . . PUNCT aji-51 520 1 whereas whereas SCONJ aji-51 520 2 insulin insulin NOUN aji-51 520 3 potentiated potentiate VERB aji-51 520 4 therapy therapy NOUN aji-51 520 5 ( ( PUNCT aji-51 520 6 ipt ipt PROPN aji-51 520 7 ) ) PUNCT aji-51 520 8 , , PUNCT aji-51 520 9 another another DET aji-51 520 10 low low ADJ aji-51 520 11 dose dose NOUN aji-51 520 12 strategy strategy NOUN aji-51 520 13 , , PUNCT aji-51 520 14 takes take VERB aji-51 520 15 physiologic physiologic ADJ aji-51 520 16 advantage advantage NOUN aji-51 520 17 of of ADP aji-51 520 18 the the DET aji-51 520 19 excessive excessive ADJ aji-51 520 20 number number NOUN aji-51 520 21 of of ADP aji-51 520 22 insulin insulin NOUN aji-51 520 23 receptors receptor NOUN aji-51 520 24 found find VERB aji-51 520 25 on on ADP aji-51 520 26 the the DET aji-51 520 27 cell cell NOUN aji-51 520 28 surface surface NOUN aji-51 520 29 of of ADP aji-51 520 30 cancer cancer NOUN aji-51 520 31 cells cell NOUN aji-51 520 32 . . PUNCT aji-51 521 1 giving give VERB aji-51 521 2 insulin insulin NOUN aji-51 521 3 just just ADV aji-51 521 4 prior prior ADV aji-51 521 5 to to ADP aji-51 521 6 the the DET aji-51 521 7 infusion infusion NOUN aji-51 521 8 of of ADP aji-51 521 9 low low ADJ aji-51 521 10 dose dose NOUN aji-51 521 11 chemotherapeutic chemotherapeutic ADJ aji-51 521 12 agents agent NOUN aji-51 521 13 , , PUNCT aji-51 521 14 usually usually ADV aji-51 521 15 in in ADP aji-51 521 16 a a DET aji-51 521 17 combination combination NOUN aji-51 521 18 designed design VERB aji-51 521 19 to to PART aji-51 521 20 intervene intervene VERB aji-51 521 21 at at ADP aji-51 521 22 several several ADJ aji-51 521 23 sites site NOUN aji-51 521 24 of of ADP aji-51 521 25 the the DET aji-51 521 26 cell cell NOUN aji-51 521 27 cycle cycle NOUN aji-51 521 28 , , PUNCT aji-51 521 29 causes cause VERB aji-51 521 30 much much ADV aji-51 521 31 fewer few ADJ aji-51 521 32 side side NOUN aji-51 521 33 effects effect NOUN aji-51 521 34 and and CCONJ aji-51 521 35 can can AUX aji-51 521 36 hold hold VERB aji-51 521 37 the the DET aji-51 521 38 cancer cancer NOUN aji-51 521 39 at at ADP aji-51 521 40 bay bay NOUN aji-51 521 41 , , PUNCT aji-51 521 42 while while SCONJ aji-51 521 43 buying buy VERB aji-51 521 44 time time NOUN aji-51 521 45 to to PART aji-51 521 46 reconstitute reconstitute VERB aji-51 521 47 an an DET aji-51 521 48 effective effective ADJ aji-51 521 49 immune immune ADJ aji-51 521 50 response response NOUN aji-51 521 51 or or CCONJ aji-51 521 52 integrate integrate VERB aji-51 521 53 another another DET aji-51 521 54 anti anti ADJ aji-51 521 55 - - ADJ aji-51 521 56 cancer cancer ADJ aji-51 521 57 therapeutic therapeutic ADJ aji-51 521 58 strategy strategy NOUN aji-51 521 59 . . PUNCT aji-51 522 1 ipt ipt PROPN aji-51 522 2 has have AUX aji-51 522 3 been be AUX aji-51 522 4 in in ADP aji-51 522 5 development development NOUN aji-51 522 6 and and CCONJ aji-51 522 7 clinical clinical ADJ aji-51 522 8 use use NOUN aji-51 522 9 since since SCONJ aji-51 522 10 the the DET aji-51 522 11 1930s 1930 NOUN aji-51 522 12 and and CCONJ aji-51 522 13 has have AUX aji-51 522 14 been be AUX aji-51 522 15 used use VERB aji-51 522 16 to to PART aji-51 522 17 help help VERB aji-51 522 18 treat treat VERB aji-51 522 19 other other ADJ aji-51 522 20 chronic chronic ADJ aji-51 522 21 diseases disease NOUN aji-51 522 22 as as ADV aji-51 522 23 well well ADV aji-51 523 1 [ [ PUNCT aji-51 523 2 277 277 NUM aji-51 523 3 - - SYM aji-51 523 4 290 290 NUM aji-51 523 5 ] ] PUNCT aji-51 523 6 . . PUNCT aji-51 524 1 cytotoxic cytotoxic ADJ aji-51 524 2 chemotherapy chemotherapy NOUN aji-51 524 3 is be AUX aji-51 524 4 usually usually ADV aji-51 524 5 administered administer VERB aji-51 524 6 as as ADP aji-51 524 7 per per ADP aji-51 524 8 a a DET aji-51 524 9 protocol protocol NOUN aji-51 524 10 derived derive VERB aji-51 524 11 by by ADP aji-51 524 12 treating treat VERB aji-51 524 13 a a DET aji-51 524 14 group group NOUN aji-51 524 15 of of ADP aji-51 524 16 stoff stoff PROPN aji-51 524 17 ; ; PUNCT aji-51 524 18 aji aji PROPN aji-51 524 19 , , PUNCT aji-51 524 20 5(1 5(1 NUM aji-51 524 21 ): ): PUNCT aji-51 524 22 1 1 NUM aji-51 524 23 - - SYM aji-51 524 24 39 39 NUM aji-51 524 25 , , PUNCT aji-51 524 26 2022 2022 NUM aji-51 524 27 ; ; PUNCT aji-51 524 28 article article NOUN aji-51 524 29 no.aji.77967 no.aji.77967 ADJ aji-51 524 30 15 15 NUM aji-51 524 31 people people NOUN aji-51 524 32 ( ( PUNCT aji-51 524 33 cohorts cohort NOUN aji-51 524 34 ) ) PUNCT aji-51 524 35 with with ADP aji-51 524 36 a a DET aji-51 524 37 similar similar ADJ aji-51 524 38 diagnosis diagnosis NOUN aji-51 524 39 . . PUNCT aji-51 525 1 these these DET aji-51 525 2 clinical clinical ADJ aji-51 525 3 trials trial NOUN aji-51 525 4 are be AUX aji-51 525 5 done do VERB aji-51 525 6 to to PART aji-51 525 7 determine determine VERB aji-51 525 8 the the DET aji-51 525 9 general general ADJ aji-51 525 10 dose dose NOUN aji-51 525 11 and and CCONJ aji-51 525 12 combination combination NOUN aji-51 525 13 of of ADP aji-51 525 14 agents agent NOUN aji-51 525 15 that that PRON aji-51 525 16 are be AUX aji-51 525 17 most most ADV aji-51 525 18 effective effective ADJ aji-51 525 19 and and CCONJ aji-51 525 20 least least ADJ aji-51 525 21 toxic toxic ADJ aji-51 525 22 according accord VERB aji-51 525 23 to to ADP aji-51 525 24 the the DET aji-51 525 25 structure structure NOUN aji-51 525 26 of of ADP aji-51 525 27 the the DET aji-51 525 28 trial trial NOUN aji-51 525 29 for for ADP aji-51 525 30 that that DET aji-51 525 31 disease disease NOUN aji-51 525 32 diagnosis diagnosis NOUN aji-51 525 33 . . PUNCT aji-51 526 1 this this DET aji-51 526 2 approach approach NOUN aji-51 526 3 is be AUX aji-51 526 4 designed design VERB aji-51 526 5 to to PART aji-51 526 6 attack attack VERB aji-51 526 7 different different ADJ aji-51 526 8 genetic genetic ADJ aji-51 526 9 targets target NOUN aji-51 526 10 and and CCONJ aji-51 526 11 the the DET aji-51 526 12 aspects aspect NOUN aji-51 526 13 of of ADP aji-51 526 14 dna dna NOUN aji-51 526 15 transcription transcription NOUN aji-51 526 16 of of ADP aji-51 526 17 rapidly rapidly ADV aji-51 526 18 dividing divide VERB aji-51 526 19 cells cell NOUN aji-51 526 20 [ [ X aji-51 526 21 291 291 NUM aji-51 526 22 - - SYM aji-51 526 23 293 293 NUM aji-51 526 24 ] ] PUNCT aji-51 526 25 . . PUNCT aji-51 527 1 a a DET aji-51 527 2 more more ADV aji-51 527 3 contemporary contemporary ADJ aji-51 527 4 way way NOUN aji-51 527 5 for for ADP aji-51 527 6 using use VERB aji-51 527 7 cytotoxic cytotoxic ADJ aji-51 527 8 agents agent NOUN aji-51 527 9 is be AUX aji-51 527 10 to to PART aji-51 527 11 target target VERB aji-51 527 12 them they PRON aji-51 527 13 so so SCONJ aji-51 527 14 that that SCONJ aji-51 527 15 the the DET aji-51 527 16 agents agent NOUN aji-51 527 17 affect affect VERB aji-51 527 18 biochemical biochemical ADJ aji-51 527 19 factors factor NOUN aji-51 527 20 or or CCONJ aji-51 527 21 cellular cellular ADJ aji-51 527 22 pathways pathway NOUN aji-51 527 23 that that PRON aji-51 527 24 are be AUX aji-51 527 25 unique unique ADJ aji-51 527 26 to to ADP aji-51 527 27 the the DET aji-51 527 28 malignant malignant ADJ aji-51 527 29 cells cell NOUN aji-51 527 30 or or CCONJ aji-51 527 31 characteristic characteristic NOUN aji-51 527 32 of of ADP aji-51 527 33 tumors tumor NOUN aji-51 527 34 based base VERB aji-51 527 35 upon upon SCONJ aji-51 527 36 genetic genetic ADJ aji-51 527 37 studies study NOUN aji-51 527 38 . . PUNCT aji-51 528 1 cytotoxic cytotoxic ADJ aji-51 528 2 chemotherapy chemotherapy NOUN aji-51 528 3 can can AUX aji-51 528 4 be be AUX aji-51 528 5 very very ADV aji-51 528 6 good good ADJ aji-51 528 7 at at ADP aji-51 528 8 killing kill VERB aji-51 528 9 rapidly rapidly ADV aji-51 528 10 dividing divide VERB aji-51 528 11 cells cell NOUN aji-51 528 12 , , PUNCT aji-51 528 13 such such ADJ aji-51 528 14 as as ADP aji-51 528 15 those those PRON aji-51 528 16 found find VERB aji-51 528 17 in in ADP aji-51 528 18 a a DET aji-51 528 19 growing grow VERB aji-51 528 20 tumor tumor NOUN aji-51 528 21 , , PUNCT aji-51 528 22 but but CCONJ aji-51 528 23 are be AUX aji-51 528 24 not not PART aji-51 528 25 good good ADJ aji-51 528 26 at at ADP aji-51 528 27 killing kill VERB aji-51 528 28 the the DET aji-51 528 29 slow slow ADV aji-51 528 30 - - PUNCT aji-51 528 31 growing grow VERB aji-51 528 32 cancer cancer NOUN aji-51 528 33 stem stem NOUN aji-51 528 34 cells cell NOUN aji-51 528 35 that that PRON aji-51 528 36 are be AUX aji-51 528 37 at at ADP aji-51 528 38 the the DET aji-51 528 39 root root NOUN aji-51 528 40 of of ADP aji-51 528 41 the the DET aji-51 528 42 problem problem NOUN aji-51 528 43 . . PUNCT aji-51 529 1 this this PRON aji-51 529 2 leads lead VERB aji-51 529 3 to to ADP aji-51 529 4 the the DET aji-51 529 5 observed observe VERB aji-51 529 6 high high ADJ aji-51 529 7 risk risk NOUN aji-51 529 8 for for ADP aji-51 529 9 recurrence recurrence NOUN aji-51 529 10 and and CCONJ aji-51 529 11 to to ADP aji-51 529 12 eventual eventual ADJ aji-51 529 13 multidrug multidrug NOUN aji-51 529 14 resistance resistance NOUN aji-51 529 15 [ [ X aji-51 529 16 294 294 NUM aji-51 529 17 ] ] PUNCT aji-51 529 18 . . PUNCT aji-51 530 1 there there PRON aji-51 530 2 is be VERB aji-51 530 3 a a DET aji-51 530 4 great great ADJ aji-51 530 5 deal deal NOUN aji-51 530 6 of of ADP aji-51 530 7 research research NOUN aji-51 530 8 currently currently ADV aji-51 530 9 engaged engage VERB aji-51 530 10 in in ADP aji-51 530 11 addressing address VERB aji-51 530 12 this this DET aji-51 530 13 problem problem NOUN aji-51 530 14 and and CCONJ aji-51 530 15 certain certain ADJ aji-51 530 16 drug drug NOUN aji-51 530 17 combinations combination NOUN aji-51 530 18 have have AUX aji-51 530 19 been be AUX aji-51 530 20 found find VERB aji-51 530 21 that that PRON aji-51 530 22 can can AUX aji-51 530 23 lessen lessen VERB aji-51 530 24 this this DET aji-51 530 25 issue issue NOUN aji-51 530 26 by by ADP aji-51 530 27 making make VERB aji-51 530 28 the the DET aji-51 530 29 cytotoxic cytotoxic ADJ aji-51 530 30 response response NOUN aji-51 530 31 more more ADV aji-51 530 32 effective effective ADJ aji-51 530 33 [ [ X aji-51 530 34 295 295 NUM aji-51 530 35 ] ] PUNCT aji-51 530 36 . . PUNCT aji-51 531 1 at at ADP aji-51 531 2 this this DET aji-51 531 3 point point NOUN aji-51 531 4 , , PUNCT aji-51 531 5 we we PRON aji-51 531 6 know know VERB aji-51 531 7 that that SCONJ aji-51 531 8 p p NOUN aji-51 531 9 - - PUNCT aji-51 531 10 glycoprotein glycoprotein NOUN aji-51 531 11 ( ( PUNCT aji-51 531 12 also also ADV aji-51 531 13 known know VERB aji-51 531 14 as as ADP aji-51 531 15 multidrug multidrug NOUN aji-51 531 16 resistance resistance NOUN aji-51 531 17 protein protein NOUN aji-51 531 18 1 1 NUM aji-51 531 19 ( ( PUNCT aji-51 531 20 mdr1 mdr1 PROPN aji-51 531 21 ) ) PUNCT aji-51 531 22 or or CCONJ aji-51 531 23 atp atp NOUN aji-51 531 24 - - PUNCT aji-51 531 25 binding bind VERB aji-51 531 26 cassette cassette NOUN aji-51 531 27 sub sub NOUN aji-51 531 28 - - ADJ aji-51 531 29 family family ADJ aji-51 531 30 b b PROPN aji-51 531 31 member member NOUN aji-51 531 32 1 1 NUM aji-51 531 33 ( ( PUNCT aji-51 531 34 abcb1 abcb1 NOUN aji-51 531 35 ) ) PUNCT aji-51 531 36 ) ) PUNCT aji-51 531 37 plays play VERB aji-51 531 38 a a DET aji-51 531 39 crucial crucial ADJ aji-51 531 40 role role NOUN aji-51 531 41 in in ADP aji-51 531 42 determining determine VERB aji-51 531 43 the the DET aji-51 531 44 neutralizing neutralizing ADJ aji-51 531 45 response response NOUN aji-51 531 46 against against ADP aji-51 531 47 chemotherapy chemotherapy NOUN aji-51 531 48 . . PUNCT aji-51 532 1 pglycoprotein pglycoprotein ADV aji-51 532 2 ( ( PUNCT aji-51 532 3 p p NOUN aji-51 532 4 - - PUNCT aji-51 532 5 gp gp NOUN aji-51 532 6 ) ) PUNCT aji-51 532 7 acts act VERB aji-51 532 8 as as ADP aji-51 532 9 an an DET aji-51 532 10 atp atp NOUN aji-51 532 11 - - PUNCT aji-51 532 12 dependent dependent ADJ aji-51 532 13 pump pump NOUN aji-51 532 14 that that PRON aji-51 532 15 pumps pump VERB aji-51 532 16 out out ADP aji-51 532 17 small small ADJ aji-51 532 18 molecules molecule NOUN aji-51 532 19 from from ADP aji-51 532 20 cells cell NOUN aji-51 532 21 , , PUNCT aji-51 532 22 including include VERB aji-51 532 23 chemotherapeutic chemotherapeutic ADJ aji-51 532 24 agents agent NOUN aji-51 532 25 , , PUNCT aji-51 532 26 before before SCONJ aji-51 532 27 they they PRON aji-51 532 28 can can AUX aji-51 532 29 exert exert VERB aji-51 532 30 their their PRON aji-51 532 31 cytotoxic cytotoxic ADJ aji-51 532 32 effects effect NOUN aji-51 532 33 . . PUNCT aji-51 533 1 research research NOUN aji-51 533 2 demonstrates demonstrate VERB aji-51 533 3 that that SCONJ aji-51 533 4 p p NOUN aji-51 533 5 - - PUNCT aji-51 533 6 glycoprotein glycoprotein NOUN aji-51 533 7 expression expression NOUN aji-51 533 8 levels level NOUN aji-51 533 9 correlate correlate VERB aji-51 533 10 inversely inversely ADV aji-51 533 11 with with ADP aji-51 533 12 drug drug NOUN aji-51 533 13 efficacy efficacy NOUN aji-51 533 14 , , PUNCT aji-51 533 15 which which PRON aji-51 533 16 suggests suggest VERB aji-51 533 17 the the DET aji-51 533 18 rationale rationale NOUN aji-51 533 19 for for ADP aji-51 533 20 developing develop VERB aji-51 533 21 pglycoprotein pglycoprotein ADJ aji-51 533 22 inhibitors inhibitor NOUN aji-51 533 23 for for ADP aji-51 533 24 treatment treatment NOUN aji-51 533 25 against against ADP aji-51 533 26 cancer cancer NOUN aji-51 533 27 [ [ X aji-51 533 28 296 296 NUM aji-51 533 29 ] ] PUNCT aji-51 533 30 . . PUNCT aji-51 534 1 while while SCONJ aji-51 534 2 new new ADJ aji-51 534 3 agents agent NOUN aji-51 534 4 are be AUX aji-51 534 5 being be AUX aji-51 534 6 developed develop VERB aji-51 534 7 and and CCONJ aji-51 534 8 going go VERB aji-51 534 9 through through ADP aji-51 534 10 drug drug NOUN aji-51 534 11 trials trial NOUN aji-51 534 12 , , PUNCT aji-51 534 13 some some DET aji-51 534 14 currently currently ADV aji-51 534 15 available available ADJ aji-51 534 16 pharmaceuticals pharmaceutical NOUN aji-51 534 17 are be AUX aji-51 534 18 helpful helpful ADJ aji-51 534 19 against against ADP aji-51 534 20 multi multi ADJ aji-51 534 21 - - ADJ aji-51 534 22 drug drug ADJ aji-51 534 23 resistance resistance NOUN aji-51 534 24 . . PUNCT aji-51 535 1 verapamil verapamil NOUN aji-51 535 2 is be AUX aji-51 535 3 an an DET aji-51 535 4 ltype ltype NOUN aji-51 535 5 calcium calcium NOUN aji-51 535 6 channel channel NOUN aji-51 535 7 blocker blocker NOUN aji-51 535 8 with with ADP aji-51 535 9 antiarrhythmic antiarrhythmic ADJ aji-51 535 10 , , PUNCT aji-51 535 11 antianginal antianginal ADJ aji-51 535 12 , , PUNCT aji-51 535 13 and and CCONJ aji-51 535 14 antihypertensive antihypertensive ADJ aji-51 535 15 activity activity NOUN aji-51 535 16 , , PUNCT aji-51 535 17 but but CCONJ aji-51 535 18 is be AUX aji-51 535 19 also also ADV aji-51 535 20 a a DET aji-51 535 21 p p NOUN aji-51 535 22 - - PUNCT aji-51 535 23 gp gp NOUN aji-51 535 24 inhibitor inhibitor NOUN aji-51 535 25 . . PUNCT aji-51 536 1 unfortunately unfortunately ADV aji-51 536 2 , , PUNCT aji-51 536 3 the the DET aji-51 536 4 dose dose NOUN aji-51 536 5 required require VERB aji-51 536 6 to to PART aji-51 536 7 achieve achieve VERB aji-51 536 8 this this DET aji-51 536 9 effect effect NOUN aji-51 536 10 can can AUX aji-51 536 11 cause cause VERB aji-51 536 12 significant significant ADJ aji-51 536 13 hypotension hypotension NOUN aji-51 536 14 thus thus ADV aji-51 536 15 limiting limit VERB aji-51 536 16 its its PRON aji-51 536 17 usefulness usefulness NOUN aji-51 536 18 [ [ X aji-51 536 19 297 297 NUM aji-51 536 20 ] ] PUNCT aji-51 536 21 . . PUNCT aji-51 537 1 other other ADJ aji-51 537 2 agents agent NOUN aji-51 537 3 that that PRON aji-51 537 4 may may AUX aji-51 537 5 be be AUX aji-51 537 6 helpful helpful ADJ aji-51 537 7 are be AUX aji-51 537 8 to to PART aji-51 537 9 be be AUX aji-51 537 10 found find VERB aji-51 537 11 within within ADP aji-51 537 12 the the DET aji-51 537 13 class class NOUN aji-51 537 14 of of ADP aji-51 537 15 drugs drug NOUN aji-51 537 16 known know VERB aji-51 537 17 as as ADP aji-51 537 18 proton proton NOUN aji-51 537 19 pump pump NOUN aji-51 537 20 inhibitors inhibitor NOUN aji-51 537 21 ( ( PUNCT aji-51 537 22 ppis ppi VERB aji-51 537 23 ) ) PUNCT aji-51 538 1 [ [ X aji-51 538 2 298 298 NUM aji-51 538 3 ] ] PUNCT aji-51 538 4 . . PUNCT aji-51 539 1 proton proton NOUN aji-51 539 2 pump pump NOUN aji-51 539 3 inhibitors inhibitor NOUN aji-51 539 4 ( ( PUNCT aji-51 539 5 ppis ppis NOUN aji-51 539 6 ) ) PUNCT aji-51 539 7 given give VERB aji-51 539 8 before before SCONJ aji-51 539 9 the the DET aji-51 539 10 chemotherapy chemotherapy NOUN aji-51 539 11 have have AUX aji-51 539 12 been be AUX aji-51 539 13 shown show VERB aji-51 539 14 to to PART aji-51 539 15 inhibit inhibit VERB aji-51 539 16 mrna mrna PROPN aji-51 539 17 levels level NOUN aji-51 539 18 of of ADP aji-51 539 19 vacuolar vacuolar ADJ aji-51 539 20 - - PUNCT aji-51 539 21 type type NOUN aji-51 539 22 atpase atpase NOUN aji-51 539 23 ( ( PUNCT aji-51 539 24 v v NOUN aji-51 539 25 - - PUNCT aji-51 539 26 atpases atpase NOUN aji-51 539 27 ) ) PUNCT aji-51 539 28 , , PUNCT aji-51 539 29 multidrug multidrug VERB aji-51 539 30 resistance resistance NOUN aji-51 539 31 mutation mutation NOUN aji-51 539 32 1 1 NUM aji-51 539 33 ( ( PUNCT aji-51 539 34 mdr1 mdr1 PROPN aji-51 539 35 ) ) PUNCT aji-51 539 36 , , PUNCT aji-51 539 37 multidrug multidrug VERB aji-51 539 38 resistance resistance NOUN aji-51 539 39 protein protein NOUN aji-51 539 40 1 1 NUM aji-51 539 41 ( ( PUNCT aji-51 539 42 mrp1 mrp1 PROPN aji-51 539 43 ) ) PUNCT aji-51 539 44 , , PUNCT aji-51 539 45 phosphatidylinositol phosphatidylinositol NOUN aji-51 539 46 3 3 NUM aji-51 539 47 - - PUNCT aji-51 539 48 kinases kinase NOUN aji-51 539 49 ( ( PUNCT aji-51 539 50 pi3k pi3k PROPN aji-51 539 51 ) ) PUNCT aji-51 539 52 , , PUNCT aji-51 539 53 akt akt PROPN aji-51 539 54 , , PUNCT aji-51 539 55 mtor mtor PROPN aji-51 539 56 , , PUNCT aji-51 539 57 and and CCONJ aji-51 539 58 hif-1α hif-1α NOUN aji-51 539 59 . . PUNCT aji-51 540 1 ppis ppis PROPN aji-51 540 2 inhibited inhibit VERB aji-51 540 3 v v NOUN aji-51 540 4 - - PUNCT aji-51 540 5 atpases atpase NOUN aji-51 540 6 and and CCONJ aji-51 540 7 down down ADV aji-51 540 8 - - PUNCT aji-51 540 9 regulated regulate VERB aji-51 540 10 the the DET aji-51 540 11 expressions expression NOUN aji-51 540 12 of of ADP aji-51 540 13 p p NOUN aji-51 540 14 - - PUNCT aji-51 540 15 gp gp NOUN aji-51 540 16 and and CCONJ aji-51 540 17 mrp1 mrp1 NOUN aji-51 540 18 in in ADP aji-51 540 19 a a DET aji-51 540 20 dose dose NOUN aji-51 540 21 - - PUNCT aji-51 540 22 dependent dependent ADJ aji-51 540 23 manner manner NOUN aji-51 540 24 both both CCONJ aji-51 540 25 in in ADP aji-51 540 26 vitro vitro X aji-51 540 27 and and CCONJ aji-51 540 28 in in ADP aji-51 540 29 vivo vivo NOUN aji-51 540 30 [ [ X aji-51 540 31 299 299 NUM aji-51 540 32 ] ] PUNCT aji-51 540 33 . . PUNCT aji-51 541 1 there there PRON aji-51 541 2 are be VERB aji-51 541 3 also also ADV aji-51 541 4 low low ADJ aji-51 541 5 concentration concentration NOUN aji-51 541 6 natural natural ADJ aji-51 541 7 agents agent NOUN aji-51 541 8 that that PRON aji-51 541 9 are be AUX aji-51 541 10 cytotoxic cytotoxic ADJ aji-51 541 11 to to ADP aji-51 541 12 cancer cancer NOUN aji-51 541 13 cells cell NOUN aji-51 541 14 that that PRON aji-51 541 15 may may AUX aji-51 541 16 be be AUX aji-51 541 17 used use VERB aji-51 541 18 with with ADP aji-51 541 19 low low ADJ aji-51 541 20 doses dose NOUN aji-51 541 21 of of ADP aji-51 541 22 cytotoxic cytotoxic ADJ aji-51 541 23 chemotherapy chemotherapy NOUN aji-51 541 24 to to PART aji-51 541 25 reduce reduce VERB aji-51 541 26 side side NOUN aji-51 541 27 effects effect NOUN aji-51 541 28 and and CCONJ aji-51 541 29 improve improve VERB aji-51 541 30 the the DET aji-51 541 31 quality quality NOUN aji-51 541 32 of of ADP aji-51 541 33 life life NOUN aji-51 541 34 . . PUNCT aji-51 542 1 in in ADP aji-51 542 2 use use NOUN aji-51 542 3 for for ADP aji-51 542 4 a a DET aji-51 542 5 100 100 NUM aji-51 542 6 years year NOUN aji-51 542 7 , , PUNCT aji-51 542 8 research research NOUN aji-51 542 9 has have AUX aji-51 542 10 shown show VERB aji-51 542 11 that that PRON aji-51 542 12 viscum viscum ADJ aji-51 542 13 album album NOUN aji-51 542 14 ( ( PUNCT aji-51 542 15 mistletoe mistletoe NOUN aji-51 542 16 ) ) PUNCT aji-51 542 17 extracts extract NOUN aji-51 542 18 ( ( PUNCT aji-51 542 19 vae vae NOUN aji-51 542 20 ) ) PUNCT aji-51 542 21 have have VERB aji-51 542 22 a a DET aji-51 542 23 significant significant ADJ aji-51 542 24 positive positive ADJ aji-51 542 25 impact impact NOUN aji-51 542 26 on on ADP aji-51 542 27 the the DET aji-51 542 28 quality quality NOUN aji-51 542 29 of of ADP aji-51 542 30 life life NOUN aji-51 542 31 and and CCONJ aji-51 542 32 the the DET aji-51 542 33 reduction reduction NOUN aji-51 542 34 of of ADP aji-51 542 35 the the DET aji-51 542 36 side side NOUN aji-51 542 37 effects effect NOUN aji-51 542 38 from from ADP aji-51 542 39 conventional conventional ADJ aji-51 542 40 therapies therapy NOUN aji-51 542 41 ( ( PUNCT aji-51 542 42 chemotherapy chemotherapy NOUN aji-51 542 43 , , PUNCT aji-51 542 44 radiation radiation NOUN aji-51 542 45 ) ) PUNCT aji-51 542 46 in in ADP aji-51 542 47 experimental experimental ADJ aji-51 542 48 trials trial NOUN aji-51 542 49 as as ADV aji-51 542 50 well well ADV aji-51 542 51 as as ADP aji-51 542 52 in in ADP aji-51 542 53 routine routine ADJ aji-51 542 54 daily daily ADJ aji-51 542 55 application application NOUN aji-51 543 1 [ [ X aji-51 543 2 300,301 300,301 NUM aji-51 543 3 ] ] PUNCT aji-51 543 4 . . PUNCT aji-51 544 1 furthermore furthermore ADV aji-51 544 2 , , PUNCT aji-51 544 3 pooled pool VERB aji-51 544 4 data datum NOUN aji-51 544 5 from from ADP aji-51 544 6 multiple multiple ADJ aji-51 544 7 clinical clinical ADJ aji-51 544 8 studies study NOUN aji-51 544 9 demonstrate demonstrate VERB aji-51 544 10 that that SCONJ aji-51 544 11 adjuvant adjuvant ADJ aji-51 544 12 treatment treatment NOUN aji-51 544 13 of of ADP aji-51 544 14 cancer cancer NOUN aji-51 544 15 patients patient NOUN aji-51 544 16 with with ADP aji-51 544 17 the the DET aji-51 544 18 vae vae PROPN aji-51 544 19 is be AUX aji-51 544 20 associated associate VERB aji-51 544 21 with with ADP aji-51 544 22 better well ADJ aji-51 544 23 overall overall ADJ aji-51 544 24 survival survival NOUN aji-51 545 1 [ [ X aji-51 545 2 302 302 NUM aji-51 545 3 ] ] PUNCT aji-51 545 4 . . PUNCT aji-51 546 1 in in ADP aji-51 546 2 some some DET aji-51 546 3 cases case NOUN aji-51 546 4 not not PART aji-51 546 5 only only ADV aji-51 546 6 is be AUX aji-51 546 7 vae vae PROPN aji-51 546 8 effective effective ADJ aji-51 546 9 as as ADP aji-51 546 10 an an DET aji-51 546 11 additional additional ADJ aji-51 546 12 cytotoxic cytotoxic ADJ aji-51 546 13 , , PUNCT aji-51 546 14 anti anti ADJ aji-51 546 15 - - ADJ aji-51 546 16 cancer cancer ADJ aji-51 546 17 agent agent NOUN aji-51 546 18 , , PUNCT aji-51 546 19 but but CCONJ aji-51 546 20 it it PRON aji-51 546 21 may may AUX aji-51 546 22 succeed succeed VERB aji-51 546 23 when when SCONJ aji-51 546 24 more more ADJ aji-51 546 25 conventional conventional ADJ aji-51 546 26 chemotherapy chemotherapy NOUN aji-51 546 27 and and CCONJ aji-51 546 28 immunotherapy immunotherapy NOUN aji-51 546 29 have have AUX aji-51 546 30 failed fail VERB aji-51 546 31 [ [ PUNCT aji-51 546 32 303 303 NUM aji-51 546 33 - - SYM aji-51 546 34 310 310 NUM aji-51 546 35 ] ] PUNCT aji-51 546 36 . . PUNCT aji-51 547 1 another another DET aji-51 547 2 important important ADJ aji-51 547 3 benefit benefit NOUN aji-51 547 4 of of ADP aji-51 547 5 vae vae PROPN aji-51 547 6 is be AUX aji-51 547 7 its its PRON aji-51 547 8 ability ability NOUN aji-51 547 9 to to PART aji-51 547 10 overcome overcome VERB aji-51 547 11 some some DET aji-51 547 12 scenarios scenario NOUN aji-51 547 13 of of ADP aji-51 547 14 chemoresistance chemoresistance NOUN aji-51 547 15 . . PUNCT aji-51 548 1 axl axl PROPN aji-51 548 2 protein protein NOUN aji-51 548 3 is be AUX aji-51 548 4 a a DET aji-51 548 5 receptor receptor NOUN aji-51 548 6 for for ADP aji-51 548 7 tyrosine tyrosine NOUN aji-51 548 8 kinases kinase NOUN aji-51 548 9 . . PUNCT aji-51 549 1 some some DET aji-51 549 2 reports report NOUN aji-51 549 3 showed show VERB aji-51 549 4 that that SCONJ aji-51 549 5 targeting target VERB aji-51 549 6 anexelekto anexelekto PROPN aji-51 549 7 ( ( PUNCT aji-51 549 8 axl axl PROPN aji-51 549 9 ) ) PUNCT aji-51 549 10 enhanced enhance VERB aji-51 549 11 egfr egfr ADJ aji-51 549 12 tki tki PROPN aji-51 549 13 response response NOUN aji-51 549 14 in in ADP aji-51 549 15 selected select VERB aji-51 549 16 egfr egfr ADJ aji-51 549 17 wild wild ADJ aji-51 549 18 type type NOUN aji-51 549 19 ( ( PUNCT aji-51 549 20 wt wt NOUN aji-51 549 21 ) ) PUNCT aji-51 549 22 nsclc nsclc NOUN aji-51 549 23 patients patient NOUN aji-51 549 24 . . PUNCT aji-51 550 1 studies study NOUN aji-51 550 2 have have AUX aji-51 550 3 found find VERB aji-51 550 4 that that SCONJ aji-51 550 5 when when SCONJ aji-51 550 6 targeting target VERB aji-51 550 7 axl axl NOUN aji-51 550 8 in in ADP aji-51 550 9 egfr egfr NOUN aji-51 550 10 wt wt NOUN aji-51 550 11 nsclc nsclc NOUN aji-51 550 12 cells cell NOUN aji-51 550 13 , , PUNCT aji-51 550 14 the the DET aji-51 550 15 cells cell NOUN aji-51 550 16 showed show VERB aji-51 550 17 a a DET aji-51 550 18 more more ADV aji-51 550 19 sensitive sensitive ADJ aji-51 550 20 response response NOUN aji-51 550 21 to to ADP aji-51 550 22 erlotinib erlotinib NOUN aji-51 550 23 than than ADP aji-51 550 24 those those PRON aji-51 550 25 that that PRON aji-51 550 26 overexpressed overexpresse VERB aji-51 550 27 axl axl PROPN aji-51 550 28 thereby thereby ADV aji-51 550 29 overcoming overcome VERB aji-51 550 30 chemoresistance chemoresistance NOUN aji-51 550 31 [ [ X aji-51 550 32 311,312 311,312 NUM aji-51 550 33 ] ] PUNCT aji-51 550 34 . . PUNCT aji-51 551 1 chemoresistance chemoresistance NOUN aji-51 551 2 is be AUX aji-51 551 3 a a DET aji-51 551 4 big big ADJ aji-51 551 5 problem problem NOUN aji-51 551 6 with with ADP aji-51 551 7 chemotherapy chemotherapy NOUN aji-51 551 8 as as SCONJ aji-51 551 9 the the DET aji-51 551 10 agents agent NOUN aji-51 551 11 seem seem VERB aji-51 551 12 to to PART aji-51 551 13 have have VERB aji-51 551 14 an an DET aji-51 551 15 almost almost ADV aji-51 551 16 evolutionary evolutionary ADJ aji-51 551 17 effect effect NOUN aji-51 551 18 on on ADP aji-51 551 19 tumors tumor NOUN aji-51 551 20 , , PUNCT aji-51 551 21 selecting select VERB aji-51 551 22 for for ADP aji-51 551 23 the the DET aji-51 551 24 most most ADV aji-51 551 25 sensitive sensitive ADJ aji-51 551 26 cancer cancer NOUN aji-51 551 27 cells cell NOUN aji-51 551 28 and and CCONJ aji-51 551 29 leaving leave VERB aji-51 551 30 the the DET aji-51 551 31 rest rest NOUN aji-51 551 32 , , PUNCT aji-51 551 33 including include VERB aji-51 551 34 the the DET aji-51 551 35 cscs cscs NOUN aji-51 551 36 untouched untouche VERB aji-51 551 37 , , PUNCT aji-51 551 38 or or CCONJ aji-51 551 39 more more ADV aji-51 551 40 mutated mutate VERB aji-51 551 41 , , PUNCT aji-51 551 42 therein therein ADV aji-51 551 43 setting set VERB aji-51 551 44 the the DET aji-51 551 45 stage stage NOUN aji-51 551 46 for for ADP aji-51 551 47 a a DET aji-51 551 48 recurrence recurrence NOUN aji-51 551 49 . . PUNCT aji-51 552 1 radiation radiation NOUN aji-51 552 2 therapy therapy NOUN aji-51 552 3 has have VERB aji-51 552 4 similar similar ADJ aji-51 552 5 drawbacks drawback NOUN aji-51 552 6 . . PUNCT aji-51 553 1 doxycycline doxycycline NOUN aji-51 553 2 is be AUX aji-51 553 3 helpful helpful ADJ aji-51 553 4 with with ADP aji-51 553 5 both both DET aji-51 553 6 treatment treatment NOUN aji-51 553 7 modalities modality NOUN aji-51 553 8 to to PART aji-51 553 9 reduce reduce VERB aji-51 553 10 chemoresistance chemoresistance NOUN aji-51 553 11 , , PUNCT aji-51 553 12 largely largely ADV aji-51 553 13 through through ADP aji-51 553 14 interrupting interrupt VERB aji-51 553 15 oxidative oxidative ADJ aji-51 553 16 phosphorylation phosphorylation NOUN aji-51 553 17 by by ADP aji-51 553 18 inhibiting inhibit VERB aji-51 553 19 moieties moiety NOUN aji-51 553 20 of of ADP aji-51 553 21 the the DET aji-51 553 22 electron electron NOUN aji-51 553 23 transport transport NOUN aji-51 553 24 chain chain NOUN aji-51 553 25 [ [ X aji-51 553 26 313,314 313,314 NUM aji-51 553 27 ] ] PUNCT aji-51 553 28 . . PUNCT aji-51 554 1 this this PRON aji-51 554 2 brings bring VERB aji-51 554 3 us we PRON aji-51 554 4 back back ADV aji-51 554 5 to to ADP aji-51 554 6 the the DET aji-51 554 7 necessity necessity NOUN aji-51 554 8 for for ADP aji-51 554 9 targeting target VERB aji-51 554 10 cscs cscs PROPN aji-51 554 11 to to PART aji-51 554 12 help help VERB aji-51 554 13 overcome overcome VERB aji-51 554 14 chemoresistance chemoresistance NOUN aji-51 554 15 [ [ X aji-51 554 16 315 315 NUM aji-51 554 17 - - SYM aji-51 554 18 319 319 NUM aji-51 554 19 ] ] PUNCT aji-51 554 20 . . PUNCT aji-51 555 1 another another DET aji-51 555 2 cytotoxic cytotoxic ADJ aji-51 555 3 strategy strategy NOUN aji-51 555 4 that that PRON aji-51 555 5 generates generate VERB aji-51 555 6 much much ADV aji-51 555 7 less less ADJ aji-51 555 8 chemoresistance chemoresistance NOUN aji-51 555 9 because because SCONJ aji-51 555 10 it it PRON aji-51 555 11 also also ADV aji-51 555 12 targets target VERB aji-51 555 13 cscs cscs PROPN aji-51 555 14 is be AUX aji-51 555 15 the the DET aji-51 555 16 use use NOUN aji-51 555 17 of of ADP aji-51 555 18 vitamin vitamin NOUN aji-51 555 19 c c NOUN aji-51 555 20 ( ( PUNCT aji-51 555 21 vc vc NOUN aji-51 555 22 ) ) PUNCT aji-51 555 23 and and CCONJ aji-51 555 24 vitamin vitamin PROPN aji-51 555 25 k(3 k(3 PROPN aji-51 555 26 ) ) PUNCT aji-51 555 27 ( ( PUNCT aji-51 555 28 vk(3 vk(3 PROPN aji-51 555 29 ) ) PUNCT aji-51 555 30 . . PUNCT aji-51 556 1 administered administer VERB aji-51 556 2 intravenously intravenously ADV aji-51 556 3 in in ADP aji-51 556 4 a a DET aji-51 556 5 vc vc NOUN aji-51 556 6 : : PUNCT aji-51 556 7 vk(3 vk(3 NOUN aji-51 556 8 ) ) PUNCT aji-51 556 9 ratio ratio NOUN aji-51 556 10 of of ADP aji-51 556 11 100:1 100:1 NUM aji-51 556 12 exhibit exhibit VERB aji-51 556 13 synergistic synergistic ADJ aji-51 556 14 antitumor antitumor NOUN aji-51 556 15 activity activity NOUN aji-51 556 16 and and CCONJ aji-51 556 17 preferentially preferentially ADV aji-51 556 18 kills kill VERB aji-51 556 19 tumor tumor PROPN aji-51 556 20 stoff stoff PROPN aji-51 556 21 ; ; PUNCT aji-51 556 22 aji aji PROPN aji-51 556 23 , , PUNCT aji-51 556 24 5(1 5(1 NUM aji-51 556 25 ): ): PUNCT aji-51 556 26 1 1 NUM aji-51 556 27 - - SYM aji-51 556 28 39 39 NUM aji-51 556 29 , , PUNCT aji-51 556 30 2022 2022 NUM aji-51 556 31 ; ; PUNCT aji-51 556 32 article article NOUN aji-51 556 33 no.aji.77967 no.aji.77967 PROPN aji-51 556 34 16 16 NUM aji-51 556 35 cells cell NOUN aji-51 556 36 without without ADP aji-51 556 37 harming harm VERB aji-51 556 38 normal normal ADJ aji-51 556 39 cells cell NOUN aji-51 556 40 [ [ X aji-51 556 41 320 320 NUM aji-51 556 42 ] ] PUNCT aji-51 556 43 . . PUNCT aji-51 557 1 this this DET aji-51 557 2 natural natural ADJ aji-51 557 3 vitamin vitamin NOUN aji-51 557 4 combination combination NOUN aji-51 557 5 accomplishes accomplish VERB aji-51 557 6 this this PRON aji-51 557 7 through through ADP aji-51 557 8 a a DET aji-51 557 9 process process NOUN aji-51 557 10 of of ADP aji-51 557 11 autoschizis autoschizi NOUN aji-51 557 12 , , PUNCT aji-51 557 13 a a DET aji-51 557 14 novel novel ADJ aji-51 557 15 type type NOUN aji-51 557 16 of of ADP aji-51 557 17 necrosis necrosis NOUN aji-51 557 18 characterized characterize VERB aji-51 557 19 by by ADP aji-51 557 20 exaggerated exaggerated ADJ aji-51 557 21 membrane membrane NOUN aji-51 557 22 damage damage NOUN aji-51 557 23 and and CCONJ aji-51 557 24 progressive progressive ADJ aji-51 557 25 loss loss NOUN aji-51 557 26 of of ADP aji-51 557 27 organelle organelle NOUN aji-51 557 28 - - PUNCT aji-51 557 29 free free ADJ aji-51 557 30 cytoplasm cytoplasm NOUN aji-51 557 31 through through ADP aji-51 557 32 a a DET aji-51 557 33 series series NOUN aji-51 557 34 of of ADP aji-51 557 35 selfexcisions selfexcision NOUN aji-51 557 36 [ [ X aji-51 557 37 321 321 NUM aji-51 557 38 ] ] PUNCT aji-51 557 39 . . PUNCT aji-51 558 1 this this DET aji-51 558 2 combination combination NOUN aji-51 558 3 also also ADV aji-51 558 4 attacks attack VERB aji-51 558 5 the the DET aji-51 558 6 dna dna NOUN aji-51 558 7 of of ADP aji-51 558 8 cancer cancer NOUN aji-51 558 9 cells cell NOUN aji-51 558 10 since since SCONJ aji-51 558 11 a a DET aji-51 558 12 deficiency deficiency NOUN aji-51 558 13 of of ADP aji-51 558 14 alkaline alkaline NOUN aji-51 558 15 and and CCONJ aji-51 558 16 acid acid NOUN aji-51 558 17 dnase dnase NOUN aji-51 558 18 is be AUX aji-51 558 19 a a DET aji-51 558 20 hallmark hallmark NOUN aji-51 558 21 in in ADP aji-51 558 22 all all DET aji-51 558 23 living live VERB aji-51 558 24 cancer cancer NOUN aji-51 558 25 cells cell NOUN aji-51 558 26 and and CCONJ aji-51 558 27 they they PRON aji-51 558 28 are be AUX aji-51 558 29 reactivated reactivate VERB aji-51 558 30 in in ADP aji-51 558 31 the the DET aji-51 558 32 early early ADJ aji-51 558 33 stages stage NOUN aji-51 558 34 of of ADP aji-51 558 35 cancer cancer NOUN aji-51 558 36 cell cell NOUN aji-51 558 37 death death NOUN aji-51 558 38 by by ADP aji-51 558 39 vitamin vitamin NOUN aji-51 558 40 c c NOUN aji-51 558 41 ( ( PUNCT aji-51 558 42 acid acid NOUN aji-51 558 43 dnase dnase NOUN aji-51 558 44 ) ) PUNCT aji-51 558 45 and and CCONJ aji-51 558 46 vitamin vitamin NOUN aji-51 558 47 k(3 k(3 PROPN aji-51 558 48 ) ) PUNCT aji-51 558 49 ( ( PUNCT aji-51 558 50 alkaline alkaline NOUN aji-51 558 51 dnase dnase NOUN aji-51 558 52 ) ) PUNCT aji-51 558 53 leading lead VERB aji-51 558 54 to to ADP aji-51 558 55 dna dna PROPN aji-51 558 56 fragmentation fragmentation NOUN aji-51 558 57 [ [ X aji-51 558 58 322 322 NUM aji-51 558 59 ] ] PUNCT aji-51 558 60 . . PUNCT aji-51 559 1 vitamin vitamin NOUN aji-51 559 2 c c NOUN aji-51 559 3 by by ADP aji-51 559 4 itself itself PRON aji-51 559 5 can can AUX aji-51 559 6 regulate regulate VERB aji-51 559 7 the the DET aji-51 559 8 proliferation proliferation NOUN aji-51 559 9 and and CCONJ aji-51 559 10 differentiation differentiation NOUN aji-51 559 11 of of ADP aji-51 559 12 cancer cancer NOUN aji-51 559 13 stem stem NOUN aji-51 559 14 cells cell NOUN aji-51 559 15 , , PUNCT aji-51 559 16 the the DET aji-51 559 17 amount amount NOUN aji-51 559 18 and and CCONJ aji-51 559 19 stability stability NOUN aji-51 559 20 of of ADP aji-51 559 21 collagen collagen NOUN aji-51 559 22 , , PUNCT aji-51 559 23 extracellular extracellular ADJ aji-51 559 24 matrix matrix NOUN aji-51 559 25 remodeling remodeling NOUN aji-51 559 26 , , PUNCT aji-51 559 27 anti anti ADJ aji-51 559 28 - - ADJ aji-51 559 29 cancer cancer ADJ aji-51 559 30 immunity immunity NOUN aji-51 559 31 , , PUNCT aji-51 559 32 and and CCONJ aji-51 559 33 hypoxia hypoxia NOUN aji-51 559 34 in in ADP aji-51 559 35 the the DET aji-51 559 36 tumor tumor NOUN aji-51 559 37 microenvironment microenvironment NOUN aji-51 559 38 , , PUNCT aji-51 559 39 hence hence ADV aji-51 559 40 epigenetically epigenetically ADV aji-51 559 41 suppressing suppress VERB aji-51 559 42 the the DET aji-51 559 43 cscs cscs PROPN aji-51 559 44 and and CCONJ aji-51 559 45 downregulating downregulating NOUN aji-51 559 46 chemoresistance chemoresistance NOUN aji-51 560 1 [ [ X aji-51 560 2 323 323 NUM aji-51 560 3 - - SYM aji-51 560 4 326 326 NUM aji-51 560 5 ] ] PUNCT aji-51 560 6 . . PUNCT aji-51 561 1 when when SCONJ aji-51 561 2 combined combine VERB aji-51 561 3 with with ADP aji-51 561 4 doxycycline doxycycline NOUN aji-51 561 5 , , PUNCT aji-51 561 6 the the DET aji-51 561 7 effect effect NOUN aji-51 561 8 is be AUX aji-51 561 9 even even ADV aji-51 561 10 more more ADV aji-51 561 11 pronounced pronounced ADJ aji-51 561 12 [ [ X aji-51 561 13 327,328 327,328 NUM aji-51 561 14 ] ] PUNCT aji-51 561 15 . . PUNCT aji-51 562 1 2.7 2.7 NUM aji-51 562 2 supportive supportive ADJ aji-51 562 3 tactics tactic NOUN aji-51 562 4 there there PRON aji-51 562 5 are be VERB aji-51 562 6 other other ADJ aji-51 562 7 therapeutic therapeutic ADJ aji-51 562 8 tactics tactic NOUN aji-51 562 9 that that PRON aji-51 562 10 may may AUX aji-51 562 11 be be AUX aji-51 562 12 synergistic synergistic ADJ aji-51 562 13 , , PUNCT aji-51 562 14 but but CCONJ aji-51 562 15 they they PRON aji-51 562 16 are be AUX aji-51 562 17 not not PART aji-51 562 18 considered consider VERB aji-51 562 19 strategies strategy NOUN aji-51 562 20 unto unto ADP aji-51 562 21 themselves themselves PRON aji-51 562 22 because because SCONJ aji-51 562 23 their their PRON aji-51 562 24 anticancer anticancer NOUN aji-51 562 25 effects effect NOUN aji-51 562 26 are be AUX aji-51 562 27 less less ADV aji-51 562 28 reliable reliable ADJ aji-51 562 29 . . PUNCT aji-51 563 1 this this PRON aji-51 563 2 includes include VERB aji-51 563 3 energy energy NOUN aji-51 563 4 - - PUNCT aji-51 563 5 based base VERB aji-51 563 6 therapies therapy NOUN aji-51 563 7 such such ADJ aji-51 563 8 as as ADP aji-51 563 9 homeopathy homeopathy NOUN aji-51 563 10 and and CCONJ aji-51 563 11 acupuncture acupuncture NOUN aji-51 563 12 , , PUNCT aji-51 563 13 and and CCONJ aji-51 563 14 psychodynamic psychodynamic ADJ aji-51 563 15 tactics tactic NOUN aji-51 563 16 like like ADP aji-51 563 17 psychoneuroimmunology psychoneuroimmunology NOUN aji-51 563 18 , , PUNCT aji-51 563 19 visualization visualization NOUN aji-51 563 20 , , PUNCT aji-51 563 21 prayer prayer NOUN aji-51 563 22 , , PUNCT aji-51 563 23 and and CCONJ aji-51 563 24 meditation meditation NOUN aji-51 563 25 practices practice NOUN aji-51 563 26 . . PUNCT aji-51 564 1 other other ADJ aji-51 564 2 tactics tactic NOUN aji-51 564 3 employ employ VERB aji-51 564 4 the the DET aji-51 564 5 use use NOUN aji-51 564 6 of of ADP aji-51 564 7 oncolytic oncolytic ADJ aji-51 564 8 viruses virus NOUN aji-51 564 9 , , PUNCT aji-51 564 10 oxidative oxidative ADJ aji-51 564 11 therapies therapy NOUN aji-51 564 12 ( ( PUNCT aji-51 564 13 ozone ozone NOUN aji-51 564 14 ) ) PUNCT aji-51 564 15 , , PUNCT aji-51 564 16 traditional traditional ADJ aji-51 564 17 chinese chinese ADJ aji-51 564 18 medicine medicine NOUN aji-51 564 19 , , PUNCT aji-51 564 20 naturopathy naturopathy NOUN aji-51 564 21 , , PUNCT aji-51 564 22 ayurvedic ayurvedic ADJ aji-51 564 23 herbal herbal ADJ aji-51 564 24 medicines medicine NOUN aji-51 564 25 , , PUNCT aji-51 564 26 and and CCONJ aji-51 564 27 detoxification detoxification NOUN aji-51 564 28 protocols protocol NOUN aji-51 564 29 , , PUNCT aji-51 564 30 to to PART aji-51 564 31 name name VERB aji-51 564 32 but but CCONJ aji-51 564 33 a a DET aji-51 564 34 few few ADJ aji-51 564 35 . . PUNCT aji-51 565 1 there there PRON aji-51 565 2 is be VERB aji-51 565 3 no no DET aji-51 565 4 doubt doubt NOUN aji-51 565 5 that that SCONJ aji-51 565 6 some some PRON aji-51 565 7 of of ADP aji-51 565 8 them they PRON aji-51 565 9 can can AUX aji-51 565 10 be be AUX aji-51 565 11 extraordinarily extraordinarily ADV aji-51 565 12 beneficial beneficial ADJ aji-51 565 13 to to ADP aji-51 565 14 the the DET aji-51 565 15 patient patient NOUN aji-51 565 16 by by ADP aji-51 565 17 reducing reduce VERB aji-51 565 18 physical physical ADJ aji-51 565 19 symptoms symptom NOUN aji-51 565 20 , , PUNCT aji-51 565 21 psychological psychological ADJ aji-51 565 22 stress stress NOUN aji-51 565 23 and and CCONJ aji-51 565 24 by by ADP aji-51 565 25 engendering engender VERB aji-51 565 26 a a DET aji-51 565 27 feeling feeling NOUN aji-51 565 28 of of ADP aji-51 565 29 more more ADJ aji-51 565 30 selfcontrol selfcontrol NOUN aji-51 565 31 against against ADP aji-51 565 32 a a DET aji-51 565 33 disease disease NOUN aji-51 565 34 that that PRON aji-51 565 35 threatens threaten VERB aji-51 565 36 total total ADJ aji-51 565 37 chaos chaos NOUN aji-51 565 38 . . PUNCT aji-51 566 1 indeed indeed ADV aji-51 566 2 hundreds hundred NOUN aji-51 566 3 of of ADP aji-51 566 4 books book NOUN aji-51 566 5 and and CCONJ aji-51 566 6 articles article NOUN aji-51 566 7 have have AUX aji-51 566 8 been be AUX aji-51 566 9 scribed scribe VERB aji-51 566 10 as as ADP aji-51 566 11 to to ADP aji-51 566 12 their their PRON aji-51 566 13 use use NOUN aji-51 566 14 and and CCONJ aji-51 566 15 intermittent intermittent ADJ aji-51 566 16 efficacy efficacy NOUN aji-51 566 17 by by ADP aji-51 566 18 notable notable ADJ aji-51 566 19 physicians physician NOUN aji-51 566 20 and and CCONJ aji-51 566 21 practitioners practitioner NOUN aji-51 566 22 ; ; PUNCT aji-51 566 23 to to ADP aji-51 566 24 this this DET aji-51 566 25 day day NOUN aji-51 566 26 the the DET aji-51 566 27 well well ADV aji-51 566 28 - - PUNCT aji-51 566 29 documented document VERB aji-51 566 30 phenomena phenomenon NOUN aji-51 566 31 of of ADP aji-51 566 32 the the DET aji-51 566 33 spontaneous spontaneous ADJ aji-51 566 34 remission remission NOUN aji-51 566 35 of of ADP aji-51 566 36 cancer cancer NOUN aji-51 566 37 remains remain VERB aji-51 566 38 a a DET aji-51 566 39 medical medical ADJ aji-51 566 40 mystery mystery NOUN aji-51 566 41 . . PUNCT aji-51 567 1 early early ADV aji-51 567 2 in in ADP aji-51 567 3 my my PRON aji-51 567 4 career career NOUN aji-51 567 5 , , PUNCT aji-51 567 6 the the DET aji-51 567 7 immunotherapeutic immunotherapeutic ADJ aji-51 567 8 strategy strategy NOUN aji-51 567 9 that that PRON aji-51 567 10 i i PRON aji-51 567 11 employed employ VERB aji-51 567 12 against against ADP aji-51 567 13 cancer cancer NOUN aji-51 567 14 was be AUX aji-51 567 15 still still ADV aji-51 567 16 considered consider VERB aji-51 567 17 something something PRON aji-51 567 18 just just ADV aji-51 567 19 short short ADJ aji-51 567 20 of of ADP aji-51 567 21 quackery quackery NOUN aji-51 567 22 , , PUNCT aji-51 567 23 and and CCONJ aji-51 567 24 the the DET aji-51 567 25 clinical clinical ADJ aji-51 567 26 responses response NOUN aji-51 567 27 to to ADP aji-51 567 28 it it PRON aji-51 567 29 were be AUX aji-51 567 30 often often ADV aji-51 567 31 attributed attribute VERB aji-51 567 32 to to ADP aji-51 567 33 this this DET aji-51 567 34 phenomenon phenomenon NOUN aji-51 567 35 . . PUNCT aji-51 568 1 3 3 X aji-51 568 2 . . X aji-51 568 3 discussion discussion NOUN aji-51 568 4 an an DET aji-51 568 5 evidence evidence NOUN aji-51 568 6 - - PUNCT aji-51 568 7 based base VERB aji-51 568 8 medical medical ADJ aji-51 568 9 practice practice NOUN aji-51 568 10 is be AUX aji-51 568 11 established establish VERB aji-51 568 12 through through ADP aji-51 568 13 the the DET aji-51 568 14 application application NOUN aji-51 568 15 and and CCONJ aji-51 568 16 integration integration NOUN aji-51 568 17 of of ADP aji-51 568 18 the the DET aji-51 568 19 best good ADJ aji-51 568 20 clinical clinical ADJ aji-51 568 21 research research NOUN aji-51 568 22 available available ADJ aji-51 568 23 at at ADP aji-51 568 24 the the DET aji-51 568 25 time time NOUN aji-51 568 26 , , PUNCT aji-51 568 27 balanced balance VERB aji-51 568 28 with with ADP aji-51 568 29 the the DET aji-51 568 30 clinicians clinician NOUN aji-51 568 31 ’ ' PUNCT aji-51 568 32 expertise expertise NOUN aji-51 568 33 and and CCONJ aji-51 568 34 the the DET aji-51 568 35 patients patient NOUN aji-51 568 36 ’ ’ PART aji-51 568 37 life life NOUN aji-51 568 38 values value NOUN aji-51 568 39 and and CCONJ aji-51 568 40 beliefs belief NOUN aji-51 568 41 [ [ X aji-51 568 42 329 329 NUM aji-51 568 43 ] ] PUNCT aji-51 568 44 . . PUNCT aji-51 569 1 evidence evidence NOUN aji-51 569 2 - - PUNCT aji-51 569 3 based base VERB aji-51 569 4 medicine medicine NOUN aji-51 569 5 may may AUX aji-51 569 6 be be AUX aji-51 569 7 considered consider VERB aji-51 569 8 as as ADP aji-51 569 9 an an DET aji-51 569 10 interdisciplinary interdisciplinary ADJ aji-51 569 11 approach approach NOUN aji-51 569 12 itself itself PRON aji-51 569 13 , , PUNCT aji-51 569 14 which which PRON aji-51 569 15 uses use VERB aji-51 569 16 techniques technique NOUN aji-51 569 17 from from ADP aji-51 569 18 science science NOUN aji-51 569 19 , , PUNCT aji-51 569 20 engineering engineering NOUN aji-51 569 21 , , PUNCT aji-51 569 22 biostatistics biostatistic NOUN aji-51 569 23 , , PUNCT aji-51 569 24 and and CCONJ aji-51 569 25 epidemiology epidemiology NOUN aji-51 569 26 , , PUNCT aji-51 569 27 such such ADJ aji-51 569 28 as as ADP aji-51 569 29 meta meta ADJ aji-51 569 30 - - PUNCT aji-51 569 31 analysis analysis NOUN aji-51 569 32 , , PUNCT aji-51 569 33 decision decision NOUN aji-51 569 34 analysis analysis NOUN aji-51 569 35 , , PUNCT aji-51 569 36 riskbenefit riskbenefit NOUN aji-51 569 37 analysis analysis NOUN aji-51 569 38 , , PUNCT aji-51 569 39 verified verify VERB aji-51 569 40 case case NOUN aji-51 569 41 reports report VERB aji-51 569 42 , , PUNCT aji-51 569 43 and and CCONJ aji-51 569 44 randomized randomize VERB aji-51 569 45 controlled control VERB aji-51 569 46 trials trial NOUN aji-51 569 47 to to PART aji-51 569 48 deliver deliver VERB aji-51 569 49 “ " PUNCT aji-51 569 50 the the DET aji-51 569 51 right right ADJ aji-51 569 52 care care NOUN aji-51 569 53 at at ADP aji-51 569 54 the the DET aji-51 569 55 right right ADJ aji-51 569 56 time time NOUN aji-51 569 57 to to ADP aji-51 569 58 the the DET aji-51 569 59 right right ADJ aji-51 569 60 patient patient NOUN aji-51 569 61 ” " PUNCT aji-51 570 1 [ [ X aji-51 570 2 330 330 NUM aji-51 570 3 ] ] PUNCT aji-51 570 4 . . PUNCT aji-51 571 1 every every DET aji-51 571 2 time time NOUN aji-51 571 3 that that PRON aji-51 571 4 a a DET aji-51 571 5 physician physician NOUN aji-51 571 6 treats treat VERB aji-51 571 7 a a DET aji-51 571 8 patient patient NOUN aji-51 571 9 for for ADP aji-51 571 10 anything anything PRON aji-51 571 11 , , PUNCT aji-51 571 12 it it PRON aji-51 571 13 is be AUX aji-51 571 14 essentially essentially ADV aji-51 571 15 a a DET aji-51 571 16 clinical clinical ADJ aji-51 571 17 trial trial NOUN aji-51 571 18 with with ADP aji-51 571 19 an an DET aji-51 571 20 “ " PUNCT aji-51 571 21 n n CCONJ aji-51 571 22 ” " PUNCT aji-51 571 23 of of ADP aji-51 571 24 1 1 NUM aji-51 571 25 . . PUNCT aji-51 572 1 thus thus ADV aji-51 572 2 the the DET aji-51 572 3 practice practice NOUN aji-51 572 4 of of ADP aji-51 572 5 evidence evidence NOUN aji-51 572 6 - - PUNCT aji-51 572 7 based base VERB aji-51 572 8 medicine medicine NOUN aji-51 572 9 tacitly tacitly ADV aji-51 572 10 dictates dictate VERB aji-51 572 11 that that SCONJ aji-51 572 12 physicians physician NOUN aji-51 572 13 should should AUX aji-51 572 14 make make VERB aji-51 572 15 " " PUNCT aji-51 572 16 conscientious conscientious ADJ aji-51 572 17 , , PUNCT aji-51 572 18 explicit explicit ADJ aji-51 572 19 , , PUNCT aji-51 572 20 and and CCONJ aji-51 572 21 judicious judicious ADJ aji-51 572 22 use use NOUN aji-51 572 23 of of ADP aji-51 572 24 their their PRON aji-51 572 25 understanding understanding NOUN aji-51 572 26 of of ADP aji-51 572 27 the the DET aji-51 572 28 best good ADJ aji-51 572 29 medical medical ADJ aji-51 572 30 information information NOUN aji-51 572 31 available available ADJ aji-51 572 32 " " PUNCT aji-51 572 33 for for ADP aji-51 572 34 the the DET aji-51 572 35 validation validation NOUN aji-51 572 36 of of ADP aji-51 572 37 the the DET aji-51 572 38 proposed propose VERB aji-51 572 39 treatment treatment NOUN aji-51 572 40 and and CCONJ aji-51 572 41 its its PRON aji-51 572 42 application application NOUN aji-51 572 43 in in ADP aji-51 572 44 patient patient ADJ aji-51 572 45 care care NOUN aji-51 572 46 in in ADP aji-51 572 47 partnership partnership NOUN aji-51 572 48 with with ADP aji-51 572 49 the the DET aji-51 572 50 patient patient NOUN aji-51 572 51 and and CCONJ aji-51 572 52 their their PRON aji-51 572 53 expectations expectation NOUN aji-51 573 1 [ [ X aji-51 573 2 331 331 NUM aji-51 573 3 ] ] PUNCT aji-51 573 4 . . PUNCT aji-51 574 1 cancer cancer NOUN aji-51 574 2 is be AUX aji-51 574 3 a a DET aji-51 574 4 serious serious ADJ aji-51 574 5 and and CCONJ aji-51 574 6 often often ADV aji-51 574 7 life life NOUN aji-51 574 8 - - PUNCT aji-51 574 9 threatening threaten VERB aji-51 574 10 disease disease NOUN aji-51 574 11 that that PRON aji-51 574 12 deserves deserve VERB aji-51 574 13 careful careful ADJ aji-51 574 14 consideration consideration NOUN aji-51 574 15 of of ADP aji-51 574 16 the the DET aji-51 574 17 benefits benefit NOUN aji-51 574 18 and and CCONJ aji-51 574 19 long long ADJ aji-51 574 20 - - PUNCT aji-51 574 21 term term NOUN aji-51 574 22 risks risk NOUN aji-51 574 23 of of ADP aji-51 574 24 each each PRON aji-51 574 25 of of ADP aji-51 574 26 these these DET aji-51 574 27 five five NUM aji-51 574 28 strategic strategic ADJ aji-51 574 29 approaches approach NOUN aji-51 574 30 , , PUNCT aji-51 574 31 evolving evolve VERB aji-51 574 32 beyond beyond ADP aji-51 574 33 cohort cohort NOUN aji-51 574 34 - - PUNCT aji-51 574 35 based base VERB aji-51 574 36 trials trial NOUN aji-51 574 37 into into ADP aji-51 574 38 an an DET aji-51 574 39 integrated integrate VERB aji-51 574 40 , , PUNCT aji-51 574 41 personalized personalized ADJ aji-51 574 42 approach approach NOUN aji-51 574 43 for for ADP aji-51 574 44 the the DET aji-51 574 45 treatment treatment NOUN aji-51 574 46 of of ADP aji-51 574 47 each each DET aji-51 574 48 patient patient NOUN aji-51 574 49 . . PUNCT aji-51 575 1 champions champion NOUN aji-51 575 2 for for ADP aji-51 575 3 the the DET aji-51 575 4 exclusive exclusive ADJ aji-51 575 5 use use NOUN aji-51 575 6 of of ADP aji-51 575 7 any any DET aji-51 575 8 one one NUM aji-51 575 9 of of ADP aji-51 575 10 these these DET aji-51 575 11 strategies strategy NOUN aji-51 575 12 abound abound VERB aji-51 575 13 , , PUNCT aji-51 575 14 but but CCONJ aji-51 575 15 it it PRON aji-51 575 16 is be AUX aji-51 575 17 my my PRON aji-51 575 18 belief belief NOUN aji-51 575 19 and and CCONJ aji-51 575 20 experience experience NOUN aji-51 575 21 that that SCONJ aji-51 575 22 the the DET aji-51 575 23 best good ADJ aji-51 575 24 answer answer NOUN aji-51 575 25 for for ADP aji-51 575 26 cancer cancer NOUN aji-51 575 27 , , PUNCT aji-51 575 28 for for ADP aji-51 575 29 any any DET aji-51 575 30 one one NUM aji-51 575 31 patient patient NOUN aji-51 575 32 , , PUNCT aji-51 575 33 will will AUX aji-51 575 34 be be AUX aji-51 575 35 found find VERB aji-51 575 36 in in ADP aji-51 575 37 their their PRON aji-51 575 38 integration integration NOUN aji-51 575 39 into into ADP aji-51 575 40 an an DET aji-51 575 41 individualized individualized ADJ aji-51 575 42 cohesive cohesive ADJ aji-51 575 43 clinical clinical ADJ aji-51 575 44 protocol protocol NOUN aji-51 575 45 . . PUNCT aji-51 576 1 research research NOUN aji-51 576 2 is be AUX aji-51 576 3 needed need VERB aji-51 576 4 to to PART aji-51 576 5 codify codify VERB aji-51 576 6 the the DET aji-51 576 7 algorithm algorithm NOUN aji-51 576 8 necessary necessary ADJ aji-51 576 9 for for ADP aji-51 576 10 applying apply VERB aji-51 576 11 the the DET aji-51 576 12 best well ADV aji-51 576 13 integrative integrative ADJ aji-51 576 14 therapeutic therapeutic ADJ aji-51 576 15 strategy strategy NOUN aji-51 576 16 given give VERB aji-51 576 17 the the DET aji-51 576 18 dynamics dynamic NOUN aji-51 576 19 of of ADP aji-51 576 20 the the DET aji-51 576 21 cancer cancer NOUN aji-51 576 22 and and CCONJ aji-51 576 23 the the DET aji-51 576 24 patient patient NOUN aji-51 576 25 ’s ’s PART aji-51 576 26 biochemistry biochemistry NOUN aji-51 576 27 , , PUNCT aji-51 576 28 genetics genetic NOUN aji-51 576 29 , , PUNCT aji-51 576 30 and and CCONJ aji-51 576 31 immunology immunology NOUN aji-51 576 32 at at ADP aji-51 576 33 any any DET aji-51 576 34 given give VERB aji-51 576 35 point point NOUN aji-51 576 36 in in ADP aji-51 576 37 their their PRON aji-51 576 38 treatment treatment NOUN aji-51 576 39 . . PUNCT aji-51 577 1 4 4 X aji-51 577 2 . . X aji-51 577 3 conclusion conclusion NOUN aji-51 577 4 cancer cancer NOUN aji-51 577 5 , , PUNCT aji-51 577 6 as as ADP aji-51 577 7 a a DET aji-51 577 8 disease disease NOUN aji-51 577 9 of of ADP aji-51 577 10 our our PRON aji-51 577 11 time time NOUN aji-51 577 12 , , PUNCT aji-51 577 13 has have AUX aji-51 577 14 been be AUX aji-51 577 15 described describe VERB aji-51 577 16 as as ADP aji-51 577 17 a a DET aji-51 577 18 “ " PUNCT aji-51 577 19 wound wound NOUN aji-51 577 20 that that PRON aji-51 577 21 does do AUX aji-51 577 22 not not PART aji-51 577 23 heal heal VERB aji-51 577 24 ” " PUNCT aji-51 577 25 and and CCONJ aji-51 577 26 is be AUX aji-51 577 27 characterized characterize VERB aji-51 577 28 as as ADP aji-51 577 29 having have VERB aji-51 577 30 numerous numerous ADJ aji-51 577 31 biochemical biochemical ADJ aji-51 577 32 dysfunctions dysfunction NOUN aji-51 577 33 at at ADP aji-51 577 34 its its PRON aji-51 577 35 core core NOUN aji-51 577 36 , , PUNCT aji-51 577 37 which which PRON aji-51 577 38 lead lead VERB aji-51 577 39 to to ADP aji-51 577 40 a a DET aji-51 577 41 multitude multitude NOUN aji-51 577 42 of of ADP aji-51 577 43 genetic genetic ADJ aji-51 577 44 aberrations aberration NOUN aji-51 577 45 and and CCONJ aji-51 577 46 pathologic pathologic ADJ aji-51 577 47 phenotypic phenotypic ADJ aji-51 577 48 expression expression NOUN aji-51 577 49 . . PUNCT aji-51 578 1 however however ADV aji-51 578 2 , , PUNCT aji-51 578 3 in in ADP aji-51 578 4 order order NOUN aji-51 578 5 for for SCONJ aji-51 578 6 these these DET aji-51 578 7 genetically genetically ADV aji-51 578 8 and and CCONJ aji-51 578 9 phenotypically phenotypically ADV aji-51 578 10 abnormal abnormal ADJ aji-51 578 11 cells cell NOUN aji-51 578 12 to to PART aji-51 578 13 survive survive VERB aji-51 578 14 and and CCONJ aji-51 578 15 thrive thrive VERB aji-51 578 16 , , PUNCT aji-51 578 17 the the DET aji-51 578 18 watchdog watchdog NOUN aji-51 578 19 of of ADP aji-51 578 20 the the DET aji-51 578 21 body body NOUN aji-51 578 22 , , PUNCT aji-51 578 23 the the DET aji-51 578 24 immune immune ADJ aji-51 578 25 system system NOUN aji-51 578 26 , , PUNCT aji-51 578 27 must must AUX aji-51 578 28 itself itself PRON aji-51 578 29 be be AUX aji-51 578 30 suffering suffer VERB aji-51 578 31 from from ADP aji-51 578 32 a a DET aji-51 578 33 number number NOUN aji-51 578 34 of of ADP aji-51 578 35 serious serious ADJ aji-51 578 36 areas area NOUN aji-51 578 37 of of ADP aji-51 578 38 structural structural ADJ aji-51 578 39 and and CCONJ aji-51 578 40 functional functional ADJ aji-51 578 41 damage damage NOUN aji-51 578 42 . . PUNCT aji-51 579 1 there there PRON aji-51 579 2 are be VERB aji-51 579 3 many many ADJ aji-51 579 4 tactics tactic NOUN aji-51 579 5 that that PRON aji-51 579 6 can can AUX aji-51 579 7 support support VERB aji-51 579 8 the the DET aji-51 579 9 therapeutic therapeutic ADJ aji-51 579 10 strategies strategy NOUN aji-51 579 11 briefly briefly ADV aji-51 579 12 described describe VERB aji-51 579 13 above above ADV aji-51 579 14 , , PUNCT aji-51 579 15 and and CCONJ aji-51 579 16 they they PRON aji-51 579 17 should should AUX aji-51 579 18 be be AUX aji-51 579 19 applied apply VERB aji-51 579 20 in in ADP aji-51 579 21 an an DET aji-51 579 22 integrative integrative ADJ aji-51 579 23 manner manner NOUN aji-51 579 24 as as SCONJ aji-51 579 25 they they PRON aji-51 579 26 are be AUX aji-51 579 27 nonexclusive nonexclusive ADJ aji-51 579 28 stoff stoff PROPN aji-51 579 29 ; ; PUNCT aji-51 579 30 aji aji PROPN aji-51 579 31 , , PUNCT aji-51 579 32 5(1 5(1 NUM aji-51 579 33 ): ): PUNCT aji-51 579 34 1 1 NUM aji-51 579 35 - - SYM aji-51 579 36 39 39 NUM aji-51 579 37 , , PUNCT aji-51 579 38 2022 2022 NUM aji-51 579 39 ; ; PUNCT aji-51 579 40 article article NOUN aji-51 579 41 no.aji.77967 no.aji.77967 NOUN aji-51 579 42 17 17 NUM aji-51 579 43 with with ADP aji-51 579 44 each each DET aji-51 579 45 other other ADJ aji-51 579 46 and and CCONJ aji-51 579 47 can can AUX aji-51 579 48 be be AUX aji-51 579 49 mutually mutually ADV aji-51 579 50 supportive supportive ADJ aji-51 579 51 [ [ X aji-51 579 52 332 332 NUM aji-51 579 53 ] ] PUNCT aji-51 579 54 . . PUNCT aji-51 580 1 however however ADV aji-51 580 2 , , PUNCT aji-51 580 3 more more ADV aji-51 580 4 aggressive aggressive ADJ aji-51 580 5 cytotoxic cytotoxic ADJ aji-51 580 6 strategies strategy NOUN aji-51 580 7 , , PUNCT aji-51 580 8 i.e. i.e. X aji-51 580 9 , , PUNCT aji-51 580 10 full full ADJ aji-51 580 11 - - PUNCT aji-51 580 12 dose dose NOUN aji-51 580 13 chemotherapy chemotherapy NOUN aji-51 580 14 and and CCONJ aji-51 580 15 radiation radiation NOUN aji-51 580 16 , , PUNCT aji-51 580 17 can can AUX aji-51 580 18 render render VERB aji-51 580 19 many many ADJ aji-51 580 20 of of ADP aji-51 580 21 these these DET aji-51 580 22 strategies strategy NOUN aji-51 580 23 null null ADJ aji-51 580 24 and and CCONJ aji-51 580 25 void void ADJ aji-51 580 26 but but CCONJ aji-51 580 27 may may AUX aji-51 580 28 be be AUX aji-51 580 29 considered consider VERB aji-51 580 30 for for ADP aji-51 580 31 possible possible ADJ aji-51 580 32 later later ADJ aji-51 580 33 use use NOUN aji-51 580 34 . . PUNCT aji-51 581 1 when when SCONJ aji-51 581 2 treating treat VERB aji-51 581 3 cancer cancer NOUN aji-51 581 4 , , PUNCT aji-51 581 5 the the DET aji-51 581 6 physician physician NOUN aji-51 581 7 and and CCONJ aji-51 581 8 patient patient NOUN aji-51 581 9 should should AUX aji-51 581 10 make make VERB aji-51 581 11 the the DET aji-51 581 12 decisions decision NOUN aji-51 581 13 together together ADV aji-51 581 14 , , PUNCT aji-51 581 15 since since SCONJ aji-51 581 16 the the DET aji-51 581 17 stakes stake NOUN aji-51 581 18 can can AUX aji-51 581 19 be be AUX aji-51 581 20 no no ADV aji-51 581 21 higher high ADJ aji-51 581 22 , , PUNCT aji-51 581 23 using use VERB aji-51 581 24 the the DET aji-51 581 25 best good ADJ aji-51 581 26 information information NOUN aji-51 581 27 available available ADJ aji-51 581 28 at at ADP aji-51 581 29 the the DET aji-51 581 30 time time NOUN aji-51 581 31 , , PUNCT aji-51 581 32 and and CCONJ aji-51 581 33 then then ADV aji-51 581 34 never never ADV aji-51 581 35 look look VERB aji-51 581 36 back back ADV aji-51 581 37 . . PUNCT aji-51 582 1 when when SCONJ aji-51 582 2 treating treat VERB aji-51 582 3 cancer cancer NOUN aji-51 582 4 there there PRON aji-51 582 5 is be VERB aji-51 582 6 but but CCONJ aji-51 582 7 one one NUM aji-51 582 8 direction direction NOUN aji-51 582 9 to to PART aji-51 582 10 go go VERB aji-51 582 11 and and CCONJ aji-51 582 12 that that PRON aji-51 582 13 is be AUX aji-51 582 14 forward forward ADV aji-51 582 15 , , PUNCT aji-51 582 16 striving strive VERB aji-51 582 17 for for ADP aji-51 582 18 ever ever ADV aji-51 582 19 - - PUNCT aji-51 582 20 increasing increase VERB aji-51 582 21 improvements improvement NOUN aji-51 582 22 in in ADP aji-51 582 23 the the DET aji-51 582 24 quality quality NOUN aji-51 582 25 and and CCONJ aji-51 582 26 quantity quantity NOUN aji-51 582 27 of of ADP aji-51 582 28 life life NOUN aji-51 582 29 with with ADP aji-51 582 30 the the DET aji-51 582 31 hope hope NOUN aji-51 582 32 of of ADP aji-51 582 33 achieving achieve VERB aji-51 582 34 a a DET aji-51 582 35 durable durable ADJ aji-51 582 36 remission remission NOUN aji-51 583 1 [ [ X aji-51 583 2 333 333 NUM aji-51 583 3 - - SYM aji-51 583 4 336 336 NUM aji-51 583 5 ] ] PUNCT aji-51 583 6 . . PUNCT aji-51 584 1 consent consent NOUN aji-51 584 2 it it PRON aji-51 584 3 is be AUX aji-51 584 4 not not PART aji-51 584 5 applicable applicable ADJ aji-51 584 6 . . PUNCT aji-51 585 1 ethical ethical ADJ aji-51 585 2 approval approval NOUN aji-51 585 3 it it PRON aji-51 585 4 is be AUX aji-51 585 5 not not PART aji-51 585 6 applicable applicable ADJ aji-51 585 7 . . PUNCT aji-51 586 1 acknowledgements acknowledgement NOUN aji-51 586 2 i i PRON aji-51 586 3 would would AUX aji-51 586 4 like like VERB aji-51 586 5 to to PART aji-51 586 6 thank thank VERB aji-51 586 7 summer summer NOUN aji-51 586 8 a. a. PROPN aji-51 586 9 stoff stoff PROPN aji-51 586 10 , , PUNCT aji-51 586 11 b.a b.a PROPN aji-51 586 12 . . PROPN aji-51 586 13 , , PUNCT aji-51 586 14 and and CCONJ aji-51 586 15 colleen colleen PROPN aji-51 586 16 a. a. NOUN aji-51 586 17 murtha murtha PROPN aji-51 586 18 - - PUNCT aji-51 586 19 stoff stoff PROPN aji-51 586 20 , , PUNCT aji-51 586 21 n.p n.p PROPN aji-51 586 22 . . PROPN aji-51 586 23 for for ADP aji-51 586 24 their their PRON aji-51 586 25 highly highly ADV aji-51 586 26 valued value VERB aji-51 586 27 editing editing NOUN aji-51 586 28 skills skill NOUN aji-51 586 29 in in ADP aji-51 586 30 preparing prepare VERB aji-51 586 31 this this DET aji-51 586 32 manuscript manuscript NOUN aji-51 586 33 . . PUNCT aji-51 587 1 competing compete VERB aji-51 587 2 interests interest NOUN aji-51 587 3 author author NOUN aji-51 587 4 has have AUX aji-51 587 5 declared declare VERB aji-51 587 6 that that SCONJ aji-51 587 7 no no DET aji-51 587 8 competing compete VERB aji-51 587 9 interests interest NOUN aji-51 587 10 exist exist VERB aji-51 587 11 . . PUNCT aji-51 588 1 references reference NOUN aji-51 588 2 1 1 NUM aji-51 588 3 . . PUNCT aji-51 589 1 byun byun NOUN aji-51 589 2 , , PUNCT aji-51 589 3 gardner gardner PROPN aji-51 589 4 k. k. PROPN aji-51 589 5 wounds wound NOUN aji-51 589 6 that that PRON aji-51 589 7 will will AUX aji-51 589 8 not not PART aji-51 589 9 heal heal VERB aji-51 589 10 . . PUNCT aji-51 590 1 am be AUX aji-51 590 2 j j PROPN aji-51 590 3 pathol pathol NOUN aji-51 590 4 . . PUNCT aji-51 591 1 2013 2013 NUM aji-51 591 2 apr;182(4):1055 apr;182(4):1055 NOUN aji-51 591 3 – – PUNCT aji-51 591 4 1064 1064 NUM aji-51 591 5 . . PUNCT aji-51 592 1 doi doi NOUN aji-51 592 2 : : PUNCT aji-51 592 3 10.1016 10.1016 NUM aji-51 592 4 / / SYM aji-51 592 5 j.ajpath.2013.01.009 j.ajpath.2013.01.009 PROPN aji-51 592 6 pmid pmid PROPN aji-51 592 7 : : PUNCT aji-51 592 8 23438473 23438473 NUM aji-51 592 9 . . PUNCT aji-51 593 1 2 2 X aji-51 593 2 . . PUNCT aji-51 593 3 hanahan hanahan PROPN aji-51 593 4 d d PROPN aji-51 593 5 , , PUNCT aji-51 593 6 weinberg weinberg PROPN aji-51 593 7 ra ra PROPN aji-51 593 8 . . PUNCT aji-51 594 1 hallmarks hallmark NOUN aji-51 594 2 of of ADP aji-51 594 3 cancer cancer NOUN aji-51 594 4 : : PUNCT aji-51 594 5 the the DET aji-51 594 6 next next ADJ aji-51 594 7 generation generation NOUN aji-51 594 8 . . PUNCT aji-51 595 1 cell cell NOUN aji-51 595 2 . . PUNCT aji-51 596 1 2011 2011 NUM aji-51 596 2 mar mar PROPN aji-51 596 3 4;144(5):646 4;144(5):646 PROPN aji-51 596 4 - - PUNCT aji-51 596 5 74 74 PROPN aji-51 596 6 . . PUNCT aji-51 597 1 doi doi NOUN aji-51 597 2 : : PUNCT aji-51 597 3 10.1016 10.1016 NUM aji-51 597 4 / / SYM aji-51 597 5 j.cell.2011.02.013 j.cell.2011.02.013 PROPN aji-51 597 6 pmid pmid PROPN aji-51 597 7 : : PUNCT aji-51 597 8 21376230 21376230 NUM aji-51 597 9 3 3 NUM aji-51 597 10 . . PUNCT aji-51 598 1 hanahan hanahan PROPN aji-51 598 2 d d PROPN aji-51 598 3 , , PUNCT aji-51 598 4 weinberg weinberg PROPN aji-51 598 5 ra ra PROPN aji-51 598 6 . . PUNCT aji-51 599 1 the the DET aji-51 599 2 hallmarks hallmark NOUN aji-51 599 3 of of ADP aji-51 599 4 cancer cancer NOUN aji-51 599 5 . . PUNCT aji-51 600 1 cell cell NOUN aji-51 600 2 . . PUNCT aji-51 601 1 2000 2000 NUM aji-51 601 2 jan jan PROPN aji-51 601 3 7;100(1):57 7;100(1):57 PROPN aji-51 601 4 - - PROPN aji-51 601 5 70 70 NUM aji-51 601 6 . . PUNCT aji-51 602 1 doi doi NOUN aji-51 602 2 : : PUNCT aji-51 602 3 10.1016 10.1016 NUM aji-51 602 4 / / SYM aji-51 602 5 s0092 s0092 PROPN aji-51 602 6 - - PUNCT aji-51 602 7 8674(00)81683 8674(00)81683 NOUN aji-51 602 8 - - PUNCT aji-51 602 9 9 9 NUM aji-51 602 10 pmid pmid NOUN aji-51 602 11 : : PUNCT aji-51 602 12 10647931 10647931 NUM aji-51 602 13 4 4 NUM aji-51 602 14 . . PUNCT aji-51 603 1 available available ADJ aji-51 603 2 : : PUNCT aji-51 603 3 https://www.atsdr.cdc.gov https://www.atsdr.cdc.gov ADJ aji-51 603 4 / / SYM aji-51 603 5 emes/ emes/ NUM aji-51 603 6 public public ADJ aji-51 603 7 / / SYM aji-51 603 8 docs docs PROPN aji-51 603 9 / / SYM aji-51 603 10 chemicals,%20cancer,%20an chemicals,%20cancer,%20an NOUN aji-51 603 11 d%20you%20fs.pdf d%20you%20fs.pdf PROPN aji-51 603 12 5 5 NUM aji-51 603 13 . . PUNCT aji-51 604 1 seyfried seyfried PROPN aji-51 604 2 t t PROPN aji-51 604 3 , , PUNCT aji-51 604 4 flores flores PROPN aji-51 604 5 r r PROPN aji-51 604 6 , , PUNCT aji-51 604 7 poff poff NOUN aji-51 604 8 a a NOUN aji-51 604 9 , , PUNCT aji-51 604 10 d’agostino d’agostino PROPN aji-51 604 11 d. d. NOUN aji-51 604 12 cancer cancer NOUN aji-51 604 13 as as ADP aji-51 604 14 a a DET aji-51 604 15 metabolic metabolic NOUN aji-51 604 16 disease disease NOUN aji-51 604 17 : : PUNCT aji-51 604 18 implications implication NOUN aji-51 604 19 for for ADP aji-51 604 20 novel novel ADJ aji-51 604 21 therapeutics therapeutic NOUN aji-51 604 22 . . PUNCT aji-51 605 1 carcinogenesis carcinogenesis NOUN aji-51 605 2 . . PUNCT aji-51 606 1 2014 2014 NUM aji-51 606 2 mar;35(3):515–527 mar;35(3):515–527 PROPN aji-51 606 3 . . PUNCT aji-51 607 1 pmid pmid NOUN aji-51 607 2 : : PUNCT aji-51 607 3 24343361 24343361 NUM aji-51 607 4 . . PUNCT aji-51 608 1 6 6 NUM aji-51 608 2 . . X aji-51 608 3 seyfried seyfrie VERB aji-51 608 4 t. t. NOUN aji-51 608 5 cancer cancer NOUN aji-51 608 6 as as ADP aji-51 608 7 a a DET aji-51 608 8 mitochondrial mitochondrial ADJ aji-51 608 9 metabolic metabolic NOUN aji-51 608 10 disease disease NOUN aji-51 608 11 . . PUNCT aji-51 609 1 front front ADJ aji-51 609 2 cell cell NOUN aji-51 609 3 dev dev PROPN aji-51 609 4 biol biol PROPN aji-51 609 5 . . PUNCT aji-51 610 1 2015;3:43 2015;3:43 NOUN aji-51 610 2 . . PUNCT aji-51 611 1 pmid pmid NOUN aji-51 611 2 : : PUNCT aji-51 611 3 26217661 26217661 NUM aji-51 611 4 7 7 NUM aji-51 611 5 . . PUNCT aji-51 611 6 seyfried seyfrie VERB aji-51 611 7 t. t. NOUN aji-51 611 8 cancer cancer NOUN aji-51 611 9 as as ADP aji-51 611 10 a a DET aji-51 611 11 metabolic metabolic NOUN aji-51 611 12 disease disease NOUN aji-51 611 13 : : PUNCT aji-51 611 14 on on ADP aji-51 611 15 the the DET aji-51 611 16 origin origin NOUN aji-51 611 17 , , PUNCT aji-51 611 18 management management NOUN aji-51 611 19 , , PUNCT aji-51 611 20 and and CCONJ aji-51 611 21 prevention prevention NOUN aji-51 611 22 of of ADP aji-51 611 23 cancer cancer NOUN aji-51 611 24 . . PUNCT aji-51 612 1 wiley wiley PROPN aji-51 612 2 . . PUNCT aji-51 613 1 1st 1st PROPN aji-51 613 2 edition edition PROPN aji-51 613 3 ( ( PUNCT aji-51 613 4 june june PROPN aji-51 613 5 26 26 NUM aji-51 613 6 , , PUNCT aji-51 613 7 2012 2012 NUM aji-51 613 8 ) ) PUNCT aji-51 613 9 , , PUNCT aji-51 613 10 n.y n.y PROPN aji-51 613 11 . . PROPN aji-51 613 12 , , PUNCT aji-51 613 13 isbn10:0470584920 isbn10:0470584920 PROPN aji-51 613 14 . . PROPN aji-51 613 15 8 8 NUM aji-51 613 16 . . PUNCT aji-51 613 17 available available ADJ aji-51 613 18 : : PUNCT aji-51 613 19 https://www.mayoclinichealthsyst https://www.mayoclinichealthsyst NOUN aji-51 613 20 em.org/hometown-health/speaking-ofhealth/healthy-food-and-a-healthy-lifestylecan-help-prevent-cancer em.org/hometown-health/speaking-ofhealth/healthy-food-and-a-healthy-lifestylecan-help-prevent-cancer NOUN aji-51 613 21 9 9 NUM aji-51 613 22 . . PUNCT aji-51 613 23 available available ADJ aji-51 613 24 : : PUNCT aji-51 613 25 https://stanfordhealthcare.org https://stanfordhealthcare.org PROPN aji-51 613 26 / / SYM aji-51 613 27 me i PRON aji-51 613 28 dical dical ADJ aji-51 613 29 - - PUNCT aji-51 613 30 clinics clinic NOUN aji-51 613 31 / / SYM aji-51 613 32 cancer cancer NOUN aji-51 613 33 - - PUNCT aji-51 613 34 nutritionservices nutritionservice NOUN aji-51 613 35 / / SYM aji-51 613 36 recipes.html recipes.html NOUN aji-51 613 37 10 10 NUM aji-51 613 38 . . PUNCT aji-51 614 1 available available ADJ aji-51 614 2 : : PUNCT aji-51 614 3 https://www.mdanderson.org https://www.mdanderson.org ADJ aji-51 614 4 / / SYM aji-51 614 5 pre pre X aji-51 614 6 vention vention NOUN aji-51 614 7 - - PUNCT aji-51 614 8 screening screening NOUN aji-51 614 9 / / SYM aji-51 614 10 manage manage NOUN aji-51 614 11 - - PUNCT aji-51 614 12 yourrisk yourrisk NOUN aji-51 614 13 / / SYM aji-51 614 14 diet.html diet.html PROPN aji-51 614 15 11 11 NUM aji-51 614 16 . . PUNCT aji-51 615 1 baudry baudry PROPN aji-51 615 2 j j PROPN aji-51 615 3 , , PUNCT aji-51 615 4 assmann assmann PROPN aji-51 615 5 ke ke PROPN aji-51 615 6 , , PUNCT aji-51 615 7 touvier touvier NOUN aji-51 615 8 m m PROPN aji-51 615 9 , , PUNCT aji-51 615 10 allès allès PROPN aji-51 615 11 b b NOUN aji-51 615 12 , , PUNCT aji-51 615 13 seconda seconda PROPN aji-51 615 14 l l PROPN aji-51 615 15 , , PUNCT aji-51 615 16 latino latino NOUN aji-51 615 17 - - PUNCT aji-51 615 18 martel martel NOUN aji-51 615 19 p p NOUN aji-51 615 20 , , PUNCT aji-51 615 21 ezzedine ezzedine NOUN aji-51 615 22 k k NOUN aji-51 615 23 , , PUNCT aji-51 615 24 galan galan PROPN aji-51 615 25 p p PROPN aji-51 615 26 , , PUNCT aji-51 615 27 hercberg hercberg PROPN aji-51 615 28 s s PROPN aji-51 615 29 , , PUNCT aji-51 615 30 lairon lairon PROPN aji-51 615 31 d d NOUN aji-51 615 32 , , PUNCT aji-51 615 33 kesseguyot kesseguyot PROPN aji-51 615 34 e. e. PROPN aji-51 615 35 association association PROPN aji-51 615 36 of of ADP aji-51 615 37 frequency frequency NOUN aji-51 615 38 of of ADP aji-51 615 39 organic organic ADJ aji-51 615 40 food food NOUN aji-51 615 41 consumption consumption NOUN aji-51 615 42 with with ADP aji-51 615 43 cancer cancer NOUN aji-51 615 44 risk risk NOUN aji-51 615 45 : : PUNCT aji-51 615 46 findings finding NOUN aji-51 615 47 from from ADP aji-51 615 48 the the DET aji-51 615 49 nutrinet nutrinet NOUN aji-51 615 50 - - PUNCT aji-51 615 51 santé santé ADJ aji-51 615 52 prospective prospective ADJ aji-51 615 53 cohort cohort NOUN aji-51 615 54 study study NOUN aji-51 615 55 . . PUNCT aji-51 616 1 jama jama PROPN aji-51 616 2 intern intern PROPN aji-51 616 3 med me VERB aji-51 616 4 . . PUNCT aji-51 617 1 2018 2018 NUM aji-51 617 2 dec dec PROPN aji-51 617 3 1;178(12):1597 1;178(12):1597 PROPN aji-51 617 4 - - SYM aji-51 617 5 1606 1606 NUM aji-51 617 6 . . PUNCT aji-51 618 1 doi doi NOUN aji-51 618 2 : : PUNCT aji-51 618 3 10.1001 10.1001 NUM aji-51 618 4 / / SYM aji-51 618 5 jamainternmed.2018.4357 jamainternmed.2018.4357 NUM aji-51 618 6 erratum erratum NOUN aji-51 618 7 in in ADP aji-51 618 8 : : PUNCT aji-51 618 9 jama jama PROPN aji-51 618 10 intern intern NOUN aji-51 618 11 med me VERB aji-51 618 12 . . PUNCT aji-51 619 1 2018 2018 NUM aji-51 619 2 dec dec PROPN aji-51 619 3 1;178(12):1732 1;178(12):1732 NUM aji-51 619 4 . . PUNCT aji-51 620 1 pmid pmid NOUN aji-51 620 2 : : PUNCT aji-51 620 3 30422212 30422212 NUM aji-51 620 4 ; ; PUNCT aji-51 620 5 pmcid pmcid ADJ aji-51 620 6 : : PUNCT aji-51 620 7 pmc6583612 pmc6583612 ADJ aji-51 620 8 . . PUNCT aji-51 621 1 12 12 NUM aji-51 621 2 . . PUNCT aji-51 622 1 weber weber PROPN aji-51 622 2 dd dd PROPN aji-51 622 3 , , PUNCT aji-51 622 4 aminzadeh aminzadeh NOUN aji-51 622 5 - - PUNCT aji-51 622 6 gohari gohari PROPN aji-51 622 7 s s PROPN aji-51 622 8 , , PUNCT aji-51 622 9 tulipan tulipan PROPN aji-51 622 10 j j PROPN aji-51 622 11 , , PUNCT aji-51 622 12 catalano catalano PROPN aji-51 622 13 l l PROPN aji-51 622 14 , , PUNCT aji-51 622 15 feichtinger feichtinger PROPN aji-51 622 16 rg rg PROPN aji-51 622 17 , , PUNCT aji-51 622 18 kofler kofler PROPN aji-51 622 19 b. b. PROPN aji-51 622 20 ketogenic ketogenic PROPN aji-51 622 21 diet diet PROPN aji-51 622 22 in in ADP aji-51 622 23 the the DET aji-51 622 24 treatment treatment NOUN aji-51 622 25 of of ADP aji-51 622 26 cancer cancer NOUN aji-51 622 27 where where SCONJ aji-51 622 28 do do AUX aji-51 622 29 we we PRON aji-51 622 30 stand stand VERB aji-51 622 31 ? ? PUNCT aji-51 623 1 mol mol ADP aji-51 623 2 metab metab NOUN aji-51 623 3 . . PUNCT aji-51 623 4 2020 2020 NUM aji-51 623 5 mar;33:102 mar;33:102 NOUN aji-51 623 6 - - SYM aji-51 623 7 121 121 NUM aji-51 623 8 . . PUNCT aji-51 624 1 doi doi NOUN aji-51 624 2 : : PUNCT aji-51 624 3 10.1016 10.1016 NUM aji-51 624 4 / / SYM aji-51 624 5 j.molmet.2019.06.026 j.molmet.2019.06.026 PROPN aji-51 624 6 epub epub PROPN aji-51 624 7 2019 2019 NUM aji-51 624 8 jul jul PROPN aji-51 624 9 27 27 NUM aji-51 624 10 . . PUNCT aji-51 625 1 pmid pmid NOUN aji-51 625 2 : : PUNCT aji-51 625 3 31399389 31399389 NUM aji-51 625 4 ; ; PUNCT aji-51 625 5 pmcid pmcid NOUN aji-51 625 6 : : PUNCT aji-51 625 7 pmc7056920 pmc7056920 ADV aji-51 625 8 . . PUNCT aji-51 626 1 13 13 NUM aji-51 626 2 . . PUNCT aji-51 627 1 quillin quillin PROPN aji-51 627 2 p. p. PROPN aji-51 627 3 beating beat VERB aji-51 627 4 cancer cancer NOUN aji-51 627 5 with with ADP aji-51 627 6 nutrition nutrition NOUN aji-51 627 7 , , PUNCT aji-51 627 8 nutrition nutrition PROPN aji-51 627 9 times times PROPN aji-51 627 10 press press PROPN aji-51 627 11 inc inc PROPN aji-51 627 12 ; ; PUNCT aji-51 627 13 4th 4th ADJ aji-51 627 14 edition edition NOUN aji-51 627 15 ; ; PUNCT aji-51 627 16 2020 2020 NUM aji-51 627 17 . . PUNCT aji-51 628 1 isbn isbn ADJ aji-51 628 2 978 978 NUM aji-51 628 3 - - SYM aji-51 628 4 1 1 NUM aji-51 628 5 - - PUNCT aji-51 628 6 7352347 7352347 NUM aji-51 628 7 - - PUNCT aji-51 628 8 0 0 NUM aji-51 628 9 - - PUNCT aji-51 628 10 0 0 NUM aji-51 628 11 . . PROPN aji-51 628 12 14 14 NUM aji-51 628 13 . . PUNCT aji-51 629 1 gonzalez gonzalez PROPN aji-51 629 2 - - PUNCT aji-51 629 3 angulo angulo PROPN aji-51 629 4 am am PROPN aji-51 629 5 , , PUNCT aji-51 629 6 meric meric NOUN aji-51 629 7 - - PUNCT aji-51 629 8 bernstam bernstam PROPN aji-51 629 9 f. f. PROPN aji-51 629 10 metformin metformin PROPN aji-51 629 11 : : PUNCT aji-51 629 12 a a DET aji-51 629 13 therapeutic therapeutic ADJ aji-51 629 14 opportunity opportunity NOUN aji-51 629 15 in in ADP aji-51 629 16 breast breast NOUN aji-51 629 17 cancer cancer NOUN aji-51 629 18 . . PUNCT aji-51 630 1 clin clin PROPN aji-51 630 2 cancer cancer NOUN aji-51 630 3 res re NOUN aji-51 630 4 . . PUNCT aji-51 631 1 2010 2010 NUM aji-51 631 2 mar mar PROPN aji-51 631 3 15;16(6):1695 15;16(6):1695 NUM aji-51 631 4 - - SYM aji-51 631 5 700 700 NUM aji-51 631 6 . . PUNCT aji-51 632 1 doi doi NOUN aji-51 632 2 : : PUNCT aji-51 632 3 10.1158/1078 10.1158/1078 NUM aji-51 632 4 - - PUNCT aji-51 632 5 0432.ccr-09 0432.ccr-09 PROPN aji-51 632 6 - - PUNCT aji-51 632 7 1805 1805 NUM aji-51 632 8 epub epub NOUN aji-51 632 9 2010 2010 NUM aji-51 632 10 mar mar PROPN aji-51 632 11 9 9 NUM aji-51 632 12 . . PUNCT aji-51 633 1 pmid pmid NOUN aji-51 633 2 : : PUNCT aji-51 633 3 20215559 20215559 NUM aji-51 633 4 ; ; PUNCT aji-51 633 5 pmcid pmcid ADJ aji-51 633 6 : : PUNCT aji-51 633 7 pmc2840206 pmc2840206 NOUN aji-51 633 8 . . PUNCT aji-51 634 1 stoff stoff PROPN aji-51 634 2 ; ; PUNCT aji-51 634 3 aji aji PROPN aji-51 634 4 , , PUNCT aji-51 634 5 5(1 5(1 NUM aji-51 634 6 ): ): PUNCT aji-51 634 7 1 1 NUM aji-51 634 8 - - SYM aji-51 634 9 39 39 NUM aji-51 634 10 , , PUNCT aji-51 634 11 2022 2022 NUM aji-51 634 12 ; ; PUNCT aji-51 634 13 article article NOUN aji-51 634 14 no.aji.77967 no.aji.77967 PROPN aji-51 634 15 18 18 NUM aji-51 634 16 15 15 NUM aji-51 634 17 . . PUNCT aji-51 635 1 zhou zhou PROPN aji-51 635 2 g g PROPN aji-51 635 3 , , PUNCT aji-51 635 4 myers myers PROPN aji-51 635 5 r r PROPN aji-51 635 6 , , PUNCT aji-51 635 7 li li PROPN aji-51 635 8 y y PROPN aji-51 635 9 , , PUNCT aji-51 635 10 chen chen PROPN aji-51 635 11 y y PROPN aji-51 635 12 , , PUNCT aji-51 635 13 shen shen NOUN aji-51 635 14 x x NOUN aji-51 635 15 , , PUNCT aji-51 635 16 fenyk fenyk NOUN aji-51 635 17 - - PUNCT aji-51 635 18 melody melody NOUN aji-51 635 19 j j PROPN aji-51 635 20 , , PUNCT aji-51 635 21 wu wu PROPN aji-51 635 22 m m PROPN aji-51 635 23 , , PUNCT aji-51 635 24 ventre ventre PROPN aji-51 635 25 j j PROPN aji-51 635 26 , , PUNCT aji-51 635 27 doebber doebber PROPN aji-51 635 28 t t PROPN aji-51 635 29 , , PUNCT aji-51 635 30 fujii fujii PROPN aji-51 635 31 n n CCONJ aji-51 635 32 , , PUNCT aji-51 635 33 musi musi PROPN aji-51 635 34 n n CCONJ aji-51 635 35 , , PUNCT aji-51 635 36 hirshman hirshman NOUN aji-51 635 37 mf mf PROPN aji-51 635 38 , , PUNCT aji-51 635 39 goodyear goodyear PROPN aji-51 635 40 lj lj PROPN aji-51 635 41 , , PUNCT aji-51 635 42 moller moller PROPN aji-51 635 43 de de PROPN aji-51 635 44 . . PROPN aji-51 635 45 role role NOUN aji-51 635 46 of of ADP aji-51 635 47 amp amp NOUN aji-51 635 48 - - PUNCT aji-51 635 49 activated activate VERB aji-51 635 50 protein protein NOUN aji-51 635 51 kinase kinase NOUN aji-51 635 52 in in ADP aji-51 635 53 mechanism mechanism NOUN aji-51 635 54 of of ADP aji-51 635 55 metformin metformin NOUN aji-51 635 56 action action NOUN aji-51 635 57 . . PUNCT aji-51 636 1 j j PROPN aji-51 636 2 clin clin PROPN aji-51 636 3 invest invest PROPN aji-51 636 4 . . PUNCT aji-51 637 1 2001 2001 NUM aji-51 637 2 oct;108(8):1167 oct;108(8):1167 ADJ aji-51 637 3 74 74 NUM aji-51 637 4 . . PUNCT aji-51 638 1 doi doi NOUN aji-51 638 2 : : PUNCT aji-51 638 3 10.1172 10.1172 NUM aji-51 638 4 / / SYM aji-51 638 5 jci13505 jci13505 NOUN aji-51 638 6 pmid pmid PROPN aji-51 638 7 : : PUNCT aji-51 638 8 11602624 11602624 NUM aji-51 638 9 ; ; PUNCT aji-51 638 10 pmcid pmcid NOUN aji-51 638 11 : : PUNCT aji-51 638 12 pmc209533 pmc209533 ADJ aji-51 638 13 . . PUNCT aji-51 639 1 16 16 NUM aji-51 639 2 . . PUNCT aji-51 640 1 shaw shaw PROPN aji-51 640 2 rj rj PROPN aji-51 640 3 , , PUNCT aji-51 640 4 lamia lamia PROPN aji-51 640 5 ka ka PROPN aji-51 640 6 , , PUNCT aji-51 640 7 vasquez vasquez PROPN aji-51 641 1 d d PROPN aji-51 641 2 , , PUNCT aji-51 641 3 koo koo PROPN aji-51 641 4 sh sh PROPN aji-51 641 5 , , PUNCT aji-51 641 6 bardeesy bardeesy ADJ aji-51 641 7 n n CCONJ aji-51 641 8 , , PUNCT aji-51 641 9 depinho depinho PROPN aji-51 641 10 ra ra PROPN aji-51 641 11 , , PUNCT aji-51 641 12 montminy montminy PROPN aji-51 641 13 m m PROPN aji-51 641 14 , , PUNCT aji-51 641 15 cantley cantley PROPN aji-51 641 16 lc lc PROPN aji-51 641 17 . . PUNCT aji-51 642 1 the the DET aji-51 642 2 kinase kinase PROPN aji-51 642 3 lkb1 lkb1 PROPN aji-51 642 4 mediates mediate VERB aji-51 642 5 glucose glucose NOUN aji-51 642 6 homeostasis homeostasis NOUN aji-51 642 7 in in ADP aji-51 642 8 liver liver NOUN aji-51 642 9 and and CCONJ aji-51 642 10 therapeutic therapeutic ADJ aji-51 642 11 effects effect NOUN aji-51 642 12 of of ADP aji-51 642 13 metformin metformin NOUN aji-51 642 14 . . PUNCT aji-51 643 1 science science NOUN aji-51 643 2 . . PUNCT aji-51 644 1 2005 2005 NUM aji-51 644 2 dec dec PROPN aji-51 644 3 9;310(5754):1642 9;310(5754):1642 NUM aji-51 644 4 - - SYM aji-51 644 5 6 6 NUM aji-51 644 6 . . PUNCT aji-51 644 7 doi doi NOUN aji-51 644 8 : : PUNCT aji-51 644 9 10.1126 10.1126 NUM aji-51 644 10 / / SYM aji-51 644 11 science.1120781 science.1120781 PROPN aji-51 644 12 epub epub NOUN aji-51 644 13 2005 2005 NUM aji-51 644 14 nov nov PROPN aji-51 644 15 24 24 NUM aji-51 644 16 . . PUNCT aji-51 645 1 pmid pmid NOUN aji-51 645 2 : : PUNCT aji-51 645 3 16308421 16308421 NUM aji-51 645 4 ; ; PUNCT aji-51 645 5 pmcid pmcid ADJ aji-51 645 6 : : PUNCT aji-51 645 7 pmc3074427 pmc3074427 NOUN aji-51 645 8 . . PUNCT aji-51 646 1 17 17 NUM aji-51 646 2 . . PUNCT aji-51 646 3 towler towler PROPN aji-51 646 4 mc mc PROPN aji-51 646 5 , , PUNCT aji-51 646 6 hardie hardie PROPN aji-51 646 7 dg dg PROPN aji-51 646 8 . . PUNCT aji-51 647 1 amp amp NOUN aji-51 647 2 - - PUNCT aji-51 647 3 activated activate VERB aji-51 647 4 protein protein NOUN aji-51 647 5 kinase kinase NOUN aji-51 647 6 in in ADP aji-51 647 7 metabolic metabolic NOUN aji-51 647 8 control control NOUN aji-51 647 9 and and CCONJ aji-51 647 10 insulin insulin NOUN aji-51 647 11 signaling signal VERB aji-51 647 12 . . PUNCT aji-51 648 1 circ circ PROPN aji-51 648 2 res re NOUN aji-51 648 3 . . PUNCT aji-51 649 1 2007 2007 NUM aji-51 649 2 feb feb PROPN aji-51 649 3 16;100(3):328 16;100(3):328 PROPN aji-51 649 4 - - SYM aji-51 649 5 41 41 NUM aji-51 649 6 . . PUNCT aji-51 650 1 doi:10.1161/01.res.0000256090.42690.0 doi:10.1161/01.res.0000256090.42690.0 NOUN aji-51 650 2 5 5 NUM aji-51 650 3 pmid pmid NOUN aji-51 650 4 : : PUNCT aji-51 650 5 17307971 17307971 NUM aji-51 650 6 . . PUNCT aji-51 651 1 18 18 NUM aji-51 651 2 . . PUNCT aji-51 651 3 guertin guertin PROPN aji-51 651 4 da da PROPN aji-51 651 5 , , PUNCT aji-51 651 6 sabatini sabatini PROPN aji-51 651 7 dm dm PROPN aji-51 651 8 . . PUNCT aji-51 651 9 defining define VERB aji-51 651 10 the the DET aji-51 651 11 role role NOUN aji-51 651 12 of of ADP aji-51 651 13 mtor mtor NOUN aji-51 651 14 in in ADP aji-51 651 15 cancer cancer NOUN aji-51 651 16 . . PUNCT aji-51 652 1 cancer cancer NOUN aji-51 652 2 cell cell NOUN aji-51 652 3 . . PUNCT aji-51 653 1 2007 2007 NUM aji-51 653 2 jul;12(1):9 jul;12(1):9 PROPN aji-51 653 3 - - SYM aji-51 653 4 22 22 NUM aji-51 653 5 . . PUNCT aji-51 654 1 doi doi NOUN aji-51 654 2 : : PUNCT aji-51 654 3 10.1016 10.1016 NUM aji-51 654 4 / / SYM aji-51 654 5 j.ccr.2007.05.008 j.ccr.2007.05.008 PROPN aji-51 654 6 pmid pmid NOUN aji-51 654 7 : : PUNCT aji-51 654 8 17613433 17613433 NUM aji-51 654 9 . . PUNCT aji-51 655 1 19 19 NUM aji-51 655 2 . . X aji-51 655 3 jalving jalve VERB aji-51 655 4 m m PROPN aji-51 655 5 , , PUNCT aji-51 655 6 gietema gietema PROPN aji-51 655 7 ja ja PROPN aji-51 655 8 , , PUNCT aji-51 655 9 lefrandt lefrandt PROPN aji-51 655 10 jd jd PROPN aji-51 655 11 , , PUNCT aji-51 655 12 de de PROPN aji-51 655 13 jong jong PROPN aji-51 655 14 s s PROPN aji-51 655 15 , , PUNCT aji-51 655 16 reyners reyners PROPN aji-51 655 17 ak ak PROPN aji-51 655 18 , , PUNCT aji-51 655 19 gans gans PROPN aji-51 655 20 ro ro X aji-51 655 21 , , PUNCT aji-51 655 22 de de PROPN aji-51 655 23 vries vries PROPN aji-51 655 24 eg eg PROPN aji-51 655 25 . . PUNCT aji-51 656 1 metformin metformin PROPN aji-51 656 2 : : PUNCT aji-51 656 3 taking take VERB aji-51 656 4 away away ADP aji-51 656 5 the the DET aji-51 656 6 candy candy NOUN aji-51 656 7 for for ADP aji-51 656 8 cancer cancer NOUN aji-51 656 9 ? ? PUNCT aji-51 657 1 eur eur PROPN aji-51 657 2 j j PROPN aji-51 657 3 cancer cancer NOUN aji-51 657 4 . . PUNCT aji-51 658 1 2010 2010 NUM aji-51 658 2 sep;46(13):2369 sep;46(13):2369 NOUN aji-51 658 3 - - PUNCT aji-51 658 4 80 80 NUM aji-51 658 5 . . PUNCT aji-51 659 1 doi doi NOUN aji-51 659 2 : : PUNCT aji-51 659 3 10.1016 10.1016 NUM aji-51 659 4 / / SYM aji-51 659 5 j.ejca.2010.06.012 j.ejca.2010.06.012 PROPN aji-51 659 6 epub epub PROPN aji-51 659 7 2010 2010 NUM aji-51 659 8 jul jul PROPN aji-51 659 9 23 23 NUM aji-51 659 10 . . PUNCT aji-51 660 1 pmid pmid NOUN aji-51 660 2 : : PUNCT aji-51 660 3 20656475 20656475 NUM aji-51 660 4 . . PUNCT aji-51 661 1 20 20 NUM aji-51 661 2 . . PUNCT aji-51 662 1 liu liu PROPN aji-51 662 2 h h PROPN aji-51 662 3 , , PUNCT aji-51 662 4 scholz scholz NOUN aji-51 662 5 c c NOUN aji-51 662 6 , , PUNCT aji-51 662 7 zang zang PROPN aji-51 662 8 c c X aji-51 662 9 , , PUNCT aji-51 662 10 schefe schefe NOUN aji-51 662 11 jh jh PROPN aji-51 662 12 , , PUNCT aji-51 662 13 habbel habbel NOUN aji-51 662 14 p p NOUN aji-51 662 15 , , PUNCT aji-51 662 16 regierer regierer ADJ aji-51 662 17 ac ac PROPN aji-51 662 18 , , PUNCT aji-51 662 19 schulz schulz PROPN aji-51 662 20 co co NOUN aji-51 662 21 , , PUNCT aji-51 662 22 possinger possinger NOUN aji-51 662 23 k k PROPN aji-51 662 24 , , PUNCT aji-51 662 25 eucker eucker NOUN aji-51 662 26 j. j. PROPN aji-51 662 27 metformin metformin PROPN aji-51 662 28 and and CCONJ aji-51 662 29 the the DET aji-51 662 30 mtor mtor PROPN aji-51 662 31 inhibitor inhibitor NOUN aji-51 662 32 everolimus everolimus NOUN aji-51 662 33 ( ( PUNCT aji-51 662 34 rad001 rad001 PROPN aji-51 662 35 ) ) PUNCT aji-51 662 36 sensitize sensitize VERB aji-51 662 37 breast breast NOUN aji-51 662 38 cancer cancer NOUN aji-51 662 39 cells cell NOUN aji-51 662 40 to to ADP aji-51 662 41 the the DET aji-51 662 42 cytotoxic cytotoxic ADJ aji-51 662 43 effect effect NOUN aji-51 662 44 of of ADP aji-51 662 45 chemotherapeutic chemotherapeutic ADJ aji-51 662 46 drugs drug NOUN aji-51 662 47 in in ADP aji-51 662 48 vitro vitro X aji-51 662 49 . . PUNCT aji-51 663 1 anticancer anticancer NOUN aji-51 663 2 res re NOUN aji-51 663 3 . . PUNCT aji-51 664 1 2012;32(5):162737 2012;32(5):162737 NUM aji-51 664 2 . . PUNCT aji-51 665 1 pmid pmid NOUN aji-51 665 2 : : PUNCT aji-51 665 3 22593441 22593441 NUM aji-51 665 4 . . PUNCT aji-51 666 1 21 21 NUM aji-51 666 2 . . PUNCT aji-51 667 1 hoesel hoesel PROPN aji-51 667 2 b b NOUN aji-51 667 3 , , PUNCT aji-51 667 4 schmid schmid PROPN aji-51 667 5 ja ja PROPN aji-51 667 6 . . PUNCT aji-51 668 1 the the DET aji-51 668 2 complexity complexity NOUN aji-51 668 3 of of ADP aji-51 668 4 nf nf ADJ aji-51 668 5 - - PUNCT aji-51 668 6 κb κb NOUN aji-51 668 7 signaling signal VERB aji-51 668 8 in in ADP aji-51 668 9 inflammation inflammation NOUN aji-51 668 10 and and CCONJ aji-51 668 11 cancer cancer NOUN aji-51 668 12 . . PUNCT aji-51 669 1 mol mol ADP aji-51 669 2 cancer cancer NOUN aji-51 669 3 . . PUNCT aji-51 670 1 2013 2013 NUM aji-51 670 2 aug aug PROPN aji-51 670 3 2;12:86 2;12:86 PROPN aji-51 670 4 . . PUNCT aji-51 671 1 doi doi NOUN aji-51 671 2 : : PUNCT aji-51 671 3 10.1186/1476 10.1186/1476 NUM aji-51 671 4 - - SYM aji-51 671 5 4598 4598 NUM aji-51 671 6 - - SYM aji-51 671 7 12 12 NUM aji-51 671 8 - - PUNCT aji-51 671 9 86 86 NUM aji-51 671 10 pmid pmid NOUN aji-51 671 11 : : PUNCT aji-51 671 12 23915189 23915189 NUM aji-51 671 13 ; ; PUNCT aji-51 671 14 pmcid pmcid NOUN aji-51 671 15 : : PUNCT aji-51 671 16 pmc3750319 pmc3750319 INTJ aji-51 671 17 . . PUNCT aji-51 672 1 22 22 NUM aji-51 672 2 . . PUNCT aji-51 673 1 shemenski shemenski PROPN aji-51 673 2 j. j. PROPN aji-51 673 3 cimetidine cimetidine PROPN aji-51 673 4 as as ADP aji-51 673 5 a a DET aji-51 673 6 novel novel ADJ aji-51 673 7 adjunctive adjunctive ADJ aji-51 673 8 treatment treatment NOUN aji-51 673 9 for for ADP aji-51 673 10 early early ADJ aji-51 673 11 stage stage NOUN aji-51 673 12 lyme lyme NOUN aji-51 673 13 disease disease NOUN aji-51 673 14 . . PUNCT aji-51 674 1 med med ADJ aji-51 674 2 hypotheses hypothesis NOUN aji-51 674 3 . . PUNCT aji-51 675 1 2019 2019 NUM aji-51 675 2 jul;128:94 jul;128:94 NOUN aji-51 675 3 - - PUNCT aji-51 675 4 100 100 NUM aji-51 675 5 . . PUNCT aji-51 676 1 doi doi NOUN aji-51 676 2 : : PUNCT aji-51 676 3 10.1016 10.1016 NUM aji-51 676 4 / / SYM aji-51 676 5 j.mehy.2016.03.015 j.mehy.2016.03.015 PROPN aji-51 676 6 epub epub PROPN aji-51 676 7 2016 2016 NUM aji-51 676 8 apr apr NOUN aji-51 676 9 9 9 NUM aji-51 676 10 . . PUNCT aji-51 677 1 pmid pmid NOUN aji-51 677 2 : : PUNCT aji-51 677 3 27107653 27107653 NUM aji-51 677 4 . . PUNCT aji-51 678 1 23 23 NUM aji-51 678 2 . . X aji-51 678 3 kotsafti kotsafti PROPN aji-51 678 4 a a DET aji-51 678 5 , , PUNCT aji-51 678 6 scarpa scarpa NOUN aji-51 678 7 m m PROPN aji-51 678 8 , , PUNCT aji-51 678 9 castagliuolo castagliuolo PROPN aji-51 678 10 i i PRON aji-51 678 11 , , PUNCT aji-51 678 12 scarpa scarpa NOUN aji-51 678 13 m. m. NOUN aji-51 678 14 reactive reactive ADJ aji-51 678 15 oxygen oxygen NOUN aji-51 678 16 species specie NOUN aji-51 678 17 and and CCONJ aji-51 678 18 antitumor antitumor PROPN aji-51 678 19 immunity immunity NOUN aji-51 678 20 - - PUNCT aji-51 678 21 from from ADP aji-51 678 22 surveillance surveillance NOUN aji-51 678 23 to to ADP aji-51 678 24 evasion evasion NOUN aji-51 678 25 . . PUNCT aji-51 679 1 cancers cancer NOUN aji-51 679 2 ( ( PUNCT aji-51 679 3 basel basel PROPN aji-51 679 4 ) ) PUNCT aji-51 679 5 . . PUNCT aji-51 680 1 2020 2020 NUM aji-51 680 2 jul jul PROPN aji-51 680 3 1;12(7):1748 1;12(7):1748 NUM aji-51 680 4 . . PUNCT aji-51 681 1 doi doi NOUN aji-51 681 2 : : PUNCT aji-51 681 3 10.3390 10.3390 NUM aji-51 681 4 / / SYM aji-51 681 5 cancers12071748 cancers12071748 NOUN aji-51 681 6 pmid pmid NOUN aji-51 681 7 : : PUNCT aji-51 681 8 32630174 32630174 NUM aji-51 681 9 ; ; PUNCT aji-51 681 10 pmcid pmcid ADJ aji-51 681 11 : : PUNCT aji-51 681 12 pmc7409327 pmc7409327 ADJ aji-51 681 13 . . PUNCT aji-51 682 1 24 24 NUM aji-51 682 2 . . PUNCT aji-51 683 1 hirsch hirsch PROPN aji-51 683 2 ha ha PROPN aji-51 683 3 , , PUNCT aji-51 683 4 iliopoulos iliopoulos PROPN aji-51 683 5 d d PROPN aji-51 683 6 , , PUNCT aji-51 683 7 struhl struhl PROPN aji-51 683 8 k. k. PROPN aji-51 683 9 metformin metformin PROPN aji-51 683 10 inhibits inhibit VERB aji-51 683 11 the the DET aji-51 683 12 inflammatory inflammatory ADJ aji-51 683 13 response response NOUN aji-51 683 14 associated associate VERB aji-51 683 15 with with ADP aji-51 683 16 cellular cellular ADJ aji-51 683 17 transformation transformation NOUN aji-51 683 18 and and CCONJ aji-51 683 19 cancer cancer NOUN aji-51 683 20 stem stem NOUN aji-51 683 21 cell cell NOUN aji-51 683 22 growth growth NOUN aji-51 683 23 . . PUNCT aji-51 684 1 proc proc PROPN aji-51 684 2 natl natl PROPN aji-51 684 3 acad acad PROPN aji-51 684 4 sci sci PROPN aji-51 684 5 u u PROPN aji-51 684 6 s s PROPN aji-51 684 7 a. a. NOUN aji-51 684 8 2013 2013 NUM aji-51 684 9 jan jan PROPN aji-51 684 10 15;110(3):972 15;110(3):972 PROPN aji-51 684 11 - - SYM aji-51 684 12 7 7 NUM aji-51 684 13 . . PUNCT aji-51 684 14 doi doi NOUN aji-51 684 15 : : PUNCT aji-51 684 16 10.1073 10.1073 NUM aji-51 684 17 / / SYM aji-51 684 18 pnas.1221055110 pnas.1221055110 PROPN aji-51 684 19 epub epub NOUN aji-51 684 20 2012 2012 NUM aji-51 684 21 dec dec PROPN aji-51 684 22 31 31 NUM aji-51 684 23 . . PUNCT aji-51 685 1 pmid pmid NOUN aji-51 685 2 : : PUNCT aji-51 685 3 23277563 23277563 NUM aji-51 685 4 ; ; PUNCT aji-51 685 5 pmcid pmcid ADJ aji-51 685 6 : : PUNCT aji-51 685 7 pmc3549132 pmc3549132 NOUN aji-51 685 8 . . PUNCT aji-51 686 1 25 25 NUM aji-51 686 2 . . PUNCT aji-51 687 1 prasad prasad PROPN aji-51 687 2 s s PROPN aji-51 687 3 , , PUNCT aji-51 687 4 ravindran ravindran PROPN aji-51 687 5 j j PROPN aji-51 687 6 , , PUNCT aji-51 687 7 aggarwal aggarwal PROPN aji-51 687 8 bb bb PROPN aji-51 687 9 . . PUNCT aji-51 687 10 nfkappab nfkappab PROPN aji-51 687 11 and and CCONJ aji-51 687 12 cancer cancer NOUN aji-51 687 13 : : PUNCT aji-51 687 14 how how SCONJ aji-51 687 15 intimate intimate ADJ aji-51 687 16 is be AUX aji-51 687 17 this this DET aji-51 687 18 relationship relationship NOUN aji-51 687 19 . . PUNCT aji-51 688 1 mol mol ADP aji-51 688 2 cell cell NOUN aji-51 688 3 biochem biochem PROPN aji-51 688 4 . . PUNCT aji-51 689 1 2010 2010 NUM aji-51 690 1 mar;336(1 mar;336(1 PROPN aji-51 690 2 - - PUNCT aji-51 690 3 2):25 2):25 NUM aji-51 690 4 - - PUNCT aji-51 690 5 37 37 NUM aji-51 690 6 . . PUNCT aji-51 691 1 doi doi NOUN aji-51 691 2 : : PUNCT aji-51 691 3 10.1007 10.1007 NUM aji-51 691 4 / / SYM aji-51 691 5 s11010 s11010 NOUN aji-51 691 6 - - PUNCT aji-51 691 7 009 009 NUM aji-51 691 8 - - PUNCT aji-51 691 9 0267 0267 NUM aji-51 691 10 - - PUNCT aji-51 691 11 2 2 NUM aji-51 691 12 epub epub NOUN aji-51 691 13 2009 2009 NUM aji-51 691 14 oct oct NOUN aji-51 691 15 8 8 NUM aji-51 691 16 . . PUNCT aji-51 692 1 pmid pmid NOUN aji-51 692 2 : : PUNCT aji-51 692 3 19823771 19823771 NUM aji-51 692 4 ; ; PUNCT aji-51 692 5 pmcid pmcid NOUN aji-51 692 6 : : PUNCT aji-51 692 7 pmc3148942 pmc3148942 ADJ aji-51 692 8 . . PUNCT aji-51 693 1 26 26 NUM aji-51 693 2 . . PUNCT aji-51 694 1 iliopoulos iliopoulos PROPN aji-51 694 2 d d PROPN aji-51 694 3 , , PUNCT aji-51 694 4 hirsch hirsch PROPN aji-51 694 5 ha ha INTJ aji-51 694 6 , , PUNCT aji-51 694 7 struhl struhl PROPN aji-51 694 8 k. k. PROPN aji-51 694 9 metformin metformin PROPN aji-51 694 10 decreases decrease VERB aji-51 694 11 the the DET aji-51 694 12 dose dose NOUN aji-51 694 13 of of ADP aji-51 694 14 chemotherapy chemotherapy NOUN aji-51 694 15 for for ADP aji-51 694 16 prolonging prolong VERB aji-51 694 17 tumor tumor NOUN aji-51 694 18 remission remission NOUN aji-51 694 19 in in ADP aji-51 694 20 mouse mouse NOUN aji-51 694 21 xenografts xenograft NOUN aji-51 694 22 involving involve VERB aji-51 694 23 multiple multiple ADJ aji-51 694 24 cancer cancer NOUN aji-51 694 25 cell cell NOUN aji-51 694 26 types type NOUN aji-51 694 27 . . PUNCT aji-51 695 1 cancer cancer NOUN aji-51 695 2 res re NOUN aji-51 695 3 . . PUNCT aji-51 696 1 2011 2011 NUM aji-51 696 2 may may AUX aji-51 696 3 1;71(9):3196 1;71(9):3196 NUM aji-51 696 4 - - PUNCT aji-51 696 5 201 201 NUM aji-51 696 6 . . PUNCT aji-51 697 1 doi doi NOUN aji-51 697 2 : : PUNCT aji-51 697 3 10.1158/0008 10.1158/0008 NUM aji-51 697 4 - - SYM aji-51 697 5 5472.can-10 5472.can-10 NUM aji-51 697 6 - - PUNCT aji-51 697 7 3471 3471 NUM aji-51 697 8 epub epub NOUN aji-51 697 9 2011 2011 NUM aji-51 697 10 mar mar PROPN aji-51 697 11 17 17 NUM aji-51 697 12 . . PUNCT aji-51 698 1 pmid pmid NOUN aji-51 698 2 : : PUNCT aji-51 698 3 21415163 21415163 NUM aji-51 698 4 ; ; PUNCT aji-51 698 5 pmcid pmcid NOUN aji-51 698 6 : : PUNCT aji-51 698 7 pmc3085572 pmc3085572 NOUN aji-51 698 8 . . PUNCT aji-51 699 1 27 27 NUM aji-51 699 2 . . PUNCT aji-51 700 1 rosa rosa PROPN aji-51 700 2 r r PROPN aji-51 700 3 , , PUNCT aji-51 700 4 d'amato d'amato PROPN aji-51 700 5 v v ADP aji-51 700 6 , , PUNCT aji-51 700 7 de de PROPN aji-51 700 8 placido placido PROPN aji-51 700 9 s s PROPN aji-51 700 10 , , PUNCT aji-51 700 11 bianco bianco PROPN aji-51 700 12 r. r. PROPN aji-51 700 13 approaches approach VERB aji-51 700 14 for for ADP aji-51 700 15 targeting target VERB aji-51 700 16 cancer cancer NOUN aji-51 700 17 stem stem NOUN aji-51 700 18 cells cell NOUN aji-51 700 19 drug drug NOUN aji-51 700 20 resistance resistance NOUN aji-51 700 21 . . PUNCT aji-51 701 1 expert expert NOUN aji-51 701 2 opin opin NOUN aji-51 701 3 drug drug NOUN aji-51 701 4 discov discov NOUN aji-51 701 5 . . PUNCT aji-51 702 1 2016 2016 NUM aji-51 702 2 dec;11(12):1201 dec;11(12):1201 NOUN aji-51 702 3 - - PUNCT aji-51 702 4 1212 1212 NUM aji-51 702 5 . . PUNCT aji-51 703 1 doi doi NOUN aji-51 703 2 : : PUNCT aji-51 703 3 10.1080/17460441.2016.1243525 10.1080/17460441.2016.1243525 NUM aji-51 703 4 epub epub NOUN aji-51 703 5 2016 2016 NUM aji-51 703 6 oct oct PROPN aji-51 703 7 14 14 NUM aji-51 703 8 . . PUNCT aji-51 704 1 pmid pmid NOUN aji-51 704 2 : : PUNCT aji-51 704 3 27700193 27700193 NUM aji-51 704 4 . . PUNCT aji-51 705 1 28 28 NUM aji-51 705 2 . . PUNCT aji-51 706 1 dragu dragu PROPN aji-51 706 2 dl dl PROPN aji-51 706 3 , , PUNCT aji-51 706 4 necula necula PROPN aji-51 706 5 lg lg PROPN aji-51 706 6 , , PUNCT aji-51 706 7 bleotu bleotu NOUN aji-51 706 8 c c PROPN aji-51 706 9 , , PUNCT aji-51 706 10 diaconu diaconu NOUN aji-51 706 11 cc cc PROPN aji-51 706 12 , , PUNCT aji-51 706 13 chivu chivu NOUN aji-51 706 14 - - PUNCT aji-51 706 15 economescu economescu NOUN aji-51 706 16 m. m. NOUN aji-51 706 17 therapies therapy NOUN aji-51 706 18 targeting target VERB aji-51 706 19 cancer cancer NOUN aji-51 706 20 stem stem NOUN aji-51 706 21 cells cell NOUN aji-51 706 22 : : PUNCT aji-51 706 23 current current ADJ aji-51 706 24 trends trend NOUN aji-51 706 25 and and CCONJ aji-51 706 26 future future ADJ aji-51 706 27 challenges challenge NOUN aji-51 706 28 . . PUNCT aji-51 707 1 world world NOUN aji-51 707 2 j j PROPN aji-51 707 3 stem stem NOUN aji-51 707 4 cells cell NOUN aji-51 707 5 . . PUNCT aji-51 708 1 2015 2015 NUM aji-51 708 2 oct oct NOUN aji-51 708 3 26;7(9):1185 26;7(9):1185 NUM aji-51 708 4 - - PUNCT aji-51 708 5 201 201 NUM aji-51 708 6 . . PUNCT aji-51 709 1 doi doi NOUN aji-51 709 2 : : PUNCT aji-51 709 3 10.4252 10.4252 NUM aji-51 709 4 / / SYM aji-51 709 5 wjsc.v7.i9.1185 wjsc.v7.i9.1185 NUM aji-51 709 6 pmid pmid NOUN aji-51 709 7 : : PUNCT aji-51 709 8 26516409 26516409 NUM aji-51 709 9 ; ; PUNCT aji-51 709 10 stoff stoff PROPN aji-51 709 11 ; ; PUNCT aji-51 709 12 aji aji PROPN aji-51 709 13 , , PUNCT aji-51 709 14 5(1 5(1 NUM aji-51 709 15 ): ): PUNCT aji-51 709 16 1 1 NUM aji-51 709 17 - - SYM aji-51 709 18 39 39 NUM aji-51 709 19 , , PUNCT aji-51 709 20 2022 2022 NUM aji-51 709 21 ; ; PUNCT aji-51 709 22 article article NOUN aji-51 709 23 no.aji.77967 no.aji.77967 PROPN aji-51 709 24 19 19 NUM aji-51 709 25 pmcid pmcid NOUN aji-51 709 26 : : PUNCT aji-51 709 27 pmc4620424 pmc4620424 PROPN aji-51 709 28 . . PUNCT aji-51 710 1 29 29 NUM aji-51 710 2 . . PUNCT aji-51 710 3 clavo clavo PROPN aji-51 710 4 b b PROPN aji-51 710 5 , , PUNCT aji-51 710 6 pérez pérez NOUN aji-51 710 7 jl jl NOUN aji-51 710 8 , , PUNCT aji-51 710 9 lópez lópez PROPN aji-51 710 10 l l PROPN aji-51 710 11 , , PUNCT aji-51 710 12 suárez suárez NOUN aji-51 710 13 g g PROPN aji-51 710 14 , , PUNCT aji-51 710 15 lloret lloret PROPN aji-51 710 16 m m PROPN aji-51 710 17 , , PUNCT aji-51 710 18 rodríguez rodríguez NOUN aji-51 710 19 v v NOUN aji-51 710 20 , , PUNCT aji-51 710 21 macías macías PROPN aji-51 710 22 d d PROPN aji-51 710 23 , , PUNCT aji-51 710 24 santana santana PROPN aji-51 710 25 m m PROPN aji-51 710 26 , , PUNCT aji-51 710 27 hernández hernández PROPN aji-51 710 28 ma ma PROPN aji-51 710 29 , , PUNCT aji-51 710 30 martín martín NOUN aji-51 710 31 - - PUNCT aji-51 710 32 oliva oliva PROPN aji-51 710 33 r r PROPN aji-51 710 34 , , PUNCT aji-51 710 35 robaina robaina NOUN aji-51 710 36 f. f. PROPN aji-51 710 37 ozone ozone NOUN aji-51 710 38 therapy therapy NOUN aji-51 710 39 for for ADP aji-51 710 40 tumor tumor NOUN aji-51 710 41 oxygenation oxygenation NOUN aji-51 710 42 : : PUNCT aji-51 710 43 a a DET aji-51 710 44 pilot pilot NOUN aji-51 710 45 study study NOUN aji-51 710 46 . . PUNCT aji-51 711 1 evid evid PROPN aji-51 711 2 based base VERB aji-51 711 3 complement complement PROPN aji-51 711 4 alternat alternat NOUN aji-51 711 5 med me VERB aji-51 711 6 . . PUNCT aji-51 712 1 2004 2004 NUM aji-51 712 2 jun jun PROPN aji-51 712 3 1;1(1):93 1;1(1):93 NUM aji-51 712 4 - - SYM aji-51 712 5 98 98 NUM aji-51 712 6 . . PUNCT aji-51 713 1 doi doi NOUN aji-51 713 2 : : PUNCT aji-51 713 3 10.1093 10.1093 NUM aji-51 713 4 / / SYM aji-51 713 5 ecam ecam NOUN aji-51 713 6 / / SYM aji-51 713 7 neh009 neh009 PROPN aji-51 713 8 pmid pmid PROPN aji-51 713 9 : : PUNCT aji-51 713 10 15257330 15257330 NUM aji-51 713 11 ; ; PUNCT aji-51 713 12 pmcid pmcid ADJ aji-51 713 13 : : PUNCT aji-51 713 14 pmc442111 pmc442111 ADJ aji-51 713 15 . . PUNCT aji-51 714 1 30 30 NUM aji-51 714 2 . . PUNCT aji-51 715 1 sweet sweet ADJ aji-51 715 2 f f PROPN aji-51 715 3 , , PUNCT aji-51 715 4 kao kao PROPN aji-51 715 5 ms ms PROPN aji-51 715 6 , , PUNCT aji-51 715 7 lee lee PROPN aji-51 715 8 sc sc PROPN aji-51 715 9 , , PUNCT aji-51 715 10 hagar hagar PROPN aji-51 715 11 wl wl PROPN aji-51 715 12 , , PUNCT aji-51 715 13 sweet sweet ADJ aji-51 715 14 we we PRON aji-51 715 15 . . PUNCT aji-51 716 1 ozone ozone NOUN aji-51 716 2 selectively selectively ADV aji-51 716 3 inhibits inhibit VERB aji-51 716 4 growth growth NOUN aji-51 716 5 of of ADP aji-51 716 6 human human ADJ aji-51 716 7 cancer cancer NOUN aji-51 716 8 cells cell NOUN aji-51 716 9 . . PUNCT aji-51 717 1 science science NOUN aji-51 717 2 . . PUNCT aji-51 718 1 1980 1980 NUM aji-51 718 2 aug aug PROPN aji-51 718 3 22;209(4459):931 22;209(4459):931 NUM aji-51 718 4 - - SYM aji-51 718 5 3 3 NUM aji-51 718 6 . . PUNCT aji-51 718 7 doi doi NOUN aji-51 718 8 : : PUNCT aji-51 718 9 10.1126 10.1126 NUM aji-51 718 10 / / SYM aji-51 718 11 science.7403859 science.7403859 PROPN aji-51 718 12 pmid pmid PROPN aji-51 718 13 : : PUNCT aji-51 718 14 7403859 7403859 NUM aji-51 718 15 . . PUNCT aji-51 719 1 31 31 NUM aji-51 719 2 . . PUNCT aji-51 720 1 bocci bocci PROPN aji-51 720 2 v v PROPN aji-51 720 3 , , PUNCT aji-51 720 4 larini larini VERB aji-51 720 5 a a PRON aji-51 720 6 , , PUNCT aji-51 720 7 micheli micheli NOUN aji-51 720 8 v. v. ADP aji-51 720 9 restoration restoration NOUN aji-51 720 10 of of ADP aji-51 720 11 normoxia normoxia NOUN aji-51 720 12 by by ADP aji-51 720 13 ozone ozone NOUN aji-51 720 14 therapy therapy NOUN aji-51 720 15 may may AUX aji-51 720 16 control control VERB aji-51 720 17 neoplastic neoplastic ADJ aji-51 720 18 growth growth NOUN aji-51 720 19 : : PUNCT aji-51 720 20 a a DET aji-51 720 21 review review NOUN aji-51 720 22 and and CCONJ aji-51 720 23 a a DET aji-51 720 24 working work VERB aji-51 720 25 hypothesis hypothesis NOUN aji-51 720 26 . . PUNCT aji-51 721 1 j j PROPN aji-51 721 2 altern altern PROPN aji-51 721 3 complement complement PROPN aji-51 721 4 med me VERB aji-51 721 5 . . PUNCT aji-51 721 6 2005 2005 NUM aji-51 721 7 apr;11(2):257 apr;11(2):257 NOUN aji-51 721 8 - - PUNCT aji-51 721 9 65 65 NUM aji-51 721 10 . . PUNCT aji-51 722 1 doi doi NOUN aji-51 722 2 : : PUNCT aji-51 722 3 10.1089 10.1089 NUM aji-51 722 4 / / SYM aji-51 722 5 acm.2005.11.257 acm.2005.11.257 PROPN aji-51 722 6 pmid pmid NOUN aji-51 722 7 : : PUNCT aji-51 722 8 15865491 15865491 NUM aji-51 722 9 . . PUNCT aji-51 723 1 32 32 NUM aji-51 723 2 . . PUNCT aji-51 724 1 luongo luongo PROPN aji-51 724 2 m m PROPN aji-51 724 3 , , PUNCT aji-51 724 4 brigida brigida PROPN aji-51 724 5 al al PROPN aji-51 724 6 , , PUNCT aji-51 724 7 mascolo mascolo PROPN aji-51 724 8 l l PROPN aji-51 724 9 , , PUNCT aji-51 724 10 gaudino gaudino PROPN aji-51 724 11 g. g. PROPN aji-51 724 12 possible possible ADJ aji-51 724 13 therapeutic therapeutic ADJ aji-51 724 14 effects effect NOUN aji-51 724 15 of of ADP aji-51 724 16 ozone ozone NOUN aji-51 724 17 mixture mixture NOUN aji-51 724 18 on on ADP aji-51 724 19 hypoxia hypoxia NOUN aji-51 724 20 in in ADP aji-51 724 21 tumor tumor NOUN aji-51 724 22 development development NOUN aji-51 724 23 . . PUNCT aji-51 725 1 anticancer anticancer NOUN aji-51 725 2 res re NOUN aji-51 725 3 . . PROPN aji-51 725 4 2017 2017 NUM aji-51 725 5 feb;37(2):425 feb;37(2):425 NOUN aji-51 725 6 - - PUNCT aji-51 725 7 435 435 NUM aji-51 725 8 . . PUNCT aji-51 726 1 doi doi NOUN aji-51 726 2 : : PUNCT aji-51 726 3 10.21873 10.21873 NUM aji-51 726 4 / / SYM aji-51 726 5 anticanres.11334 anticanres.11334 PROPN aji-51 726 6 pmid pmid PROPN aji-51 726 7 : : PUNCT aji-51 726 8 28179287 28179287 NUM aji-51 726 9 . . PUNCT aji-51 727 1 33 33 NUM aji-51 727 2 . . PUNCT aji-51 728 1 cooke cooke PROPN aji-51 728 2 m m PROPN aji-51 728 3 , , PUNCT aji-51 728 4 iosia iosia PROPN aji-51 728 5 m m PROPN aji-51 728 6 , , PUNCT aji-51 728 7 buford buford PROPN aji-51 728 8 t t PROPN aji-51 728 9 , , PUNCT aji-51 728 10 shelmadine shelmadine NOUN aji-51 728 11 b b NUM aji-51 728 12 , , PUNCT aji-51 728 13 hudson hudson PROPN aji-51 728 14 g g PROPN aji-51 728 15 , , PUNCT aji-51 728 16 kerksick kerksick NOUN aji-51 728 17 c c PROPN aji-51 728 18 , , PUNCT aji-51 728 19 rasmussen rasmussen PROPN aji-51 728 20 c c PROPN aji-51 728 21 , , PUNCT aji-51 728 22 greenwood greenwood PROPN aji-51 728 23 m m PROPN aji-51 728 24 , , PUNCT aji-51 728 25 leutholtz leutholtz PROPN aji-51 728 26 b b PROPN aji-51 728 27 , , PUNCT aji-51 728 28 willoughby willoughby PROPN aji-51 728 29 d d PROPN aji-51 728 30 , , PUNCT aji-51 728 31 kreider kreider PROPN aji-51 728 32 r. r. PROPN aji-51 728 33 effects effect NOUN aji-51 728 34 of of ADP aji-51 728 35 acute acute ADJ aji-51 728 36 and and CCONJ aji-51 728 37 14 14 NUM aji-51 728 38 - - PUNCT aji-51 728 39 day day NOUN aji-51 728 40 coenzyme coenzyme PROPN aji-51 728 41 q10 q10 PROPN aji-51 728 42 supplementation supplementation NOUN aji-51 728 43 on on ADP aji-51 728 44 exercise exercise NOUN aji-51 728 45 performance performance NOUN aji-51 728 46 in in ADP aji-51 728 47 both both CCONJ aji-51 728 48 trained train VERB aji-51 728 49 and and CCONJ aji-51 728 50 untrained untrained ADJ aji-51 728 51 individuals individual NOUN aji-51 728 52 . . PUNCT aji-51 729 1 j j PROPN aji-51 729 2 int int PROPN aji-51 729 3 soc soc PROPN aji-51 729 4 sports sport NOUN aji-51 729 5 nutr nutr PROPN aji-51 729 6 . . PROPN aji-51 729 7 2008 2008 NUM aji-51 729 8 mar mar PROPN aji-51 729 9 4;5:8 4;5:8 PROPN aji-51 729 10 . . PUNCT aji-51 730 1 doi doi NOUN aji-51 730 2 : : PUNCT aji-51 730 3 10.1186/1550 10.1186/1550 NUM aji-51 730 4 - - SYM aji-51 730 5 2783 2783 NUM aji-51 730 6 - - SYM aji-51 730 7 5 5 NUM aji-51 730 8 - - SYM aji-51 730 9 8 8 NUM aji-51 730 10 pmid pmid NOUN aji-51 730 11 : : PUNCT aji-51 730 12 18318910 18318910 NUM aji-51 730 13 ; ; PUNCT aji-51 730 14 pmcid pmcid ADJ aji-51 730 15 : : PUNCT aji-51 730 16 pmc231563 pmc231563 NOUN aji-51 730 17 34 34 NUM aji-51 730 18 . . PUNCT aji-51 731 1 smith smith PROPN aji-51 731 2 nl nl PROPN aji-51 731 3 , , PUNCT aji-51 731 4 wilson wilson PROPN aji-51 731 5 al al PROPN aji-51 731 6 , , PUNCT aji-51 731 7 gandhi gandhi PROPN aji-51 731 8 j j PROPN aji-51 731 9 , , PUNCT aji-51 731 10 vatsia vatsia PROPN aji-51 731 11 s s PROPN aji-51 731 12 , , PUNCT aji-51 731 13 khan khan PROPN aji-51 731 14 sa sa PROPN aji-51 731 15 . . PUNCT aji-51 731 16 ozone ozone NOUN aji-51 731 17 therapy therapy NOUN aji-51 731 18 : : PUNCT aji-51 731 19 an an DET aji-51 731 20 overview overview NOUN aji-51 731 21 of of ADP aji-51 731 22 pharmacodynamics pharmacodynamic NOUN aji-51 731 23 , , PUNCT aji-51 731 24 current current ADJ aji-51 731 25 research research NOUN aji-51 731 26 , , PUNCT aji-51 731 27 and and CCONJ aji-51 731 28 clinical clinical ADJ aji-51 731 29 utility utility NOUN aji-51 731 30 . . PUNCT aji-51 732 1 med med ADJ aji-51 732 2 gas gas NOUN aji-51 732 3 res re NOUN aji-51 732 4 . . PROPN aji-51 732 5 2017 2017 NUM aji-51 732 6 oct oct NOUN aji-51 732 7 17;7(3):212 17;7(3):212 NUM aji-51 732 8 - - SYM aji-51 732 9 219 219 NUM aji-51 732 10 . . PUNCT aji-51 733 1 doi doi NOUN aji-51 733 2 : : PUNCT aji-51 733 3 10.4103/2045 10.4103/2045 NUM aji-51 733 4 - - PUNCT aji-51 733 5 9912.215752 9912.215752 NOUN aji-51 733 6 pmid pmid NOUN aji-51 733 7 : : PUNCT aji-51 733 8 29152215 29152215 NUM aji-51 733 9 ; ; PUNCT aji-51 733 10 pmcid pmcid ADJ aji-51 733 11 : : PUNCT aji-51 733 12 pmc5674660 pmc5674660 NOUN aji-51 733 13 . . PUNCT aji-51 734 1 35 35 NUM aji-51 734 2 . . X aji-51 734 3 re re VERB aji-51 734 4 l l PROPN aji-51 734 5 , , PUNCT aji-51 734 6 mawsouf mawsouf PROPN aji-51 734 7 mn mn PROPN aji-51 734 8 , , PUNCT aji-51 734 9 menéndez menéndez PROPN aji-51 734 10 s s PROPN aji-51 734 11 , , PUNCT aji-51 734 12 león león PROPN aji-51 734 13 os os PROPN aji-51 734 14 , , PUNCT aji-51 734 15 sánchez sánchez PROPN aji-51 734 16 gm gm PROPN aji-51 734 17 , , PUNCT aji-51 734 18 hernández hernández PROPN aji-51 734 19 f. f. PROPN aji-51 734 20 ozone ozone NOUN aji-51 734 21 therapy therapy NOUN aji-51 734 22 : : PUNCT aji-51 734 23 clinical clinical ADJ aji-51 734 24 and and CCONJ aji-51 734 25 basic basic ADJ aji-51 734 26 evidence evidence NOUN aji-51 734 27 of of ADP aji-51 734 28 its its PRON aji-51 734 29 therapeutic therapeutic ADJ aji-51 734 30 potential potential NOUN aji-51 734 31 . . PUNCT aji-51 735 1 arch arch ADJ aji-51 735 2 med med ADJ aji-51 735 3 res re NOUN aji-51 735 4 . . PUNCT aji-51 735 5 2008 2008 NUM aji-51 735 6 jan;39(1):17 jan;39(1):17 PROPN aji-51 735 7 - - SYM aji-51 735 8 26 26 NUM aji-51 735 9 . . PUNCT aji-51 736 1 doi doi NOUN aji-51 736 2 : : PUNCT aji-51 736 3 10.1016 10.1016 NUM aji-51 736 4 / / SYM aji-51 736 5 j.arcmed.2007.07.005 j.arcmed.2007.07.005 PROPN aji-51 736 6 epub epub NOUN aji-51 736 7 2007 2007 NUM aji-51 736 8 sep sep PROPN aji-51 736 9 29 29 NUM aji-51 736 10 . . PUNCT aji-51 737 1 pmid pmid NOUN aji-51 737 2 : : PUNCT aji-51 737 3 18067991 18067991 NUM aji-51 737 4 . . PUNCT aji-51 738 1 36 36 NUM aji-51 738 2 . . PUNCT aji-51 739 1 ballantyne ballantyne PROPN aji-51 739 2 cm cm PROPN aji-51 739 3 , , PUNCT aji-51 739 4 nambi nambi NOUN aji-51 739 5 v. v. ADP aji-51 739 6 markers marker NOUN aji-51 739 7 of of ADP aji-51 739 8 inflammation inflammation NOUN aji-51 739 9 and and CCONJ aji-51 739 10 their their PRON aji-51 739 11 clinical clinical ADJ aji-51 739 12 significance significance NOUN aji-51 739 13 . . PUNCT aji-51 740 1 atheroscler atheroscler PROPN aji-51 740 2 suppl suppl PROPN aji-51 740 3 . . PUNCT aji-51 741 1 2005 2005 NUM aji-51 741 2 may;6(2):21 may;6(2):21 NOUN aji-51 741 3 - - SYM aji-51 741 4 9 9 NUM aji-51 741 5 . . PUNCT aji-51 741 6 doi:10.1016 doi:10.1016 PROPN aji-51 741 7 / / SYM aji-51 741 8 j.atherosclerosissup.2005.02 j.atherosclerosissup.2005.02 PROPN aji-51 741 9 . . PUNCT aji-51 742 1 005 005 NUM aji-51 742 2 pmid pmid NOUN aji-51 742 3 : : PUNCT aji-51 742 4 15823493 15823493 NUM aji-51 742 5 . . PUNCT aji-51 743 1 37 37 NUM aji-51 743 2 . . PUNCT aji-51 744 1 il'yasova il'yasova PROPN aji-51 744 2 d d PROPN aji-51 744 3 , , PUNCT aji-51 744 4 colbert colbert PROPN aji-51 744 5 lh lh PROPN aji-51 744 6 , , PUNCT aji-51 744 7 harris harris PROPN aji-51 744 8 tb tb PROPN aji-51 744 9 , , PUNCT aji-51 744 10 newman newman PROPN aji-51 744 11 ab ab PROPN aji-51 744 12 , , PUNCT aji-51 744 13 bauer bauer PROPN aji-51 744 14 dc dc PROPN aji-51 744 15 , , PUNCT aji-51 744 16 satterfield satterfield PROPN aji-51 744 17 s s PROPN aji-51 744 18 , , PUNCT aji-51 744 19 kritchevsky kritchevsky PROPN aji-51 744 20 sb sb PROPN aji-51 744 21 . . PROPN aji-51 744 22 circulating circulate VERB aji-51 744 23 levels level NOUN aji-51 744 24 of of ADP aji-51 744 25 inflammatory inflammatory ADJ aji-51 744 26 markers marker NOUN aji-51 744 27 and and CCONJ aji-51 744 28 cancer cancer NOUN aji-51 744 29 risk risk NOUN aji-51 744 30 in in ADP aji-51 744 31 the the DET aji-51 744 32 health health NOUN aji-51 744 33 aging aging NOUN aji-51 744 34 and and CCONJ aji-51 744 35 body body NOUN aji-51 744 36 composition composition NOUN aji-51 744 37 cohort cohort NOUN aji-51 744 38 . . PUNCT aji-51 745 1 cancer cancer NOUN aji-51 745 2 epidemiol epidemiol PROPN aji-51 745 3 biomarkers biomarkers PROPN aji-51 745 4 prev prev X aji-51 745 5 . . PUNCT aji-51 746 1 2005 2005 NUM aji-51 746 2 oct;14(10):2413 oct;14(10):2413 NOUN aji-51 746 3 - - SYM aji-51 746 4 8 8 NUM aji-51 746 5 . . PUNCT aji-51 747 1 doi doi NOUN aji-51 747 2 : : PUNCT aji-51 747 3 10.1158/1055 10.1158/1055 NUM aji-51 747 4 - - PUNCT aji-51 747 5 9965.epi-05 9965.epi-05 NUM aji-51 747 6 - - PUNCT aji-51 747 7 0316 0316 NUM aji-51 747 8 pmid pmid PROPN aji-51 747 9 : : PUNCT aji-51 747 10 16214925 16214925 NUM aji-51 747 11 . . PUNCT aji-51 748 1 38 38 NUM aji-51 748 2 . . PUNCT aji-51 748 3 coussens coussens PROPN aji-51 748 4 lm lm PROPN aji-51 748 5 , , PUNCT aji-51 748 6 werb werb ADJ aji-51 748 7 z. z. PROPN aji-51 748 8 inflammation inflammation NOUN aji-51 748 9 and and CCONJ aji-51 748 10 cancer cancer NOUN aji-51 748 11 . . PUNCT aji-51 749 1 nature nature NOUN aji-51 749 2 . . PUNCT aji-51 750 1 2002 2002 NUM aji-51 750 2 dec dec PROPN aji-51 750 3 1926;420(6917):860 1926;420(6917):860 NUM aji-51 750 4 - - SYM aji-51 750 5 7 7 NUM aji-51 750 6 . . PUNCT aji-51 750 7 doi doi NOUN aji-51 750 8 : : PUNCT aji-51 750 9 10.1038 10.1038 NUM aji-51 750 10 / / SYM aji-51 750 11 nature01322 nature01322 PROPN aji-51 750 12 pmid pmid PROPN aji-51 750 13 : : PUNCT aji-51 750 14 12490959 12490959 NUM aji-51 750 15 ; ; PUNCT aji-51 750 16 pmcid pmcid ADJ aji-51 750 17 : : PUNCT aji-51 750 18 pmc2803035 pmc2803035 NOUN aji-51 750 19 . . PUNCT aji-51 751 1 39 39 NUM aji-51 751 2 . . PUNCT aji-51 752 1 singh singh PROPN aji-51 752 2 n n PART aji-51 752 3 , , PUNCT aji-51 752 4 baby baby NOUN aji-51 752 5 d d NOUN aji-51 752 6 , , PUNCT aji-51 752 7 rajguru rajguru ADJ aji-51 752 8 jp jp NOUN aji-51 752 9 , , PUNCT aji-51 752 10 patil patil PROPN aji-51 752 11 pb pb PROPN aji-51 752 12 , , PUNCT aji-51 752 13 thakkannavar thakkannavar PROPN aji-51 752 14 ss ss PROPN aji-51 752 15 , , PUNCT aji-51 752 16 pujari pujari PROPN aji-51 752 17 vb vb PROPN aji-51 752 18 . . PROPN aji-51 752 19 inflammation inflammation NOUN aji-51 752 20 and and CCONJ aji-51 752 21 cancer cancer NOUN aji-51 752 22 . . PUNCT aji-51 753 1 ann ann PROPN aji-51 753 2 afr afr PROPN aji-51 753 3 med med PROPN aji-51 753 4 . . PUNCT aji-51 754 1 2019 2019 NUM aji-51 754 2 julsep;18(3):121 julsep;18(3):121 NOUN aji-51 754 3 - - SYM aji-51 754 4 126 126 NUM aji-51 754 5 . . PUNCT aji-51 755 1 doi doi NOUN aji-51 755 2 : : PUNCT aji-51 755 3 10.4103 10.4103 NUM aji-51 755 4 / / SYM aji-51 755 5 aam.aam_56_18 aam.aam_56_18 PROPN aji-51 755 6 pmid pmid NOUN aji-51 755 7 : : PUNCT aji-51 755 8 31417011 31417011 NUM aji-51 755 9 ; ; PUNCT aji-51 755 10 pmcid pmcid ADJ aji-51 755 11 : : PUNCT aji-51 755 12 pmc6704802 pmc6704802 NOUN aji-51 755 13 . . PUNCT aji-51 756 1 40 40 NUM aji-51 756 2 . . PUNCT aji-51 757 1 gupta gupta PROPN aji-51 757 2 s s PROPN aji-51 757 3 , , PUNCT aji-51 757 4 srivastava srivastava PROPN aji-51 757 5 m m PROPN aji-51 757 6 , , PUNCT aji-51 757 7 ahmad ahmad PROPN aji-51 757 8 n n PRON aji-51 757 9 , , PUNCT aji-51 757 10 bostwick bostwick PROPN aji-51 757 11 dg dg PROPN aji-51 757 12 , , PUNCT aji-51 757 13 mukhtar mukhtar PROPN aji-51 757 14 h. h. PROPN aji-51 757 15 over over ADP aji-51 757 16 - - PUNCT aji-51 757 17 expression expression NOUN aji-51 757 18 of of ADP aji-51 757 19 cyclooxygenase-2 cyclooxygenase-2 NUM aji-51 757 20 in in ADP aji-51 757 21 human human ADJ aji-51 757 22 prostate prostate NOUN aji-51 757 23 adenocarcinoma adenocarcinoma NOUN aji-51 757 24 . . PUNCT aji-51 758 1 prostate prostate NOUN aji-51 758 2 . . PUNCT aji-51 759 1 2000 2000 NUM aji-51 760 1 jan;42(1):73 jan;42(1):73 ADV aji-51 760 2 - - PUNCT aji-51 760 3 8 8 NUM aji-51 760 4 . . PUNCT aji-51 761 1 doi doi NOUN aji-51 761 2 : : PUNCT aji-51 761 3 10.1002/(sici)10970045(20000101)42:1<73::aidpros9>3.0.co;2 10.1002/(sici)10970045(20000101)42:1<73::aidpros9>3.0.co;2 NUM aji-51 761 4 - - PUNCT aji-51 761 5 g g NOUN aji-51 761 6 pmid pmid NOUN aji-51 761 7 : : PUNCT aji-51 761 8 10579801 10579801 NUM aji-51 761 9 . . PUNCT aji-51 762 1 41 41 NUM aji-51 762 2 . . PUNCT aji-51 763 1 chen chen PROPN aji-51 763 2 yj yj PROPN aji-51 763 3 , , PUNCT aji-51 763 4 wang wang PROPN aji-51 763 5 ls ls PROPN aji-51 763 6 , , PUNCT aji-51 763 7 wang wang PROPN aji-51 763 8 ph ph PROPN aji-51 763 9 , , PUNCT aji-51 763 10 lai lai PROPN aji-51 763 11 cr cr PROPN aji-51 763 12 , , PUNCT aji-51 763 13 yen yen PROPN aji-51 763 14 ms ms PROPN aji-51 763 15 , , PUNCT aji-51 763 16 ng ng PROPN aji-51 763 17 ht ht PROPN aji-51 763 18 , , PUNCT aji-51 763 19 yuan yuan PROPN aji-51 763 20 cc cc PROPN aji-51 763 21 . . PROPN aji-51 763 22 high high ADJ aji-51 763 23 cyclooxygenase-2 cyclooxygenase-2 NUM aji-51 763 24 expression expression NOUN aji-51 763 25 in in ADP aji-51 763 26 cervical cervical ADJ aji-51 763 27 adenocarcinomas adenocarcinoma NOUN aji-51 763 28 . . PUNCT aji-51 764 1 gynecol gynecol ADJ aji-51 764 2 oncol oncol ADJ aji-51 764 3 . . PUNCT aji-51 765 1 2003 2003 NUM aji-51 765 2 mar;88(3):379 mar;88(3):379 NOUN aji-51 765 3 - - SYM aji-51 765 4 85 85 NUM aji-51 765 5 . . PUNCT aji-51 766 1 doi doi NOUN aji-51 766 2 : : PUNCT aji-51 766 3 10.1016 10.1016 NUM aji-51 766 4 / / SYM aji-51 766 5 s0090 s0090 PROPN aji-51 766 6 - - PUNCT aji-51 766 7 8258(02)00066 8258(02)00066 NUM aji-51 766 8 - - SYM aji-51 766 9 5 5 NUM aji-51 766 10 pmid pmid NOUN aji-51 766 11 : : PUNCT aji-51 766 12 12648590 12648590 NUM aji-51 766 13 . . PUNCT aji-51 767 1 42 42 NUM aji-51 767 2 . . PUNCT aji-51 768 1 cheng cheng PROPN aji-51 768 2 h h PROPN aji-51 768 3 , , PUNCT aji-51 768 4 lu lu PROPN aji-51 768 5 c c NOUN aji-51 768 6 , , PUNCT aji-51 768 7 tang tang X aji-51 768 8 r r NOUN aji-51 768 9 , , PUNCT aji-51 768 10 pan pan NOUN aji-51 768 11 y y PROPN aji-51 768 12 , , PUNCT aji-51 768 13 bao bao PROPN aji-51 768 14 s s PROPN aji-51 768 15 , , PUNCT aji-51 768 16 qiu qiu PROPN aji-51 768 17 y y PROPN aji-51 768 18 , , PUNCT aji-51 768 19 xie xie PROPN aji-51 768 20 m. m. PROPN aji-51 768 21 ellagic ellagic PROPN aji-51 768 22 acid acid PROPN aji-51 768 23 inhibits inhibit VERB aji-51 768 24 the the DET aji-51 768 25 proliferation proliferation NOUN aji-51 768 26 of of ADP aji-51 768 27 human human ADJ aji-51 768 28 pancreatic pancreatic ADJ aji-51 768 29 carcinoma carcinoma NOUN aji-51 769 1 panc-1 panc-1 NOUN aji-51 769 2 cells cell NOUN aji-51 769 3 in in ADP aji-51 769 4 vitro vitro X aji-51 769 5 and and CCONJ aji-51 769 6 in in ADP aji-51 769 7 vivo vivo NOUN aji-51 769 8 . . PUNCT aji-51 770 1 oncotarget oncotarget NOUN aji-51 770 2 . . PUNCT aji-51 771 1 2017 2017 NUM aji-51 771 2 feb feb PROPN aji-51 771 3 14;8(7):1230112310 14;8(7):1230112310 NUM aji-51 771 4 . . PUNCT aji-51 772 1 doi doi NOUN aji-51 772 2 : : PUNCT aji-51 772 3 10.18632 10.18632 NUM aji-51 772 4 / / SYM aji-51 772 5 oncotarget.14811 oncotarget.14811 NUM aji-51 772 6 pmid pmid PROPN aji-51 772 7 : : PUNCT aji-51 772 8 28135203 28135203 NUM aji-51 772 9 ; ; PUNCT aji-51 772 10 pmcid pmcid NOUN aji-51 772 11 : : PUNCT aji-51 772 12 pmc5355345 pmc5355345 ADJ aji-51 772 13 . . PUNCT aji-51 773 1 43 43 NUM aji-51 773 2 . . PUNCT aji-51 774 1 maroon maroon PROPN aji-51 774 2 jc jc PROPN aji-51 774 3 , , PUNCT aji-51 774 4 bost bost PROPN aji-51 774 5 jw jw PROPN aji-51 774 6 , , PUNCT aji-51 774 7 maroon maroon NOUN aji-51 774 8 a. a. NOUN aji-51 774 9 natural natural ADJ aji-51 774 10 anti anti ADJ aji-51 774 11 - - ADJ aji-51 774 12 inflammatory inflammatory ADJ aji-51 774 13 agents agent NOUN aji-51 774 14 for for ADP aji-51 774 15 pain pain NOUN aji-51 774 16 relief relief NOUN aji-51 774 17 . . PUNCT aji-51 775 1 surg surg PROPN aji-51 775 2 neurol neurol PROPN aji-51 775 3 int int PROPN aji-51 775 4 . . PUNCT aji-51 776 1 2010 2010 NUM aji-51 776 2 dec dec PROPN aji-51 776 3 13;1:80 13;1:80 NUM aji-51 776 4 . . PUNCT aji-51 777 1 doi doi NOUN aji-51 777 2 : : PUNCT aji-51 777 3 10.4103/2152 10.4103/2152 NUM aji-51 777 4 - - PUNCT aji-51 777 5 7806.73804 7806.73804 NUM aji-51 777 6 stoff stoff NOUN aji-51 777 7 ; ; PUNCT aji-51 777 8 aji aji PROPN aji-51 777 9 , , PUNCT aji-51 777 10 5(1 5(1 NUM aji-51 777 11 ): ): PUNCT aji-51 777 12 1 1 NUM aji-51 777 13 - - SYM aji-51 777 14 39 39 NUM aji-51 777 15 , , PUNCT aji-51 777 16 2022 2022 NUM aji-51 777 17 ; ; PUNCT aji-51 777 18 article article NOUN aji-51 777 19 no.aji.77967 no.aji.77967 PROPN aji-51 777 20 20 20 NUM aji-51 777 21 pmid pmid NOUN aji-51 777 22 : : PUNCT aji-51 777 23 21206541 21206541 NUM aji-51 777 24 ; ; PUNCT aji-51 777 25 pmcid pmcid NOUN aji-51 777 26 : : PUNCT aji-51 777 27 pmc3011108 pmc3011108 PROPN aji-51 777 28 . . PUNCT aji-51 778 1 44 44 NUM aji-51 778 2 . . PUNCT aji-51 779 1 bogaty bogaty PROPN aji-51 779 2 p p PROPN aji-51 779 3 , , PUNCT aji-51 779 4 brophy brophy PROPN aji-51 779 5 jm jm PROPN aji-51 779 6 , , PUNCT aji-51 779 7 noel noel PROPN aji-51 779 8 m m PROPN aji-51 779 9 , , PUNCT aji-51 779 10 boyer boyer PROPN aji-51 779 11 l l PROPN aji-51 779 12 , , PUNCT aji-51 779 13 simard simard PROPN aji-51 779 14 s s PROPN aji-51 779 15 , , PUNCT aji-51 779 16 bertrand bertrand PROPN aji-51 779 17 f f PROPN aji-51 779 18 , , PUNCT aji-51 779 19 dagenais dagenais PROPN aji-51 779 20 gr gr PROPN aji-51 779 21 . . PROPN aji-51 779 22 impact impact NOUN aji-51 779 23 of of ADP aji-51 779 24 prolonged prolonged ADJ aji-51 779 25 cyclooxygenase-2 cyclooxygenase-2 NUM aji-51 779 26 inhibition inhibition NOUN aji-51 779 27 on on ADP aji-51 779 28 inflammatory inflammatory ADJ aji-51 779 29 markers marker NOUN aji-51 779 30 and and CCONJ aji-51 779 31 endothelial endothelial ADJ aji-51 779 32 function function NOUN aji-51 779 33 in in ADP aji-51 779 34 patients patient NOUN aji-51 779 35 with with ADP aji-51 779 36 ischemic ischemic ADJ aji-51 779 37 heart heart NOUN aji-51 779 38 disease disease NOUN aji-51 779 39 and and CCONJ aji-51 779 40 raised raise VERB aji-51 779 41 creactive creactive ADJ aji-51 779 42 protein protein NOUN aji-51 779 43 : : PUNCT aji-51 779 44 a a DET aji-51 779 45 randomized randomized ADJ aji-51 779 46 placebocontrolled placebocontrolle VERB aji-51 779 47 study study NOUN aji-51 779 48 . . PUNCT aji-51 780 1 circulation circulation NOUN aji-51 780 2 . . PUNCT aji-51 781 1 2004 2004 NUM aji-51 781 2 aug aug PROPN aji-51 781 3 24;110(8):934 24;110(8):934 NOUN aji-51 781 4 - - SYM aji-51 781 5 9 9 NUM aji-51 781 6 . . PUNCT aji-51 782 1 doi:10.1161/01.cir.0000139338.12464.5 doi:10.1161/01.cir.0000139338.12464.5 PROPN aji-51 782 2 f f PROPN aji-51 782 3 epub epub PROPN aji-51 782 4 2004 2004 NUM aji-51 782 5 aug aug PROPN aji-51 782 6 9 9 NUM aji-51 782 7 . . PUNCT aji-51 783 1 pmid pmid NOUN aji-51 783 2 : : PUNCT aji-51 783 3 15302800 15302800 NUM aji-51 783 4 . . PUNCT aji-51 784 1 45 45 NUM aji-51 784 2 . . X aji-51 785 1 jendrossek jendrossek PROPN aji-51 785 2 v. v. ADP aji-51 785 3 targeting target VERB aji-51 785 4 apoptosis apoptosis NOUN aji-51 785 5 pathways pathway NOUN aji-51 785 6 by by ADP aji-51 785 7 celecoxib celecoxib NOUN aji-51 785 8 in in ADP aji-51 785 9 cancer cancer NOUN aji-51 785 10 . . PUNCT aji-51 786 1 cancer cancer PROPN aji-51 786 2 lett lett PROPN aji-51 786 3 . . PUNCT aji-51 787 1 2013 2013 NUM aji-51 787 2 may may PROPN aji-51 787 3 28;332(2):313 28;332(2):313 NUM aji-51 787 4 - - SYM aji-51 787 5 24 24 NUM aji-51 787 6 . . PUNCT aji-51 788 1 doi doi NOUN aji-51 788 2 : : PUNCT aji-51 788 3 10.1016 10.1016 NUM aji-51 788 4 / / SYM aji-51 788 5 j.canlet.2011.01.012 j.canlet.2011.01.012 PROPN aji-51 788 6 epub epub PROPN aji-51 788 7 2011 2011 NUM aji-51 788 8 feb feb NOUN aji-51 788 9 22 22 NUM aji-51 788 10 . . PUNCT aji-51 789 1 pmid pmid NOUN aji-51 789 2 : : PUNCT aji-51 789 3 21345578 21345578 NUM aji-51 789 4 . . PUNCT aji-51 790 1 46 46 NUM aji-51 790 2 . . PUNCT aji-51 791 1 cancer cancer NOUN aji-51 791 2 research research PROPN aji-51 791 3 uk uk PROPN aji-51 791 4 , , PUNCT aji-51 791 5 feeling feel VERB aji-51 791 6 the the DET aji-51 791 7 heat heat NOUN aji-51 791 8 - - PUNCT aji-51 791 9 the the DET aji-51 791 10 link link NOUN aji-51 791 11 between between ADP aji-51 791 12 inflammation inflammation NOUN aji-51 791 13 and and CCONJ aji-51 791 14 cancer cancer NOUN aji-51 791 15 . . PUNCT aji-51 792 1 available available ADJ aji-51 792 2 : : PUNCT aji-51 792 3 https://scienceblog.cancerresear https://scienceblog.cancerresear ADJ aji-51 792 4 chuk.org/2013/02/01/feeling-the-heat-thelink-between-inflammation-and-cancer/ chuk.org/2013/02/01/feeling-the-heat-thelink-between-inflammation-and-cancer/ NOUN aji-51 792 5 accessed access VERB aji-51 792 6 : : PUNCT aji-51 792 7 9/10/21 9/10/21 NUM aji-51 792 8 47 47 NUM aji-51 792 9 . . PUNCT aji-51 793 1 national national PROPN aji-51 793 2 cancer cancer PROPN aji-51 793 3 institute institute PROPN aji-51 793 4 , , PUNCT aji-51 793 5 cancer cancer NOUN aji-51 793 6 - - PUNCT aji-51 793 7 causing cause VERB aji-51 793 8 substances substance NOUN aji-51 793 9 in in ADP aji-51 793 10 the the DET aji-51 793 11 environment environment NOUN aji-51 793 12 . . PUNCT aji-51 794 1 available available ADJ aji-51 794 2 : : PUNCT aji-51 794 3 https://www.cancer.gov https://www.cancer.gov ADJ aji-51 794 4 / / SYM aji-51 794 5 aboutcancer aboutcancer NOUN aji-51 794 6 / / SYM aji-51 794 7 causes cause NOUN aji-51 794 8 - - PUNCT aji-51 794 9 prevention prevention NOUN aji-51 794 10 / / SYM aji-51 794 11 risk risk NOUN aji-51 794 12 / / SYM aji-51 794 13 substances substance NOUN aji-51 794 14 accessed access VERB aji-51 794 15 : : PUNCT aji-51 794 16 9/10/21 9/10/21 NUM aji-51 794 17 48 48 NUM aji-51 794 18 . . PUNCT aji-51 795 1 chemicals chemical NOUN aji-51 795 2 , , PUNCT aji-51 795 3 cancer cancer NOUN aji-51 795 4 , , PUNCT aji-51 795 5 and and CCONJ aji-51 795 6 you you PRON aji-51 795 7 . . PUNCT aji-51 796 1 available available ADJ aji-51 796 2 : : PUNCT aji-51 796 3 https://www.atsdr.cdc.gov https://www.atsdr.cdc.gov ADJ aji-51 796 4 / / SYM aji-51 796 5 emes/ emes/ NUM aji-51 796 6 public public ADJ aji-51 796 7 / / SYM aji-51 796 8 docs docs PROPN aji-51 796 9 / / SYM aji-51 796 10 chemicals,%20cancer,%20an chemicals,%20cancer,%20an PROPN aji-51 796 11 d%20you%20fs.pdf d%20you%20fs.pdf PROPN aji-51 796 12 accessed access VERB aji-51 796 13 : : PUNCT aji-51 796 14 9/10/21 9/10/21 NUM aji-51 796 15 49 49 NUM aji-51 796 16 . . PUNCT aji-51 797 1 american american ADJ aji-51 797 2 cancer cancer NOUN aji-51 797 3 society society NOUN aji-51 797 4 , , PUNCT aji-51 797 5 known know VERB aji-51 797 6 and and CCONJ aji-51 797 7 probably probably ADV aji-51 797 8 human human ADJ aji-51 797 9 carcinogens carcinogen NOUN aji-51 797 10 . . PUNCT aji-51 798 1 available available ADJ aji-51 798 2 : : PUNCT aji-51 798 3 https://www.cancer.org https://www.cancer.org NUM aji-51 798 4 / / SYM aji-51 798 5 cancer cancer NOUN aji-51 798 6 / / SYM aji-51 798 7 ca ca NOUN aji-51 798 8 ncer ncer NOUN aji-51 798 9 - - PUNCT aji-51 798 10 causes cause NOUN aji-51 798 11 / / SYM aji-51 798 12 general general ADJ aji-51 798 13 - - PUNCT aji-51 798 14 info info NOUN aji-51 798 15 / / SYM aji-51 798 16 known know VERB aji-51 798 17 - - PUNCT aji-51 798 18 andprobable andprobable ADJ aji-51 798 19 - - PUNCT aji-51 798 20 human human NOUN aji-51 798 21 - - PUNCT aji-51 798 22 carcinogens.html carcinogens.html NOUN aji-51 798 23 accessed access VERB aji-51 798 24 : : PUNCT aji-51 798 25 9/10/21 9/10/21 NUM aji-51 798 26 50 50 NUM aji-51 798 27 . . PUNCT aji-51 799 1 hosseini hosseini PROPN aji-51 799 2 m m PROPN aji-51 799 3 , , PUNCT aji-51 799 4 houshmand houshmand PROPN aji-51 799 5 m m PROPN aji-51 799 6 , , PUNCT aji-51 799 7 ebrahimi ebrahimi PROPN aji-51 799 8 a. a. PROPN aji-51 799 9 mthfr mthfr PROPN aji-51 799 10 polymorphisms polymorphism NOUN aji-51 799 11 and and CCONJ aji-51 799 12 breast breast NOUN aji-51 799 13 cancer cancer NOUN aji-51 799 14 risk risk NOUN aji-51 799 15 . . PUNCT aji-51 800 1 arch arch PROPN aji-51 800 2 med med PROPN aji-51 800 3 sci sci PROPN aji-51 800 4 . . PROPN aji-51 800 5 2011 2011 NUM aji-51 800 6 feb;7(1):134 feb;7(1):134 X aji-51 800 7 - - SYM aji-51 800 8 7 7 NUM aji-51 800 9 . . PUNCT aji-51 800 10 doi doi NOUN aji-51 800 11 : : PUNCT aji-51 800 12 10.5114 10.5114 NUM aji-51 800 13 / / SYM aji-51 800 14 aoms.2011.20618 aoms.2011.20618 PUNCT aji-51 800 15 epub epub PROPN aji-51 800 16 2011 2011 NUM aji-51 800 17 mar mar PROPN aji-51 800 18 8 8 NUM aji-51 800 19 . . PUNCT aji-51 801 1 pmid pmid NOUN aji-51 801 2 : : PUNCT aji-51 801 3 22291746 22291746 NUM aji-51 801 4 ; ; PUNCT aji-51 801 5 pmcid pmcid ADJ aji-51 801 6 : : PUNCT aji-51 801 7 pmc3258688 pmc3258688 NOUN aji-51 801 8 . . PUNCT aji-51 802 1 51 51 NUM aji-51 802 2 . . PUNCT aji-51 803 1 what what PRON aji-51 803 2 does do AUX aji-51 803 3 the the DET aji-51 803 4 mthfr mthfr PROPN aji-51 803 5 gene gene NOUN aji-51 803 6 mutation mutation NOUN aji-51 803 7 cause cause NOUN aji-51 803 8 ? ? PUNCT aji-51 804 1 available available ADJ aji-51 804 2 : : PUNCT aji-51 804 3 https://www.medicinenet.com https://www.medicinenet.com X aji-51 804 4 / / SYM aji-51 804 5 wh wh NOUN aji-51 804 6 at_does_the_mthfr_gene_mutation_cause/ at_does_the_mthfr_gene_mutation_cause/ NOUN aji-51 804 7 article.htm article.htm X aji-51 804 8 52 52 NUM aji-51 804 9 . . PUNCT aji-51 805 1 wajed wajed PROPN aji-51 805 2 sa sa PROPN aji-51 805 3 , , PUNCT aji-51 805 4 laird laird PROPN aji-51 805 5 pw pw PROPN aji-51 805 6 , , PUNCT aji-51 805 7 demeester demeester NOUN aji-51 805 8 tr tr VERB aji-51 805 9 . . PROPN aji-51 805 10 dna dna PROPN aji-51 805 11 methylation methylation NOUN aji-51 805 12 : : PUNCT aji-51 805 13 an an DET aji-51 805 14 alternative alternative ADJ aji-51 805 15 pathway pathway NOUN aji-51 805 16 to to ADP aji-51 805 17 cancer cancer NOUN aji-51 805 18 . . PUNCT aji-51 806 1 ann ann PROPN aji-51 806 2 surg surg PROPN aji-51 806 3 . . PUNCT aji-51 807 1 2001 2001 NUM aji-51 807 2 jul;234(1):10 jul;234(1):10 NOUN aji-51 807 3 - - PUNCT aji-51 807 4 20 20 NUM aji-51 807 5 . . PUNCT aji-51 808 1 doi doi NOUN aji-51 808 2 : : PUNCT aji-51 808 3 10.1097/00000658 10.1097/00000658 NUM aji-51 808 4 - - SYM aji-51 808 5 200107000 200107000 NUM aji-51 808 6 - - PUNCT aji-51 808 7 00003 00003 NUM aji-51 808 8 pmid pmid NOUN aji-51 808 9 : : PUNCT aji-51 808 10 11420478 11420478 NUM aji-51 808 11 ; ; PUNCT aji-51 808 12 pmcid pmcid ADJ aji-51 808 13 : : PUNCT aji-51 808 14 pmc1421942 pmc1421942 ADJ aji-51 808 15 . . PUNCT aji-51 809 1 53 53 NUM aji-51 809 2 . . PUNCT aji-51 809 3 brasky brasky PROPN aji-51 809 4 tm tm PROPN aji-51 809 5 , , PUNCT aji-51 809 6 white white PROPN aji-51 809 7 e e PROPN aji-51 809 8 , , PUNCT aji-51 809 9 chen chen PROPN aji-51 809 10 cl cl PROPN aji-51 809 11 . . PUNCT aji-51 810 1 long long ADJ aji-51 810 2 - - PUNCT aji-51 810 3 term term NOUN aji-51 810 4 , , PUNCT aji-51 810 5 supplemental supplemental NOUN aji-51 810 6 , , PUNCT aji-51 810 7 one one NUM aji-51 810 8 - - PUNCT aji-51 810 9 carbon carbon NOUN aji-51 810 10 metabolismrelated metabolismrelate VERB aji-51 810 11 vitamin vitamin NOUN aji-51 810 12 b b NOUN aji-51 810 13 use use NOUN aji-51 810 14 in in ADP aji-51 810 15 relation relation NOUN aji-51 810 16 to to ADP aji-51 810 17 lung lung NOUN aji-51 810 18 cancer cancer NOUN aji-51 810 19 risk risk NOUN aji-51 810 20 in in ADP aji-51 810 21 the the DET aji-51 810 22 vitamins vitamin NOUN aji-51 810 23 and and CCONJ aji-51 810 24 lifestyle lifestyle NOUN aji-51 810 25 ( ( PUNCT aji-51 810 26 vital vital ADJ aji-51 810 27 ) ) PUNCT aji-51 810 28 cohort cohort NOUN aji-51 810 29 . . PUNCT aji-51 811 1 j j PROPN aji-51 811 2 clin clin PROPN aji-51 811 3 oncol oncol PROPN aji-51 811 4 . . PUNCT aji-51 812 1 2017 2017 NUM aji-51 812 2 oct oct NOUN aji-51 812 3 20;35(30):3440 20;35(30):3440 NUM aji-51 812 4 - - SYM aji-51 812 5 3448 3448 NUM aji-51 812 6 . . PUNCT aji-51 813 1 doi doi NOUN aji-51 813 2 : : PUNCT aji-51 813 3 10.1200 10.1200 NUM aji-51 813 4 / / SYM aji-51 813 5 jco.2017.72.7735 jco.2017.72.7735 PROPN aji-51 813 6 epub epub PROPN aji-51 813 7 2017 2017 NUM aji-51 813 8 aug aug PROPN aji-51 813 9 22 22 NUM aji-51 813 10 . . PUNCT aji-51 814 1 pmid pmid NOUN aji-51 814 2 : : PUNCT aji-51 814 3 28829668 28829668 NUM aji-51 814 4 ; ; PUNCT aji-51 814 5 pmcid pmcid NOUN aji-51 814 6 : : PUNCT aji-51 814 7 pmc5648175 pmc5648175 ADJ aji-51 814 8 . . PUNCT aji-51 815 1 54 54 NUM aji-51 815 2 . . PUNCT aji-51 816 1 peterson peterson PROPN aji-51 816 2 ct ct PROPN aji-51 816 3 , , PUNCT aji-51 816 4 rodionov rodionov NOUN aji-51 816 5 da da PROPN aji-51 816 6 , , PUNCT aji-51 816 7 osterman osterman PROPN aji-51 816 8 al al PROPN aji-51 816 9 , , PUNCT aji-51 816 10 peterson peterson PROPN aji-51 816 11 sn sn PROPN aji-51 816 12 . . PUNCT aji-51 817 1 b b NOUN aji-51 817 2 vitamins vitamin NOUN aji-51 817 3 and and CCONJ aji-51 817 4 their their PRON aji-51 817 5 role role NOUN aji-51 817 6 in in ADP aji-51 817 7 immune immune ADJ aji-51 817 8 regulation regulation NOUN aji-51 817 9 and and CCONJ aji-51 817 10 cancer cancer NOUN aji-51 817 11 . . PUNCT aji-51 818 1 nutrients nutrient NOUN aji-51 818 2 . . PUNCT aji-51 819 1 2020 2020 NUM aji-51 819 2 nov nov PROPN aji-51 819 3 4;12(11):3380 4;12(11):3380 SYM aji-51 819 4 . . PUNCT aji-51 819 5 doi doi NOUN aji-51 819 6 : : PUNCT aji-51 819 7 10.3390 10.3390 NUM aji-51 819 8 / / SYM aji-51 819 9 nu12113380 nu12113380 PROPN aji-51 819 10 pmid pmid PROPN aji-51 819 11 : : PUNCT aji-51 819 12 33158037 33158037 NUM aji-51 819 13 ; ; PUNCT aji-51 819 14 pmcid pmcid ADJ aji-51 819 15 : : PUNCT aji-51 819 16 pmc7693142 pmc7693142 PROPN aji-51 819 17 . . PUNCT aji-51 820 1 55 55 NUM aji-51 820 2 . . PUNCT aji-51 821 1 available available ADJ aji-51 821 2 : : PUNCT aji-51 821 3 https://www.medicalnewstoday.c https://www.medicalnewstoday.c PROPN aji-51 821 4 om om PROPN aji-51 821 5 / / SYM aji-51 821 6 articles/324863#risk articles/324863#risk NOUN aji-51 821 7 - - PUNCT aji-51 821 8 factors factor NOUN aji-51 821 9 56 56 NUM aji-51 821 10 . . PUNCT aji-51 822 1 reuter reuter PROPN aji-51 822 2 s s PROPN aji-51 822 3 , , PUNCT aji-51 822 4 gupta gupta PROPN aji-51 822 5 sc sc PROPN aji-51 822 6 , , PUNCT aji-51 822 7 chaturvedi chaturvedi PROPN aji-51 822 8 mm mm PROPN aji-51 822 9 , , PUNCT aji-51 822 10 aggarwal aggarwal PROPN aji-51 822 11 bb bb PROPN aji-51 822 12 . . PROPN aji-51 822 13 oxidative oxidative ADJ aji-51 822 14 stress stress NOUN aji-51 822 15 , , PUNCT aji-51 822 16 inflammation inflammation NOUN aji-51 822 17 , , PUNCT aji-51 822 18 and and CCONJ aji-51 822 19 cancer cancer NOUN aji-51 822 20 : : PUNCT aji-51 822 21 how how SCONJ aji-51 822 22 are be AUX aji-51 822 23 they they PRON aji-51 822 24 linked link VERB aji-51 822 25 ? ? PUNCT aji-51 823 1 free free ADJ aji-51 823 2 radic radic ADJ aji-51 823 3 biol biol PROPN aji-51 823 4 med me VERB aji-51 823 5 . . PUNCT aji-51 824 1 2010 2010 NUM aji-51 824 2 dec dec PROPN aji-51 824 3 1;49(11):1603 1;49(11):1603 PROPN aji-51 824 4 - - SYM aji-51 824 5 16 16 NUM aji-51 824 6 . . PUNCT aji-51 825 1 doi doi NOUN aji-51 825 2 : : PUNCT aji-51 825 3 10.1016 10.1016 NUM aji-51 825 4 / / SYM aji-51 825 5 j.freeradbiomed.2010.09.006 j.freeradbiomed.2010.09.006 PROPN aji-51 825 6 epub epub NOUN aji-51 825 7 2010 2010 NUM aji-51 825 8 sep sep PROPN aji-51 825 9 16 16 NUM aji-51 825 10 . . PUNCT aji-51 826 1 pmid pmid NOUN aji-51 826 2 : : PUNCT aji-51 826 3 20840865 20840865 NUM aji-51 826 4 ; ; PUNCT aji-51 826 5 pmcid pmcid ADJ aji-51 826 6 : : PUNCT aji-51 826 7 pmc2990475 pmc2990475 NOUN aji-51 826 8 . . PUNCT aji-51 827 1 57 57 NUM aji-51 827 2 . . PUNCT aji-51 828 1 duwe duwe PROPN aji-51 828 2 ak ak PROPN aji-51 828 3 , , PUNCT aji-51 828 4 werkmeister werkmeister PROPN aji-51 828 5 j j PROPN aji-51 828 6 , , PUNCT aji-51 828 7 roder roder PROPN aji-51 828 8 jc jc PROPN aji-51 828 9 , , PUNCT aji-51 828 10 lauzon lauzon NOUN aji-51 828 11 r r NOUN aji-51 828 12 , , PUNCT aji-51 828 13 payne payne PROPN aji-51 828 14 u. u. PROPN aji-51 828 15 natural natural PROPN aji-51 828 16 killer killer NOUN aji-51 828 17 cellmediated cellmediate VERB aji-51 828 18 lysis lysis NOUN aji-51 828 19 involves involve VERB aji-51 828 20 an an DET aji-51 828 21 hydroxyl hydroxyl NOUN aji-51 828 22 radical radical ADJ aji-51 828 23 - - PUNCT aji-51 828 24 dependent dependent ADJ aji-51 828 25 step step NOUN aji-51 828 26 . . PUNCT aji-51 829 1 j j PROPN aji-51 829 2 immunol immunol NOUN aji-51 829 3 . . PUNCT aji-51 830 1 1985 1985 NUM aji-51 830 2 apr;134(4):2637 apr;134(4):2637 PROPN aji-51 830 3 - - SYM aji-51 830 4 44 44 NUM aji-51 830 5 . . PUNCT aji-51 831 1 pmid pmid NOUN aji-51 831 2 : : PUNCT aji-51 831 3 2982948 2982948 NUM aji-51 831 4 . . PUNCT aji-51 832 1 58 58 NUM aji-51 832 2 . . PUNCT aji-51 833 1 wang wang PROPN aji-51 833 2 j j PROPN aji-51 833 3 , , PUNCT aji-51 833 4 yi yi PROPN aji-51 833 5 j. j. PROPN aji-51 833 6 cancer cancer PROPN aji-51 833 7 cell cell NOUN aji-51 833 8 killing kill VERB aji-51 833 9 via via ADP aji-51 833 10 ros ros PROPN aji-51 833 11 : : PUNCT aji-51 833 12 to to PART aji-51 833 13 increase increase VERB aji-51 833 14 or or CCONJ aji-51 833 15 decrease decrease VERB aji-51 833 16 , , PUNCT aji-51 833 17 that that PRON aji-51 833 18 is be AUX aji-51 833 19 the the DET aji-51 833 20 question question NOUN aji-51 833 21 . . PUNCT aji-51 834 1 cancer cancer NOUN aji-51 834 2 biol biol PROPN aji-51 834 3 ther ther ADV aji-51 834 4 . . PUNCT aji-51 835 1 2008 2008 NUM aji-51 836 1 dec;7(12):1875 dec;7(12):1875 NOUN aji-51 836 2 - - PUNCT aji-51 836 3 84 84 NUM aji-51 836 4 . . PUNCT aji-51 837 1 doi doi NOUN aji-51 837 2 : : PUNCT aji-51 837 3 10.4161 10.4161 NUM aji-51 837 4 / / SYM aji-51 837 5 cbt.7.12.7067 cbt.7.12.7067 X aji-51 837 6 epub epub NOUN aji-51 837 7 2008 2008 NUM aji-51 837 8 dec dec PROPN aji-51 837 9 24 24 NUM aji-51 837 10 . . PUNCT aji-51 838 1 pmid pmid NOUN aji-51 838 2 : : PUNCT aji-51 838 3 18981733 18981733 NUM aji-51 838 4 . . PUNCT aji-51 839 1 59 59 NUM aji-51 839 2 . . PUNCT aji-51 840 1 kim kim PROPN aji-51 840 2 sj sj PROPN aji-51 840 3 , , PUNCT aji-51 840 4 kim kim PROPN aji-51 840 5 hs hs PROPN aji-51 840 6 , , PUNCT aji-51 840 7 seo seo PROPN aji-51 840 8 yr yr PROPN aji-51 840 9 . . PUNCT aji-51 841 1 understanding understanding NOUN aji-51 841 2 of of ADP aji-51 841 3 ros ros PROPN aji-51 841 4 - - PUNCT aji-51 841 5 inducing induce VERB aji-51 841 6 strategy strategy NOUN aji-51 841 7 in in ADP aji-51 841 8 anticancer anticancer NOUN aji-51 841 9 therapy therapy NOUN aji-51 841 10 . . PUNCT aji-51 842 1 oxid oxid PROPN aji-51 842 2 med med PROPN aji-51 842 3 cell cell NOUN aji-51 842 4 longev longev NOUN aji-51 842 5 . . PUNCT aji-51 843 1 2019 2019 NUM aji-51 843 2 dec dec PROPN aji-51 843 3 18;2019:5381692 18;2019:5381692 NUM aji-51 843 4 . . PUNCT aji-51 844 1 doi doi NOUN aji-51 844 2 : : PUNCT aji-51 844 3 10.1155/2019/5381692 10.1155/2019/5381692 NUM aji-51 844 4 pmid pmid NOUN aji-51 844 5 : : PUNCT aji-51 844 6 31929855 31929855 NUM aji-51 844 7 ; ; PUNCT aji-51 844 8 pmcid pmcid NOUN aji-51 844 9 : : PUNCT aji-51 844 10 pmc6939418 pmc6939418 NOUN aji-51 844 11 . . PUNCT aji-51 845 1 60 60 NUM aji-51 845 2 . . PUNCT aji-51 846 1 perillo perillo PROPN aji-51 846 2 b b PROPN aji-51 846 3 , , PUNCT aji-51 846 4 di di NOUN aji-51 846 5 donato donato PROPN aji-51 846 6 m m PROPN aji-51 846 7 , , PUNCT aji-51 846 8 pezone pezone NOUN aji-51 846 9 a a PRON aji-51 846 10 , , PUNCT aji-51 846 11 di di NOUN aji-51 846 12 zazzo zazzo PROPN aji-51 846 13 e e PROPN aji-51 846 14 , , PUNCT aji-51 846 15 giovannelli giovannelli NOUN aji-51 846 16 p p NOUN aji-51 846 17 , , PUNCT aji-51 846 18 galasso galasso NOUN aji-51 846 19 g g NOUN aji-51 846 20 , , PUNCT aji-51 846 21 castoria castoria NOUN aji-51 846 22 g g NOUN aji-51 846 23 , , PUNCT aji-51 846 24 migliaccio migliaccio NOUN aji-51 846 25 a. a. NOUN aji-51 846 26 ros ros PROPN aji-51 846 27 in in ADP aji-51 846 28 cancer cancer NOUN aji-51 846 29 stoff stoff PROPN aji-51 846 30 ; ; PUNCT aji-51 846 31 aji aji PROPN aji-51 846 32 , , PUNCT aji-51 846 33 5(1 5(1 NUM aji-51 846 34 ): ): PUNCT aji-51 846 35 1 1 NUM aji-51 846 36 - - SYM aji-51 846 37 39 39 NUM aji-51 846 38 , , PUNCT aji-51 846 39 2022 2022 NUM aji-51 846 40 ; ; PUNCT aji-51 846 41 article article NOUN aji-51 846 42 no.aji.77967 no.aji.77967 PROPN aji-51 846 43 21 21 NUM aji-51 846 44 therapy therapy NOUN aji-51 846 45 : : PUNCT aji-51 846 46 the the DET aji-51 846 47 bright bright ADJ aji-51 846 48 side side NOUN aji-51 846 49 of of ADP aji-51 846 50 the the DET aji-51 846 51 moon moon NOUN aji-51 846 52 . . PUNCT aji-51 847 1 exp exp NOUN aji-51 847 2 mol mol ADP aji-51 847 3 med med PROPN aji-51 847 4 . . PUNCT aji-51 847 5 2020 2020 NUM aji-51 847 6 feb;52(2):192 feb;52(2):192 NOUN aji-51 847 7 - - PUNCT aji-51 847 8 203 203 NUM aji-51 847 9 . . PUNCT aji-51 848 1 doi doi NOUN aji-51 848 2 : : PUNCT aji-51 848 3 10.1038 10.1038 NUM aji-51 848 4 / / SYM aji-51 848 5 s12276 s12276 NOUN aji-51 848 6 - - PUNCT aji-51 848 7 020 020 NUM aji-51 848 8 - - PUNCT aji-51 848 9 0384 0384 NUM aji-51 848 10 - - SYM aji-51 848 11 2 2 NUM aji-51 848 12 epub epub NOUN aji-51 848 13 2020 2020 NUM aji-51 848 14 feb feb PROPN aji-51 848 15 14 14 NUM aji-51 848 16 . . PUNCT aji-51 849 1 pmid pmid NOUN aji-51 849 2 : : PUNCT aji-51 849 3 32060354 32060354 NUM aji-51 849 4 ; ; PUNCT aji-51 849 5 pmcid pmcid PROPN aji-51 849 6 : : PUNCT aji-51 849 7 pmc7062874 pmc7062874 NOUN aji-51 849 8 . . PUNCT aji-51 850 1 61 61 NUM aji-51 850 2 . . X aji-51 850 3 liou liou PROPN aji-51 850 4 gy gy PROPN aji-51 850 5 , , PUNCT aji-51 850 6 storz storz ADJ aji-51 850 7 p. p. PROPN aji-51 850 8 reactive reactive ADJ aji-51 850 9 oxygen oxygen NOUN aji-51 850 10 species specie NOUN aji-51 850 11 in in ADP aji-51 850 12 cancer cancer NOUN aji-51 850 13 . . PUNCT aji-51 851 1 free free ADJ aji-51 851 2 radic radic ADJ aji-51 851 3 res re NOUN aji-51 851 4 . . PUNCT aji-51 851 5 2010 2010 NUM aji-51 851 6 may;44(5):479 may;44(5):479 NOUN aji-51 851 7 - - PUNCT aji-51 851 8 96 96 NUM aji-51 851 9 . . PUNCT aji-51 852 1 doi doi NOUN aji-51 852 2 : : PUNCT aji-51 852 3 10.3109/10715761003667554 10.3109/10715761003667554 NUM aji-51 852 4 pmid pmid NOUN aji-51 852 5 : : PUNCT aji-51 852 6 20370557 20370557 NUM aji-51 852 7 ; ; PUNCT aji-51 852 8 pmcid pmcid ADJ aji-51 852 9 : : PUNCT aji-51 852 10 pmc3880197 pmc3880197 NOUN aji-51 852 11 . . PUNCT aji-51 853 1 62 62 NUM aji-51 853 2 . . PUNCT aji-51 854 1 hegedűs hegedűs PROPN aji-51 854 2 c c PROPN aji-51 854 3 , , PUNCT aji-51 854 4 kovács kovács PROPN aji-51 854 5 k k PROPN aji-51 854 6 , , PUNCT aji-51 854 7 polgár polgár PROPN aji-51 854 8 z z PROPN aji-51 854 9 , , PUNCT aji-51 854 10 regdon regdon PROPN aji-51 854 11 z z PROPN aji-51 854 12 , , PUNCT aji-51 854 13 szabó szabó VERB aji-51 854 14 é é PROPN aji-51 854 15 , , PUNCT aji-51 854 16 robaszkiewicz robaszkiewicz VERB aji-51 854 17 a a PRON aji-51 854 18 , , PUNCT aji-51 854 19 forman forman PROPN aji-51 854 20 hj hj PROPN aji-51 854 21 , , PUNCT aji-51 854 22 martner martner NOUN aji-51 854 23 a a NOUN aji-51 854 24 , , PUNCT aji-51 854 25 virág virág PROPN aji-51 854 26 l. l. PROPN aji-51 854 27 redox redox PROPN aji-51 854 28 control control PROPN aji-51 854 29 of of ADP aji-51 854 30 cancer cancer NOUN aji-51 854 31 cell cell NOUN aji-51 854 32 destruction destruction NOUN aji-51 854 33 . . PUNCT aji-51 855 1 redox redox ADJ aji-51 855 2 biol biol PROPN aji-51 855 3 . . PUNCT aji-51 856 1 2018 2018 NUM aji-51 856 2 jun;16:59 jun;16:59 NOUN aji-51 856 3 - - SYM aji-51 856 4 74 74 NUM aji-51 856 5 . . PUNCT aji-51 857 1 doi doi NOUN aji-51 857 2 : : PUNCT aji-51 857 3 10.1016 10.1016 NUM aji-51 857 4 / / SYM aji-51 857 5 j.redox.2018.01.015 j.redox.2018.01.015 PROPN aji-51 857 6 epub epub PROPN aji-51 857 7 2018 2018 NUM aji-51 857 8 feb feb NOUN aji-51 857 9 3 3 NUM aji-51 857 10 . . PUNCT aji-51 857 11 pmid pmid NOUN aji-51 857 12 : : PUNCT aji-51 857 13 29477046 29477046 NUM aji-51 857 14 ; ; PUNCT aji-51 857 15 pmcid pmcid ADJ aji-51 857 16 : : PUNCT aji-51 857 17 pmc5842284 pmc5842284 NOUN aji-51 857 18 . . PUNCT aji-51 858 1 63 63 NUM aji-51 858 2 . . PUNCT aji-51 859 1 siegers siegers PROPN aji-51 859 2 cp cp PROPN aji-51 859 3 , , PUNCT aji-51 859 4 andresen andresen PROPN aji-51 859 5 s s PROPN aji-51 859 6 , , PUNCT aji-51 859 7 keogh keogh PROPN aji-51 859 8 jp jp PROPN aji-51 859 9 . . PROPN aji-51 860 1 does do AUX aji-51 860 2 cimetidine cimetidine NOUN aji-51 860 3 improve improve VERB aji-51 860 4 prospects prospect NOUN aji-51 860 5 for for ADP aji-51 860 6 cancer cancer NOUN aji-51 860 7 patients patient NOUN aji-51 860 8 ? ? PUNCT aji-51 860 9 . . PUNCT aji-51 861 1 a a DET aji-51 861 2 reappraisal reappraisal NOUN aji-51 861 3 of of ADP aji-51 861 4 the the DET aji-51 861 5 evidence evidence NOUN aji-51 861 6 to to ADP aji-51 861 7 date date NOUN aji-51 861 8 . . PUNCT aji-51 862 1 digestion digestion NOUN aji-51 862 2 . . PUNCT aji-51 863 1 1999 1999 NUM aji-51 863 2 sep sep PROPN aji-51 863 3 - - PUNCT aji-51 863 4 oct;60(5):41521 oct;60(5):41521 PROPN aji-51 863 5 . . PUNCT aji-51 863 6 doi doi PROPN aji-51 863 7 : : PUNCT aji-51 863 8 10.1159/000007686 10.1159/000007686 NUM aji-51 863 9 pmid pmid NOUN aji-51 863 10 : : PUNCT aji-51 863 11 10473965 10473965 NUM aji-51 863 12 . . PUNCT aji-51 864 1 64 64 NUM aji-51 864 2 . . PUNCT aji-51 865 1 navaneethakrishnan navaneethakrishnan PROPN aji-51 865 2 s s PROPN aji-51 865 3 , , PUNCT aji-51 865 4 rosales rosales PROPN aji-51 865 5 jl jl PROPN aji-51 865 6 , , PUNCT aji-51 865 7 lee lee PROPN aji-51 865 8 ky ky PROPN aji-51 865 9 . . PUNCT aji-51 866 1 ros ros PROPN aji-51 866 2 - - PUNCT aji-51 866 3 mediated mediate VERB aji-51 866 4 cancer cancer NOUN aji-51 866 5 cell cell NOUN aji-51 866 6 killing kill VERB aji-51 866 7 through through ADP aji-51 866 8 dietary dietary ADJ aji-51 866 9 phytochemicals phytochemical NOUN aji-51 866 10 . . PUNCT aji-51 867 1 oxid oxid PROPN aji-51 867 2 med med PROPN aji-51 867 3 cell cell NOUN aji-51 867 4 longev longev NOUN aji-51 867 5 . . PUNCT aji-51 868 1 2019 2019 NUM aji-51 868 2 may may AUX aji-51 868 3 14;2019 14;2019 NUM aji-51 868 4 : : PUNCT aji-51 868 5 9051542 9051542 NUM aji-51 868 6 . . PUNCT aji-51 869 1 doi doi NOUN aji-51 869 2 : : PUNCT aji-51 869 3 10.1155/2019/9051542 10.1155/2019/9051542 NUM aji-51 869 4 pmid pmid NOUN aji-51 869 5 : : PUNCT aji-51 869 6 31217841 31217841 NUM aji-51 869 7 ; ; PUNCT aji-51 869 8 pmcid pmcid NOUN aji-51 869 9 : : PUNCT aji-51 869 10 pmc6536988 pmc6536988 PROPN aji-51 869 11 . . PUNCT aji-51 870 1 65 65 NUM aji-51 870 2 . . PUNCT aji-51 871 1 sharif sharif PROPN aji-51 871 2 t t PROPN aji-51 871 3 , , PUNCT aji-51 871 4 et et PROPN aji-51 871 5 al al PROPN aji-51 871 6 . . PUNCT aji-51 872 1 the the DET aji-51 872 2 polyphenolic polyphenolic NOUN aji-51 872 3 - - PUNCT aji-51 872 4 rich rich ADJ aji-51 872 5 aronia aronia NOUN aji-51 872 6 melanocarpa melanocarpa PROPN aji-51 872 7 juice juice PROPN aji-51 872 8 kills kill VERB aji-51 872 9 teratocarcinomal teratocarcinomal ADJ aji-51 872 10 cancer cancer NOUN aji-51 872 11 stem stem NOUN aji-51 872 12 - - PUNCT aji-51 872 13 like like ADJ aji-51 872 14 cells cell NOUN aji-51 872 15 , , PUNCT aji-51 872 16 but but CCONJ aji-51 872 17 not not PART aji-51 872 18 their their PRON aji-51 872 19 differentiated differentiated ADJ aji-51 872 20 counterparts counterpart NOUN aji-51 872 21 . . PUNCT aji-51 873 1 journal journal NOUN aji-51 873 2 of of ADP aji-51 873 3 functional functional ADJ aji-51 873 4 foods food NOUN aji-51 873 5 ; ; PUNCT aji-51 873 6 july july PROPN aji-51 873 7 2013 2013 NUM aji-51 873 8 . . PUNCT aji-51 874 1 doi doi NOUN aji-51 874 2 : : PUNCT aji-51 874 3 10.1016 10.1016 NUM aji-51 874 4 / / SYM aji-51 874 5 j.jff.2013.04.007 j.jff.2013.04.007 PROPN aji-51 874 6 66 66 NUM aji-51 874 7 . . PUNCT aji-51 875 1 pizzino pizzino PROPN aji-51 875 2 g g PROPN aji-51 875 3 , , PUNCT aji-51 875 4 irrera irrera NOUN aji-51 875 5 n n CCONJ aji-51 875 6 , , PUNCT aji-51 875 7 cucinotta cucinotta PROPN aji-51 875 8 m m PROPN aji-51 875 9 , , PUNCT aji-51 875 10 pallio pallio NOUN aji-51 875 11 g g PROPN aji-51 875 12 , , PUNCT aji-51 875 13 mannino mannino PROPN aji-51 875 14 f f PROPN aji-51 875 15 , , PUNCT aji-51 875 16 arcoraci arcoraci NOUN aji-51 875 17 v v NOUN aji-51 875 18 , , PUNCT aji-51 875 19 squadrito squadrito PROPN aji-51 875 20 f f PROPN aji-51 875 21 , , PUNCT aji-51 875 22 altavilla altavilla PROPN aji-51 875 23 d d PROPN aji-51 875 24 , , PUNCT aji-51 875 25 bitto bitto NOUN aji-51 875 26 a. a. NOUN aji-51 875 27 oxidative oxidative ADJ aji-51 875 28 stress stress NOUN aji-51 875 29 : : PUNCT aji-51 875 30 harms harm NOUN aji-51 875 31 and and CCONJ aji-51 875 32 benefits benefit NOUN aji-51 875 33 for for ADP aji-51 875 34 human human ADJ aji-51 875 35 health health NOUN aji-51 875 36 . . PUNCT aji-51 876 1 oxid oxid PROPN aji-51 876 2 med med PROPN aji-51 876 3 cell cell NOUN aji-51 876 4 longev longev NOUN aji-51 876 5 . . PUNCT aji-51 877 1 2017;2017:8416763 2017;2017:8416763 NUM aji-51 877 2 . . PUNCT aji-51 878 1 doi doi NOUN aji-51 878 2 : : PUNCT aji-51 878 3 10.1155/2017/8416763 10.1155/2017/8416763 NUM aji-51 878 4 epub epub NOUN aji-51 878 5 2017 2017 NUM aji-51 878 6 jul jul PROPN aji-51 878 7 27 27 NUM aji-51 878 8 . . PUNCT aji-51 879 1 pmid pmid NOUN aji-51 879 2 : : PUNCT aji-51 879 3 28819546 28819546 NUM aji-51 879 4 ; ; PUNCT aji-51 879 5 pmcid pmcid ADJ aji-51 879 6 : : PUNCT aji-51 879 7 pmc5551541 pmc5551541 NOUN aji-51 879 8 . . PUNCT aji-51 880 1 67 67 NUM aji-51 880 2 . . PUNCT aji-51 881 1 kheirandish kheirandish PROPN aji-51 881 2 m m PROPN aji-51 881 3 , , PUNCT aji-51 881 4 mahboobi mahboobi PROPN aji-51 881 5 h h NOUN aji-51 881 6 , , PUNCT aji-51 881 7 yazdanparast yazdanparast PROPN aji-51 881 8 m m PROPN aji-51 881 9 , , PUNCT aji-51 881 10 kamal kamal PROPN aji-51 881 11 w w PROPN aji-51 881 12 , , PUNCT aji-51 881 13 kamal kamal PROPN aji-51 881 14 ma ma PROPN aji-51 881 15 . . PROPN aji-51 881 16 anti anti ADJ aji-51 881 17 - - ADJ aji-51 881 18 cancer cancer ADJ aji-51 881 19 effects effect NOUN aji-51 881 20 of of ADP aji-51 881 21 metformin metformin NOUN aji-51 881 22 : : PUNCT aji-51 881 23 recent recent ADJ aji-51 881 24 evidences evidence NOUN aji-51 881 25 for for ADP aji-51 881 26 its its PRON aji-51 881 27 role role NOUN aji-51 881 28 in in ADP aji-51 881 29 prevention prevention NOUN aji-51 881 30 and and CCONJ aji-51 881 31 treatment treatment NOUN aji-51 881 32 of of ADP aji-51 881 33 cancer cancer NOUN aji-51 881 34 . . PUNCT aji-51 882 1 curr curr PROPN aji-51 882 2 drug drug PROPN aji-51 882 3 metab metab PROPN aji-51 882 4 . . PUNCT aji-51 883 1 2018;19(9):793797 2018;19(9):793797 NUM aji-51 883 2 . . PUNCT aji-51 884 1 doi:10.2174/13892002196661804161618 doi:10.2174/13892002196661804161618 NOUN aji-51 884 2 46 46 NUM aji-51 884 3 pmid pmid NOUN aji-51 884 4 : : PUNCT aji-51 884 5 29663879 29663879 NUM aji-51 884 6 . . PUNCT aji-51 885 1 68 68 NUM aji-51 885 2 . . PUNCT aji-51 886 1 aljofan aljofan PROPN aji-51 886 2 m m PROPN aji-51 886 3 , , PUNCT aji-51 886 4 riethmacher riethmacher ADJ aji-51 886 5 d. d. NOUN aji-51 886 6 anticancer anticancer NOUN aji-51 886 7 activity activity NOUN aji-51 886 8 of of ADP aji-51 886 9 metformin metformin NOUN aji-51 886 10 : : PUNCT aji-51 886 11 a a DET aji-51 886 12 systematic systematic ADJ aji-51 886 13 review review NOUN aji-51 886 14 of of ADP aji-51 886 15 the the DET aji-51 886 16 literature literature NOUN aji-51 886 17 . . PUNCT aji-51 887 1 future future ADJ aji-51 887 2 sci sci PROPN aji-51 887 3 oa oa PROPN aji-51 887 4 . . PROPN aji-51 887 5 2019 2019 NUM aji-51 887 6 aug aug NOUN aji-51 887 7 22;5(8):fso410 22;5(8):fso410 NUM aji-51 887 8 . . PUNCT aji-51 888 1 doi doi NOUN aji-51 888 2 : : PUNCT aji-51 888 3 10.2144 10.2144 NUM aji-51 888 4 / / SYM aji-51 888 5 fsoa-2019 fsoa-2019 NOUN aji-51 888 6 - - PUNCT aji-51 888 7 0053 0053 NUM aji-51 888 8 pmid pmid NOUN aji-51 888 9 : : PUNCT aji-51 888 10 31534778 31534778 NUM aji-51 888 11 ; ; PUNCT aji-51 888 12 pmcid pmcid NOUN aji-51 888 13 : : PUNCT aji-51 888 14 pmc6745597 pmc6745597 ADJ aji-51 888 15 . . PUNCT aji-51 889 1 69 69 NUM aji-51 889 2 . . PUNCT aji-51 890 1 wang wang PROPN aji-51 890 2 y y PROPN aji-51 890 3 , , PUNCT aji-51 890 4 liu liu PROPN aji-51 890 5 y y PROPN aji-51 890 6 , , PUNCT aji-51 890 7 du du PROPN aji-51 890 8 x x PROPN aji-51 890 9 , , PUNCT aji-51 890 10 ma ma PROPN aji-51 890 11 h h PROPN aji-51 890 12 , , PUNCT aji-51 890 13 yao yao PROPN aji-51 890 14 j. j. PROPN aji-51 890 15 the the DET aji-51 890 16 anti anti ADJ aji-51 890 17 - - ADJ aji-51 890 18 cancer cancer ADJ aji-51 890 19 mechanisms mechanism NOUN aji-51 890 20 of of ADP aji-51 890 21 berberine berberine NOUN aji-51 890 22 : : PUNCT aji-51 890 23 a a DET aji-51 890 24 review review NOUN aji-51 890 25 . . PUNCT aji-51 891 1 cancer cancer NOUN aji-51 891 2 manag manag PROPN aji-51 891 3 res re NOUN aji-51 891 4 . . PUNCT aji-51 891 5 2020 2020 NUM aji-51 891 6 jan jan PROPN aji-51 891 7 30;12:695 30;12:695 NUM aji-51 891 8 - - SYM aji-51 891 9 702 702 NUM aji-51 891 10 . . PUNCT aji-51 891 11 doi doi NOUN aji-51 891 12 : : PUNCT aji-51 891 13 10.2147 10.2147 NUM aji-51 891 14 / / SYM aji-51 891 15 cmar.s242329 cmar.s242329 ADJ aji-51 891 16 pmid pmid NOUN aji-51 891 17 : : PUNCT aji-51 891 18 32099466 32099466 NUM aji-51 891 19 ; ; PUNCT aji-51 891 20 pmcid pmcid NOUN aji-51 891 21 : : PUNCT aji-51 891 22 pmc6996556 pmc6996556 NOUN aji-51 891 23 . . PUNCT aji-51 892 1 70 70 NUM aji-51 892 2 . . X aji-51 893 1 dong dong PROPN aji-51 893 2 h h PROPN aji-51 893 3 , , PUNCT aji-51 893 4 wang wang PROPN aji-51 893 5 n n PROPN aji-51 893 6 , , PUNCT aji-51 893 7 zhao zhao PROPN aji-51 893 8 l l PROPN aji-51 893 9 , , PUNCT aji-51 893 10 lu lu PROPN aji-51 893 11 f. f. PROPN aji-51 893 12 berberine berberine PROPN aji-51 893 13 in in ADP aji-51 893 14 the the DET aji-51 893 15 treatment treatment NOUN aji-51 893 16 of of ADP aji-51 893 17 type type NOUN aji-51 893 18 2 2 NUM aji-51 893 19 diabetes diabetes NOUN aji-51 893 20 mellitus mellitus NOUN aji-51 893 21 : : PUNCT aji-51 893 22 a a DET aji-51 893 23 systemic systemic ADJ aji-51 893 24 review review NOUN aji-51 893 25 and and CCONJ aji-51 893 26 meta meta ADJ aji-51 893 27 - - PUNCT aji-51 893 28 analysis analysis NOUN aji-51 893 29 . . PUNCT aji-51 894 1 evid evid PROPN aji-51 894 2 based base VERB aji-51 894 3 complement complement PROPN aji-51 894 4 alternat alternat NOUN aji-51 894 5 med me VERB aji-51 894 6 . . PUNCT aji-51 895 1 2012;2012:591654 2012;2012:591654 NUM aji-51 895 2 . . PUNCT aji-51 896 1 doi doi NOUN aji-51 896 2 : : PUNCT aji-51 896 3 10.1155/2012/591654 10.1155/2012/591654 NUM aji-51 896 4 epub epub NOUN aji-51 896 5 2012 2012 NUM aji-51 896 6 oct oct NOUN aji-51 896 7 15 15 NUM aji-51 896 8 . . PUNCT aji-51 897 1 pmid pmid NOUN aji-51 897 2 : : PUNCT aji-51 897 3 23118793 23118793 NUM aji-51 897 4 ; ; PUNCT aji-51 897 5 pmcid pmcid ADJ aji-51 897 6 : : PUNCT aji-51 897 7 pmc3478874 pmc3478874 NOUN aji-51 897 8 . . PUNCT aji-51 898 1 71 71 NUM aji-51 898 2 . . X aji-51 899 1 patel patel PROPN aji-51 899 2 sm sm PROPN aji-51 899 3 , , PUNCT aji-51 899 4 nagulapalli nagulapalli PROPN aji-51 899 5 venkata venkata PROPN aji-51 899 6 kc kc PROPN aji-51 899 7 , , PUNCT aji-51 899 8 bhattacharyya bhattacharyya PROPN aji-51 899 9 p p X aji-51 899 10 , , PUNCT aji-51 899 11 sethi sethi PROPN aji-51 899 12 g g PROPN aji-51 899 13 , , PUNCT aji-51 899 14 bishayee bishayee ADJ aji-51 899 15 a. a. NOUN aji-51 899 16 potential potential NOUN aji-51 899 17 of of ADP aji-51 899 18 neem neem NOUN aji-51 899 19 ( ( PUNCT aji-51 899 20 azadirachta azadirachta VERB aji-51 899 21 indica indica PROPN aji-51 899 22 l. l. PROPN aji-51 899 23 ) ) PUNCT aji-51 899 24 for for ADP aji-51 899 25 prevention prevention NOUN aji-51 899 26 and and CCONJ aji-51 899 27 treatment treatment NOUN aji-51 899 28 of of ADP aji-51 899 29 oncologic oncologic NOUN aji-51 899 30 diseases disease NOUN aji-51 899 31 . . PUNCT aji-51 900 1 semin semin PROPN aji-51 900 2 cancer cancer PROPN aji-51 900 3 biol biol PROPN aji-51 900 4 . . PUNCT aji-51 901 1 2016 2016 NUM aji-51 901 2 oct;4041:100 oct;4041:100 PROPN aji-51 901 3 - - PUNCT aji-51 901 4 115 115 NUM aji-51 901 5 . . PUNCT aji-51 902 1 doi doi NOUN aji-51 902 2 : : PUNCT aji-51 902 3 10.1016 10.1016 NUM aji-51 902 4 / / SYM aji-51 902 5 j.semcancer.2016.03.002 j.semcancer.2016.03.002 PROPN aji-51 902 6 epub epub PROPN aji-51 902 7 2016 2016 NUM aji-51 902 8 mar mar PROPN aji-51 902 9 24 24 NUM aji-51 902 10 . . PUNCT aji-51 903 1 pmid pmid NOUN aji-51 903 2 : : PUNCT aji-51 903 3 27019417 27019417 NUM aji-51 903 4 . . PUNCT aji-51 904 1 72 72 NUM aji-51 904 2 . . PUNCT aji-51 905 1 khosla khosla PROPN aji-51 905 2 p p PROPN aji-51 905 3 , , PUNCT aji-51 905 4 bhanwra bhanwra PROPN aji-51 905 5 s s PROPN aji-51 905 6 , , PUNCT aji-51 905 7 singh singh PROPN aji-51 905 8 j j PROPN aji-51 905 9 , , PUNCT aji-51 905 10 seth seth PROPN aji-51 905 11 s s PROPN aji-51 905 12 , , PUNCT aji-51 905 13 srivastava srivastava PROPN aji-51 905 14 rk rk PROPN aji-51 905 15 . . PUNCT aji-51 906 1 a a DET aji-51 906 2 study study NOUN aji-51 906 3 of of ADP aji-51 906 4 hypoglycaemic hypoglycaemic ADJ aji-51 906 5 effects effect NOUN aji-51 906 6 of of ADP aji-51 906 7 azadirachta azadirachta PROPN aji-51 906 8 indica indica PROPN aji-51 906 9 ( ( PUNCT aji-51 906 10 neem neem NOUN aji-51 906 11 ) ) PUNCT aji-51 906 12 in in ADP aji-51 906 13 normaland normaland NOUN aji-51 906 14 alloxan alloxan NOUN aji-51 906 15 diabetic diabetic ADJ aji-51 906 16 rabbits rabbit NOUN aji-51 906 17 . . PUNCT aji-51 907 1 indian indian PROPN aji-51 907 2 j j PROPN aji-51 907 3 physiol physiol PROPN aji-51 907 4 pharmacol pharmacol PROPN aji-51 907 5 . . PUNCT aji-51 908 1 2000 2000 NUM aji-51 908 2 jan;44(1):6974 jan;44(1):6974 PROPN aji-51 908 3 . . PUNCT aji-51 909 1 pmid pmid PROPN aji-51 909 2 : : PUNCT aji-51 909 3 10919098 10919098 NUM aji-51 909 4 . . PUNCT aji-51 910 1 73 73 NUM aji-51 910 2 . . PUNCT aji-51 911 1 mishan mishan PROPN aji-51 911 2 ma ma PROPN aji-51 911 3 , , PUNCT aji-51 911 4 khazeei khazeei VERB aji-51 911 5 tabari tabari PROPN aji-51 911 6 ma ma PROPN aji-51 911 7 , , PUNCT aji-51 911 8 zargari zargari PROPN aji-51 911 9 m m PROPN aji-51 911 10 , , PUNCT aji-51 911 11 bagheri bagheri ADJ aji-51 911 12 a. a. NOUN aji-51 911 13 micrornas microrna NOUN aji-51 911 14 in in ADP aji-51 911 15 the the DET aji-51 911 16 anticancer anticancer NOUN aji-51 911 17 effects effect NOUN aji-51 911 18 of of ADP aji-51 911 19 celecoxib celecoxib NOUN aji-51 911 20 : : PUNCT aji-51 911 21 a a DET aji-51 911 22 systematic systematic ADJ aji-51 911 23 review review NOUN aji-51 911 24 . . PUNCT aji-51 912 1 eur eur PROPN aji-51 912 2 j j PROPN aji-51 912 3 pharmacol pharmacol PROPN aji-51 912 4 . . PUNCT aji-51 913 1 2020 2020 NUM aji-51 913 2 sep sep PROPN aji-51 913 3 5;882:173325 5;882:173325 PROPN aji-51 913 4 . . PUNCT aji-51 914 1 doi doi PROPN aji-51 914 2 : : PUNCT aji-51 914 3 10.1016 10.1016 NUM aji-51 914 4 / / SYM aji-51 914 5 j.ejphar.2020.173325 j.ejphar.2020.173325 PROPN aji-51 914 6 epub epub PROPN aji-51 914 7 2020 2020 NUM aji-51 914 8 jun jun PROPN aji-51 914 9 29 29 NUM aji-51 914 10 . . PUNCT aji-51 915 1 pmid pmid NOUN aji-51 915 2 : : PUNCT aji-51 915 3 32615181 32615181 NUM aji-51 915 4 . . PUNCT aji-51 916 1 74 74 NUM aji-51 916 2 . . PUNCT aji-51 917 1 carter carter PROPN aji-51 917 2 a. a. PROPN aji-51 917 3 curry curry PROPN aji-51 917 4 compound compound PROPN aji-51 917 5 fights fight VERB aji-51 917 6 cancer cancer NOUN aji-51 917 7 in in ADP aji-51 917 8 the the DET aji-51 917 9 clinic clinic NOUN aji-51 917 10 . . PUNCT aji-51 918 1 j j PROPN aji-51 918 2 natl natl PROPN aji-51 918 3 cancer cancer PROPN aji-51 918 4 inst inst PROPN aji-51 918 5 . . PROPN aji-51 919 1 2008 2008 NUM aji-51 919 2 may may AUX aji-51 919 3 7;100(9):616 7;100(9):616 PROPN aji-51 919 4 - - PUNCT aji-51 919 5 7 7 NUM aji-51 919 6 . . PUNCT aji-51 920 1 doi doi NOUN aji-51 920 2 : : PUNCT aji-51 920 3 10.1093 10.1093 NUM aji-51 920 4 / / SYM aji-51 920 5 jnci jnci PROPN aji-51 920 6 / / SYM aji-51 920 7 djn141 djn141 PROPN aji-51 920 8 stoff stoff PROPN aji-51 920 9 ; ; PUNCT aji-51 920 10 aji aji PROPN aji-51 920 11 , , PUNCT aji-51 920 12 5(1 5(1 NUM aji-51 920 13 ): ): PUNCT aji-51 920 14 1 1 NUM aji-51 920 15 - - SYM aji-51 920 16 39 39 NUM aji-51 920 17 , , PUNCT aji-51 920 18 2022 2022 NUM aji-51 920 19 ; ; PUNCT aji-51 920 20 article article NOUN aji-51 920 21 no.aji.77967 no.aji.77967 PROPN aji-51 920 22 22 22 NUM aji-51 920 23 epub epub NOUN aji-51 920 24 2008 2008 NUM aji-51 920 25 apr apr NOUN aji-51 920 26 29 29 NUM aji-51 920 27 . . PUNCT aji-51 921 1 pmid pmid NOUN aji-51 921 2 : : PUNCT aji-51 921 3 18445813 18445813 NUM aji-51 921 4 . . PUNCT aji-51 922 1 75 75 NUM aji-51 922 2 . . PUNCT aji-51 923 1 menon menon PROPN aji-51 923 2 vp vp PROPN aji-51 923 3 , , PUNCT aji-51 923 4 sudheer sudheer PROPN aji-51 923 5 ar ar PROPN aji-51 923 6 . . PROPN aji-51 923 7 antioxidant antioxidant PROPN aji-51 923 8 and and CCONJ aji-51 923 9 anti anti ADJ aji-51 923 10 - - ADJ aji-51 923 11 inflammatory inflammatory ADJ aji-51 923 12 properties property NOUN aji-51 923 13 of of ADP aji-51 923 14 curcumin curcumin NOUN aji-51 923 15 . . PUNCT aji-51 924 1 adv adv PROPN aji-51 924 2 exp exp NOUN aji-51 924 3 med med ADJ aji-51 924 4 biol biol NOUN aji-51 924 5 . . PUNCT aji-51 925 1 2007;595:105 2007;595:105 NUM aji-51 925 2 - - SYM aji-51 925 3 25 25 NUM aji-51 925 4 . . PUNCT aji-51 925 5 doi doi NOUN aji-51 925 6 : : PUNCT aji-51 925 7 10.1007/978 10.1007/978 NUM aji-51 925 8 - - SYM aji-51 925 9 0 0 NUM aji-51 925 10 - - PUNCT aji-51 925 11 387 387 NUM aji-51 925 12 - - NUM aji-51 925 13 46401 46401 NUM aji-51 925 14 - - PUNCT aji-51 925 15 5_3 5_3 NUM aji-51 925 16 pmid pmid NOUN aji-51 925 17 : : PUNCT aji-51 925 18 17569207 17569207 NUM aji-51 925 19 . . PUNCT aji-51 926 1 76 76 NUM aji-51 926 2 . . PUNCT aji-51 927 1 nallathambi nallathambi PROPN aji-51 927 2 r r NOUN aji-51 927 3 , , PUNCT aji-51 927 4 poulev poulev NOUN aji-51 927 5 a a PRON aji-51 927 6 , , PUNCT aji-51 927 7 zuk zuk PROPN aji-51 927 8 jb jb PROPN aji-51 927 9 , , PUNCT aji-51 927 10 raskin raskin PROPN aji-51 927 11 i. i. PROPN aji-51 927 12 proanthocyanidin proanthocyanidin ADJ aji-51 927 13 - - PUNCT aji-51 927 14 rich rich ADJ aji-51 927 15 grape grape NOUN aji-51 927 16 seed seed NOUN aji-51 927 17 extract extract NOUN aji-51 927 18 reduces reduce VERB aji-51 927 19 inflammation inflammation NOUN aji-51 927 20 and and CCONJ aji-51 927 21 oxidative oxidative ADJ aji-51 927 22 stress stress NOUN aji-51 927 23 and and CCONJ aji-51 927 24 restores restore VERB aji-51 927 25 tight tight ADJ aji-51 927 26 junction junction NOUN aji-51 927 27 barrier barrier NOUN aji-51 927 28 function function NOUN aji-51 927 29 in in ADP aji-51 927 30 caco-2 caco-2 NUM aji-51 927 31 colon colon NOUN aji-51 927 32 cells cell NOUN aji-51 927 33 . . PUNCT aji-51 928 1 nutrients nutrient NOUN aji-51 928 2 . . PUNCT aji-51 929 1 2020 2020 NUM aji-51 929 2 jun jun PROPN aji-51 929 3 1;12(6):1623 1;12(6):1623 NUM aji-51 929 4 . . PUNCT aji-51 930 1 doi doi NOUN aji-51 930 2 : : PUNCT aji-51 930 3 10.3390 10.3390 NUM aji-51 930 4 / / SYM aji-51 930 5 nu12061623 nu12061623 PROPN aji-51 930 6 pmid pmid NOUN aji-51 930 7 : : PUNCT aji-51 930 8 32492806 32492806 NUM aji-51 930 9 ; ; PUNCT aji-51 930 10 pmcid pmcid ADJ aji-51 930 11 : : PUNCT aji-51 930 12 pmc7352846 pmc7352846 NOUN aji-51 930 13 . . PUNCT aji-51 931 1 77 77 NUM aji-51 931 2 . . PUNCT aji-51 932 1 wang wang PROPN aji-51 932 2 h h PROPN aji-51 932 3 , , PUNCT aji-51 932 4 khor khor PROPN aji-51 932 5 to to ADP aji-51 932 6 , , PUNCT aji-51 932 7 shu shu PROPN aji-51 932 8 l l PROPN aji-51 932 9 , , PUNCT aji-51 932 10 su su PROPN aji-51 932 11 zy zy PROPN aji-51 932 12 , , PUNCT aji-51 932 13 fuentes fuentes PROPN aji-51 932 14 f f PROPN aji-51 932 15 , , PUNCT aji-51 932 16 lee lee PROPN aji-51 932 17 jh jh PROPN aji-51 932 18 , , PUNCT aji-51 932 19 kong kong PROPN aji-51 933 1 an an DET aji-51 933 2 . . PUNCT aji-51 933 3 plants plant NOUN aji-51 933 4 vs. vs. ADP aji-51 933 5 cancer cancer NOUN aji-51 933 6 : : PUNCT aji-51 933 7 a a DET aji-51 933 8 review review NOUN aji-51 933 9 on on ADP aji-51 933 10 natural natural ADJ aji-51 933 11 phytochemicals phytochemical NOUN aji-51 933 12 in in ADP aji-51 933 13 preventing prevent VERB aji-51 933 14 and and CCONJ aji-51 933 15 treating treat VERB aji-51 933 16 cancers cancer NOUN aji-51 933 17 and and CCONJ aji-51 933 18 their their PRON aji-51 933 19 druggability druggability NOUN aji-51 933 20 . . PUNCT aji-51 934 1 anticancer anticancer NOUN aji-51 934 2 agents agent NOUN aji-51 934 3 med med PROPN aji-51 934 4 chem chem NOUN aji-51 934 5 . . PUNCT aji-51 935 1 2012 2012 NUM aji-51 935 2 dec;12(10):1281 dec;12(10):1281 NOUN aji-51 935 3 - - SYM aji-51 935 4 305 305 NUM aji-51 935 5 . . PUNCT aji-51 936 1 doi doi NOUN aji-51 936 2 : : PUNCT aji-51 936 3 10.2174/187152012803833026 10.2174/187152012803833026 NUM aji-51 936 4 pmid pmid NOUN aji-51 936 5 : : PUNCT aji-51 936 6 22583408 22583408 NUM aji-51 936 7 ; ; PUNCT aji-51 936 8 pmcid pmcid ADJ aji-51 936 9 : : PUNCT aji-51 936 10 pmc4017674 pmc4017674 ADV aji-51 936 11 . . PUNCT aji-51 937 1 78 78 NUM aji-51 937 2 . . PUNCT aji-51 938 1 kubecova kubecova PROPN aji-51 938 2 m m PROPN aji-51 938 3 , , PUNCT aji-51 938 4 kolostova kolostova X aji-51 939 1 k k X aji-51 939 2 , , PUNCT aji-51 939 3 pinterova pinterova PROPN aji-51 939 4 d d PROPN aji-51 939 5 , , PUNCT aji-51 939 6 kacprzak kacprzak PROPN aji-51 939 7 g g PROPN aji-51 939 8 , , PUNCT aji-51 939 9 bobek bobek PROPN aji-51 939 10 v. v. ADP aji-51 939 11 cimetidine cimetidine PROPN aji-51 939 12 : : PUNCT aji-51 939 13 an an DET aji-51 939 14 anticancer anticancer NOUN aji-51 939 15 drug drug NOUN aji-51 939 16 ? ? PUNCT aji-51 940 1 eur eur PROPN aji-51 940 2 j j PROPN aji-51 940 3 pharm pharm PROPN aji-51 940 4 sci sci PROPN aji-51 940 5 . . PROPN aji-51 940 6 2011 2011 NUM aji-51 940 7 apr apr PROPN aji-51 940 8 18;42(5):439 18;42(5):439 NUM aji-51 940 9 - - SYM aji-51 940 10 44 44 NUM aji-51 940 11 . . PUNCT aji-51 941 1 doi doi NOUN aji-51 941 2 : : PUNCT aji-51 941 3 10.1016 10.1016 NUM aji-51 941 4 / / SYM aji-51 941 5 j.ejps.2011.02.004 j.ejps.2011.02.004 PROPN aji-51 941 6 epub epub PROPN aji-51 941 7 2011 2011 NUM aji-51 941 8 feb feb NOUN aji-51 941 9 15 15 NUM aji-51 941 10 . . PUNCT aji-51 942 1 pmid pmid NOUN aji-51 942 2 : : PUNCT aji-51 942 3 21329756 21329756 NUM aji-51 942 4 . . PUNCT aji-51 943 1 79 79 NUM aji-51 943 2 . . PUNCT aji-51 944 1 hegde hegde PROPN aji-51 944 2 p p PROPN aji-51 944 3 , , PUNCT aji-51 944 4 maddur maddur PROPN aji-51 944 5 ms ms PROPN aji-51 944 6 , , PUNCT aji-51 944 7 friboulet friboulet NOUN aji-51 944 8 a a PRON aji-51 944 9 , , PUNCT aji-51 944 10 bayry bayry PROPN aji-51 944 11 j j PROPN aji-51 944 12 , , PUNCT aji-51 944 13 kaveri kaveri PROPN aji-51 944 14 sv sv PROPN aji-51 944 15 . . PROPN aji-51 944 16 viscum viscum PROPN aji-51 944 17 album album NOUN aji-51 944 18 exerts exert VERB aji-51 944 19 antiinflammatory antiinflammatory NOUN aji-51 944 20 effect effect NOUN aji-51 944 21 by by ADP aji-51 944 22 selectively selectively ADV aji-51 944 23 inhibiting inhibit VERB aji-51 944 24 cytokine cytokine NOUN aji-51 944 25 - - PUNCT aji-51 944 26 induced induce VERB aji-51 944 27 expression expression NOUN aji-51 944 28 of of ADP aji-51 944 29 cyclooxygenase-2 cyclooxygenase-2 PROPN aji-51 944 30 . . PUNCT aji-51 945 1 plos plos PROPN aji-51 945 2 one one NUM aji-51 945 3 . . PUNCT aji-51 946 1 2011;6(10):e26312 2011;6(10):e26312 NUM aji-51 946 2 . . PUNCT aji-51 946 3 doi doi NOUN aji-51 946 4 : : PUNCT aji-51 946 5 10.1371 10.1371 NUM aji-51 946 6 / / SYM aji-51 946 7 journal.pone.0026312 journal.pone.0026312 PROPN aji-51 946 8 epub epub NOUN aji-51 946 9 2011 2011 NUM aji-51 946 10 oct oct NOUN aji-51 946 11 18 18 NUM aji-51 946 12 . . PUNCT aji-51 947 1 pmid pmid NOUN aji-51 947 2 : : PUNCT aji-51 947 3 22028854 22028854 NUM aji-51 947 4 ; ; PUNCT aji-51 947 5 pmcid pmcid NOUN aji-51 947 6 : : PUNCT aji-51 947 7 pmc3196571 pmc3196571 ADJ aji-51 947 8 . . PUNCT aji-51 948 1 80 80 NUM aji-51 948 2 . . PUNCT aji-51 949 1 stewart stewart PROPN aji-51 949 2 dj dj PROPN aji-51 949 3 , , PUNCT aji-51 949 4 issa issa PROPN aji-51 949 5 jp jp PROPN aji-51 949 6 , , PUNCT aji-51 949 7 kurzrock kurzrock PROPN aji-51 949 8 r r PROPN aji-51 949 9 , , PUNCT aji-51 949 10 nunez nunez PROPN aji-51 949 11 mi mi PROPN aji-51 949 12 , , PUNCT aji-51 949 13 jelinek jelinek PROPN aji-51 949 14 j j PROPN aji-51 949 15 , , PUNCT aji-51 949 16 hong hong PROPN aji-51 949 17 d d PROPN aji-51 949 18 , , PUNCT aji-51 949 19 oki oki PROPN aji-51 949 20 y y PROPN aji-51 949 21 , , PUNCT aji-51 949 22 guo guo PROPN aji-51 949 23 z z PROPN aji-51 949 24 , , PUNCT aji-51 949 25 gupta gupta PROPN aji-51 949 26 s s PART aji-51 949 27 , , PUNCT aji-51 949 28 wistuba wistuba PROPN aji-51 949 29 ii ii PROPN aji-51 949 30 . . PUNCT aji-51 950 1 decitabine decitabine PROPN aji-51 950 2 effect effect VERB aji-51 950 3 on on ADP aji-51 950 4 tumor tumor NOUN aji-51 950 5 global global ADJ aji-51 950 6 dna dna PROPN aji-51 950 7 methylation methylation NOUN aji-51 950 8 and and CCONJ aji-51 950 9 other other ADJ aji-51 950 10 parameters parameter NOUN aji-51 950 11 in in ADP aji-51 950 12 a a DET aji-51 950 13 phase phase NOUN aji-51 950 14 i i PRON aji-51 950 15 trial trial NOUN aji-51 950 16 in in ADP aji-51 950 17 refractory refractory NOUN aji-51 950 18 solid solid ADJ aji-51 950 19 tumors tumor NOUN aji-51 950 20 and and CCONJ aji-51 950 21 lymphomas lymphoma NOUN aji-51 950 22 . . PUNCT aji-51 951 1 clin clin PROPN aji-51 951 2 cancer cancer NOUN aji-51 951 3 res re NOUN aji-51 951 4 . . PUNCT aji-51 951 5 2009 2009 NUM aji-51 951 6 jun jun PROPN aji-51 951 7 1;15(11 1;15(11 NUM aji-51 951 8 ): ): PUNCT aji-51 951 9 3881 3881 NUM aji-51 951 10 - - SYM aji-51 951 11 8 8 NUM aji-51 951 12 . . PUNCT aji-51 952 1 doi doi NOUN aji-51 952 2 : : PUNCT aji-51 952 3 10.1158/1078 10.1158/1078 NUM aji-51 952 4 - - PUNCT aji-51 952 5 0432.ccr-08 0432.ccr-08 NOUN aji-51 952 6 - - PUNCT aji-51 952 7 2196 2196 NUM aji-51 952 8 epub epub NOUN aji-51 952 9 2009 2009 NUM aji-51 952 10 may may AUX aji-51 952 11 26 26 NUM aji-51 952 12 . . PUNCT aji-51 953 1 pmid pmid NOUN aji-51 953 2 : : PUNCT aji-51 953 3 19470736 19470736 NUM aji-51 953 4 . . PUNCT aji-51 954 1 81 81 NUM aji-51 954 2 . . PUNCT aji-51 955 1 akone akone PROPN aji-51 955 2 sh sh PROPN aji-51 955 3 , , PUNCT aji-51 955 4 ntie ntie PROPN aji-51 955 5 - - PUNCT aji-51 955 6 kang kang PROPN aji-51 955 7 f f PROPN aji-51 955 8 , , PUNCT aji-51 955 9 stuhldreier stuhldreier NOUN aji-51 955 10 f f NOUN aji-51 955 11 , , PUNCT aji-51 955 12 ewonkem ewonkem VERB aji-51 955 13 mb mb ADP aji-51 955 14 , , PUNCT aji-51 955 15 noah noah PROPN aji-51 955 16 am be AUX aji-51 955 17 , , PUNCT aji-51 955 18 mouelle mouelle NOUN aji-51 955 19 sem sem PROPN aji-51 955 20 , , PUNCT aji-51 955 21 müller müller PROPN aji-51 955 22 r. r. PROPN aji-51 955 23 natural natural PROPN aji-51 955 24 products product NOUN aji-51 955 25 impacting impact VERB aji-51 955 26 dna dna PROPN aji-51 955 27 methyltransferases methyltransferase NOUN aji-51 955 28 and and CCONJ aji-51 955 29 histone histone NOUN aji-51 955 30 deacetylases deacetylase NOUN aji-51 955 31 . . PUNCT aji-51 956 1 front front ADJ aji-51 956 2 pharmacol pharmacol PROPN aji-51 956 3 . . PUNCT aji-51 957 1 2020 2020 NUM aji-51 957 2 aug aug PROPN aji-51 957 3 13;11:992 13;11:992 NUM aji-51 957 4 . . PUNCT aji-51 958 1 doi doi NOUN aji-51 958 2 : : PUNCT aji-51 958 3 10.3389 10.3389 NUM aji-51 958 4 / / SYM aji-51 958 5 fphar.2020.00992 fphar.2020.00992 NUM aji-51 958 6 pmid pmid PROPN aji-51 958 7 : : PUNCT aji-51 958 8 32903500 32903500 NUM aji-51 958 9 ; ; PUNCT aji-51 958 10 pmcid pmcid NOUN aji-51 958 11 : : PUNCT aji-51 958 12 pmc7438611 pmc7438611 NOUN aji-51 958 13 . . PUNCT aji-51 959 1 82 82 NUM aji-51 959 2 . . PUNCT aji-51 959 3 sanmartín sanmartín NOUN aji-51 959 4 - - PUNCT aji-51 959 5 suárez suárez NOUN aji-51 959 6 c c PROPN aji-51 959 7 , , PUNCT aji-51 959 8 soto soto PROPN aji-51 959 9 - - PUNCT aji-51 959 10 otero otero PROPN aji-51 959 11 r r PROPN aji-51 959 12 , , PUNCT aji-51 959 13 sánchez sánchez NOUN aji-51 959 14 - - PUNCT aji-51 959 15 sellero sellero NOUN aji-51 959 16 i i PRON aji-51 959 17 , , PUNCT aji-51 959 18 méndez méndez PROPN aji-51 959 19 - - PUNCT aji-51 959 20 álvarez álvarez PROPN aji-51 959 21 e. e. PROPN aji-51 959 22 antioxidant antioxidant PROPN aji-51 959 23 properties property NOUN aji-51 959 24 of of ADP aji-51 959 25 dimethyl dimethyl NOUN aji-51 959 26 sulfoxide sulfoxide NOUN aji-51 959 27 and and CCONJ aji-51 959 28 its its PRON aji-51 959 29 viability viability NOUN aji-51 959 30 as as ADP aji-51 959 31 a a DET aji-51 959 32 solvent solvent NOUN aji-51 959 33 in in ADP aji-51 959 34 the the DET aji-51 959 35 evaluation evaluation NOUN aji-51 959 36 of of ADP aji-51 959 37 neuroprotective neuroprotective ADJ aji-51 959 38 antioxidants antioxidant NOUN aji-51 959 39 . . PUNCT aji-51 960 1 j j PROPN aji-51 960 2 pharmacol pharmacol PROPN aji-51 960 3 toxicol toxicol PROPN aji-51 960 4 methods method NOUN aji-51 960 5 . . PUNCT aji-51 961 1 2011 2011 NUM aji-51 961 2 marapr;63(2):209 marapr;63(2):209 NOUN aji-51 961 3 - - SYM aji-51 961 4 15 15 NUM aji-51 961 5 . . PUNCT aji-51 962 1 doi doi NOUN aji-51 962 2 : : PUNCT aji-51 962 3 10.1016 10.1016 NUM aji-51 962 4 / / SYM aji-51 962 5 j.vascn.2010.10.004 j.vascn.2010.10.004 PROPN aji-51 962 6 epub epub NOUN aji-51 962 7 2010 2010 NUM aji-51 962 8 nov nov NOUN aji-51 962 9 6 6 NUM aji-51 962 10 . . PUNCT aji-51 963 1 pmid pmid NOUN aji-51 963 2 : : PUNCT aji-51 963 3 21059397 21059397 NUM aji-51 963 4 . . PUNCT aji-51 964 1 83 83 NUM aji-51 964 2 . . PUNCT aji-51 965 1 arteaga arteaga PROPN aji-51 965 2 e e PROPN aji-51 965 3 , , PUNCT aji-51 965 4 villaseca villaseca NOUN aji-51 965 5 p p NOUN aji-51 965 6 , , PUNCT aji-51 965 7 bianchi bianchi PROPN aji-51 965 8 m m PROPN aji-51 965 9 , , PUNCT aji-51 965 10 rojas rojas PROPN aji-51 965 11 a a PROPN aji-51 965 12 , , PUNCT aji-51 965 13 marshall marshall PROPN aji-51 965 14 g. g. PROPN aji-51 965 15 raloxifene raloxifene PROPN aji-51 965 16 is be AUX aji-51 965 17 a a DET aji-51 965 18 better well ADJ aji-51 965 19 antioxidant antioxidant NOUN aji-51 965 20 of of ADP aji-51 965 21 low low ADJ aji-51 965 22 - - PUNCT aji-51 965 23 density density NOUN aji-51 965 24 lipoprotein lipoprotein NOUN aji-51 965 25 than than ADP aji-51 965 26 estradiol estradiol PROPN aji-51 965 27 or or CCONJ aji-51 965 28 tamoxifen tamoxifen NOUN aji-51 965 29 in in ADP aji-51 965 30 postmenopausal postmenopausal ADJ aji-51 965 31 women woman NOUN aji-51 965 32 in in ADP aji-51 965 33 vitro vitro X aji-51 965 34 . . PUNCT aji-51 966 1 menopause menopause NOUN aji-51 966 2 . . PUNCT aji-51 967 1 2003 2003 NUM aji-51 967 2 marapr;10(2):142 marapr;10(2):142 NOUN aji-51 967 3 - - SYM aji-51 967 4 6 6 NUM aji-51 967 5 . . PUNCT aji-51 967 6 doi doi NOUN aji-51 967 7 : : PUNCT aji-51 967 8 10.1097/00042192 10.1097/00042192 NUM aji-51 967 9 - - PUNCT aji-51 967 10 200310020 200310020 NUM aji-51 967 11 - - SYM aji-51 967 12 00005 00005 NUM aji-51 967 13 pmid pmid NOUN aji-51 967 14 : : PUNCT aji-51 967 15 12627039 12627039 NUM aji-51 967 16 . . PUNCT aji-51 968 1 84 84 NUM aji-51 968 2 . . PUNCT aji-51 969 1 frei frei PROPN aji-51 969 2 b b PROPN aji-51 969 3 , , PUNCT aji-51 969 4 mccall mccall PROPN aji-51 969 5 mr mr PROPN aji-51 969 6 . . PROPN aji-51 969 7 antioxidant antioxidant PROPN aji-51 969 8 vitamins vitamin NOUN aji-51 969 9 : : PUNCT aji-51 969 10 evidence evidence NOUN aji-51 969 11 from from ADP aji-51 969 12 biomarkers biomarker NOUN aji-51 969 13 in in ADP aji-51 969 14 humans human NOUN aji-51 969 15 . . PUNCT aji-51 970 1 bibl bibl PROPN aji-51 970 2 nutr nutr PROPN aji-51 970 3 dieta dieta PROPN aji-51 970 4 . . PUNCT aji-51 971 1 2001;(55):46 2001;(55):46 NUM aji-51 971 2 - - SYM aji-51 971 3 67 67 NUM aji-51 971 4 . . PUNCT aji-51 972 1 doi doi NOUN aji-51 972 2 : : PUNCT aji-51 972 3 10.1159/000059462 10.1159/000059462 NUM aji-51 972 4 pmid pmid NOUN aji-51 972 5 : : PUNCT aji-51 972 6 11125585 11125585 NUM aji-51 972 7 . . PUNCT aji-51 972 8 85 85 NUM aji-51 972 9 . . PUNCT aji-51 973 1 joyce joyce PROPN aji-51 973 2 ja ja PROPN aji-51 973 3 , , PUNCT aji-51 973 4 pollard pollard PROPN aji-51 973 5 jw jw PROPN aji-51 973 6 . . PUNCT aji-51 974 1 microenvironmental microenvironmental ADJ aji-51 974 2 regulation regulation NOUN aji-51 974 3 of of ADP aji-51 974 4 metastasis metastasis NOUN aji-51 974 5 . . PUNCT aji-51 975 1 nat nat PROPN aji-51 975 2 rev rev PROPN aji-51 975 3 cancer cancer NOUN aji-51 975 4 . . PUNCT aji-51 976 1 2009 2009 NUM aji-51 976 2 apr;9(4):239 apr;9(4):239 PROPN aji-51 976 3 - - PUNCT aji-51 976 4 52 52 NUM aji-51 976 5 . . PUNCT aji-51 976 6 doi doi NOUN aji-51 976 7 : : PUNCT aji-51 976 8 10.1038 10.1038 NUM aji-51 976 9 / / SYM aji-51 976 10 nrc2618 nrc2618 PROPN aji-51 976 11 epub epub PROPN aji-51 976 12 2008 2008 NUM aji-51 976 13 mar mar PROPN aji-51 976 14 12 12 NUM aji-51 976 15 . . PUNCT aji-51 977 1 pmid pmid NOUN aji-51 977 2 : : PUNCT aji-51 977 3 19279573 19279573 NUM aji-51 977 4 ; ; PUNCT aji-51 977 5 pmcid pmcid NOUN aji-51 977 6 : : PUNCT aji-51 977 7 pmc3251309 pmc3251309 NOUN aji-51 977 8 . . PUNCT aji-51 978 1 86 86 NUM aji-51 978 2 . . PUNCT aji-51 979 1 available available ADJ aji-51 979 2 : : PUNCT aji-51 979 3 https://www.newsmedical.net https://www.newsmedical.net NOUN aji-51 979 4 / / SYM aji-51 979 5 life life NOUN aji-51 979 6 - - PUNCT aji-51 979 7 sciences science NOUN aji-51 979 8 / / SYM aji-51 979 9 what what PRON aji-51 979 10 - - PUNCT aji-51 979 11 is be AUX aji-51 979 12 - - PUNCT aji-51 979 13 thetumor thetumor NOUN aji-51 979 14 - - PUNCT aji-51 979 15 microenvironment.aspx microenvironment.aspx NUM aji-51 979 16 87 87 NUM aji-51 979 17 . . PUNCT aji-51 980 1 hanahan hanahan PROPN aji-51 980 2 d d PROPN aji-51 980 3 , , PUNCT aji-51 980 4 coussens coussen NOUN aji-51 980 5 lm lm PROPN aji-51 980 6 . . PUNCT aji-51 981 1 accessories accessory NOUN aji-51 981 2 to to ADP aji-51 981 3 the the DET aji-51 981 4 crime crime NOUN aji-51 981 5 : : PUNCT aji-51 981 6 functions function NOUN aji-51 981 7 of of ADP aji-51 981 8 cells cell NOUN aji-51 981 9 recruited recruit VERB aji-51 981 10 to to ADP aji-51 981 11 the the DET aji-51 981 12 tumor tumor NOUN aji-51 981 13 microenvironment microenvironment NOUN aji-51 981 14 . . PUNCT aji-51 982 1 cancer cancer NOUN aji-51 982 2 cell cell NOUN aji-51 982 3 . . PUNCT aji-51 983 1 2012 2012 NUM aji-51 983 2 mar mar PROPN aji-51 983 3 20;21(3):309 20;21(3):309 PROPN aji-51 983 4 - - SYM aji-51 983 5 22 22 NUM aji-51 983 6 . . PUNCT aji-51 984 1 doi doi NOUN aji-51 984 2 : : PUNCT aji-51 984 3 10.1016 10.1016 NUM aji-51 984 4 / / SYM aji-51 984 5 j.ccr.2012.02.022 j.ccr.2012.02.022 PROPN aji-51 984 6 pmid pmid PROPN aji-51 984 7 : : PUNCT aji-51 984 8 22439926 22439926 NUM aji-51 984 9 . . PUNCT aji-51 985 1 88 88 NUM aji-51 985 2 . . PUNCT aji-51 986 1 wang wang PROPN aji-51 986 2 m m PROPN aji-51 986 3 , , PUNCT aji-51 986 4 zhao zhao PROPN aji-51 986 5 j j PROPN aji-51 986 6 , , PUNCT aji-51 986 7 zhang zhang PROPN aji-51 986 8 l l PROPN aji-51 986 9 , , PUNCT aji-51 986 10 wei wei PROPN aji-51 986 11 f f PROPN aji-51 986 12 , , PUNCT aji-51 986 13 lian lian PROPN aji-51 986 14 y y PROPN aji-51 986 15 , , PUNCT aji-51 986 16 wu wu PROPN aji-51 986 17 y y PROPN aji-51 986 18 , , PUNCT aji-51 986 19 gong gong PROPN aji-51 986 20 z z PROPN aji-51 986 21 , , PUNCT aji-51 986 22 zhang zhang PROPN aji-51 986 23 s s PROPN aji-51 986 24 , , PUNCT aji-51 986 25 zhou zhou PROPN aji-51 986 26 j j PROPN aji-51 986 27 , , PUNCT aji-51 986 28 cao cao PROPN aji-51 986 29 k k PROPN aji-51 986 30 , , PUNCT aji-51 986 31 li li PROPN aji-51 986 32 x x PROPN aji-51 986 33 , , PUNCT aji-51 986 34 xiong xiong PROPN aji-51 986 35 w w PROPN aji-51 986 36 , , PUNCT aji-51 986 37 li li PROPN aji-51 986 38 g g PROPN aji-51 986 39 , , PUNCT aji-51 986 40 zeng zeng PROPN aji-51 986 41 z z PROPN aji-51 986 42 , , PUNCT aji-51 986 43 guo guo PROPN aji-51 986 44 c. c. PROPN aji-51 986 45 role role NOUN aji-51 986 46 of of ADP aji-51 986 47 tumor tumor NOUN aji-51 986 48 microenvironment microenvironment NOUN aji-51 986 49 in in ADP aji-51 986 50 tumorigenesis tumorigenesis NOUN aji-51 986 51 . . PUNCT aji-51 987 1 journal journal PROPN aji-51 987 2 of of ADP aji-51 987 3 cancer cancer NOUN aji-51 988 1 [ [ X aji-51 988 2 online online X aji-51 988 3 ] ] X aji-51 988 4 . . PUNCT aji-51 989 1 2017;8(5):761773 2017;8(5):761773 X aji-51 989 2 . . PUNCT aji-51 990 1 available available ADJ aji-51 990 2 : : PUNCT aji-51 990 3 https://www.ncbi.nlm.nih.gov https://www.ncbi.nlm.nih.gov ADJ aji-51 990 4 / / SYM aji-51 990 5 pm pm NOUN aji-51 990 6 c c NOUN aji-51 990 7 / / SYM aji-51 990 8 articles article NOUN aji-51 990 9 / / SYM aji-51 990 10 pmc5381164/ pmc5381164/ PROPN aji-51 990 11 89 89 NUM aji-51 990 12 . . PUNCT aji-51 991 1 available available ADJ aji-51 991 2 : : PUNCT aji-51 991 3 https://www.natera.com https://www.natera.com X aji-51 991 4 / / SYM aji-51 991 5 oncology oncology NOUN aji-51 991 6 /signatera /signatera NOUN aji-51 991 7 - - PUNCT aji-51 991 8 advanced advanced ADJ aji-51 991 9 - - PUNCT aji-51 991 10 cancer cancer NOUN aji-51 991 11 - - PUNCT aji-51 991 12 detection/ detection/ NUM aji-51 991 13 90 90 NUM aji-51 991 14 . . PUNCT aji-51 992 1 frisch frisch PROPN aji-51 992 2 j j PROPN aji-51 992 3 , , PUNCT aji-51 992 4 angenendt angenendt ADP aji-51 992 5 a a PRON aji-51 992 6 , , PUNCT aji-51 992 7 hoth hoth PROPN aji-51 992 8 m m PROPN aji-51 992 9 , , PUNCT aji-51 992 10 prates prate VERB aji-51 992 11 roma roma PROPN aji-51 992 12 l l PROPN aji-51 992 13 , , PUNCT aji-51 992 14 lis lis ADJ aji-51 992 15 a. a. NOUN aji-51 992 16 stim stim NOUN aji-51 992 17 - - PUNCT aji-51 992 18 orai orai NOUN aji-51 992 19 channels channel NOUN aji-51 992 20 and and CCONJ aji-51 992 21 reactive reactive ADJ aji-51 992 22 oxygen oxygen NOUN aji-51 992 23 species specie NOUN aji-51 992 24 in in ADP aji-51 992 25 the the DET aji-51 992 26 tumor tumor NOUN aji-51 992 27 stoff stoff PROPN aji-51 992 28 ; ; PUNCT aji-51 992 29 aji aji PROPN aji-51 992 30 , , PUNCT aji-51 992 31 5(1 5(1 NUM aji-51 992 32 ): ): PUNCT aji-51 992 33 1 1 NUM aji-51 992 34 - - SYM aji-51 992 35 39 39 NUM aji-51 992 36 , , PUNCT aji-51 992 37 2022 2022 NUM aji-51 992 38 ; ; PUNCT aji-51 992 39 article article NOUN aji-51 992 40 no.aji.77967 no.aji.77967 VERB aji-51 992 41 23 23 NUM aji-51 992 42 microenvironment microenvironment NOUN aji-51 992 43 . . PUNCT aji-51 993 1 cancers cancer NOUN aji-51 993 2 ( ( PUNCT aji-51 993 3 basel basel PROPN aji-51 993 4 ) ) PUNCT aji-51 993 5 . . PUNCT aji-51 994 1 2019 2019 NUM aji-51 994 2 mar mar PROPN aji-51 994 3 30;11(4):457 30;11(4):457 NUM aji-51 994 4 . . PUNCT aji-51 995 1 doi doi NOUN aji-51 995 2 : : PUNCT aji-51 995 3 10.3390 10.3390 NUM aji-51 995 4 / / SYM aji-51 995 5 cancers11040457 cancers11040457 PRON aji-51 995 6 pmid pmid NOUN aji-51 995 7 : : PUNCT aji-51 995 8 30935064 30935064 NUM aji-51 995 9 ; ; PUNCT aji-51 995 10 pmcid pmcid NOUN aji-51 995 11 : : PUNCT aji-51 996 1 pmc6520831 pmc6520831 PROPN aji-51 996 2 . . PUNCT aji-51 997 1 91 91 NUM aji-51 997 2 . . PUNCT aji-51 998 1 balkwill balkwill PROPN aji-51 998 2 f f PROPN aji-51 998 3 , , PUNCT aji-51 998 4 capasso capasso PROPN aji-51 998 5 m m PROPN aji-51 998 6 , , PUNCT aji-51 998 7 hagemann hagemann PROPN aji-51 998 8 t. t. PROPN aji-51 998 9 the the DET aji-51 998 10 tumor tumor NOUN aji-51 998 11 microenvironment microenvironment NOUN aji-51 998 12 at at ADP aji-51 998 13 a a DET aji-51 998 14 glance glance NOUN aji-51 998 15 . . PUNCT aji-51 999 1 journal journal NOUN aji-51 999 2 of of ADP aji-51 999 3 cell cell NOUN aji-51 999 4 science science NOUN aji-51 999 5 , , PUNCT aji-51 1000 1 [ [ X aji-51 1000 2 online online X aji-51 1000 3 ] ] X aji-51 1000 4 . . PUNCT aji-51 1001 1 2012;125(23):5591 2012;125(23):5591 NUM aji-51 1001 2 - - SYM aji-51 1001 3 5596 5596 NUM aji-51 1001 4 . . PUNCT aji-51 1002 1 available available ADJ aji-51 1002 2 : : PUNCT aji-51 1002 3 https://jcs.biologists.org https://jcs.biologists.org PROPN aji-51 1002 4 / / SYM aji-51 1002 5 content/1 content/1 NUM aji-51 1002 6 25/23/5591 25/23/5591 NUM aji-51 1002 7 pmid pmid NOUN aji-51 1002 8 : : PUNCT aji-51 1002 9 23420197 23420197 NUM aji-51 1002 10 . . PUNCT aji-51 1003 1 92 92 NUM aji-51 1003 2 . . PUNCT aji-51 1004 1 hao hao PROPN aji-51 1004 2 g g PROPN aji-51 1004 3 , , PUNCT aji-51 1004 4 zhi zhi PROPN aji-51 1004 5 ping ping PROPN aji-51 1004 6 xu xu PROPN aji-51 1004 7 and and CCONJ aji-51 1004 8 li li PROPN aji-51 1004 9 li li PROPN aji-51 1004 10 . . PUNCT aji-51 1004 11 manipulating manipulate VERB aji-51 1004 12 extracellular extracellular ADJ aji-51 1004 13 tumour tumour NOUN aji-51 1004 14 ph ph NOUN aji-51 1004 15 : : PUNCT aji-51 1004 16 an an DET aji-51 1004 17 effective effective ADJ aji-51 1004 18 target target NOUN aji-51 1004 19 for for ADP aji-51 1004 20 cancer cancer NOUN aji-51 1004 21 therapy therapy NOUN aji-51 1004 22 ( ( PUNCT aji-51 1004 23 review review NOUN aji-51 1004 24 article article NOUN aji-51 1004 25 ) ) PUNCT aji-51 1004 26 . . PUNCT aji-51 1005 1 rsc rsc PROPN aji-51 1005 2 adv adv PROPN aji-51 1005 3 . . PUNCT aji-51 1006 1 2018;8:22182 2018;8:22182 PROPN aji-51 1006 2 - - PUNCT aji-51 1006 3 22192 22192 NUM aji-51 1006 4 . . PUNCT aji-51 1007 1 doi doi NOUN aji-51 1007 2 : : PUNCT aji-51 1007 3 10.1039 10.1039 NUM aji-51 1007 4 / / SYM aji-51 1007 5 c8ra02095 c8ra02095 NOUN aji-51 1007 6 g g NOUN aji-51 1007 7 93 93 NUM aji-51 1007 8 . . PUNCT aji-51 1008 1 richard richard PROPN aji-51 1008 2 sollazzo sollazzo PROPN aji-51 1008 3 , , PUNCT aji-51 1008 4 m.d m.d PROPN aji-51 1008 5 . . PROPN aji-51 1008 6 dabim dabim PROPN aji-51 1008 7 , , PUNCT aji-51 1008 8 cns cns PROPN aji-51 1008 9 , , PUNCT aji-51 1008 10 daam daam PROPN aji-51 1008 11 , , PUNCT aji-51 1008 12 faaim faaim NOUN aji-51 1008 13 , , PUNCT aji-51 1008 14 personal personal ADJ aji-51 1008 15 communication communication NOUN aji-51 1008 16 , , PUNCT aji-51 1008 17 8/14/21 8/14/21 NUM aji-51 1008 18 . . PUNCT aji-51 1008 19 94 94 NUM aji-51 1008 20 . . PUNCT aji-51 1009 1 yang yang PROPN aji-51 1009 2 m m PROPN aji-51 1009 3 , , PUNCT aji-51 1009 4 zhong zhong PROPN aji-51 1009 5 x x PROPN aji-51 1009 6 , , PUNCT aji-51 1009 7 yuan yuan PROPN aji-51 1009 8 y. y. PROPN aji-51 1009 9 does do AUX aji-51 1009 10 baking bake VERB aji-51 1009 11 soda soda NOUN aji-51 1009 12 function function NOUN aji-51 1009 13 as as ADP aji-51 1009 14 a a DET aji-51 1009 15 magic magic ADJ aji-51 1009 16 bullet bullet NOUN aji-51 1009 17 for for ADP aji-51 1009 18 patients patient NOUN aji-51 1009 19 with with ADP aji-51 1009 20 cancer cancer NOUN aji-51 1009 21 ? ? PUNCT aji-51 1010 1 a a DET aji-51 1010 2 mini mini ADJ aji-51 1010 3 review review NOUN aji-51 1010 4 . . PUNCT aji-51 1011 1 integr integr PROPN aji-51 1011 2 cancer cancer PROPN aji-51 1011 3 ther ther ADV aji-51 1011 4 . . PUNCT aji-51 1012 1 2020 2020 NUM aji-51 1012 2 jandec;19:1534735420922579 jandec;19:1534735420922579 PROPN aji-51 1012 3 . . PUNCT aji-51 1013 1 doi doi NOUN aji-51 1013 2 : : PUNCT aji-51 1013 3 10.1177/1534735420922579 10.1177/1534735420922579 NUM aji-51 1013 4 pmid pmid NOUN aji-51 1013 5 : : PUNCT aji-51 1013 6 32448009 32448009 NUM aji-51 1013 7 ; ; PUNCT aji-51 1013 8 pmcid pmcid ADJ aji-51 1013 9 : : PUNCT aji-51 1013 10 pmc7249593 pmc7249593 PROPN aji-51 1013 11 . . PUNCT aji-51 1014 1 95 95 NUM aji-51 1014 2 . . PUNCT aji-51 1015 1 nordenström nordenström NOUN aji-51 1015 2 bew bew PROPN aji-51 1015 3 . . PUNCT aji-51 1016 1 electrochemical electrochemical ADJ aji-51 1016 2 treatment treatment NOUN aji-51 1016 3 of of ADP aji-51 1016 4 cancer.annales cancer.annale NOUN aji-51 1016 5 de de X aji-51 1016 6 radiologie radiologie NOUN aji-51 1016 7 . . PUNCT aji-51 1017 1 1985;28:128–129 1985;28:128–129 NUM aji-51 1017 2 . . PUNCT aji-51 1018 1 96 96 NUM aji-51 1018 2 . . PUNCT aji-51 1019 1 nordenström nordenström PROPN aji-51 1019 2 b. b. PROPN aji-51 1019 3 electrochemical electrochemical ADJ aji-51 1019 4 treatment treatment NOUN aji-51 1019 5 of of ADP aji-51 1019 6 cancer cancer NOUN aji-51 1019 7 . . PUNCT aji-51 1020 1 i i PRON aji-51 1020 2 : : PUNCT aji-51 1020 3 variable variable ADJ aji-51 1020 4 response response NOUN aji-51 1020 5 to to ADP aji-51 1020 6 anodic anodic ADJ aji-51 1020 7 and and CCONJ aji-51 1020 8 cathodic cathodic NOUN aji-51 1020 9 fields field NOUN aji-51 1020 10 . . PUNCT aji-51 1021 1 am be AUX aji-51 1021 2 j j PROPN aji-51 1021 3 clin clin PROPN aji-51 1021 4 oncol oncol PROPN aji-51 1021 5 . . PUNCT aji-51 1022 1 1989 1989 NUM aji-51 1022 2 dec;12(6):530 dec;12(6):530 ADV aji-51 1022 3 - - PUNCT aji-51 1022 4 6 6 NUM aji-51 1022 5 . . PUNCT aji-51 1023 1 pmid:2556014 pmid:2556014 NOUN aji-51 1023 2 . . PROPN aji-51 1024 1 97 97 NUM aji-51 1024 2 . . PUNCT aji-51 1025 1 xin xin PROPN aji-51 1025 2 y y PROPN aji-51 1025 3 , , PUNCT aji-51 1025 4 xue xue PROPN aji-51 1025 5 f f PROPN aji-51 1025 6 , , PUNCT aji-51 1025 7 ge ge PROPN aji-51 1025 8 b b PROPN aji-51 1025 9 , , PUNCT aji-51 1025 10 zhao zhao PROPN aji-51 1025 11 f f PROPN aji-51 1025 12 , , PUNCT aji-51 1025 13 shi shi PROPN aji-51 1025 14 b b PROPN aji-51 1025 15 , , PUNCT aji-51 1025 16 zhang zhang PROPN aji-51 1025 17 w. w. PROPN aji-51 1025 18 electrochemical electrochemical ADJ aji-51 1025 19 treatment treatment NOUN aji-51 1025 20 of of ADP aji-51 1025 21 lung lung NOUN aji-51 1025 22 cancer cancer NOUN aji-51 1025 23 . . PUNCT aji-51 1026 1 bioelectromagnetics bioelectromagnetic NOUN aji-51 1026 2 . . PUNCT aji-51 1027 1 1997;18(1):813 1997;18(1):813 NUM aji-51 1027 2 . . PUNCT aji-51 1028 1 pmid pmid NOUN aji-51 1028 2 : : PUNCT aji-51 1028 3 9125236 9125236 NUM aji-51 1028 4 . . PUNCT aji-51 1029 1 98 98 NUM aji-51 1029 2 . . PUNCT aji-51 1030 1 gweon gweon PROPN aji-51 1030 2 ej ej PROPN aji-51 1030 3 , , PUNCT aji-51 1030 4 kim kim PROPN aji-51 1030 5 sj sj PROPN aji-51 1030 6 . . PUNCT aji-51 1030 7 resveratrol resveratrol NOUN aji-51 1030 8 attenuates attenuate NOUN aji-51 1030 9 matrix matrix NOUN aji-51 1030 10 metalloproteinase-9 metalloproteinase-9 NUM aji-51 1030 11 and and CCONJ aji-51 1030 12 -2regulated -2regulate VERB aji-51 1030 13 differentiation differentiation NOUN aji-51 1030 14 of of ADP aji-51 1030 15 htb94 htb94 ADJ aji-51 1030 16 chondrosarcoma chondrosarcoma NOUN aji-51 1030 17 cells cell NOUN aji-51 1030 18 through through ADP aji-51 1030 19 the the DET aji-51 1030 20 p38 p38 NOUN aji-51 1030 21 kinase kinase NOUN aji-51 1030 22 and and CCONJ aji-51 1030 23 jnk jnk PROPN aji-51 1030 24 pathways pathway NOUN aji-51 1030 25 . . PUNCT aji-51 1031 1 oncol oncol PROPN aji-51 1031 2 rep rep PROPN aji-51 1031 3 . . PROPN aji-51 1031 4 2014 2014 NUM aji-51 1031 5 jul;32(1):71 jul;32(1):71 PROPN aji-51 1031 6 - - PUNCT aji-51 1031 7 8 8 NUM aji-51 1031 8 . . PUNCT aji-51 1031 9 doi doi NOUN aji-51 1031 10 : : PUNCT aji-51 1031 11 10.3892 10.3892 NUM aji-51 1031 12 / / SYM aji-51 1031 13 or.2014.3192 or.2014.3192 NOUN aji-51 1031 14 epub epub VERB aji-51 1031 15 2014 2014 NUM aji-51 1031 16 may may PROPN aji-51 1031 17 16 16 NUM aji-51 1031 18 . . PUNCT aji-51 1032 1 pmid pmid NOUN aji-51 1032 2 : : PUNCT aji-51 1032 3 24841706 24841706 NUM aji-51 1032 4 . . PUNCT aji-51 1033 1 99 99 NUM aji-51 1033 2 . . PUNCT aji-51 1033 3 yu yu PROPN aji-51 1033 4 hb hb PROPN aji-51 1033 5 , , PUNCT aji-51 1033 6 zhang zhang PROPN aji-51 1033 7 hf hf PROPN aji-51 1033 8 , , PUNCT aji-51 1033 9 zhang zhang PROPN aji-51 1033 10 x x PROPN aji-51 1033 11 , , PUNCT aji-51 1033 12 li li PROPN aji-51 1033 13 dy dy PROPN aji-51 1033 14 , , PUNCT aji-51 1033 15 xue xue PROPN aji-51 1033 16 hz hz PROPN aji-51 1033 17 , , PUNCT aji-51 1033 18 pan pan PROPN aji-51 1033 19 ce ce PROPN aji-51 1033 20 , , PUNCT aji-51 1034 1 zhao zhao PROPN aji-51 1034 2 sh sh PROPN aji-51 1034 3 . . PROPN aji-51 1034 4 resveratrol resveratrol PROPN aji-51 1034 5 inhibits inhibit VERB aji-51 1034 6 vegf vegf NOUN aji-51 1034 7 expression expression NOUN aji-51 1034 8 of of ADP aji-51 1034 9 human human ADJ aji-51 1034 10 hepatocellular hepatocellular ADJ aji-51 1034 11 carcinoma carcinoma NOUN aji-51 1034 12 cells cell NOUN aji-51 1034 13 through through ADP aji-51 1034 14 a a DET aji-51 1034 15 nf nf ADJ aji-51 1034 16 - - PUNCT aji-51 1034 17 kappa kappa ADJ aji-51 1034 18 bmediated bmediate VERB aji-51 1034 19 mechanism mechanism NOUN aji-51 1034 20 . . PUNCT aji-51 1035 1 hepatogastroenterology hepatogastroenterology NOUN aji-51 1035 2 . . PUNCT aji-51 1036 1 2010 2010 NUM aji-51 1036 2 sepoct;57(102 sepoct;57(102 NUM aji-51 1036 3 - - PUNCT aji-51 1036 4 103):1241 103):1241 NUM aji-51 1036 5 - - PUNCT aji-51 1036 6 6 6 NUM aji-51 1036 7 . . PUNCT aji-51 1037 1 pmid pmid NOUN aji-51 1037 2 : : PUNCT aji-51 1037 3 21410066 21410066 NUM aji-51 1037 4 . . PUNCT aji-51 1038 1 100 100 NUM aji-51 1038 2 . . PUNCT aji-51 1039 1 zhang zhang PROPN aji-51 1039 2 c c PROPN aji-51 1039 3 , , PUNCT aji-51 1039 4 kim kim PROPN aji-51 1039 5 sk sk PROPN aji-51 1039 6 . . PROPN aji-51 1039 7 matrix matrix NOUN aji-51 1039 8 metalloproteinase metalloproteinase NOUN aji-51 1039 9 inhibitors inhibitor NOUN aji-51 1039 10 ( ( PUNCT aji-51 1039 11 mmpis mmpis NOUN aji-51 1039 12 ) ) PUNCT aji-51 1039 13 from from ADP aji-51 1039 14 marine marine ADJ aji-51 1039 15 natural natural ADJ aji-51 1039 16 products product NOUN aji-51 1039 17 : : PUNCT aji-51 1039 18 the the DET aji-51 1039 19 current current ADJ aji-51 1039 20 situation situation NOUN aji-51 1039 21 and and CCONJ aji-51 1039 22 future future ADJ aji-51 1039 23 prospects prospect NOUN aji-51 1039 24 . . PUNCT aji-51 1040 1 mar mar PROPN aji-51 1040 2 drugs drug NOUN aji-51 1040 3 . . PUNCT aji-51 1041 1 2009 2009 NUM aji-51 1041 2 mar mar PROPN aji-51 1041 3 31;7(2):71 31;7(2):71 NUM aji-51 1041 4 - - SYM aji-51 1041 5 84 84 NUM aji-51 1041 6 . . PUNCT aji-51 1042 1 doi doi NOUN aji-51 1042 2 : : PUNCT aji-51 1042 3 10.3390 10.3390 NUM aji-51 1042 4 / / SYM aji-51 1042 5 md7020071 md7020071 ADJ aji-51 1042 6 pmid pmid NOUN aji-51 1042 7 : : PUNCT aji-51 1042 8 19597572 19597572 NUM aji-51 1042 9 ; ; PUNCT aji-51 1042 10 pmcid pmcid ADJ aji-51 1042 11 : : PUNCT aji-51 1042 12 pmc2707034 pmc2707034 NOUN aji-51 1042 13 . . PUNCT aji-51 1043 1 101 101 NUM aji-51 1043 2 . . PUNCT aji-51 1044 1 available available ADJ aji-51 1044 2 : : PUNCT aji-51 1044 3 https://www.cancer.gov https://www.cancer.gov ADJ aji-51 1044 4 / / SYM aji-51 1044 5 publicati publicati NOUN aji-51 1044 6 ons ons PROPN aji-51 1044 7 / / SYM aji-51 1044 8 dictionaries dictionary NOUN aji-51 1044 9 / / SYM aji-51 1044 10 cancer cancer NOUN aji-51 1044 11 - - PUNCT aji-51 1044 12 drug drug NOUN aji-51 1044 13 / / SYM aji-51 1044 14 def def ADJ aji-51 1044 15 / / SYM aji-51 1044 16 sharkcartilage sharkcartilage NOUN aji-51 1044 17 - - PUNCT aji-51 1044 18 extract extract NOUN aji-51 1044 19 - - PUNCT aji-51 1044 20 ae-941 ae-941 NOUN aji-51 1044 21 102 102 NUM aji-51 1044 22 . . PUNCT aji-51 1045 1 kunte kunte PROPN aji-51 1045 2 m m PROPN aji-51 1045 3 , , PUNCT aji-51 1045 4 desai desai PROPN aji-51 1045 5 k. k. PROPN aji-51 1046 1 the the DET aji-51 1046 2 protein protein NOUN aji-51 1046 3 extract extract NOUN aji-51 1046 4 of of ADP aji-51 1046 5 chlorella chlorella NOUN aji-51 1046 6 minutissima minutissima NOUN aji-51 1046 7 inhibits inhibit VERB aji-51 1046 8 the the DET aji-51 1046 9 expression expression NOUN aji-51 1046 10 of of ADP aji-51 1046 11 mmp-1 mmp-1 NOUN aji-51 1046 12 , , PUNCT aji-51 1046 13 mmp-2 mmp-2 NUM aji-51 1046 14 and and CCONJ aji-51 1046 15 mmp-9 mmp-9 NOUN aji-51 1046 16 in in ADP aji-51 1046 17 cancer cancer NOUN aji-51 1046 18 cells cell NOUN aji-51 1046 19 through through ADP aji-51 1046 20 upregulation upregulation NOUN aji-51 1046 21 of of ADP aji-51 1046 22 timp-3 timp-3 NUM aji-51 1046 23 and and CCONJ aji-51 1046 24 down down ADP aji-51 1046 25 regulation regulation NOUN aji-51 1046 26 of of ADP aji-51 1046 27 c c PROPN aji-51 1046 28 - - PUNCT aji-51 1046 29 jun jun PROPN aji-51 1046 30 . . PROPN aji-51 1046 31 cell cell PROPN aji-51 1046 32 j. j. PROPN aji-51 1046 33 2018 2018 NUM aji-51 1046 34 jul;20(2):211 jul;20(2):211 PROPN aji-51 1046 35 - - PUNCT aji-51 1046 36 219 219 PROPN aji-51 1046 37 . . PUNCT aji-51 1047 1 doi doi NOUN aji-51 1047 2 : : PUNCT aji-51 1047 3 10.22074 10.22074 NUM aji-51 1047 4 / / SYM aji-51 1047 5 cellj.2018.5277 cellj.2018.5277 PROPN aji-51 1047 6 epub epub NOUN aji-51 1047 7 2018 2018 NUM aji-51 1047 8 mar mar PROPN aji-51 1047 9 18 18 NUM aji-51 1047 10 . . PUNCT aji-51 1048 1 pmid pmid NOUN aji-51 1048 2 : : PUNCT aji-51 1048 3 29633599 29633599 NUM aji-51 1048 4 ; ; PUNCT aji-51 1048 5 pmcid pmcid ADJ aji-51 1048 6 : : PUNCT aji-51 1048 7 pmc5893293 pmc5893293 NOUN aji-51 1048 8 . . PUNCT aji-51 1049 1 103 103 NUM aji-51 1049 2 . . PUNCT aji-51 1050 1 raeeszadeh raeeszadeh NOUN aji-51 1050 2 - - PUNCT aji-51 1050 3 sarmazdeh sarmazdeh NOUN aji-51 1050 4 m m NOUN aji-51 1050 5 , , PUNCT aji-51 1050 6 do do VERB aji-51 1050 7 ld ld PROPN aji-51 1050 8 , , PUNCT aji-51 1050 9 hritz hritz PROPN aji-51 1050 10 bg bg PROPN aji-51 1050 11 . . PROPN aji-51 1050 12 metalloproteinases metalloproteinase NOUN aji-51 1050 13 and and CCONJ aji-51 1050 14 their their PRON aji-51 1050 15 inhibitors inhibitor NOUN aji-51 1050 16 : : PUNCT aji-51 1050 17 potential potential ADJ aji-51 1050 18 for for ADP aji-51 1050 19 the the DET aji-51 1050 20 development development NOUN aji-51 1050 21 of of ADP aji-51 1050 22 new new ADJ aji-51 1050 23 therapeutics therapeutic NOUN aji-51 1050 24 . . PUNCT aji-51 1051 1 cells cell NOUN aji-51 1051 2 . . PUNCT aji-51 1052 1 2020 2020 NUM aji-51 1052 2 may may PROPN aji-51 1052 3 25;9(5):1313 25;9(5):1313 NUM aji-51 1052 4 . . PUNCT aji-51 1053 1 doi doi NOUN aji-51 1053 2 : : PUNCT aji-51 1053 3 10.3390 10.3390 NUM aji-51 1053 4 / / SYM aji-51 1053 5 cells9051313 cells9051313 PROPN aji-51 1053 6 pmid pmid PROPN aji-51 1053 7 : : PUNCT aji-51 1053 8 32466129 32466129 NUM aji-51 1053 9 ; ; PUNCT aji-51 1053 10 pmcid pmcid ADJ aji-51 1053 11 : : PUNCT aji-51 1053 12 pmc7290391 pmc7290391 NOUN aji-51 1053 13 . . PUNCT aji-51 1054 1 104 104 X aji-51 1054 2 . . PUNCT aji-51 1055 1 cione cione PROPN aji-51 1055 2 e e PROPN aji-51 1055 3 , , PUNCT aji-51 1055 4 la la PROPN aji-51 1055 5 torre torre PROPN aji-51 1055 6 c c AUX aji-51 1055 7 , , PUNCT aji-51 1055 8 cannataro cannataro NOUN aji-51 1055 9 r r NOUN aji-51 1055 10 , , PUNCT aji-51 1055 11 caroleo caroleo PROPN aji-51 1055 12 mc mc PROPN aji-51 1055 13 , , PUNCT aji-51 1055 14 plastina plastina VERB aji-51 1055 15 p p NOUN aji-51 1055 16 , , PUNCT aji-51 1055 17 gallelli gallelli PROPN aji-51 1055 18 l. l. PROPN aji-51 1055 19 quercetin quercetin PROPN aji-51 1055 20 , , PUNCT aji-51 1055 21 epigallocatechin epigallocatechin PROPN aji-51 1055 22 gallate gallate PROPN aji-51 1055 23 , , PUNCT aji-51 1055 24 curcumin curcumin NOUN aji-51 1055 25 , , PUNCT aji-51 1055 26 and and CCONJ aji-51 1055 27 resveratrol resveratrol NOUN aji-51 1055 28 : : PUNCT aji-51 1055 29 from from ADP aji-51 1055 30 dietary dietary ADJ aji-51 1055 31 sources source NOUN aji-51 1055 32 to to ADP aji-51 1055 33 human human PROPN aji-51 1055 34 microrna microrna PROPN aji-51 1055 35 modulation modulation NOUN aji-51 1055 36 . . PUNCT aji-51 1056 1 molecules molecule NOUN aji-51 1056 2 . . PUNCT aji-51 1057 1 2019 2019 NUM aji-51 1057 2 dec dec PROPN aji-51 1057 3 23;25(1):63 23;25(1):63 NUM aji-51 1057 4 . . PUNCT aji-51 1058 1 doi doi NOUN aji-51 1058 2 : : PUNCT aji-51 1058 3 10.3390 10.3390 NUM aji-51 1058 4 / / SYM aji-51 1058 5 molecules25010063 molecules25010063 PROPN aji-51 1058 6 pmid pmid PROPN aji-51 1058 7 : : PUNCT aji-51 1058 8 31878082 31878082 NUM aji-51 1058 9 ; ; PUNCT aji-51 1058 10 pmcid pmcid ADJ aji-51 1058 11 : : PUNCT aji-51 1058 12 pmc6983040 pmc6983040 NOUN aji-51 1058 13 . . PUNCT aji-51 1059 1 105 105 NUM aji-51 1059 2 . . PUNCT aji-51 1060 1 niedzwiecki niedzwiecki PROPN aji-51 1060 2 a a PROPN aji-51 1060 3 , , PUNCT aji-51 1060 4 roomi roomi NOUN aji-51 1060 5 mw mw PROPN aji-51 1060 6 , , PUNCT aji-51 1060 7 kalinovsky kalinovsky PROPN aji-51 1060 8 t t PROPN aji-51 1060 9 , , PUNCT aji-51 1060 10 rath rath PROPN aji-51 1060 11 m. m. PROPN aji-51 1060 12 micronutrient micronutrient NOUN aji-51 1060 13 synergy synergy NOUN aji-51 1060 14 -- -- PUNCT aji-51 1060 15 a a DET aji-51 1060 16 new new ADJ aji-51 1060 17 tool tool NOUN aji-51 1060 18 in in ADP aji-51 1060 19 effective effective ADJ aji-51 1060 20 control control NOUN aji-51 1060 21 of of ADP aji-51 1060 22 metastasis metastasis NOUN aji-51 1060 23 and and CCONJ aji-51 1060 24 other other ADJ aji-51 1060 25 key key ADJ aji-51 1060 26 mechanisms mechanism NOUN aji-51 1060 27 of of ADP aji-51 1060 28 cancer cancer NOUN aji-51 1060 29 . . PUNCT aji-51 1061 1 cancer cancer NOUN aji-51 1061 2 metastasis metastasis NOUN aji-51 1061 3 rev rev VERB aji-51 1061 4 . . PROPN aji-51 1061 5 2010 2010 NUM aji-51 1061 6 sep;29(3):529 sep;29(3):529 NOUN aji-51 1061 7 - - SYM aji-51 1061 8 42 42 NUM aji-51 1061 9 . . PUNCT aji-51 1062 1 doi doi NOUN aji-51 1062 2 : : PUNCT aji-51 1062 3 10.1007 10.1007 NUM aji-51 1062 4 / / SYM aji-51 1062 5 s10555 s10555 NOUN aji-51 1062 6 - - PUNCT aji-51 1062 7 010 010 NUM aji-51 1062 8 - - PUNCT aji-51 1062 9 9244 9244 NUM aji-51 1062 10 - - PUNCT aji-51 1062 11 1 1 NUM aji-51 1062 12 pmid pmid NOUN aji-51 1062 13 : : PUNCT aji-51 1062 14 20717705 20717705 NUM aji-51 1062 15 ; ; PUNCT aji-51 1062 16 pmcid pmcid ADJ aji-51 1062 17 : : PUNCT aji-51 1062 18 pmc2933847 pmc2933847 NOUN aji-51 1062 19 . . PUNCT aji-51 1063 1 106 106 NUM aji-51 1063 2 . . PUNCT aji-51 1064 1 roomi roomi PROPN aji-51 1064 2 mw mw PROPN aji-51 1064 3 , , PUNCT aji-51 1064 4 monterrey monterrey PROPN aji-51 1064 5 jc jc PROPN aji-51 1064 6 , , PUNCT aji-51 1064 7 kalinovsky kalinovsky PROPN aji-51 1064 8 t t PROPN aji-51 1064 9 , , PUNCT aji-51 1064 10 rath rath PROPN aji-51 1064 11 m m PROPN aji-51 1064 12 , , PUNCT aji-51 1064 13 niedzwiecki niedzwiecki PROPN aji-51 1064 14 a. a. PROPN aji-51 1064 15 comparative comparative PROPN aji-51 1064 16 effects effect NOUN aji-51 1064 17 of of ADP aji-51 1064 18 egcg egcg NOUN aji-51 1064 19 , , PUNCT aji-51 1064 20 green green ADJ aji-51 1064 21 tea tea NOUN aji-51 1064 22 and and CCONJ aji-51 1064 23 a a DET aji-51 1064 24 nutrient nutrient NOUN aji-51 1064 25 mixture mixture NOUN aji-51 1064 26 on on ADP aji-51 1064 27 the the DET aji-51 1064 28 patterns pattern NOUN aji-51 1064 29 of of ADP aji-51 1064 30 mmp-2 mmp-2 NUM aji-51 1064 31 and and CCONJ aji-51 1064 32 mmp-9 mmp-9 NOUN aji-51 1064 33 expression expression NOUN aji-51 1064 34 in in ADP aji-51 1064 35 cancer cancer NOUN aji-51 1064 36 cell cell NOUN aji-51 1064 37 lines line NOUN aji-51 1064 38 . . PUNCT aji-51 1065 1 oncol oncol PROPN aji-51 1065 2 rep rep PROPN aji-51 1065 3 . . PROPN aji-51 1065 4 2010 2010 NUM aji-51 1065 5 sep;24(3):747 sep;24(3):747 PROPN aji-51 1065 6 - - SYM aji-51 1065 7 57 57 NUM aji-51 1065 8 . . PUNCT aji-51 1066 1 doi doi NOUN aji-51 1066 2 : : PUNCT aji-51 1066 3 10.3892 10.3892 NUM aji-51 1066 4 / / SYM aji-51 1066 5 or_00000917 or_00000917 NOUN aji-51 1066 6 pmid pmid PROPN aji-51 1066 7 : : PUNCT aji-51 1066 8 20664983 20664983 NUM aji-51 1066 9 . . PUNCT aji-51 1067 1 107 107 NUM aji-51 1067 2 . . PUNCT aji-51 1068 1 sagar sagar PROPN aji-51 1068 2 sm sm PROPN aji-51 1068 3 , , PUNCT aji-51 1068 4 yance yance NOUN aji-51 1068 5 d d PROPN aji-51 1068 6 , , PUNCT aji-51 1068 7 wong wong PROPN aji-51 1068 8 rk rk PROPN aji-51 1068 9 . . PROPN aji-51 1068 10 natural natural ADJ aji-51 1068 11 health health NOUN aji-51 1068 12 products product NOUN aji-51 1068 13 that that PRON aji-51 1068 14 inhibit inhibit VERB aji-51 1068 15 angiogenesis angiogenesis NOUN aji-51 1068 16 : : PUNCT aji-51 1068 17 a a DET aji-51 1068 18 stoff stoff NOUN aji-51 1068 19 ; ; PUNCT aji-51 1068 20 aji aji PROPN aji-51 1068 21 , , PUNCT aji-51 1068 22 5(1 5(1 NUM aji-51 1068 23 ): ): PUNCT aji-51 1068 24 1 1 NUM aji-51 1068 25 - - SYM aji-51 1068 26 39 39 NUM aji-51 1068 27 , , PUNCT aji-51 1068 28 2022 2022 NUM aji-51 1068 29 ; ; PUNCT aji-51 1068 30 article article NOUN aji-51 1068 31 no.aji.77967 no.aji.77967 NOUN aji-51 1068 32 24 24 NUM aji-51 1068 33 potential potential ADJ aji-51 1068 34 source source NOUN aji-51 1068 35 for for ADP aji-51 1068 36 investigational investigational ADJ aji-51 1068 37 new new ADJ aji-51 1068 38 agents agent NOUN aji-51 1068 39 to to PART aji-51 1068 40 treat treat VERB aji-51 1068 41 cancer cancer NOUN aji-51 1068 42 - - PUNCT aji-51 1068 43 part part NOUN aji-51 1068 44 1 1 NUM aji-51 1068 45 . . PUNCT aji-51 1069 1 curr curr PROPN aji-51 1069 2 oncol oncol PROPN aji-51 1069 3 . . PUNCT aji-51 1070 1 2006 2006 NUM aji-51 1070 2 feb;13(1):14 feb;13(1):14 NOUN aji-51 1070 3 - - SYM aji-51 1070 4 26 26 NUM aji-51 1070 5 . . PUNCT aji-51 1071 1 pmid pmid NOUN aji-51 1071 2 : : PUNCT aji-51 1071 3 17576437 17576437 NUM aji-51 1071 4 ; ; PUNCT aji-51 1071 5 pmcid pmcid ADJ aji-51 1071 6 : : PUNCT aji-51 1071 7 pmc1891166 pmc1891166 ADJ aji-51 1071 8 . . PUNCT aji-51 1072 1 108 108 NUM aji-51 1072 2 . . PUNCT aji-51 1073 1 sagar sagar PROPN aji-51 1073 2 sm sm PROPN aji-51 1073 3 , , PUNCT aji-51 1073 4 yance yance NOUN aji-51 1073 5 d d PROPN aji-51 1073 6 , , PUNCT aji-51 1073 7 wong wong PROPN aji-51 1073 8 rk rk PROPN aji-51 1073 9 . . PROPN aji-51 1073 10 natural natural ADJ aji-51 1073 11 health health NOUN aji-51 1073 12 products product NOUN aji-51 1073 13 that that PRON aji-51 1073 14 inhibit inhibit VERB aji-51 1073 15 angiogenesis angiogenesis NOUN aji-51 1073 16 : : PUNCT aji-51 1073 17 a a DET aji-51 1073 18 potential potential ADJ aji-51 1073 19 source source NOUN aji-51 1073 20 for for ADP aji-51 1073 21 investigational investigational ADJ aji-51 1073 22 new new ADJ aji-51 1073 23 agents agent NOUN aji-51 1073 24 to to PART aji-51 1073 25 treat treat VERB aji-51 1073 26 cancer cancer NOUN aji-51 1073 27 - - PUNCT aji-51 1073 28 part part NOUN aji-51 1073 29 2 2 NUM aji-51 1073 30 . . PUNCT aji-51 1074 1 curr curr PROPN aji-51 1074 2 oncol oncol PROPN aji-51 1074 3 . . PUNCT aji-51 1075 1 2006 2006 NUM aji-51 1075 2 jun;13(3):99 jun;13(3):99 PROPN aji-51 1075 3 - - PUNCT aji-51 1075 4 107 107 PROPN aji-51 1075 5 . . PUNCT aji-51 1076 1 pmid pmid NOUN aji-51 1076 2 : : PUNCT aji-51 1076 3 17576449 17576449 NUM aji-51 1076 4 ; ; PUNCT aji-51 1076 5 pmcid pmcid ADJ aji-51 1076 6 : : PUNCT aji-51 1076 7 pmc1891180 pmc1891180 NOUN aji-51 1076 8 . . PUNCT aji-51 1077 1 109 109 NUM aji-51 1077 2 . . PUNCT aji-51 1078 1 niedzwiecki niedzwiecki PROPN aji-51 1078 2 a a PROPN aji-51 1078 3 , , PUNCT aji-51 1078 4 roomi roomi NOUN aji-51 1078 5 mw mw PROPN aji-51 1078 6 , , PUNCT aji-51 1078 7 kalinovsky kalinovsky PROPN aji-51 1078 8 t t PROPN aji-51 1078 9 , , PUNCT aji-51 1078 10 rath rath PROPN aji-51 1078 11 m. m. PROPN aji-51 1078 12 anticancer anticancer NOUN aji-51 1078 13 efficacy efficacy NOUN aji-51 1078 14 of of ADP aji-51 1078 15 polyphenols polyphenol NOUN aji-51 1078 16 and and CCONJ aji-51 1078 17 their their PRON aji-51 1078 18 combinations combination NOUN aji-51 1078 19 nutrients nutrient NOUN aji-51 1078 20 . . PUNCT aji-51 1079 1 2016 2016 NUM aji-51 1079 2 sep sep PROPN aji-51 1079 3 9;8(9):552 9;8(9):552 NOUN aji-51 1079 4 . . PUNCT aji-51 1080 1 doi doi NOUN aji-51 1080 2 : : PUNCT aji-51 1080 3 10.3390 10.3390 NUM aji-51 1080 4 / / SYM aji-51 1080 5 nu8090552 nu8090552 NOUN aji-51 1080 6 pmid pmid NOUN aji-51 1080 7 : : PUNCT aji-51 1080 8 27618095 27618095 NUM aji-51 1080 9 ; ; PUNCT aji-51 1080 10 pmcid pmcid ADJ aji-51 1080 11 : : PUNCT aji-51 1080 12 pmc5037537 pmc5037537 NOUN aji-51 1080 13 . . PUNCT aji-51 1081 1 110 110 NUM aji-51 1081 2 . . PUNCT aji-51 1082 1 metwally metwally ADV aji-51 1082 2 aa aa PROPN aji-51 1082 3 , , PUNCT aji-51 1082 4 el el PROPN aji-51 1082 5 - - PROPN aji-51 1082 6 ahmady ahmady NOUN aji-51 1082 7 sh sh PROPN aji-51 1082 8 , , PUNCT aji-51 1082 9 hathout hathout PROPN aji-51 1082 10 rm rm PROPN aji-51 1082 11 . . PUNCT aji-51 1083 1 selecting select VERB aji-51 1083 2 optimum optimum ADJ aji-51 1083 3 protein protein NOUN aji-51 1083 4 nano nano NOUN aji-51 1083 5 - - PUNCT aji-51 1083 6 carriers carrier NOUN aji-51 1083 7 for for ADP aji-51 1083 8 natural natural ADJ aji-51 1083 9 polyphenols polyphenol NOUN aji-51 1083 10 using use VERB aji-51 1083 11 chemoinformatics chemoinformatic NOUN aji-51 1083 12 tools tool NOUN aji-51 1083 13 . . PUNCT aji-51 1084 1 phytomedicine phytomedicine NOUN aji-51 1084 2 . . PUNCT aji-51 1085 1 2016 2016 NUM aji-51 1085 2 dec dec PROPN aji-51 1085 3 15;23(14):1764 15;23(14):1764 NUM aji-51 1085 4 - - SYM aji-51 1085 5 1770 1770 NUM aji-51 1085 6 . . PUNCT aji-51 1086 1 doi doi NOUN aji-51 1086 2 : : PUNCT aji-51 1086 3 10.1016 10.1016 NUM aji-51 1086 4 / / SYM aji-51 1086 5 j.phymed.2016.10.020 j.phymed.2016.10.020 PROPN aji-51 1086 6 epub epub PROPN aji-51 1086 7 2016 2016 NUM aji-51 1086 8 oct oct PROPN aji-51 1086 9 28 28 NUM aji-51 1086 10 . . PUNCT aji-51 1087 1 pmid pmid NOUN aji-51 1087 2 : : PUNCT aji-51 1087 3 27912878 27912878 NUM aji-51 1087 4 . . PUNCT aji-51 1088 1 111 111 NUM aji-51 1088 2 . . PUNCT aji-51 1089 1 davatgaran davatgaran ADJ aji-51 1089 2 - - PUNCT aji-51 1089 3 taghipour taghipour NOUN aji-51 1089 4 y y NOUN aji-51 1089 5 , , PUNCT aji-51 1089 6 masoomzadeh masoomzadeh PROPN aji-51 1089 7 s s PROPN aji-51 1089 8 , , PUNCT aji-51 1089 9 farzaei farzaei PROPN aji-51 1089 10 mh mh PROPN aji-51 1089 11 , , PUNCT aji-51 1089 12 bahramsoltani bahramsoltani NOUN aji-51 1089 13 r r NOUN aji-51 1089 14 , , PUNCT aji-51 1089 15 karimisoureh karimisoureh NOUN aji-51 1089 16 z z NOUN aji-51 1089 17 , , PUNCT aji-51 1089 18 rahimi rahimi ADJ aji-51 1089 19 r r NOUN aji-51 1089 20 , , PUNCT aji-51 1089 21 abdollahi abdollahi ADJ aji-51 1089 22 m. m. NOUN aji-51 1089 23 polyphenol polyphenol NOUN aji-51 1089 24 nanoformulations nanoformulation NOUN aji-51 1089 25 for for ADP aji-51 1089 26 cancer cancer NOUN aji-51 1089 27 therapy therapy NOUN aji-51 1089 28 : : PUNCT aji-51 1089 29 experimental experimental ADJ aji-51 1089 30 evidence evidence NOUN aji-51 1089 31 and and CCONJ aji-51 1089 32 clinical clinical ADJ aji-51 1089 33 perspective perspective NOUN aji-51 1089 34 . . PUNCT aji-51 1090 1 international international ADJ aji-51 1090 2 journal journal PROPN aji-51 1090 3 of of ADP aji-51 1090 4 nanomedicine nanomedicine NOUN aji-51 1090 5 . . PUNCT aji-51 1091 1 2017;12:2689–2702 2017;12:2689–2702 NUM aji-51 1091 2 . . PUNCT aji-51 1092 1 available available ADJ aji-51 1092 2 : : PUNCT aji-51 1092 3 https://doi.org/10.2147 https://doi.org/10.2147 NOUN aji-51 1092 4 / / SYM aji-51 1092 5 ijn.s131 ijn.s131 NUM aji-51 1092 6 973 973 NUM aji-51 1092 7 pmid pmid NOUN aji-51 1092 8 : : PUNCT aji-51 1092 9 28435252 28435252 NUM aji-51 1092 10 . . PUNCT aji-51 1093 1 112 112 NUM aji-51 1093 2 . . PUNCT aji-51 1094 1 available available ADJ aji-51 1094 2 : : PUNCT aji-51 1094 3 https://www.ncbi.nlm.nih.gov https://www.ncbi.nlm.nih.gov ADJ aji-51 1094 4 / / SYM aji-51 1094 5 pm pm NOUN aji-51 1094 6 c/?term c/?term NOUN aji-51 1094 7 = = SYM aji-51 1094 8 epigenetic+toxins+and+human+c epigenetic+toxins+and+human+c NOUN aji-51 1094 9 ancers ancer NOUN aji-51 1094 10 113 113 NUM aji-51 1094 11 . . PUNCT aji-51 1095 1 baccarelli baccarelli VERB aji-51 1095 2 a a PRON aji-51 1095 3 , , PUNCT aji-51 1095 4 bollati bollati NOUN aji-51 1095 5 v. v. ADP aji-51 1095 6 epigenetics epigenetic NOUN aji-51 1095 7 and and CCONJ aji-51 1095 8 environmental environmental ADJ aji-51 1095 9 chemicals chemical NOUN aji-51 1095 10 . . PUNCT aji-51 1096 1 curr curr PROPN aji-51 1096 2 opin opin NOUN aji-51 1096 3 pediatr pediatr NOUN aji-51 1096 4 . . PUNCT aji-51 1096 5 2009 2009 NUM aji-51 1096 6 apr;21(2):243 apr;21(2):243 PROPN aji-51 1096 7 - - PUNCT aji-51 1096 8 51 51 NUM aji-51 1096 9 . . PUNCT aji-51 1097 1 doi doi NOUN aji-51 1097 2 : : PUNCT aji-51 1097 3 10.1097 10.1097 NUM aji-51 1097 4 / / SYM aji-51 1097 5 mop.0b013e32832925cc mop.0b013e32832925cc ADP aji-51 1097 6 pmid pmid PROPN aji-51 1097 7 : : PUNCT aji-51 1097 8 19663042 19663042 NUM aji-51 1097 9 ; ; PUNCT aji-51 1097 10 pmcid pmcid NOUN aji-51 1097 11 : : PUNCT aji-51 1097 12 pmc3035853 pmc3035853 NOUN aji-51 1097 13 . . PUNCT aji-51 1098 1 114 114 NUM aji-51 1098 2 . . PUNCT aji-51 1099 1 kim kim PROPN aji-51 1099 2 m m PROPN aji-51 1099 3 , , PUNCT aji-51 1099 4 bae bae PROPN aji-51 1099 5 m m PROPN aji-51 1099 6 , , PUNCT aji-51 1099 7 na na PROPN aji-51 1099 8 h h NOUN aji-51 1099 9 , , PUNCT aji-51 1099 10 yang yang PROPN aji-51 1099 11 m. m. PROPN aji-51 1099 12 environmental environmental ADJ aji-51 1099 13 toxicants toxicant NOUN aji-51 1099 14 -- -- PUNCT aji-51 1099 15 induced induce VERB aji-51 1099 16 epigenetic epigenetic ADJ aji-51 1099 17 alterations alteration NOUN aji-51 1099 18 and and CCONJ aji-51 1099 19 their their PRON aji-51 1099 20 reversers reverser NOUN aji-51 1099 21 . . PUNCT aji-51 1100 1 j j PROPN aji-51 1100 2 environ environ PROPN aji-51 1100 3 sci sci PROPN aji-51 1100 4 health health PROPN aji-51 1100 5 c c PROPN aji-51 1100 6 environ environ PROPN aji-51 1100 7 carcinog carcinog PROPN aji-51 1100 8 ecotoxicol ecotoxicol PROPN aji-51 1100 9 rev rev PROPN aji-51 1100 10 . . PUNCT aji-51 1101 1 2012;30(4):323 2012;30(4):323 NUM aji-51 1101 2 - - PUNCT aji-51 1101 3 67 67 NUM aji-51 1101 4 . . PUNCT aji-51 1102 1 doi doi NOUN aji-51 1102 2 : : PUNCT aji-51 1102 3 10.1080/10590501.2012.731959 10.1080/10590501.2012.731959 NUM aji-51 1102 4 . . PUNCT aji-51 1103 1 erratum erratum PROPN aji-51 1103 2 in in ADP aji-51 1103 3 : : PUNCT aji-51 1103 4 j j PROPN aji-51 1103 5 environ environ PROPN aji-51 1103 6 sci sci PROPN aji-51 1103 7 health health PROPN aji-51 1103 8 c c PROPN aji-51 1103 9 environ environ PROPN aji-51 1103 10 carcinog carcinog PROPN aji-51 1103 11 ecotoxicol ecotoxicol PROPN aji-51 1103 12 rev rev PROPN aji-51 1103 13 . . PUNCT aji-51 1103 14 2013;31(3):285 2013;31(3):285 NUM aji-51 1103 15 . . PUNCT aji-51 1104 1 pmid pmid NOUN aji-51 1104 2 : : PUNCT aji-51 1104 3 23167630 23167630 NUM aji-51 1104 4 . . PUNCT aji-51 1105 1 115 115 NUM aji-51 1105 2 . . PUNCT aji-51 1106 1 cai cai PROPN aji-51 1106 2 ff ff NOUN aji-51 1106 3 , , PUNCT aji-51 1106 4 kohler kohler PROPN aji-51 1106 5 c c PROPN aji-51 1106 6 , , PUNCT aji-51 1106 7 zhang zhang PROPN aji-51 1106 8 b b PROPN aji-51 1106 9 , , PUNCT aji-51 1106 10 wang wang PROPN aji-51 1106 11 mh mh PROPN aji-51 1106 12 , , PUNCT aji-51 1106 13 chen chen PROPN aji-51 1106 14 wj wj PROPN aji-51 1106 15 , , PUNCT aji-51 1106 16 zhong zhong PROPN aji-51 1106 17 xy xy PROPN aji-51 1106 18 . . PUNCT aji-51 1107 1 epigenetic epigenetic ADJ aji-51 1107 2 therapy therapy NOUN aji-51 1107 3 for for ADP aji-51 1107 4 breast breast NOUN aji-51 1107 5 cancer cancer NOUN aji-51 1107 6 . . PUNCT aji-51 1108 1 int int PROPN aji-51 1108 2 j j PROPN aji-51 1108 3 mol mol ADP aji-51 1108 4 sci sci PROPN aji-51 1108 5 . . PUNCT aji-51 1109 1 2011;12(7):4465 2011;12(7):4465 NUM aji-51 1109 2 - - SYM aji-51 1109 3 87 87 NUM aji-51 1109 4 . . PUNCT aji-51 1110 1 doi doi NOUN aji-51 1110 2 : : PUNCT aji-51 1110 3 10.3390 10.3390 NUM aji-51 1110 4 / / SYM aji-51 1110 5 ijms12074465 ijms12074465 PROPN aji-51 1110 6 epub epub NOUN aji-51 1110 7 2011 2011 NUM aji-51 1110 8 jul jul PROPN aji-51 1110 9 11 11 NUM aji-51 1110 10 . . PUNCT aji-51 1111 1 pmid pmid NOUN aji-51 1111 2 : : PUNCT aji-51 1111 3 21845090 21845090 NUM aji-51 1111 4 ; ; PUNCT aji-51 1111 5 pmcid pmcid NOUN aji-51 1111 6 : : PUNCT aji-51 1111 7 pmc3155363 pmc3155363 ADJ aji-51 1111 8 . . PUNCT aji-51 1112 1 116 116 NUM aji-51 1112 2 . . PUNCT aji-51 1113 1 oh oh NUM aji-51 1113 2 s s PROPN aji-51 1113 3 , , PUNCT aji-51 1113 4 ko ko PROPN aji-51 1113 5 jy jy PROPN aji-51 1113 6 , , PUNCT aji-51 1114 1 oh oh INTJ aji-51 1114 2 c c X aji-51 1114 3 , , PUNCT aji-51 1115 1 yoo yoo PROPN aji-51 1115 2 kh kh PROPN aji-51 1115 3 . . PUNCT aji-51 1116 1 targeting target VERB aji-51 1116 2 the the DET aji-51 1116 3 epigenome epigenome NOUN aji-51 1116 4 as as ADP aji-51 1116 5 a a DET aji-51 1116 6 novel novel ADJ aji-51 1116 7 therapeutic therapeutic ADJ aji-51 1116 8 approach approach NOUN aji-51 1116 9 for for ADP aji-51 1116 10 breast breast NOUN aji-51 1116 11 cancer cancer NOUN aji-51 1116 12 . . PUNCT aji-51 1117 1 adv adv PROPN aji-51 1117 2 exp exp NOUN aji-51 1117 3 med med ADJ aji-51 1117 4 biol biol NOUN aji-51 1117 5 . . PUNCT aji-51 1118 1 2017;1026:287 2017;1026:287 PROPN aji-51 1118 2 - - SYM aji-51 1118 3 313 313 NUM aji-51 1118 4 . . PUNCT aji-51 1119 1 doi doi NOUN aji-51 1119 2 : : PUNCT aji-51 1119 3 10.1007/978 10.1007/978 NUM aji-51 1119 4 - - SYM aji-51 1119 5 981 981 NUM aji-51 1119 6 - - PUNCT aji-51 1119 7 10 10 NUM aji-51 1119 8 - - PUNCT aji-51 1119 9 6020 6020 NUM aji-51 1119 10 - - SYM aji-51 1119 11 5_14 5_14 NUM aji-51 1119 12 pmid pmid NOUN aji-51 1119 13 : : PUNCT aji-51 1119 14 29282690 29282690 NUM aji-51 1119 15 . . PUNCT aji-51 1120 1 117 117 NUM aji-51 1120 2 . . PUNCT aji-51 1121 1 falahi falahi PROPN aji-51 1121 2 f f PROPN aji-51 1121 3 , , PUNCT aji-51 1121 4 van van PROPN aji-51 1121 5 kruchten kruchten PROPN aji-51 1121 6 m m PROPN aji-51 1121 7 , , PUNCT aji-51 1121 8 martinet martinet NOUN aji-51 1121 9 n n CCONJ aji-51 1121 10 , , PUNCT aji-51 1121 11 hospers hospers PROPN aji-51 1121 12 ga ga PROPN aji-51 1121 13 , , PUNCT aji-51 1121 14 rots rot VERB aji-51 1121 15 mg mg PROPN aji-51 1121 16 . . PUNCT aji-51 1122 1 current current ADJ aji-51 1122 2 and and CCONJ aji-51 1122 3 upcoming upcoming ADJ aji-51 1122 4 approaches approach NOUN aji-51 1122 5 to to PART aji-51 1122 6 exploit exploit VERB aji-51 1122 7 the the DET aji-51 1122 8 reversibility reversibility NOUN aji-51 1122 9 of of ADP aji-51 1122 10 epigenetic epigenetic ADJ aji-51 1122 11 mutations mutation NOUN aji-51 1122 12 in in ADP aji-51 1122 13 breast breast NOUN aji-51 1122 14 cancer cancer NOUN aji-51 1122 15 . . PUNCT aji-51 1123 1 breast breast NOUN aji-51 1123 2 cancer cancer NOUN aji-51 1123 3 res re NOUN aji-51 1123 4 . . PUNCT aji-51 1124 1 2014 2014 NUM aji-51 1124 2 jul jul PROPN aji-51 1124 3 29;16(4):412 29;16(4):412 NUM aji-51 1124 4 . . PUNCT aji-51 1125 1 doi doi NOUN aji-51 1125 2 : : PUNCT aji-51 1125 3 10.1186 10.1186 NUM aji-51 1125 4 / / SYM aji-51 1125 5 s13058 s13058 NOUN aji-51 1125 6 - - PUNCT aji-51 1125 7 014 014 NUM aji-51 1125 8 - - PUNCT aji-51 1125 9 0412 0412 NUM aji-51 1125 10 - - PUNCT aji-51 1125 11 z z NOUN aji-51 1125 12 pmid pmid NOUN aji-51 1125 13 : : PUNCT aji-51 1125 14 25410383 25410383 NUM aji-51 1125 15 ; ; PUNCT aji-51 1125 16 pmcid pmcid ADJ aji-51 1125 17 : : PUNCT aji-51 1125 18 pmc4303227 pmc4303227 ADJ aji-51 1125 19 . . PUNCT aji-51 1126 1 118 118 NUM aji-51 1126 2 . . PUNCT aji-51 1126 3 hillyar hillyar PROPN aji-51 1126 4 c c PROPN aji-51 1126 5 , , PUNCT aji-51 1126 6 rallis rallis PROPN aji-51 1126 7 ks ks PROPN aji-51 1126 8 , , PUNCT aji-51 1126 9 varghese varghese PROPN aji-51 1126 10 j. j. PROPN aji-51 1126 11 advances advance VERB aji-51 1126 12 in in ADP aji-51 1126 13 epigenetic epigenetic ADJ aji-51 1126 14 cancer cancer NOUN aji-51 1126 15 therapeutics therapeutic NOUN aji-51 1126 16 . . PUNCT aji-51 1127 1 cureus cureus NOUN aji-51 1127 2 . . PUNCT aji-51 1128 1 2020 2020 NUM aji-51 1128 2 nov nov PROPN aji-51 1128 3 27;12(11):e11725 27;12(11):e11725 NUM aji-51 1128 4 . . PUNCT aji-51 1129 1 doi doi NOUN aji-51 1129 2 : : PUNCT aji-51 1129 3 10.7759 10.7759 NUM aji-51 1129 4 / / SYM aji-51 1129 5 cureus.11725 cureus.11725 PROPN aji-51 1129 6 pmid pmid NOUN aji-51 1129 7 : : PUNCT aji-51 1129 8 33391954 33391954 NUM aji-51 1129 9 ; ; PUNCT aji-51 1129 10 pmcid pmcid ADJ aji-51 1129 11 : : PUNCT aji-51 1129 12 pmc7772155 pmc7772155 NOUN aji-51 1129 13 . . PUNCT aji-51 1130 1 119 119 NUM aji-51 1130 2 . . PUNCT aji-51 1131 1 tsai tsai PROPN aji-51 1131 2 hc hc PROPN aji-51 1131 3 , , PUNCT aji-51 1131 4 et et PROPN aji-51 1131 5 al al PROPN aji-51 1131 6 . . PROPN aji-51 1131 7 transient transient PROPN aji-51 1131 8 low low ADJ aji-51 1131 9 doses dose NOUN aji-51 1131 10 of of ADP aji-51 1131 11 dna dna NOUN aji-51 1131 12 - - PUNCT aji-51 1131 13 demethylating demethylate VERB aji-51 1131 14 agents agent NOUN aji-51 1131 15 exert exert VERB aji-51 1131 16 durable durable ADJ aji-51 1131 17 antitumor antitumor PROPN aji-51 1131 18 effects effect NOUN aji-51 1131 19 on on ADP aji-51 1131 20 hematological hematological ADJ aji-51 1131 21 and and CCONJ aji-51 1131 22 epithelial epithelial ADJ aji-51 1131 23 tumor tumor NOUN aji-51 1131 24 cells cell NOUN aji-51 1131 25 . . PUNCT aji-51 1132 1 cancer cancer NOUN aji-51 1132 2 cell cell NOUN aji-51 1132 3 . . PUNCT aji-51 1133 1 2012 2012 NUM aji-51 1133 2 mar mar PROPN aji-51 1133 3 20;21(3):430 20;21(3):430 PROPN aji-51 1133 4 - - PUNCT aji-51 1133 5 46 46 PROPN aji-51 1133 6 . . PUNCT aji-51 1134 1 doi doi NOUN aji-51 1134 2 : : PUNCT aji-51 1134 3 10.1016 10.1016 NUM aji-51 1134 4 / / SYM aji-51 1134 5 j.ccr.2011.12.029 j.ccr.2011.12.029 PROPN aji-51 1134 6 pmid pmid PROPN aji-51 1134 7 : : PUNCT aji-51 1134 8 22439938 22439938 NUM aji-51 1134 9 ; ; PUNCT aji-51 1134 10 pmcid pmcid ADJ aji-51 1134 11 : : PUNCT aji-51 1134 12 pmc3312044 pmc3312044 PROPN aji-51 1134 13 . . PUNCT aji-51 1135 1 120 120 NUM aji-51 1135 2 . . PUNCT aji-51 1136 1 tao tao PROPN aji-51 1136 2 y y PROPN aji-51 1136 3 , , PUNCT aji-51 1136 4 liu liu PROPN aji-51 1136 5 s s PROPN aji-51 1136 6 , , PUNCT aji-51 1136 7 briones briones PROPN aji-51 1136 8 v v PROPN aji-51 1136 9 , , PUNCT aji-51 1136 10 geiman geiman NOUN aji-51 1136 11 tm tm NOUN aji-51 1136 12 , , PUNCT aji-51 1136 13 muegge muegge PROPN aji-51 1136 14 k. k. PROPN aji-51 1136 15 treatment treatment PROPN aji-51 1136 16 of of ADP aji-51 1136 17 breast breast NOUN aji-51 1136 18 cancer cancer NOUN aji-51 1136 19 cells cell NOUN aji-51 1136 20 with with ADP aji-51 1136 21 dna dna PROPN aji-51 1136 22 demethylating demethylate VERB aji-51 1136 23 agents agent NOUN aji-51 1136 24 leads lead VERB aji-51 1136 25 to to ADP aji-51 1136 26 a a DET aji-51 1136 27 release release NOUN aji-51 1136 28 of of ADP aji-51 1136 29 pol pol PROPN aji-51 1136 30 ii ii PROPN aji-51 1136 31 stalling stall VERB aji-51 1136 32 at at ADP aji-51 1136 33 genes gene NOUN aji-51 1136 34 with with ADP aji-51 1136 35 dna dna PROPN aji-51 1136 36 - - PUNCT aji-51 1136 37 hypermethylated hypermethylate VERB aji-51 1136 38 regions region NOUN aji-51 1136 39 upstream upstream ADJ aji-51 1136 40 of of ADP aji-51 1136 41 tss tss NOUN aji-51 1136 42 . . PUNCT aji-51 1137 1 nucleic nucleic ADJ aji-51 1137 2 acids acid NOUN aji-51 1137 3 res re NOUN aji-51 1137 4 . . PUNCT aji-51 1137 5 2011 2011 NUM aji-51 1137 6 dec;39(22):9508 dec;39(22):9508 NOUN aji-51 1137 7 - - PUNCT aji-51 1137 8 20 20 NUM aji-51 1137 9 . . PUNCT aji-51 1138 1 doi doi NOUN aji-51 1138 2 : : PUNCT aji-51 1138 3 10.1093 10.1093 NUM aji-51 1138 4 / / SYM aji-51 1138 5 nar nar NOUN aji-51 1138 6 / / SYM aji-51 1138 7 gkr611 gkr611 NOUN aji-51 1138 8 epub epub NOUN aji-51 1138 9 2011 2011 NUM aji-51 1138 10 aug aug PROPN aji-51 1138 11 31 31 NUM aji-51 1138 12 . . PUNCT aji-51 1139 1 pmid pmid NOUN aji-51 1139 2 : : PUNCT aji-51 1139 3 21880597 21880597 NUM aji-51 1139 4 ; ; PUNCT aji-51 1139 5 pmcid pmcid NOUN aji-51 1139 6 : : PUNCT aji-51 1139 7 pmc3239205 pmc3239205 NOUN aji-51 1139 8 . . PUNCT aji-51 1140 1 121 121 NUM aji-51 1140 2 . . PUNCT aji-51 1141 1 issa issa PROPN aji-51 1141 2 jp jp PROPN aji-51 1141 3 , , PUNCT aji-51 1141 4 garcia garcia PROPN aji-51 1141 5 - - PUNCT aji-51 1141 6 manero manero PROPN aji-51 1141 7 g g PROPN aji-51 1141 8 , , PUNCT aji-51 1141 9 giles giles PROPN aji-51 1141 10 fj fj PROPN aji-51 1141 11 , , PUNCT aji-51 1141 12 mannari mannari ADJ aji-51 1141 13 r r NOUN aji-51 1141 14 , , PUNCT aji-51 1141 15 thomas thomas PROPN aji-51 1141 16 d d PROPN aji-51 1141 17 , , PUNCT aji-51 1141 18 faderl faderl PROPN aji-51 1141 19 s s PROPN aji-51 1141 20 , , PUNCT aji-51 1141 21 bayar bayar PROPN aji-51 1141 22 e e PROPN aji-51 1141 23 , , PUNCT aji-51 1141 24 lyons lyons PROPN aji-51 1141 25 j j PROPN aji-51 1141 26 , , PUNCT aji-51 1141 27 rosenfeld rosenfeld PROPN aji-51 1141 28 cs cs PROPN aji-51 1141 29 , , PUNCT aji-51 1141 30 cortes corte VERB aji-51 1141 31 j j PROPN aji-51 1141 32 , , PUNCT aji-51 1141 33 kantarjian kantarjian ADJ aji-51 1141 34 hm hm INTJ aji-51 1141 35 . . PROPN aji-51 1141 36 phase phase NOUN aji-51 1141 37 1 1 NUM aji-51 1141 38 study study NOUN aji-51 1141 39 of of ADP aji-51 1141 40 low low ADJ aji-51 1141 41 - - PUNCT aji-51 1141 42 dose dose NOUN aji-51 1141 43 prolonged prolonged ADJ aji-51 1141 44 exposure exposure NOUN aji-51 1141 45 schedules schedule NOUN aji-51 1141 46 of of ADP aji-51 1141 47 the the DET aji-51 1141 48 hypomethylating hypomethylate VERB aji-51 1141 49 agent agent NOUN aji-51 1141 50 5 5 NUM aji-51 1141 51 - - PUNCT aji-51 1141 52 aza-2'deoxycytidine aza-2'deoxycytidine ADJ aji-51 1141 53 ( ( PUNCT aji-51 1141 54 decitabine decitabine NOUN aji-51 1141 55 ) ) PUNCT aji-51 1141 56 in in ADP aji-51 1141 57 hematopoietic hematopoietic ADJ aji-51 1141 58 malignancies malignancy NOUN aji-51 1141 59 . . PUNCT aji-51 1142 1 blood blood NOUN aji-51 1142 2 . . PUNCT aji-51 1143 1 2004 2004 NUM aji-51 1143 2 mar mar PROPN aji-51 1143 3 1;103(5):1635 1;103(5):1635 PROPN aji-51 1143 4 - - PUNCT aji-51 1143 5 40 40 NUM aji-51 1143 6 . . PUNCT aji-51 1144 1 doi doi NOUN aji-51 1144 2 : : PUNCT aji-51 1144 3 10.1182 10.1182 NUM aji-51 1144 4 / / SYM aji-51 1144 5 blood-2003 blood-2003 NOUN aji-51 1144 6 - - PUNCT aji-51 1144 7 03 03 NUM aji-51 1144 8 - - PUNCT aji-51 1144 9 0687 0687 NUM aji-51 1144 10 epub epub NOUN aji-51 1144 11 2003 2003 NUM aji-51 1144 12 nov nov NOUN aji-51 1144 13 6 6 NUM aji-51 1144 14 . . PUNCT aji-51 1145 1 stoff stoff PROPN aji-51 1145 2 ; ; PUNCT aji-51 1145 3 aji aji PROPN aji-51 1145 4 , , PUNCT aji-51 1145 5 5(1 5(1 NUM aji-51 1145 6 ): ): PUNCT aji-51 1145 7 1 1 NUM aji-51 1145 8 - - SYM aji-51 1145 9 39 39 NUM aji-51 1145 10 , , PUNCT aji-51 1145 11 2022 2022 NUM aji-51 1145 12 ; ; PUNCT aji-51 1145 13 article article NOUN aji-51 1145 14 no.aji.77967 no.aji.77967 PROPN aji-51 1145 15 25 25 NUM aji-51 1145 16 pmid pmid NOUN aji-51 1145 17 : : PUNCT aji-51 1145 18 14604977 14604977 NUM aji-51 1145 19 . . PUNCT aji-51 1146 1 122 122 NUM aji-51 1146 2 . . PUNCT aji-51 1147 1 chen chen PROPN aji-51 1147 2 zp zp PROPN aji-51 1147 3 , , PUNCT aji-51 1147 4 schell schell PROPN aji-51 1147 5 jb jb PROPN aji-51 1147 6 , , PUNCT aji-51 1147 7 ho ho PROPN aji-51 1147 8 ct ct PROPN aji-51 1147 9 , , PUNCT aji-51 1147 10 chen chen PROPN aji-51 1147 11 ky ky PROPN aji-51 1147 12 . . PROPN aji-51 1148 1 green green PROPN aji-51 1148 2 tea tea PROPN aji-51 1148 3 epigallocatechin epigallocatechin PROPN aji-51 1148 4 gallate gallate PROPN aji-51 1148 5 shows show VERB aji-51 1148 6 a a DET aji-51 1148 7 pronounced pronounce VERB aji-51 1148 8 growth growth NOUN aji-51 1148 9 inhibitory inhibitory ADJ aji-51 1148 10 effect effect NOUN aji-51 1148 11 on on ADP aji-51 1148 12 cancerous cancerous ADJ aji-51 1148 13 cells cell NOUN aji-51 1148 14 but but CCONJ aji-51 1148 15 not not PART aji-51 1148 16 on on ADP aji-51 1148 17 their their PRON aji-51 1148 18 normal normal ADJ aji-51 1148 19 counterparts counterpart NOUN aji-51 1148 20 . . PUNCT aji-51 1149 1 cancer cancer PROPN aji-51 1149 2 lett lett PROPN aji-51 1149 3 . . PUNCT aji-51 1150 1 1998 1998 NUM aji-51 1150 2 jul jul PROPN aji-51 1150 3 17;129(2):173 17;129(2):173 PROPN aji-51 1150 4 - - PUNCT aji-51 1150 5 9 9 NUM aji-51 1150 6 . . PUNCT aji-51 1150 7 doi doi NOUN aji-51 1150 8 : : PUNCT aji-51 1150 9 10.1016 10.1016 NUM aji-51 1150 10 / / SYM aji-51 1150 11 s0304 s0304 ADJ aji-51 1150 12 - - PUNCT aji-51 1150 13 3835(98)00108 3835(98)00108 NUM aji-51 1150 14 - - PUNCT aji-51 1150 15 6 6 NUM aji-51 1150 16 pmid pmid NOUN aji-51 1150 17 : : PUNCT aji-51 1150 18 9719459 9719459 NUM aji-51 1150 19 123 123 NUM aji-51 1150 20 . . PUNCT aji-51 1151 1 morré morré PROPN aji-51 1151 2 dj dj PROPN aji-51 1151 3 , , PUNCT aji-51 1151 4 morré morré ADJ aji-51 1151 5 dm dm PROPN aji-51 1151 6 . . PUNCT aji-51 1151 7 synergistic synergistic ADJ aji-51 1151 8 capsicum capsicum NOUN aji-51 1151 9 - - PUNCT aji-51 1151 10 tea tea NOUN aji-51 1151 11 mixtures mixture NOUN aji-51 1151 12 with with ADP aji-51 1151 13 anticancer anticancer NOUN aji-51 1151 14 activity activity NOUN aji-51 1151 15 . . PUNCT aji-51 1152 1 j j PROPN aji-51 1152 2 pharm pharm PROPN aji-51 1152 3 pharmacol pharmacol PROPN aji-51 1152 4 . . PUNCT aji-51 1153 1 2003 2003 NUM aji-51 1153 2 jul;55(7):987 jul;55(7):987 PROPN aji-51 1153 3 - - SYM aji-51 1153 4 94 94 NUM aji-51 1153 5 . . PUNCT aji-51 1154 1 doi doi NOUN aji-51 1154 2 : : PUNCT aji-51 1154 3 10.1211/0022357021521 10.1211/0022357021521 NUM aji-51 1154 4 pmid pmid NOUN aji-51 1154 5 : : PUNCT aji-51 1154 6 12906756 12906756 NUM aji-51 1154 7 . . PUNCT aji-51 1155 1 124 124 NUM aji-51 1155 2 . . PUNCT aji-51 1156 1 chueh chueh PROPN aji-51 1156 2 pj pj PROPN aji-51 1156 3 , , PUNCT aji-51 1156 4 wu wu PROPN aji-51 1156 5 ly ly PROPN aji-51 1156 6 , , PUNCT aji-51 1156 7 morré morré ADJ aji-51 1156 8 dm dm PROPN aji-51 1156 9 , , PUNCT aji-51 1156 10 morré morré NOUN aji-51 1156 11 dj dj NOUN aji-51 1156 12 . . PUNCT aji-51 1157 1 tnox tnox PROPN aji-51 1157 2 is be AUX aji-51 1157 3 both both PRON aji-51 1157 4 necessary necessary ADJ aji-51 1157 5 and and CCONJ aji-51 1157 6 sufficient sufficient ADJ aji-51 1157 7 as as ADP aji-51 1157 8 a a DET aji-51 1157 9 cellular cellular ADJ aji-51 1157 10 target target NOUN aji-51 1157 11 for for ADP aji-51 1157 12 the the DET aji-51 1157 13 anticancer anticancer NOUN aji-51 1157 14 actions action NOUN aji-51 1157 15 of of ADP aji-51 1157 16 capsaicin capsaicin PROPN aji-51 1157 17 and and CCONJ aji-51 1157 18 the the DET aji-51 1157 19 green green ADJ aji-51 1157 20 tea tea NOUN aji-51 1157 21 catechin catechin NOUN aji-51 1157 22 ( ( PUNCT aji-51 1157 23 -)epigallocatechin-3 -)epigallocatechin-3 INTJ aji-51 1157 24 - - PUNCT aji-51 1157 25 gallate gallate NOUN aji-51 1157 26 . . PUNCT aji-51 1158 1 biofactors biofactor NOUN aji-51 1158 2 . . PUNCT aji-51 1159 1 2004;20(4):235 2004;20(4):235 NUM aji-51 1159 2 - - PUNCT aji-51 1159 3 49 49 NUM aji-51 1159 4 . . PUNCT aji-51 1160 1 pmid pmid NOUN aji-51 1160 2 : : PUNCT aji-51 1160 3 15706060 15706060 NUM aji-51 1160 4 . . PUNCT aji-51 1161 1 125 125 NUM aji-51 1161 2 . . PUNCT aji-51 1162 1 chang chang PROPN aji-51 1162 2 cf cf PROPN aji-51 1162 3 , , PUNCT aji-51 1162 4 islam islam PROPN aji-51 1162 5 a a PROPN aji-51 1162 6 , , PUNCT aji-51 1162 7 liu liu PROPN aji-51 1162 8 pf pf PROPN aji-51 1162 9 , , PUNCT aji-51 1162 10 zhan zhan PROPN aji-51 1162 11 jh jh PROPN aji-51 1162 12 , , PUNCT aji-51 1162 13 chueh chueh PROPN aji-51 1162 14 pj pj PROPN aji-51 1162 15 . . PUNCT aji-51 1163 1 capsaicin capsaicin PROPN aji-51 1163 2 acts act VERB aji-51 1163 3 through through ADP aji-51 1163 4 tnox tnox PROPN aji-51 1163 5 ( ( PUNCT aji-51 1163 6 enox2 enox2 NOUN aji-51 1163 7 ) ) PUNCT aji-51 1163 8 to to PART aji-51 1163 9 induce induce VERB aji-51 1163 10 autophagic autophagic ADJ aji-51 1163 11 apoptosis apoptosis NOUN aji-51 1163 12 in in ADP aji-51 1163 13 p53 p53 NOUN aji-51 1163 14 - - PUNCT aji-51 1163 15 mutated mutate VERB aji-51 1163 16 hsc-3 hsc-3 NOUN aji-51 1163 17 cells cell NOUN aji-51 1163 18 but but CCONJ aji-51 1163 19 autophagy autophagy NOUN aji-51 1163 20 in in ADP aji-51 1163 21 p53 p53 NOUN aji-51 1163 22 - - PUNCT aji-51 1163 23 functional functional ADJ aji-51 1163 24 sas sas PROPN aji-51 1163 25 oral oral ADJ aji-51 1163 26 cancer cancer NOUN aji-51 1163 27 cells cell NOUN aji-51 1163 28 . . PUNCT aji-51 1164 1 am be AUX aji-51 1164 2 j j PROPN aji-51 1164 3 cancer cancer NOUN aji-51 1164 4 res re NOUN aji-51 1164 5 . . PROPN aji-51 1165 1 2020 2020 NUM aji-51 1165 2 oct oct PROPN aji-51 1165 3 1;10(10):3230 1;10(10):3230 NUM aji-51 1165 4 - - SYM aji-51 1165 5 3247 3247 NUM aji-51 1165 6 . . PUNCT aji-51 1166 1 pmid pmid NOUN aji-51 1166 2 : : PUNCT aji-51 1166 3 33163267 33163267 NUM aji-51 1166 4 ; ; PUNCT aji-51 1166 5 pmcid pmcid ADJ aji-51 1166 6 : : PUNCT aji-51 1166 7 pmc7642647 pmc7642647 NOUN aji-51 1166 8 . . PUNCT aji-51 1167 1 126 126 NUM aji-51 1167 2 . . PUNCT aji-51 1168 1 guais guais PROPN aji-51 1168 2 a a PROPN aji-51 1168 3 , , PUNCT aji-51 1168 4 baronzio baronzio NOUN aji-51 1168 5 g g NOUN aji-51 1168 6 , , PUNCT aji-51 1168 7 sanders sanders PROPN aji-51 1168 8 e e PROPN aji-51 1168 9 , , PUNCT aji-51 1168 10 campion campion NOUN aji-51 1168 11 f f PROPN aji-51 1168 12 , , PUNCT aji-51 1168 13 mainini mainini PROPN aji-51 1168 14 c c PROPN aji-51 1168 15 , , PUNCT aji-51 1168 16 fiorentini fiorentini VERB aji-51 1168 17 g g NOUN aji-51 1168 18 , , PUNCT aji-51 1168 19 montagnani montagnani PROPN aji-51 1168 20 f f PROPN aji-51 1168 21 , , PUNCT aji-51 1168 22 behzadi behzadi PROPN aji-51 1168 23 m m PROPN aji-51 1168 24 , , PUNCT aji-51 1168 25 schwartz schwartz PROPN aji-51 1168 26 l l PROPN aji-51 1168 27 , , PUNCT aji-51 1168 28 abolhassani abolhassani PROPN aji-51 1168 29 m. m. NOUN aji-51 1168 30 adding add VERB aji-51 1168 31 a a DET aji-51 1168 32 combination combination NOUN aji-51 1168 33 of of ADP aji-51 1168 34 hydroxycitrate hydroxycitrate ADJ aji-51 1168 35 and and CCONJ aji-51 1168 36 lipoic lipoic ADJ aji-51 1168 37 acid acid NOUN aji-51 1168 38 ( ( PUNCT aji-51 1168 39 metabloc metabloc NOUN aji-51 1168 40 ™ ™ NOUN aji-51 1168 41 ) ) PUNCT aji-51 1168 42 to to ADP aji-51 1168 43 chemotherapy chemotherapy NOUN aji-51 1168 44 improves improve VERB aji-51 1168 45 effectiveness effectiveness NOUN aji-51 1168 46 against against ADP aji-51 1168 47 tumor tumor NOUN aji-51 1168 48 development development NOUN aji-51 1168 49 : : PUNCT aji-51 1168 50 experimental experimental ADJ aji-51 1168 51 results result NOUN aji-51 1168 52 and and CCONJ aji-51 1168 53 case case NOUN aji-51 1168 54 report report NOUN aji-51 1168 55 . . PUNCT aji-51 1169 1 invest invest VERB aji-51 1169 2 new new ADJ aji-51 1169 3 drugs drug NOUN aji-51 1169 4 . . PUNCT aji-51 1170 1 2012 2012 NUM aji-51 1170 2 feb;30(1):200 feb;30(1):200 NOUN aji-51 1170 3 - - PUNCT aji-51 1170 4 11 11 NUM aji-51 1170 5 . . PUNCT aji-51 1171 1 doi doi NOUN aji-51 1171 2 : : PUNCT aji-51 1171 3 10.1007 10.1007 NUM aji-51 1171 4 / / SYM aji-51 1171 5 s10637 s10637 PROPN aji-51 1171 6 - - PUNCT aji-51 1171 7 010 010 NUM aji-51 1171 8 - - PUNCT aji-51 1171 9 9552 9552 NUM aji-51 1171 10 - - PUNCT aji-51 1171 11 x x SYM aji-51 1171 12 epub epub PROPN aji-51 1171 13 2010 2010 NUM aji-51 1171 14 oct oct NOUN aji-51 1171 15 8 8 NUM aji-51 1171 16 . . PUNCT aji-51 1172 1 pmid pmid NOUN aji-51 1172 2 : : PUNCT aji-51 1172 3 20931262 20931262 NUM aji-51 1172 4 . . PUNCT aji-51 1173 1 127 127 NUM aji-51 1173 2 . . PUNCT aji-51 1174 1 schwartz schwartz PROPN aji-51 1174 2 l l PROPN aji-51 1174 3 , , PUNCT aji-51 1174 4 abolhassani abolhassani PROPN aji-51 1174 5 m m PROPN aji-51 1174 6 , , PUNCT aji-51 1174 7 guais guais PROPN aji-51 1174 8 a a PROPN aji-51 1174 9 , , PUNCT aji-51 1174 10 sanders sanders PROPN aji-51 1174 11 e e PROPN aji-51 1174 12 , , PUNCT aji-51 1174 13 steyaert steyaert VERB aji-51 1174 14 jm jm PROPN aji-51 1174 15 , , PUNCT aji-51 1174 16 campion campion NOUN aji-51 1174 17 f f PROPN aji-51 1174 18 , , PUNCT aji-51 1174 19 israël israël NOUN aji-51 1174 20 m. m. NOUN aji-51 1174 21 a a DET aji-51 1174 22 combination combination NOUN aji-51 1174 23 of of ADP aji-51 1174 24 alpha alpha NOUN aji-51 1174 25 lipoic lipoic NOUN aji-51 1174 26 acid acid NOUN aji-51 1174 27 and and CCONJ aji-51 1174 28 calcium calcium NOUN aji-51 1174 29 hydroxycitrate hydroxycitrate NOUN aji-51 1174 30 is be AUX aji-51 1174 31 efficient efficient ADJ aji-51 1174 32 against against ADP aji-51 1174 33 mouse mouse NOUN aji-51 1174 34 cancer cancer NOUN aji-51 1174 35 models model NOUN aji-51 1174 36 : : PUNCT aji-51 1174 37 preliminary preliminary ADJ aji-51 1174 38 results result NOUN aji-51 1174 39 . . PUNCT aji-51 1175 1 oncol oncol PROPN aji-51 1175 2 rep rep PROPN aji-51 1175 3 . . PROPN aji-51 1175 4 2010 2010 NUM aji-51 1175 5 may;23(5):1407 may;23(5):1407 PROPN aji-51 1175 6 - - PUNCT aji-51 1175 7 16 16 PROPN aji-51 1175 8 . . PUNCT aji-51 1176 1 doi doi NOUN aji-51 1176 2 : : PUNCT aji-51 1176 3 10.3892 10.3892 NUM aji-51 1176 4 / / SYM aji-51 1176 5 or_00000778 or_00000778 NUM aji-51 1176 6 pmid pmid PROPN aji-51 1176 7 : : PUNCT aji-51 1176 8 20372858 20372858 NUM aji-51 1176 9 . . PUNCT aji-51 1177 1 128 128 NUM aji-51 1177 2 . . PUNCT aji-51 1178 1 schwartz schwartz PROPN aji-51 1178 2 l l PROPN aji-51 1178 3 , , PUNCT aji-51 1178 4 buhler buhler PROPN aji-51 1178 5 l l PROPN aji-51 1178 6 , , PUNCT aji-51 1178 7 icard icard PROPN aji-51 1178 8 p p PROPN aji-51 1178 9 , , PUNCT aji-51 1178 10 lincet lincet PROPN aji-51 1178 11 h h PROPN aji-51 1178 12 , , PUNCT aji-51 1178 13 steyaert steyaert VERB aji-51 1178 14 jm jm PROPN aji-51 1178 15 . . PROPN aji-51 1178 16 metabolic metabolic PROPN aji-51 1178 17 treatment treatment NOUN aji-51 1178 18 of of ADP aji-51 1178 19 cancer cancer NOUN aji-51 1178 20 : : PUNCT aji-51 1178 21 intermediate intermediate ADJ aji-51 1178 22 results result NOUN aji-51 1178 23 of of ADP aji-51 1178 24 a a DET aji-51 1178 25 prospective prospective ADJ aji-51 1178 26 case case NOUN aji-51 1178 27 series series NOUN aji-51 1178 28 . . PUNCT aji-51 1179 1 anticancer anticancer NOUN aji-51 1179 2 res re NOUN aji-51 1179 3 . . PUNCT aji-51 1179 4 2014 2014 NUM aji-51 1179 5 feb;34(2):973 feb;34(2):973 NOUN aji-51 1179 6 - - PUNCT aji-51 1179 7 80 80 NUM aji-51 1179 8 . . PUNCT aji-51 1180 1 pmid pmid NOUN aji-51 1180 2 : : PUNCT aji-51 1180 3 24511042 24511042 NUM aji-51 1180 4 . . PUNCT aji-51 1181 1 129 129 NUM aji-51 1181 2 . . PUNCT aji-51 1182 1 guais guais PROPN aji-51 1182 2 a a PROPN aji-51 1182 3 , , PUNCT aji-51 1182 4 baronzio baronzio NOUN aji-51 1182 5 g g NOUN aji-51 1182 6 , , PUNCT aji-51 1182 7 sanders sanders PROPN aji-51 1182 8 e e PROPN aji-51 1182 9 , , PUNCT aji-51 1182 10 campion campion NOUN aji-51 1182 11 f f PROPN aji-51 1182 12 , , PUNCT aji-51 1182 13 mainini mainini PROPN aji-51 1182 14 c c PROPN aji-51 1182 15 , , PUNCT aji-51 1182 16 fiorentini fiorentini VERB aji-51 1182 17 g g NOUN aji-51 1182 18 , , PUNCT aji-51 1182 19 montagnani montagnani PROPN aji-51 1182 20 f f PROPN aji-51 1182 21 , , PUNCT aji-51 1182 22 behzadi behzadi PROPN aji-51 1182 23 m m PROPN aji-51 1182 24 , , PUNCT aji-51 1182 25 schwartz schwartz PROPN aji-51 1182 26 l l PROPN aji-51 1182 27 , , PUNCT aji-51 1182 28 abolhassani abolhassani PROPN aji-51 1182 29 m. m. NOUN aji-51 1182 30 adding add VERB aji-51 1182 31 a a DET aji-51 1182 32 combination combination NOUN aji-51 1182 33 of of ADP aji-51 1182 34 hydroxycitrate hydroxycitrate ADJ aji-51 1182 35 and and CCONJ aji-51 1182 36 lipoic lipoic ADJ aji-51 1182 37 acid acid NOUN aji-51 1182 38 ( ( PUNCT aji-51 1182 39 metabloc metabloc NOUN aji-51 1182 40 ™ ™ NOUN aji-51 1182 41 ) ) PUNCT aji-51 1182 42 to to ADP aji-51 1182 43 chemotherapy chemotherapy NOUN aji-51 1182 44 improves improve VERB aji-51 1182 45 effectiveness effectiveness NOUN aji-51 1182 46 against against ADP aji-51 1182 47 tumor tumor NOUN aji-51 1182 48 development development NOUN aji-51 1182 49 : : PUNCT aji-51 1182 50 experimental experimental ADJ aji-51 1182 51 results result NOUN aji-51 1182 52 and and CCONJ aji-51 1182 53 case case NOUN aji-51 1182 54 report report NOUN aji-51 1182 55 . . PUNCT aji-51 1183 1 invest invest VERB aji-51 1183 2 new new ADJ aji-51 1183 3 drugs drug NOUN aji-51 1183 4 . . PUNCT aji-51 1184 1 2012 2012 NUM aji-51 1184 2 feb;30(1):200 feb;30(1):200 NOUN aji-51 1184 3 - - PUNCT aji-51 1184 4 11 11 NUM aji-51 1184 5 . . PUNCT aji-51 1185 1 doi doi NOUN aji-51 1185 2 : : PUNCT aji-51 1185 3 10.1007 10.1007 NUM aji-51 1185 4 / / SYM aji-51 1185 5 s10637 s10637 PROPN aji-51 1185 6 - - PUNCT aji-51 1185 7 010 010 NUM aji-51 1185 8 - - PUNCT aji-51 1185 9 9552 9552 NUM aji-51 1185 10 - - PUNCT aji-51 1185 11 x x SYM aji-51 1185 12 epub epub PROPN aji-51 1185 13 2010 2010 NUM aji-51 1185 14 oct oct NOUN aji-51 1185 15 8 8 NUM aji-51 1185 16 . . PUNCT aji-51 1186 1 pmid pmid NOUN aji-51 1186 2 : : PUNCT aji-51 1186 3 20931262 20931262 NUM aji-51 1186 4 . . PUNCT aji-51 1187 1 130 130 NUM aji-51 1187 2 . . PUNCT aji-51 1188 1 arima arima PROPN aji-51 1188 2 y y PROPN aji-51 1188 3 , , PUNCT aji-51 1188 4 nobusue nobusue PROPN aji-51 1188 5 h h PROPN aji-51 1188 6 , , PUNCT aji-51 1188 7 saya saya PROPN aji-51 1188 8 h. h. PROPN aji-51 1188 9 targeting target VERB aji-51 1188 10 of of ADP aji-51 1188 11 cancer cancer NOUN aji-51 1188 12 stem stem NOUN aji-51 1188 13 cells cell NOUN aji-51 1188 14 by by ADP aji-51 1188 15 differentiation differentiation NOUN aji-51 1188 16 therapy therapy NOUN aji-51 1188 17 . . PUNCT aji-51 1189 1 cancer cancer PROPN aji-51 1189 2 sci sci PROPN aji-51 1189 3 . . PROPN aji-51 1189 4 2020 2020 NUM aji-51 1189 5 aug;111(8):2689 aug;111(8):2689 NOUN aji-51 1189 6 - - SYM aji-51 1189 7 2695 2695 NUM aji-51 1189 8 . . PUNCT aji-51 1190 1 doi doi NOUN aji-51 1190 2 : : PUNCT aji-51 1190 3 10.1111 10.1111 NUM aji-51 1190 4 / / SYM aji-51 1190 5 cas.14504 cas.14504 X aji-51 1190 6 epub epub PROPN aji-51 1190 7 2020 2020 NUM aji-51 1190 8 jun jun PROPN aji-51 1190 9 22 22 NUM aji-51 1190 10 . . PUNCT aji-51 1191 1 pmid pmid NOUN aji-51 1191 2 : : PUNCT aji-51 1191 3 32462706 32462706 NUM aji-51 1191 4 ; ; PUNCT aji-51 1191 5 pmcid pmcid NOUN aji-51 1191 6 : : PUNCT aji-51 1191 7 pmc7419023 pmc7419023 ADJ aji-51 1191 8 . . PUNCT aji-51 1192 1 131 131 NUM aji-51 1192 2 . . PUNCT aji-51 1193 1 tunçer tunçer PROPN aji-51 1193 2 s s PROPN aji-51 1193 3 , , PUNCT aji-51 1193 4 gurbanov gurbanov VERB aji-51 1193 5 r r NOUN aji-51 1193 6 , , PUNCT aji-51 1193 7 sheraj sheraj VERB aji-51 1193 8 i i PRON aji-51 1193 9 , , PUNCT aji-51 1193 10 solel solel ADJ aji-51 1193 11 e e NOUN aji-51 1193 12 , , PUNCT aji-51 1193 13 esenturk esenturk NOUN aji-51 1193 14 o o NOUN aji-51 1193 15 , , PUNCT aji-51 1193 16 banerjee banerjee PROPN aji-51 1193 17 s. s. PROPN aji-51 1193 18 low low PROPN aji-51 1193 19 dose dose PROPN aji-51 1193 20 dimethyl dimethyl NOUN aji-51 1193 21 sulfoxide sulfoxide NOUN aji-51 1193 22 driven drive VERB aji-51 1193 23 gross gross ADJ aji-51 1193 24 molecular molecular ADJ aji-51 1193 25 changes change NOUN aji-51 1193 26 have have VERB aji-51 1193 27 the the DET aji-51 1193 28 potential potential NOUN aji-51 1193 29 to to PART aji-51 1193 30 interfere interfere VERB aji-51 1193 31 with with ADP aji-51 1193 32 various various ADJ aji-51 1193 33 cellular cellular ADJ aji-51 1193 34 processes process NOUN aji-51 1193 35 . . PUNCT aji-51 1194 1 scientific scientific ADJ aji-51 1194 2 reports report NOUN aji-51 1194 3 . . PUNCT aji-51 1195 1 2018;8(1):14828 2018;8(1):14828 X aji-51 1195 2 . . PUNCT aji-51 1195 3 available available ADJ aji-51 1195 4 : : PUNCT aji-51 1195 5 https://doi.org/10.1038 https://doi.org/10.1038 NOUN aji-51 1195 6 / / SYM aji-51 1195 7 s41598018 s41598018 PROPN aji-51 1195 8 - - PUNCT aji-51 1195 9 33234 33234 NUM aji-51 1195 10 - - PUNCT aji-51 1195 11 z z NOUN aji-51 1195 12 pmid pmid NOUN aji-51 1195 13 : : PUNCT aji-51 1195 14 30287873 30287873 NUM aji-51 1195 15 . . PUNCT aji-51 1196 1 132 132 NUM aji-51 1196 2 . . PUNCT aji-51 1196 3 fiore fiore NOUN aji-51 1196 4 m m PROPN aji-51 1196 5 , , PUNCT aji-51 1196 6 zanier zanier ADJ aji-51 1196 7 r r NOUN aji-51 1196 8 , , PUNCT aji-51 1196 9 degrassi degrassi VERB aji-51 1196 10 f. f. PROPN aji-51 1196 11 reversible reversible ADJ aji-51 1196 12 g(1 g(1 NOUN aji-51 1196 13 ) ) PUNCT aji-51 1196 14 arrest arrest NOUN aji-51 1196 15 by by ADP aji-51 1196 16 dimethyl dimethyl NOUN aji-51 1196 17 sulfoxide sulfoxide NOUN aji-51 1196 18 as as ADP aji-51 1196 19 a a DET aji-51 1196 20 new new ADJ aji-51 1196 21 method method NOUN aji-51 1196 22 to to PART aji-51 1196 23 synchronize synchronize VERB aji-51 1196 24 chinese chinese ADJ aji-51 1196 25 hamster hamster NOUN aji-51 1196 26 cells cell NOUN aji-51 1196 27 . . PUNCT aji-51 1197 1 mutagenesis mutagenesis NOUN aji-51 1197 2 . . PUNCT aji-51 1198 1 2002;17:419–424 2002;17:419–424 PROPN aji-51 1198 2 . . PROPN aji-51 1199 1 133 133 NUM aji-51 1199 2 . . PUNCT aji-51 1200 1 ossowski ossowski PROPN aji-51 1200 2 l l PROPN aji-51 1200 3 , , PUNCT aji-51 1200 4 belin belin PROPN aji-51 1200 5 d. d. PROPN aji-51 1200 6 effect effect PROPN aji-51 1200 7 of of ADP aji-51 1200 8 dimethyl dimethyl NOUN aji-51 1200 9 sulfoxide sulfoxide NOUN aji-51 1200 10 on on ADP aji-51 1200 11 human human ADJ aji-51 1200 12 carcinoma carcinoma NOUN aji-51 1200 13 cells cell NOUN aji-51 1200 14 , , PUNCT aji-51 1200 15 inhibition inhibition NOUN aji-51 1200 16 of of ADP aji-51 1200 17 plasminogen plasminogen NOUN aji-51 1200 18 activator activator NOUN aji-51 1200 19 synthesis synthesis NOUN aji-51 1200 20 , , PUNCT aji-51 1200 21 change change NOUN aji-51 1200 22 in in ADP aji-51 1200 23 cell cell NOUN aji-51 1200 24 morphology morphology NOUN aji-51 1200 25 , , PUNCT aji-51 1200 26 and and CCONJ aji-51 1200 27 alteration alteration NOUN aji-51 1200 28 of of ADP aji-51 1200 29 response response NOUN aji-51 1200 30 to to ADP aji-51 1200 31 cholera cholera NOUN aji-51 1200 32 toxin toxin NOUN aji-51 1200 33 . . PUNCT aji-51 1201 1 molecular molecular ADJ aji-51 1201 2 and and CCONJ aji-51 1201 3 cellular cellular ADJ aji-51 1201 4 biology biology NOUN aji-51 1201 5 . . PUNCT aji-51 1202 1 1985;5(12):3552–3559 1985;5(12):3552–3559 NUM aji-51 1202 2 . . PUNCT aji-51 1203 1 available available ADJ aji-51 1203 2 : : PUNCT aji-51 1203 3 https://doi.org/10.1128 https://doi.org/10.1128 NOUN aji-51 1203 4 / / SYM aji-51 1203 5 mcb.5.12 mcb.5.12 NOUN aji-51 1203 6 . . NOUN aji-51 1203 7 3552 3552 NUM aji-51 1203 8 - - PUNCT aji-51 1203 9 3559.1985 3559.1985 NUM aji-51 1203 10 pmid pmid NOUN aji-51 1203 11 : : PUNCT aji-51 1203 12 3837848 3837848 NUM aji-51 1203 13 . . PUNCT aji-51 1204 1 134 134 NUM aji-51 1204 2 . . X aji-51 1204 3 breitman breitman NOUN aji-51 1204 4 tr tr VERB aji-51 1204 5 , , PUNCT aji-51 1204 6 he he PRON aji-51 1204 7 ry ry VERB aji-51 1204 8 . . PUNCT aji-51 1204 9 combinations combination NOUN aji-51 1204 10 of of ADP aji-51 1204 11 retinoic retinoic ADJ aji-51 1204 12 acid acid NOUN aji-51 1204 13 with with ADP aji-51 1204 14 either either DET aji-51 1204 15 sodium sodium NOUN aji-51 1204 16 butyrate butyrate NOUN aji-51 1204 17 , , PUNCT aji-51 1204 18 dimethyl dimethyl NOUN aji-51 1204 19 sulfoxide sulfoxide NOUN aji-51 1204 20 , , PUNCT aji-51 1204 21 or or CCONJ aji-51 1204 22 hexamethylene hexamethylene VERB aji-51 1204 23 bisacetamide bisacetamide NOUN aji-51 1204 24 synergistically synergistically ADV aji-51 1204 25 induce induce VERB aji-51 1204 26 differentiation differentiation NOUN aji-51 1204 27 of of ADP aji-51 1204 28 the the DET aji-51 1204 29 human human ADJ aji-51 1204 30 myeloid myeloid NOUN aji-51 1204 31 leukemia leukemia NOUN aji-51 1204 32 cell cell NOUN aji-51 1204 33 line line NOUN aji-51 1204 34 hl60 hl60 PROPN aji-51 1204 35 . . PUNCT aji-51 1205 1 cancer cancer NOUN aji-51 1205 2 res re NOUN aji-51 1205 3 . . PUNCT aji-51 1205 4 1990 1990 NUM aji-51 1205 5 oct oct NOUN aji-51 1205 6 1;50(19):6268 1;50(19):6268 NUM aji-51 1205 7 - - SYM aji-51 1205 8 73 73 NUM aji-51 1205 9 . . PUNCT aji-51 1206 1 pmid pmid NOUN aji-51 1206 2 : : PUNCT aji-51 1206 3 2400989 2400989 NUM aji-51 1206 4 . . PUNCT aji-51 1207 1 135 135 NUM aji-51 1207 2 . . PUNCT aji-51 1208 1 grunt grunt PROPN aji-51 1208 2 tw tw PROPN aji-51 1208 3 , , PUNCT aji-51 1208 4 somay somay AUX aji-51 1208 5 c c PROPN aji-51 1208 6 , , PUNCT aji-51 1208 7 pavelka pavelka PROPN aji-51 1208 8 m m PROPN aji-51 1208 9 , , PUNCT aji-51 1208 10 ellinger ellinger NOUN aji-51 1208 11 a a NOUN aji-51 1208 12 , , PUNCT aji-51 1208 13 dittrich dittrich NOUN aji-51 1208 14 e e NOUN aji-51 1208 15 , , PUNCT aji-51 1208 16 dittrich dittrich VERB aji-51 1208 17 c. c. NOUN aji-51 1209 1 the the DET aji-51 1209 2 effects effect NOUN aji-51 1209 3 of of ADP aji-51 1209 4 dimethyl dimethyl NOUN aji-51 1209 5 sulfoxide sulfoxide NOUN aji-51 1209 6 and and CCONJ aji-51 1209 7 retinoic retinoic PROPN aji-51 1209 8 acid acid NOUN aji-51 1209 9 on on ADP aji-51 1209 10 the the DET aji-51 1209 11 cell cell NOUN aji-51 1209 12 growth growth NOUN aji-51 1209 13 and and CCONJ aji-51 1209 14 the the DET aji-51 1209 15 phenotype phenotype NOUN aji-51 1209 16 of of ADP aji-51 1209 17 ovarian ovarian ADJ aji-51 1209 18 cancer cancer NOUN aji-51 1209 19 cells cell NOUN aji-51 1209 20 . . PUNCT aji-51 1210 1 j j PROPN aji-51 1210 2 cell cell PROPN aji-51 1210 3 sci sci PROPN aji-51 1210 4 . . PROPN aji-51 1210 5 1991 1991 NUM aji-51 1210 6 nov;100 nov;100 PROPN aji-51 1210 7 ( ( PUNCT aji-51 1210 8 pt pt PROPN aji-51 1210 9 3):657 3):657 NUM aji-51 1210 10 - - PUNCT aji-51 1210 11 66 66 NUM aji-51 1210 12 . . PUNCT aji-51 1211 1 stoff stoff PROPN aji-51 1211 2 ; ; PUNCT aji-51 1211 3 aji aji PROPN aji-51 1211 4 , , PUNCT aji-51 1211 5 5(1 5(1 NUM aji-51 1211 6 ): ): PUNCT aji-51 1211 7 1 1 NUM aji-51 1211 8 - - SYM aji-51 1211 9 39 39 NUM aji-51 1211 10 , , PUNCT aji-51 1211 11 2022 2022 NUM aji-51 1211 12 ; ; PUNCT aji-51 1211 13 article article NOUN aji-51 1211 14 no.aji.77967 no.aji.77967 PROPN aji-51 1211 15 26 26 NUM aji-51 1211 16 pmid pmid NOUN aji-51 1211 17 : : PUNCT aji-51 1211 18 1808213 1808213 NUM aji-51 1211 19 . . PUNCT aji-51 1212 1 136 136 NUM aji-51 1212 2 . . PUNCT aji-51 1213 1 fleet fleet PROPN aji-51 1213 2 jc jc PROPN aji-51 1213 3 , , PUNCT aji-51 1213 4 desmet desmet PROPN aji-51 1213 5 m m PROPN aji-51 1213 6 , , PUNCT aji-51 1213 7 johnson johnson PROPN aji-51 1213 8 r r PROPN aji-51 1213 9 , , PUNCT aji-51 1213 10 li li PROPN aji-51 1213 11 y. y. PROPN aji-51 1213 12 vitamin vitamin PROPN aji-51 1213 13 d d PROPN aji-51 1213 14 and and CCONJ aji-51 1213 15 cancer cancer NOUN aji-51 1213 16 : : PUNCT aji-51 1213 17 a a DET aji-51 1213 18 review review NOUN aji-51 1213 19 of of ADP aji-51 1213 20 molecular molecular ADJ aji-51 1213 21 mechanisms mechanism NOUN aji-51 1213 22 . . PUNCT aji-51 1214 1 biochem biochem PROPN aji-51 1214 2 j. j. PROPN aji-51 1214 3 2012 2012 NUM aji-51 1214 4 jan jan PROPN aji-51 1214 5 1;441(1):61 1;441(1):61 PROPN aji-51 1214 6 - - PUNCT aji-51 1214 7 76 76 NUM aji-51 1214 8 . . PUNCT aji-51 1215 1 doi doi NOUN aji-51 1215 2 : : PUNCT aji-51 1215 3 10.1042 10.1042 NUM aji-51 1215 4 / / SYM aji-51 1215 5 bj20110744 bj20110744 ADJ aji-51 1215 6 pmid pmid NOUN aji-51 1215 7 : : PUNCT aji-51 1215 8 22168439 22168439 NUM aji-51 1215 9 ; ; PUNCT aji-51 1215 10 pmcid pmcid ADJ aji-51 1215 11 : : PUNCT aji-51 1215 12 pmc4572477 pmc4572477 NOUN aji-51 1215 13 . . PUNCT aji-51 1216 1 137 137 NUM aji-51 1216 2 . . PUNCT aji-51 1217 1 pandolfi pandolfi NOUN aji-51 1217 2 f f NOUN aji-51 1217 3 , , PUNCT aji-51 1217 4 franza franza ADJ aji-51 1217 5 l l NOUN aji-51 1217 6 , , PUNCT aji-51 1217 7 mandolini mandolini PROPN aji-51 1217 8 c c PROPN aji-51 1217 9 , , PUNCT aji-51 1217 10 conti conti PROPN aji-51 1217 11 p. p. PROPN aji-51 1217 12 immune immune ADJ aji-51 1217 13 modulation modulation NOUN aji-51 1217 14 by by ADP aji-51 1217 15 vitamin vitamin NOUN aji-51 1217 16 d d NOUN aji-51 1217 17 : : PUNCT aji-51 1217 18 special special ADJ aji-51 1217 19 emphasis emphasis NOUN aji-51 1217 20 on on ADP aji-51 1217 21 its its PRON aji-51 1217 22 role role NOUN aji-51 1217 23 in in ADP aji-51 1217 24 prevention prevention NOUN aji-51 1217 25 and and CCONJ aji-51 1217 26 treatment treatment NOUN aji-51 1217 27 of of ADP aji-51 1217 28 cancer cancer NOUN aji-51 1217 29 . . PUNCT aji-51 1218 1 clin clin PROPN aji-51 1218 2 ther ther PROPN aji-51 1218 3 . . PUNCT aji-51 1219 1 2017 2017 NUM aji-51 1219 2 may;39(5):884 may;39(5):884 NOUN aji-51 1219 3 - - SYM aji-51 1219 4 893 893 NUM aji-51 1219 5 . . PUNCT aji-51 1220 1 doi doi NOUN aji-51 1220 2 : : PUNCT aji-51 1220 3 10.1016 10.1016 NUM aji-51 1220 4 / / SYM aji-51 1220 5 j.clinthera.2017.03.012 j.clinthera.2017.03.012 PROPN aji-51 1220 6 epub epub PROPN aji-51 1220 7 2017 2017 NUM aji-51 1220 8 apr apr PROPN aji-51 1220 9 18 18 NUM aji-51 1220 10 . . PUNCT aji-51 1221 1 pmid pmid NOUN aji-51 1221 2 : : PUNCT aji-51 1221 3 28431765 28431765 NUM aji-51 1221 4 . . PUNCT aji-51 1222 1 138 138 NUM aji-51 1222 2 . . PUNCT aji-51 1223 1 chatterjee chatterjee PROPN aji-51 1223 2 m. m. PROPN aji-51 1223 3 vitamin vitamin PROPN aji-51 1223 4 d d NOUN aji-51 1223 5 and and CCONJ aji-51 1223 6 genomic genomic ADJ aji-51 1223 7 stability stability NOUN aji-51 1223 8 . . PUNCT aji-51 1224 1 mutat mutat ADJ aji-51 1224 2 res re NOUN aji-51 1224 3 . . PUNCT aji-51 1224 4 2001 2001 NUM aji-51 1224 5 apr apr NOUN aji-51 1224 6 18;475(12):69 18;475(12):69 NUM aji-51 1224 7 - - SYM aji-51 1224 8 87 87 NUM aji-51 1224 9 . . PUNCT aji-51 1225 1 doi doi NOUN aji-51 1225 2 : : PUNCT aji-51 1225 3 10.1016 10.1016 NUM aji-51 1225 4 / / SYM aji-51 1225 5 s0027 s0027 NOUN aji-51 1225 6 - - PUNCT aji-51 1225 7 5107(01)00080 5107(01)00080 NOUN aji-51 1225 8 - - PUNCT aji-51 1225 9 x x SYM aji-51 1225 10 pmid pmid NOUN aji-51 1225 11 : : PUNCT aji-51 1225 12 11295155 11295155 NUM aji-51 1225 13 . . PUNCT aji-51 1226 1 139 139 NUM aji-51 1226 2 . . PUNCT aji-51 1227 1 vuolo vuolo PROPN aji-51 1227 2 l l PROPN aji-51 1227 3 , , PUNCT aji-51 1227 4 di di X aji-51 1227 5 somma somma PROPN aji-51 1227 6 c c PROPN aji-51 1227 7 , , PUNCT aji-51 1227 8 faggiano faggiano NOUN aji-51 1227 9 a a X aji-51 1227 10 , , PUNCT aji-51 1227 11 colao colao VERB aji-51 1227 12 a. a. NOUN aji-51 1227 13 vitamin vitamin NOUN aji-51 1227 14 d d NOUN aji-51 1227 15 and and CCONJ aji-51 1227 16 cancer cancer NOUN aji-51 1227 17 . . PUNCT aji-51 1228 1 front front ADJ aji-51 1228 2 endocrinol endocrinol NOUN aji-51 1228 3 ( ( PUNCT aji-51 1228 4 lausanne lausanne PROPN aji-51 1228 5 ) ) PUNCT aji-51 1228 6 . . PUNCT aji-51 1229 1 2012 2012 NUM aji-51 1229 2 apr apr NOUN aji-51 1229 3 23;3:58 23;3:58 NUM aji-51 1229 4 . . PUNCT aji-51 1229 5 doi doi NOUN aji-51 1229 6 : : PUNCT aji-51 1229 7 10.3389 10.3389 NUM aji-51 1229 8 / / SYM aji-51 1229 9 fendo.2012.00058 fendo.2012.00058 ADJ aji-51 1229 10 pmid pmid PROPN aji-51 1229 11 : : PUNCT aji-51 1229 12 22649423 22649423 NUM aji-51 1229 13 ; ; PUNCT aji-51 1229 14 pmcid pmcid ADJ aji-51 1229 15 : : PUNCT aji-51 1229 16 pmc3355893 pmc3355893 ADJ aji-51 1229 17 . . PUNCT aji-51 1230 1 140 140 NUM aji-51 1230 2 . . X aji-51 1230 3 bikle bikle NOUN aji-51 1230 4 dd dd PROPN aji-51 1230 5 . . PUNCT aji-51 1230 6 vitamin vitamin NOUN aji-51 1230 7 d d NOUN aji-51 1230 8 and and CCONJ aji-51 1230 9 cancer cancer NOUN aji-51 1230 10 : : PUNCT aji-51 1230 11 the the DET aji-51 1230 12 promise promise NOUN aji-51 1230 13 not not PART aji-51 1230 14 yet yet ADV aji-51 1230 15 fulfilled fulfil VERB aji-51 1230 16 . . PUNCT aji-51 1231 1 endocrine endocrine NOUN aji-51 1231 2 . . PUNCT aji-51 1232 1 2014 2014 NUM aji-51 1233 1 may;46(1):29 may;46(1):29 PROPN aji-51 1233 2 - - PUNCT aji-51 1233 3 38 38 PROPN aji-51 1233 4 . . PUNCT aji-51 1234 1 doi doi NOUN aji-51 1234 2 : : PUNCT aji-51 1234 3 10.1007 10.1007 NUM aji-51 1234 4 / / SYM aji-51 1234 5 s12020 s12020 NOUN aji-51 1234 6 - - PUNCT aji-51 1234 7 013 013 NUM aji-51 1234 8 - - PUNCT aji-51 1234 9 0146 0146 NUM aji-51 1234 10 - - SYM aji-51 1234 11 1 1 NUM aji-51 1234 12 epub epub NOUN aji-51 1234 13 2014 2014 NUM aji-51 1234 14 jan jan PROPN aji-51 1234 15 9 9 NUM aji-51 1234 16 . . PUNCT aji-51 1235 1 pmid pmid NOUN aji-51 1235 2 : : PUNCT aji-51 1235 3 24402695 24402695 NUM aji-51 1235 4 ; ; PUNCT aji-51 1235 5 pmcid pmcid NOUN aji-51 1235 6 : : PUNCT aji-51 1235 7 pmc3976762 pmc3976762 NOUN aji-51 1235 8 . . PUNCT aji-51 1236 1 141 141 NUM aji-51 1236 2 . . PUNCT aji-51 1237 1 thomson thomson PROPN aji-51 1237 2 ca ca PROPN aji-51 1237 3 , , PUNCT aji-51 1237 4 ho ho PROPN aji-51 1237 5 e e PROPN aji-51 1237 6 , , PUNCT aji-51 1237 7 strom strom PROPN aji-51 1237 8 mb mb PROPN aji-51 1237 9 . . PROPN aji-51 1237 10 chemopreventive chemopreventive ADJ aji-51 1237 11 properties property NOUN aji-51 1237 12 of of ADP aji-51 1237 13 3,3'diindolylmethane 3,3'diindolylmethane NUM aji-51 1237 14 in in ADP aji-51 1237 15 breast breast NOUN aji-51 1237 16 cancer cancer NOUN aji-51 1237 17 : : PUNCT aji-51 1237 18 evidence evidence NOUN aji-51 1237 19 from from ADP aji-51 1237 20 experimental experimental ADJ aji-51 1237 21 and and CCONJ aji-51 1237 22 human human ADJ aji-51 1237 23 studies study NOUN aji-51 1237 24 . . PUNCT aji-51 1238 1 nutr nutr PROPN aji-51 1238 2 rev rev PROPN aji-51 1238 3 . . PROPN aji-51 1238 4 2016 2016 NUM aji-51 1238 5 jul;74(7):432 jul;74(7):432 PROPN aji-51 1238 6 - - PUNCT aji-51 1238 7 43 43 PROPN aji-51 1238 8 . . PUNCT aji-51 1239 1 doi doi NOUN aji-51 1239 2 : : PUNCT aji-51 1239 3 10.1093 10.1093 NUM aji-51 1239 4 / / SYM aji-51 1239 5 nutrit nutrit PROPN aji-51 1239 6 / / SYM aji-51 1239 7 nuw010 nuw010 PROPN aji-51 1239 8 epub epub PROPN aji-51 1239 9 2016 2016 NUM aji-51 1239 10 may may AUX aji-51 1239 11 31 31 NUM aji-51 1239 12 . . PUNCT aji-51 1240 1 pmid pmid NOUN aji-51 1240 2 : : PUNCT aji-51 1240 3 27261275 27261275 NUM aji-51 1240 4 ; ; PUNCT aji-51 1240 5 pmcid pmcid ADJ aji-51 1240 6 : : PUNCT aji-51 1240 7 pmc5059820 pmc5059820 NOUN aji-51 1240 8 . . PUNCT aji-51 1241 1 142 142 NUM aji-51 1241 2 . . PUNCT aji-51 1242 1 safe safe ADJ aji-51 1242 2 s s NOUN aji-51 1242 3 , , PUNCT aji-51 1242 4 papineni papineni NOUN aji-51 1242 5 s s PROPN aji-51 1242 6 , , PUNCT aji-51 1242 7 chintharlapalli chintharlapalli PROPN aji-51 1242 8 s. s. PROPN aji-51 1242 9 cancer cancer PROPN aji-51 1242 10 chemotherapy chemotherapy PROPN aji-51 1242 11 with with ADP aji-51 1242 12 indole-3carbinol indole-3carbinol PROPN aji-51 1242 13 , , PUNCT aji-51 1242 14 bis(3'-indolyl)methane bis(3'-indolyl)methane ADJ aji-51 1242 15 and and CCONJ aji-51 1242 16 synthetic synthetic ADJ aji-51 1242 17 analogs analog NOUN aji-51 1242 18 . . PUNCT aji-51 1243 1 cancer cancer PROPN aji-51 1243 2 lett lett PROPN aji-51 1243 3 . . PROPN aji-51 1244 1 2008 2008 NUM aji-51 1244 2 oct oct NOUN aji-51 1244 3 8;269(2):326 8;269(2):326 NUM aji-51 1244 4 - - SYM aji-51 1244 5 38 38 NUM aji-51 1244 6 . . PUNCT aji-51 1245 1 doi doi NOUN aji-51 1245 2 : : PUNCT aji-51 1245 3 10.1016 10.1016 NUM aji-51 1245 4 / / SYM aji-51 1245 5 j.canlet.2008.04.021 j.canlet.2008.04.021 PROPN aji-51 1245 6 epub epub PROPN aji-51 1245 7 2008 2008 NUM aji-51 1245 8 may may PROPN aji-51 1245 9 22 22 NUM aji-51 1245 10 . . PUNCT aji-51 1246 1 pmid pmid NOUN aji-51 1246 2 : : PUNCT aji-51 1246 3 18501502 18501502 NUM aji-51 1246 4 ; ; PUNCT aji-51 1246 5 pmcid pmcid ADJ aji-51 1246 6 : : PUNCT aji-51 1246 7 pmc2574232 pmc2574232 NOUN aji-51 1246 8 . . PUNCT aji-51 1247 1 143 143 X aji-51 1247 2 . . PUNCT aji-51 1248 1 weng weng PROPN aji-51 1248 2 jr jr PROPN aji-51 1248 3 , , PUNCT aji-51 1248 4 tsai tsai PROPN aji-51 1248 5 ch ch PROPN aji-51 1248 6 , , PUNCT aji-51 1248 7 kulp kulp NOUN aji-51 1248 8 sk sk PROPN aji-51 1248 9 , , PUNCT aji-51 1248 10 chen chen PROPN aji-51 1248 11 cs cs PROPN aji-51 1248 12 . . PROPN aji-51 1248 13 indole-3 indole-3 PROPN aji-51 1248 14 - - PUNCT aji-51 1248 15 carbinol carbinol NOUN aji-51 1248 16 as as ADP aji-51 1248 17 a a DET aji-51 1248 18 chemopreventive chemopreventive ADJ aji-51 1248 19 and and CCONJ aji-51 1248 20 anti anti ADJ aji-51 1248 21 - - ADJ aji-51 1248 22 cancer cancer ADJ aji-51 1248 23 agent agent NOUN aji-51 1248 24 . . PUNCT aji-51 1249 1 cancer cancer PROPN aji-51 1249 2 lett lett PROPN aji-51 1249 3 . . PROPN aji-51 1250 1 2008 2008 NUM aji-51 1250 2 apr apr NOUN aji-51 1250 3 18;262(2):153 18;262(2):153 NUM aji-51 1250 4 - - SYM aji-51 1250 5 63 63 NUM aji-51 1250 6 . . PUNCT aji-51 1251 1 doi doi NOUN aji-51 1251 2 : : PUNCT aji-51 1251 3 10.1016 10.1016 NUM aji-51 1251 4 / / SYM aji-51 1251 5 j.canlet.2008.01.033 j.canlet.2008.01.033 PROPN aji-51 1251 6 epub epub PROPN aji-51 1251 7 2008 2008 NUM aji-51 1251 8 mar mar PROPN aji-51 1251 9 7 7 NUM aji-51 1251 10 . . PUNCT aji-51 1252 1 pmid pmid NOUN aji-51 1252 2 : : PUNCT aji-51 1252 3 18314259 18314259 NUM aji-51 1252 4 ; ; PUNCT aji-51 1252 5 pmcid pmcid NOUN aji-51 1252 6 : : PUNCT aji-51 1252 7 pmc2814317 pmc2814317 ADJ aji-51 1252 8 . . PUNCT aji-51 1253 1 144 144 NUM aji-51 1253 2 . . PUNCT aji-51 1254 1 rahman rahman PROPN aji-51 1254 2 km km PROPN aji-51 1254 3 , , PUNCT aji-51 1254 4 ali ali PROPN aji-51 1254 5 s s PROPN aji-51 1254 6 , , PUNCT aji-51 1254 7 aboukameel aboukameel NOUN aji-51 1254 8 a a NOUN aji-51 1254 9 , , PUNCT aji-51 1254 10 sarkar sarkar PROPN aji-51 1254 11 sh sh PROPN aji-51 1254 12 , , PUNCT aji-51 1254 13 wang wang PROPN aji-51 1254 14 z z PROPN aji-51 1254 15 , , PUNCT aji-51 1254 16 philip philip PROPN aji-51 1254 17 pa pa PROPN aji-51 1254 18 , , PUNCT aji-51 1254 19 sakr sakr PROPN aji-51 1254 20 wa wa PROPN aji-51 1254 21 , , PUNCT aji-51 1254 22 raz raz NOUN aji-51 1254 23 a. a. NOUN aji-51 1254 24 inactivation inactivation NOUN aji-51 1254 25 of of ADP aji-51 1254 26 nf nf NOUN aji-51 1254 27 - - PUNCT aji-51 1254 28 kappab kappab NOUN aji-51 1254 29 by by ADP aji-51 1254 30 3,3'diindolylmethane 3,3'diindolylmethane NUM aji-51 1254 31 contributes contribute VERB aji-51 1254 32 to to ADP aji-51 1254 33 increased increase VERB aji-51 1254 34 apoptosis apoptosis NOUN aji-51 1254 35 induced induce VERB aji-51 1254 36 by by ADP aji-51 1254 37 chemotherapeutic chemotherapeutic ADJ aji-51 1254 38 agent agent NOUN aji-51 1254 39 in in ADP aji-51 1254 40 breast breast NOUN aji-51 1254 41 cancer cancer NOUN aji-51 1254 42 cells cell NOUN aji-51 1254 43 . . PUNCT aji-51 1255 1 mol mol ADP aji-51 1255 2 cancer cancer NOUN aji-51 1255 3 ther ther PROPN aji-51 1255 4 . . PUNCT aji-51 1256 1 2007 2007 NUM aji-51 1256 2 oct;6(10):2757 oct;6(10):2757 NOUN aji-51 1256 3 - - SYM aji-51 1256 4 65 65 NUM aji-51 1256 5 . . PUNCT aji-51 1257 1 doi doi NOUN aji-51 1257 2 : : PUNCT aji-51 1257 3 10.1158/1535 10.1158/1535 NUM aji-51 1257 4 - - PUNCT aji-51 1257 5 7163.mct-07 7163.mct-07 NUM aji-51 1257 6 - - PUNCT aji-51 1257 7 0336 0336 NUM aji-51 1257 8 epub epub NOUN aji-51 1257 9 2007 2007 NUM aji-51 1257 10 oct oct NOUN aji-51 1257 11 3 3 NUM aji-51 1257 12 . . PUNCT aji-51 1258 1 pmid pmid NOUN aji-51 1258 2 : : PUNCT aji-51 1258 3 17913854 17913854 NUM aji-51 1258 4 . . PUNCT aji-51 1259 1 145 145 NUM aji-51 1259 2 . . PUNCT aji-51 1259 3 palomera palomera NOUN aji-51 1259 4 - - PUNCT aji-51 1259 5 sanchez sanchez PROPN aji-51 1259 6 z z PROPN aji-51 1259 7 , , PUNCT aji-51 1259 8 watson watson PROPN aji-51 1259 9 gw gw PROPN aji-51 1259 10 , , PUNCT aji-51 1259 11 wong wong PROPN aji-51 1259 12 cp cp PROPN aji-51 1259 13 , , PUNCT aji-51 1259 14 beaver beaver PROPN aji-51 1259 15 lm lm PROPN aji-51 1259 16 , , PUNCT aji-51 1259 17 williams williams PROPN aji-51 1259 18 de de PROPN aji-51 1259 19 , , PUNCT aji-51 1259 20 dashwood dashwood PROPN aji-51 1259 21 rh rh PROPN aji-51 1259 22 , , PUNCT aji-51 1259 23 ho ho PROPN aji-51 1259 24 e. e. PROPN aji-51 1260 1 the the DET aji-51 1260 2 phytochemical phytochemical ADJ aji-51 1260 3 3,3'diindolylmethane 3,3'diindolylmethane NUM aji-51 1260 4 decreases decrease VERB aji-51 1260 5 expression expression NOUN aji-51 1260 6 of of ADP aji-51 1260 7 ar ar NOUN aji-51 1260 8 - - PUNCT aji-51 1260 9 controlled control VERB aji-51 1260 10 dna dna PROPN aji-51 1260 11 damage damage NOUN aji-51 1260 12 repair repair NOUN aji-51 1260 13 genes gene NOUN aji-51 1260 14 through through ADP aji-51 1260 15 repressive repressive ADJ aji-51 1260 16 chromatin chromatin NOUN aji-51 1260 17 modifications modification NOUN aji-51 1260 18 and and CCONJ aji-51 1260 19 is be AUX aji-51 1260 20 associated associate VERB aji-51 1260 21 with with ADP aji-51 1260 22 dna dna PROPN aji-51 1260 23 damage damage NOUN aji-51 1260 24 in in ADP aji-51 1260 25 prostate prostate NOUN aji-51 1260 26 cancer cancer NOUN aji-51 1260 27 cells cell NOUN aji-51 1260 28 . . PUNCT aji-51 1261 1 j j PROPN aji-51 1261 2 nutr nutr PROPN aji-51 1261 3 biochem biochem PROPN aji-51 1261 4 . . PUNCT aji-51 1262 1 2017 2017 NUM aji-51 1262 2 sep;47:113 sep;47:113 PROPN aji-51 1262 3 - - SYM aji-51 1262 4 119 119 NUM aji-51 1262 5 . . PUNCT aji-51 1263 1 doi doi NOUN aji-51 1263 2 : : PUNCT aji-51 1263 3 10.1016 10.1016 NUM aji-51 1263 4 / / SYM aji-51 1263 5 j.jnutbio.2017.05.005 j.jnutbio.2017.05.005 PROPN aji-51 1263 6 epub epub PROPN aji-51 1263 7 2017 2017 NUM aji-51 1263 8 may may AUX aji-51 1263 9 25 25 NUM aji-51 1263 10 . . PUNCT aji-51 1264 1 pmid pmid NOUN aji-51 1264 2 : : PUNCT aji-51 1264 3 28582660 28582660 NUM aji-51 1264 4 ; ; PUNCT aji-51 1264 5 pmcid pmcid ADJ aji-51 1264 6 : : PUNCT aji-51 1264 7 pmc5583029 pmc5583029 NOUN aji-51 1264 8 . . PUNCT aji-51 1265 1 146 146 NUM aji-51 1265 2 . . PUNCT aji-51 1265 3 watson watson PROPN aji-51 1265 4 wg wg PROPN aji-51 1265 5 , , PUNCT aji-51 1265 6 beaver beaver PROPN aji-51 1265 7 ml ml PROPN aji-51 1265 8 , , PUNCT aji-51 1265 9 williams williams PROPN aji-51 1265 10 ed ed PROPN aji-51 1265 11 , , PUNCT aji-51 1265 12 dashwood dashwood PROPN aji-51 1265 13 hr hr PROPN aji-51 1265 14 , , PUNCT aji-51 1265 15 ho ho PROPN aji-51 1265 16 e. e. PROPN aji-51 1265 17 phytochemicals phytochemical NOUN aji-51 1265 18 from from ADP aji-51 1265 19 cruciferous cruciferous ADJ aji-51 1265 20 vegetables vegetable NOUN aji-51 1265 21 , , PUNCT aji-51 1265 22 epigenetics epigenetic NOUN aji-51 1265 23 , , PUNCT aji-51 1265 24 and and CCONJ aji-51 1265 25 prostate prostate NOUN aji-51 1265 26 cancer cancer NOUN aji-51 1265 27 prevention prevention NOUN aji-51 1265 28 . . PUNCT aji-51 1266 1 aaps aaps PROPN aji-51 1267 1 j. j. PROPN aji-51 1267 2 2013 2013 NUM aji-51 1267 3 oct;15(4):951 oct;15(4):951 PROPN aji-51 1267 4 - - PROPN aji-51 1267 5 61 61 NUM aji-51 1267 6 . . PUNCT aji-51 1268 1 doi doi NOUN aji-51 1268 2 : : PUNCT aji-51 1268 3 10.1208 10.1208 NUM aji-51 1268 4 / / SYM aji-51 1268 5 s12248 s12248 NOUN aji-51 1268 6 - - PUNCT aji-51 1268 7 013 013 NUM aji-51 1268 8 - - PUNCT aji-51 1268 9 9504 9504 NUM aji-51 1268 10 - - SYM aji-51 1268 11 4 4 NUM aji-51 1268 12 epub epub NOUN aji-51 1268 13 2013 2013 NUM aji-51 1268 14 jun jun PROPN aji-51 1268 15 26 26 NUM aji-51 1268 16 . . PUNCT aji-51 1269 1 pmid pmid NOUN aji-51 1269 2 : : PUNCT aji-51 1269 3 23800833 23800833 NUM aji-51 1269 4 ; ; PUNCT aji-51 1269 5 pmcid pmcid ADJ aji-51 1269 6 : : PUNCT aji-51 1269 7 pmc3787240 pmc3787240 NOUN aji-51 1269 8 . . PUNCT aji-51 1270 1 147 147 NUM aji-51 1270 2 . . PUNCT aji-51 1271 1 ravindran ravindran PROPN aji-51 1271 2 j j PROPN aji-51 1271 3 , , PUNCT aji-51 1271 4 prasad prasad PROPN aji-51 1271 5 s s PROPN aji-51 1271 6 , , PUNCT aji-51 1271 7 aggarwal aggarwal PROPN aji-51 1271 8 bb bb PROPN aji-51 1271 9 . . PUNCT aji-51 1271 10 curcumin curcumin PROPN aji-51 1271 11 and and CCONJ aji-51 1271 12 cancer cancer NOUN aji-51 1271 13 cells cell NOUN aji-51 1271 14 : : PUNCT aji-51 1271 15 how how SCONJ aji-51 1271 16 many many ADJ aji-51 1271 17 ways way NOUN aji-51 1271 18 can can AUX aji-51 1271 19 curry curry VERB aji-51 1271 20 kill kill VERB aji-51 1271 21 tumor tumor NOUN aji-51 1271 22 cells cell NOUN aji-51 1271 23 selectively selectively ADV aji-51 1271 24 ? ? PUNCT aji-51 1272 1 aaps aap VERB aji-51 1272 2 j. j. PROPN aji-51 1272 3 2009 2009 NUM aji-51 1272 4 sep;11(3):495 sep;11(3):495 PROPN aji-51 1272 5 - - PUNCT aji-51 1272 6 510 510 NUM aji-51 1272 7 . . PUNCT aji-51 1273 1 doi doi NOUN aji-51 1273 2 : : PUNCT aji-51 1273 3 10.1208 10.1208 NUM aji-51 1273 4 / / SYM aji-51 1273 5 s12248 s12248 PROPN aji-51 1273 6 - - PUNCT aji-51 1273 7 009 009 NUM aji-51 1273 8 - - PUNCT aji-51 1273 9 9128 9128 NUM aji-51 1273 10 - - PUNCT aji-51 1273 11 x x SYM aji-51 1273 12 epub epub NOUN aji-51 1273 13 2009 2009 NUM aji-51 1273 14 jul jul PROPN aji-51 1273 15 10 10 NUM aji-51 1273 16 . . PUNCT aji-51 1274 1 pmid pmid NOUN aji-51 1274 2 : : PUNCT aji-51 1274 3 19590964 19590964 NUM aji-51 1274 4 ; ; PUNCT aji-51 1274 5 pmcid pmcid ADJ aji-51 1274 6 : : PUNCT aji-51 1274 7 pmc2758121 pmc2758121 NOUN aji-51 1274 8 . . PUNCT aji-51 1275 1 148 148 NUM aji-51 1275 2 . . PUNCT aji-51 1276 1 park park PROPN aji-51 1276 2 w w PROPN aji-51 1276 3 , , PUNCT aji-51 1276 4 amin amin PROPN aji-51 1276 5 ar ar PROPN aji-51 1276 6 , , PUNCT aji-51 1276 7 chen chen PROPN aji-51 1276 8 zg zg PROPN aji-51 1276 9 , , PUNCT aji-51 1276 10 shin shin PROPN aji-51 1277 1 dm dm PROPN aji-51 1277 2 . . PUNCT aji-51 1278 1 new new ADJ aji-51 1278 2 perspectives perspective NOUN aji-51 1278 3 of of ADP aji-51 1278 4 curcumin curcumin NOUN aji-51 1278 5 in in ADP aji-51 1278 6 cancer cancer NOUN aji-51 1278 7 prevention prevention NOUN aji-51 1278 8 . . PUNCT aji-51 1279 1 cancer cancer NOUN aji-51 1279 2 prev prev PROPN aji-51 1279 3 res res PROPN aji-51 1279 4 ( ( PUNCT aji-51 1279 5 phila phila PROPN aji-51 1279 6 ) ) PUNCT aji-51 1279 7 . . PUNCT aji-51 1280 1 2013 2013 NUM aji-51 1280 2 may;6(5):387 may;6(5):387 NOUN aji-51 1280 3 - - PUNCT aji-51 1280 4 400 400 NUM aji-51 1280 5 . . PUNCT aji-51 1281 1 doi doi NOUN aji-51 1281 2 : : PUNCT aji-51 1281 3 10.1158/1940 10.1158/1940 NUM aji-51 1281 4 - - PUNCT aji-51 1281 5 6207.capr-12 6207.capr-12 PROPN aji-51 1281 6 - - PUNCT aji-51 1281 7 0410 0410 NUM aji-51 1281 8 epub epub NOUN aji-51 1281 9 2013 2013 NUM aji-51 1281 10 mar mar PROPN aji-51 1281 11 6 6 NUM aji-51 1281 12 . . PUNCT aji-51 1281 13 erratum erratum PROPN aji-51 1281 14 in in ADP aji-51 1281 15 : : PUNCT aji-51 1281 16 cancer cancer NOUN aji-51 1281 17 prev prev X aji-51 1281 18 res re NOUN aji-51 1281 19 ( ( PUNCT aji-51 1281 20 phila phila PROPN aji-51 1281 21 ) ) PUNCT aji-51 1281 22 . . PUNCT aji-51 1282 1 2017 2017 NUM aji-51 1282 2 jun;10 jun;10 PROPN aji-51 1282 3 ( ( PUNCT aji-51 1282 4 6):371 6):371 NUM aji-51 1282 5 . . PUNCT aji-51 1283 1 pmid pmid NOUN aji-51 1283 2 : : PUNCT aji-51 1283 3 23466484 23466484 NUM aji-51 1283 4 ; ; PUNCT aji-51 1283 5 pmcid pmcid ADJ aji-51 1283 6 : : PUNCT aji-51 1283 7 pmc3693758 pmc3693758 NOUN aji-51 1283 8 . . PUNCT aji-51 1284 1 149 149 NUM aji-51 1284 2 . . PUNCT aji-51 1285 1 ji ji PROPN aji-51 1285 2 z. z. PROPN aji-51 1285 3 targeting target VERB aji-51 1285 4 dna dna PROPN aji-51 1285 5 damage damage NOUN aji-51 1285 6 and and CCONJ aji-51 1285 7 repair repair NOUN aji-51 1285 8 by by ADP aji-51 1285 9 curcumin curcumin NOUN aji-51 1285 10 . . PUNCT aji-51 1286 1 breast breast NOUN aji-51 1286 2 cancer cancer NOUN aji-51 1286 3 ( ( PUNCT aji-51 1286 4 auckl auckl NOUN aji-51 1286 5 ) ) PUNCT aji-51 1286 6 . . PUNCT aji-51 1287 1 2010 2010 NUM aji-51 1287 2 feb feb NOUN aji-51 1287 3 16;4:1 16;4:1 NUM aji-51 1287 4 - - SYM aji-51 1287 5 3 3 NUM aji-51 1287 6 . . PUNCT aji-51 1288 1 pmid pmid NOUN aji-51 1288 2 : : PUNCT aji-51 1288 3 20697527 20697527 NUM aji-51 1288 4 ; ; PUNCT aji-51 1288 5 stoff stoff PROPN aji-51 1288 6 ; ; PUNCT aji-51 1288 7 aji aji PROPN aji-51 1288 8 , , PUNCT aji-51 1288 9 5(1 5(1 NUM aji-51 1288 10 ): ): PUNCT aji-51 1288 11 1 1 NUM aji-51 1288 12 - - SYM aji-51 1288 13 39 39 NUM aji-51 1288 14 , , PUNCT aji-51 1288 15 2022 2022 NUM aji-51 1288 16 ; ; PUNCT aji-51 1288 17 article article NOUN aji-51 1288 18 no.aji.77967 no.aji.77967 PROPN aji-51 1288 19 27 27 NUM aji-51 1288 20 pmcid pmcid NOUN aji-51 1288 21 : : PUNCT aji-51 1288 22 pmc2914279 pmc2914279 NOUN aji-51 1288 23 . . PUNCT aji-51 1289 1 150 150 NUM aji-51 1289 2 . . PUNCT aji-51 1290 1 tortorella tortorella PROPN aji-51 1290 2 sm sm PROPN aji-51 1290 3 , , PUNCT aji-51 1290 4 royce royce PROPN aji-51 1290 5 sg sg PROPN aji-51 1290 6 , , PUNCT aji-51 1290 7 licciardi licciardi PROPN aji-51 1290 8 pv pv NOUN aji-51 1290 9 , , PUNCT aji-51 1290 10 karagiannis karagiannis PROPN aji-51 1290 11 tc tc X aji-51 1290 12 . . PUNCT aji-51 1291 1 dietary dietary ADJ aji-51 1291 2 sulforaphane sulforaphane NOUN aji-51 1291 3 in in ADP aji-51 1291 4 cancer cancer NOUN aji-51 1291 5 chemoprevention chemoprevention NOUN aji-51 1291 6 : : PUNCT aji-51 1291 7 the the DET aji-51 1291 8 role role NOUN aji-51 1291 9 of of ADP aji-51 1291 10 epigenetic epigenetic ADJ aji-51 1291 11 regulation regulation NOUN aji-51 1291 12 and and CCONJ aji-51 1291 13 hdac hdac NOUN aji-51 1291 14 inhibition inhibition NOUN aji-51 1291 15 . . PUNCT aji-51 1292 1 antioxid antioxid NOUN aji-51 1292 2 redox redox NOUN aji-51 1292 3 signal signal NOUN aji-51 1292 4 . . PUNCT aji-51 1293 1 2015 2015 NUM aji-51 1293 2 jun jun PROPN aji-51 1293 3 1;22(16):1382 1;22(16):1382 NUM aji-51 1293 4 - - SYM aji-51 1293 5 424 424 NUM aji-51 1293 6 . . PUNCT aji-51 1293 7 doi doi NOUN aji-51 1293 8 : : PUNCT aji-51 1293 9 10.1089 10.1089 NUM aji-51 1293 10 / / SYM aji-51 1293 11 ars.2014.6097 ars.2014.6097 PROPN aji-51 1293 12 epub epub NOUN aji-51 1293 13 2014 2014 NUM aji-51 1293 14 dec dec PROPN aji-51 1293 15 19 19 NUM aji-51 1293 16 . . PUNCT aji-51 1293 17 pmid pmid NOUN aji-51 1293 18 : : PUNCT aji-51 1293 19 25364882 25364882 NUM aji-51 1293 20 ; ; PUNCT aji-51 1293 21 pmcid pmcid ADJ aji-51 1293 22 : : PUNCT aji-51 1293 23 pmc4432495 pmc4432495 NOUN aji-51 1293 24 . . PUNCT aji-51 1294 1 151 151 NUM aji-51 1294 2 . . PUNCT aji-51 1295 1 clarke clarke PROPN aji-51 1295 2 jd jd PROPN aji-51 1295 3 , , PUNCT aji-51 1295 4 hsu hsu PROPN aji-51 1295 5 a a PROPN aji-51 1295 6 , , PUNCT aji-51 1295 7 yu yu PROPN aji-51 1295 8 z z PROPN aji-51 1295 9 , , PUNCT aji-51 1295 10 dashwood dashwood PROPN aji-51 1295 11 rh rh PROPN aji-51 1295 12 , , PUNCT aji-51 1295 13 ho ho PROPN aji-51 1295 14 e. e. PROPN aji-51 1295 15 differential differential PROPN aji-51 1295 16 effects effect NOUN aji-51 1295 17 of of ADP aji-51 1295 18 sulforaphane sulforaphane NOUN aji-51 1295 19 on on ADP aji-51 1295 20 histone histone NOUN aji-51 1295 21 deacetylases deacetylase NOUN aji-51 1295 22 , , PUNCT aji-51 1295 23 cell cell NOUN aji-51 1295 24 cycle cycle NOUN aji-51 1295 25 arrest arrest NOUN aji-51 1295 26 and and CCONJ aji-51 1295 27 apoptosis apoptosis NOUN aji-51 1295 28 in in ADP aji-51 1295 29 normal normal ADJ aji-51 1295 30 prostate prostate NOUN aji-51 1295 31 cells cell NOUN aji-51 1295 32 versus versus ADP aji-51 1295 33 hyperplastic hyperplastic ADJ aji-51 1295 34 and and CCONJ aji-51 1295 35 cancerous cancerous ADJ aji-51 1295 36 prostate prostate NOUN aji-51 1295 37 cells cell NOUN aji-51 1295 38 . . PUNCT aji-51 1296 1 mol mol ADP aji-51 1296 2 nutr nutr PROPN aji-51 1296 3 food food NOUN aji-51 1296 4 res re NOUN aji-51 1296 5 . . PUNCT aji-51 1296 6 2011 2011 NUM aji-51 1296 7 jul;55(7):999 jul;55(7):999 PROPN aji-51 1296 8 - - PUNCT aji-51 1296 9 1009 1009 NUM aji-51 1296 10 . . PUNCT aji-51 1297 1 doi doi NOUN aji-51 1297 2 : : PUNCT aji-51 1297 3 10.1002 10.1002 NUM aji-51 1297 4 / / SYM aji-51 1297 5 mnfr.201000547 mnfr.201000547 PROPN aji-51 1297 6 epub epub NOUN aji-51 1297 7 2011 2011 NUM aji-51 1297 8 mar mar PROPN aji-51 1297 9 4 4 NUM aji-51 1297 10 . . PUNCT aji-51 1298 1 pmid pmid NOUN aji-51 1298 2 : : PUNCT aji-51 1298 3 21374800 21374800 NUM aji-51 1298 4 ; ; PUNCT aji-51 1298 5 pmcid pmcid NOUN aji-51 1298 6 : : PUNCT aji-51 1298 7 pmc3129466 pmc3129466 PROPN aji-51 1298 8 . . PUNCT aji-51 1299 1 152 152 NUM aji-51 1299 2 . . PUNCT aji-51 1300 1 clarke clarke PROPN aji-51 1300 2 jd jd PROPN aji-51 1300 3 , , PUNCT aji-51 1300 4 dashwood dashwood PROPN aji-51 1300 5 rh rh PROPN aji-51 1300 6 , , PUNCT aji-51 1300 7 ho ho PROPN aji-51 1300 8 e. e. PROPN aji-51 1300 9 multitargeted multitargete VERB aji-51 1300 10 prevention prevention NOUN aji-51 1300 11 of of ADP aji-51 1300 12 cancer cancer NOUN aji-51 1300 13 by by ADP aji-51 1300 14 sulforaphane sulforaphane NOUN aji-51 1300 15 . . PUNCT aji-51 1301 1 cancer cancer PROPN aji-51 1301 2 lett lett PROPN aji-51 1301 3 . . PROPN aji-51 1302 1 2008 2008 NUM aji-51 1302 2 oct oct PROPN aji-51 1302 3 8;269(2):291 8;269(2):291 PROPN aji-51 1302 4 - - PUNCT aji-51 1302 5 304 304 PROPN aji-51 1302 6 . . PUNCT aji-51 1303 1 doi doi NOUN aji-51 1303 2 : : PUNCT aji-51 1303 3 10.1016 10.1016 NUM aji-51 1303 4 / / SYM aji-51 1303 5 j.canlet.2008.04.018 j.canlet.2008.04.018 PROPN aji-51 1303 6 epub epub VERB aji-51 1303 7 2008 2008 NUM aji-51 1303 8 may may PROPN aji-51 1303 9 27 27 NUM aji-51 1303 10 . . PUNCT aji-51 1304 1 pmid pmid NOUN aji-51 1304 2 : : PUNCT aji-51 1304 3 18504070 18504070 NUM aji-51 1304 4 ; ; PUNCT aji-51 1304 5 pmcid pmcid ADJ aji-51 1304 6 : : PUNCT aji-51 1304 7 pmc2579766 pmc2579766 ADJ aji-51 1304 8 . . PUNCT aji-51 1305 1 153 153 NUM aji-51 1305 2 . . PUNCT aji-51 1306 1 cho cho PROPN aji-51 1306 2 sd sd PROPN aji-51 1306 3 , , PUNCT aji-51 1306 4 li li PROPN aji-51 1306 5 g g PROPN aji-51 1306 6 , , PUNCT aji-51 1306 7 hu hu PROPN aji-51 1306 8 h h PROPN aji-51 1306 9 , , PUNCT aji-51 1306 10 jiang jiang PROPN aji-51 1306 11 c c PROPN aji-51 1306 12 , , PUNCT aji-51 1306 13 kang kang PROPN aji-51 1306 14 ks ks PROPN aji-51 1306 15 , , PUNCT aji-51 1306 16 lee lee PROPN aji-51 1306 17 ys ys PROPN aji-51 1306 18 , , PUNCT aji-51 1306 19 kim kim PROPN aji-51 1306 20 sh sh PROPN aji-51 1306 21 , , PUNCT aji-51 1306 22 lu lu PROPN aji-51 1306 23 j. j. PROPN aji-51 1306 24 involvement involvement PROPN aji-51 1306 25 of of ADP aji-51 1306 26 cjun cjun PROPN aji-51 1306 27 n n CCONJ aji-51 1306 28 - - PUNCT aji-51 1306 29 terminal terminal ADJ aji-51 1306 30 kinase kinase NOUN aji-51 1306 31 in in ADP aji-51 1306 32 g2 g2 PROPN aji-51 1306 33 / / SYM aji-51 1306 34 m m NOUN aji-51 1306 35 arrest arrest NOUN aji-51 1306 36 and and CCONJ aji-51 1306 37 caspase caspase NOUN aji-51 1306 38 - - PUNCT aji-51 1306 39 mediated mediate VERB aji-51 1306 40 apoptosis apoptosis NOUN aji-51 1306 41 induced induce VERB aji-51 1306 42 by by ADP aji-51 1306 43 sulforaphane sulforaphane NOUN aji-51 1306 44 in in ADP aji-51 1306 45 du145 du145 PROPN aji-51 1306 46 prostate prostate NOUN aji-51 1306 47 cancer cancer NOUN aji-51 1306 48 cells cell NOUN aji-51 1306 49 . . PUNCT aji-51 1307 1 nutr nutr NOUN aji-51 1307 2 cancer cancer NOUN aji-51 1307 3 . . PUNCT aji-51 1308 1 2005;52(2):213 2005;52(2):213 NUM aji-51 1308 2 - - SYM aji-51 1308 3 24 24 NUM aji-51 1308 4 . . PUNCT aji-51 1308 5 doi doi NOUN aji-51 1308 6 : : PUNCT aji-51 1308 7 10.1207 10.1207 NUM aji-51 1308 8 / / SYM aji-51 1308 9 s15327914nc5202_11 s15327914nc5202_11 NUM aji-51 1308 10 pmid pmid NOUN aji-51 1308 11 : : PUNCT aji-51 1308 12 16201852 16201852 NUM aji-51 1308 13 . . PUNCT aji-51 1309 1 154 154 NUM aji-51 1309 2 . . PUNCT aji-51 1309 3 berquin berquin PROPN aji-51 1310 1 i i PRON aji-51 1310 2 m m PROPN aji-51 1310 3 , , PUNCT aji-51 1310 4 edwards edwards PROPN aji-51 1310 5 ij ij PROPN aji-51 1310 6 , , PUNCT aji-51 1310 7 chen chen PROPN aji-51 1310 8 yq yq PROPN aji-51 1310 9 . . PROPN aji-51 1310 10 multitargeted multitargete VERB aji-51 1310 11 therapy therapy NOUN aji-51 1310 12 of of ADP aji-51 1310 13 cancer cancer NOUN aji-51 1310 14 by by ADP aji-51 1310 15 omega-3 omega-3 NUM aji-51 1310 16 fatty fatty NOUN aji-51 1310 17 acids acid NOUN aji-51 1310 18 . . PUNCT aji-51 1311 1 cancer cancer NOUN aji-51 1311 2 lett lett PROPN aji-51 1311 3 . . PROPN aji-51 1312 1 2008 2008 NUM aji-51 1312 2 oct oct PROPN aji-51 1312 3 8;269(2):363 8;269(2):363 NUM aji-51 1312 4 - - SYM aji-51 1312 5 77 77 NUM aji-51 1312 6 . . PUNCT aji-51 1313 1 doi doi NOUN aji-51 1313 2 : : PUNCT aji-51 1313 3 10.1016 10.1016 NUM aji-51 1313 4 / / SYM aji-51 1313 5 j.canlet.2008.03.044 j.canlet.2008.03.044 PROPN aji-51 1313 6 epub epub NOUN aji-51 1313 7 2008 2008 NUM aji-51 1313 8 may may PROPN aji-51 1313 9 13 13 NUM aji-51 1313 10 . . PUNCT aji-51 1314 1 pmid pmid NOUN aji-51 1314 2 : : PUNCT aji-51 1314 3 18479809 18479809 NUM aji-51 1314 4 ; ; PUNCT aji-51 1314 5 pmcid pmcid ADJ aji-51 1314 6 : : PUNCT aji-51 1314 7 pmc2572135 pmc2572135 NOUN aji-51 1314 8 . . PUNCT aji-51 1315 1 155 155 NUM aji-51 1315 2 . . PUNCT aji-51 1316 1 jiang jiang PROPN aji-51 1316 2 y y PROPN aji-51 1316 3 , , PUNCT aji-51 1316 4 djuric djuric PROPN aji-51 1316 5 z z PROPN aji-51 1316 6 , , PUNCT aji-51 1316 7 sen sen PROPN aji-51 1316 8 a a PROPN aji-51 1316 9 , , PUNCT aji-51 1316 10 ren ren PROPN aji-51 1316 11 j j PROPN aji-51 1316 12 , , PUNCT aji-51 1316 13 kuklev kuklev NOUN aji-51 1316 14 d d PROPN aji-51 1316 15 , , PUNCT aji-51 1316 16 waters water VERB aji-51 1316 17 i i PRON aji-51 1316 18 , , PUNCT aji-51 1316 19 zhao zhao PROPN aji-51 1316 20 l l PROPN aji-51 1316 21 , , PUNCT aji-51 1316 22 uhlson uhlson NOUN aji-51 1316 23 cl cl NOUN aji-51 1316 24 , , PUNCT aji-51 1316 25 hong hong PROPN aji-51 1316 26 yh yh PROPN aji-51 1316 27 , , PUNCT aji-51 1316 28 murphy murphy PROPN aji-51 1316 29 rc rc PROPN aji-51 1316 30 , , PUNCT aji-51 1316 31 normolle normolle PROPN aji-51 1316 32 dp dp PROPN aji-51 1316 33 , , PUNCT aji-51 1316 34 smith smith PROPN aji-51 1316 35 wl wl PROPN aji-51 1316 36 , , PUNCT aji-51 1316 37 brenner brenner PROPN aji-51 1316 38 de de PROPN aji-51 1316 39 . . PROPN aji-51 1316 40 biomarkers biomarker NOUN aji-51 1316 41 for for ADP aji-51 1316 42 personalizing personalize VERB aji-51 1316 43 omega-3 omega-3 NUM aji-51 1316 44 fatty fatty NOUN aji-51 1316 45 acid acid NOUN aji-51 1316 46 dosing dosing NOUN aji-51 1316 47 . . PUNCT aji-51 1317 1 cancer cancer NOUN aji-51 1317 2 prev prev PROPN aji-51 1317 3 res res PROPN aji-51 1317 4 ( ( PUNCT aji-51 1317 5 phila phila PROPN aji-51 1317 6 ) ) PUNCT aji-51 1317 7 . . PUNCT aji-51 1318 1 2014 2014 NUM aji-51 1319 1 oct;7(10):1011 oct;7(10):1011 NUM aji-51 1319 2 - - SYM aji-51 1319 3 22 22 NUM aji-51 1319 4 . . PUNCT aji-51 1320 1 doi doi NOUN aji-51 1320 2 : : PUNCT aji-51 1320 3 10.1158/1940 10.1158/1940 NUM aji-51 1320 4 - - PUNCT aji-51 1320 5 6207.capr-14 6207.capr-14 NUM aji-51 1320 6 - - PUNCT aji-51 1320 7 0134 0134 NUM aji-51 1320 8 epub epub NOUN aji-51 1320 9 2014 2014 NUM aji-51 1320 10 aug aug PROPN aji-51 1320 11 19 19 NUM aji-51 1320 12 . . PUNCT aji-51 1321 1 pmid pmid NOUN aji-51 1321 2 : : PUNCT aji-51 1321 3 25139294 25139294 NUM aji-51 1321 4 ; ; PUNCT aji-51 1321 5 pmcid pmcid NOUN aji-51 1321 6 : : PUNCT aji-51 1321 7 pmc4185239 pmc4185239 NOUN aji-51 1321 8 . . PUNCT aji-51 1322 1 156 156 NUM aji-51 1322 2 . . PUNCT aji-51 1323 1 fabian fabian PROPN aji-51 1323 2 cj cj PROPN aji-51 1323 3 , , PUNCT aji-51 1323 4 kimler kimler PROPN aji-51 1323 5 bf bf PROPN aji-51 1323 6 , , PUNCT aji-51 1323 7 phillips phillips PROPN aji-51 1323 8 ta ta PROPN aji-51 1323 9 , , PUNCT aji-51 1323 10 nydegger nydegger NOUN aji-51 1323 11 jl jl PROPN aji-51 1323 12 , , PUNCT aji-51 1323 13 kreutzjans kreutzjans PROPN aji-51 1323 14 al al PROPN aji-51 1323 15 , , PUNCT aji-51 1323 16 carlson carlson PROPN aji-51 1323 17 se se PROPN aji-51 1323 18 , , PUNCT aji-51 1323 19 hidaka hidaka ADJ aji-51 1323 20 bh bh PROPN aji-51 1323 21 , , PUNCT aji-51 1323 22 metheny metheny PROPN aji-51 1323 23 t t PROPN aji-51 1323 24 , , PUNCT aji-51 1323 25 zalles zalle NOUN aji-51 1323 26 cm cm PROPN aji-51 1323 27 , , PUNCT aji-51 1323 28 mills mill NOUN aji-51 1323 29 gb gb ADP aji-51 1323 30 , , PUNCT aji-51 1323 31 powers power NOUN aji-51 1323 32 kr kr PROPN aji-51 1323 33 , , PUNCT aji-51 1323 34 sullivan sullivan PROPN aji-51 1323 35 dk dk PROPN aji-51 1323 36 , , PUNCT aji-51 1323 37 petroff petroff NOUN aji-51 1323 38 bk bk ADP aji-51 1323 39 , , PUNCT aji-51 1323 40 hensing hense VERB aji-51 1323 41 wl wl PROPN aji-51 1323 42 , , PUNCT aji-51 1323 43 fridley fridley PROPN aji-51 1323 44 bl bl PROPN aji-51 1323 45 , , PUNCT aji-51 1323 46 hursting hurste VERB aji-51 1323 47 sd sd NOUN aji-51 1323 48 . . PUNCT aji-51 1324 1 modulation modulation NOUN aji-51 1324 2 of of ADP aji-51 1324 3 breast breast NOUN aji-51 1324 4 cancer cancer NOUN aji-51 1324 5 risk risk NOUN aji-51 1324 6 biomarkers biomarker NOUN aji-51 1324 7 by by ADP aji-51 1324 8 high high ADJ aji-51 1324 9 - - PUNCT aji-51 1324 10 dose dose VERB aji-51 1324 11 omega-3 omega-3 NUM aji-51 1324 12 fatty fatty NOUN aji-51 1324 13 acids acid NOUN aji-51 1324 14 : : PUNCT aji-51 1324 15 phase phase NOUN aji-51 1324 16 ii ii PROPN aji-51 1324 17 pilot pilot NOUN aji-51 1324 18 study study NOUN aji-51 1324 19 in in ADP aji-51 1324 20 postmenopausal postmenopausal ADJ aji-51 1324 21 women woman NOUN aji-51 1324 22 . . PUNCT aji-51 1325 1 cancer cancer NOUN aji-51 1325 2 prev prev PROPN aji-51 1325 3 res res PROPN aji-51 1325 4 ( ( PUNCT aji-51 1325 5 phila phila PROPN aji-51 1325 6 ) ) PUNCT aji-51 1325 7 . . PUNCT aji-51 1326 1 2015 2015 NUM aji-51 1326 2 oct;8(10):922 oct;8(10):922 PROPN aji-51 1326 3 - - SYM aji-51 1326 4 31 31 NUM aji-51 1326 5 . . PUNCT aji-51 1327 1 doi doi NOUN aji-51 1327 2 : : PUNCT aji-51 1327 3 10.1158/1940 10.1158/1940 NUM aji-51 1327 4 - - PUNCT aji-51 1327 5 6207.capr-14 6207.capr-14 NUM aji-51 1327 6 - - PUNCT aji-51 1327 7 0336 0336 NUM aji-51 1327 8 epub epub NOUN aji-51 1327 9 2015 2015 NUM aji-51 1327 10 aug aug PROPN aji-51 1327 11 14 14 NUM aji-51 1327 12 . . PUNCT aji-51 1328 1 pmid pmid NOUN aji-51 1328 2 : : PUNCT aji-51 1328 3 26276744 26276744 NUM aji-51 1328 4 ; ; PUNCT aji-51 1328 5 pmcid pmcid ADJ aji-51 1328 6 : : PUNCT aji-51 1328 7 pmc4596784 pmc4596784 NOUN aji-51 1328 8 . . PUNCT aji-51 1329 1 157 157 NUM aji-51 1329 2 . . PUNCT aji-51 1330 1 khadge khadge PROPN aji-51 1330 2 s s PROPN aji-51 1330 3 , , PUNCT aji-51 1330 4 thiele thiele PROPN aji-51 1330 5 gm gm PROPN aji-51 1330 6 , , PUNCT aji-51 1330 7 sharp sharp PROPN aji-51 1330 8 jg jg PROPN aji-51 1330 9 , , PUNCT aji-51 1330 10 mcguire mcguire PROPN aji-51 1330 11 tr tr VERB aji-51 1330 12 , , PUNCT aji-51 1330 13 klassen klassen PROPN aji-51 1330 14 lw lw PROPN aji-51 1330 15 , , PUNCT aji-51 1330 16 black black ADJ aji-51 1330 17 pn pn PROPN aji-51 1330 18 , , PUNCT aji-51 1330 19 dirusso dirusso PROPN aji-51 1330 20 cc cc PROPN aji-51 1330 21 , , PUNCT aji-51 1330 22 talmadge talmadge PROPN aji-51 1330 23 je je PROPN aji-51 1330 24 . . PUNCT aji-51 1331 1 long long ADJ aji-51 1331 2 - - PUNCT aji-51 1331 3 chain chain NOUN aji-51 1331 4 omega-3 omega-3 NUM aji-51 1331 5 polyunsaturated polyunsaturated ADJ aji-51 1331 6 fatty fatty NOUN aji-51 1331 7 acids acid NOUN aji-51 1331 8 modulate modulate VERB aji-51 1331 9 mammary mammary ADJ aji-51 1331 10 gland gland NOUN aji-51 1331 11 composition composition NOUN aji-51 1331 12 and and CCONJ aji-51 1331 13 inflammation inflammation NOUN aji-51 1331 14 . . PUNCT aji-51 1332 1 j j PROPN aji-51 1332 2 mammary mammary ADJ aji-51 1332 3 gland gland NOUN aji-51 1332 4 biol biol PROPN aji-51 1332 5 neoplasia neoplasia NOUN aji-51 1332 6 . . PUNCT aji-51 1333 1 2018 2018 NUM aji-51 1333 2 jun;23(1 jun;23(1 PROPN aji-51 1333 3 - - PUNCT aji-51 1333 4 2):43 2):43 NUM aji-51 1333 5 58 58 NUM aji-51 1333 6 . . PUNCT aji-51 1334 1 doi doi NOUN aji-51 1334 2 : : PUNCT aji-51 1334 3 10.1007 10.1007 NUM aji-51 1334 4 / / SYM aji-51 1334 5 s10911 s10911 NOUN aji-51 1334 6 - - PUNCT aji-51 1334 7 018 018 NUM aji-51 1334 8 - - PUNCT aji-51 1334 9 9391 9391 NUM aji-51 1334 10 - - SYM aji-51 1334 11 5 5 NUM aji-51 1334 12 epub epub NOUN aji-51 1334 13 2018 2018 NUM aji-51 1334 14 mar mar PROPN aji-51 1334 15 25 25 NUM aji-51 1334 16 . . PUNCT aji-51 1335 1 pmid pmid NOUN aji-51 1335 2 : : PUNCT aji-51 1335 3 29574638 29574638 NUM aji-51 1335 4 . . PUNCT aji-51 1336 1 158 158 NUM aji-51 1336 2 . . PUNCT aji-51 1337 1 mcguire mcguire PROPN aji-51 1337 2 a a PRON aji-51 1337 3 , , PUNCT aji-51 1337 4 brown brown PROPN aji-51 1337 5 ja ja PROPN aji-51 1337 6 , , PUNCT aji-51 1337 7 kerin kerin PROPN aji-51 1337 8 mj mj PROPN aji-51 1337 9 . . PUNCT aji-51 1338 1 metastatic metastatic ADJ aji-51 1338 2 breast breast NOUN aji-51 1338 3 cancer cancer NOUN aji-51 1338 4 : : PUNCT aji-51 1338 5 the the DET aji-51 1338 6 potential potential NOUN aji-51 1338 7 of of ADP aji-51 1338 8 mirna mirna NOUN aji-51 1338 9 for for ADP aji-51 1338 10 diagnosis diagnosis NOUN aji-51 1338 11 and and CCONJ aji-51 1338 12 treatment treatment NOUN aji-51 1338 13 monitoring monitoring NOUN aji-51 1338 14 . . PUNCT aji-51 1339 1 cancer cancer NOUN aji-51 1339 2 metastasis metastasis NOUN aji-51 1339 3 rev rev VERB aji-51 1339 4 . . PROPN aji-51 1339 5 2015 2015 NUM aji-51 1339 6 mar;34(1):145 mar;34(1):145 NOUN aji-51 1339 7 - - SYM aji-51 1339 8 55 55 NUM aji-51 1339 9 . . PUNCT aji-51 1340 1 doi doi NOUN aji-51 1340 2 : : PUNCT aji-51 1340 3 10.1007 10.1007 NUM aji-51 1340 4 / / SYM aji-51 1340 5 s10555 s10555 NOUN aji-51 1340 6 - - PUNCT aji-51 1340 7 015 015 NUM aji-51 1340 8 - - PUNCT aji-51 1340 9 9551 9551 NUM aji-51 1340 10 - - SYM aji-51 1340 11 7 7 NUM aji-51 1340 12 pmid pmid NOUN aji-51 1340 13 : : PUNCT aji-51 1340 14 25721950 25721950 NUM aji-51 1340 15 ; ; PUNCT aji-51 1340 16 pmcid pmcid ADJ aji-51 1340 17 : : PUNCT aji-51 1340 18 pmc4368851 pmc4368851 NOUN aji-51 1340 19 . . PUNCT aji-51 1341 1 159 159 NUM aji-51 1341 2 . . PUNCT aji-51 1341 3 hardman hardman NOUN aji-51 1341 4 we we PRON aji-51 1341 5 . . PUNCT aji-51 1342 1 omega-3 omega-3 NUM aji-51 1342 2 fatty fatty NOUN aji-51 1342 3 acids acid NOUN aji-51 1342 4 to to PART aji-51 1342 5 augment augment VERB aji-51 1342 6 cancer cancer NOUN aji-51 1342 7 therapy therapy NOUN aji-51 1342 8 . . PUNCT aji-51 1343 1 j j PROPN aji-51 1343 2 nutr nutr PROPN aji-51 1343 3 . . PROPN aji-51 1343 4 2002 2002 NUM aji-51 1343 5 nov;132(11 nov;132(11 PROPN aji-51 1343 6 suppl):3508s-3512s suppl):3508s-3512s PROPN aji-51 1343 7 . . PROPN aji-51 1343 8 doi doi PROPN aji-51 1343 9 : : PUNCT aji-51 1343 10 10.1093 10.1093 NUM aji-51 1343 11 / / SYM aji-51 1343 12 jn/132.11.3508s jn/132.11.3508s PROPN aji-51 1343 13 . . PUNCT aji-51 1344 1 pmid pmid NOUN aji-51 1344 2 : : PUNCT aji-51 1344 3 12421878 12421878 NUM aji-51 1344 4 . . PUNCT aji-51 1345 1 160 160 NUM aji-51 1345 2 . . PUNCT aji-51 1345 3 available available ADJ aji-51 1345 4 : : PUNCT aji-51 1345 5 https://medlineplus.gov https://medlineplus.gov PROPN aji-51 1345 6 / / SYM aji-51 1345 7 genetics/ genetics/ PROPN aji-51 1345 8 understanding understanding NOUN aji-51 1345 9 / / SYM aji-51 1345 10 precisionmedicine precisionmedicine NOUN aji-51 1345 11 / / SYM aji-51 1345 12 definition definition NOUN aji-51 1345 13 / / SYM aji-51 1345 14 161 161 NUM aji-51 1345 15 . . PUNCT aji-51 1346 1 willis willis PROPN aji-51 1346 2 re re PROPN aji-51 1346 3 . . PROPN aji-51 1346 4 targeted target VERB aji-51 1346 5 cancer cancer NOUN aji-51 1346 6 therapy therapy NOUN aji-51 1346 7 : : PUNCT aji-51 1346 8 vital vital ADJ aji-51 1346 9 oncogenes oncogene NOUN aji-51 1346 10 and and CCONJ aji-51 1346 11 a a DET aji-51 1346 12 new new ADJ aji-51 1346 13 molecular molecular ADJ aji-51 1346 14 genetic genetic ADJ aji-51 1346 15 paradigm paradigm NOUN aji-51 1346 16 for for ADP aji-51 1346 17 cancer cancer NOUN aji-51 1346 18 initiation initiation NOUN aji-51 1346 19 progression progression NOUN aji-51 1346 20 and and CCONJ aji-51 1346 21 treatment treatment NOUN aji-51 1346 22 . . PUNCT aji-51 1347 1 int int PROPN aji-51 1347 2 j j PROPN aji-51 1347 3 mol mol ADP aji-51 1347 4 sci sci PROPN aji-51 1347 5 . . PROPN aji-51 1348 1 2016 2016 NUM aji-51 1348 2 sep sep PROPN aji-51 1348 3 14;17(9):1552 14;17(9):1552 NUM aji-51 1348 4 . . PUNCT aji-51 1349 1 doi doi NOUN aji-51 1349 2 : : PUNCT aji-51 1349 3 10.3390 10.3390 NUM aji-51 1349 4 / / SYM aji-51 1349 5 ijms17091552 ijms17091552 PROPN aji-51 1349 6 pmid pmid PROPN aji-51 1349 7 : : PUNCT aji-51 1349 8 27649156 27649156 NUM aji-51 1349 9 ; ; PUNCT aji-51 1349 10 pmcid pmcid ADJ aji-51 1349 11 : : PUNCT aji-51 1349 12 pmc5037825 pmc5037825 NOUN aji-51 1349 13 . . PUNCT aji-51 1350 1 162 162 NUM aji-51 1350 2 . . PUNCT aji-51 1351 1 bielski bielski PROPN aji-51 1351 2 cm cm PROPN aji-51 1351 3 , , PUNCT aji-51 1351 4 taylor taylor PROPN aji-51 1351 5 bs bs PROPN aji-51 1351 6 . . PUNCT aji-51 1352 1 homing home VERB aji-51 1352 2 in in ADP aji-51 1352 3 on on ADP aji-51 1352 4 genomic genomic ADJ aji-51 1352 5 instability instability NOUN aji-51 1352 6 as as ADP aji-51 1352 7 a a DET aji-51 1352 8 therapeutic therapeutic ADJ aji-51 1352 9 target target NOUN aji-51 1352 10 in in ADP aji-51 1352 11 cancer cancer NOUN aji-51 1352 12 . . PUNCT aji-51 1353 1 nat nat PROPN aji-51 1353 2 commun commun PROPN aji-51 1353 3 . . PUNCT aji-51 1354 1 2021 2021 NUM aji-51 1354 2 jun jun PROPN aji-51 1354 3 16;12(1):3663 16;12(1):3663 NUM aji-51 1354 4 . . PUNCT aji-51 1355 1 doi doi NOUN aji-51 1355 2 : : PUNCT aji-51 1355 3 10.1038 10.1038 NUM aji-51 1355 4 / / SYM aji-51 1355 5 s41467 s41467 NOUN aji-51 1355 6 - - PUNCT aji-51 1355 7 021 021 NUM aji-51 1355 8 - - PUNCT aji-51 1355 9 23965 23965 NUM aji-51 1355 10 - - SYM aji-51 1355 11 5 5 NUM aji-51 1355 12 pmid pmid NOUN aji-51 1355 13 : : PUNCT aji-51 1355 14 34135330 34135330 NUM aji-51 1355 15 ; ; PUNCT aji-51 1355 16 pmcid pmcid NOUN aji-51 1355 17 : : PUNCT aji-51 1355 18 pmc8209011 pmc8209011 PROPN aji-51 1355 19 . . PUNCT aji-51 1356 1 stoff stoff PROPN aji-51 1356 2 ; ; PUNCT aji-51 1356 3 aji aji PROPN aji-51 1356 4 , , PUNCT aji-51 1356 5 5(1 5(1 NUM aji-51 1356 6 ): ): PUNCT aji-51 1356 7 1 1 NUM aji-51 1356 8 - - SYM aji-51 1356 9 39 39 NUM aji-51 1356 10 , , PUNCT aji-51 1356 11 2022 2022 NUM aji-51 1356 12 ; ; PUNCT aji-51 1356 13 article article NOUN aji-51 1356 14 no.aji.77967 no.aji.77967 PROPN aji-51 1356 15 28 28 NUM aji-51 1356 16 163 163 NUM aji-51 1356 17 . . PUNCT aji-51 1357 1 available available ADJ aji-51 1357 2 : : PUNCT aji-51 1357 3 https://www.carislifesciences.co https://www.carislifesciences.co PROPN aji-51 1357 4 m m PROPN aji-51 1357 5 / / SYM aji-51 1357 6 our our PRON aji-51 1357 7 - - PUNCT aji-51 1357 8 technology/ technology/ NUM aji-51 1357 9 164 164 NUM aji-51 1357 10 . . PUNCT aji-51 1358 1 available available ADJ aji-51 1358 2 : : PUNCT aji-51 1358 3 https://www.foundationmedicine https://www.foundationmedicine PROPN aji-51 1358 4 . . PUNCT aji-51 1358 5 com com NOUN aji-51 1358 6 / / SYM aji-51 1358 7 test test NOUN aji-51 1358 8 / / SYM aji-51 1358 9 foundationone foundationone ADJ aji-51 1358 10 - - PUNCT aji-51 1358 11 liquid liquid ADJ aji-51 1358 12 - - PUNCT aji-51 1358 13 cdx cdx NOUN aji-51 1358 14 165 165 NUM aji-51 1358 15 . . PUNCT aji-51 1359 1 huang huang PROPN aji-51 1359 2 c c PROPN aji-51 1359 3 , , PUNCT aji-51 1359 4 chen chen PROPN aji-51 1359 5 l l PROPN aji-51 1359 6 , , PUNCT aji-51 1359 7 savage savage PROPN aji-51 1359 8 sr sr PROPN aji-51 1359 9 , , PUNCT aji-51 1359 10 eguez eguez VERB aji-51 1359 11 rv rv PROPN aji-51 1359 12 , , PUNCT aji-51 1359 13 dou dou PROPN aji-51 1359 14 y y PROPN aji-51 1359 15 , , PUNCT aji-51 1359 16 li li PROPN aji-51 1359 17 y y PROPN aji-51 1359 18 , , PUNCT aji-51 1359 19 da da PROPN aji-51 1359 20 veiga veiga PROPN aji-51 1359 21 leprevost leprevost ADV aji-51 1359 22 f f NOUN aji-51 1359 23 , , PUNCT aji-51 1359 24 jaehnig jaehnig PROPN aji-51 1359 25 ej ej PROPN aji-51 1359 26 , , PUNCT aji-51 1359 27 lei lei PROPN aji-51 1359 28 jt jt PROPN aji-51 1359 29 , , PUNCT aji-51 1359 30 wen wen PROPN aji-51 1359 31 b b PROPN aji-51 1359 32 , , PUNCT aji-51 1359 33 schnaubelt schnaubelt VERB aji-51 1359 34 m. m. NOUN aji-51 1359 35 proteogenomic proteogenomic ADJ aji-51 1359 36 insights insight NOUN aji-51 1359 37 into into ADP aji-51 1359 38 the the DET aji-51 1359 39 biology biology NOUN aji-51 1359 40 and and CCONJ aji-51 1359 41 treatment treatment NOUN aji-51 1359 42 of of ADP aji-51 1359 43 hpv hpv NOUN aji-51 1359 44 - - PUNCT aji-51 1359 45 negative negative ADJ aji-51 1359 46 head head NOUN aji-51 1359 47 and and CCONJ aji-51 1359 48 neck neck VERB aji-51 1359 49 squamous squamous ADJ aji-51 1359 50 cell cell NOUN aji-51 1359 51 carcinoma carcinoma NOUN aji-51 1359 52 . . PUNCT aji-51 1360 1 cancer cancer NOUN aji-51 1360 2 cell cell NOUN aji-51 1360 3 . . PUNCT aji-51 1361 1 2021 2021 NUM aji-51 1361 2 mar mar PROPN aji-51 1361 3 8;39(3):361 8;39(3):361 PROPN aji-51 1361 4 - - SYM aji-51 1361 5 79 79 NUM aji-51 1361 6 . . PUNCT aji-51 1362 1 166 166 NUM aji-51 1362 2 . . PUNCT aji-51 1363 1 available available ADJ aji-51 1363 2 : : PUNCT aji-51 1363 3 https://www.cancer.gov https://www.cancer.gov ADJ aji-51 1363 4 / / SYM aji-51 1363 5 aboutcancer aboutcancer ADJ aji-51 1363 6 / / SYM aji-51 1363 7 treatment treatment NOUN aji-51 1363 8 / / SYM aji-51 1363 9 types type NOUN aji-51 1363 10 / / SYM aji-51 1363 11 targetedtherapies targetedtherapie NOUN aji-51 1363 12 / / SYM aji-51 1363 13 targeted target VERB aji-51 1363 14 - - PUNCT aji-51 1363 15 therapies therapy NOUN aji-51 1363 16 - - PUNCT aji-51 1363 17 fact fact NOUN aji-51 1363 18 - - PUNCT aji-51 1363 19 sheet sheet NOUN aji-51 1363 20 167 167 NUM aji-51 1363 21 . . PUNCT aji-51 1364 1 guide guide VERB aji-51 1364 2 treatment treatment NOUN aji-51 1364 3 decisions decision NOUN aji-51 1364 4 in in ADP aji-51 1364 5 the the DET aji-51 1364 6 first first ADJ aji-51 1364 7 - - PUNCT aji-51 1364 8 line line NOUN aji-51 1364 9 with with ADP aji-51 1364 10 guardant360 guardant360 PROPN aji-51 1364 11 , , PUNCT aji-51 1364 12 rec rec NOUN aji-51 1364 13 - - PUNCT aji-51 1364 14 mkt-000039 mkt-000039 NOUN aji-51 1364 15 r7 r7 NOUN aji-51 1364 16 . . PUNCT aji-51 1365 1 168 168 NUM aji-51 1365 2 . . PUNCT aji-51 1366 1 advani advani PROPN aji-51 1366 2 d d PROPN aji-51 1366 3 , , PUNCT aji-51 1366 4 sharma sharma PROPN aji-51 1366 5 s s PROPN aji-51 1366 6 , , PUNCT aji-51 1366 7 kumari kumari PROPN aji-51 1366 8 s s PROPN aji-51 1366 9 , , PUNCT aji-51 1366 10 ambasta ambasta ADJ aji-51 1366 11 rk rk NOUN aji-51 1366 12 , , PUNCT aji-51 1366 13 kumar kumar PROPN aji-51 1366 14 p. p. PROPN aji-51 1366 15 precision precision PROPN aji-51 1366 16 oncology oncology NOUN aji-51 1366 17 , , PUNCT aji-51 1366 18 signaling signal VERB aji-51 1366 19 and and CCONJ aji-51 1366 20 anticancer anticancer NOUN aji-51 1366 21 agents agent NOUN aji-51 1366 22 in in ADP aji-51 1366 23 cancer cancer NOUN aji-51 1366 24 therapeutics therapeutic NOUN aji-51 1366 25 . . PUNCT aji-51 1367 1 anticancer anticancer NOUN aji-51 1367 2 gents gent NOUN aji-51 1367 3 med med PROPN aji-51 1367 4 chem chem NOUN aji-51 1367 5 . . PUNCT aji-51 1368 1 2021 2021 NUM aji-51 1368 2 mar mar PROPN aji-51 1368 3 7 7 NUM aji-51 1368 4 . . PUNCT aji-51 1368 5 doi doi PROPN aji-51 1368 6 : : PUNCT aji-51 1368 7 10.2174/1871520621666210308101029 10.2174/1871520621666210308101029 NUM aji-51 1368 8 epub epub NOUN aji-51 1368 9 ahead ahead ADV aji-51 1368 10 of of ADP aji-51 1368 11 print print NOUN aji-51 1368 12 . . PUNCT aji-51 1369 1 pmid pmid NOUN aji-51 1369 2 : : PUNCT aji-51 1369 3 33687887 33687887 NUM aji-51 1369 4 . . PUNCT aji-51 1370 1 169 169 NUM aji-51 1370 2 . . PUNCT aji-51 1371 1 ho ho PROPN aji-51 1371 2 w. w. PROPN aji-51 1371 3 naturally naturally ADV aji-51 1371 4 occurring occur VERB aji-51 1371 5 small small ADJ aji-51 1371 6 molecules molecule NOUN aji-51 1371 7 for for ADP aji-51 1371 8 disease disease NOUN aji-51 1371 9 and and CCONJ aji-51 1371 10 cancer cancer NOUN aji-51 1371 11 treatment treatment NOUN aji-51 1371 12 . . PUNCT aji-51 1372 1 world world PROPN aji-51 1372 2 scientific scientific PROPN aji-51 1372 3 , , PUNCT aji-51 1372 4 hackensack hackensack PROPN aji-51 1372 5 , , PUNCT aji-51 1372 6 n.j n.j PROPN aji-51 1372 7 . . PROPN aji-51 1372 8 , , PUNCT aji-51 1372 9 u.s.a u.s.a PROPN aji-51 1372 10 . . PUNCT aji-51 1372 11 ; ; PUNCT aji-51 1372 12 2019 2019 NUM aji-51 1372 13 . . PUNCT aji-51 1373 1 isbn isbn ADJ aji-51 1373 2 : : PUNCT aji-51 1373 3 9789814525626 9789814525626 NUM aji-51 1373 4 170 170 NUM aji-51 1373 5 . . PUNCT aji-51 1374 1 somasundaram somasundaram PROPN aji-51 1374 2 s. s. PROPN aji-51 1374 3 natural natural ADJ aji-51 1374 4 products product NOUN aji-51 1374 5 interactions interaction NOUN aji-51 1374 6 on on ADP aji-51 1374 7 genomes genome NOUN aji-51 1374 8 . . PUNCT aji-51 1375 1 crc crc PROPN aji-51 1375 2 press press PROPN aji-51 1375 3 , , PUNCT aji-51 1375 4 boca boca PROPN aji-51 1375 5 raton raton PROPN aji-51 1375 6 , , PUNCT aji-51 1375 7 fl fl PROPN aji-51 1375 8 , , PUNCT aji-51 1375 9 u.s.a u.s.a PROPN aji-51 1375 10 . . PUNCT aji-51 1375 11 ; ; PUNCT aji-51 1375 12 2016 2016 NUM aji-51 1375 13 . . PUNCT aji-51 1376 1 isbn-13 isbn-13 PROPN aji-51 1376 2 978 978 NUM aji-51 1376 3 - - PUNCT aji-51 1376 4 1 1 NUM aji-51 1376 5 - - PUNCT aji-51 1376 6 4398 4398 NUM aji-51 1376 7 - - PUNCT aji-51 1376 8 7231 7231 NUM aji-51 1376 9 - - SYM aji-51 1376 10 4 4 NUM aji-51 1376 11 171 171 NUM aji-51 1376 12 . . PUNCT aji-51 1377 1 sharif sharif PROPN aji-51 1377 2 t t PROPN aji-51 1377 3 , , PUNCT aji-51 1377 4 alhosin alhosin PROPN aji-51 1377 5 m m PROPN aji-51 1377 6 , , PUNCT aji-51 1377 7 auger auger NOUN aji-51 1377 8 c c PROPN aji-51 1377 9 , , PUNCT aji-51 1377 10 minker minker NOUN aji-51 1377 11 c c NOUN aji-51 1377 12 , , PUNCT aji-51 1377 13 kim kim PROPN aji-51 1377 14 jh jh PROPN aji-51 1377 15 , , PUNCT aji-51 1377 16 etienne etienne PROPN aji-51 1377 17 - - PUNCT aji-51 1377 18 selloum selloum PROPN aji-51 1377 19 n n CCONJ aji-51 1377 20 , , PUNCT aji-51 1377 21 bories borie NOUN aji-51 1377 22 p p PROPN aji-51 1377 23 , , PUNCT aji-51 1377 24 gronemeyer gronemeyer PROPN aji-51 1377 25 h h PROPN aji-51 1377 26 , , PUNCT aji-51 1377 27 lobstein lobstein PROPN aji-51 1377 28 a a PRON aji-51 1377 29 , , PUNCT aji-51 1377 30 bronner bronner NOUN aji-51 1377 31 c c NOUN aji-51 1377 32 , , PUNCT aji-51 1377 33 fuhrmann fuhrmann NOUN aji-51 1377 34 g g PROPN aji-51 1377 35 , , PUNCT aji-51 1377 36 schini schini ADJ aji-51 1377 37 - - ADJ aji-51 1377 38 kerth kerth ADJ aji-51 1377 39 vb vb PROPN aji-51 1377 40 . . PUNCT aji-51 1378 1 aronia aronia PROPN aji-51 1378 2 melanocarpa melanocarpa PROPN aji-51 1378 3 juice juice PROPN aji-51 1378 4 induces induce VERB aji-51 1378 5 a a DET aji-51 1378 6 redoxsensitive redoxsensitive ADJ aji-51 1378 7 p73 p73 NOUN aji-51 1378 8 - - PUNCT aji-51 1378 9 related relate VERB aji-51 1378 10 caspase caspase NOUN aji-51 1378 11 3 3 NUM aji-51 1378 12 - - PUNCT aji-51 1378 13 dependent dependent ADJ aji-51 1378 14 apoptosis apoptosis NOUN aji-51 1378 15 in in ADP aji-51 1378 16 human human ADJ aji-51 1378 17 leukemia leukemia NOUN aji-51 1378 18 cells cell NOUN aji-51 1378 19 . . PUNCT aji-51 1379 1 plos plos PROPN aji-51 1379 2 one one NUM aji-51 1379 3 . . PUNCT aji-51 1380 1 2012;7(3):e32526 2012;7(3):e32526 NUM aji-51 1380 2 . . PUNCT aji-51 1381 1 doi doi NOUN aji-51 1381 2 : : PUNCT aji-51 1381 3 10.1371 10.1371 NUM aji-51 1381 4 / / SYM aji-51 1381 5 journal.pone.0032526 journal.pone.0032526 PROPN aji-51 1381 6 epub epub PROPN aji-51 1381 7 2012 2012 NUM aji-51 1381 8 mar mar PROPN aji-51 1381 9 8 8 NUM aji-51 1381 10 . . PUNCT aji-51 1382 1 pmid pmid NOUN aji-51 1382 2 : : PUNCT aji-51 1382 3 22412883 22412883 NUM aji-51 1382 4 ; ; PUNCT aji-51 1382 5 pmcid pmcid ADJ aji-51 1382 6 : : PUNCT aji-51 1382 7 pmc3297612 pmc3297612 NOUN aji-51 1382 8 . . PUNCT aji-51 1383 1 172 172 NUM aji-51 1383 2 . . PUNCT aji-51 1384 1 sharif sharif PROPN aji-51 1384 2 t t PROPN aji-51 1384 3 , , PUNCT aji-51 1384 4 et et PROPN aji-51 1384 5 al al PROPN aji-51 1384 6 . . PUNCT aji-51 1385 1 the the DET aji-51 1385 2 polyphenolic polyphenolic NOUN aji-51 1385 3 - - PUNCT aji-51 1385 4 rich rich ADJ aji-51 1385 5 aronia aronia NOUN aji-51 1385 6 melanocarpa melanocarpa PROPN aji-51 1385 7 juice juice PROPN aji-51 1385 8 kills kill VERB aji-51 1385 9 teratocarcinomal teratocarcinomal ADJ aji-51 1385 10 cancer cancer NOUN aji-51 1385 11 stem stem NOUN aji-51 1385 12 - - PUNCT aji-51 1385 13 like like ADJ aji-51 1385 14 cells cell NOUN aji-51 1385 15 , , PUNCT aji-51 1385 16 but but CCONJ aji-51 1385 17 not not PART aji-51 1385 18 their their PRON aji-51 1385 19 differentiated differentiated ADJ aji-51 1385 20 counterparts counterpart NOUN aji-51 1385 21 . . PUNCT aji-51 1386 1 journal journal NOUN aji-51 1386 2 of of ADP aji-51 1386 3 functional functional ADJ aji-51 1386 4 foods food NOUN aji-51 1386 5 . . PUNCT aji-51 1387 1 july july PROPN aji-51 1387 2 2013;5(3):1244 2013;5(3):1244 NUM aji-51 1387 3 - - SYM aji-51 1387 4 1252 1252 NUM aji-51 1387 5 . . PUNCT aji-51 1388 1 173 173 NUM aji-51 1388 2 . . PUNCT aji-51 1389 1 spencer spencer PROPN aji-51 1389 2 l l PROPN aji-51 1389 3 , , PUNCT aji-51 1389 4 mann mann PROPN aji-51 1389 5 c c PROPN aji-51 1389 6 , , PUNCT aji-51 1389 7 metcalfe metcalfe PROPN aji-51 1389 8 m m PROPN aji-51 1389 9 , , PUNCT aji-51 1389 10 webb webb PROPN aji-51 1389 11 m m PROPN aji-51 1389 12 , , PUNCT aji-51 1389 13 pollard pollard PROPN aji-51 1389 14 c c PROPN aji-51 1389 15 , , PUNCT aji-51 1389 16 spencer spencer PROPN aji-51 1389 17 d d PROPN aji-51 1389 18 , , PUNCT aji-51 1389 19 berry berry NOUN aji-51 1389 20 d d NOUN aji-51 1389 21 , , PUNCT aji-51 1389 22 steward steward PROPN aji-51 1389 23 w w PROPN aji-51 1389 24 , , PUNCT aji-51 1389 25 dennison dennison PROPN aji-51 1389 26 a. a. PROPN aji-51 1389 27 the the DET aji-51 1389 28 effect effect NOUN aji-51 1389 29 of of ADP aji-51 1389 30 omega-3 omega-3 NUM aji-51 1389 31 fas fas NOUN aji-51 1389 32 on on ADP aji-51 1389 33 tumour tumour NOUN aji-51 1389 34 angiogenesis angiogenesis NOUN aji-51 1389 35 and and CCONJ aji-51 1389 36 their their PRON aji-51 1389 37 therapeutic therapeutic ADJ aji-51 1389 38 potential potential NOUN aji-51 1389 39 . . PUNCT aji-51 1390 1 eur eur PROPN aji-51 1390 2 j j PROPN aji-51 1390 3 cancer cancer NOUN aji-51 1390 4 . . PUNCT aji-51 1391 1 2009 2009 NUM aji-51 1391 2 aug;45(12):2077 aug;45(12):2077 X aji-51 1391 3 - - SYM aji-51 1391 4 86 86 NUM aji-51 1391 5 . . PUNCT aji-51 1392 1 doi doi NOUN aji-51 1392 2 : : PUNCT aji-51 1392 3 10.1016 10.1016 NUM aji-51 1392 4 / / SYM aji-51 1392 5 j.ejca.2009.04.026 j.ejca.2009.04.026 PROPN aji-51 1392 6 epub epub NOUN aji-51 1392 7 2009 2009 NUM aji-51 1392 8 jun jun PROPN aji-51 1392 9 1 1 NUM aji-51 1392 10 . . PUNCT aji-51 1393 1 pmid pmid NOUN aji-51 1393 2 : : PUNCT aji-51 1393 3 19493674 19493674 NUM aji-51 1393 4 . . PUNCT aji-51 1394 1 174 174 NUM aji-51 1394 2 . . PUNCT aji-51 1395 1 kowshik kowshik PROPN aji-51 1395 2 j j PROPN aji-51 1395 3 , , PUNCT aji-51 1395 4 baba baba PROPN aji-51 1395 5 ab ab PROPN aji-51 1395 6 , , PUNCT aji-51 1395 7 giri giri PROPN aji-51 1395 8 h h PROPN aji-51 1395 9 , , PUNCT aji-51 1395 10 deepak deepak PROPN aji-51 1395 11 reddy reddy PROPN aji-51 1395 12 g g PROPN aji-51 1395 13 , , PUNCT aji-51 1395 14 dixit dixit PROPN aji-51 1395 15 m m PROPN aji-51 1395 16 , , PUNCT aji-51 1395 17 nagini nagini PROPN aji-51 1395 18 s. s. PROPN aji-51 1395 19 astaxanthin astaxanthin PROPN aji-51 1395 20 inhibits inhibit VERB aji-51 1395 21 jak jak PROPN aji-51 1395 22 / / SYM aji-51 1395 23 stat-3 stat-3 PROPN aji-51 1395 24 signaling signal VERB aji-51 1395 25 to to PART aji-51 1395 26 abrogate abrogate VERB aji-51 1395 27 cell cell NOUN aji-51 1395 28 proliferation proliferation NOUN aji-51 1395 29 , , PUNCT aji-51 1395 30 invasion invasion NOUN aji-51 1395 31 and and CCONJ aji-51 1395 32 angiogenesis angiogenesis NOUN aji-51 1395 33 in in ADP aji-51 1395 34 a a DET aji-51 1395 35 hamster hamster NOUN aji-51 1395 36 model model NOUN aji-51 1395 37 of of ADP aji-51 1395 38 oral oral ADJ aji-51 1395 39 cancer cancer NOUN aji-51 1395 40 . . PUNCT aji-51 1396 1 plos plos PROPN aji-51 1396 2 one one NUM aji-51 1396 3 . . PUNCT aji-51 1397 1 2014 2014 NUM aji-51 1397 2 oct oct PROPN aji-51 1397 3 8;9(10):e109114 8;9(10):e109114 PROPN aji-51 1397 4 . . PUNCT aji-51 1398 1 doi doi NOUN aji-51 1398 2 : : PUNCT aji-51 1398 3 10.1371 10.1371 NUM aji-51 1398 4 / / SYM aji-51 1398 5 journal.pone.0109114 journal.pone.0109114 PROPN aji-51 1398 6 pmid pmid PROPN aji-51 1398 7 : : PUNCT aji-51 1398 8 25296162 25296162 NUM aji-51 1398 9 ; ; PUNCT aji-51 1398 10 pmcid pmcid ADJ aji-51 1398 11 : : PUNCT aji-51 1398 12 pmc4189964 pmc4189964 ADV aji-51 1398 13 . . PUNCT aji-51 1399 1 175 175 NUM aji-51 1399 2 . . PUNCT aji-51 1400 1 kowshik kowshik PROPN aji-51 1400 2 j j PROPN aji-51 1400 3 , , PUNCT aji-51 1400 4 nivetha nivetha PROPN aji-51 1400 5 r r PROPN aji-51 1400 6 , , PUNCT aji-51 1400 7 ranjani ranjani X aji-51 1400 8 s s PROPN aji-51 1400 9 , , PUNCT aji-51 1400 10 venkatesan venkatesan ADJ aji-51 1400 11 p p X aji-51 1400 12 , , PUNCT aji-51 1400 13 selvamuthukumar selvamuthukumar PROPN aji-51 1400 14 s s PROPN aji-51 1400 15 , , PUNCT aji-51 1400 16 veeravarmal veeravarmal ADJ aji-51 1400 17 v v ADP aji-51 1400 18 , , PUNCT aji-51 1400 19 nagini nagini PROPN aji-51 1400 20 s. s. PROPN aji-51 1400 21 astaxanthin astaxanthin PROPN aji-51 1400 22 inhibits inhibit VERB aji-51 1400 23 hallmarks hallmark NOUN aji-51 1400 24 of of ADP aji-51 1400 25 cancer cancer NOUN aji-51 1400 26 by by ADP aji-51 1400 27 targeting target VERB aji-51 1400 28 the the DET aji-51 1400 29 pi3k pi3k PROPN aji-51 1400 30 / / SYM aji-51 1400 31 nf nf NOUN aji-51 1400 32 - - PUNCT aji-51 1400 33 κβ κβ NOUN aji-51 1400 34 / / SYM aji-51 1400 35 stat3 stat3 NOUN aji-51 1400 36 signalling signal VERB aji-51 1400 37 axis axis NOUN aji-51 1400 38 in in ADP aji-51 1400 39 oral oral ADJ aji-51 1400 40 squamous squamous ADJ aji-51 1400 41 cell cell NOUN aji-51 1400 42 carcinoma carcinoma NOUN aji-51 1400 43 models model NOUN aji-51 1400 44 . . PUNCT aji-51 1401 1 iubmb iubmb NOUN aji-51 1401 2 life life NOUN aji-51 1401 3 . . PUNCT aji-51 1402 1 2019 2019 NUM aji-51 1402 2 oct;71(10):1595 oct;71(10):1595 NOUN aji-51 1402 3 - - SYM aji-51 1402 4 1610 1610 NUM aji-51 1402 5 . . PUNCT aji-51 1403 1 doi doi NOUN aji-51 1403 2 : : PUNCT aji-51 1403 3 10.1002 10.1002 NUM aji-51 1403 4 / / SYM aji-51 1403 5 iub.2104 iub.2104 PROPN aji-51 1403 6 epub epub PROPN aji-51 1403 7 2019 2019 NUM aji-51 1403 8 jun jun PROPN aji-51 1403 9 28 28 NUM aji-51 1403 10 . . PUNCT aji-51 1404 1 pmid pmid NOUN aji-51 1404 2 : : PUNCT aji-51 1404 3 31251469 31251469 NUM aji-51 1404 4 . . PUNCT aji-51 1405 1 176 176 NUM aji-51 1405 2 . . PUNCT aji-51 1406 1 fan fan PROPN aji-51 1406 2 j j PROPN aji-51 1406 3 , , PUNCT aji-51 1406 4 wu wu PROPN aji-51 1406 5 m m PROPN aji-51 1406 6 , , PUNCT aji-51 1406 7 wang wang PROPN aji-51 1406 8 j j PROPN aji-51 1406 9 , , PUNCT aji-51 1406 10 ren ren PROPN aji-51 1406 11 d d PROPN aji-51 1406 12 , , PUNCT aji-51 1406 13 zhao zhao PROPN aji-51 1406 14 j j PROPN aji-51 1406 15 , , PUNCT aji-51 1406 16 yang yang PROPN aji-51 1406 17 g. g. PROPN aji-51 1407 1 1,7 1,7 PROPN aji-51 1407 2 - - PUNCT aji-51 1407 3 bis(4 bis(4 NOUN aji-51 1407 4 - - PUNCT aji-51 1407 5 hydroxyphenyl)-1,4heptadien-3 hydroxyphenyl)-1,4heptadien-3 NOUN aji-51 1407 6 - - PUNCT aji-51 1407 7 one one NUM aji-51 1407 8 induces induce VERB aji-51 1407 9 lung lung NOUN aji-51 1407 10 cancer cancer NOUN aji-51 1407 11 cell cell NOUN aji-51 1407 12 apoptosis apoptosis NOUN aji-51 1407 13 via via ADP aji-51 1407 14 the the DET aji-51 1407 15 pi3k pi3k PROPN aji-51 1407 16 / / SYM aji-51 1407 17 akt akt PROPN aji-51 1407 18 and and CCONJ aji-51 1407 19 erk1/2 erk1/2 PROPN aji-51 1407 20 pathways pathway NOUN aji-51 1407 21 . . PUNCT aji-51 1408 1 j j PROPN aji-51 1408 2 cell cell NOUN aji-51 1408 3 physiol physiol PROPN aji-51 1408 4 . . PUNCT aji-51 1409 1 2019;234:6336 2019;234:6336 NUM aji-51 1409 2 – – PUNCT aji-51 1409 3 6349 6349 NUM aji-51 1409 4 . . PUNCT aji-51 1410 1 doi doi NOUN aji-51 1410 2 : : PUNCT aji-51 1410 3 10.1002 10.1002 NUM aji-51 1410 4 / / SYM aji-51 1410 5 jcp.27364 jcp.27364 NUM aji-51 1410 6 pmid pmid NOUN aji-51 1410 7 : : PUNCT aji-51 1410 8 30246250 30246250 NUM aji-51 1410 9 . . PUNCT aji-51 1411 1 177 177 NUM aji-51 1411 2 . . PUNCT aji-51 1412 1 aldieri aldieri PROPN aji-51 1412 2 e e PROPN aji-51 1412 3 , , PUNCT aji-51 1412 4 atragene atragene NOUN aji-51 1412 5 d d NOUN aji-51 1412 6 , , PUNCT aji-51 1412 7 bergandi bergandi PROPN aji-51 1412 8 l l PROPN aji-51 1412 9 , , PUNCT aji-51 1412 10 riganti riganti PROPN aji-51 1412 11 c c PROPN aji-51 1412 12 , , PUNCT aji-51 1412 13 costamagna costamagna NOUN aji-51 1412 14 c c PROPN aji-51 1412 15 , , PUNCT aji-51 1412 16 bosia bosia PROPN aji-51 1412 17 a a PRON aji-51 1412 18 , , PUNCT aji-51 1412 19 ghigo ghigo PROPN aji-51 1412 20 d. d. PROPN aji-51 1412 21 artemisinin artemisinin PROPN aji-51 1412 22 inhibits inhibit VERB aji-51 1412 23 inducible inducible ADJ aji-51 1412 24 nitric nitric ADJ aji-51 1412 25 oxide oxide NOUN aji-51 1412 26 synthase synthase NOUN aji-51 1412 27 and and CCONJ aji-51 1412 28 nuclear nuclear ADJ aji-51 1412 29 factor factor NOUN aji-51 1412 30 nf nf NOUN aji-51 1412 31 - - PUNCT aji-51 1412 32 kb kb NOUN aji-51 1412 33 activation activation NOUN aji-51 1412 34 . . PUNCT aji-51 1413 1 febs febs PROPN aji-51 1413 2 lett lett PROPN aji-51 1413 3 . . PUNCT aji-51 1414 1 2003 2003 NUM aji-51 1414 2 sep sep NOUN aji-51 1414 3 25;552(23):141 25;552(23):141 NUM aji-51 1414 4 - - SYM aji-51 1414 5 4 4 NUM aji-51 1414 6 . . PUNCT aji-51 1414 7 doi doi NOUN aji-51 1414 8 : : PUNCT aji-51 1414 9 10.1016 10.1016 NUM aji-51 1414 10 / / SYM aji-51 1414 11 s0014 s0014 PROPN aji-51 1414 12 - - PUNCT aji-51 1414 13 5793(03)00905 5793(03)00905 NUM aji-51 1414 14 - - PUNCT aji-51 1414 15 0 0 NUM aji-51 1414 16 pmid pmid NOUN aji-51 1414 17 : : PUNCT aji-51 1414 18 14527676 14527676 NUM aji-51 1414 19 . . PUNCT aji-51 1415 1 178 178 NUM aji-51 1415 2 . . PUNCT aji-51 1416 1 kim kim PROPN aji-51 1416 2 jh jh PROPN aji-51 1416 3 , , PUNCT aji-51 1416 4 shim shim NOUN aji-51 1416 5 js js PROPN aji-51 1416 6 , , PUNCT aji-51 1416 7 lee lee PROPN aji-51 1416 8 sk sk PROPN aji-51 1416 9 , , PUNCT aji-51 1416 10 kim kim PROPN aji-51 1416 11 kw kw PROPN aji-51 1416 12 , , PUNCT aji-51 1416 13 rha rha PROPN aji-51 1416 14 sy sy PROPN aji-51 1416 15 , , PUNCT aji-51 1416 16 chung chung PROPN aji-51 1416 17 hc hc PROPN aji-51 1416 18 , , PUNCT aji-51 1416 19 kwon kwon PROPN aji-51 1416 20 hj hj PROPN aji-51 1416 21 . . PROPN aji-51 1416 22 microarraybased microarraybase VERB aji-51 1416 23 analysis analysis NOUN aji-51 1416 24 of of ADP aji-51 1416 25 anti anti ADJ aji-51 1416 26 - - ADJ aji-51 1416 27 angiogenic angiogenic ADJ aji-51 1416 28 activity activity NOUN aji-51 1416 29 of of ADP aji-51 1416 30 demethoxycurcumin demethoxycurcumin NOUN aji-51 1416 31 on on ADP aji-51 1416 32 human human ADJ aji-51 1416 33 umbilical umbilical ADJ aji-51 1416 34 vein vein ADJ aji-51 1416 35 endothelial endothelial ADJ aji-51 1416 36 cells cell NOUN aji-51 1416 37 : : PUNCT aji-51 1416 38 crucial crucial ADJ aji-51 1416 39 involvement involvement NOUN aji-51 1416 40 of of ADP aji-51 1416 41 the the DET aji-51 1416 42 down down NOUN aji-51 1416 43 - - PUNCT aji-51 1416 44 regulation regulation NOUN aji-51 1416 45 of of ADP aji-51 1416 46 matrix matrix NOUN aji-51 1416 47 metalloproteinase metalloproteinase NOUN aji-51 1416 48 . . PUNCT aji-51 1417 1 jpn jpn PROPN aji-51 1417 2 j j PROPN aji-51 1417 3 cancer cancer NOUN aji-51 1417 4 res re NOUN aji-51 1417 5 . . PROPN aji-51 1417 6 2002 2002 NUM aji-51 1417 7 dec;93(12):1378 dec;93(12):1378 PROPN aji-51 1417 8 - - PUNCT aji-51 1417 9 85 85 NUM aji-51 1417 10 . . PUNCT aji-51 1418 1 doi doi NOUN aji-51 1418 2 : : PUNCT aji-51 1418 3 10.1111 10.1111 NUM aji-51 1418 4 / / SYM aji-51 1418 5 j.1349 j.1349 PROPN aji-51 1418 6 - - PUNCT aji-51 1418 7 7006.2002.tb01247.x 7006.2002.tb01247.x NUM aji-51 1418 8 pmid pmid NOUN aji-51 1418 9 : : PUNCT aji-51 1418 10 12495478 12495478 NUM aji-51 1418 11 ; ; PUNCT aji-51 1418 12 pmcid pmcid NOUN aji-51 1418 13 : : PUNCT aji-51 1418 14 pmc5926931 pmc5926931 ADV aji-51 1418 15 . . PUNCT aji-51 1419 1 179 179 NUM aji-51 1419 2 . . PUNCT aji-51 1420 1 huynh huynh PROPN aji-51 1420 2 h h PROPN aji-51 1420 3 , , PUNCT aji-51 1420 4 nguyen nguyen PROPN aji-51 1420 5 tt tt PROPN aji-51 1420 6 , , PUNCT aji-51 1420 7 chan chan PROPN aji-51 1420 8 e e PROPN aji-51 1420 9 , , PUNCT aji-51 1420 10 tran tran PROPN aji-51 1420 11 e. e. PROPN aji-51 1420 12 inhibition inhibition NOUN aji-51 1420 13 of of ADP aji-51 1420 14 erbb-2 erbb-2 NOUN aji-51 1420 15 and and CCONJ aji-51 1420 16 erbb-3 erbb-3 NUM aji-51 1420 17 expression expression NOUN aji-51 1420 18 by by ADP aji-51 1420 19 quercetin quercetin NOUN aji-51 1420 20 prevents prevent NOUN aji-51 1420 21 transforming transform VERB aji-51 1420 22 growth growth NOUN aji-51 1420 23 factor factor NOUN aji-51 1420 24 alpha alpha NOUN aji-51 1420 25 ( ( PUNCT aji-51 1420 26 tgf tgf NOUN aji-51 1420 27 - - PUNCT aji-51 1420 28 alpha)and alpha)and NOUN aji-51 1420 29 epidermal epidermal ADJ aji-51 1420 30 growth growth NOUN aji-51 1420 31 factor factor NOUN aji-51 1420 32 ( ( PUNCT aji-51 1420 33 egf)-induced egf)-induce VERB aji-51 1420 34 human human ADJ aji-51 1420 35 pc-3 pc-3 NOUN aji-51 1420 36 stoff stoff PROPN aji-51 1420 37 ; ; PUNCT aji-51 1420 38 aji aji PROPN aji-51 1420 39 , , PUNCT aji-51 1420 40 5(1 5(1 NUM aji-51 1420 41 ): ): PUNCT aji-51 1420 42 1 1 NUM aji-51 1420 43 - - SYM aji-51 1420 44 39 39 NUM aji-51 1420 45 , , PUNCT aji-51 1420 46 2022 2022 NUM aji-51 1420 47 ; ; PUNCT aji-51 1420 48 article article NOUN aji-51 1420 49 no.aji.77967 no.aji.77967 NOUN aji-51 1420 50 29 29 NUM aji-51 1420 51 prostate prostate NOUN aji-51 1420 52 cancer cancer NOUN aji-51 1420 53 cell cell NOUN aji-51 1420 54 proliferation proliferation NOUN aji-51 1420 55 . . PUNCT aji-51 1421 1 int int NOUN aji-51 1421 2 j j PROPN aji-51 1421 3 oncol oncol ADJ aji-51 1421 4 . . PUNCT aji-51 1422 1 2003 2003 NUM aji-51 1422 2 sep;23(3):821 sep;23(3):821 PROPN aji-51 1422 3 - - PUNCT aji-51 1422 4 9 9 NUM aji-51 1422 5 . . PUNCT aji-51 1423 1 pmid pmid NOUN aji-51 1423 2 : : PUNCT aji-51 1423 3 12888923 12888923 NUM aji-51 1423 4 . . PUNCT aji-51 1424 1 180 180 NUM aji-51 1424 2 . . PUNCT aji-51 1425 1 jiang jiang PROPN aji-51 1425 2 c c PROPN aji-51 1425 3 , , PUNCT aji-51 1425 4 agarwal agarwal PROPN aji-51 1425 5 r r PROPN aji-51 1425 6 , , PUNCT aji-51 1425 7 lü lü PROPN aji-51 1425 8 j. j. PROPN aji-51 1425 9 anti anti ADJ aji-51 1425 10 - - ADJ aji-51 1425 11 angiogenic angiogenic ADJ aji-51 1425 12 potential potential NOUN aji-51 1425 13 of of ADP aji-51 1425 14 a a DET aji-51 1425 15 cancer cancer NOUN aji-51 1425 16 chemopreventive chemopreventive ADJ aji-51 1425 17 flavonoid flavonoid NOUN aji-51 1425 18 antioxidant antioxidant NOUN aji-51 1425 19 , , PUNCT aji-51 1425 20 silymarin silymarin NOUN aji-51 1425 21 : : PUNCT aji-51 1425 22 inhibition inhibition NOUN aji-51 1425 23 of of ADP aji-51 1425 24 key key ADJ aji-51 1425 25 attributes attribute NOUN aji-51 1425 26 of of ADP aji-51 1425 27 vascular vascular ADJ aji-51 1425 28 endothelial endothelial ADJ aji-51 1425 29 cells cell NOUN aji-51 1425 30 and and CCONJ aji-51 1425 31 angiogenic angiogenic ADJ aji-51 1425 32 cytokine cytokine ADJ aji-51 1425 33 secretion secretion NOUN aji-51 1425 34 by by ADP aji-51 1425 35 cancer cancer NOUN aji-51 1425 36 epithelial epithelial ADJ aji-51 1425 37 cells cell NOUN aji-51 1425 38 . . PUNCT aji-51 1426 1 biochem biochem PROPN aji-51 1426 2 biophys biophys PROPN aji-51 1426 3 res re NOUN aji-51 1426 4 commun commun PROPN aji-51 1426 5 . . PUNCT aji-51 1427 1 2000 2000 NUM aji-51 1427 2 sep sep PROPN aji-51 1427 3 16;276(1):3718 16;276(1):3718 NUM aji-51 1427 4 . . PUNCT aji-51 1428 1 doi doi NOUN aji-51 1428 2 : : PUNCT aji-51 1428 3 10.1006 10.1006 NUM aji-51 1428 4 / / SYM aji-51 1428 5 bbrc.2000.3474 bbrc.2000.3474 PROPN aji-51 1428 6 pmid pmid PROPN aji-51 1428 7 : : PUNCT aji-51 1428 8 11006131 11006131 NUM aji-51 1428 9 . . PUNCT aji-51 1429 1 181 181 NUM aji-51 1429 2 . . PUNCT aji-51 1429 3 tang tang PROPN aji-51 1429 4 fy fy PROPN aji-51 1429 5 , , PUNCT aji-51 1429 6 nguyen nguyen PROPN aji-51 1429 7 n n CCONJ aji-51 1429 8 , , PUNCT aji-51 1429 9 meydani meydani ADJ aji-51 1429 10 m. m. NOUN aji-51 1429 11 green green ADJ aji-51 1429 12 tea tea NOUN aji-51 1429 13 catechins catechin NOUN aji-51 1429 14 inhibit inhibit VERB aji-51 1429 15 vegf vegf NOUN aji-51 1429 16 - - PUNCT aji-51 1429 17 induced induce VERB aji-51 1429 18 angiogenesis angiogenesis NOUN aji-51 1429 19 in in ADP aji-51 1429 20 vitro vitro X aji-51 1429 21 through through ADP aji-51 1429 22 suppression suppression NOUN aji-51 1429 23 of of ADP aji-51 1429 24 ve ve NOUN aji-51 1429 25 - - PUNCT aji-51 1429 26 cadherin cadherin NOUN aji-51 1429 27 phosphorylation phosphorylation NOUN aji-51 1429 28 and and CCONJ aji-51 1429 29 inactivation inactivation NOUN aji-51 1429 30 of of ADP aji-51 1429 31 akt akt PROPN aji-51 1429 32 molecule molecule PROPN aji-51 1429 33 . . PUNCT aji-51 1430 1 int int NOUN aji-51 1430 2 j j PROPN aji-51 1430 3 cancer cancer NOUN aji-51 1430 4 . . PUNCT aji-51 1431 1 2003 2003 NUM aji-51 1431 2 oct oct NOUN aji-51 1431 3 10;106(6):871 10;106(6):871 PROPN aji-51 1431 4 - - PUNCT aji-51 1431 5 8 8 NUM aji-51 1431 6 . . PUNCT aji-51 1432 1 doi doi NOUN aji-51 1432 2 : : PUNCT aji-51 1432 3 10.1002 10.1002 NUM aji-51 1432 4 / / SYM aji-51 1432 5 ijc.11325 ijc.11325 PROPN aji-51 1432 6 pmid pmid PROPN aji-51 1432 7 : : PUNCT aji-51 1432 8 12918064 12918064 NUM aji-51 1432 9 . . PUNCT aji-51 1433 1 182 182 NUM aji-51 1433 2 . . PUNCT aji-51 1434 1 ahuja ahuja PROPN aji-51 1434 2 a a PROPN aji-51 1434 3 , , PUNCT aji-51 1434 4 kim kim PROPN aji-51 1434 5 jh jh PROPN aji-51 1434 6 , , PUNCT aji-51 1434 7 kim kim PROPN aji-51 1434 8 jh jh PROPN aji-51 1434 9 , , PUNCT aji-51 1434 10 yi yi PROPN aji-51 1434 11 ys ys PROPN aji-51 1434 12 , , PUNCT aji-51 1434 13 cho cho PROPN aji-51 1434 14 jy jy PROPN aji-51 1434 15 . . PUNCT aji-51 1435 1 functional functional ADJ aji-51 1435 2 role role NOUN aji-51 1435 3 of of ADP aji-51 1435 4 ginseng ginseng NOUN aji-51 1435 5 - - PUNCT aji-51 1435 6 derived derive VERB aji-51 1435 7 compounds compound NOUN aji-51 1435 8 in in ADP aji-51 1435 9 cancer cancer NOUN aji-51 1435 10 . . PUNCT aji-51 1436 1 j j PROPN aji-51 1436 2 ginseng ginseng NOUN aji-51 1436 3 res re NOUN aji-51 1436 4 . . PROPN aji-51 1436 5 2018 2018 NUM aji-51 1436 6 jul;42(3):248 jul;42(3):248 PROPN aji-51 1436 7 - - PUNCT aji-51 1436 8 254 254 NUM aji-51 1436 9 . . PUNCT aji-51 1437 1 doi doi NOUN aji-51 1437 2 : : PUNCT aji-51 1437 3 10.1016 10.1016 NUM aji-51 1437 4 / / SYM aji-51 1437 5 j.jgr.2017.04.009 j.jgr.2017.04.009 PROPN aji-51 1437 6 epub epub PROPN aji-51 1437 7 2017 2017 NUM aji-51 1437 8 may may PROPN aji-51 1437 9 15 15 NUM aji-51 1437 10 . . PUNCT aji-51 1438 1 pmid pmid NOUN aji-51 1438 2 : : PUNCT aji-51 1438 3 29983605 29983605 NUM aji-51 1438 4 ; ; PUNCT aji-51 1438 5 pmcid pmcid ADJ aji-51 1438 6 : : PUNCT aji-51 1438 7 pmc6026353 pmc6026353 NOUN aji-51 1438 8 . . PUNCT aji-51 1439 1 183 183 NUM aji-51 1439 2 . . PUNCT aji-51 1440 1 wang wang PROPN aji-51 1440 2 zy zy PROPN aji-51 1440 3 , , PUNCT aji-51 1440 4 nixon nixon PROPN aji-51 1440 5 dw dw PROPN aji-51 1440 6 . . PROPN aji-51 1440 7 licorice licorice PROPN aji-51 1440 8 and and CCONJ aji-51 1440 9 cancer cancer NOUN aji-51 1440 10 . . PUNCT aji-51 1441 1 nutr nutr NOUN aji-51 1441 2 cancer cancer NOUN aji-51 1441 3 . . PUNCT aji-51 1442 1 2001;39(1):1 2001;39(1):1 NUM aji-51 1442 2 - - SYM aji-51 1442 3 11 11 NUM aji-51 1442 4 . . PUNCT aji-51 1443 1 doi doi NOUN aji-51 1443 2 : : PUNCT aji-51 1443 3 10.1207 10.1207 NUM aji-51 1443 4 / / SYM aji-51 1443 5 s15327914nc391_1 s15327914nc391_1 PROPN aji-51 1443 6 pmid pmid NOUN aji-51 1443 7 : : PUNCT aji-51 1443 8 11588889 11588889 NUM aji-51 1443 9 . . PUNCT aji-51 1444 1 184 184 NUM aji-51 1444 2 . . PUNCT aji-51 1445 1 powell powell PROPN aji-51 1445 2 cb cb PROPN aji-51 1445 3 , , PUNCT aji-51 1445 4 fung fung PROPN aji-51 1445 5 p p X aji-51 1445 6 , , PUNCT aji-51 1445 7 jackson jackson PROPN aji-51 1445 8 j j PROPN aji-51 1445 9 , , PUNCT aji-51 1445 10 dall'era dall'era PROPN aji-51 1445 11 j j PROPN aji-51 1445 12 , , PUNCT aji-51 1445 13 lewkowicz lewkowicz NOUN aji-51 1445 14 d d PROPN aji-51 1445 15 , , PUNCT aji-51 1445 16 cohen cohen PROPN aji-51 1445 17 i i PROPN aji-51 1445 18 , , PUNCT aji-51 1445 19 smith smith PROPN aji-51 1445 20 - - PUNCT aji-51 1445 21 mccune mccune PROPN aji-51 1445 22 k. k. PROPN aji-51 1445 23 aqueous aqueous PROPN aji-51 1445 24 extract extract NOUN aji-51 1445 25 of of ADP aji-51 1445 26 herba herba PROPN aji-51 1445 27 scutellaria scutellaria NOUN aji-51 1445 28 barbatae barbatae NOUN aji-51 1445 29 , , PUNCT aji-51 1445 30 a a DET aji-51 1445 31 chinese chinese ADJ aji-51 1445 32 herb herb NOUN aji-51 1445 33 used use VERB aji-51 1445 34 for for ADP aji-51 1445 35 ovarian ovarian ADJ aji-51 1445 36 cancer cancer NOUN aji-51 1445 37 , , PUNCT aji-51 1445 38 induces induce VERB aji-51 1445 39 apoptosis apoptosis NOUN aji-51 1445 40 of of ADP aji-51 1445 41 ovarian ovarian ADJ aji-51 1445 42 cancer cancer NOUN aji-51 1445 43 cell cell NOUN aji-51 1445 44 lines line NOUN aji-51 1445 45 . . PUNCT aji-51 1446 1 gynecol gynecol ADJ aji-51 1446 2 oncol oncol ADJ aji-51 1446 3 . . PUNCT aji-51 1447 1 2003 2003 NUM aji-51 1447 2 nov;91(2):332 nov;91(2):332 PROPN aji-51 1447 3 - - SYM aji-51 1447 4 40 40 NUM aji-51 1447 5 . . PUNCT aji-51 1448 1 doi doi NOUN aji-51 1448 2 : : PUNCT aji-51 1448 3 10.1016 10.1016 NUM aji-51 1448 4 / / SYM aji-51 1448 5 j.ygyno.2003.07.004 j.ygyno.2003.07.004 PROPN aji-51 1448 6 pmid pmid PROPN aji-51 1448 7 : : PUNCT aji-51 1448 8 14599863 14599863 NUM aji-51 1448 9 . . PUNCT aji-51 1449 1 185 185 NUM aji-51 1449 2 . . PUNCT aji-51 1450 1 alessandro alessandro PROPN aji-51 1450 2 palmioli palmioli PROPN aji-51 1450 3 , , PUNCT aji-51 1450 4 et et PROPN aji-51 1450 5 al al PROPN aji-51 1450 6 . . PROPN aji-51 1450 7 natural natural ADJ aji-51 1450 8 compounds compound NOUN aji-51 1450 9 in in ADP aji-51 1450 10 cancer cancer NOUN aji-51 1450 11 prevention prevention NOUN aji-51 1450 12 : : PUNCT aji-51 1450 13 effects effect NOUN aji-51 1450 14 of of ADP aji-51 1450 15 coffee coffee NOUN aji-51 1450 16 extracts extract NOUN aji-51 1450 17 and and CCONJ aji-51 1450 18 their their PRON aji-51 1450 19 main main ADJ aji-51 1450 20 polyphenolic polyphenolic ADJ aji-51 1450 21 component component NOUN aji-51 1450 22 , , PUNCT aji-51 1450 23 5 5 NUM aji-51 1450 24 - - PUNCT aji-51 1450 25 ocaffeoylquinic ocaffeoylquinic ADJ aji-51 1450 26 acid acid NOUN aji-51 1450 27 , , PUNCT aji-51 1450 28 on on ADP aji-51 1450 29 oncogenic oncogenic ADJ aji-51 1450 30 ras ra NOUN aji-51 1450 31 proteins protein NOUN aji-51 1450 32 . . PUNCT aji-51 1451 1 chem chem NOUN aji-51 1451 2 asian asian PROPN aji-51 1451 3 j. j. PROPN aji-51 1451 4 2017 2017 NUM aji-51 1451 5 sep sep PROPN aji-51 1451 6 19;12(18):2457 19;12(18):2457 NUM aji-51 1451 7 - - SYM aji-51 1451 8 2466 2466 NUM aji-51 1451 9 . . PUNCT aji-51 1452 1 pmid pmid NOUN aji-51 1452 2 : : PUNCT aji-51 1452 3 28719146 28719146 NUM aji-51 1452 4 . . PUNCT aji-51 1453 1 186 186 NUM aji-51 1453 2 . . PUNCT aji-51 1453 3 fofaria fofaria PROPN aji-51 1453 4 nm nm PROPN aji-51 1453 5 , , PUNCT aji-51 1453 6 ramachandran ramachandran PROPN aji-51 1453 7 s s PROPN aji-51 1453 8 , , PUNCT aji-51 1453 9 srivastava srivastava PROPN aji-51 1453 10 sk sk PROPN aji-51 1453 11 . . PUNCT aji-51 1454 1 therapeutic therapeutic ADJ aji-51 1454 2 potential potential NOUN aji-51 1454 3 of of ADP aji-51 1454 4 black black ADJ aji-51 1454 5 pepper pepper NOUN aji-51 1454 6 compound compound NOUN aji-51 1454 7 for for ADP aji-51 1454 8 braf braf NOUN aji-51 1454 9 resistant resistant ADJ aji-51 1454 10 melanoma melanoma NOUN aji-51 1454 11 . . PUNCT aji-51 1455 1 presented present VERB aji-51 1455 2 at at ADP aji-51 1455 3 the the DET aji-51 1455 4 2nd 2nd ADJ aji-51 1455 5 international international ADJ aji-51 1455 6 conference conference NOUN aji-51 1455 7 on on ADP aji-51 1455 8 natural natural ADJ aji-51 1455 9 products product NOUN aji-51 1455 10 for for ADP aji-51 1455 11 cancer cancer NOUN aji-51 1455 12 prevention prevention NOUN aji-51 1455 13 and and CCONJ aji-51 1455 14 therapy therapy NOUN aji-51 1455 15 , , PUNCT aji-51 1455 16 kayseri kayseri PROPN aji-51 1455 17 , , PUNCT aji-51 1455 18 turkey turkey PROPN aji-51 1455 19 , , PUNCT aji-51 1455 20 8–11 8–11 PROPN aji-51 1455 21 november november PROPN aji-51 1455 22 2017 2017 NUM aji-51 1455 23 . . PUNCT aji-51 1456 1 187 187 NUM aji-51 1456 2 . . PUNCT aji-51 1456 3 riedel riedel PROPN aji-51 1456 4 , , PUNCT aji-51 1456 5 stefan stefan PROPN aji-51 1456 6 . . PUNCT aji-51 1457 1 edward edward PROPN aji-51 1457 2 jenner jenner PROPN aji-51 1457 3 and and CCONJ aji-51 1457 4 the the DET aji-51 1457 5 history history NOUN aji-51 1457 6 of of ADP aji-51 1457 7 smallpox smallpox NOUN aji-51 1457 8 and and CCONJ aji-51 1457 9 vaccination vaccination NOUN aji-51 1457 10 . . PUNCT aji-51 1458 1 proceedings proceeding NOUN aji-51 1458 2 ( ( PUNCT aji-51 1458 3 baylor baylor PROPN aji-51 1458 4 university university PROPN aji-51 1458 5 . . PUNCT aji-51 1459 1 medical medical ADJ aji-51 1459 2 center center NOUN aji-51 1459 3 ) ) PUNCT aji-51 1459 4 . . PUNCT aji-51 1460 1 baylor baylor PROPN aji-51 1460 2 university university PROPN aji-51 1460 3 medical medical ADJ aji-51 1460 4 center center NOUN aji-51 1460 5 . . PUNCT aji-51 1461 1 january january PROPN aji-51 1461 2 2005;18(1):21–25 2005;18(1):21–25 PROPN aji-51 1461 3 . . PUNCT aji-51 1461 4 doi doi PROPN aji-51 1461 5 : : PUNCT aji-51 1461 6 10.1080/08998280.2005.11928028 10.1080/08998280.2005.11928028 NUM aji-51 1461 7 pmc pmc PROPN aji-51 1461 8 : : PUNCT aji-51 1461 9 1200696 1200696 NUM aji-51 1461 10 . . PUNCT aji-51 1462 1 pmid:16200144 pmid:16200144 ADJ aji-51 1462 2 . . PROPN aji-51 1462 3 188 188 NUM aji-51 1462 4 . . PUNCT aji-51 1463 1 baxby baxby PROPN aji-51 1463 2 , , PUNCT aji-51 1463 3 derrick derrick PROPN aji-51 1463 4 . . PUNCT aji-51 1464 1 jenner jenner PROPN aji-51 1464 2 , , PUNCT aji-51 1464 3 edward edward PROPN aji-51 1464 4 ( ( PUNCT aji-51 1464 5 1749 1749 NUM aji-51 1464 6 – – PUNCT aji-51 1464 7 1823 1823 NUM aji-51 1464 8 ) ) PUNCT aji-51 1464 9 . . PUNCT aji-51 1465 1 oxford oxford PROPN aji-51 1465 2 dictionary dictionary PROPN aji-51 1465 3 of of ADP aji-51 1465 4 national national PROPN aji-51 1465 5 biography biography NOUN aji-51 1465 6 . . PUNCT aji-51 1466 1 oxford oxford PROPN aji-51 1466 2 university university PROPN aji-51 1466 3 press press NOUN aji-51 1466 4 . . PUNCT aji-51 1467 1 189 189 NUM aji-51 1467 2 . . PUNCT aji-51 1467 3 george george PROPN aji-51 1467 4 pearson pearson PROPN aji-51 1467 5 , , PUNCT aji-51 1467 6 ed ed NOUN aji-51 1467 7 . . PROPN aji-51 1467 8 , , PUNCT aji-51 1467 9 an an DET aji-51 1467 10 inquiry inquiry NOUN aji-51 1467 11 concerning concern VERB aji-51 1467 12 the the DET aji-51 1467 13 history history NOUN aji-51 1467 14 of of ADP aji-51 1467 15 the the DET aji-51 1467 16 cowpox cowpox NOUN aji-51 1467 17 , , PUNCT aji-51 1467 18 principally principally ADV aji-51 1467 19 with with ADP aji-51 1467 20 a a DET aji-51 1467 21 view view NOUN aji-51 1467 22 to to PART aji-51 1467 23 supersede supersede VERB aji-51 1467 24 and and CCONJ aji-51 1467 25 extinguish extinguish VERB aji-51 1467 26 the the DET aji-51 1467 27 smallpox smallpox NOUN aji-51 1467 28 ( ( PUNCT aji-51 1467 29 london london PROPN aji-51 1467 30 , , PUNCT aji-51 1467 31 england england PROPN aji-51 1467 32 : : PUNCT aji-51 1467 33 j. j. PROPN aji-51 1467 34 johnson johnson PROPN aji-51 1467 35 , , PUNCT aji-51 1467 36 1798);102–104 1798);102–104 NUM aji-51 1467 37 . . PUNCT aji-51 1468 1 190 190 NUM aji-51 1468 2 . . PUNCT aji-51 1469 1 thurston thurston PROPN aji-51 1469 2 l l PROPN aji-51 1469 3 , , PUNCT aji-51 1469 4 williams williams PROPN aji-51 1469 5 g. g. PROPN aji-51 1469 6 an an DET aji-51 1469 7 examination examination NOUN aji-51 1469 8 of of ADP aji-51 1469 9 john john PROPN aji-51 1469 10 fewster fewster PROPN aji-51 1469 11 's 's PART aji-51 1469 12 role role NOUN aji-51 1469 13 in in ADP aji-51 1469 14 the the DET aji-51 1469 15 discovery discovery NOUN aji-51 1469 16 of of ADP aji-51 1469 17 smallpox smallpox NOUN aji-51 1469 18 vaccination vaccination NOUN aji-51 1469 19 . . PUNCT aji-51 1470 1 j j PROPN aji-51 1470 2 r r PROPN aji-51 1470 3 coll coll PROPN aji-51 1470 4 physicians physician NOUN aji-51 1470 5 edinb edinb NOUN aji-51 1470 6 . . PUNCT aji-51 1471 1 2015;45(2):173 2015;45(2):173 NUM aji-51 1471 2 - - PUNCT aji-51 1471 3 9 9 NUM aji-51 1471 4 . . PUNCT aji-51 1471 5 doi doi NOUN aji-51 1471 6 : : PUNCT aji-51 1471 7 10.4997 10.4997 NUM aji-51 1471 8 / / SYM aji-51 1471 9 jrcpe.2015.217 jrcpe.2015.217 NOUN aji-51 1471 10 pmid pmid NOUN aji-51 1471 11 : : PUNCT aji-51 1471 12 26181536 26181536 NUM aji-51 1471 13 . . PUNCT aji-51 1472 1 191 191 NUM aji-51 1472 2 . . PUNCT aji-51 1472 3 plett plett PROPN aji-51 1472 4 pc pc PROPN aji-51 1472 5 . . PUNCT aji-51 1473 1 peter peter PROPN aji-51 1473 2 plett plett PROPN aji-51 1473 3 und und PROPN aji-51 1473 4 die die VERB aji-51 1473 5 übrigen übrigen ADJ aji-51 1473 6 entdecker entdecker NOUN aji-51 1473 7 der der NOUN aji-51 1473 8 kuhpockenimpfung kuhpockenimpfung PROPN aji-51 1473 9 vor vor PROPN aji-51 1473 10 edward edward PROPN aji-51 1473 11 jenner jenner PROPN aji-51 1474 1 [ [ X aji-51 1474 2 peter peter PROPN aji-51 1474 3 plett plett NOUN aji-51 1474 4 and and CCONJ aji-51 1474 5 other other ADJ aji-51 1474 6 discoverers discoverer NOUN aji-51 1474 7 of of ADP aji-51 1474 8 cowpox cowpox ADJ aji-51 1474 9 vaccination vaccination NOUN aji-51 1474 10 before before ADP aji-51 1474 11 edward edward PROPN aji-51 1474 12 jenner jenner PROPN aji-51 1474 13 ] ] PUNCT aji-51 1474 14 . . PUNCT aji-51 1475 1 sudhoffs sudhoff NOUN aji-51 1475 2 arch arch VERB aji-51 1475 3 . . PUNCT aji-51 1476 1 2006;90(2):219 2006;90(2):219 NUM aji-51 1476 2 - - PUNCT aji-51 1476 3 32 32 NUM aji-51 1476 4 . . PUNCT aji-51 1477 1 german german NOUN aji-51 1477 2 . . PUNCT aji-51 1478 1 pmid pmid NOUN aji-51 1478 2 : : PUNCT aji-51 1478 3 17338405 17338405 NUM aji-51 1478 4 . . PUNCT aji-51 1479 1 192 192 NUM aji-51 1479 2 . . X aji-51 1479 3 history history NOUN aji-51 1479 4 – – PUNCT aji-51 1479 5 edward edward PROPN aji-51 1479 6 jenner jenner PROPN aji-51 1479 7 ( ( PUNCT aji-51 1479 8 1749–1823 1749–1823 NUM aji-51 1479 9 ) ) PUNCT aji-51 1479 10 . . PUNCT aji-51 1480 1 bbc bbc PROPN aji-51 1480 2 . . PROPN aji-51 1481 1 1 1 NUM aji-51 1481 2 november november PROPN aji-51 1481 3 2006 2006 NUM aji-51 1481 4 . . PUNCT aji-51 1482 1 193 193 NUM aji-51 1482 2 . . PUNCT aji-51 1483 1 available available ADJ aji-51 1483 2 : : PUNCT aji-51 1483 3 https://www.cancer.gov https://www.cancer.gov ADJ aji-51 1483 4 / / SYM aji-51 1483 5 publicati publicati NOUN aji-51 1483 6 ons ons PROPN aji-51 1483 7 / / SYM aji-51 1483 8 dictionaries dictionary NOUN aji-51 1483 9 / / SYM aji-51 1483 10 cancerterms cancerterm NOUN aji-51 1483 11 / / SYM aji-51 1483 12 def def ADJ aji-51 1483 13 / / SYM aji-51 1483 14 abscopal abscopal ADJ aji-51 1483 15 - - PUNCT aji-51 1483 16 effect effect NOUN aji-51 1483 17 194 194 NUM aji-51 1483 18 . . PUNCT aji-51 1484 1 mole mole PROPN aji-51 1484 2 rh rh PROPN aji-51 1484 3 . . PROPN aji-51 1484 4 whole whole ADJ aji-51 1484 5 body body NOUN aji-51 1484 6 irradiation irradiation NOUN aji-51 1484 7 ; ; PUNCT aji-51 1484 8 radiobiology radiobiology NOUN aji-51 1484 9 or or CCONJ aji-51 1484 10 medicine medicine NOUN aji-51 1484 11 ? ? PUNCT aji-51 1485 1 br br PROPN aji-51 1485 2 j j PROPN aji-51 1485 3 radiol radiol PROPN aji-51 1485 4 . . PUNCT aji-51 1486 1 1953 1953 NUM aji-51 1486 2 may;26(305):234 may;26(305):234 NOUN aji-51 1486 3 - - PUNCT aji-51 1486 4 41 41 NUM aji-51 1486 5 . . PUNCT aji-51 1487 1 doi doi NOUN aji-51 1487 2 : : PUNCT aji-51 1487 3 10.1259/0007 10.1259/0007 NUM aji-51 1487 4 - - SYM aji-51 1487 5 1285 1285 NUM aji-51 1487 6 - - PUNCT aji-51 1487 7 26 26 NUM aji-51 1487 8 - - PUNCT aji-51 1487 9 305 305 NUM aji-51 1487 10 - - SYM aji-51 1487 11 234 234 NUM aji-51 1487 12 pmid pmid NOUN aji-51 1487 13 : : PUNCT aji-51 1487 14 13042090 13042090 NUM aji-51 1487 15 . . PUNCT aji-51 1488 1 195 195 NUM aji-51 1488 2 . . PUNCT aji-51 1488 3 demaria demaria PROPN aji-51 1488 4 s s PROPN aji-51 1488 5 , , PUNCT aji-51 1488 6 formenti formenti PROPN aji-51 1488 7 sc sc PROPN aji-51 1488 8 . . PUNCT aji-51 1489 1 the the DET aji-51 1489 2 abscopal abscopal ADJ aji-51 1489 3 effect effect NOUN aji-51 1489 4 67 67 NUM aji-51 1489 5 years year NOUN aji-51 1489 6 later later ADV aji-51 1489 7 : : PUNCT aji-51 1489 8 from from ADP aji-51 1489 9 a a DET aji-51 1489 10 side side NOUN aji-51 1489 11 story story NOUN aji-51 1489 12 to to ADP aji-51 1489 13 center center ADJ aji-51 1489 14 stage stage NOUN aji-51 1489 15 . . PUNCT aji-51 1490 1 br br PROPN aji-51 1490 2 j j PROPN aji-51 1490 3 radiol radiol PROPN aji-51 1490 4 . . PUNCT aji-51 1491 1 2020 2020 NUM aji-51 1491 2 may may AUX aji-51 1491 3 1;93(1109):20200042 1;93(1109):20200042 NUM aji-51 1491 4 . . PUNCT aji-51 1492 1 doi doi NOUN aji-51 1492 2 : : PUNCT aji-51 1492 3 10.1259 10.1259 NUM aji-51 1492 4 / / SYM aji-51 1492 5 bjr.20200042 bjr.20200042 NUM aji-51 1492 6 epub epub NOUN aji-51 1492 7 2020 2020 NUM aji-51 1492 8 feb feb PROPN aji-51 1492 9 28 28 NUM aji-51 1492 10 . . PUNCT aji-51 1493 1 pmid pmid NOUN aji-51 1493 2 : : PUNCT aji-51 1493 3 32101479 32101479 NUM aji-51 1493 4 ; ; PUNCT aji-51 1493 5 pmcid pmcid ADJ aji-51 1493 6 : : PUNCT aji-51 1493 7 pmc7217574 pmc7217574 NOUN aji-51 1493 8 . . PUNCT aji-51 1494 1 196 196 NUM aji-51 1494 2 . . PUNCT aji-51 1495 1 hodi hodi PROPN aji-51 1495 2 fs fs PROPN aji-51 1495 3 , , PUNCT aji-51 1495 4 dranoff dranoff PROPN aji-51 1495 5 g. g. PROPN aji-51 1495 6 the the DET aji-51 1495 7 biologic biologic NOUN aji-51 1495 8 importance importance NOUN aji-51 1495 9 of of ADP aji-51 1495 10 tumor tumor NOUN aji-51 1495 11 - - PUNCT aji-51 1495 12 infiltrating infiltrate VERB aji-51 1495 13 lymphocytes lymphocyte NOUN aji-51 1495 14 . . PUNCT aji-51 1496 1 j j PROPN aji-51 1496 2 cutan cutan PROPN aji-51 1496 3 pathol pathol PROPN aji-51 1496 4 . . PUNCT aji-51 1497 1 2010 2010 NUM aji-51 1497 2 apr;37 apr;37 NOUN aji-51 1497 3 suppl suppl ADJ aji-51 1497 4 1(01):48 1(01):48 PROPN aji-51 1497 5 - - SYM aji-51 1497 6 53 53 NUM aji-51 1497 7 . . PUNCT aji-51 1497 8 doi doi NOUN aji-51 1497 9 : : PUNCT aji-51 1497 10 10.1111 10.1111 NUM aji-51 1497 11 / / SYM aji-51 1497 12 j.1600 j.1600 NOUN aji-51 1497 13 - - PUNCT aji-51 1497 14 0560.2010.01506.x 0560.2010.01506.x VERB aji-51 1497 15 pmid pmid NOUN aji-51 1497 16 : : PUNCT aji-51 1497 17 20482675 20482675 NUM aji-51 1497 18 ; ; PUNCT aji-51 1497 19 pmcid pmcid ADJ aji-51 1497 20 : : PUNCT aji-51 1497 21 pmc3905324 pmc3905324 NOUN aji-51 1497 22 . . PUNCT aji-51 1498 1 stoff stoff PROPN aji-51 1498 2 ; ; PUNCT aji-51 1498 3 aji aji PROPN aji-51 1498 4 , , PUNCT aji-51 1498 5 5(1 5(1 NUM aji-51 1498 6 ): ): PUNCT aji-51 1498 7 1 1 NUM aji-51 1498 8 - - SYM aji-51 1498 9 39 39 NUM aji-51 1498 10 , , PUNCT aji-51 1498 11 2022 2022 NUM aji-51 1498 12 ; ; PUNCT aji-51 1498 13 article article NOUN aji-51 1498 14 no.aji.77967 no.aji.77967 PROPN aji-51 1498 15 30 30 NUM aji-51 1498 16 197 197 NUM aji-51 1498 17 . . PUNCT aji-51 1499 1 abdo abdo PROPN aji-51 1499 2 j j PROPN aji-51 1499 3 , , PUNCT aji-51 1499 4 cornell cornell PROPN aji-51 1499 5 dl dl PROPN aji-51 1499 6 , , PUNCT aji-51 1499 7 mittal mittal PROPN aji-51 1499 8 sk sk PROPN aji-51 1499 9 , , PUNCT aji-51 1499 10 agrawal agrawal PROPN aji-51 1499 11 dk dk PROPN aji-51 1499 12 . . PROPN aji-51 1499 13 immunotherapy immunotherapy PROPN aji-51 1499 14 plus plus CCONJ aji-51 1499 15 cryotherapy cryotherapy NOUN aji-51 1499 16 : : PUNCT aji-51 1499 17 potential potential ADJ aji-51 1499 18 augmented augment VERB aji-51 1499 19 abscopal abscopal ADJ aji-51 1499 20 effect effect NOUN aji-51 1499 21 for for ADP aji-51 1499 22 advanced advanced ADJ aji-51 1499 23 cancers cancer NOUN aji-51 1499 24 . . PUNCT aji-51 1500 1 front front ADJ aji-51 1500 2 oncol oncol ADJ aji-51 1500 3 . . PUNCT aji-51 1501 1 2018 2018 NUM aji-51 1501 2 mar mar PROPN aji-51 1501 3 28;8:85 28;8:85 NUM aji-51 1501 4 . . PUNCT aji-51 1501 5 doi doi NOUN aji-51 1501 6 : : PUNCT aji-51 1501 7 10.3389 10.3389 NUM aji-51 1501 8 / / SYM aji-51 1501 9 fonc.2018.00085 fonc.2018.00085 ADJ aji-51 1501 10 pmid pmid PROPN aji-51 1501 11 : : PUNCT aji-51 1501 12 29644213 29644213 NUM aji-51 1501 13 ; ; PUNCT aji-51 1501 14 pmcid pmcid NOUN aji-51 1501 15 : : PUNCT aji-51 1501 16 pmc5882833 pmc5882833 NOUN aji-51 1501 17 . . PUNCT aji-51 1502 1 198 198 NUM aji-51 1502 2 . . PUNCT aji-51 1503 1 yang yang PROPN aji-51 1503 2 x x PROPN aji-51 1503 3 , , PUNCT aji-51 1503 4 guo guo PROPN aji-51 1503 5 y y PROPN aji-51 1503 6 , , PUNCT aji-51 1503 7 guo guo PROPN aji-51 1503 8 z z PROPN aji-51 1503 9 , , PUNCT aji-51 1503 10 si si PROPN aji-51 1503 11 t t PROPN aji-51 1503 12 , , PUNCT aji-51 1503 13 xing xing PROPN aji-51 1503 14 w w PROPN aji-51 1503 15 , , PUNCT aji-51 1503 16 yu yu PROPN aji-51 1503 17 w w PROPN aji-51 1503 18 , , PUNCT aji-51 1503 19 wang wang PROPN aji-51 1503 20 y. y. PROPN aji-51 1503 21 cryoablation cryoablation PROPN aji-51 1503 22 inhibition inhibition NOUN aji-51 1503 23 of of ADP aji-51 1503 24 distant distant ADJ aji-51 1503 25 untreated untreated ADJ aji-51 1503 26 tumors tumor NOUN aji-51 1503 27 ( ( PUNCT aji-51 1503 28 abscopal abscopal ADJ aji-51 1503 29 effect effect NOUN aji-51 1503 30 ) ) PUNCT aji-51 1503 31 is be AUX aji-51 1503 32 immune immune ADJ aji-51 1503 33 mediated mediate VERB aji-51 1503 34 . . PUNCT aji-51 1504 1 oncotarget oncotarget NOUN aji-51 1504 2 . . PUNCT aji-51 1505 1 2018 2018 NUM aji-51 1505 2 jan jan PROPN aji-51 1505 3 18;10(41):4180 18;10(41):4180 PROPN aji-51 1505 4 - - PUNCT aji-51 1505 5 4191 4191 NUM aji-51 1505 6 . . PUNCT aji-51 1506 1 doi doi NOUN aji-51 1506 2 : : PUNCT aji-51 1506 3 10.18632 10.18632 NUM aji-51 1506 4 / / SYM aji-51 1506 5 oncotarget.24105 oncotarget.24105 PROPN aji-51 1506 6 pmid pmid PROPN aji-51 1506 7 : : PUNCT aji-51 1506 8 31289616 31289616 NUM aji-51 1506 9 ; ; PUNCT aji-51 1506 10 pmcid pmcid ADJ aji-51 1506 11 : : PUNCT aji-51 1506 12 pmc6609244 pmc6609244 NOUN aji-51 1506 13 . . PUNCT aji-51 1507 1 199 199 NUM aji-51 1507 2 . . PUNCT aji-51 1508 1 dewan dewan PROPN aji-51 1508 2 mz mz PROPN aji-51 1508 3 , , PUNCT aji-51 1508 4 galloway galloway PROPN aji-51 1508 5 ae ae PROPN aji-51 1508 6 , , PUNCT aji-51 1508 7 kawashima kawashima PROPN aji-51 1508 8 n n CCONJ aji-51 1508 9 , , PUNCT aji-51 1508 10 dewyngaert dewyngaert PROPN aji-51 1508 11 jk jk PROPN aji-51 1508 12 , , PUNCT aji-51 1508 13 babb babb PROPN aji-51 1508 14 js js PROPN aji-51 1508 15 , , PUNCT aji-51 1508 16 formenti formenti PROPN aji-51 1508 17 sc sc PROPN aji-51 1508 18 , , PUNCT aji-51 1508 19 demaria demaria PROPN aji-51 1508 20 s. s. PROPN aji-51 1508 21 fractionated fractionate VERB aji-51 1508 22 but but CCONJ aji-51 1508 23 not not PART aji-51 1508 24 singledose singledose NOUN aji-51 1508 25 radiotherapy radiotherapy NOUN aji-51 1508 26 induces induce VERB aji-51 1508 27 an an DET aji-51 1508 28 immunemediated immunemediate VERB aji-51 1508 29 abscopal abscopal ADJ aji-51 1508 30 effect effect NOUN aji-51 1508 31 when when SCONJ aji-51 1508 32 combined combine VERB aji-51 1508 33 with with ADP aji-51 1508 34 anti anti ADJ aji-51 1508 35 - - ADJ aji-51 1508 36 ctla-4 ctla-4 ADJ aji-51 1508 37 antibody antibody NOUN aji-51 1508 38 . . PUNCT aji-51 1509 1 clin clin PROPN aji-51 1509 2 cancer cancer NOUN aji-51 1509 3 res re NOUN aji-51 1509 4 . . PUNCT aji-51 1510 1 2009 2009 NUM aji-51 1510 2 sep sep NOUN aji-51 1510 3 1;15(17):5379 1;15(17):5379 NUM aji-51 1510 4 - - SYM aji-51 1510 5 88 88 NUM aji-51 1510 6 . . PUNCT aji-51 1511 1 doi doi NOUN aji-51 1511 2 : : PUNCT aji-51 1511 3 10.1158/1078 10.1158/1078 NUM aji-51 1511 4 - - PUNCT aji-51 1511 5 0432.ccr-09 0432.ccr-09 PROPN aji-51 1511 6 - - PUNCT aji-51 1511 7 0265 0265 NUM aji-51 1511 8 epub epub NOUN aji-51 1511 9 2009 2009 NUM aji-51 1511 10 aug aug PROPN aji-51 1511 11 25 25 NUM aji-51 1511 12 . . PUNCT aji-51 1512 1 pmid pmid NOUN aji-51 1512 2 : : PUNCT aji-51 1512 3 19706802 19706802 NUM aji-51 1512 4 ; ; PUNCT aji-51 1512 5 pmcid pmcid ADJ aji-51 1512 6 : : PUNCT aji-51 1512 7 pmc2746048 pmc2746048 ADJ aji-51 1512 8 . . PUNCT aji-51 1513 1 200 200 NUM aji-51 1513 2 . . PUNCT aji-51 1514 1 liu liu PROPN aji-51 1514 2 sz sz PROPN aji-51 1514 3 . . PUNCT aji-51 1514 4 cancer cancer NOUN aji-51 1514 5 control control NOUN aji-51 1514 6 related relate VERB aji-51 1514 7 to to ADP aji-51 1514 8 stimulation stimulation NOUN aji-51 1514 9 of of ADP aji-51 1514 10 immunity immunity NOUN aji-51 1514 11 by by ADP aji-51 1514 12 low low ADJ aji-51 1514 13 - - PUNCT aji-51 1514 14 dose dose NOUN aji-51 1514 15 radiation radiation NOUN aji-51 1514 16 . . PUNCT aji-51 1515 1 dose dose NOUN aji-51 1515 2 response response NOUN aji-51 1515 3 . . PUNCT aji-51 1516 1 2006 2006 NUM aji-51 1516 2 aug aug PROPN aji-51 1516 3 28;5(1):39 28;5(1):39 NUM aji-51 1516 4 - - SYM aji-51 1516 5 47 47 NUM aji-51 1516 6 . . PUNCT aji-51 1517 1 doi doi NOUN aji-51 1517 2 : : PUNCT aji-51 1517 3 10.2203 10.2203 NUM aji-51 1517 4 / / SYM aji-51 1517 5 dose dose NOUN aji-51 1517 6 - - PUNCT aji-51 1517 7 response.06 response.06 NOUN aji-51 1517 8 - - PUNCT aji-51 1517 9 108.liu 108.liu NUM aji-51 1517 10 pmid pmid NOUN aji-51 1517 11 : : PUNCT aji-51 1517 12 18648611 18648611 NUM aji-51 1517 13 ; ; PUNCT aji-51 1517 14 pmcid pmcid ADJ aji-51 1517 15 : : PUNCT aji-51 1517 16 pmc2477702 pmc2477702 NOUN aji-51 1517 17 . . PUNCT aji-51 1517 18 201 201 NUM aji-51 1517 19 . . PUNCT aji-51 1518 1 liu liu PROPN aji-51 1518 2 sz sz PROPN aji-51 1518 3 . . PUNCT aji-51 1519 1 nonlinear nonlinear PROPN aji-51 1519 2 dose dose PROPN aji-51 1519 3 - - PUNCT aji-51 1519 4 response response NOUN aji-51 1519 5 relationship relationship NOUN aji-51 1519 6 in in ADP aji-51 1519 7 the the DET aji-51 1519 8 immune immune ADJ aji-51 1519 9 system system NOUN aji-51 1519 10 following follow VERB aji-51 1519 11 exposure exposure NOUN aji-51 1519 12 to to ADP aji-51 1519 13 ionizing ionize VERB aji-51 1519 14 radiation radiation NOUN aji-51 1519 15 : : PUNCT aji-51 1519 16 mechanisms mechanism NOUN aji-51 1519 17 and and CCONJ aji-51 1519 18 implications implication NOUN aji-51 1519 19 . . PUNCT aji-51 1520 1 nonlinearity nonlinearity NOUN aji-51 1520 2 biol biol PROPN aji-51 1520 3 toxicol toxicol PROPN aji-51 1520 4 med me VERB aji-51 1520 5 . . PUNCT aji-51 1520 6 2003 2003 NUM aji-51 1521 1 jan;1(1):71 jan;1(1):71 VERB aji-51 1521 2 - - X aji-51 1521 3 92 92 NUM aji-51 1521 4 . . PUNCT aji-51 1522 1 doi doi NOUN aji-51 1522 2 : : PUNCT aji-51 1522 3 10.1080/15401420390844483 10.1080/15401420390844483 NUM aji-51 1522 4 pmid pmid PROPN aji-51 1522 5 : : PUNCT aji-51 1522 6 19330113 19330113 NUM aji-51 1522 7 ; ; PUNCT aji-51 1522 8 pmcid pmcid ADJ aji-51 1522 9 : : PUNCT aji-51 1522 10 pmc2651616 pmc2651616 NOUN aji-51 1522 11 . . PUNCT aji-51 1523 1 202 202 NUM aji-51 1523 2 . . PUNCT aji-51 1524 1 zhou zhou PROPN aji-51 1524 2 l l PROPN aji-51 1524 3 , , PUNCT aji-51 1524 4 zhang zhang PROPN aji-51 1524 5 x x PROPN aji-51 1524 6 , , PUNCT aji-51 1524 7 li li PROPN aji-51 1524 8 h h PROPN aji-51 1524 9 , , PUNCT aji-51 1524 10 niu niu PROPN aji-51 1524 11 c c PROPN aji-51 1524 12 , , PUNCT aji-51 1524 13 yu yu PROPN aji-51 1525 1 d d PROPN aji-51 1525 2 , , PUNCT aji-51 1525 3 yang yang PROPN aji-51 1525 4 g g PROPN aji-51 1525 5 , , PUNCT aji-51 1525 6 liang liang PROPN aji-51 1525 7 x x PROPN aji-51 1525 8 , , PUNCT aji-51 1525 9 wen wen PROPN aji-51 1525 10 x x PROPN aji-51 1525 11 , , PUNCT aji-51 1525 12 li li PROPN aji-51 1525 13 m m PROPN aji-51 1525 14 , , PUNCT aji-51 1525 15 cui cui VERB aji-51 1525 16 j. j. PROPN aji-51 1525 17 validating validate VERB aji-51 1525 18 the the DET aji-51 1525 19 pivotal pivotal ADJ aji-51 1525 20 role role NOUN aji-51 1525 21 of of ADP aji-51 1525 22 the the DET aji-51 1525 23 immune immune ADJ aji-51 1525 24 system system NOUN aji-51 1525 25 in in ADP aji-51 1525 26 low low ADJ aji-51 1525 27 - - PUNCT aji-51 1525 28 dose dose NOUN aji-51 1525 29 radiation radiation NOUN aji-51 1525 30 - - PUNCT aji-51 1525 31 induced induce VERB aji-51 1525 32 tumor tumor NOUN aji-51 1525 33 inhibition inhibition NOUN aji-51 1525 34 in in ADP aji-51 1525 35 lewis lewis PROPN aji-51 1525 36 lung lung NOUN aji-51 1525 37 cancer cancer NOUN aji-51 1525 38 - - PUNCT aji-51 1525 39 bearing bear VERB aji-51 1525 40 mice mouse NOUN aji-51 1525 41 . . PUNCT aji-51 1526 1 cancer cancer NOUN aji-51 1526 2 med med PROPN aji-51 1526 3 . . PUNCT aji-51 1527 1 2018 2018 NUM aji-51 1527 2 apr;7(4):1338 apr;7(4):1338 NOUN aji-51 1527 3 - - PUNCT aji-51 1527 4 1348 1348 NUM aji-51 1527 5 . . PUNCT aji-51 1528 1 doi doi NOUN aji-51 1528 2 : : PUNCT aji-51 1528 3 10.1002 10.1002 NUM aji-51 1528 4 / / SYM aji-51 1528 5 cam4.1344 cam4.1344 PROPN aji-51 1528 6 epub epub PROPN aji-51 1528 7 2018 2018 NUM aji-51 1528 8 feb feb NOUN aji-51 1528 9 25 25 NUM aji-51 1528 10 . . PUNCT aji-51 1529 1 pmid pmid NOUN aji-51 1529 2 : : PUNCT aji-51 1529 3 29479834 29479834 NUM aji-51 1529 4 ; ; PUNCT aji-51 1529 5 pmcid pmcid ADJ aji-51 1529 6 : : PUNCT aji-51 1529 7 pmc5911597 pmc5911597 NOUN aji-51 1529 8 . . PUNCT aji-51 1530 1 203 203 NUM aji-51 1530 2 . . PUNCT aji-51 1531 1 takahashi takahashi PROPN aji-51 1531 2 y y PROPN aji-51 1531 3 , , PUNCT aji-51 1531 4 matsutani matsutani PROPN aji-51 1531 5 n n CCONJ aji-51 1531 6 , , PUNCT aji-51 1531 7 nakayama nakayama PROPN aji-51 1531 8 t t PROPN aji-51 1531 9 , , PUNCT aji-51 1531 10 dejima dejima PROPN aji-51 1531 11 h h PROPN aji-51 1531 12 , , PUNCT aji-51 1531 13 uehara uehara PROPN aji-51 1531 14 h h PROPN aji-51 1531 15 , , PUNCT aji-51 1531 16 kawamura kawamura PROPN aji-51 1531 17 m. m. PROPN aji-51 1531 18 immunological immunological ADJ aji-51 1531 19 effect effect NOUN aji-51 1531 20 of of ADP aji-51 1531 21 local local ADJ aji-51 1531 22 ablation ablation NOUN aji-51 1531 23 combined combine VERB aji-51 1531 24 with with ADP aji-51 1531 25 immunotherapy immunotherapy NOUN aji-51 1531 26 on on ADP aji-51 1531 27 solid solid ADJ aji-51 1531 28 malignancies malignancy NOUN aji-51 1531 29 . . PUNCT aji-51 1532 1 chin chin PROPN aji-51 1532 2 j j PROPN aji-51 1532 3 cancer cancer PROPN aji-51 1532 4 . . PUNCT aji-51 1533 1 2017 2017 NUM aji-51 1533 2 jun jun PROPN aji-51 1533 3 7;36(1):49 7;36(1):49 NUM aji-51 1533 4 . . PUNCT aji-51 1533 5 doi doi NOUN aji-51 1533 6 : : PUNCT aji-51 1533 7 10.1186 10.1186 NUM aji-51 1533 8 / / SYM aji-51 1533 9 s40880 s40880 VERB aji-51 1533 10 - - PUNCT aji-51 1533 11 017 017 NUM aji-51 1533 12 - - PUNCT aji-51 1533 13 0216 0216 NUM aji-51 1533 14 - - SYM aji-51 1533 15 5 5 NUM aji-51 1533 16 pmid pmid NOUN aji-51 1533 17 : : PUNCT aji-51 1533 18 28592286 28592286 NUM aji-51 1533 19 ; ; PUNCT aji-51 1533 20 pmcid pmcid ADJ aji-51 1533 21 : : PUNCT aji-51 1533 22 pmc5463413 pmc5463413 ADJ aji-51 1533 23 . . PUNCT aji-51 1534 1 204 204 NUM aji-51 1534 2 . . PUNCT aji-51 1534 3 mauri mauri PROPN aji-51 1534 4 g g PROPN aji-51 1534 5 , , PUNCT aji-51 1534 6 nicosia nicosia PROPN aji-51 1534 7 l l PROPN aji-51 1534 8 , , PUNCT aji-51 1534 9 xu xu PROPN aji-51 1535 1 z z X aji-51 1535 2 , , PUNCT aji-51 1535 3 di di PROPN aji-51 1535 4 pietro pietro PROPN aji-51 1535 5 s s PROPN aji-51 1535 6 , , PUNCT aji-51 1535 7 monfardini monfardini ADJ aji-51 1535 8 l l NOUN aji-51 1535 9 , , PUNCT aji-51 1535 10 bonomo bonomo NOUN aji-51 1535 11 g g NOUN aji-51 1535 12 , , PUNCT aji-51 1535 13 varano varano VERB aji-51 1535 14 gm gm PROPN aji-51 1535 15 , , PUNCT aji-51 1535 16 prada prada PROPN aji-51 1535 17 f f PROPN aji-51 1535 18 , , PUNCT aji-51 1535 19 della della PROPN aji-51 1535 20 vigna vigna PROPN aji-51 1535 21 p p PROPN aji-51 1535 22 , , PUNCT aji-51 1535 23 orsi orsi PROPN aji-51 1535 24 f. f. PROPN aji-51 1535 25 focused focus VERB aji-51 1535 26 ultrasound ultrasound PROPN aji-51 1535 27 : : PUNCT aji-51 1535 28 tumour tumour ADJ aji-51 1535 29 ablation ablation NOUN aji-51 1535 30 and and CCONJ aji-51 1535 31 its its PRON aji-51 1535 32 potential potential NOUN aji-51 1535 33 to to PART aji-51 1535 34 enhance enhance VERB aji-51 1535 35 immunological immunological ADJ aji-51 1535 36 therapy therapy NOUN aji-51 1535 37 to to ADP aji-51 1535 38 cancer cancer NOUN aji-51 1535 39 . . PUNCT aji-51 1536 1 br br PROPN aji-51 1536 2 j j PROPN aji-51 1536 3 radiol radiol PROPN aji-51 1536 4 . . PUNCT aji-51 1537 1 2018 2018 NUM aji-51 1537 2 feb;91(1083):20170641 feb;91(1083):20170641 NOUN aji-51 1537 3 . . PUNCT aji-51 1538 1 doi doi NOUN aji-51 1538 2 : : PUNCT aji-51 1538 3 10.1259 10.1259 NUM aji-51 1538 4 / / SYM aji-51 1538 5 bjr.20170641 bjr.20170641 PROPN aji-51 1538 6 epub epub PROPN aji-51 1538 7 2018 2018 NUM aji-51 1538 8 jan jan PROPN aji-51 1538 9 17 17 NUM aji-51 1538 10 . . PUNCT aji-51 1539 1 pmid pmid NOUN aji-51 1539 2 : : PUNCT aji-51 1539 3 29168922 29168922 NUM aji-51 1539 4 ; ; PUNCT aji-51 1539 5 pmcid pmcid ADJ aji-51 1539 6 : : PUNCT aji-51 1539 7 pmc5965486 pmc5965486 NOUN aji-51 1539 8 . . PUNCT aji-51 1540 1 205 205 NUM aji-51 1540 2 . . PUNCT aji-51 1541 1 ko ko PROPN aji-51 1541 2 ec ec PROPN aji-51 1541 3 , , PUNCT aji-51 1541 4 formenti formenti PROPN aji-51 1541 5 sc sc PROPN aji-51 1541 6 . . PROPN aji-51 1541 7 radiotherapy radiotherapy PROPN aji-51 1541 8 and and CCONJ aji-51 1541 9 checkpoint checkpoint NOUN aji-51 1541 10 inhibitors inhibitor NOUN aji-51 1541 11 : : PUNCT aji-51 1541 12 a a DET aji-51 1541 13 winning win VERB aji-51 1541 14 new new ADJ aji-51 1541 15 combination combination NOUN aji-51 1541 16 ? ? PUNCT aji-51 1542 1 ther ther INTJ aji-51 1542 2 adv adv PROPN aji-51 1542 3 med med PROPN aji-51 1542 4 oncol oncol ADJ aji-51 1542 5 . . PUNCT aji-51 1543 1 2018 2018 NUM aji-51 1543 2 apr apr NOUN aji-51 1543 3 11;10:1758835918768240 11;10:1758835918768240 NUM aji-51 1543 4 . . PUNCT aji-51 1544 1 doi doi NOUN aji-51 1544 2 : : PUNCT aji-51 1544 3 10.1177/1758835918768240 10.1177/1758835918768240 NUM aji-51 1544 4 pmid pmid NOUN aji-51 1544 5 : : PUNCT aji-51 1544 6 29662550 29662550 NUM aji-51 1544 7 ; ; PUNCT aji-51 1544 8 pmcid pmcid ADJ aji-51 1544 9 : : PUNCT aji-51 1544 10 pmc5898659 pmc5898659 NOUN aji-51 1544 11 . . PUNCT aji-51 1545 1 206 206 NUM aji-51 1545 2 . . PUNCT aji-51 1546 1 zhao zhao PROPN aji-51 1546 2 x x PROPN aji-51 1546 3 , , PUNCT aji-51 1546 4 shao shao PROPN aji-51 1546 5 c. c. PROPN aji-51 1546 6 radiotherapy radiotherapy PROPN aji-51 1546 7 - - PUNCT aji-51 1546 8 mediated mediate VERB aji-51 1546 9 immunomodulation immunomodulation NOUN aji-51 1546 10 and and CCONJ aji-51 1546 11 anti anti ADJ aji-51 1546 12 - - ADJ aji-51 1546 13 tumor tumor ADJ aji-51 1546 14 abscopal abscopal ADJ aji-51 1546 15 effect effect NOUN aji-51 1546 16 combining combine VERB aji-51 1546 17 immune immune ADJ aji-51 1546 18 checkpoint checkpoint NOUN aji-51 1546 19 blockade blockade NOUN aji-51 1546 20 . . PUNCT aji-51 1547 1 cancers cancer NOUN aji-51 1547 2 ( ( PUNCT aji-51 1547 3 basel basel PROPN aji-51 1547 4 ) ) PUNCT aji-51 1547 5 . . PUNCT aji-51 1548 1 2020 2020 NUM aji-51 1548 2 sep sep NOUN aji-51 1548 3 25;12(10):2762 25;12(10):2762 NUM aji-51 1548 4 . . PUNCT aji-51 1549 1 doi doi NOUN aji-51 1549 2 : : PUNCT aji-51 1549 3 10.3390 10.3390 NUM aji-51 1549 4 / / SYM aji-51 1549 5 cancers12102762 cancers12102762 PROPN aji-51 1549 6 pmid pmid PROPN aji-51 1549 7 : : PUNCT aji-51 1549 8 32992835 32992835 NUM aji-51 1549 9 ; ; PUNCT aji-51 1549 10 pmcid pmcid PROPN aji-51 1549 11 : : PUNCT aji-51 1549 12 pmc7600068 pmc7600068 PROPN aji-51 1549 13 . . PUNCT aji-51 1550 1 207 207 NUM aji-51 1550 2 . . PUNCT aji-51 1551 1 stoff stoff PROPN aji-51 1551 2 ja ja PROPN aji-51 1551 3 , , PUNCT aji-51 1551 4 clinical clinical ADJ aji-51 1551 5 onco onco NOUN aji-51 1551 6 - - PUNCT aji-51 1551 7 immunology immunology NOUN aji-51 1551 8 : : PUNCT aji-51 1551 9 immune immune ADJ aji-51 1551 10 reconstitution reconstitution NOUN aji-51 1551 11 , , PUNCT aji-51 1551 12 a a DET aji-51 1551 13 place place NOUN aji-51 1551 14 to to PART aji-51 1551 15 start start VERB aji-51 1551 16 . . PUNCT aji-51 1552 1 current current ADJ aji-51 1552 2 trends trend NOUN aji-51 1552 3 in in ADP aji-51 1552 4 immunology immunology NOUN aji-51 1552 5 . . PUNCT aji-51 1553 1 2020;21:115 2020;21:115 NOUN aji-51 1553 2 . . PUNCT aji-51 1554 1 issn issn PROPN aji-51 1554 2 : : PUNCT aji-51 1554 3 0972 0972 NUM aji-51 1554 4 - - SYM aji-51 1554 5 4567 4567 NUM aji-51 1554 6 208 208 NUM aji-51 1554 7 . . PUNCT aji-51 1555 1 caris caris PROPN aji-51 1555 2 life life PROPN aji-51 1555 3 sciences sciences PROPN aji-51 1555 4 , , PUNCT aji-51 1555 5 immunotherapy immunotherapy NOUN aji-51 1555 6 . . PUNCT aji-51 1556 1 available available ADJ aji-51 1556 2 : : PUNCT aji-51 1556 3 https://www.carislifesciences.com https://www.carislifesciences.com NUM aji-51 1556 4 / / SYM aji-51 1556 5 cmioverview cmioverview NOUN aji-51 1556 6 / / SYM aji-51 1556 7 immunotherapy/ immunotherapy/ NUM aji-51 1556 8 accessed access VERB aji-51 1556 9 : : PUNCT aji-51 1556 10 august august PROPN aji-51 1556 11 10 10 NUM aji-51 1556 12 , , PUNCT aji-51 1556 13 2018 2018 NUM aji-51 1556 14 209 209 NUM aji-51 1556 15 . . PUNCT aji-51 1557 1 korneev korneev PROPN aji-51 1557 2 kv kv PROPN aji-51 1557 3 , , PUNCT aji-51 1557 4 atretkhany atretkhany ADJ aji-51 1557 5 kn kn PROPN aji-51 1557 6 , , PUNCT aji-51 1557 7 drutskaya drutskaya PROPN aji-51 1557 8 ms ms PROPN aji-51 1557 9 , , PUNCT aji-51 1557 10 grivennikov grivennikov PROPN aji-51 1557 11 si si PROPN aji-51 1557 12 , , PUNCT aji-51 1557 13 kuprash kuprash PROPN aji-51 1557 14 dv dv PROPN aji-51 1557 15 , , PUNCT aji-51 1557 16 nedospasov nedospasov PROPN aji-51 1557 17 sa sa PROPN aji-51 1557 18 . . PUNCT aji-51 1558 1 tlr tlr PROPN aji-51 1558 2 - - PUNCT aji-51 1558 3 signaling signal VERB aji-51 1558 4 and and CCONJ aji-51 1558 5 proinflammatory proinflammatory ADJ aji-51 1558 6 cytokines cytokine NOUN aji-51 1558 7 as as ADP aji-51 1558 8 drivers driver NOUN aji-51 1558 9 of of ADP aji-51 1558 10 tumorigenesis tumorigenesis NOUN aji-51 1558 11 . . PUNCT aji-51 1559 1 cytokine cytokine NOUN aji-51 1559 2 . . PUNCT aji-51 1560 1 2017 2017 NUM aji-51 1560 2 jan;89:127135 jan;89:127135 NOUN aji-51 1560 3 . . PUNCT aji-51 1561 1 doi doi NOUN aji-51 1561 2 : : PUNCT aji-51 1561 3 10.1016 10.1016 NUM aji-51 1561 4 / / SYM aji-51 1561 5 j.cyto.2016.01.021 j.cyto.2016.01.021 PROPN aji-51 1561 6 epub epub PROPN aji-51 1561 7 2016 2016 NUM aji-51 1561 8 feb feb NOUN aji-51 1561 9 4 4 NUM aji-51 1561 10 . . PUNCT aji-51 1562 1 pmid pmid NOUN aji-51 1562 2 : : PUNCT aji-51 1562 3 26854213 26854213 NUM aji-51 1562 4 . . PUNCT aji-51 1563 1 210 210 NUM aji-51 1563 2 . . PUNCT aji-51 1564 1 riddell riddell PROPN aji-51 1564 2 sr sr PROPN aji-51 1564 3 . . PUNCT aji-51 1565 1 progress progress PROPN aji-51 1565 2 in in ADP aji-51 1565 3 cancer cancer NOUN aji-51 1565 4 vaccines vaccine NOUN aji-51 1565 5 by by ADP aji-51 1565 6 enhanced enhance VERB aji-51 1565 7 self self NOUN aji-51 1565 8 - - PUNCT aji-51 1565 9 presentation presentation NOUN aji-51 1565 10 . . PUNCT aji-51 1566 1 proceedings proceeding NOUN aji-51 1566 2 of of ADP aji-51 1566 3 the the DET aji-51 1566 4 national national ADJ aji-51 1566 5 acadamy acadamy NOUN aji-51 1566 6 of of ADP aji-51 1566 7 sciences science NOUN aji-51 1566 8 of of ADP aji-51 1566 9 the the DET aji-51 1566 10 united united PROPN aji-51 1566 11 states states PROPN aji-51 1566 12 of of ADP aji-51 1566 13 america america PROPN aji-51 1566 14 . . PUNCT aji-51 1567 1 2001;98(16):8933–8935 2001;98(16):8933–8935 ADV aji-51 1567 2 . . PUNCT aji-51 1568 1 211 211 NUM aji-51 1568 2 . . PUNCT aji-51 1569 1 syn syn PROPN aji-51 1569 2 nl nl PROPN aji-51 1569 3 , , PUNCT aji-51 1569 4 teng teng PROPN aji-51 1569 5 mwl mwl PROPN aji-51 1569 6 , , PUNCT aji-51 1569 7 mok mok PROPN aji-51 1569 8 tsk tsk PROPN aji-51 1569 9 , , PUNCT aji-51 1569 10 soo soo PROPN aji-51 1569 11 ra ra PROPN aji-51 1569 12 . . PUNCT aji-51 1570 1 de de PROPN aji-51 1570 2 - - NOUN aji-51 1570 3 novo novo NOUN aji-51 1570 4 and and CCONJ aji-51 1570 5 acquired acquire VERB aji-51 1570 6 resistance resistance NOUN aji-51 1570 7 to to ADP aji-51 1570 8 immune immune ADJ aji-51 1570 9 checkpoint checkpoint NOUN aji-51 1570 10 targeting target VERB aji-51 1570 11 . . PUNCT aji-51 1571 1 lancet lancet PROPN aji-51 1571 2 oncol oncol PROPN aji-51 1571 3 . . PUNCT aji-51 1572 1 2017 2017 NUM aji-51 1572 2 dec;18(12):e731 dec;18(12):e731 NOUN aji-51 1572 3 - - PUNCT aji-51 1572 4 e741 e741 PROPN aji-51 1572 5 . . PUNCT aji-51 1573 1 doi doi NOUN aji-51 1573 2 : : PUNCT aji-51 1573 3 10.1016 10.1016 NUM aji-51 1573 4 / / SYM aji-51 1573 5 s1470 s1470 PROPN aji-51 1573 6 - - PUNCT aji-51 1573 7 2045(17)30607 2045(17)30607 NUM aji-51 1573 8 - - PUNCT aji-51 1573 9 1 1 NUM aji-51 1573 10 stoff stoff NOUN aji-51 1573 11 ; ; PUNCT aji-51 1573 12 aji aji PROPN aji-51 1573 13 , , PUNCT aji-51 1573 14 5(1 5(1 NUM aji-51 1573 15 ): ): PUNCT aji-51 1573 16 1 1 NUM aji-51 1573 17 - - SYM aji-51 1573 18 39 39 NUM aji-51 1573 19 , , PUNCT aji-51 1573 20 2022 2022 NUM aji-51 1573 21 ; ; PUNCT aji-51 1573 22 article article NOUN aji-51 1573 23 no.aji.77967 no.aji.77967 PROPN aji-51 1573 24 31 31 NUM aji-51 1573 25 pmid pmid NOUN aji-51 1573 26 : : PUNCT aji-51 1573 27 29208439 29208439 NUM aji-51 1573 28 . . PUNCT aji-51 1574 1 212 212 NUM aji-51 1574 2 . . PUNCT aji-51 1574 3 tang tang PROPN aji-51 1574 4 xj xj PROPN aji-51 1574 5 , , PUNCT aji-51 1574 6 sun sun PROPN aji-51 1574 7 xy xy PROPN aji-51 1574 8 , , PUNCT aji-51 1574 9 huang huang PROPN aji-51 1574 10 km km PROPN aji-51 1574 11 , , PUNCT aji-51 1574 12 zhang zhang PROPN aji-51 1574 13 l l PROPN aji-51 1574 14 , , PUNCT aji-51 1574 15 yang yang PROPN aji-51 1574 16 zs zs PROPN aji-51 1574 17 , , PUNCT aji-51 1574 18 zou zou PROPN aji-51 1574 19 dd dd PROPN aji-51 1574 20 , , PUNCT aji-51 1574 21 wang wang PROPN aji-51 1574 22 b b PROPN aji-51 1574 23 , , PUNCT aji-51 1574 24 warnock warnock PROPN aji-51 1574 25 gl gl PROPN aji-51 1574 26 , , PUNCT aji-51 1574 27 dai dai PROPN aji-51 1574 28 lj lj PROPN aji-51 1574 29 , , PUNCT aji-51 1574 30 luo luo PROPN aji-51 1574 31 j. j. PROPN aji-51 1574 32 therapeutic therapeutic ADJ aji-51 1574 33 potential potential NOUN aji-51 1574 34 of of ADP aji-51 1574 35 car car NOUN aji-51 1574 36 - - PUNCT aji-51 1574 37 t t NOUN aji-51 1574 38 cell cell NOUN aji-51 1574 39 - - PUNCT aji-51 1574 40 derived derive VERB aji-51 1574 41 exosomes exosome NOUN aji-51 1574 42 : : PUNCT aji-51 1574 43 a a DET aji-51 1574 44 cell cell NOUN aji-51 1574 45 - - PUNCT aji-51 1574 46 free free ADJ aji-51 1574 47 modality modality NOUN aji-51 1574 48 for for ADP aji-51 1574 49 targeted target VERB aji-51 1574 50 cancer cancer NOUN aji-51 1574 51 therapy therapy NOUN aji-51 1574 52 . . PUNCT aji-51 1575 1 oncotarget oncotarget NOUN aji-51 1575 2 . . PUNCT aji-51 1576 1 2015 2015 NUM aji-51 1576 2 dec dec PROPN aji-51 1576 3 29;6(42):44179 29;6(42):44179 PROPN aji-51 1576 4 - - SYM aji-51 1576 5 90 90 NUM aji-51 1576 6 . . PUNCT aji-51 1577 1 doi doi NOUN aji-51 1577 2 : : PUNCT aji-51 1577 3 10.18632 10.18632 NUM aji-51 1577 4 / / SYM aji-51 1577 5 oncotarget.6175 oncotarget.6175 PROPN aji-51 1577 6 pmid pmid NOUN aji-51 1577 7 : : PUNCT aji-51 1577 8 26496034 26496034 NUM aji-51 1577 9 ; ; PUNCT aji-51 1577 10 pmcid pmcid ADJ aji-51 1577 11 : : PUNCT aji-51 1577 12 pmc4792550 pmc4792550 NOUN aji-51 1577 13 . . PUNCT aji-51 1578 1 213 213 NUM aji-51 1578 2 . . PUNCT aji-51 1579 1 hartmann hartmann PROPN aji-51 1579 2 j j PROPN aji-51 1579 3 , , PUNCT aji-51 1579 4 schüßler schüßler PROPN aji-51 1579 5 - - PUNCT aji-51 1579 6 lenz lenz PROPN aji-51 1579 7 m m PROPN aji-51 1579 8 , , PUNCT aji-51 1579 9 bondanza bondanza VERB aji-51 1579 10 a a PRON aji-51 1579 11 , , PUNCT aji-51 1579 12 buchholz buchholz PROPN aji-51 1579 13 cj cj PROPN aji-51 1579 14 . . PUNCT aji-51 1580 1 clinical clinical ADJ aji-51 1580 2 development development NOUN aji-51 1580 3 of of ADP aji-51 1580 4 car car NOUN aji-51 1580 5 t t NOUN aji-51 1580 6 cells cell NOUN aji-51 1580 7 - - PUNCT aji-51 1580 8 challenges challenge NOUN aji-51 1580 9 and and CCONJ aji-51 1580 10 opportunities opportunity NOUN aji-51 1580 11 in in ADP aji-51 1580 12 translating translate VERB aji-51 1580 13 innovative innovative ADJ aji-51 1580 14 treatment treatment NOUN aji-51 1580 15 concepts concept NOUN aji-51 1580 16 . . PUNCT aji-51 1581 1 embo embo NOUN aji-51 1581 2 mol mol ADP aji-51 1581 3 med med PROPN aji-51 1581 4 . . PUNCT aji-51 1581 5 2017 2017 NUM aji-51 1581 6 sep;9(9):1183 sep;9(9):1183 NOUN aji-51 1581 7 - - PUNCT aji-51 1581 8 1197 1197 NUM aji-51 1581 9 . . PUNCT aji-51 1582 1 doi doi NOUN aji-51 1582 2 : : PUNCT aji-51 1582 3 10.15252 10.15252 NUM aji-51 1582 4 / / SYM aji-51 1582 5 emmm.201607485 emmm.201607485 PROPN aji-51 1582 6 pmid pmid PROPN aji-51 1582 7 : : PUNCT aji-51 1582 8 28765140 28765140 NUM aji-51 1582 9 ; ; PUNCT aji-51 1582 10 pmcid pmcid ADJ aji-51 1582 11 : : PUNCT aji-51 1582 12 pmc5582407 pmc5582407 NOUN aji-51 1582 13 . . PUNCT aji-51 1583 1 214 214 NUM aji-51 1583 2 . . PUNCT aji-51 1584 1 sadelain sadelain PROPN aji-51 1584 2 m m PROPN aji-51 1584 3 , , PUNCT aji-51 1584 4 brentjens brentjen NOUN aji-51 1584 5 r r NOUN aji-51 1584 6 , , PUNCT aji-51 1584 7 rivière rivière PROPN aji-51 1584 8 i. i. PROPN aji-51 1584 9 the the DET aji-51 1584 10 basic basic ADJ aji-51 1584 11 principles principle NOUN aji-51 1584 12 of of ADP aji-51 1584 13 chimeric chimeric ADJ aji-51 1584 14 antigen antigen ADJ aji-51 1584 15 receptor receptor NOUN aji-51 1584 16 design design NOUN aji-51 1584 17 . . PUNCT aji-51 1585 1 cancer cancer NOUN aji-51 1585 2 discov discov NOUN aji-51 1585 3 . . PUNCT aji-51 1586 1 2013 2013 NUM aji-51 1586 2 apr;3(4):388 apr;3(4):388 NOUN aji-51 1586 3 - - PROPN aji-51 1586 4 98 98 NUM aji-51 1586 5 . . PUNCT aji-51 1587 1 doi doi NOUN aji-51 1587 2 : : PUNCT aji-51 1587 3 10.1158/2159 10.1158/2159 NUM aji-51 1587 4 - - PUNCT aji-51 1587 5 8290.cd-12 8290.cd-12 NOUN aji-51 1587 6 - - PUNCT aji-51 1587 7 0548 0548 NUM aji-51 1587 8 epub epub NOUN aji-51 1587 9 2013 2013 NUM aji-51 1587 10 apr apr NOUN aji-51 1587 11 2 2 NUM aji-51 1587 12 . . PUNCT aji-51 1588 1 pmid pmid NOUN aji-51 1588 2 : : PUNCT aji-51 1588 3 23550147 23550147 NUM aji-51 1588 4 ; ; PUNCT aji-51 1588 5 pmcid pmcid NOUN aji-51 1588 6 : : PUNCT aji-51 1588 7 pmc3667586 pmc3667586 ADJ aji-51 1588 8 . . PUNCT aji-51 1589 1 215 215 NUM aji-51 1589 2 . . PUNCT aji-51 1590 1 srivastava srivastava PROPN aji-51 1590 2 s s PROPN aji-51 1590 3 , , PUNCT aji-51 1590 4 riddell riddell PROPN aji-51 1590 5 sr sr PROPN aji-51 1590 6 . . PUNCT aji-51 1591 1 engineering engineering NOUN aji-51 1591 2 car car NOUN aji-51 1591 3 - - PUNCT aji-51 1591 4 t t NOUN aji-51 1591 5 cells cell NOUN aji-51 1591 6 : : PUNCT aji-51 1591 7 design design NOUN aji-51 1591 8 concepts concept NOUN aji-51 1591 9 . . PUNCT aji-51 1592 1 trends trend NOUN aji-51 1592 2 immunol immunol NOUN aji-51 1592 3 . . PUNCT aji-51 1593 1 2015 2015 NUM aji-51 1593 2 aug;36(8):494 aug;36(8):494 NOUN aji-51 1593 3 - - PUNCT aji-51 1593 4 502 502 NUM aji-51 1593 5 . . PUNCT aji-51 1594 1 doi doi NOUN aji-51 1594 2 : : PUNCT aji-51 1594 3 10.1016 10.1016 NUM aji-51 1594 4 / / SYM aji-51 1594 5 j.it.2015.06.004 j.it.2015.06.004 PROPN aji-51 1594 6 epub epub NOUN aji-51 1594 7 2015 2015 NUM aji-51 1594 8 jul jul PROPN aji-51 1594 9 11 11 NUM aji-51 1594 10 . . PUNCT aji-51 1595 1 pmid pmid NOUN aji-51 1595 2 : : PUNCT aji-51 1595 3 26169254 26169254 NUM aji-51 1595 4 ; ; PUNCT aji-51 1595 5 pmcid pmcid ADJ aji-51 1595 6 : : PUNCT aji-51 1595 7 pmc4746114 pmc4746114 NOUN aji-51 1595 8 . . PUNCT aji-51 1596 1 216 216 NUM aji-51 1596 2 . . PUNCT aji-51 1596 3 hu hu PROPN aji-51 1596 4 zi zi PROPN aji-51 1596 5 , , PUNCT aji-51 1596 6 mcarthur mcarthur PROPN aji-51 1596 7 hl hl PROPN aji-51 1596 8 , , PUNCT aji-51 1596 9 ho ho PROPN aji-51 1596 10 ay ay PROPN aji-51 1596 11 . . PUNCT aji-51 1597 1 the the DET aji-51 1597 2 abscopal abscopal ADJ aji-51 1597 3 effect effect NOUN aji-51 1597 4 of of ADP aji-51 1597 5 radiation radiation NOUN aji-51 1597 6 therapy therapy NOUN aji-51 1597 7 : : PUNCT aji-51 1597 8 what what PRON aji-51 1597 9 is be AUX aji-51 1597 10 it it PRON aji-51 1597 11 and and CCONJ aji-51 1597 12 how how SCONJ aji-51 1597 13 can can AUX aji-51 1597 14 we we PRON aji-51 1597 15 use use VERB aji-51 1597 16 it it PRON aji-51 1597 17 in in ADP aji-51 1597 18 breast breast NOUN aji-51 1597 19 cancer cancer NOUN aji-51 1597 20 ? ? PUNCT aji-51 1598 1 curr curr PROPN aji-51 1598 2 breast breast PROPN aji-51 1598 3 cancer cancer PROPN aji-51 1598 4 rep rep PROPN aji-51 1598 5 . . PROPN aji-51 1599 1 2017;9(1):45 2017;9(1):45 PROPN aji-51 1599 2 - - SYM aji-51 1599 3 51 51 NUM aji-51 1599 4 . . PUNCT aji-51 1599 5 doi doi NOUN aji-51 1599 6 : : PUNCT aji-51 1599 7 10.1007 10.1007 NUM aji-51 1599 8 / / SYM aji-51 1599 9 s12609 s12609 NOUN aji-51 1599 10 - - PUNCT aji-51 1599 11 017 017 NUM aji-51 1599 12 - - PUNCT aji-51 1599 13 0234 0234 NUM aji-51 1599 14 - - PUNCT aji-51 1599 15 y y PROPN aji-51 1599 16 epub epub PROPN aji-51 1599 17 2017 2017 NUM aji-51 1599 18 mar mar PROPN aji-51 1599 19 2 2 NUM aji-51 1599 20 . . PUNCT aji-51 1600 1 pmid pmid NOUN aji-51 1600 2 : : PUNCT aji-51 1600 3 28344743 28344743 NUM aji-51 1600 4 ; ; PUNCT aji-51 1600 5 pmcid pmcid ADJ aji-51 1600 6 : : PUNCT aji-51 1600 7 pmc5346418 pmc5346418 NOUN aji-51 1600 8 . . PUNCT aji-51 1601 1 217 217 NUM aji-51 1601 2 . . PUNCT aji-51 1602 1 reynders reynder NOUN aji-51 1602 2 k k PROPN aji-51 1602 3 , , PUNCT aji-51 1602 4 illidge illidge PROPN aji-51 1602 5 t t PROPN aji-51 1602 6 , , PUNCT aji-51 1602 7 siva siva PROPN aji-51 1602 8 s s PROPN aji-51 1602 9 , , PUNCT aji-51 1602 10 chang chang PROPN aji-51 1602 11 jy jy PROPN aji-51 1602 12 , , PUNCT aji-51 1602 13 de de PROPN aji-51 1602 14 ruysscher ruysscher PROPN aji-51 1602 15 d. d. PROPN aji-51 1602 16 the the DET aji-51 1602 17 abscopal abscopal ADJ aji-51 1602 18 effect effect NOUN aji-51 1602 19 of of ADP aji-51 1602 20 local local ADJ aji-51 1602 21 radiotherapy radiotherapy NOUN aji-51 1602 22 : : PUNCT aji-51 1602 23 using use VERB aji-51 1602 24 immunotherapy immunotherapy NOUN aji-51 1602 25 to to PART aji-51 1602 26 make make VERB aji-51 1602 27 a a DET aji-51 1602 28 rare rare ADJ aji-51 1602 29 event event NOUN aji-51 1602 30 clinically clinically ADV aji-51 1602 31 relevant relevant ADJ aji-51 1602 32 . . PUNCT aji-51 1603 1 cancer cancer NOUN aji-51 1603 2 treat treat PROPN aji-51 1603 3 rev rev VERB aji-51 1603 4 . . PROPN aji-51 1603 5 2015 2015 NUM aji-51 1603 6 jun;41(6):503 jun;41(6):503 PROPN aji-51 1603 7 - - PUNCT aji-51 1603 8 10 10 NUM aji-51 1603 9 . . PUNCT aji-51 1604 1 doi doi NOUN aji-51 1604 2 : : PUNCT aji-51 1604 3 10.1016 10.1016 NUM aji-51 1604 4 / / SYM aji-51 1604 5 j.ctrv.2015.03.011 j.ctrv.2015.03.011 PROPN aji-51 1604 6 epub epub PROPN aji-51 1604 7 2015 2015 NUM aji-51 1604 8 mar mar PROPN aji-51 1604 9 28 28 NUM aji-51 1604 10 . . PUNCT aji-51 1605 1 pmid pmid NOUN aji-51 1605 2 : : PUNCT aji-51 1605 3 25872878 25872878 NUM aji-51 1605 4 ; ; PUNCT aji-51 1605 5 pmcid pmcid ADJ aji-51 1605 6 : : PUNCT aji-51 1605 7 pmc4816218 pmc4816218 NOUN aji-51 1605 8 . . PUNCT aji-51 1606 1 218 218 NUM aji-51 1606 2 . . PUNCT aji-51 1607 1 chicas chicas NOUN aji-51 1607 2 - - PUNCT aji-51 1607 3 sett sett PROPN aji-51 1607 4 r r PROPN aji-51 1607 5 , , PUNCT aji-51 1607 6 morales morale NOUN aji-51 1607 7 - - PUNCT aji-51 1607 8 orue orue NOUN aji-51 1607 9 i i PROPN aji-51 1607 10 , , PUNCT aji-51 1607 11 rodriguezabreu rodriguezabreu PROPN aji-51 1607 12 d d PROPN aji-51 1607 13 , , PUNCT aji-51 1607 14 lara lara PROPN aji-51 1607 15 - - PUNCT aji-51 1607 16 jimenez jimenez PROPN aji-51 1607 17 p. p. NOUN aji-51 1607 18 combining combine VERB aji-51 1607 19 radiotherapy radiotherapy NOUN aji-51 1607 20 and and CCONJ aji-51 1607 21 ipilimumab ipilimumab NOUN aji-51 1607 22 induces induce VERB aji-51 1607 23 clinically clinically ADV aji-51 1607 24 relevant relevant ADJ aji-51 1607 25 radiation radiation NOUN aji-51 1607 26 - - PUNCT aji-51 1607 27 induced induce VERB aji-51 1607 28 abscopal abscopal ADJ aji-51 1607 29 effects effect NOUN aji-51 1607 30 in in ADP aji-51 1607 31 metastatic metastatic ADJ aji-51 1607 32 melanoma melanoma NOUN aji-51 1607 33 patients patient NOUN aji-51 1607 34 : : PUNCT aji-51 1607 35 a a DET aji-51 1607 36 systematic systematic ADJ aji-51 1607 37 review review NOUN aji-51 1607 38 . . PUNCT aji-51 1608 1 clin clin PROPN aji-51 1608 2 transl transl PROPN aji-51 1608 3 radiat radiat PROPN aji-51 1608 4 oncol oncol PROPN aji-51 1608 5 . . PUNCT aji-51 1609 1 2017 2017 NUM aji-51 1609 2 dec dec PROPN aji-51 1609 3 23;9:5 23;9:5 NUM aji-51 1609 4 - - SYM aji-51 1609 5 11 11 NUM aji-51 1609 6 . . PUNCT aji-51 1610 1 doi doi NOUN aji-51 1610 2 : : PUNCT aji-51 1610 3 10.1016 10.1016 NUM aji-51 1610 4 / / SYM aji-51 1610 5 j.ctro.2017.12.004 j.ctro.2017.12.004 PROPN aji-51 1610 6 pmid pmid PROPN aji-51 1610 7 : : PUNCT aji-51 1610 8 29594244 29594244 NUM aji-51 1610 9 ; ; PUNCT aji-51 1610 10 pmcid pmcid ADJ aji-51 1610 11 : : PUNCT aji-51 1610 12 pmc5862682 pmc5862682 ADV aji-51 1610 13 . . PUNCT aji-51 1611 1 219 219 NUM aji-51 1611 2 . . PUNCT aji-51 1612 1 stoff stoff PROPN aji-51 1612 2 j j PROPN aji-51 1612 3 , , PUNCT aji-51 1612 4 clouatre clouatre PROPN aji-51 1612 5 j. j. PROPN aji-51 1612 6 the the DET aji-51 1612 7 prostate prostate NOUN aji-51 1612 8 miracle miracle NOUN aji-51 1612 9 . . PUNCT aji-51 1613 1 new new PROPN aji-51 1613 2 york york PROPN aji-51 1613 3 : : PUNCT aji-51 1613 4 kensington kensington PROPN aji-51 1613 5 publishing publishing PROPN aji-51 1613 6 corp corp PROPN aji-51 1613 7 . . PROPN aji-51 1613 8 , , PUNCT aji-51 1613 9 2000:199;chapter 2000:199;chapter NUM aji-51 1613 10 7 7 NUM aji-51 1613 11 . . PUNCT aji-51 1614 1 isbn isbn ADJ aji-51 1614 2 : : PUNCT aji-51 1614 3 1 1 NUM aji-51 1614 4 - - SYM aji-51 1614 5 57566 57566 NUM aji-51 1614 6 - - SYM aji-51 1614 7 544 544 NUM aji-51 1614 8 - - SYM aji-51 1614 9 1 1 NUM aji-51 1614 10 220 220 NUM aji-51 1614 11 . . PUNCT aji-51 1615 1 nemoto nemoto PROPN aji-51 1615 2 t t PROPN aji-51 1615 3 , , PUNCT aji-51 1615 4 han han PROPN aji-51 1615 5 t t PROPN aji-51 1615 6 , , PUNCT aji-51 1615 7 minowada minowada PROPN aji-51 1615 8 j j PROPN aji-51 1615 9 , , PUNCT aji-51 1615 10 angkur angkur PROPN aji-51 1615 11 v v NOUN aji-51 1615 12 , , PUNCT aji-51 1615 13 chamberlain chamberlain PROPN aji-51 1615 14 a a PROPN aji-51 1615 15 , , PUNCT aji-51 1615 16 dao dao PROPN aji-51 1615 17 l. l. PROPN aji-51 1615 18 cellmediated cellmediate VERB aji-51 1615 19 immune immune ADJ aji-51 1615 20 status status NOUN aji-51 1615 21 of of ADP aji-51 1615 22 breast breast NOUN aji-51 1615 23 cancer cancer NOUN aji-51 1615 24 patients patient NOUN aji-51 1615 25 : : PUNCT aji-51 1615 26 evaluation evaluation NOUN aji-51 1615 27 by by ADP aji-51 1615 28 skin skin NOUN aji-51 1615 29 tests test NOUN aji-51 1615 30 , , PUNCT aji-51 1615 31 lymphocyte lymphocyte ADJ aji-51 1615 32 stimulation stimulation NOUN aji-51 1615 33 , , PUNCT aji-51 1615 34 and and CCONJ aji-51 1615 35 counts count NOUN aji-51 1615 36 of of ADP aji-51 1615 37 rosette rosette NOUN aji-51 1615 38 - - PUNCT aji-51 1615 39 forming form VERB aji-51 1615 40 cells cell NOUN aji-51 1615 41 . . PUNCT aji-51 1616 1 j j PROPN aji-51 1616 2 natl natl PROPN aji-51 1616 3 cancer cancer PROPN aji-51 1616 4 inst inst PROPN aji-51 1616 5 . . PROPN aji-51 1616 6 1974 1974 NUM aji-51 1616 7 sep;53(3 sep;53(3 NUM aji-51 1616 8 ): ): PUNCT aji-51 1616 9 641 641 NUM aji-51 1616 10 - - SYM aji-51 1616 11 5 5 NUM aji-51 1616 12 . . PUNCT aji-51 1617 1 pmid pmid NOUN aji-51 1617 2 : : PUNCT aji-51 1617 3 4606319 4606319 NUM aji-51 1617 4 . . PUNCT aji-51 1618 1 221 221 NUM aji-51 1618 2 . . PUNCT aji-51 1619 1 kniker kniker PROPN aji-51 1619 2 wt wt PROPN aji-51 1619 3 , , PUNCT aji-51 1619 4 lesourd lesourd PROPN aji-51 1619 5 bm bm PROPN aji-51 1619 6 , , PUNCT aji-51 1619 7 mcbryde mcbryde PROPN aji-51 1619 8 jl jl NOUN aji-51 1619 9 , , PUNCT aji-51 1619 10 corriel corriel PROPN aji-51 1619 11 rn rn PROPN aji-51 1619 12 . . PROPN aji-51 1619 13 cell cell NOUN aji-51 1619 14 - - PUNCT aji-51 1619 15 mediated mediate VERB aji-51 1619 16 immunity immunity NOUN aji-51 1619 17 assessed assess VERB aji-51 1619 18 by by ADP aji-51 1619 19 multitest multitest ADJ aji-51 1619 20 cmi cmi PROPN aji-51 1619 21 skin skin NOUN aji-51 1619 22 testing testing NOUN aji-51 1619 23 in in ADP aji-51 1619 24 infants infant NOUN aji-51 1619 25 and and CCONJ aji-51 1619 26 preschool preschool ADJ aji-51 1619 27 children child NOUN aji-51 1619 28 . . PUNCT aji-51 1620 1 am be AUX aji-51 1620 2 j j PROPN aji-51 1620 3 dis dis PROPN aji-51 1620 4 child child NOUN aji-51 1620 5 . . PUNCT aji-51 1621 1 1985;139(8):840–845 1985;139(8):840–845 X aji-51 1621 2 . . PUNCT aji-51 1621 3 doi:10.1001 doi:10.1001 PROPN aji-51 1621 4 / / SYM aji-51 1621 5 archpedi.1985.02140100102 archpedi.1985.02140100102 PROPN aji-51 1621 6 044 044 NUM aji-51 1621 7 222 222 NUM aji-51 1621 8 . . PUNCT aji-51 1622 1 mertins mertin NOUN aji-51 1622 2 sd sd PROPN aji-51 1622 3 . . PUNCT aji-51 1623 1 cancer cancer NOUN aji-51 1623 2 stem stem NOUN aji-51 1623 3 cells cell NOUN aji-51 1623 4 : : PUNCT aji-51 1623 5 a a DET aji-51 1623 6 systems system NOUN aji-51 1623 7 biology biology NOUN aji-51 1623 8 view view NOUN aji-51 1623 9 of of ADP aji-51 1623 10 their their PRON aji-51 1623 11 role role NOUN aji-51 1623 12 in in ADP aji-51 1623 13 prognosis prognosis NOUN aji-51 1623 14 and and CCONJ aji-51 1623 15 therapy therapy NOUN aji-51 1623 16 . . PUNCT aji-51 1624 1 anticancer anticancer NOUN aji-51 1624 2 drugs drug NOUN aji-51 1624 3 . . PUNCT aji-51 1625 1 2014 2014 NUM aji-51 1625 2 apr;25(4):353 apr;25(4):353 PROPN aji-51 1625 3 - - SYM aji-51 1625 4 67 67 NUM aji-51 1625 5 . . PUNCT aji-51 1626 1 doi doi NOUN aji-51 1626 2 : : PUNCT aji-51 1626 3 10.1097 10.1097 NUM aji-51 1626 4 / / SYM aji-51 1626 5 cad.0000000000000075 cad.0000000000000075 NUM aji-51 1626 6 pmid pmid NOUN aji-51 1626 7 : : PUNCT aji-51 1626 8 24418909 24418909 NUM aji-51 1626 9 ; ; PUNCT aji-51 1626 10 pmcid pmcid ADJ aji-51 1626 11 : : PUNCT aji-51 1626 12 pmc4010870 pmc4010870 NOUN aji-51 1626 13 . . PUNCT aji-51 1627 1 223 223 NUM aji-51 1627 2 . . PUNCT aji-51 1628 1 qiu qiu PROPN aji-51 1628 2 h h PROPN aji-51 1628 3 , , PUNCT aji-51 1628 4 fang fang X aji-51 1628 5 x x PROPN aji-51 1628 6 , , PUNCT aji-51 1628 7 luo luo PROPN aji-51 1628 8 q q PROPN aji-51 1628 9 , , PUNCT aji-51 1628 10 ouyang ouyang PROPN aji-51 1628 11 g. g. PROPN aji-51 1628 12 cancer cancer NOUN aji-51 1628 13 stem stem NOUN aji-51 1628 14 cells cell NOUN aji-51 1628 15 : : PUNCT aji-51 1628 16 a a DET aji-51 1628 17 potential potential ADJ aji-51 1628 18 target target NOUN aji-51 1628 19 for for ADP aji-51 1628 20 cancer cancer NOUN aji-51 1628 21 therapy therapy NOUN aji-51 1628 22 . . PUNCT aji-51 1629 1 cell cell NOUN aji-51 1629 2 mol mol ADP aji-51 1629 3 life life PROPN aji-51 1629 4 sci sci PROPN aji-51 1629 5 . . PROPN aji-51 1629 6 2015 2015 NUM aji-51 1629 7 sep;72(18):3411 sep;72(18):3411 NOUN aji-51 1629 8 - - SYM aji-51 1629 9 24 24 NUM aji-51 1629 10 . . PUNCT aji-51 1629 11 doi doi NOUN aji-51 1629 12 : : PUNCT aji-51 1629 13 10.1007 10.1007 NUM aji-51 1629 14 / / SYM aji-51 1629 15 s00018 s00018 NOUN aji-51 1629 16 - - PUNCT aji-51 1629 17 015 015 NUM aji-51 1629 18 - - PUNCT aji-51 1629 19 1920 1920 NUM aji-51 1629 20 - - SYM aji-51 1629 21 4 4 NUM aji-51 1629 22 epub epub NOUN aji-51 1629 23 2015 2015 NUM aji-51 1629 24 may may PROPN aji-51 1629 25 13 13 NUM aji-51 1629 26 . . PUNCT aji-51 1630 1 pmid pmid NOUN aji-51 1630 2 : : PUNCT aji-51 1630 3 25967289 25967289 NUM aji-51 1630 4 . . PUNCT aji-51 1631 1 224 224 NUM aji-51 1631 2 . . PUNCT aji-51 1632 1 maitland maitland PROPN aji-51 1632 2 nj nj PROPN aji-51 1632 3 , , PUNCT aji-51 1632 4 collins collins PROPN aji-51 1632 5 at at ADP aji-51 1632 6 . . PUNCT aji-51 1633 1 cancer cancer NOUN aji-51 1633 2 stem stem NOUN aji-51 1633 3 cells cell NOUN aji-51 1633 4 a a DET aji-51 1633 5 therapeutic therapeutic ADJ aji-51 1633 6 target target NOUN aji-51 1633 7 ? ? PUNCT aji-51 1634 1 curr curr PROPN aji-51 1634 2 opin opin NOUN aji-51 1634 3 mol mol ADP aji-51 1634 4 ther ther ADV aji-51 1634 5 . . PUNCT aji-51 1635 1 2010 2010 NUM aji-51 1635 2 dec;12(6):662 dec;12(6):662 NOUN aji-51 1635 3 - - PUNCT aji-51 1635 4 73 73 NUM aji-51 1635 5 . . PUNCT aji-51 1636 1 pmid pmid NOUN aji-51 1636 2 : : PUNCT aji-51 1636 3 21154158 21154158 NUM aji-51 1636 4 . . PUNCT aji-51 1637 1 225 225 NUM aji-51 1637 2 . . PUNCT aji-51 1637 3 garcía garcía ADJ aji-51 1637 4 - - PUNCT aji-51 1637 5 rubiño rubiño NOUN aji-51 1637 6 me i PRON aji-51 1637 7 , , PUNCT aji-51 1637 8 lozano lozano PROPN aji-51 1637 9 - - PUNCT aji-51 1637 10 lópez lópez PROPN aji-51 1637 11 c c NOUN aji-51 1637 12 , , PUNCT aji-51 1637 13 campos campos PROPN aji-51 1637 14 jm jm PROPN aji-51 1637 15 . . PROPN aji-51 1637 16 inhibitors inhibitor NOUN aji-51 1637 17 of of ADP aji-51 1637 18 cancer cancer NOUN aji-51 1637 19 stem stem NOUN aji-51 1637 20 cells cell NOUN aji-51 1637 21 . . PUNCT aji-51 1638 1 anticancer anticancer NOUN aji-51 1638 2 agents agent NOUN aji-51 1638 3 med med PROPN aji-51 1638 4 chem chem NOUN aji-51 1638 5 . . PUNCT aji-51 1639 1 2016;16(10):1230 2016;16(10):1230 NUM aji-51 1639 2 - - SYM aji-51 1639 3 9 9 NUM aji-51 1639 4 . . PUNCT aji-51 1639 5 doi doi NOUN aji-51 1639 6 : : PUNCT aji-51 1639 7 10.2174/1871520616666160330104715 10.2174/1871520616666160330104715 NUM aji-51 1639 8 pmid pmid NOUN aji-51 1639 9 : : PUNCT aji-51 1639 10 27025655 27025655 NUM aji-51 1639 11 . . PUNCT aji-51 1640 1 226 226 NUM aji-51 1640 2 . . PUNCT aji-51 1641 1 ablett ablett PROPN aji-51 1641 2 mp mp PROPN aji-51 1641 3 , , PUNCT aji-51 1641 4 singh singh PROPN aji-51 1641 5 jk jk PROPN aji-51 1641 6 , , PUNCT aji-51 1641 7 clarke clarke PROPN aji-51 1641 8 rb rb PROPN aji-51 1641 9 . . PUNCT aji-51 1642 1 stem stem NOUN aji-51 1642 2 cells cell NOUN aji-51 1642 3 in in ADP aji-51 1642 4 breast breast NOUN aji-51 1642 5 tumours tumours PROPN aji-51 1642 6 : : PUNCT aji-51 1642 7 are be AUX aji-51 1642 8 they they PRON aji-51 1642 9 ready ready ADJ aji-51 1642 10 for for ADP aji-51 1642 11 the the DET aji-51 1642 12 clinic clinic NOUN aji-51 1642 13 ? ? PUNCT aji-51 1643 1 eur eur PROPN aji-51 1643 2 j j PROPN aji-51 1643 3 cancer cancer NOUN aji-51 1643 4 . . PUNCT aji-51 1644 1 2012 2012 NUM aji-51 1644 2 sep;48(14):2104 sep;48(14):2104 NOUN aji-51 1644 3 - - PUNCT aji-51 1644 4 16 16 NUM aji-51 1644 5 . . PUNCT aji-51 1645 1 doi doi NOUN aji-51 1645 2 : : PUNCT aji-51 1645 3 10.1016 10.1016 NUM aji-51 1645 4 / / SYM aji-51 1645 5 j.ejca.2012.03.019 j.ejca.2012.03.019 PROPN aji-51 1645 6 epub epub NOUN aji-51 1645 7 2012 2012 NUM aji-51 1645 8 apr apr NOUN aji-51 1645 9 26 26 NUM aji-51 1645 10 . . PUNCT aji-51 1646 1 pmid pmid NOUN aji-51 1646 2 : : PUNCT aji-51 1646 3 22542086 22542086 NUM aji-51 1646 4 . . PUNCT aji-51 1647 1 stoff stoff PROPN aji-51 1647 2 ; ; PUNCT aji-51 1647 3 aji aji PROPN aji-51 1647 4 , , PUNCT aji-51 1647 5 5(1 5(1 NUM aji-51 1647 6 ): ): PUNCT aji-51 1647 7 1 1 NUM aji-51 1647 8 - - SYM aji-51 1647 9 39 39 NUM aji-51 1647 10 , , PUNCT aji-51 1647 11 2022 2022 NUM aji-51 1647 12 ; ; PUNCT aji-51 1647 13 article article NOUN aji-51 1647 14 no.aji.77967 no.aji.77967 PROPN aji-51 1647 15 32 32 NUM aji-51 1647 16 227 227 NUM aji-51 1647 17 . . PUNCT aji-51 1648 1 kharkar kharkar PROPN aji-51 1648 2 ps ps PROPN aji-51 1648 3 . . PROPN aji-51 1648 4 cancer cancer NOUN aji-51 1648 5 stem stem NOUN aji-51 1648 6 cell cell NOUN aji-51 1648 7 ( ( PUNCT aji-51 1648 8 csc csc NOUN aji-51 1648 9 ) ) PUNCT aji-51 1648 10 inhibitors inhibitor NOUN aji-51 1648 11 : : PUNCT aji-51 1648 12 a a DET aji-51 1648 13 review review NOUN aji-51 1648 14 of of ADP aji-51 1648 15 recent recent ADJ aji-51 1648 16 patents patent NOUN aji-51 1648 17 ( ( PUNCT aji-51 1648 18 2012 2012 NUM aji-51 1648 19 - - SYM aji-51 1648 20 2015 2015 NUM aji-51 1648 21 ) ) PUNCT aji-51 1648 22 . . PUNCT aji-51 1649 1 expert expert NOUN aji-51 1649 2 opin opin NOUN aji-51 1649 3 ther ther ADV aji-51 1650 1 pat pat PROPN aji-51 1650 2 . . PROPN aji-51 1650 3 2017 2017 NUM aji-51 1650 4 jul;27(7):753 jul;27(7):753 NOUN aji-51 1650 5 - - PUNCT aji-51 1650 6 761 761 NUM aji-51 1650 7 . . PUNCT aji-51 1651 1 doi doi NOUN aji-51 1651 2 : : PUNCT aji-51 1651 3 10.1080/13543776.2017.1325465 10.1080/13543776.2017.1325465 NUM aji-51 1651 4 epub epub NOUN aji-51 1651 5 2017 2017 NUM aji-51 1651 6 may may PROPN aji-51 1651 7 5 5 NUM aji-51 1651 8 . . PUNCT aji-51 1652 1 pmid pmid NOUN aji-51 1652 2 : : PUNCT aji-51 1652 3 28460551 28460551 NUM aji-51 1652 4 . . PUNCT aji-51 1653 1 228 228 NUM aji-51 1653 2 . . PUNCT aji-51 1654 1 chen chen PROPN aji-51 1654 2 k k PROPN aji-51 1654 3 , , PUNCT aji-51 1654 4 huang huang PROPN aji-51 1654 5 yh yh PROPN aji-51 1654 6 , , PUNCT aji-51 1654 7 chen chen PROPN aji-51 1654 8 jl jl PROPN aji-51 1654 9 . . PUNCT aji-51 1654 10 understanding understanding NOUN aji-51 1654 11 and and CCONJ aji-51 1654 12 targeting target VERB aji-51 1654 13 cancer cancer NOUN aji-51 1654 14 stem stem NOUN aji-51 1654 15 cells cell NOUN aji-51 1654 16 : : PUNCT aji-51 1654 17 therapeutic therapeutic ADJ aji-51 1654 18 implications implication NOUN aji-51 1654 19 and and CCONJ aji-51 1654 20 challenges challenge NOUN aji-51 1654 21 . . PUNCT aji-51 1655 1 acta acta PROPN aji-51 1655 2 pharmacol pharmacol PROPN aji-51 1655 3 sin sin NOUN aji-51 1655 4 . . PUNCT aji-51 1656 1 2013 2013 NUM aji-51 1656 2 jun;34(6):732 jun;34(6):732 PROPN aji-51 1656 3 - - PUNCT aji-51 1656 4 40 40 NUM aji-51 1656 5 . . PUNCT aji-51 1657 1 doi doi NOUN aji-51 1657 2 : : PUNCT aji-51 1657 3 10.1038 10.1038 NUM aji-51 1657 4 / / SYM aji-51 1657 5 aps.2013.27 aps.2013.27 PROPN aji-51 1657 6 epub epub PROPN aji-51 1657 7 2013 2013 NUM aji-51 1657 8 may may PROPN aji-51 1657 9 20 20 NUM aji-51 1657 10 . . PUNCT aji-51 1658 1 pmid pmid NOUN aji-51 1658 2 : : PUNCT aji-51 1658 3 23685952 23685952 NUM aji-51 1658 4 ; ; PUNCT aji-51 1658 5 pmcid pmcid NOUN aji-51 1658 6 : : PUNCT aji-51 1658 7 pmc3674516 pmc3674516 NOUN aji-51 1658 8 . . PUNCT aji-51 1659 1 229 229 NUM aji-51 1659 2 . . PUNCT aji-51 1660 1 hirsch hirsch PROPN aji-51 1660 2 ha ha INTJ aji-51 1660 3 , , PUNCT aji-51 1660 4 iliopoulos iliopoulos PROPN aji-51 1660 5 d d PROPN aji-51 1660 6 , , PUNCT aji-51 1660 7 tsichlis tsichlis PROPN aji-51 1660 8 pn pn NOUN aji-51 1660 9 , , PUNCT aji-51 1660 10 struhl struhl PROPN aji-51 1660 11 k. k. PROPN aji-51 1660 12 metformin metformin PROPN aji-51 1660 13 selectively selectively ADV aji-51 1660 14 targets target VERB aji-51 1660 15 cancer cancer NOUN aji-51 1660 16 stem stem NOUN aji-51 1660 17 cells cell NOUN aji-51 1660 18 , , PUNCT aji-51 1660 19 and and CCONJ aji-51 1660 20 acts act VERB aji-51 1660 21 together together ADV aji-51 1660 22 with with ADP aji-51 1660 23 chemotherapy chemotherapy NOUN aji-51 1660 24 to to PART aji-51 1660 25 block block VERB aji-51 1660 26 tumor tumor NOUN aji-51 1660 27 growth growth NOUN aji-51 1660 28 and and CCONJ aji-51 1660 29 prolong prolong PROPN aji-51 1660 30 remission remission NOUN aji-51 1660 31 . . PUNCT aji-51 1661 1 cancer cancer NOUN aji-51 1661 2 res re NOUN aji-51 1661 3 . . PUNCT aji-51 1661 4 2009 2009 NUM aji-51 1661 5 oct oct NOUN aji-51 1661 6 1;69(19):7507 1;69(19):7507 NUM aji-51 1661 7 - - SYM aji-51 1661 8 11 11 NUM aji-51 1661 9 . . PUNCT aji-51 1662 1 doi doi NOUN aji-51 1662 2 : : PUNCT aji-51 1662 3 10.1158/0008 10.1158/0008 NUM aji-51 1662 4 - - SYM aji-51 1662 5 5472.can-09 5472.can-09 NUM aji-51 1662 6 - - PUNCT aji-51 1662 7 2994 2994 NUM aji-51 1662 8 epub epub NOUN aji-51 1662 9 2009 2009 NUM aji-51 1662 10 sep sep PROPN aji-51 1662 11 14 14 NUM aji-51 1662 12 . . PUNCT aji-51 1663 1 erratum erratum PROPN aji-51 1663 2 in in ADP aji-51 1663 3 : : PUNCT aji-51 1663 4 cancer cancer NOUN aji-51 1663 5 res re NOUN aji-51 1663 6 . . PUNCT aji-51 1663 7 2009 2009 NUM aji-51 1663 8 nov nov NOUN aji-51 1663 9 15;69(22):8832 15;69(22):8832 NUM aji-51 1663 10 . . PUNCT aji-51 1664 1 pmid pmid NOUN aji-51 1664 2 : : PUNCT aji-51 1664 3 19752085 19752085 NUM aji-51 1664 4 ; ; PUNCT aji-51 1664 5 pmcid pmcid NOUN aji-51 1664 6 : : PUNCT aji-51 1664 7 pmc2756324 pmc2756324 ADJ aji-51 1664 8 . . PUNCT aji-51 1665 1 230 230 NUM aji-51 1665 2 . . PUNCT aji-51 1666 1 hirsch hirsch PROPN aji-51 1666 2 ha ha PROPN aji-51 1666 3 , , PUNCT aji-51 1666 4 iliopoulos iliopoulos PROPN aji-51 1666 5 d d PROPN aji-51 1666 6 , , PUNCT aji-51 1666 7 struhl struhl PROPN aji-51 1666 8 k. k. PROPN aji-51 1666 9 metformin metformin PROPN aji-51 1666 10 inhibits inhibit VERB aji-51 1666 11 the the DET aji-51 1666 12 inflammatory inflammatory ADJ aji-51 1666 13 response response NOUN aji-51 1666 14 associated associate VERB aji-51 1666 15 with with ADP aji-51 1666 16 cellular cellular ADJ aji-51 1666 17 transformation transformation NOUN aji-51 1666 18 and and CCONJ aji-51 1666 19 cancer cancer NOUN aji-51 1666 20 stem stem NOUN aji-51 1666 21 cell cell NOUN aji-51 1666 22 growth growth NOUN aji-51 1666 23 . . PUNCT aji-51 1667 1 proc proc PROPN aji-51 1667 2 natl natl PROPN aji-51 1667 3 acad acad PROPN aji-51 1667 4 sci sci PROPN aji-51 1667 5 u u PROPN aji-51 1667 6 s s PROPN aji-51 1667 7 a. a. NOUN aji-51 1667 8 2013 2013 NUM aji-51 1667 9 jan jan PROPN aji-51 1667 10 15;110(3):972 15;110(3):972 PROPN aji-51 1667 11 - - SYM aji-51 1667 12 7 7 NUM aji-51 1667 13 . . PUNCT aji-51 1667 14 doi doi NOUN aji-51 1667 15 : : PUNCT aji-51 1667 16 10.1073 10.1073 NUM aji-51 1667 17 / / SYM aji-51 1667 18 pnas.1221055110 pnas.1221055110 PROPN aji-51 1667 19 epub epub NOUN aji-51 1667 20 2012 2012 NUM aji-51 1667 21 dec dec PROPN aji-51 1667 22 31 31 NUM aji-51 1667 23 . . PUNCT aji-51 1668 1 pmid pmid NOUN aji-51 1668 2 : : PUNCT aji-51 1668 3 23277563 23277563 NUM aji-51 1668 4 ; ; PUNCT aji-51 1668 5 pmcid pmcid ADJ aji-51 1668 6 : : PUNCT aji-51 1668 7 pmc3549132 pmc3549132 NOUN aji-51 1668 8 . . PUNCT aji-51 1669 1 231 231 NUM aji-51 1669 2 . . PUNCT aji-51 1670 1 prasad prasad PROPN aji-51 1670 2 s s PROPN aji-51 1670 3 , , PUNCT aji-51 1670 4 ravindran ravindran PROPN aji-51 1670 5 j j PROPN aji-51 1670 6 , , PUNCT aji-51 1670 7 aggarwal aggarwal PROPN aji-51 1670 8 bb bb PROPN aji-51 1670 9 . . PUNCT aji-51 1670 10 nfkappab nfkappab PROPN aji-51 1670 11 and and CCONJ aji-51 1670 12 cancer cancer NOUN aji-51 1670 13 : : PUNCT aji-51 1670 14 how how SCONJ aji-51 1670 15 intimate intimate ADJ aji-51 1670 16 is be AUX aji-51 1670 17 this this DET aji-51 1670 18 relationship relationship NOUN aji-51 1670 19 . . PUNCT aji-51 1671 1 mol mol ADP aji-51 1671 2 cell cell NOUN aji-51 1671 3 biochem biochem PROPN aji-51 1671 4 . . PUNCT aji-51 1672 1 2010 2010 NUM aji-51 1673 1 mar;336(1 mar;336(1 PROPN aji-51 1673 2 - - PUNCT aji-51 1673 3 2):25 2):25 NUM aji-51 1673 4 - - PUNCT aji-51 1673 5 37 37 NUM aji-51 1673 6 . . PUNCT aji-51 1674 1 doi doi NOUN aji-51 1674 2 : : PUNCT aji-51 1674 3 10.1007 10.1007 NUM aji-51 1674 4 / / SYM aji-51 1674 5 s11010 s11010 NOUN aji-51 1674 6 - - PUNCT aji-51 1674 7 009 009 NUM aji-51 1674 8 - - PUNCT aji-51 1674 9 0267 0267 NUM aji-51 1674 10 - - PUNCT aji-51 1674 11 2 2 NUM aji-51 1674 12 epub epub NOUN aji-51 1674 13 2009 2009 NUM aji-51 1674 14 oct oct NOUN aji-51 1674 15 8 8 NUM aji-51 1674 16 . . PUNCT aji-51 1675 1 pmid pmid NOUN aji-51 1675 2 : : PUNCT aji-51 1675 3 19823771 19823771 NUM aji-51 1675 4 ; ; PUNCT aji-51 1675 5 pmcid pmcid NOUN aji-51 1675 6 : : PUNCT aji-51 1675 7 pmc3148942 pmc3148942 ADJ aji-51 1675 8 . . PUNCT aji-51 1676 1 232 232 X aji-51 1676 2 . . PUNCT aji-51 1677 1 iliopoulos iliopoulos PROPN aji-51 1677 2 d d PROPN aji-51 1677 3 , , PUNCT aji-51 1677 4 hirsch hirsch PROPN aji-51 1677 5 ha ha INTJ aji-51 1677 6 , , PUNCT aji-51 1677 7 struhl struhl PROPN aji-51 1677 8 k. k. PROPN aji-51 1677 9 metformin metformin PROPN aji-51 1677 10 decreases decrease VERB aji-51 1677 11 the the DET aji-51 1677 12 dose dose NOUN aji-51 1677 13 of of ADP aji-51 1677 14 chemotherapy chemotherapy NOUN aji-51 1677 15 for for ADP aji-51 1677 16 prolonging prolong VERB aji-51 1677 17 tumor tumor NOUN aji-51 1677 18 remission remission NOUN aji-51 1677 19 in in ADP aji-51 1677 20 mouse mouse NOUN aji-51 1677 21 xenografts xenograft NOUN aji-51 1677 22 involving involve VERB aji-51 1677 23 multiple multiple ADJ aji-51 1677 24 cancer cancer NOUN aji-51 1677 25 cell cell NOUN aji-51 1677 26 types type NOUN aji-51 1677 27 . . PUNCT aji-51 1678 1 cancer cancer NOUN aji-51 1678 2 res re NOUN aji-51 1678 3 . . PUNCT aji-51 1679 1 2011 2011 NUM aji-51 1679 2 may may AUX aji-51 1679 3 1;71(9):3196 1;71(9):3196 NUM aji-51 1679 4 - - PUNCT aji-51 1679 5 201 201 NUM aji-51 1679 6 . . PUNCT aji-51 1680 1 doi doi NOUN aji-51 1680 2 : : PUNCT aji-51 1680 3 10.1158/0008 10.1158/0008 NUM aji-51 1680 4 - - SYM aji-51 1680 5 5472.can-10 5472.can-10 NUM aji-51 1680 6 - - PUNCT aji-51 1680 7 3471 3471 NUM aji-51 1680 8 epub epub NOUN aji-51 1680 9 2011 2011 NUM aji-51 1680 10 mar mar PROPN aji-51 1680 11 17 17 NUM aji-51 1680 12 . . PUNCT aji-51 1681 1 pmid pmid NOUN aji-51 1681 2 : : PUNCT aji-51 1681 3 21415163 21415163 NUM aji-51 1681 4 ; ; PUNCT aji-51 1681 5 pmcid pmcid NOUN aji-51 1681 6 : : PUNCT aji-51 1681 7 pmc3085572 pmc3085572 NOUN aji-51 1681 8 . . PUNCT aji-51 1682 1 233 233 NUM aji-51 1682 2 . . PUNCT aji-51 1683 1 rosa rosa PROPN aji-51 1683 2 r r PROPN aji-51 1683 3 , , PUNCT aji-51 1683 4 d'amato d'amato PROPN aji-51 1683 5 v v ADP aji-51 1683 6 , , PUNCT aji-51 1683 7 de de PROPN aji-51 1683 8 placido placido PROPN aji-51 1683 9 s s PROPN aji-51 1683 10 , , PUNCT aji-51 1683 11 bianco bianco PROPN aji-51 1683 12 r. r. PROPN aji-51 1683 13 approaches approach VERB aji-51 1683 14 for for ADP aji-51 1683 15 targeting target VERB aji-51 1683 16 cancer cancer NOUN aji-51 1683 17 stem stem NOUN aji-51 1683 18 cells cell NOUN aji-51 1683 19 drug drug NOUN aji-51 1683 20 resistance resistance NOUN aji-51 1683 21 . . PUNCT aji-51 1684 1 expert expert NOUN aji-51 1684 2 opin opin NOUN aji-51 1684 3 drug drug NOUN aji-51 1684 4 discov discov NOUN aji-51 1684 5 . . PUNCT aji-51 1685 1 2016 2016 NUM aji-51 1685 2 dec;11(12):1201 dec;11(12):1201 NOUN aji-51 1685 3 - - PUNCT aji-51 1685 4 1212 1212 NUM aji-51 1685 5 . . PUNCT aji-51 1686 1 doi doi NOUN aji-51 1686 2 : : PUNCT aji-51 1686 3 10.1080/17460441.2016.1243525 10.1080/17460441.2016.1243525 NUM aji-51 1686 4 epub epub NOUN aji-51 1686 5 2016 2016 NUM aji-51 1686 6 oct oct PROPN aji-51 1686 7 14 14 NUM aji-51 1686 8 . . PUNCT aji-51 1687 1 pmid pmid NOUN aji-51 1687 2 : : PUNCT aji-51 1687 3 27700193 27700193 NUM aji-51 1687 4 . . PUNCT aji-51 1688 1 234 234 NUM aji-51 1688 2 . . PUNCT aji-51 1688 3 dragu dragu PROPN aji-51 1688 4 dl dl PROPN aji-51 1688 5 , , PUNCT aji-51 1688 6 necula necula PROPN aji-51 1688 7 lg lg PROPN aji-51 1688 8 , , PUNCT aji-51 1688 9 bleotu bleotu NOUN aji-51 1688 10 c c PROPN aji-51 1688 11 , , PUNCT aji-51 1688 12 diaconu diaconu NOUN aji-51 1688 13 cc cc PROPN aji-51 1688 14 , , PUNCT aji-51 1688 15 chivu chivu NOUN aji-51 1688 16 - - PUNCT aji-51 1688 17 economescu economescu NOUN aji-51 1688 18 m. m. NOUN aji-51 1688 19 therapies therapy NOUN aji-51 1688 20 targeting target VERB aji-51 1688 21 cancer cancer NOUN aji-51 1688 22 stem stem NOUN aji-51 1688 23 cells cell NOUN aji-51 1688 24 : : PUNCT aji-51 1688 25 current current ADJ aji-51 1688 26 trends trend NOUN aji-51 1688 27 and and CCONJ aji-51 1688 28 future future ADJ aji-51 1688 29 challenges challenge NOUN aji-51 1688 30 . . PUNCT aji-51 1689 1 world world NOUN aji-51 1689 2 j j PROPN aji-51 1689 3 stem stem NOUN aji-51 1689 4 cells cell NOUN aji-51 1689 5 . . PUNCT aji-51 1690 1 2015 2015 NUM aji-51 1690 2 oct oct NOUN aji-51 1690 3 26;7(9):1185 26;7(9):1185 NUM aji-51 1690 4 - - PUNCT aji-51 1690 5 201 201 NUM aji-51 1690 6 . . PUNCT aji-51 1691 1 doi doi NOUN aji-51 1691 2 : : PUNCT aji-51 1691 3 10.4252 10.4252 NUM aji-51 1691 4 / / SYM aji-51 1691 5 wjsc.v7.i9.1185 wjsc.v7.i9.1185 NUM aji-51 1691 6 pmid pmid NOUN aji-51 1691 7 : : PUNCT aji-51 1691 8 26516409 26516409 NUM aji-51 1691 9 ; ; PUNCT aji-51 1691 10 pmcid pmcid PROPN aji-51 1691 11 : : PUNCT aji-51 1691 12 pmc4620424 pmc4620424 PROPN aji-51 1691 13 . . PUNCT aji-51 1692 1 235 235 NUM aji-51 1692 2 . . PUNCT aji-51 1693 1 kim kim PROPN aji-51 1693 2 yr yr PROPN aji-51 1693 3 , , PUNCT aji-51 1693 4 yoo yoo PROPN aji-51 1693 5 jk jk PROPN aji-51 1693 6 , , PUNCT aji-51 1693 7 jeong jeong PROPN aji-51 1693 8 cw cw PROPN aji-51 1693 9 , , PUNCT aji-51 1693 10 choi choi PROPN aji-51 1693 11 jw jw PROPN aji-51 1693 12 . . PROPN aji-51 1693 13 selective selective ADJ aji-51 1693 14 killing killing NOUN aji-51 1693 15 of of ADP aji-51 1693 16 circulating circulate VERB aji-51 1693 17 tumor tumor NOUN aji-51 1693 18 cells cell NOUN aji-51 1693 19 prevents prevent VERB aji-51 1693 20 metastasis metastasis PRON aji-51 1693 21 and and CCONJ aji-51 1693 22 extends extend VERB aji-51 1693 23 survival survival NOUN aji-51 1693 24 . . PUNCT aji-51 1694 1 j j PROPN aji-51 1694 2 hematol hematol PROPN aji-51 1694 3 oncol oncol ADJ aji-51 1694 4 . . PUNCT aji-51 1695 1 2018 2018 NUM aji-51 1695 2 sep sep NOUN aji-51 1695 3 10;11(1):114 10;11(1):114 NUM aji-51 1695 4 . . PUNCT aji-51 1696 1 doi doi NOUN aji-51 1696 2 : : PUNCT aji-51 1696 3 10.1186 10.1186 NUM aji-51 1696 4 / / SYM aji-51 1696 5 s13045 s13045 NOUN aji-51 1696 6 - - PUNCT aji-51 1696 7 018 018 NUM aji-51 1696 8 - - PUNCT aji-51 1696 9 0658 0658 NUM aji-51 1696 10 - - SYM aji-51 1696 11 5 5 NUM aji-51 1696 12 erratum erratum NOUN aji-51 1696 13 in in ADP aji-51 1696 14 : : PUNCT aji-51 1696 15 j j PROPN aji-51 1696 16 hematol hematol PROPN aji-51 1696 17 oncol oncol ADJ aji-51 1696 18 . . PUNCT aji-51 1697 1 2019 2019 NUM aji-51 1697 2 jan jan PROPN aji-51 1697 3 9;12(1):5 9;12(1):5 NUM aji-51 1697 4 . . PUNCT aji-51 1698 1 pmid pmid NOUN aji-51 1698 2 : : PUNCT aji-51 1698 3 30201021 30201021 NUM aji-51 1698 4 ; ; PUNCT aji-51 1698 5 pmcid pmcid ADJ aji-51 1698 6 : : PUNCT aji-51 1698 7 pmc6131899 pmc6131899 NOUN aji-51 1698 8 . . PUNCT aji-51 1699 1 236 236 NUM aji-51 1699 2 . . PUNCT aji-51 1700 1 hanahan hanahan PROPN aji-51 1700 2 d d PROPN aji-51 1700 3 , , PUNCT aji-51 1700 4 weinberg weinberg PROPN aji-51 1700 5 ra ra PROPN aji-51 1700 6 . . PUNCT aji-51 1701 1 hallmarks hallmark NOUN aji-51 1701 2 of of ADP aji-51 1701 3 cancer cancer NOUN aji-51 1701 4 : : PUNCT aji-51 1701 5 the the DET aji-51 1701 6 next next ADJ aji-51 1701 7 generation generation NOUN aji-51 1701 8 . . PUNCT aji-51 1702 1 cell cell NOUN aji-51 1702 2 . . PUNCT aji-51 1703 1 2011 2011 NUM aji-51 1703 2 mar mar PROPN aji-51 1703 3 4;144(5):646 4;144(5):646 PROPN aji-51 1703 4 - - PUNCT aji-51 1703 5 74 74 PROPN aji-51 1703 6 . . PUNCT aji-51 1704 1 doi doi NOUN aji-51 1704 2 : : PUNCT aji-51 1704 3 10.1016 10.1016 NUM aji-51 1704 4 / / SYM aji-51 1704 5 j.cell.2011.02.013 j.cell.2011.02.013 PROPN aji-51 1704 6 pmid pmid PROPN aji-51 1704 7 : : PUNCT aji-51 1704 8 21376230 21376230 NUM aji-51 1704 9 . . PUNCT aji-51 1705 1 237 237 NUM aji-51 1705 2 . . PUNCT aji-51 1706 1 curtarelli curtarelli PROPN aji-51 1706 2 rb rb PROPN aji-51 1706 3 , , PUNCT aji-51 1706 4 gonçalves gonçalves PROPN aji-51 1706 5 jm jm PROPN aji-51 1706 6 , , PUNCT aji-51 1706 7 dos do VERB aji-51 1706 8 santos santos PROPN aji-51 1706 9 lgp lgp PROPN aji-51 1706 10 , , PUNCT aji-51 1706 11 savi savi VERB aji-51 1706 12 mg mg PROPN aji-51 1706 13 , , PUNCT aji-51 1706 14 nör nör PROPN aji-51 1706 15 je je PROPN aji-51 1706 16 , , PUNCT aji-51 1706 17 mezzomo mezzomo PROPN aji-51 1706 18 lam lam PROPN aji-51 1706 19 , , PUNCT aji-51 1706 20 rodríguez rodríguez VERB aji-51 1706 21 cordeiro cordeiro PROPN aji-51 1706 22 mm mm PROPN aji-51 1706 23 . . PUNCT aji-51 1707 1 expression expression NOUN aji-51 1707 2 of of ADP aji-51 1707 3 cancer cancer NOUN aji-51 1707 4 stem stem NOUN aji-51 1707 5 cell cell NOUN aji-51 1707 6 biomarkers biomarker NOUN aji-51 1707 7 in in ADP aji-51 1707 8 human human ADJ aji-51 1707 9 head head NOUN aji-51 1707 10 and and CCONJ aji-51 1707 11 neck neck NOUN aji-51 1707 12 carcinomas carcinoma NOUN aji-51 1707 13 : : PUNCT aji-51 1707 14 a a DET aji-51 1707 15 systematic systematic ADJ aji-51 1707 16 review review NOUN aji-51 1707 17 . . PUNCT aji-51 1708 1 stem stem NOUN aji-51 1708 2 cell cell PROPN aji-51 1708 3 rev rev PROPN aji-51 1708 4 rep rep PROPN aji-51 1708 5 . . PROPN aji-51 1708 6 2018 2018 NUM aji-51 1708 7 dec;14(6):769 dec;14(6):769 NOUN aji-51 1708 8 - - PUNCT aji-51 1708 9 784 784 NUM aji-51 1708 10 . . PUNCT aji-51 1709 1 doi doi NOUN aji-51 1709 2 : : PUNCT aji-51 1709 3 10.1007 10.1007 NUM aji-51 1709 4 / / SYM aji-51 1709 5 s12015 s12015 PROPN aji-51 1709 6 - - PUNCT aji-51 1709 7 018 018 NUM aji-51 1709 8 - - PUNCT aji-51 1709 9 9839 9839 NUM aji-51 1709 10 - - SYM aji-51 1709 11 4 4 NUM aji-51 1709 12 pmid pmid NOUN aji-51 1709 13 : : PUNCT aji-51 1709 14 30076557 30076557 NUM aji-51 1709 15 . . PUNCT aji-51 1710 1 238 238 NUM aji-51 1710 2 . . PUNCT aji-51 1711 1 walcher walcher PROPN aji-51 1711 2 l l NOUN aji-51 1711 3 , , PUNCT aji-51 1711 4 kistenmacher kistenmacher PROPN aji-51 1711 5 ak ak PROPN aji-51 1711 6 , , PUNCT aji-51 1711 7 suo suo PROPN aji-51 1711 8 h h PROPN aji-51 1711 9 , , PUNCT aji-51 1711 10 kitte kitte NOUN aji-51 1711 11 r r NOUN aji-51 1711 12 , , PUNCT aji-51 1711 13 dluczek dluczek NOUN aji-51 1711 14 s s PROPN aji-51 1711 15 , , PUNCT aji-51 1711 16 strauß strauß VERB aji-51 1711 17 a a DET aji-51 1711 18 , , PUNCT aji-51 1711 19 blaudszun blaudszun PROPN aji-51 1711 20 ar ar PROPN aji-51 1711 21 , , PUNCT aji-51 1711 22 yevsa yevsa NOUN aji-51 1711 23 t t PROPN aji-51 1711 24 , , PUNCT aji-51 1711 25 fricke fricke PROPN aji-51 1711 26 s s PROPN aji-51 1711 27 , , PUNCT aji-51 1711 28 kossatz kossatz NOUN aji-51 1711 29 - - PUNCT aji-51 1711 30 boehlert boehlert PROPN aji-51 1711 31 u. u. PROPN aji-51 1711 32 cancer cancer NOUN aji-51 1711 33 stem stem NOUN aji-51 1711 34 cells cell NOUN aji-51 1711 35 - - PUNCT aji-51 1711 36 origins origin NOUN aji-51 1711 37 and and CCONJ aji-51 1711 38 biomarkers biomarker NOUN aji-51 1711 39 : : PUNCT aji-51 1711 40 perspectives perspective NOUN aji-51 1711 41 for for ADP aji-51 1711 42 targeted target VERB aji-51 1711 43 personalized personalized ADJ aji-51 1711 44 therapies therapy NOUN aji-51 1711 45 . . PUNCT aji-51 1712 1 front front ADJ aji-51 1712 2 immunol immunol NOUN aji-51 1712 3 . . PUNCT aji-51 1713 1 2020 2020 NUM aji-51 1713 2 aug aug PROPN aji-51 1713 3 7;11:1280 7;11:1280 PROPN aji-51 1713 4 . . PUNCT aji-51 1714 1 doi doi NOUN aji-51 1714 2 : : PUNCT aji-51 1714 3 10.3389 10.3389 NUM aji-51 1714 4 / / SYM aji-51 1714 5 fimmu.2020.01280 fimmu.2020.01280 NOUN aji-51 1714 6 pmid pmid NOUN aji-51 1714 7 : : PUNCT aji-51 1714 8 32849491 32849491 NUM aji-51 1714 9 ; ; PUNCT aji-51 1714 10 pmcid pmcid NOUN aji-51 1714 11 : : PUNCT aji-51 1714 12 pmc7426526 pmc7426526 NOUN aji-51 1714 13 . . PUNCT aji-51 1715 1 239 239 NUM aji-51 1715 2 . . PUNCT aji-51 1715 3 guo guo PROPN aji-51 1715 4 r r PROPN aji-51 1715 5 , , PUNCT aji-51 1715 6 chu chu PROPN aji-51 1715 7 a a PRON aji-51 1715 8 , , PUNCT aji-51 1715 9 gong gong PROPN aji-51 1715 10 y. y. PROPN aji-51 1715 11 identification identification NOUN aji-51 1715 12 of of ADP aji-51 1715 13 cancer cancer NOUN aji-51 1715 14 stem stem NOUN aji-51 1715 15 cell cell NOUN aji-51 1715 16 - - PUNCT aji-51 1715 17 related relate VERB aji-51 1715 18 biomarkers biomarker NOUN aji-51 1715 19 in in ADP aji-51 1715 20 intestinal intestinal ADJ aji-51 1715 21 - - PUNCT aji-51 1715 22 type type NOUN aji-51 1715 23 and and CCONJ aji-51 1715 24 diffuse diffuse NOUN aji-51 1715 25 - - PUNCT aji-51 1715 26 type type NOUN aji-51 1715 27 gastric gastric ADJ aji-51 1715 28 cancer cancer NOUN aji-51 1715 29 by by ADP aji-51 1715 30 stemness stemness ADJ aji-51 1715 31 index index NOUN aji-51 1715 32 and and CCONJ aji-51 1715 33 weighted weight VERB aji-51 1715 34 correlation correlation NOUN aji-51 1715 35 network network NOUN aji-51 1715 36 analysis analysis NOUN aji-51 1715 37 . . PUNCT aji-51 1716 1 j j PROPN aji-51 1716 2 transl transl PROPN aji-51 1716 3 med med PROPN aji-51 1716 4 . . PUNCT aji-51 1717 1 2020 2020 NUM aji-51 1717 2 nov nov PROPN aji-51 1717 3 7;18(1):418 7;18(1):418 NUM aji-51 1717 4 . . PUNCT aji-51 1718 1 doi doi NOUN aji-51 1718 2 : : PUNCT aji-51 1718 3 10.1186 10.1186 NUM aji-51 1718 4 / / SYM aji-51 1718 5 s12967 s12967 NOUN aji-51 1718 6 - - PUNCT aji-51 1718 7 020 020 NUM aji-51 1718 8 - - PUNCT aji-51 1718 9 02587 02587 NUM aji-51 1718 10 - - SYM aji-51 1718 11 3 3 NUM aji-51 1718 12 pmid pmid NOUN aji-51 1718 13 : : PUNCT aji-51 1718 14 33160391 33160391 NUM aji-51 1718 15 ; ; PUNCT aji-51 1718 16 pmcid pmcid NOUN aji-51 1718 17 : : PUNCT aji-51 1718 18 pmc7648412 pmc7648412 PROPN aji-51 1718 19 . . PUNCT aji-51 1719 1 stoff stoff PROPN aji-51 1719 2 ; ; PUNCT aji-51 1719 3 aji aji PROPN aji-51 1719 4 , , PUNCT aji-51 1719 5 5(1 5(1 NUM aji-51 1719 6 ): ): PUNCT aji-51 1719 7 1 1 NUM aji-51 1719 8 - - SYM aji-51 1719 9 39 39 NUM aji-51 1719 10 , , PUNCT aji-51 1719 11 2022 2022 NUM aji-51 1719 12 ; ; PUNCT aji-51 1719 13 article article NOUN aji-51 1719 14 no.aji.77967 no.aji.77967 VERB aji-51 1719 15 33 33 NUM aji-51 1719 16 240 240 NUM aji-51 1719 17 . . PUNCT aji-51 1720 1 zeng zeng PROPN aji-51 1720 2 s s PROPN aji-51 1720 3 , , PUNCT aji-51 1720 4 shen shen PROPN aji-51 1720 5 wh wh PROPN aji-51 1720 6 , , PUNCT aji-51 1720 7 liu liu PROPN aji-51 1720 8 l. l. PROPN aji-51 1720 9 senescence senescence PROPN aji-51 1720 10 and and CCONJ aji-51 1720 11 cancer cancer NOUN aji-51 1720 12 . . PUNCT aji-51 1721 1 cancer cancer NOUN aji-51 1721 2 transl transl PROPN aji-51 1721 3 med me VERB aji-51 1721 4 . . PUNCT aji-51 1722 1 2018 2018 NUM aji-51 1722 2 mayjun;4(3):70 mayjun;4(3):70 X aji-51 1722 3 - - SYM aji-51 1722 4 74 74 NUM aji-51 1722 5 . . PUNCT aji-51 1723 1 doi doi NOUN aji-51 1723 2 : : PUNCT aji-51 1723 3 10.4103 10.4103 NUM aji-51 1723 4 / / SYM aji-51 1723 5 ctm.ctm_22_18 ctm.ctm_22_18 PROPN aji-51 1723 6 epub epub PROPN aji-51 1723 7 2018 2018 NUM aji-51 1723 8 jun jun PROPN aji-51 1723 9 29 29 NUM aji-51 1723 10 . . PUNCT aji-51 1724 1 pmid pmid NOUN aji-51 1724 2 : : PUNCT aji-51 1724 3 30766922 30766922 NUM aji-51 1724 4 ; ; PUNCT aji-51 1724 5 pmcid pmcid ADJ aji-51 1724 6 : : PUNCT aji-51 1724 7 pmc6372122 pmc6372122 PROPN aji-51 1724 8 . . PUNCT aji-51 1725 1 241 241 X aji-51 1725 2 . . PUNCT aji-51 1725 3 basu basu PROPN aji-51 1725 4 ak ak PROPN aji-51 1725 5 . . PROPN aji-51 1725 6 dna dna PROPN aji-51 1725 7 damage damage NOUN aji-51 1725 8 , , PUNCT aji-51 1725 9 mutagenesis mutagenesis NOUN aji-51 1725 10 and and CCONJ aji-51 1725 11 cancer cancer NOUN aji-51 1725 12 . . PUNCT aji-51 1726 1 int int PROPN aji-51 1726 2 j j PROPN aji-51 1726 3 mol mol ADP aji-51 1726 4 sci sci PROPN aji-51 1726 5 . . PROPN aji-51 1726 6 2018 2018 NUM aji-51 1726 7 mar mar PROPN aji-51 1726 8 23;19(4):970 23;19(4):970 PROPN aji-51 1726 9 . . PUNCT aji-51 1727 1 doi doi NOUN aji-51 1727 2 : : PUNCT aji-51 1727 3 10.3390 10.3390 NUM aji-51 1727 4 / / SYM aji-51 1727 5 ijms19040970 ijms19040970 PROPN aji-51 1727 6 pmid pmid PROPN aji-51 1727 7 : : PUNCT aji-51 1727 8 29570697 29570697 NUM aji-51 1727 9 ; ; PUNCT aji-51 1727 10 pmcid pmcid ADJ aji-51 1727 11 : : PUNCT aji-51 1727 12 pmc5979367 pmc5979367 NOUN aji-51 1727 13 . . PUNCT aji-51 1728 1 242 242 NUM aji-51 1728 2 . . PUNCT aji-51 1729 1 reya reya PROPN aji-51 1729 2 t t PROPN aji-51 1729 3 , , PUNCT aji-51 1729 4 morrison morrison PROPN aji-51 1729 5 sj sj PROPN aji-51 1729 6 , , PUNCT aji-51 1729 7 clarke clarke PROPN aji-51 1729 8 mf mf PROPN aji-51 1729 9 , , PUNCT aji-51 1729 10 weissman weissman PROPN aji-51 1729 11 il il PROPN aji-51 1729 12 . . PROPN aji-51 1729 13 stem stem NOUN aji-51 1729 14 cells cell NOUN aji-51 1729 15 , , PUNCT aji-51 1729 16 cancer cancer NOUN aji-51 1729 17 , , PUNCT aji-51 1729 18 and and CCONJ aji-51 1729 19 cancer cancer NOUN aji-51 1729 20 stem stem NOUN aji-51 1729 21 cells cell NOUN aji-51 1729 22 . . PUNCT aji-51 1730 1 nature nature NOUN aji-51 1730 2 . . PUNCT aji-51 1731 1 2001 2001 NUM aji-51 1731 2 nov nov PROPN aji-51 1731 3 1;414(6859):105 1;414(6859):105 NUM aji-51 1731 4 - - SYM aji-51 1731 5 11 11 NUM aji-51 1731 6 . . PUNCT aji-51 1732 1 doi doi NOUN aji-51 1732 2 : : PUNCT aji-51 1732 3 10.1038/35102167 10.1038/35102167 NUM aji-51 1732 4 pmid pmid NOUN aji-51 1732 5 : : PUNCT aji-51 1732 6 11689955 11689955 NUM aji-51 1732 7 243 243 NUM aji-51 1732 8 . . PUNCT aji-51 1732 9 yu yu PROPN aji-51 1733 1 z z PROPN aji-51 1733 2 , , PUNCT aji-51 1733 3 pestell pestell PROPN aji-51 1733 4 tg tg PROPN aji-51 1733 5 , , PUNCT aji-51 1733 6 lisanti lisanti PROPN aji-51 1733 7 mp mp PROPN aji-51 1733 8 , , PUNCT aji-51 1733 9 pestell pestell PROPN aji-51 1733 10 rg rg PROPN aji-51 1733 11 . . PROPN aji-51 1733 12 cancer cancer NOUN aji-51 1733 13 stem stem NOUN aji-51 1733 14 cells cell NOUN aji-51 1733 15 . . PUNCT aji-51 1734 1 int int PROPN aji-51 1734 2 j j PROPN aji-51 1734 3 biochem biochem PROPN aji-51 1734 4 cell cell NOUN aji-51 1734 5 biol biol PROPN aji-51 1734 6 . . PUNCT aji-51 1735 1 2012 2012 NUM aji-51 1735 2 dec;44(12):2144 dec;44(12):2144 X aji-51 1735 3 - - SYM aji-51 1735 4 51 51 NUM aji-51 1735 5 . . PUNCT aji-51 1735 6 doi doi NOUN aji-51 1735 7 : : PUNCT aji-51 1735 8 10.1016 10.1016 NUM aji-51 1735 9 / / SYM aji-51 1735 10 j.biocel.2012.08.022 j.biocel.2012.08.022 PROPN aji-51 1735 11 epub epub PROPN aji-51 1735 12 2012 2012 NUM aji-51 1735 13 sep sep NOUN aji-51 1735 14 2 2 NUM aji-51 1735 15 . . PUNCT aji-51 1736 1 pmid pmid NOUN aji-51 1736 2 : : PUNCT aji-51 1736 3 22981632 22981632 NUM aji-51 1736 4 ; ; PUNCT aji-51 1736 5 pmcid pmcid ADJ aji-51 1736 6 : : PUNCT aji-51 1736 7 pmc3496019 pmc3496019 NOUN aji-51 1736 8 . . PUNCT aji-51 1737 1 244 244 NUM aji-51 1737 2 . . PUNCT aji-51 1738 1 osman osman PROPN aji-51 1738 2 a a PRON aji-51 1738 3 , , PUNCT aji-51 1738 4 afify afify VERB aji-51 1738 5 sm sm PROPN aji-51 1738 6 , , PUNCT aji-51 1738 7 hassan hassan PROPN aji-51 1738 8 g g PROPN aji-51 1738 9 , , PUNCT aji-51 1738 10 fu fu PROPN aji-51 1738 11 x x NOUN aji-51 1738 12 , , PUNCT aji-51 1738 13 seno seno PROPN aji-51 1738 14 a a PROPN aji-51 1738 15 , , PUNCT aji-51 1738 16 seno seno NOUN aji-51 1738 17 m. m. NOUN aji-51 1738 18 revisiting revisit VERB aji-51 1738 19 cancer cancer NOUN aji-51 1738 20 stem stem NOUN aji-51 1738 21 cells cell NOUN aji-51 1738 22 as as ADP aji-51 1738 23 the the DET aji-51 1738 24 origin origin NOUN aji-51 1738 25 of of ADP aji-51 1738 26 cancer cancer NOUN aji-51 1738 27 - - PUNCT aji-51 1738 28 associated associate VERB aji-51 1738 29 cells cell NOUN aji-51 1738 30 in in ADP aji-51 1738 31 the the DET aji-51 1738 32 tumor tumor NOUN aji-51 1738 33 microenvironment microenvironment NOUN aji-51 1738 34 : : PUNCT aji-51 1738 35 a a DET aji-51 1738 36 hypothetical hypothetical ADJ aji-51 1738 37 view view NOUN aji-51 1738 38 from from ADP aji-51 1738 39 the the DET aji-51 1738 40 potential potential NOUN aji-51 1738 41 of of ADP aji-51 1738 42 ipscs ipsc NOUN aji-51 1738 43 . . PUNCT aji-51 1739 1 cancers cancer NOUN aji-51 1739 2 ( ( PUNCT aji-51 1739 3 basel basel PROPN aji-51 1739 4 ) ) PUNCT aji-51 1739 5 . . PUNCT aji-51 1740 1 2020 2020 NUM aji-51 1740 2 apr apr PROPN aji-51 1740 3 4;12(4):879 4;12(4):879 NUM aji-51 1740 4 . . PUNCT aji-51 1741 1 doi doi NOUN aji-51 1741 2 : : PUNCT aji-51 1741 3 10.3390 10.3390 NUM aji-51 1741 4 / / SYM aji-51 1741 5 cancers12040879 cancers12040879 ADJ aji-51 1741 6 pmid pmid NOUN aji-51 1741 7 : : PUNCT aji-51 1741 8 32260363 32260363 NUM aji-51 1741 9 ; ; PUNCT aji-51 1741 10 pmcid pmcid ADJ aji-51 1741 11 : : PUNCT aji-51 1741 12 pmc7226406 pmc7226406 NOUN aji-51 1741 13 . . PUNCT aji-51 1742 1 245 245 NUM aji-51 1742 2 . . PUNCT aji-51 1743 1 forster forster PROPN aji-51 1743 2 t t PROPN aji-51 1743 3 , , PUNCT aji-51 1743 4 rausch rausch PROPN aji-51 1743 5 v v PROPN aji-51 1743 6 , , PUNCT aji-51 1743 7 zhang zhang PROPN aji-51 1743 8 y y PROPN aji-51 1743 9 , , PUNCT aji-51 1743 10 isayev isayev ADJ aji-51 1743 11 o o NOUN aji-51 1743 12 , , PUNCT aji-51 1743 13 heilmann heilmann PROPN aji-51 1743 14 k k PROPN aji-51 1743 15 , , PUNCT aji-51 1743 16 schoensiegel schoensiegel PROPN aji-51 1743 17 f f PROPN aji-51 1743 18 , , PUNCT aji-51 1743 19 liu liu PROPN aji-51 1743 20 l l PROPN aji-51 1743 21 , , PUNCT aji-51 1743 22 nessling nessle VERB aji-51 1743 23 m m PRON aji-51 1743 24 , , PUNCT aji-51 1743 25 richter richter PROPN aji-51 1743 26 k k PROPN aji-51 1743 27 , , PUNCT aji-51 1743 28 labsch labsch VERB aji-51 1743 29 s s PRON aji-51 1743 30 , , PUNCT aji-51 1743 31 nwaeburu nwaeburu ADV aji-51 1743 32 cc cc PROPN aji-51 1743 33 , , PUNCT aji-51 1743 34 mattern mattern PROPN aji-51 1743 35 j j PROPN aji-51 1743 36 , , PUNCT aji-51 1743 37 gladkich gladkich PROPN aji-51 1743 38 j j PROPN aji-51 1743 39 , , PUNCT aji-51 1743 40 giese giese ADJ aji-51 1743 41 n n CCONJ aji-51 1743 42 , , PUNCT aji-51 1743 43 werner werner PROPN aji-51 1743 44 j j PROPN aji-51 1743 45 , , PUNCT aji-51 1743 46 schemmer schemmer NOUN aji-51 1743 47 p p NOUN aji-51 1743 48 , , PUNCT aji-51 1743 49 gross gross ADJ aji-51 1743 50 w w NOUN aji-51 1743 51 , , PUNCT aji-51 1743 52 gebhard gebhard NOUN aji-51 1743 53 mm mm PROPN aji-51 1743 54 , , PUNCT aji-51 1743 55 gerhauser gerhauser NOUN aji-51 1743 56 c c NOUN aji-51 1743 57 , , PUNCT aji-51 1743 58 schaefer schaefer PROPN aji-51 1743 59 m m PROPN aji-51 1743 60 , , PUNCT aji-51 1743 61 herr herr PROPN aji-51 1743 62 i. i. PROPN aji-51 1743 63 sulforaphane sulforaphane PROPN aji-51 1743 64 counteracts counteract VERB aji-51 1743 65 aggressiveness aggressiveness NOUN aji-51 1743 66 of of ADP aji-51 1743 67 pancreatic pancreatic ADJ aji-51 1743 68 cancer cancer NOUN aji-51 1743 69 driven drive VERB aji-51 1743 70 by by ADP aji-51 1743 71 dysregulated dysregulate VERB aji-51 1743 72 cx43 cx43 PROPN aji-51 1743 73 - - PUNCT aji-51 1743 74 mediated mediate VERB aji-51 1743 75 gap gap NOUN aji-51 1743 76 junctional junctional ADJ aji-51 1743 77 intercellular intercellular ADJ aji-51 1743 78 communication communication NOUN aji-51 1743 79 . . PUNCT aji-51 1744 1 oncotarget oncotarget NOUN aji-51 1744 2 . . PUNCT aji-51 1745 1 2014 2014 NUM aji-51 1745 2 mar mar PROPN aji-51 1745 3 30;5(6):1621 30;5(6):1621 PROPN aji-51 1745 4 - - SYM aji-51 1745 5 34 34 NUM aji-51 1745 6 . . PUNCT aji-51 1746 1 doi doi NOUN aji-51 1746 2 : : PUNCT aji-51 1746 3 10.18632 10.18632 NUM aji-51 1746 4 / / SYM aji-51 1746 5 oncotarget.1764 oncotarget.1764 PROPN aji-51 1746 6 pmid pmid PROPN aji-51 1746 7 : : PUNCT aji-51 1746 8 24742583 24742583 NUM aji-51 1746 9 ; ; PUNCT aji-51 1746 10 pmcid pmcid ADJ aji-51 1746 11 : : PUNCT aji-51 1746 12 pmc4039235 pmc4039235 NOUN aji-51 1746 13 . . PUNCT aji-51 1747 1 246 246 NUM aji-51 1747 2 . . PUNCT aji-51 1748 1 li li PROPN aji-51 1748 2 y y PROPN aji-51 1748 3 , , PUNCT aji-51 1748 4 zhang zhang PROPN aji-51 1748 5 t t PROPN aji-51 1748 6 , , PUNCT aji-51 1748 7 korkaya korkaya PROPN aji-51 1748 8 h h PROPN aji-51 1748 9 , , PUNCT aji-51 1748 10 liu liu PROPN aji-51 1748 11 s s PROPN aji-51 1748 12 , , PUNCT aji-51 1748 13 lee lee PROPN aji-51 1748 14 hf hf PROPN aji-51 1748 15 , , PUNCT aji-51 1748 16 newman newman PROPN aji-51 1748 17 b b PROPN aji-51 1748 18 , , PUNCT aji-51 1748 19 yu yu PROPN aji-51 1748 20 y y PROPN aji-51 1748 21 , , PUNCT aji-51 1748 22 clouthier clouthier PROPN aji-51 1748 23 sg sg PROPN aji-51 1748 24 , , PUNCT aji-51 1748 25 schwartz schwartz PROPN aji-51 1748 26 sj sj PROPN aji-51 1748 27 , , PUNCT aji-51 1748 28 wicha wicha PROPN aji-51 1748 29 ms ms PROPN aji-51 1748 30 , , PUNCT aji-51 1748 31 sun sun PROPN aji-51 1748 32 d. d. PROPN aji-51 1748 33 sulforaphane sulforaphane PROPN aji-51 1748 34 , , PUNCT aji-51 1748 35 a a DET aji-51 1748 36 dietary dietary ADJ aji-51 1748 37 component component NOUN aji-51 1748 38 of of ADP aji-51 1748 39 broccoli broccoli NOUN aji-51 1748 40 / / SYM aji-51 1748 41 broccoli broccoli NOUN aji-51 1748 42 sprouts sprout NOUN aji-51 1748 43 , , PUNCT aji-51 1748 44 inhibits inhibit VERB aji-51 1748 45 breast breast NOUN aji-51 1748 46 cancer cancer NOUN aji-51 1748 47 stem stem NOUN aji-51 1748 48 cells cell NOUN aji-51 1748 49 . . PUNCT aji-51 1749 1 clin clin PROPN aji-51 1749 2 cancer cancer NOUN aji-51 1749 3 res re NOUN aji-51 1749 4 . . PUNCT aji-51 1750 1 2010 2010 NUM aji-51 1750 2 may may AUX aji-51 1750 3 1;16(9):258090 1;16(9):258090 NUM aji-51 1750 4 . . PUNCT aji-51 1751 1 doi doi NOUN aji-51 1751 2 : : PUNCT aji-51 1751 3 10.1158/1078 10.1158/1078 NUM aji-51 1751 4 - - PUNCT aji-51 1751 5 0432.ccr-09 0432.ccr-09 PROPN aji-51 1751 6 - - PUNCT aji-51 1751 7 2937 2937 NUM aji-51 1751 8 epub epub NOUN aji-51 1751 9 2010 2010 NUM aji-51 1751 10 apr apr NOUN aji-51 1751 11 13 13 NUM aji-51 1751 12 . . PUNCT aji-51 1752 1 pmid pmid NOUN aji-51 1752 2 : : PUNCT aji-51 1752 3 20388854 20388854 NUM aji-51 1752 4 ; ; PUNCT aji-51 1752 5 pmcid pmcid NOUN aji-51 1752 6 : : PUNCT aji-51 1752 7 pmc2862133 pmc2862133 NOUN aji-51 1752 8 . . PUNCT aji-51 1753 1 247 247 NUM aji-51 1753 2 . . PUNCT aji-51 1753 3 sarkar sarkar PROPN aji-51 1753 4 fh fh PROPN aji-51 1753 5 , , PUNCT aji-51 1753 6 li li PROPN aji-51 1753 7 y y PROPN aji-51 1753 8 , , PUNCT aji-51 1753 9 wang wang PROPN aji-51 1753 10 z z PROPN aji-51 1753 11 , , PUNCT aji-51 1753 12 kong kong PROPN aji-51 1753 13 d. d. PROPN aji-51 1753 14 cellular cellular PROPN aji-51 1753 15 signaling signal VERB aji-51 1753 16 perturbation perturbation NOUN aji-51 1753 17 by by ADP aji-51 1753 18 natural natural ADJ aji-51 1753 19 products product NOUN aji-51 1753 20 . . PUNCT aji-51 1754 1 cell cell NOUN aji-51 1754 2 signal signal NOUN aji-51 1754 3 . . PUNCT aji-51 1755 1 2009 2009 NUM aji-51 1755 2 nov;21(11):1541 nov;21(11):1541 NOUN aji-51 1755 3 - - PUNCT aji-51 1755 4 7 7 NUM aji-51 1755 5 . . PUNCT aji-51 1755 6 doi doi NOUN aji-51 1755 7 : : PUNCT aji-51 1755 8 10.1016 10.1016 NUM aji-51 1755 9 / / SYM aji-51 1755 10 j.cellsig.2009.03.009 j.cellsig.2009.03.009 PROPN aji-51 1755 11 epub epub PROPN aji-51 1755 12 2009 2009 NUM aji-51 1755 13 mar mar PROPN aji-51 1755 14 16 16 NUM aji-51 1755 15 . . PUNCT aji-51 1756 1 pmid pmid NOUN aji-51 1756 2 : : PUNCT aji-51 1756 3 19298854 19298854 NUM aji-51 1756 4 ; ; PUNCT aji-51 1756 5 pmcid pmcid ADJ aji-51 1756 6 : : PUNCT aji-51 1756 7 pmc2756420 pmc2756420 NOUN aji-51 1756 8 . . PUNCT aji-51 1757 1 248 248 NUM aji-51 1757 2 . . PUNCT aji-51 1758 1 jin jin PROPN aji-51 1758 2 h h PROPN aji-51 1758 3 , , PUNCT aji-51 1758 4 gong gong PROPN aji-51 1758 5 w w PROPN aji-51 1758 6 , , PUNCT aji-51 1758 7 zhang zhang PROPN aji-51 1758 8 c c PROPN aji-51 1758 9 , , PUNCT aji-51 1758 10 wang wang PROPN aji-51 1758 11 s. s. PROPN aji-51 1758 12 epigallocatechin epigallocatechin PROPN aji-51 1758 13 gallate gallate PROPN aji-51 1758 14 inhibits inhibit VERB aji-51 1758 15 the the DET aji-51 1758 16 proliferation proliferation NOUN aji-51 1758 17 of of ADP aji-51 1758 18 colorectal colorectal ADJ aji-51 1758 19 cancer cancer NOUN aji-51 1758 20 cells cell NOUN aji-51 1758 21 by by ADP aji-51 1758 22 regulating regulate VERB aji-51 1758 23 notch notch ADJ aji-51 1758 24 signaling signal VERB aji-51 1758 25 . . PUNCT aji-51 1759 1 onco onco NOUN aji-51 1759 2 targets target NOUN aji-51 1759 3 ther ther ADV aji-51 1759 4 . . PUNCT aji-51 1760 1 2013;6:145 2013;6:145 NUM aji-51 1760 2 - - SYM aji-51 1760 3 53 53 NUM aji-51 1760 4 . . PUNCT aji-51 1761 1 doi doi NOUN aji-51 1761 2 : : PUNCT aji-51 1761 3 10.2147 10.2147 NUM aji-51 1761 4 / / SYM aji-51 1761 5 ott.s40914 ott.s40914 NOUN aji-51 1761 6 epub epub PROPN aji-51 1761 7 2013 2013 NUM aji-51 1761 8 mar mar PROPN aji-51 1761 9 8 8 NUM aji-51 1761 10 . . PUNCT aji-51 1762 1 pmid pmid NOUN aji-51 1762 2 : : PUNCT aji-51 1762 3 23525843 23525843 NUM aji-51 1762 4 ; ; PUNCT aji-51 1762 5 pmcid pmcid ADJ aji-51 1762 6 : : PUNCT aji-51 1762 7 pmc3596123 pmc3596123 NOUN aji-51 1762 8 . . PUNCT aji-51 1763 1 249 249 NUM aji-51 1763 2 . . PUNCT aji-51 1764 1 ogawa ogawa PROPN aji-51 1764 2 k k PROPN aji-51 1764 3 , , PUNCT aji-51 1764 4 hara hara PROPN aji-51 1764 5 t t PROPN aji-51 1764 6 , , PUNCT aji-51 1764 7 shimizu shimizu PROPN aji-51 1764 8 m m PROPN aji-51 1764 9 , , PUNCT aji-51 1764 10 nagano nagano PROPN aji-51 1764 11 j j PROPN aji-51 1764 12 , , PUNCT aji-51 1764 13 ohno ohno PROPN aji-51 1764 14 t t PROPN aji-51 1764 15 , , PUNCT aji-51 1764 16 hoshi hoshi PROPN aji-51 1764 17 m m PROPN aji-51 1764 18 , , PUNCT aji-51 1764 19 ito ito PROPN aji-51 1764 20 h h PROPN aji-51 1764 21 , , PUNCT aji-51 1764 22 tsurumi tsurumi PROPN aji-51 1764 23 h h PROPN aji-51 1764 24 , , PUNCT aji-51 1764 25 saito saito PROPN aji-51 1764 26 k k PROPN aji-51 1764 27 , , PUNCT aji-51 1764 28 seishima seishima PROPN aji-51 1764 29 m m PROPN aji-51 1764 30 , , PUNCT aji-51 1764 31 moriwaki moriwaki PROPN aji-51 1764 32 h. h. PROPN aji-51 1764 33 ( ( PUNCT aji-51 1764 34 -)epigallocatechin -)epigallocatechin INTJ aji-51 1764 35 gallate gallate PROPN aji-51 1764 36 inhibits inhibit VERB aji-51 1764 37 the the DET aji-51 1764 38 expression expression NOUN aji-51 1764 39 of of ADP aji-51 1764 40 indoleamine indoleamine NOUN aji-51 1764 41 2,3dioxygenase 2,3dioxygenase PROPN aji-51 1764 42 in in ADP aji-51 1764 43 human human ADJ aji-51 1764 44 colorectal colorectal ADJ aji-51 1764 45 cancer cancer NOUN aji-51 1764 46 cells cell NOUN aji-51 1764 47 . . PUNCT aji-51 1765 1 oncol oncol ADJ aji-51 1765 2 lett lett PROPN aji-51 1765 3 . . PUNCT aji-51 1766 1 2012 2012 NUM aji-51 1766 2 sep;4(3):546 sep;4(3):546 PROPN aji-51 1766 3 - - ADJ aji-51 1766 4 550 550 NUM aji-51 1766 5 . . PUNCT aji-51 1767 1 doi doi NOUN aji-51 1767 2 : : PUNCT aji-51 1767 3 10.3892 10.3892 NUM aji-51 1767 4 / / SYM aji-51 1767 5 ol.2012.761 ol.2012.761 VERB aji-51 1767 6 epub epub NOUN aji-51 1767 7 2012 2012 NUM aji-51 1767 8 jun jun PROPN aji-51 1767 9 15 15 NUM aji-51 1767 10 . . PUNCT aji-51 1768 1 pmid pmid NOUN aji-51 1768 2 : : PUNCT aji-51 1768 3 23741252 23741252 NUM aji-51 1768 4 ; ; PUNCT aji-51 1768 5 pmcid pmcid NOUN aji-51 1768 6 : : PUNCT aji-51 1768 7 pmc3673646 pmc3673646 NOUN aji-51 1768 8 . . PUNCT aji-51 1769 1 250 250 NUM aji-51 1769 2 . . PUNCT aji-51 1770 1 moselhy moselhy PROPN aji-51 1770 2 j j PROPN aji-51 1770 3 , , PUNCT aji-51 1770 4 srinivasan srinivasan PROPN aji-51 1770 5 s s PROPN aji-51 1770 6 , , PUNCT aji-51 1770 7 ankem ankem ADJ aji-51 1770 8 mk mk PROPN aji-51 1770 9 , , PUNCT aji-51 1770 10 damodaran damodaran VERB aji-51 1770 11 c. c. PROPN aji-51 1770 12 natural natural ADJ aji-51 1770 13 products product NOUN aji-51 1770 14 that that PRON aji-51 1770 15 target target VERB aji-51 1770 16 cancer cancer NOUN aji-51 1770 17 stem stem NOUN aji-51 1770 18 cells cell NOUN aji-51 1770 19 . . PUNCT aji-51 1771 1 anticancer anticancer NOUN aji-51 1771 2 res re NOUN aji-51 1771 3 . . PROPN aji-51 1771 4 2015 2015 NUM aji-51 1771 5 nov;35(11):5773 nov;35(11):5773 X aji-51 1771 6 - - PUNCT aji-51 1771 7 88 88 NUM aji-51 1771 8 . . PUNCT aji-51 1772 1 pmid pmid NOUN aji-51 1772 2 : : PUNCT aji-51 1772 3 26503998 26503998 NUM aji-51 1772 4 ; ; PUNCT aji-51 1772 5 pmcid pmcid NOUN aji-51 1772 6 : : PUNCT aji-51 1772 7 pmc7523548 pmc7523548 ADJ aji-51 1772 8 . . PUNCT aji-51 1773 1 251 251 NUM aji-51 1773 2 . . PUNCT aji-51 1774 1 weaver weaver PROPN aji-51 1774 2 ba ba PROPN aji-51 1774 3 . . PUNCT aji-51 1775 1 how how SCONJ aji-51 1775 2 taxol taxol PROPN aji-51 1775 3 / / SYM aji-51 1775 4 paclitaxel paclitaxel PROPN aji-51 1775 5 kills kill VERB aji-51 1775 6 cancer cancer NOUN aji-51 1775 7 cells cell NOUN aji-51 1775 8 . . PUNCT aji-51 1776 1 mol mol ADP aji-51 1776 2 biol biol ADJ aji-51 1776 3 cell cell NOUN aji-51 1776 4 . . PUNCT aji-51 1777 1 2014 2014 NUM aji-51 1777 2 sep sep NOUN aji-51 1777 3 15;25(18):2677 15;25(18):2677 NUM aji-51 1777 4 - - PUNCT aji-51 1777 5 81 81 NUM aji-51 1777 6 . . PUNCT aji-51 1778 1 doi doi NOUN aji-51 1778 2 : : PUNCT aji-51 1778 3 10.1091 10.1091 NUM aji-51 1778 4 / / SYM aji-51 1778 5 mbc.e14 mbc.e14 ADJ aji-51 1778 6 - - PUNCT aji-51 1778 7 04 04 NUM aji-51 1778 8 - - PUNCT aji-51 1778 9 0916 0916 NUM aji-51 1778 10 pmid pmid NOUN aji-51 1778 11 : : PUNCT aji-51 1778 12 25213191 25213191 NUM aji-51 1778 13 ; ; PUNCT aji-51 1778 14 pmcid pmcid ADJ aji-51 1778 15 : : PUNCT aji-51 1778 16 pmc4161504 pmc4161504 NOUN aji-51 1778 17 . . PUNCT aji-51 1779 1 252 252 NUM aji-51 1779 2 . . PUNCT aji-51 1780 1 moudi moudi PROPN aji-51 1780 2 m m PROPN aji-51 1780 3 , , PUNCT aji-51 1780 4 go go VERB aji-51 1780 5 r r NOUN aji-51 1780 6 , , PUNCT aji-51 1780 7 yien yien PROPN aji-51 1780 8 cy cy PROPN aji-51 1780 9 , , PUNCT aji-51 1780 10 nazre nazre ADJ aji-51 1780 11 m. m. NOUN aji-51 1780 12 vinca vinca NOUN aji-51 1780 13 alkaloids alkaloid NOUN aji-51 1780 14 . . PUNCT aji-51 1781 1 int int PROPN aji-51 1781 2 j j PROPN aji-51 1781 3 prev prev X aji-51 1781 4 med med PROPN aji-51 1781 5 . . PUNCT aji-51 1782 1 2013 2013 NUM aji-51 1782 2 nov;4(11):1231 nov;4(11):1231 NUM aji-51 1782 3 - - SYM aji-51 1782 4 5 5 NUM aji-51 1782 5 . . PUNCT aji-51 1783 1 pmid pmid NOUN aji-51 1783 2 : : PUNCT aji-51 1783 3 24404355 24404355 NUM aji-51 1783 4 ; ; PUNCT aji-51 1783 5 pmcid pmcid ADJ aji-51 1783 6 : : PUNCT aji-51 1783 7 pmc3883245 pmc3883245 NOUN aji-51 1783 8 . . PUNCT aji-51 1784 1 253 253 NUM aji-51 1784 2 . . PUNCT aji-51 1785 1 saini saini PROPN aji-51 1785 2 n n PROPN aji-51 1785 3 , , PUNCT aji-51 1785 4 yang yang PROPN aji-51 1785 5 x. x. PROPN aji-51 1785 6 metformin metformin PROPN aji-51 1785 7 as as ADP aji-51 1785 8 an an DET aji-51 1785 9 anticancer anticancer NOUN aji-51 1785 10 agent agent NOUN aji-51 1785 11 : : PUNCT aji-51 1785 12 actions action NOUN aji-51 1785 13 and and CCONJ aji-51 1785 14 mechanisms mechanism NOUN aji-51 1785 15 targeting target VERB aji-51 1785 16 cancer cancer NOUN aji-51 1785 17 stem stem NOUN aji-51 1785 18 cells cell NOUN aji-51 1785 19 . . PUNCT aji-51 1786 1 acta acta PROPN aji-51 1786 2 biochim biochim PROPN aji-51 1786 3 biophys biophy NOUN aji-51 1786 4 sin sin NOUN aji-51 1786 5 ( ( PUNCT aji-51 1786 6 shanghai shanghai PROPN aji-51 1786 7 ) ) PUNCT aji-51 1786 8 . . PUNCT aji-51 1787 1 2018 2018 NUM aji-51 1787 2 feb feb X aji-51 1787 3 1;50(2):133 1;50(2):133 NUM aji-51 1787 4 - - SYM aji-51 1787 5 143 143 NUM aji-51 1787 6 . . PUNCT aji-51 1788 1 doi doi NOUN aji-51 1788 2 : : PUNCT aji-51 1788 3 10.1093 10.1093 NUM aji-51 1788 4 / / SYM aji-51 1788 5 abbs abbs PROPN aji-51 1788 6 / / SYM aji-51 1788 7 gmx106 gmx106 PROPN aji-51 1788 8 pmid pmid PROPN aji-51 1788 9 : : PUNCT aji-51 1788 10 29342230 29342230 NUM aji-51 1788 11 . . PUNCT aji-51 1789 1 254 254 NUM aji-51 1789 2 . . PUNCT aji-51 1790 1 kim kim PROPN aji-51 1790 2 th th PROPN aji-51 1790 3 , , PUNCT aji-51 1790 4 suh suh PROPN aji-51 1790 5 dh dh PROPN aji-51 1790 6 , , PUNCT aji-51 1790 7 kim kim PROPN aji-51 1790 8 mk mk PROPN aji-51 1790 9 , , PUNCT aji-51 1790 10 song song NOUN aji-51 1790 11 ys ys PROPN aji-51 1790 12 . . PUNCT aji-51 1791 1 metformin metformin PROPN aji-51 1791 2 against against ADP aji-51 1791 3 cancer cancer NOUN aji-51 1791 4 stem stem NOUN aji-51 1791 5 cells cell NOUN aji-51 1791 6 through through ADP aji-51 1791 7 the the DET aji-51 1791 8 modulation modulation NOUN aji-51 1791 9 of of ADP aji-51 1791 10 energy energy NOUN aji-51 1791 11 stoff stoff PROPN aji-51 1791 12 ; ; PUNCT aji-51 1791 13 aji aji PROPN aji-51 1791 14 , , PUNCT aji-51 1791 15 5(1 5(1 NUM aji-51 1791 16 ): ): PUNCT aji-51 1791 17 1 1 NUM aji-51 1791 18 - - SYM aji-51 1791 19 39 39 NUM aji-51 1791 20 , , PUNCT aji-51 1791 21 2022 2022 NUM aji-51 1791 22 ; ; PUNCT aji-51 1791 23 article article NOUN aji-51 1791 24 no.aji.77967 no.aji.77967 PROPN aji-51 1791 25 34 34 NUM aji-51 1791 26 metabolism metabolism NOUN aji-51 1791 27 : : PUNCT aji-51 1791 28 special special ADJ aji-51 1791 29 considerations consideration NOUN aji-51 1791 30 on on ADP aji-51 1791 31 ovarian ovarian ADJ aji-51 1791 32 cancer cancer NOUN aji-51 1791 33 . . PUNCT aji-51 1792 1 biomed biome VERB aji-51 1792 2 res re NOUN aji-51 1792 3 int int NOUN aji-51 1792 4 . . PUNCT aji-51 1793 1 2014;2014:132702 2014;2014:132702 NUM aji-51 1793 2 . . PUNCT aji-51 1794 1 doi doi NOUN aji-51 1794 2 : : PUNCT aji-51 1794 3 10.1155/2014/132702 10.1155/2014/132702 NUM aji-51 1794 4 epub epub NOUN aji-51 1794 5 2014 2014 NUM aji-51 1794 6 jun jun PROPN aji-51 1794 7 24 24 NUM aji-51 1794 8 . . PUNCT aji-51 1795 1 pmid pmid NOUN aji-51 1795 2 : : PUNCT aji-51 1795 3 25050322 25050322 NUM aji-51 1795 4 ; ; PUNCT aji-51 1795 5 pmcid pmcid ADJ aji-51 1795 6 : : PUNCT aji-51 1795 7 pmc4094711 pmc4094711 NOUN aji-51 1795 8 . . PUNCT aji-51 1796 1 255 255 NUM aji-51 1796 2 . . PUNCT aji-51 1797 1 zhao zhao PROPN aji-51 1797 2 b b PROPN aji-51 1797 3 , , PUNCT aji-51 1797 4 luo luo PROPN aji-51 1797 5 j j PROPN aji-51 1797 6 , , PUNCT aji-51 1797 7 wang wang PROPN aji-51 1797 8 y y PROPN aji-51 1797 9 , , PUNCT aji-51 1797 10 zhou zhou PROPN aji-51 1797 11 l l PROPN aji-51 1797 12 , , PUNCT aji-51 1797 13 che che PROPN aji-51 1797 14 j j PROPN aji-51 1797 15 , , PUNCT aji-51 1797 16 wang wang PROPN aji-51 1797 17 f f PROPN aji-51 1797 18 , , PUNCT aji-51 1797 19 peng peng PROPN aji-51 1797 20 s s PROPN aji-51 1797 21 , , PUNCT aji-51 1797 22 zhang zhang PROPN aji-51 1797 23 g g PROPN aji-51 1797 24 , , PUNCT aji-51 1797 25 shang shang PROPN aji-51 1797 26 p. p. PROPN aji-51 1797 27 metformin metformin PROPN aji-51 1797 28 suppresses suppress VERB aji-51 1797 29 self self NOUN aji-51 1797 30 - - PUNCT aji-51 1797 31 renewal renewal NOUN aji-51 1797 32 ability ability NOUN aji-51 1797 33 and and CCONJ aji-51 1797 34 tumorigenicity tumorigenicity NOUN aji-51 1797 35 of of ADP aji-51 1797 36 osteosarcoma osteosarcoma ADJ aji-51 1797 37 stem stem NOUN aji-51 1797 38 cells cell NOUN aji-51 1797 39 via via ADP aji-51 1797 40 reactive reactive ADJ aji-51 1797 41 oxygen oxygen NOUN aji-51 1797 42 species specie NOUN aji-51 1797 43 - - PUNCT aji-51 1797 44 mediated mediate VERB aji-51 1797 45 apoptosis apoptosis NOUN aji-51 1797 46 and and CCONJ aji-51 1797 47 autophagy autophagy NOUN aji-51 1797 48 . . PUNCT aji-51 1798 1 oxid oxid PROPN aji-51 1798 2 med med PROPN aji-51 1798 3 cell cell NOUN aji-51 1798 4 longev longev NOUN aji-51 1798 5 . . PUNCT aji-51 1799 1 2019 2019 NUM aji-51 1799 2 nov nov NOUN aji-51 1799 3 18;2019:9290728 18;2019:9290728 NUM aji-51 1799 4 . . PUNCT aji-51 1800 1 doi doi NOUN aji-51 1800 2 : : PUNCT aji-51 1800 3 10.1155/2019/9290728 10.1155/2019/9290728 NUM aji-51 1800 4 pmid pmid NOUN aji-51 1800 5 : : PUNCT aji-51 1800 6 31827709 31827709 NUM aji-51 1800 7 ; ; PUNCT aji-51 1800 8 pmcid pmcid ADJ aji-51 1800 9 : : PUNCT aji-51 1800 10 pmc6885828 pmc6885828 NOUN aji-51 1800 11 . . PUNCT aji-51 1801 1 256 256 NUM aji-51 1801 2 . . PUNCT aji-51 1801 3 daugan daugan PROPN aji-51 1801 4 m m PROPN aji-51 1801 5 , , PUNCT aji-51 1801 6 dufaÿ dufaÿ PROPN aji-51 1801 7 wojcicki wojcicki PROPN aji-51 1801 8 a a PROPN aji-51 1801 9 , , PUNCT aji-51 1801 10 d'hayer d'hayer PROPN aji-51 1801 11 b b PROPN aji-51 1801 12 , , PUNCT aji-51 1801 13 boudy boudy PROPN aji-51 1801 14 v. v. CCONJ aji-51 1801 15 metformin metformin PROPN aji-51 1801 16 : : PUNCT aji-51 1801 17 an an DET aji-51 1801 18 anti anti ADJ aji-51 1801 19 - - ADJ aji-51 1801 20 diabetic diabetic ADJ aji-51 1801 21 drug drug NOUN aji-51 1801 22 to to PART aji-51 1801 23 fight fight VERB aji-51 1801 24 cancer cancer NOUN aji-51 1801 25 . . PUNCT aji-51 1802 1 pharmacol pharmacol NOUN aji-51 1802 2 res re NOUN aji-51 1802 3 . . PUNCT aji-51 1803 1 2016 2016 NUM aji-51 1803 2 nov;113(pt nov;113(pt PUNCT aji-51 1803 3 a):675 a):675 PROPN aji-51 1803 4 - - PUNCT aji-51 1803 5 685 685 NUM aji-51 1803 6 . . PUNCT aji-51 1804 1 doi doi NOUN aji-51 1804 2 : : PUNCT aji-51 1804 3 10.1016 10.1016 NUM aji-51 1804 4 / / SYM aji-51 1804 5 j.phrs.2016.10.006 j.phrs.2016.10.006 PROPN aji-51 1804 6 epub epub PROPN aji-51 1804 7 2016 2016 NUM aji-51 1804 8 oct oct PROPN aji-51 1804 9 5 5 NUM aji-51 1804 10 . . PUNCT aji-51 1805 1 pmid pmid NOUN aji-51 1805 2 : : PUNCT aji-51 1805 3 27720766 27720766 NUM aji-51 1805 4 . . PUNCT aji-51 1806 1 257 257 NUM aji-51 1806 2 . . X aji-51 1807 1 rico rico PROPN aji-51 1807 2 m m PROPN aji-51 1807 3 , , PUNCT aji-51 1807 4 baglioni baglioni PROPN aji-51 1807 5 m m PROPN aji-51 1807 6 , , PUNCT aji-51 1807 7 bondarenko bondarenko PROPN aji-51 1807 8 m m PRON aji-51 1807 9 , , PUNCT aji-51 1807 10 laluce laluce PROPN aji-51 1807 11 nc nc PROPN aji-51 1807 12 , , PUNCT aji-51 1807 13 rozados rozados PROPN aji-51 1807 14 v v NOUN aji-51 1807 15 , , PUNCT aji-51 1807 16 andré andré ADJ aji-51 1807 17 n n PRON aji-51 1807 18 , , PUNCT aji-51 1807 19 carré carré NOUN aji-51 1807 20 m m NOUN aji-51 1807 21 , , PUNCT aji-51 1807 22 scharovsky scharovsky PROPN aji-51 1807 23 og og PROPN aji-51 1807 24 , , PUNCT aji-51 1807 25 menacho menacho PROPN aji-51 1807 26 márquez márquez PROPN aji-51 1807 27 m. m. PROPN aji-51 1807 28 metformin metformin PROPN aji-51 1807 29 and and CCONJ aji-51 1807 30 propranolol propranolol NOUN aji-51 1807 31 combination combination NOUN aji-51 1807 32 prevents prevent VERB aji-51 1807 33 cancer cancer NOUN aji-51 1807 34 progression progression NOUN aji-51 1807 35 and and CCONJ aji-51 1807 36 metastasis metastasis NOUN aji-51 1807 37 in in ADP aji-51 1807 38 different different ADJ aji-51 1807 39 breast breast NOUN aji-51 1807 40 cancer cancer NOUN aji-51 1807 41 models model NOUN aji-51 1807 42 . . PUNCT aji-51 1808 1 oncotarget oncotarget NOUN aji-51 1808 2 . . PUNCT aji-51 1809 1 2017 2017 NUM aji-51 1809 2 jan jan PROPN aji-51 1809 3 10;8(2):2874 10;8(2):2874 NUM aji-51 1809 4 - - PUNCT aji-51 1809 5 2889 2889 NUM aji-51 1809 6 . . PUNCT aji-51 1810 1 doi doi NOUN aji-51 1810 2 : : PUNCT aji-51 1810 3 10.18632 10.18632 NUM aji-51 1810 4 / / SYM aji-51 1810 5 oncotarget.13760 oncotarget.13760 NUM aji-51 1810 6 pmid pmid NOUN aji-51 1810 7 : : PUNCT aji-51 1810 8 27926515 27926515 NUM aji-51 1810 9 ; ; PUNCT aji-51 1810 10 pmcid pmcid ADJ aji-51 1810 11 : : PUNCT aji-51 1810 12 pmc5356849 pmc5356849 NOUN aji-51 1810 13 . . PUNCT aji-51 1811 1 258 258 NUM aji-51 1811 2 . . PUNCT aji-51 1811 3 talarico talarico NOUN aji-51 1811 4 g g PROPN aji-51 1811 5 , , PUNCT aji-51 1811 6 orecchioni orecchioni PROPN aji-51 1811 7 s s PROPN aji-51 1811 8 , , PUNCT aji-51 1811 9 dallaglio dallaglio PROPN aji-51 1811 10 k k NOUN aji-51 1811 11 , , PUNCT aji-51 1811 12 reggiani reggiani VERB aji-51 1811 13 f f PROPN aji-51 1811 14 , , PUNCT aji-51 1811 15 mancuso mancuso PROPN aji-51 1811 16 p p PROPN aji-51 1811 17 , , PUNCT aji-51 1811 18 calleri calleri NOUN aji-51 1811 19 a a NOUN aji-51 1811 20 , , PUNCT aji-51 1811 21 gregato gregato NOUN aji-51 1811 22 g g NOUN aji-51 1811 23 , , PUNCT aji-51 1811 24 labanca labanca NOUN aji-51 1811 25 v v PROPN aji-51 1811 26 , , PUNCT aji-51 1811 27 rossi rossi PROPN aji-51 1811 28 t t PROPN aji-51 1811 29 , , PUNCT aji-51 1811 30 noonan noonan PROPN aji-51 1811 31 dm dm PROPN aji-51 1811 32 , , PUNCT aji-51 1811 33 albini albini PROPN aji-51 1811 34 a a PRON aji-51 1811 35 , , PUNCT aji-51 1812 1 bertolini bertolini PROPN aji-51 1812 2 f. f. PROPN aji-51 1812 3 aspirin aspirin PROPN aji-51 1812 4 and and CCONJ aji-51 1812 5 atenolol atenolol PROPN aji-51 1812 6 enhance enhance VERB aji-51 1812 7 metformin metformin NOUN aji-51 1812 8 activity activity NOUN aji-51 1812 9 against against ADP aji-51 1812 10 breast breast NOUN aji-51 1812 11 cancer cancer NOUN aji-51 1812 12 by by ADP aji-51 1812 13 targeting target VERB aji-51 1812 14 both both CCONJ aji-51 1812 15 neoplastic neoplastic ADJ aji-51 1812 16 and and CCONJ aji-51 1812 17 microenvironment microenvironment ADJ aji-51 1812 18 cells cell NOUN aji-51 1812 19 . . PUNCT aji-51 1813 1 sci sci PROPN aji-51 1813 2 rep rep PROPN aji-51 1813 3 . . PROPN aji-51 1813 4 2016 2016 NUM aji-51 1813 5 jan jan PROPN aji-51 1813 6 5;6:18673 5;6:18673 NUM aji-51 1813 7 . . PUNCT aji-51 1813 8 doi doi NOUN aji-51 1813 9 : : PUNCT aji-51 1813 10 10.1038 10.1038 NUM aji-51 1813 11 / / SYM aji-51 1813 12 srep18673 srep18673 PROPN aji-51 1813 13 pmid pmid PROPN aji-51 1813 14 : : PUNCT aji-51 1813 15 26728433 26728433 NUM aji-51 1813 16 ; ; PUNCT aji-51 1813 17 pmcid pmcid NOUN aji-51 1813 18 : : PUNCT aji-51 1813 19 pmc4700497 pmc4700497 PROPN aji-51 1813 20 . . PUNCT aji-51 1814 1 259 259 NUM aji-51 1814 2 . . PUNCT aji-51 1814 3 available available ADJ aji-51 1814 4 : : PUNCT aji-51 1814 5 https://www.anticancerfund.org https://www.anticancerfund.org NUM aji-51 1814 6 / / SYM aji-51 1814 7 e e NOUN aji-51 1814 8 n n CCONJ aji-51 1814 9 / / SYM aji-51 1814 10 redo redo PROPN aji-51 1814 11 - - PUNCT aji-51 1814 12 db db NOUN aji-51 1814 13 accessed access VERB aji-51 1814 14 9/4/21 9/4/21 NUM aji-51 1814 15 260 260 NUM aji-51 1814 16 . . PUNCT aji-51 1815 1 lamb lamb PROPN aji-51 1815 2 r r PROPN aji-51 1815 3 , , PUNCT aji-51 1815 4 ozsvari ozsvari PROPN aji-51 1815 5 b b NUM aji-51 1815 6 , , PUNCT aji-51 1815 7 lisanti lisanti ADJ aji-51 1815 8 cl cl NOUN aji-51 1815 9 , , PUNCT aji-51 1815 10 tanowitz tanowitz PROPN aji-51 1815 11 hb hb PROPN aji-51 1815 12 , , PUNCT aji-51 1815 13 howell howell PROPN aji-51 1815 14 a a PROPN aji-51 1815 15 , , PUNCT aji-51 1815 16 martinez martinez PROPN aji-51 1815 17 - - PUNCT aji-51 1815 18 outschoorn outschoorn VERB aji-51 1815 19 ue ue PROPN aji-51 1815 20 , , PUNCT aji-51 1815 21 sotgia sotgia PROPN aji-51 1815 22 f f PROPN aji-51 1815 23 , , PUNCT aji-51 1815 24 lisanti lisanti PROPN aji-51 1815 25 mp mp PROPN aji-51 1815 26 . . PUNCT aji-51 1815 27 antibiotics antibiotic NOUN aji-51 1815 28 that that PRON aji-51 1815 29 target target VERB aji-51 1815 30 mitochondria mitochondria NOUN aji-51 1815 31 effectively effectively ADV aji-51 1815 32 eradicate eradicate VERB aji-51 1815 33 cancer cancer NOUN aji-51 1815 34 stem stem NOUN aji-51 1815 35 cells cell NOUN aji-51 1815 36 , , PUNCT aji-51 1815 37 across across ADP aji-51 1815 38 multiple multiple ADJ aji-51 1815 39 tumor tumor NOUN aji-51 1815 40 types type NOUN aji-51 1815 41 : : PUNCT aji-51 1815 42 treating treat VERB aji-51 1815 43 cancer cancer NOUN aji-51 1815 44 like like ADP aji-51 1815 45 an an DET aji-51 1815 46 infectious infectious ADJ aji-51 1815 47 disease disease NOUN aji-51 1815 48 . . PUNCT aji-51 1816 1 oncotarget oncotarget NOUN aji-51 1816 2 . . PUNCT aji-51 1817 1 2015 2015 NUM aji-51 1817 2 mar mar PROPN aji-51 1817 3 10;6(7):4569 10;6(7):4569 PROPN aji-51 1817 4 - - PUNCT aji-51 1817 5 84 84 NUM aji-51 1817 6 . . PUNCT aji-51 1818 1 doi doi NOUN aji-51 1818 2 : : PUNCT aji-51 1818 3 10.18632 10.18632 NUM aji-51 1818 4 / / SYM aji-51 1818 5 oncotarget.3174 oncotarget.3174 PROPN aji-51 1818 6 pmid pmid PROPN aji-51 1818 7 : : PUNCT aji-51 1818 8 25625193 25625193 NUM aji-51 1818 9 ; ; PUNCT aji-51 1818 10 pmcid pmcid ADJ aji-51 1818 11 : : PUNCT aji-51 1818 12 pmc4467100 pmc4467100 NOUN aji-51 1818 13 . . PUNCT aji-51 1819 1 261 261 NUM aji-51 1819 2 . . PUNCT aji-51 1819 3 sotgia sotgia PROPN aji-51 1819 4 f f X aji-51 1819 5 , , PUNCT aji-51 1819 6 ozsvari ozsvari PROPN aji-51 1819 7 b b NUM aji-51 1819 8 , , PUNCT aji-51 1819 9 fiorillo fiorillo NOUN aji-51 1819 10 m m PROPN aji-51 1819 11 , , PUNCT aji-51 1819 12 de de PROPN aji-51 1819 13 francesco francesco PROPN aji-51 1819 14 em em PRON aji-51 1819 15 , , PUNCT aji-51 1819 16 bonuccelli bonuccelli PROPN aji-51 1819 17 g g PROPN aji-51 1819 18 , , PUNCT aji-51 1819 19 lisanti lisanti PROPN aji-51 1819 20 mp mp PROPN aji-51 1819 21 . . PUNCT aji-51 1820 1 a a DET aji-51 1820 2 mitochondrial mitochondrial ADJ aji-51 1820 3 based base VERB aji-51 1820 4 oncology oncology NOUN aji-51 1820 5 platform platform NOUN aji-51 1820 6 for for ADP aji-51 1820 7 targeting target VERB aji-51 1820 8 cancer cancer NOUN aji-51 1820 9 stem stem NOUN aji-51 1820 10 cells cell NOUN aji-51 1820 11 ( ( PUNCT aji-51 1820 12 cscs cscs PROPN aji-51 1820 13 ): ): PUNCT aji-51 1820 14 mitoonc mitoonc PROPN aji-51 1820 15 - - PUNCT aji-51 1820 16 rx rx ADJ aji-51 1820 17 . . PROPN aji-51 1820 18 cell cell NOUN aji-51 1820 19 cycle cycle NOUN aji-51 1820 20 . . PUNCT aji-51 1821 1 2018;17(17):20912100 2018;17(17):20912100 X aji-51 1821 2 . . X aji-51 1821 3 doi doi NOUN aji-51 1821 4 : : PUNCT aji-51 1821 5 10.1080/15384101.2018.1515551 10.1080/15384101.2018.1515551 NUM aji-51 1821 6 epub epub NOUN aji-51 1821 7 2018 2018 NUM aji-51 1821 8 sep sep PROPN aji-51 1821 9 26 26 NUM aji-51 1821 10 . . PUNCT aji-51 1822 1 pmid pmid NOUN aji-51 1822 2 : : PUNCT aji-51 1822 3 30257595 30257595 NUM aji-51 1822 4 ; ; PUNCT aji-51 1822 5 pmcid pmcid NOUN aji-51 1822 6 : : PUNCT aji-51 1822 7 pmc6226227 pmc6226227 VERB aji-51 1822 8 . . PUNCT aji-51 1823 1 262 262 X aji-51 1823 2 . . PUNCT aji-51 1824 1 qiao qiao PROPN aji-51 1824 2 x x PROPN aji-51 1824 3 , , PUNCT aji-51 1824 4 wang wang PROPN aji-51 1824 5 x x PROPN aji-51 1824 6 , , PUNCT aji-51 1824 7 shang shang PROPN aji-51 1824 8 y y PROPN aji-51 1824 9 , , PUNCT aji-51 1824 10 li li PROPN aji-51 1824 11 y y PROPN aji-51 1824 12 , , PUNCT aji-51 1824 13 chen chen PROPN aji-51 1824 14 sz sz PROPN aji-51 1824 15 . . PUNCT aji-51 1824 16 azithromycin azithromycin PROPN aji-51 1824 17 enhances enhance VERB aji-51 1824 18 anticancer anticancer NOUN aji-51 1824 19 activity activity NOUN aji-51 1824 20 of of ADP aji-51 1824 21 trail trail NOUN aji-51 1824 22 by by ADP aji-51 1824 23 inhibiting inhibit VERB aji-51 1824 24 autophagy autophagy NOUN aji-51 1824 25 and and CCONJ aji-51 1824 26 upregulating upregulate VERB aji-51 1824 27 the the DET aji-51 1824 28 protein protein NOUN aji-51 1824 29 levels level NOUN aji-51 1824 30 of of ADP aji-51 1824 31 dr4/5 dr4/5 PROPN aji-51 1824 32 in in ADP aji-51 1824 33 colon colon NOUN aji-51 1824 34 cancer cancer NOUN aji-51 1824 35 cells cell NOUN aji-51 1824 36 in in ADP aji-51 1824 37 vitro vitro X aji-51 1824 38 and and CCONJ aji-51 1824 39 in in ADP aji-51 1824 40 vivo vivo NOUN aji-51 1824 41 . . PUNCT aji-51 1825 1 cancer cancer NOUN aji-51 1825 2 commun commun PROPN aji-51 1825 3 ( ( PUNCT aji-51 1825 4 lond lond PROPN aji-51 1825 5 ) ) PUNCT aji-51 1825 6 . . PUNCT aji-51 1826 1 2018 2018 NUM aji-51 1826 2 jul jul PROPN aji-51 1826 3 3;38(1):43 3;38(1):43 PROPN aji-51 1826 4 . . PUNCT aji-51 1827 1 doi doi NOUN aji-51 1827 2 : : PUNCT aji-51 1827 3 10.1186 10.1186 NUM aji-51 1827 4 / / SYM aji-51 1827 5 s40880 s40880 VERB aji-51 1827 6 - - PUNCT aji-51 1827 7 018 018 NUM aji-51 1827 8 - - PUNCT aji-51 1827 9 0309 0309 NUM aji-51 1827 10 - - PUNCT aji-51 1827 11 9 9 NUM aji-51 1827 12 pmid pmid NOUN aji-51 1827 13 : : PUNCT aji-51 1827 14 29970185 29970185 NUM aji-51 1827 15 ; ; PUNCT aji-51 1827 16 pmcid pmcid ADJ aji-51 1827 17 : : PUNCT aji-51 1827 18 pmc6029027 pmc6029027 NOUN aji-51 1827 19 . . PUNCT aji-51 1828 1 263 263 NUM aji-51 1828 2 . . PUNCT aji-51 1829 1 satheesh satheesh PROPN aji-51 1829 2 nj nj PROPN aji-51 1829 3 , , PUNCT aji-51 1829 4 samuel samuel PROPN aji-51 1829 5 sm sm PROPN aji-51 1829 6 , , PUNCT aji-51 1829 7 büsselberg büsselberg PROPN aji-51 1829 8 d. d. PROPN aji-51 1829 9 combination combination NOUN aji-51 1829 10 therapy therapy NOUN aji-51 1829 11 with with ADP aji-51 1829 12 vitamin vitamin NOUN aji-51 1829 13 c c NOUN aji-51 1829 14 could could AUX aji-51 1829 15 eradicate eradicate VERB aji-51 1829 16 cancer cancer NOUN aji-51 1829 17 stem stem NOUN aji-51 1829 18 cells cell NOUN aji-51 1829 19 . . PUNCT aji-51 1830 1 biomolecules biomolecule NOUN aji-51 1830 2 . . PUNCT aji-51 1831 1 2020 2020 NUM aji-51 1831 2 jan jan PROPN aji-51 1831 3 3;10(1):79 3;10(1):79 PROPN aji-51 1831 4 . . PUNCT aji-51 1832 1 doi doi NOUN aji-51 1832 2 : : PUNCT aji-51 1832 3 10.3390 10.3390 NUM aji-51 1832 4 / / SYM aji-51 1832 5 biom10010079 biom10010079 PROPN aji-51 1832 6 pmid pmid PROPN aji-51 1832 7 : : PUNCT aji-51 1832 8 31947879 31947879 NUM aji-51 1832 9 ; ; PUNCT aji-51 1832 10 pmcid pmcid ADJ aji-51 1832 11 : : PUNCT aji-51 1832 12 pmc7022456 pmc7022456 NOUN aji-51 1832 13 . . PUNCT aji-51 1833 1 264 264 NUM aji-51 1833 2 . . PUNCT aji-51 1834 1 fiorillo fiorillo PROPN aji-51 1834 2 m m PROPN aji-51 1834 3 , , PUNCT aji-51 1834 4 tóth tóth PROPN aji-51 1834 5 f f PROPN aji-51 1834 6 , , PUNCT aji-51 1834 7 sotgia sotgia PROPN aji-51 1834 8 f f PROPN aji-51 1834 9 , , PUNCT aji-51 1834 10 lisanti lisanti PROPN aji-51 1834 11 mp mp PROPN aji-51 1834 12 . . PROPN aji-51 1834 13 doxycycline doxycycline PROPN aji-51 1834 14 , , PUNCT aji-51 1834 15 azithromycin azithromycin PROPN aji-51 1834 16 and and CCONJ aji-51 1834 17 vitamin vitamin NOUN aji-51 1834 18 c c PROPN aji-51 1834 19 ( ( PUNCT aji-51 1834 20 dav dav NOUN aji-51 1834 21 ): ): PUNCT aji-51 1834 22 a a DET aji-51 1834 23 potent potent ADJ aji-51 1834 24 combination combination NOUN aji-51 1834 25 therapy therapy NOUN aji-51 1834 26 for for ADP aji-51 1834 27 targeting target VERB aji-51 1834 28 mitochondria mitochondria NOUN aji-51 1834 29 and and CCONJ aji-51 1834 30 eradicating eradicate VERB aji-51 1834 31 cancer cancer NOUN aji-51 1834 32 stem stem NOUN aji-51 1834 33 cells cell NOUN aji-51 1834 34 ( ( PUNCT aji-51 1834 35 cscs cscs PROPN aji-51 1834 36 ) ) PUNCT aji-51 1834 37 . . PUNCT aji-51 1835 1 aging age VERB aji-51 1835 2 ( ( PUNCT aji-51 1835 3 albany albany PROPN aji-51 1835 4 ny ny PROPN aji-51 1835 5 ) ) PUNCT aji-51 1835 6 . . PUNCT aji-51 1836 1 2019 2019 NUM aji-51 1836 2 apr apr NOUN aji-51 1836 3 19;11(8):2202 19;11(8):2202 NUM aji-51 1836 4 - - PUNCT aji-51 1836 5 2216 2216 NUM aji-51 1836 6 . . PUNCT aji-51 1837 1 doi doi NOUN aji-51 1837 2 : : PUNCT aji-51 1837 3 10.18632 10.18632 NUM aji-51 1837 4 / / SYM aji-51 1837 5 aging.101905 aging.101905 PROPN aji-51 1837 6 . . PUNCT aji-51 1838 1 pmid pmid NOUN aji-51 1838 2 : : PUNCT aji-51 1838 3 31002656 31002656 NUM aji-51 1838 4 ; ; PUNCT aji-51 1838 5 pmcid pmcid NOUN aji-51 1838 6 : : PUNCT aji-51 1838 7 pmc6520007 pmc6520007 NOUN aji-51 1838 8 . . PUNCT aji-51 1839 1 265 265 NUM aji-51 1839 2 . . PUNCT aji-51 1839 3 beckwitt beckwitt PROPN aji-51 1839 4 ch ch PROPN aji-51 1839 5 , , PUNCT aji-51 1839 6 shiraha shiraha PROPN aji-51 1839 7 k k NOUN aji-51 1839 8 , , PUNCT aji-51 1839 9 wells wells PROPN aji-51 1839 10 a. a. PROPN aji-51 1839 11 lipophilic lipophilic PROPN aji-51 1839 12 statins statin NOUN aji-51 1839 13 limit limit VERB aji-51 1839 14 cancer cancer NOUN aji-51 1839 15 cell cell NOUN aji-51 1839 16 growth growth NOUN aji-51 1839 17 and and CCONJ aji-51 1839 18 survival survival NOUN aji-51 1839 19 , , PUNCT aji-51 1839 20 via via ADP aji-51 1839 21 involvement involvement NOUN aji-51 1839 22 of of ADP aji-51 1839 23 akt akt PROPN aji-51 1839 24 signaling signal VERB aji-51 1839 25 . . PUNCT aji-51 1840 1 plos plos PROPN aji-51 1840 2 one one NUM aji-51 1840 3 . . PUNCT aji-51 1841 1 2018 2018 NUM aji-51 1841 2 may may PROPN aji-51 1841 3 15;13(5):e0197422 15;13(5):e0197422 NUM aji-51 1841 4 . . PUNCT aji-51 1842 1 doi doi NOUN aji-51 1842 2 : : PUNCT aji-51 1842 3 10.1371 10.1371 NUM aji-51 1842 4 / / SYM aji-51 1842 5 journal.pone.0197422 journal.pone.0197422 ADJ aji-51 1842 6 pmid pmid PROPN aji-51 1842 7 : : PUNCT aji-51 1842 8 29763460 29763460 NUM aji-51 1842 9 ; ; PUNCT aji-51 1842 10 pmcid pmcid NOUN aji-51 1842 11 : : PUNCT aji-51 1842 12 pmc5953490 pmc5953490 ADJ aji-51 1842 13 . . PUNCT aji-51 1843 1 266 266 NUM aji-51 1843 2 . . PUNCT aji-51 1844 1 song song PROPN aji-51 1844 2 s s PROPN aji-51 1844 3 , , PUNCT aji-51 1844 4 zhang zhang PROPN aji-51 1844 5 y y PROPN aji-51 1844 6 , , PUNCT aji-51 1844 7 ding ding PROPN aji-51 1844 8 t t PROPN aji-51 1844 9 , , PUNCT aji-51 1844 10 ji ji PROPN aji-51 1844 11 n n PROPN aji-51 1844 12 , , PUNCT aji-51 1844 13 zhao zhao PROPN aji-51 1844 14 h. h. PROPN aji-51 1845 1 the the DET aji-51 1845 2 dual dual ADJ aji-51 1845 3 role role NOUN aji-51 1845 4 of of ADP aji-51 1845 5 macropinocytosis macropinocytosis NOUN aji-51 1845 6 in in ADP aji-51 1845 7 cancers cancer NOUN aji-51 1845 8 : : PUNCT aji-51 1845 9 promoting promote VERB aji-51 1845 10 growth growth NOUN aji-51 1845 11 and and CCONJ aji-51 1845 12 inducing induce VERB aji-51 1845 13 methuosis methuosis NOUN aji-51 1845 14 to to PART aji-51 1845 15 participate participate VERB aji-51 1845 16 in in ADP aji-51 1845 17 anticancer anticancer NOUN aji-51 1845 18 therapies therapy NOUN aji-51 1845 19 as as ADP aji-51 1845 20 targets target NOUN aji-51 1845 21 . . PUNCT aji-51 1846 1 front front ADJ aji-51 1846 2 oncol oncol ADJ aji-51 1846 3 . . PUNCT aji-51 1847 1 2021 2021 NUM aji-51 1847 2 jan jan PROPN aji-51 1847 3 19;10:570108 19;10:570108 NUM aji-51 1847 4 . . PUNCT aji-51 1848 1 doi doi NOUN aji-51 1848 2 : : PUNCT aji-51 1848 3 10.3389 10.3389 NUM aji-51 1848 4 / / SYM aji-51 1848 5 fonc.2020.570108 fonc.2020.570108 PROPN aji-51 1848 6 pmid pmid NOUN aji-51 1848 7 : : PUNCT aji-51 1848 8 33542897 33542897 NUM aji-51 1848 9 ; ; PUNCT aji-51 1848 10 pmcid pmcid ADJ aji-51 1848 11 : : PUNCT aji-51 1848 12 pmc7851083 pmc7851083 NOUN aji-51 1848 13 . . PUNCT aji-51 1849 1 267 267 NUM aji-51 1849 2 . . X aji-51 1849 3 osaki osaki PROPN aji-51 1849 4 m m PROPN aji-51 1849 5 , , PUNCT aji-51 1849 6 okada okada PROPN aji-51 1849 7 f. f. PROPN aji-51 1849 8 exosomes exosome NOUN aji-51 1849 9 and and CCONJ aji-51 1849 10 their their PRON aji-51 1849 11 role role NOUN aji-51 1849 12 in in ADP aji-51 1849 13 cancer cancer NOUN aji-51 1849 14 progression progression NOUN aji-51 1849 15 . . PUNCT aji-51 1850 1 yonago yonago PROPN aji-51 1850 2 acta acta PROPN aji-51 1850 3 med med PROPN aji-51 1850 4 . . PUNCT aji-51 1851 1 2019 2019 NUM aji-51 1851 2 jun jun PROPN aji-51 1851 3 20;62(2):182 20;62(2):182 NUM aji-51 1851 4 - - SYM aji-51 1851 5 190 190 NUM aji-51 1851 6 . . PUNCT aji-51 1852 1 stoff stoff PROPN aji-51 1852 2 ; ; PUNCT aji-51 1852 3 aji aji PROPN aji-51 1852 4 , , PUNCT aji-51 1852 5 5(1 5(1 NUM aji-51 1852 6 ): ): PUNCT aji-51 1852 7 1 1 NUM aji-51 1852 8 - - SYM aji-51 1852 9 39 39 NUM aji-51 1852 10 , , PUNCT aji-51 1852 11 2022 2022 NUM aji-51 1852 12 ; ; PUNCT aji-51 1852 13 article article NOUN aji-51 1852 14 no.aji.77967 no.aji.77967 PROPN aji-51 1852 15 35 35 NUM aji-51 1852 16 doi doi NOUN aji-51 1852 17 : : PUNCT aji-51 1852 18 10.33160 10.33160 NUM aji-51 1852 19 / / SYM aji-51 1852 20 yam.2019.06.002 yam.2019.06.002 NOUN aji-51 1852 21 pmid pmid PROPN aji-51 1852 22 : : PUNCT aji-51 1852 23 31320822 31320822 NUM aji-51 1852 24 ; ; PUNCT aji-51 1852 25 pmcid pmcid ADJ aji-51 1852 26 : : PUNCT aji-51 1852 27 pmc6584259 pmc6584259 NOUN aji-51 1852 28 . . PUNCT aji-51 1853 1 268 268 NUM aji-51 1853 2 . . PUNCT aji-51 1854 1 yáñez yáñez NOUN aji-51 1854 2 - - PUNCT aji-51 1854 3 mó mó PROPN aji-51 1854 4 m m PROPN aji-51 1854 5 , , PUNCT aji-51 1854 6 et et VERB aji-51 1854 7 at at ADP aji-51 1854 8 . . PUNCT aji-51 1855 1 biological biological ADJ aji-51 1855 2 properties property NOUN aji-51 1855 3 of of ADP aji-51 1855 4 extracellular extracellular ADJ aji-51 1855 5 vesicles vesicle NOUN aji-51 1855 6 and and CCONJ aji-51 1855 7 their their PRON aji-51 1855 8 physiological physiological ADJ aji-51 1855 9 functions function NOUN aji-51 1855 10 . . PUNCT aji-51 1856 1 j j PROPN aji-51 1856 2 extracell extracell PROPN aji-51 1856 3 vesicles vesicle NOUN aji-51 1856 4 . . PUNCT aji-51 1857 1 2015 2015 NUM aji-51 1857 2 may may AUX aji-51 1857 3 14;4:27066 14;4:27066 NUM aji-51 1857 4 . . PUNCT aji-51 1858 1 doi doi NOUN aji-51 1858 2 : : PUNCT aji-51 1858 3 10.3402 10.3402 NUM aji-51 1858 4 / / SYM aji-51 1858 5 jev.v4.27066 jev.v4.27066 PROPN aji-51 1858 6 pmid pmid PROPN aji-51 1858 7 : : PUNCT aji-51 1858 8 25979354 25979354 NUM aji-51 1858 9 ; ; PUNCT aji-51 1858 10 pmcid pmcid ADJ aji-51 1858 11 : : PUNCT aji-51 1858 12 pmc4433489 pmc4433489 NOUN aji-51 1858 13 . . PUNCT aji-51 1859 1 269 269 NUM aji-51 1859 2 . . PUNCT aji-51 1859 3 katsuda katsuda PROPN aji-51 1859 4 t t PROPN aji-51 1859 5 , , PUNCT aji-51 1859 6 kosaka kosaka PROPN aji-51 1859 7 n n PROPN aji-51 1859 8 , , PUNCT aji-51 1859 9 ochiya ochiya PROPN aji-51 1859 10 t. t. PROPN aji-51 1860 1 the the DET aji-51 1860 2 roles role NOUN aji-51 1860 3 of of ADP aji-51 1860 4 extracellular extracellular ADJ aji-51 1860 5 vesicles vesicle NOUN aji-51 1860 6 in in ADP aji-51 1860 7 cancer cancer NOUN aji-51 1860 8 biology biology NOUN aji-51 1860 9 : : PUNCT aji-51 1860 10 toward toward ADP aji-51 1860 11 the the DET aji-51 1860 12 development development NOUN aji-51 1860 13 of of ADP aji-51 1860 14 novel novel ADJ aji-51 1860 15 cancer cancer NOUN aji-51 1860 16 biomarkers biomarker NOUN aji-51 1860 17 . . PUNCT aji-51 1861 1 proteomics proteomic NOUN aji-51 1861 2 . . PUNCT aji-51 1861 3 2014 2014 NUM aji-51 1862 1 mar;14(45):412 mar;14(45):412 VERB aji-51 1862 2 - - SYM aji-51 1862 3 25 25 NUM aji-51 1862 4 . . PUNCT aji-51 1863 1 doi doi NOUN aji-51 1863 2 : : PUNCT aji-51 1863 3 10.1002 10.1002 NUM aji-51 1863 4 / / SYM aji-51 1863 5 pmic.201300389 pmic.201300389 PROPN aji-51 1863 6 pmid pmid PROPN aji-51 1863 7 : : PUNCT aji-51 1863 8 24339442 24339442 NUM aji-51 1863 9 . . PUNCT aji-51 1864 1 270 270 NUM aji-51 1864 2 . . PUNCT aji-51 1865 1 taylor taylor PROPN aji-51 1865 2 dd dd PROPN aji-51 1865 3 , , PUNCT aji-51 1865 4 gercel gercel PROPN aji-51 1865 5 - - PUNCT aji-51 1865 6 taylor taylor PROPN aji-51 1865 7 c. c. PROPN aji-51 1865 8 exosomes exosome NOUN aji-51 1865 9 / / SYM aji-51 1865 10 microvesicles microvesicle NOUN aji-51 1865 11 : : PUNCT aji-51 1865 12 mediators mediator NOUN aji-51 1865 13 of of ADP aji-51 1865 14 cancer cancer NOUN aji-51 1865 15 - - PUNCT aji-51 1865 16 associated associate VERB aji-51 1865 17 immunosuppressive immunosuppressive ADJ aji-51 1865 18 microenvironments microenvironment NOUN aji-51 1865 19 . . PUNCT aji-51 1866 1 semin semin PROPN aji-51 1866 2 immunopathol immunopathol PROPN aji-51 1866 3 . . PUNCT aji-51 1867 1 2011 2011 NUM aji-51 1867 2 sep;33(5):441 sep;33(5):441 NOUN aji-51 1867 3 - - PUNCT aji-51 1867 4 54 54 NUM aji-51 1867 5 . . PUNCT aji-51 1868 1 doi doi NOUN aji-51 1868 2 : : PUNCT aji-51 1868 3 10.1007 10.1007 NUM aji-51 1868 4 / / SYM aji-51 1868 5 s00281 s00281 NOUN aji-51 1868 6 - - PUNCT aji-51 1868 7 010 010 NUM aji-51 1868 8 - - PUNCT aji-51 1868 9 0234 0234 NUM aji-51 1868 10 - - SYM aji-51 1868 11 8 8 NUM aji-51 1868 12 epub epub NOUN aji-51 1868 13 2011 2011 NUM aji-51 1868 14 jun jun PROPN aji-51 1868 15 19 19 NUM aji-51 1868 16 . . PUNCT aji-51 1869 1 pmid pmid NOUN aji-51 1869 2 : : PUNCT aji-51 1869 3 21688197 21688197 NUM aji-51 1869 4 . . PUNCT aji-51 1870 1 271 271 NUM aji-51 1870 2 . . PUNCT aji-51 1871 1 seo seo NOUN aji-51 1871 2 n n CCONJ aji-51 1871 3 , , PUNCT aji-51 1871 4 akiyoshi akiyoshi VERB aji-51 1871 5 k k NOUN aji-51 1871 6 , , PUNCT aji-51 1871 7 shiku shiku PROPN aji-51 1871 8 h. h. PROPN aji-51 1871 9 exosomemediated exosomemediate VERB aji-51 1871 10 regulation regulation NOUN aji-51 1871 11 of of ADP aji-51 1871 12 tumor tumor NOUN aji-51 1871 13 immunology immunology NOUN aji-51 1871 14 . . PUNCT aji-51 1872 1 cancer cancer PROPN aji-51 1872 2 sci sci PROPN aji-51 1872 3 . . PROPN aji-51 1872 4 2018 2018 NUM aji-51 1872 5 oct;109(10):2998 oct;109(10):2998 PROPN aji-51 1872 6 - - PUNCT aji-51 1872 7 3004 3004 NUM aji-51 1872 8 . . PUNCT aji-51 1873 1 doi doi NOUN aji-51 1873 2 : : PUNCT aji-51 1873 3 10.1111 10.1111 NUM aji-51 1873 4 / / SYM aji-51 1873 5 cas.13735 cas.13735 NUM aji-51 1873 6 epub epub NOUN aji-51 1873 7 2018 2018 NUM aji-51 1873 8 aug aug PROPN aji-51 1873 9 1 1 NUM aji-51 1873 10 . . PUNCT aji-51 1874 1 pmid pmid NOUN aji-51 1874 2 : : PUNCT aji-51 1874 3 29999574 29999574 NUM aji-51 1874 4 ; ; PUNCT aji-51 1874 5 pmcid pmcid NOUN aji-51 1874 6 : : PUNCT aji-51 1874 7 pmc6172045 pmc6172045 NOUN aji-51 1874 8 . . PUNCT aji-51 1875 1 272 272 NUM aji-51 1875 2 . . PUNCT aji-51 1875 3 lugini lugini PROPN aji-51 1875 4 l l PROPN aji-51 1875 5 , , PUNCT aji-51 1875 6 cecchetti cecchetti PROPN aji-51 1875 7 s s PROPN aji-51 1875 8 , , PUNCT aji-51 1875 9 huber huber PROPN aji-51 1875 10 v v PROPN aji-51 1875 11 , , PUNCT aji-51 1875 12 luciani luciani PROPN aji-51 1875 13 f f PROPN aji-51 1875 14 , , PUNCT aji-51 1875 15 macchia macchia PROPN aji-51 1875 16 g g PROPN aji-51 1875 17 , , PUNCT aji-51 1875 18 spadaro spadaro NOUN aji-51 1875 19 f f PROPN aji-51 1875 20 , , PUNCT aji-51 1875 21 paris paris PROPN aji-51 1875 22 l l PROPN aji-51 1875 23 , , PUNCT aji-51 1875 24 abalsamo abalsamo PROPN aji-51 1875 25 l l NOUN aji-51 1875 26 , , PUNCT aji-51 1875 27 colone colone NOUN aji-51 1875 28 m m PROPN aji-51 1875 29 , , PUNCT aji-51 1875 30 molinari molinari PROPN aji-51 1875 31 a a PROPN aji-51 1875 32 , , PUNCT aji-51 1875 33 podo podo PROPN aji-51 1875 34 f f PROPN aji-51 1875 35 , , PUNCT aji-51 1875 36 rivoltini rivoltini PROPN aji-51 1875 37 l l PROPN aji-51 1875 38 , , PUNCT aji-51 1875 39 ramoni ramoni PROPN aji-51 1875 40 c c NOUN aji-51 1875 41 , , PUNCT aji-51 1875 42 fais fais PROPN aji-51 1875 43 s. s. PROPN aji-51 1875 44 immune immune PROPN aji-51 1875 45 surveillance surveillance NOUN aji-51 1875 46 properties property NOUN aji-51 1875 47 of of ADP aji-51 1875 48 human human ADJ aji-51 1875 49 nk nk PROPN aji-51 1875 50 cell cell NOUN aji-51 1875 51 - - PUNCT aji-51 1875 52 derived derive VERB aji-51 1875 53 exosomes exosome NOUN aji-51 1875 54 . . PUNCT aji-51 1876 1 j j PROPN aji-51 1876 2 immunol immunol NOUN aji-51 1876 3 . . PUNCT aji-51 1877 1 2012 2012 NUM aji-51 1877 2 sep sep NOUN aji-51 1877 3 15;189(6):2833 15;189(6):2833 NUM aji-51 1877 4 - - SYM aji-51 1877 5 42 42 NUM aji-51 1877 6 . . PUNCT aji-51 1878 1 doi doi NOUN aji-51 1878 2 : : PUNCT aji-51 1878 3 10.4049 10.4049 NUM aji-51 1878 4 / / SYM aji-51 1878 5 jimmunol.1101988 jimmunol.1101988 PROPN aji-51 1878 6 epub epub PROPN aji-51 1878 7 2012 2012 NUM aji-51 1878 8 aug aug PROPN aji-51 1878 9 17 17 NUM aji-51 1878 10 . . PUNCT aji-51 1879 1 pmid pmid NOUN aji-51 1879 2 : : PUNCT aji-51 1879 3 22904309 22904309 NUM aji-51 1879 4 . . PUNCT aji-51 1880 1 273 273 NUM aji-51 1880 2 . . PUNCT aji-51 1881 1 nam nam PROPN aji-51 1881 2 gh gh PROPN aji-51 1881 3 , , PUNCT aji-51 1881 4 choi choi PROPN aji-51 1881 5 y y PROPN aji-51 1881 6 , , PUNCT aji-51 1881 7 kim kim PROPN aji-51 1881 8 gb gb PROPN aji-51 1881 9 , , PUNCT aji-51 1881 10 kim kim PROPN aji-51 1881 11 s s PROPN aji-51 1881 12 , , PUNCT aji-51 1881 13 kim kim PROPN aji-51 1881 14 sa sa PROPN aji-51 1881 15 , , PUNCT aji-51 1881 16 kim kim PROPN aji-51 1881 17 is be AUX aji-51 1881 18 . . PUNCT aji-51 1882 1 emerging emerge VERB aji-51 1882 2 prospects prospect NOUN aji-51 1882 3 of of ADP aji-51 1882 4 exosomes exosome NOUN aji-51 1882 5 for for ADP aji-51 1882 6 cancer cancer NOUN aji-51 1882 7 treatment treatment NOUN aji-51 1882 8 : : PUNCT aji-51 1882 9 from from ADP aji-51 1882 10 conventional conventional ADJ aji-51 1882 11 therapy therapy NOUN aji-51 1882 12 to to ADP aji-51 1882 13 immunotherapy immunotherapy NOUN aji-51 1882 14 . . PUNCT aji-51 1883 1 adv adv PROPN aji-51 1883 2 mater mater PROPN aji-51 1883 3 . . PUNCT aji-51 1884 1 2020 2020 NUM aji-51 1885 1 dec;32(51):e2002440 dec;32(51):e2002440 PROPN aji-51 1885 2 . . PUNCT aji-51 1885 3 doi doi NOUN aji-51 1885 4 : : PUNCT aji-51 1885 5 10.1002 10.1002 NUM aji-51 1885 6 / / SYM aji-51 1885 7 adma.202002440 adma.202002440 PROPN aji-51 1885 8 epub epub NOUN aji-51 1885 9 2020 2020 NUM aji-51 1885 10 oct oct PROPN aji-51 1885 11 5 5 NUM aji-51 1885 12 . . PUNCT aji-51 1886 1 pmid pmid NOUN aji-51 1886 2 : : PUNCT aji-51 1886 3 33015883 33015883 NUM aji-51 1886 4 . . PUNCT aji-51 1887 1 274 274 NUM aji-51 1887 2 . . PUNCT aji-51 1887 3 lee lee PROPN aji-51 1887 4 nk nk PROPN aji-51 1887 5 , , PUNCT aji-51 1887 6 kothandan kothandan PROPN aji-51 1887 7 vk vk PROPN aji-51 1887 8 , , PUNCT aji-51 1887 9 kothandan kothandan PROPN aji-51 1887 10 s s PROPN aji-51 1887 11 , , PUNCT aji-51 1887 12 byun byun PROPN aji-51 1887 13 y y PROPN aji-51 1887 14 , , PUNCT aji-51 1887 15 hwang hwang PROPN aji-51 1887 16 sr sr PROPN aji-51 1887 17 . . PUNCT aji-51 1888 1 exosomes exosome NOUN aji-51 1888 2 and and CCONJ aji-51 1888 3 cancer cancer NOUN aji-51 1888 4 stem stem NOUN aji-51 1888 5 cells cell NOUN aji-51 1888 6 in in ADP aji-51 1888 7 cancer cancer NOUN aji-51 1888 8 immunity immunity NOUN aji-51 1888 9 : : PUNCT aji-51 1888 10 current current ADJ aji-51 1888 11 reports report NOUN aji-51 1888 12 and and CCONJ aji-51 1888 13 future future ADJ aji-51 1888 14 directions direction NOUN aji-51 1888 15 . . PUNCT aji-51 1889 1 vaccines vaccine NOUN aji-51 1889 2 ( ( PUNCT aji-51 1889 3 basel basel PROPN aji-51 1889 4 ) ) PUNCT aji-51 1889 5 . . PUNCT aji-51 1890 1 2021 2021 NUM aji-51 1890 2 may may AUX aji-51 1890 3 1;9(5):441 1;9(5):441 NUM aji-51 1890 4 . . PUNCT aji-51 1891 1 doi doi NOUN aji-51 1891 2 : : PUNCT aji-51 1891 3 10.3390 10.3390 NUM aji-51 1891 4 / / SYM aji-51 1891 5 vaccines9050441 vaccines9050441 NUM aji-51 1891 6 pmid pmid NOUN aji-51 1891 7 : : PUNCT aji-51 1891 8 34062950 34062950 NUM aji-51 1891 9 ; ; PUNCT aji-51 1891 10 pmcid pmcid NOUN aji-51 1891 11 : : PUNCT aji-51 1891 12 pmc8147426 pmc8147426 NOUN aji-51 1891 13 . . PUNCT aji-51 1892 1 275 275 NUM aji-51 1892 2 . . X aji-51 1893 1 you you PRON aji-51 1893 2 b b PROPN aji-51 1893 3 , , PUNCT aji-51 1893 4 xu xu PROPN aji-51 1893 5 w w PROPN aji-51 1893 6 , , PUNCT aji-51 1893 7 zhang zhang PROPN aji-51 1893 8 b. b. PROPN aji-51 1893 9 engineering engineering PROPN aji-51 1893 10 exosomes exosome NOUN aji-51 1893 11 : : PUNCT aji-51 1893 12 a a DET aji-51 1893 13 new new ADJ aji-51 1893 14 direction direction NOUN aji-51 1893 15 for for ADP aji-51 1893 16 anticancer anticancer NOUN aji-51 1893 17 treatment treatment NOUN aji-51 1893 18 . . PUNCT aji-51 1894 1 am be AUX aji-51 1894 2 j j PROPN aji-51 1894 3 cancer cancer NOUN aji-51 1894 4 res re NOUN aji-51 1894 5 . . PROPN aji-51 1895 1 2018 2018 NUM aji-51 1895 2 aug aug PROPN aji-51 1895 3 1;8(8):1332 1;8(8):1332 NUM aji-51 1895 4 - - SYM aji-51 1895 5 1342 1342 NUM aji-51 1895 6 . . PUNCT aji-51 1896 1 pmid pmid NOUN aji-51 1896 2 : : PUNCT aji-51 1896 3 30210908 30210908 NUM aji-51 1896 4 ; ; PUNCT aji-51 1896 5 pmcid pmcid NOUN aji-51 1896 6 : : PUNCT aji-51 1896 7 pmc6129493 pmc6129493 PROPN aji-51 1896 8 . . PUNCT aji-51 1897 1 276 276 X aji-51 1897 2 . . PUNCT aji-51 1897 3 dai dai PROPN aji-51 1897 4 j j PROPN aji-51 1897 5 , , PUNCT aji-51 1897 6 su su PROPN aji-51 1897 7 y y PROPN aji-51 1897 8 , , PUNCT aji-51 1897 9 zhong zhong PROPN aji-51 1897 10 s s PROPN aji-51 1897 11 , , PUNCT aji-51 1897 12 cong cong NOUN aji-51 1897 13 l l PROPN aji-51 1897 14 , , PUNCT aji-51 1897 15 liu liu PROPN aji-51 1897 16 b b PROPN aji-51 1897 17 , , PUNCT aji-51 1897 18 yang yang PROPN aji-51 1897 19 j j PROPN aji-51 1897 20 , , PUNCT aji-51 1897 21 tao tao PROPN aji-51 1897 22 y y PROPN aji-51 1897 23 , , PUNCT aji-51 1897 24 he he PRON aji-51 1897 25 z z PROPN aji-51 1897 26 , , PUNCT aji-51 1897 27 chen chen PROPN aji-51 1897 28 c c PROPN aji-51 1897 29 , , PUNCT aji-51 1897 30 jiang jiang PROPN aji-51 1897 31 y. y. PROPN aji-51 1897 32 exosomes exosomes PROPN aji-51 1897 33 : : PUNCT aji-51 1897 34 key key ADJ aji-51 1897 35 players player NOUN aji-51 1897 36 in in ADP aji-51 1897 37 cancer cancer NOUN aji-51 1897 38 and and CCONJ aji-51 1897 39 potential potential ADJ aji-51 1897 40 therapeutic therapeutic ADJ aji-51 1897 41 strategy strategy NOUN aji-51 1897 42 . . PUNCT aji-51 1898 1 signal signal PROPN aji-51 1898 2 transduct transduct NOUN aji-51 1898 3 target target NOUN aji-51 1898 4 ther ther ADV aji-51 1898 5 . . PUNCT aji-51 1899 1 2020 2020 NUM aji-51 1899 2 aug aug PROPN aji-51 1899 3 5;5(1):145 5;5(1):145 PROPN aji-51 1899 4 . . PUNCT aji-51 1900 1 doi doi NOUN aji-51 1900 2 : : PUNCT aji-51 1900 3 10.1038 10.1038 NUM aji-51 1900 4 / / SYM aji-51 1900 5 s41392 s41392 VERB aji-51 1900 6 - - PUNCT aji-51 1900 7 020 020 NUM aji-51 1900 8 - - PUNCT aji-51 1900 9 00261 00261 NUM aji-51 1900 10 - - SYM aji-51 1900 11 0 0 NUM aji-51 1900 12 pmid pmid NOUN aji-51 1900 13 : : PUNCT aji-51 1900 14 32759948 32759948 NUM aji-51 1900 15 ; ; PUNCT aji-51 1900 16 pmcid pmcid NOUN aji-51 1900 17 : : PUNCT aji-51 1900 18 pmc7406508 pmc7406508 ADJ aji-51 1900 19 . . PUNCT aji-51 1901 1 277 277 NUM aji-51 1901 2 . . PUNCT aji-51 1902 1 khwaja khwaja PROPN aji-51 1902 2 ta ta PROPN aji-51 1902 3 , , PUNCT aji-51 1902 4 dias dias PROPN aji-51 1902 5 cb cb PROPN aji-51 1902 6 , , PUNCT aji-51 1902 7 pentecost pentecost PROPN aji-51 1902 8 s. s. PROPN aji-51 1903 1 recent recent ADJ aji-51 1903 2 studies study NOUN aji-51 1903 3 on on ADP aji-51 1903 4 the the DET aji-51 1903 5 anticancer anticancer NOUN aji-51 1903 6 activities activity NOUN aji-51 1903 7 of of ADP aji-51 1903 8 mistletoe mistletoe NOUN aji-51 1903 9 ( ( PUNCT aji-51 1903 10 viscum viscum PROPN aji-51 1903 11 album album NOUN aji-51 1903 12 ) ) PUNCT aji-51 1903 13 and and CCONJ aji-51 1903 14 its its PRON aji-51 1903 15 alkaloids alkaloid NOUN aji-51 1903 16 . . PUNCT aji-51 1903 17 oncology oncology NOUN aji-51 1903 18 . . PUNCT aji-51 1904 1 1986;43 1986;43 NUM aji-51 1904 2 suppl suppl ADJ aji-51 1904 3 1:42 1:42 NUM aji-51 1904 4 - - SYM aji-51 1904 5 50 50 NUM aji-51 1904 6 . . PUNCT aji-51 1905 1 doi doi NOUN aji-51 1905 2 : : PUNCT aji-51 1905 3 10.1159/000226419 10.1159/000226419 NUM aji-51 1905 4 pmid pmid NOUN aji-51 1905 5 : : PUNCT aji-51 1905 6 3543783 3543783 NUM aji-51 1905 7 . . PUNCT aji-51 1906 1 278 278 NUM aji-51 1906 2 . . PUNCT aji-51 1907 1 zarković zarković PROPN aji-51 1907 2 n n CCONJ aji-51 1907 3 , , PUNCT aji-51 1907 4 kalisnik kalisnik PROPN aji-51 1907 5 t t PROPN aji-51 1907 6 , , PUNCT aji-51 1907 7 loncarić loncarić VERB aji-51 1907 8 i i PRON aji-51 1907 9 , , PUNCT aji-51 1907 10 borović borović PROPN aji-51 1907 11 s s PROPN aji-51 1907 12 , , PUNCT aji-51 1907 13 mang mang PROPN aji-51 1907 14 s s PROPN aji-51 1907 15 , , PUNCT aji-51 1907 16 kissel kissel PROPN aji-51 1907 17 d d PROPN aji-51 1907 18 , , PUNCT aji-51 1907 19 konitzer konitzer PROPN aji-51 1907 20 m m PROPN aji-51 1907 21 , , PUNCT aji-51 1907 22 jurin jurin PROPN aji-51 1907 23 m m PROPN aji-51 1907 24 , , PUNCT aji-51 1907 25 grainza grainza PROPN aji-51 1907 26 s. s. PROPN aji-51 1907 27 comparison comparison NOUN aji-51 1907 28 of of ADP aji-51 1907 29 the the DET aji-51 1907 30 effects effect NOUN aji-51 1907 31 of of ADP aji-51 1907 32 viscum viscum ADJ aji-51 1907 33 album album NOUN aji-51 1907 34 lectin lectin NOUN aji-51 1907 35 ml-1 ml-1 PUNCT aji-51 1907 36 and and CCONJ aji-51 1907 37 fresh fresh ADJ aji-51 1907 38 plant plant NOUN aji-51 1907 39 extract extract NOUN aji-51 1907 40 ( ( PUNCT aji-51 1907 41 isorel isorel ADV aji-51 1907 42 ) ) PUNCT aji-51 1907 43 on on ADP aji-51 1907 44 the the DET aji-51 1907 45 cell cell NOUN aji-51 1907 46 growth growth NOUN aji-51 1907 47 in in ADP aji-51 1907 48 vitro vitro X aji-51 1907 49 and and CCONJ aji-51 1907 50 tumorigenicity tumorigenicity NOUN aji-51 1907 51 of of ADP aji-51 1907 52 melanoma melanoma PROPN aji-51 1907 53 b16f10 b16f10 NOUN aji-51 1907 54 . . PUNCT aji-51 1908 1 cancer cancer NOUN aji-51 1908 2 biother biother PROPN aji-51 1908 3 radiopharm radiopharm NOUN aji-51 1908 4 . . PUNCT aji-51 1909 1 1998 1998 NUM aji-51 1909 2 apr;13(2):121 apr;13(2):121 NUM aji-51 1909 3 - - SYM aji-51 1909 4 31 31 NUM aji-51 1909 5 . . PUNCT aji-51 1910 1 doi doi NOUN aji-51 1910 2 : : PUNCT aji-51 1910 3 10.1089 10.1089 NUM aji-51 1910 4 / / SYM aji-51 1910 5 cbr.1998.13.121 cbr.1998.13.121 NOUN aji-51 1910 6 pmid pmid NOUN aji-51 1910 7 : : PUNCT aji-51 1910 8 10850348 10850348 NUM aji-51 1910 9 . . PUNCT aji-51 1911 1 279 279 NUM aji-51 1911 2 . . PUNCT aji-51 1912 1 park park PROPN aji-51 1912 2 jh jh PROPN aji-51 1912 3 , , PUNCT aji-51 1912 4 hyun hyun PROPN aji-51 1912 5 ck ck PROPN aji-51 1912 6 , , PUNCT aji-51 1912 7 shin shin PROPN aji-51 1912 8 hk hk PROPN aji-51 1912 9 . . PUNCT aji-51 1913 1 cytotoxic cytotoxic ADJ aji-51 1913 2 effects effect NOUN aji-51 1913 3 of of ADP aji-51 1913 4 the the DET aji-51 1913 5 components component NOUN aji-51 1913 6 in in ADP aji-51 1913 7 heat heat NOUN aji-51 1913 8 - - PUNCT aji-51 1913 9 treated treat VERB aji-51 1913 10 mistletoe mistletoe NOUN aji-51 1913 11 ( ( PUNCT aji-51 1913 12 viscum viscum PROPN aji-51 1913 13 album album NOUN aji-51 1913 14 ) ) PUNCT aji-51 1913 15 . . PUNCT aji-51 1914 1 cancer cancer PROPN aji-51 1914 2 lett lett PROPN aji-51 1914 3 . . PUNCT aji-51 1915 1 1999 1999 NUM aji-51 1915 2 may may PROPN aji-51 1915 3 24;139(2):207 24;139(2):207 NOUN aji-51 1915 4 - - SYM aji-51 1915 5 13 13 NUM aji-51 1915 6 . . PUNCT aji-51 1916 1 doi doi NOUN aji-51 1916 2 : : PUNCT aji-51 1916 3 10.1016 10.1016 NUM aji-51 1916 4 / / SYM aji-51 1916 5 s0304 s0304 ADJ aji-51 1916 6 - - PUNCT aji-51 1916 7 3835(99)00043 3835(99)00043 NUM aji-51 1916 8 - - PUNCT aji-51 1916 9 9 9 NUM aji-51 1916 10 pmid pmid NOUN aji-51 1916 11 : : PUNCT aji-51 1916 12 10395180 10395180 NUM aji-51 1916 13 . . PUNCT aji-51 1917 1 280 280 NUM aji-51 1917 2 . . PUNCT aji-51 1917 3 pasquier pasquier PROPN aji-51 1917 4 e e PROPN aji-51 1917 5 , , PUNCT aji-51 1917 6 kavallaris kavallaris PROPN aji-51 1917 7 m m PROPN aji-51 1917 8 , , PUNCT aji-51 1917 9 andré andré VERB aji-51 1917 10 n. n. PROPN aji-51 1917 11 metronomic metronomic PROPN aji-51 1917 12 chemotherapy chemotherapy NOUN aji-51 1917 13 : : PUNCT aji-51 1917 14 new new ADJ aji-51 1917 15 rationale rationale NOUN aji-51 1917 16 for for ADP aji-51 1917 17 new new ADJ aji-51 1917 18 directions direction NOUN aji-51 1917 19 . . PUNCT aji-51 1918 1 nat nat PROPN aji-51 1918 2 rev rev VERB aji-51 1918 3 clin clin PROPN aji-51 1918 4 oncol oncol PROPN aji-51 1918 5 . . PUNCT aji-51 1919 1 2010 2010 NUM aji-51 1919 2 aug;7(8):455 aug;7(8):455 NUM aji-51 1919 3 - - PUNCT aji-51 1919 4 65 65 NUM aji-51 1919 5 . . PUNCT aji-51 1920 1 doi doi NOUN aji-51 1920 2 : : PUNCT aji-51 1920 3 10.1038 10.1038 NUM aji-51 1920 4 / / SYM aji-51 1920 5 nrclinonc.2010.82 nrclinonc.2010.82 NOUN aji-51 1920 6 epub epub PROPN aji-51 1920 7 2010 2010 NUM aji-51 1920 8 jun jun PROPN aji-51 1920 9 8 8 NUM aji-51 1920 10 . . PUNCT aji-51 1921 1 pmid pmid NOUN aji-51 1921 2 : : PUNCT aji-51 1921 3 20531380 20531380 NUM aji-51 1921 4 . . PUNCT aji-51 1922 1 281 281 NUM aji-51 1922 2 . . PUNCT aji-51 1923 1 damyanov damyanov NOUN aji-51 1923 2 c c PROPN aji-51 1923 3 , , PUNCT aji-51 1923 4 gerasimova gerasimova X aji-51 1923 5 d d X aji-51 1923 6 , , PUNCT aji-51 1923 7 maslev maslev PROPN aji-51 1923 8 i i NOUN aji-51 1923 9 , , PUNCT aji-51 1923 10 gavrilov gavrilov ADV aji-51 1923 11 v. v. CCONJ aji-51 1923 12 low low ADV aji-51 1923 13 - - PUNCT aji-51 1923 14 dose dose NOUN aji-51 1923 15 chemotherapy chemotherapy NOUN aji-51 1923 16 with with ADP aji-51 1923 17 insulin insulin NOUN aji-51 1923 18 ( ( PUNCT aji-51 1923 19 insulin insulin NOUN aji-51 1923 20 potentiation potentiation NOUN aji-51 1923 21 therapy therapy NOUN aji-51 1923 22 ) ) PUNCT aji-51 1923 23 in in ADP aji-51 1923 24 combination combination NOUN aji-51 1923 25 with with ADP aji-51 1923 26 hormone hormone NOUN aji-51 1923 27 therapy therapy NOUN aji-51 1923 28 for for ADP aji-51 1923 29 treatment treatment NOUN aji-51 1923 30 of of ADP aji-51 1923 31 castration castration NOUN aji-51 1923 32 - - PUNCT aji-51 1923 33 resistant resistant ADJ aji-51 1923 34 prostate prostate NOUN aji-51 1923 35 cancer cancer NOUN aji-51 1923 36 . . PUNCT aji-51 1924 1 isrn isrn PROPN aji-51 1924 2 urol urol PROPN aji-51 1924 3 . . PUNCT aji-51 1925 1 2012;2012:140182 2012;2012:140182 NOUN aji-51 1925 2 . . PUNCT aji-51 1926 1 doi doi PROPN aji-51 1926 2 : : PUNCT aji-51 1926 3 10.5402/2012/140182 10.5402/2012/140182 NUM aji-51 1926 4 epub epub NOUN aji-51 1926 5 2012 2012 NUM aji-51 1926 6 may may AUX aji-51 1926 7 8 8 NUM aji-51 1926 8 . . PUNCT aji-51 1927 1 pmid pmid NOUN aji-51 1927 2 : : PUNCT aji-51 1927 3 22649741 22649741 NUM aji-51 1927 4 ; ; PUNCT aji-51 1927 5 pmcid pmcid ADJ aji-51 1927 6 : : PUNCT aji-51 1927 7 pmc3357525 pmc3357525 NOUN aji-51 1927 8 . . PUNCT aji-51 1928 1 stoff stoff PROPN aji-51 1928 2 ; ; PUNCT aji-51 1928 3 aji aji PROPN aji-51 1928 4 , , PUNCT aji-51 1928 5 5(1 5(1 NUM aji-51 1928 6 ): ): PUNCT aji-51 1928 7 1 1 NUM aji-51 1928 8 - - SYM aji-51 1928 9 39 39 NUM aji-51 1928 10 , , PUNCT aji-51 1928 11 2022 2022 NUM aji-51 1928 12 ; ; PUNCT aji-51 1928 13 article article NOUN aji-51 1928 14 no.aji.77967 no.aji.77967 VERB aji-51 1928 15 36 36 NUM aji-51 1928 16 282 282 NUM aji-51 1928 17 . . PUNCT aji-51 1929 1 jiao jiao PROPN aji-51 1929 2 sc sc PROPN aji-51 1929 3 , , PUNCT aji-51 1929 4 huang huang PROPN aji-51 1929 5 j j PROPN aji-51 1929 6 , , PUNCT aji-51 1929 7 sun sun PROPN aji-51 1929 8 y y PROPN aji-51 1929 9 , , PUNCT aji-51 1929 10 lu lu PROPN aji-51 1929 11 sx sx PROPN aji-51 1929 12 . . PUNCT aji-51 1930 1 the the DET aji-51 1930 2 effect effect NOUN aji-51 1930 3 of of ADP aji-51 1930 4 insulin insulin NOUN aji-51 1930 5 on on ADP aji-51 1930 6 chemotherapeutic chemotherapeutic ADJ aji-51 1930 7 drug drug NOUN aji-51 1930 8 sensitivity sensitivity NOUN aji-51 1930 9 in in ADP aji-51 1930 10 human human ADJ aji-51 1930 11 esophageal esophageal NOUN aji-51 1930 12 and and CCONJ aji-51 1930 13 lung lung NOUN aji-51 1930 14 cancer cancer NOUN aji-51 1930 15 cells cell NOUN aji-51 1930 16 . . PUNCT aji-51 1931 1 zhonghua zhonghua PROPN aji-51 1931 2 yi yi PROPN aji-51 1931 3 xue xue PROPN aji-51 1931 4 za za PROPN aji-51 1931 5 zhi zhi PROPN aji-51 1931 6 . . PROPN aji-51 1932 1 2003 2003 NUM aji-51 1932 2 feb feb PROPN aji-51 1932 3 10;83(3):195 10;83(3):195 NUM aji-51 1932 4 - - SYM aji-51 1932 5 7 7 NUM aji-51 1932 6 . . PUNCT aji-51 1932 7 chinese chinese PROPN aji-51 1932 8 . . PUNCT aji-51 1933 1 pmid pmid NOUN aji-51 1933 2 : : PUNCT aji-51 1933 3 12812659 12812659 NUM aji-51 1933 4 . . PUNCT aji-51 1934 1 283 283 NUM aji-51 1934 2 . . PUNCT aji-51 1935 1 lasalvia lasalvia PROPN aji-51 1935 2 - - PUNCT aji-51 1935 3 prisco prisco PROPN aji-51 1935 4 e e PROPN aji-51 1935 5 , , PUNCT aji-51 1935 6 cucchi cucchi PROPN aji-51 1935 7 s s PROPN aji-51 1935 8 , , PUNCT aji-51 1935 9 vázquez vázquez PROPN aji-51 1935 10 j j PROPN aji-51 1935 11 , , PUNCT aji-51 1935 12 lasalvia lasalvia PROPN aji-51 1935 13 - - PUNCT aji-51 1935 14 galante galante PROPN aji-51 1935 15 e e PROPN aji-51 1935 16 , , PUNCT aji-51 1935 17 golomar golomar PROPN aji-51 1935 18 w w PROPN aji-51 1935 19 , , PUNCT aji-51 1935 20 gordon gordon PROPN aji-51 1935 21 w. w. PROPN aji-51 1935 22 insulin insulin PROPN aji-51 1935 23 - - PUNCT aji-51 1935 24 induced induce VERB aji-51 1935 25 enhancement enhancement NOUN aji-51 1935 26 of of ADP aji-51 1935 27 antitumoral antitumoral ADJ aji-51 1935 28 response response NOUN aji-51 1935 29 to to PART aji-51 1935 30 methotrexate methotrexate VERB aji-51 1935 31 in in ADP aji-51 1935 32 breast breast NOUN aji-51 1935 33 cancer cancer NOUN aji-51 1935 34 patients patient NOUN aji-51 1935 35 . . PUNCT aji-51 1936 1 cancer cancer NOUN aji-51 1936 2 chemother chemother PROPN aji-51 1936 3 pharmacol pharmacol PROPN aji-51 1936 4 . . PUNCT aji-51 1937 1 2004 2004 NUM aji-51 1937 2 mar;53(3):220 mar;53(3):220 NOUN aji-51 1937 3 - - SYM aji-51 1937 4 4 4 NUM aji-51 1937 5 . . PUNCT aji-51 1938 1 doi doi NOUN aji-51 1938 2 : : PUNCT aji-51 1938 3 10.1007 10.1007 NUM aji-51 1938 4 / / SYM aji-51 1938 5 s00280 s00280 NOUN aji-51 1938 6 - - PUNCT aji-51 1938 7 003 003 NUM aji-51 1938 8 - - PUNCT aji-51 1938 9 0716 0716 NUM aji-51 1938 10 - - SYM aji-51 1938 11 7 7 NUM aji-51 1938 12 epub epub NOUN aji-51 1938 13 2003 2003 NUM aji-51 1938 14 dec dec PROPN aji-51 1938 15 4 4 NUM aji-51 1938 16 . . PUNCT aji-51 1939 1 pmid pmid NOUN aji-51 1939 2 : : PUNCT aji-51 1939 3 14655024 14655024 NUM aji-51 1939 4 . . PUNCT aji-51 1940 1 284 284 NUM aji-51 1940 2 . . PUNCT aji-51 1941 1 devita devita PROPN aji-51 1941 2 vt vt PROPN aji-51 1941 3 jr jr PROPN aji-51 1941 4 , , PUNCT aji-51 1941 5 chu chu PROPN aji-51 1941 6 e. e. PROPN aji-51 1941 7 a a DET aji-51 1941 8 history history NOUN aji-51 1941 9 of of ADP aji-51 1941 10 cancer cancer NOUN aji-51 1941 11 chemotherapy chemotherapy NOUN aji-51 1941 12 . . PUNCT aji-51 1942 1 cancer cancer NOUN aji-51 1942 2 res re NOUN aji-51 1942 3 . . PROPN aji-51 1942 4 2008 2008 NUM aji-51 1942 5 nov nov NOUN aji-51 1942 6 1;68(21):8643 1;68(21):8643 PROPN aji-51 1942 7 - - SYM aji-51 1942 8 53 53 NUM aji-51 1942 9 . . PUNCT aji-51 1943 1 doi doi NOUN aji-51 1943 2 : : PUNCT aji-51 1943 3 10.1158/0008 10.1158/0008 NUM aji-51 1943 4 - - PUNCT aji-51 1943 5 5472.can-07 5472.can-07 NUM aji-51 1943 6 - - PUNCT aji-51 1943 7 6611 6611 NUM aji-51 1943 8 pmid pmid NOUN aji-51 1943 9 : : PUNCT aji-51 1943 10 18974103 18974103 NUM aji-51 1943 11 . . PUNCT aji-51 1944 1 285 285 NUM aji-51 1944 2 . . PUNCT aji-51 1945 1 the the DET aji-51 1945 2 ayre ayre PROPN aji-51 1945 3 clinic clinic PROPN aji-51 1945 4 for for ADP aji-51 1945 5 contemporary contemporary ADJ aji-51 1945 6 medicine medicine NOUN aji-51 1945 7 , , PUNCT aji-51 1945 8 development development NOUN aji-51 1945 9 of of ADP aji-51 1945 10 ipt ipt PROPN aji-51 1945 11 . . PUNCT aji-51 1946 1 available available ADJ aji-51 1946 2 : : PUNCT aji-51 1946 3 http://contemporarymedicine.net/ http://contemporarymedicine.net/ VERB aji-51 1946 4 development development NOUN aji-51 1946 5 - - PUNCT aji-51 1946 6 of of ADP aji-51 1946 7 - - PUNCT aji-51 1946 8 ipt/ ipt/ VERB aji-51 1946 9 accessed access VERB aji-51 1946 10 9/10/21 9/10/21 NUM aji-51 1946 11 286 286 NUM aji-51 1946 12 . . PUNCT aji-51 1947 1 agrawal agrawal PROPN aji-51 1947 2 s s PROPN aji-51 1947 3 , , PUNCT aji-51 1947 4 woźniak woźniak PROPN aji-51 1947 5 m m PROPN aji-51 1947 6 , , PUNCT aji-51 1947 7 łuc łuc PROPN aji-51 1947 8 m m PROPN aji-51 1947 9 , , PUNCT aji-51 1947 10 makuch makuch PROPN aji-51 1947 11 s s NOUN aji-51 1947 12 , , PUNCT aji-51 1947 13 pielka pielka NOUN aji-51 1947 14 e e NOUN aji-51 1947 15 , , PUNCT aji-51 1947 16 agrawal agrawal PROPN aji-51 1947 17 ak ak PROPN aji-51 1947 18 , , PUNCT aji-51 1947 19 wietrzyk wietrzyk PROPN aji-51 1947 20 j j NOUN aji-51 1947 21 , , PUNCT aji-51 1947 22 banach banach NOUN aji-51 1947 23 j j PROPN aji-51 1947 24 , , PUNCT aji-51 1947 25 gamian gamian PROPN aji-51 1947 26 a a PRON aji-51 1947 27 , , PUNCT aji-51 1947 28 pizon pizon PROPN aji-51 1947 29 m m PROPN aji-51 1947 30 , , PUNCT aji-51 1947 31 ziółkowski ziółkowski PROPN aji-51 1947 32 p. p. NOUN aji-51 1947 33 insulin insulin NOUN aji-51 1947 34 enhancement enhancement NOUN aji-51 1947 35 of of ADP aji-51 1947 36 the the DET aji-51 1947 37 antitumor antitumor PROPN aji-51 1947 38 activity activity NOUN aji-51 1947 39 of of ADP aji-51 1947 40 chemotherapeutic chemotherapeutic ADJ aji-51 1947 41 agents agent NOUN aji-51 1947 42 in in ADP aji-51 1947 43 colorectal colorectal ADJ aji-51 1947 44 cancer cancer NOUN aji-51 1947 45 is be AUX aji-51 1947 46 linked link VERB aji-51 1947 47 with with ADP aji-51 1947 48 downregulating downregulating NOUN aji-51 1947 49 pik3ca pik3ca PROPN aji-51 1947 50 and and CCONJ aji-51 1947 51 grb2 grb2 PROPN aji-51 1947 52 . . PUNCT aji-51 1948 1 sci sci PROPN aji-51 1948 2 rep rep PROPN aji-51 1948 3 . . PROPN aji-51 1948 4 2019 2019 NUM aji-51 1948 5 nov nov PROPN aji-51 1948 6 12;9(1):16647 12;9(1):16647 NUM aji-51 1948 7 . . PUNCT aji-51 1949 1 doi doi NOUN aji-51 1949 2 : : PUNCT aji-51 1949 3 10.1038 10.1038 NUM aji-51 1949 4 / / SYM aji-51 1949 5 s41598 s41598 NOUN aji-51 1949 6 - - PUNCT aji-51 1949 7 019 019 NUM aji-51 1949 8 - - PUNCT aji-51 1949 9 53145 53145 NUM aji-51 1949 10 - - PUNCT aji-51 1949 11 x x SYM aji-51 1949 12 pmid pmid NOUN aji-51 1949 13 : : PUNCT aji-51 1949 14 31719636 31719636 NUM aji-51 1949 15 ; ; PUNCT aji-51 1949 16 pmcid pmcid NOUN aji-51 1949 17 : : PUNCT aji-51 1949 18 pmc6851401 pmc6851401 NOUN aji-51 1949 19 . . PUNCT aji-51 1950 1 287 287 NUM aji-51 1950 2 . . PUNCT aji-51 1951 1 damyanov damyanov NOUN aji-51 1951 2 c c PROPN aji-51 1951 3 , , PUNCT aji-51 1951 4 radoslavova radoslavova VERB aji-51 1951 5 m m PRON aji-51 1951 6 , , PUNCT aji-51 1951 7 gavrilov gavrilov ADV aji-51 1951 8 v v NOUN aji-51 1951 9 , , PUNCT aji-51 1951 10 stoeva stoeva PROPN aji-51 1951 11 d. d. PROPN aji-51 1951 12 low low PROPN aji-51 1951 13 dose dose PROPN aji-51 1951 14 chemotherapy chemotherapy NOUN aji-51 1951 15 in in ADP aji-51 1951 16 combination combination NOUN aji-51 1951 17 with with ADP aji-51 1951 18 insulin insulin NOUN aji-51 1951 19 for for ADP aji-51 1951 20 the the DET aji-51 1951 21 treatment treatment NOUN aji-51 1951 22 of of ADP aji-51 1951 23 advanced advanced ADJ aji-51 1951 24 metastatic metastatic ADJ aji-51 1951 25 tumors tumor NOUN aji-51 1951 26 . . PUNCT aji-51 1952 1 preliminary preliminary ADJ aji-51 1952 2 experience experience NOUN aji-51 1952 3 . . PUNCT aji-51 1953 1 j j PROPN aji-51 1953 2 buon buon PROPN aji-51 1953 3 . . PUNCT aji-51 1954 1 2009 2009 NUM aji-51 1954 2 oct oct NOUN aji-51 1954 3 - - PUNCT aji-51 1954 4 dec;14(4):711 dec;14(4):711 NOUN aji-51 1954 5 - - PUNCT aji-51 1954 6 5 5 NUM aji-51 1954 7 . . PUNCT aji-51 1954 8 pmid pmid NOUN aji-51 1954 9 : : PUNCT aji-51 1954 10 20148468 20148468 NUM aji-51 1954 11 . . PUNCT aji-51 1955 1 288 288 NUM aji-51 1955 2 . . PUNCT aji-51 1956 1 ayre ayre PROPN aji-51 1956 2 sg sg PROPN aji-51 1956 3 , , PUNCT aji-51 1956 4 garcia garcia PROPN aji-51 1956 5 y y PROPN aji-51 1956 6 bellon bellon NOUN aji-51 1956 7 dp dp PROPN aji-51 1956 8 , , PUNCT aji-51 1956 9 garcia garcia PROPN aji-51 1956 10 dp dp PROPN aji-51 1957 1 jr jr PROPN aji-51 1957 2 . . PUNCT aji-51 1957 3 insulin insulin NOUN aji-51 1957 4 , , PUNCT aji-51 1957 5 chemotherapy chemotherapy NOUN aji-51 1957 6 , , PUNCT aji-51 1957 7 and and CCONJ aji-51 1957 8 the the DET aji-51 1957 9 mechanisms mechanism NOUN aji-51 1957 10 of of ADP aji-51 1957 11 malignancy malignancy NOUN aji-51 1957 12 : : PUNCT aji-51 1957 13 the the DET aji-51 1957 14 design design NOUN aji-51 1957 15 and and CCONJ aji-51 1957 16 the the DET aji-51 1957 17 demise demise NOUN aji-51 1957 18 of of ADP aji-51 1957 19 cancer cancer NOUN aji-51 1957 20 . . PUNCT aji-51 1958 1 med med ADJ aji-51 1958 2 hypotheses hypothesis NOUN aji-51 1958 3 . . PUNCT aji-51 1959 1 2000 2000 NUM aji-51 1959 2 oct;55(4):330 oct;55(4):330 NUM aji-51 1959 3 - - PUNCT aji-51 1959 4 4 4 NUM aji-51 1959 5 . . PUNCT aji-51 1959 6 doi doi NOUN aji-51 1959 7 : : PUNCT aji-51 1959 8 10.1054 10.1054 NUM aji-51 1959 9 / / SYM aji-51 1959 10 mehy.2000.1063 mehy.2000.1063 NUM aji-51 1959 11 pmid pmid NOUN aji-51 1959 12 : : PUNCT aji-51 1959 13 11000062 11000062 NUM aji-51 1959 14 . . PUNCT aji-51 1960 1 289 289 NUM aji-51 1960 2 . . PUNCT aji-51 1961 1 available available ADJ aji-51 1961 2 : : PUNCT aji-51 1961 3 https://cam https://cam ADJ aji-51 1961 4 - - PUNCT aji-51 1961 5 cancer.org cancer.org X aji-51 1961 6 / / SYM aji-51 1961 7 en en NOUN aji-51 1961 8 / / SYM aji-51 1961 9 insulinpotentiation insulinpotentiation NOUN aji-51 1961 10 - - PUNCT aji-51 1961 11 therapy therapy NOUN aji-51 1961 12 290 290 NUM aji-51 1961 13 . . PUNCT aji-51 1962 1 available available ADJ aji-51 1962 2 : : PUNCT aji-51 1962 3 https://contemporarymedicine.net https://contemporarymedicine.net PROPN aji-51 1962 4 /articles /article NOUN aji-51 1962 5 - - PUNCT aji-51 1962 6 and and CCONJ aji-51 1962 7 - - PUNCT aji-51 1962 8 publications/ publications/ NUM aji-51 1962 9 291 291 NUM aji-51 1962 10 . . PUNCT aji-51 1963 1 available available ADJ aji-51 1963 2 : : PUNCT aji-51 1963 3 https://www.cancertherapyadviso https://www.cancertherapyadviso NOUN aji-51 1963 4 r.com/home/cancer-treatment-regimens/ r.com/home/cancer-treatment-regimens/ NOUN aji-51 1963 5 292 292 NUM aji-51 1963 6 . . PUNCT aji-51 1964 1 xie xie PROPN aji-51 1964 2 l l PROPN aji-51 1964 3 , , PUNCT aji-51 1964 4 zhao zhao PROPN aji-51 1964 5 t t PROPN aji-51 1964 6 , , PUNCT aji-51 1964 7 cai cai PROPN aji-51 1964 8 j j PROPN aji-51 1964 9 , , PUNCT aji-51 1964 10 su su PROPN aji-51 1964 11 y y PROPN aji-51 1964 12 , , PUNCT aji-51 1964 13 wang wang PROPN aji-51 1964 14 z z PROPN aji-51 1964 15 , , PUNCT aji-51 1964 16 dong dong PROPN aji-51 1964 17 w. w. PROPN aji-51 1964 18 methotrexate methotrexate PROPN aji-51 1964 19 induces induce VERB aji-51 1964 20 dna dna PROPN aji-51 1964 21 damage damage NOUN aji-51 1964 22 and and CCONJ aji-51 1964 23 inhibits inhibit VERB aji-51 1964 24 homologous homologous ADJ aji-51 1964 25 recombination recombination NOUN aji-51 1964 26 repair repair NOUN aji-51 1964 27 in in ADP aji-51 1964 28 choriocarcinoma choriocarcinoma NOUN aji-51 1964 29 cells cell NOUN aji-51 1964 30 . . PUNCT aji-51 1965 1 onco onco NOUN aji-51 1965 2 targets target NOUN aji-51 1965 3 ther ther ADV aji-51 1965 4 . . PUNCT aji-51 1966 1 2016 2016 NUM aji-51 1966 2 nov nov PROPN aji-51 1966 3 17;9:7115 17;9:7115 PROPN aji-51 1966 4 - - PUNCT aji-51 1966 5 7122 7122 NUM aji-51 1966 6 . . PUNCT aji-51 1967 1 doi doi NOUN aji-51 1967 2 : : PUNCT aji-51 1967 3 10.2147 10.2147 NUM aji-51 1967 4 / / SYM aji-51 1967 5 ott.s116387 ott.s116387 NUM aji-51 1967 6 pmid pmid PROPN aji-51 1967 7 : : PUNCT aji-51 1967 8 27895503 27895503 NUM aji-51 1967 9 ; ; PUNCT aji-51 1967 10 pmcid pmcid ADJ aji-51 1967 11 : : PUNCT aji-51 1967 12 pmc5119623 pmc5119623 NOUN aji-51 1967 13 . . PUNCT aji-51 1968 1 293 293 NUM aji-51 1968 2 . . PUNCT aji-51 1969 1 moon moon PROPN aji-51 1969 2 jw jw PROPN aji-51 1969 3 , , PUNCT aji-51 1969 4 lee lee PROPN aji-51 1969 5 sk sk PROPN aji-51 1969 6 , , PUNCT aji-51 1969 7 lee lee PROPN aji-51 1969 8 jo jo PROPN aji-51 1969 9 , , PUNCT aji-51 1969 10 kim kim PROPN aji-51 1969 11 n n CCONJ aji-51 1969 12 , , PUNCT aji-51 1969 13 lee lee PROPN aji-51 1969 14 yw yw PROPN aji-51 1969 15 , , PUNCT aji-51 1969 16 kim kim PROPN aji-51 1969 17 sj sj PROPN aji-51 1969 18 , , PUNCT aji-51 1969 19 kang kang PROPN aji-51 1969 20 hj hj PROPN aji-51 1969 21 , , PUNCT aji-51 1969 22 kim kim PROPN aji-51 1969 23 j j PROPN aji-51 1969 24 , , PUNCT aji-51 1969 25 kim kim PROPN aji-51 1969 26 hs hs PROPN aji-51 1969 27 , , PUNCT aji-51 1969 28 park park PROPN aji-51 1969 29 sh sh PROPN aji-51 1969 30 . . PROPN aji-51 1969 31 identification identification NOUN aji-51 1969 32 of of ADP aji-51 1969 33 novel novel ADJ aji-51 1969 34 hypermethylated hypermethylate VERB aji-51 1969 35 genes gene NOUN aji-51 1969 36 and and CCONJ aji-51 1969 37 demethylating demethylate VERB aji-51 1969 38 effect effect NOUN aji-51 1969 39 of of ADP aji-51 1969 40 vincristine vincristine NOUN aji-51 1969 41 in in ADP aji-51 1969 42 colorectal colorectal ADJ aji-51 1969 43 cancer cancer NOUN aji-51 1969 44 . . PUNCT aji-51 1970 1 j j PROPN aji-51 1970 2 exp exp PROPN aji-51 1970 3 clin clin PROPN aji-51 1970 4 cancer cancer NOUN aji-51 1970 5 res re NOUN aji-51 1970 6 . . PROPN aji-51 1970 7 2014 2014 NUM aji-51 1970 8 jan jan PROPN aji-51 1970 9 6;33(1):4 6;33(1):4 PROPN aji-51 1970 10 . . PUNCT aji-51 1971 1 doi doi NOUN aji-51 1971 2 : : PUNCT aji-51 1971 3 10.1186/1756 10.1186/1756 NUM aji-51 1971 4 - - SYM aji-51 1971 5 9966 9966 NUM aji-51 1971 6 - - SYM aji-51 1971 7 33 33 NUM aji-51 1971 8 - - SYM aji-51 1971 9 4 4 NUM aji-51 1971 10 pmid pmid NOUN aji-51 1971 11 : : PUNCT aji-51 1971 12 24393480 24393480 NUM aji-51 1971 13 ; ; PUNCT aji-51 1971 14 pmcid pmcid NOUN aji-51 1971 15 : : PUNCT aji-51 1971 16 pmc3923411 pmc3923411 ADJ aji-51 1971 17 . . PUNCT aji-51 1972 1 294 294 NUM aji-51 1972 2 . . PUNCT aji-51 1973 1 huang huang PROPN aji-51 1973 2 t t PROPN aji-51 1973 3 , , PUNCT aji-51 1973 4 song song NOUN aji-51 1973 5 x x NOUN aji-51 1973 6 , , PUNCT aji-51 1973 7 xu xu PROPN aji-51 1974 1 d d PROPN aji-51 1974 2 , , PUNCT aji-51 1974 3 tiek tiek PROPN aji-51 1974 4 d d NOUN aji-51 1974 5 , , PUNCT aji-51 1974 6 goenka goenka PROPN aji-51 1974 7 a a PROPN aji-51 1974 8 , , PUNCT aji-51 1974 9 wu wu PROPN aji-51 1974 10 b b PROPN aji-51 1974 11 , , PUNCT aji-51 1974 12 sastry sastry PROPN aji-51 1974 13 n n PROPN aji-51 1974 14 , , PUNCT aji-51 1974 15 hu hu PROPN aji-51 1974 16 b b PROPN aji-51 1974 17 , , PUNCT aji-51 1974 18 cheng cheng PROPN aji-51 1974 19 sy sy PROPN aji-51 1974 20 . . PUNCT aji-51 1974 21 stem stem NOUN aji-51 1974 22 cell cell NOUN aji-51 1974 23 programs program NOUN aji-51 1974 24 in in ADP aji-51 1974 25 cancer cancer NOUN aji-51 1974 26 initiation initiation NOUN aji-51 1974 27 , , PUNCT aji-51 1974 28 progression progression NOUN aji-51 1974 29 , , PUNCT aji-51 1974 30 and and CCONJ aji-51 1974 31 therapy therapy NOUN aji-51 1974 32 resistance resistance NOUN aji-51 1974 33 . . PUNCT aji-51 1975 1 theranostics theranostic NOUN aji-51 1975 2 . . PUNCT aji-51 1976 1 2020 2020 NUM aji-51 1976 2 jul jul PROPN aji-51 1976 3 9;10(19):87218743 9;10(19):87218743 NUM aji-51 1976 4 . . PUNCT aji-51 1977 1 doi doi NOUN aji-51 1977 2 : : PUNCT aji-51 1977 3 10.7150 10.7150 NUM aji-51 1977 4 / / SYM aji-51 1977 5 thno.41648 thno.41648 PROPN aji-51 1977 6 pmid pmid PROPN aji-51 1977 7 : : PUNCT aji-51 1977 8 32754274 32754274 NUM aji-51 1977 9 ; ; PUNCT aji-51 1977 10 pmcid pmcid ADJ aji-51 1977 11 : : PUNCT aji-51 1977 12 pmc7392012 pmc7392012 NOUN aji-51 1977 13 . . PUNCT aji-51 1978 1 295 295 NUM aji-51 1978 2 . . PUNCT aji-51 1978 3 masui masui PROPN aji-51 1978 4 k k PROPN aji-51 1978 5 , , PUNCT aji-51 1978 6 gini gini PROPN aji-51 1978 7 b b PROPN aji-51 1978 8 , , PUNCT aji-51 1978 9 wykosky wykosky PROPN aji-51 1978 10 j j PROPN aji-51 1978 11 , , PUNCT aji-51 1978 12 zanca zanca PROPN aji-51 1978 13 c c PROPN aji-51 1978 14 , , PUNCT aji-51 1978 15 mischel mischel PROPN aji-51 1978 16 ps ps PROPN aji-51 1978 17 , , PUNCT aji-51 1978 18 furnari furnari PROPN aji-51 1978 19 fb fb PROPN aji-51 1978 20 , , PUNCT aji-51 1978 21 cavenee cavenee NOUN aji-51 1978 22 wk wk PROPN aji-51 1978 23 . . PUNCT aji-51 1979 1 a a DET aji-51 1979 2 tale tale NOUN aji-51 1979 3 of of ADP aji-51 1979 4 two two NUM aji-51 1979 5 approaches approach NOUN aji-51 1979 6 : : PUNCT aji-51 1979 7 complementary complementary ADJ aji-51 1979 8 mechanisms mechanism NOUN aji-51 1979 9 of of ADP aji-51 1979 10 cytotoxic cytotoxic ADJ aji-51 1979 11 and and CCONJ aji-51 1979 12 targeted target VERB aji-51 1979 13 therapy therapy NOUN aji-51 1979 14 resistance resistance NOUN aji-51 1979 15 may may AUX aji-51 1979 16 inform inform VERB aji-51 1979 17 nextgeneration nextgeneration NOUN aji-51 1979 18 cancer cancer NOUN aji-51 1979 19 treatments treatment NOUN aji-51 1979 20 . . PUNCT aji-51 1980 1 carcinogenesis carcinogenesis NOUN aji-51 1980 2 . . PUNCT aji-51 1981 1 2013 2013 NUM aji-51 1981 2 apr;34(4):725 apr;34(4):725 NOUN aji-51 1981 3 - - SYM aji-51 1981 4 38 38 NUM aji-51 1981 5 . . PUNCT aji-51 1982 1 doi doi NOUN aji-51 1982 2 : : PUNCT aji-51 1982 3 10.1093 10.1093 NUM aji-51 1982 4 / / SYM aji-51 1982 5 carcin carcin PROPN aji-51 1982 6 / / SYM aji-51 1982 7 bgt086 bgt086 PROPN aji-51 1982 8 epub epub NOUN aji-51 1982 9 2013 2013 NUM aji-51 1982 10 mar mar PROPN aji-51 1982 11 1 1 NUM aji-51 1982 12 . . PUNCT aji-51 1983 1 pmid pmid NOUN aji-51 1983 2 : : PUNCT aji-51 1983 3 23455378 23455378 NUM aji-51 1983 4 ; ; PUNCT aji-51 1983 5 pmcid pmcid NOUN aji-51 1983 6 : : PUNCT aji-51 1983 7 pmc3616676 pmc3616676 ADJ aji-51 1983 8 . . PUNCT aji-51 1984 1 296 296 NUM aji-51 1984 2 . . PUNCT aji-51 1985 1 lai lai PROPN aji-51 1985 2 ji ji PROPN aji-51 1985 3 , , PUNCT aji-51 1985 4 tseng tseng PROPN aji-51 1985 5 yj yj PROPN aji-51 1985 6 , , PUNCT aji-51 1985 7 chen chen PROPN aji-51 1985 8 mh mh PROPN aji-51 1985 9 , , PUNCT aji-51 1985 10 huang huang PROPN aji-51 1985 11 cf cf PROPN aji-51 1985 12 , , PUNCT aji-51 1985 13 chang chang PROPN aji-51 1985 14 pm pm PROPN aji-51 1985 15 . . PUNCT aji-51 1986 1 clinical clinical ADJ aji-51 1986 2 perspective perspective NOUN aji-51 1986 3 of of ADP aji-51 1986 4 fda fda PROPN aji-51 1986 5 approved approve VERB aji-51 1986 6 drugs drug NOUN aji-51 1986 7 with with ADP aji-51 1986 8 p p NOUN aji-51 1986 9 - - PUNCT aji-51 1986 10 glycoprotein glycoprotein NOUN aji-51 1986 11 inhibition inhibition NOUN aji-51 1986 12 activities activity NOUN aji-51 1986 13 for for ADP aji-51 1986 14 potential potential ADJ aji-51 1986 15 cancer cancer NOUN aji-51 1986 16 therapeutics therapeutic NOUN aji-51 1986 17 . . PUNCT aji-51 1987 1 front front ADJ aji-51 1987 2 oncol oncol ADJ aji-51 1987 3 . . PUNCT aji-51 1988 1 2020 2020 NUM aji-51 1989 1 nov nov PROPN aji-51 1989 2 16;10:561936 16;10:561936 NUM aji-51 1989 3 . . PUNCT aji-51 1990 1 doi doi NOUN aji-51 1990 2 : : PUNCT aji-51 1990 3 10.3389 10.3389 NUM aji-51 1990 4 / / SYM aji-51 1990 5 fonc.2020.561936 fonc.2020.561936 NUM aji-51 1990 6 pmid pmid NOUN aji-51 1990 7 : : PUNCT aji-51 1990 8 33312947 33312947 NUM aji-51 1990 9 ; ; PUNCT aji-51 1990 10 pmcid pmcid PROPN aji-51 1990 11 : : PUNCT aji-51 1990 12 pmc7704056 pmc7704056 PROPN aji-51 1990 13 . . PUNCT aji-51 1991 1 297 297 NUM aji-51 1991 2 . . PUNCT aji-51 1992 1 nanayakkara nanayakkara PROPN aji-51 1992 2 ak ak PROPN aji-51 1992 3 , , PUNCT aji-51 1992 4 follit follit NOUN aji-51 1992 5 ca ca PROPN aji-51 1992 6 , , PUNCT aji-51 1992 7 chen chen PROPN aji-51 1992 8 g g PROPN aji-51 1992 9 , , PUNCT aji-51 1992 10 williams williams PROPN aji-51 1992 11 ns ns PROPN aji-51 1992 12 , , PUNCT aji-51 1992 13 vogel vogel NOUN aji-51 1992 14 pd pd PROPN aji-51 1992 15 , , PUNCT aji-51 1992 16 wise wise ADJ aji-51 1992 17 jg jg PROPN aji-51 1992 18 . . PUNCT aji-51 1992 19 targeted target VERB aji-51 1992 20 inhibitors inhibitor NOUN aji-51 1992 21 of of ADP aji-51 1992 22 p p NOUN aji-51 1992 23 - - PUNCT aji-51 1992 24 glycoprotein glycoprotein NOUN aji-51 1992 25 increase increase NOUN aji-51 1992 26 chemotherapeutic chemotherapeutic NOUN aji-51 1992 27 - - PUNCT aji-51 1992 28 induced induce VERB aji-51 1992 29 mortality mortality NOUN aji-51 1992 30 of of ADP aji-51 1992 31 multidrug multidrug NOUN aji-51 1992 32 resistant resistant ADJ aji-51 1992 33 tumor tumor NOUN aji-51 1992 34 cells cell NOUN aji-51 1992 35 . . PUNCT aji-51 1993 1 sci sci PROPN aji-51 1993 2 rep rep PROPN aji-51 1993 3 . . PROPN aji-51 1993 4 2018 2018 NUM aji-51 1993 5 jan jan PROPN aji-51 1993 6 17;8(1):967 17;8(1):967 NUM aji-51 1993 7 . . PUNCT aji-51 1994 1 doi doi NOUN aji-51 1994 2 : : PUNCT aji-51 1994 3 10.1038 10.1038 NUM aji-51 1994 4 / / SYM aji-51 1994 5 s41598 s41598 NOUN aji-51 1994 6 - - PUNCT aji-51 1994 7 018 018 NUM aji-51 1994 8 - - PUNCT aji-51 1994 9 19325 19325 NUM aji-51 1994 10 - - PUNCT aji-51 1994 11 x x SYM aji-51 1994 12 pmid pmid NOUN aji-51 1994 13 : : PUNCT aji-51 1994 14 29343829 29343829 NUM aji-51 1994 15 ; ; PUNCT aji-51 1994 16 pmcid pmcid NOUN aji-51 1994 17 : : PUNCT aji-51 1994 18 pmc5772368 pmc5772368 NOUN aji-51 1994 19 . . PUNCT aji-51 1995 1 298 298 X aji-51 1995 2 . . PUNCT aji-51 1995 3 de de PROPN aji-51 1995 4 milito milito PROPN aji-51 1995 5 a a PROPN aji-51 1995 6 , , PUNCT aji-51 1995 7 fais fais PROPN aji-51 1995 8 s. s. PROPN aji-51 1995 9 proton proton PROPN aji-51 1995 10 pump pump NOUN aji-51 1995 11 inhibitors inhibitor NOUN aji-51 1995 12 may may AUX aji-51 1995 13 reduce reduce VERB aji-51 1995 14 tumour tumour NOUN aji-51 1995 15 resistance resistance NOUN aji-51 1995 16 . . PUNCT aji-51 1996 1 expert expert PROPN aji-51 1996 2 stoff stoff PROPN aji-51 1996 3 ; ; PUNCT aji-51 1996 4 aji aji PROPN aji-51 1996 5 , , PUNCT aji-51 1996 6 5(1 5(1 NUM aji-51 1996 7 ): ): PUNCT aji-51 1996 8 1 1 NUM aji-51 1996 9 - - SYM aji-51 1996 10 39 39 NUM aji-51 1996 11 , , PUNCT aji-51 1996 12 2022 2022 NUM aji-51 1996 13 ; ; PUNCT aji-51 1996 14 article article NOUN aji-51 1996 15 no.aji.77967 no.aji.77967 NOUN aji-51 1996 16 37 37 NUM aji-51 1996 17 opin opin NOUN aji-51 1996 18 pharmacother pharmacother ADJ aji-51 1996 19 . . PUNCT aji-51 1997 1 2005 2005 NUM aji-51 1997 2 jun;6(7):104954 jun;6(7):104954 PROPN aji-51 1997 3 . . PUNCT aji-51 1998 1 doi doi NOUN aji-51 1998 2 : : PUNCT aji-51 1998 3 10.1517/14656566.6.7.1049 10.1517/14656566.6.7.1049 NUM aji-51 1998 4 pmid pmid NOUN aji-51 1998 5 : : PUNCT aji-51 1998 6 15957961 15957961 NUM aji-51 1998 7 . . PUNCT aji-51 1999 1 299 299 NUM aji-51 1999 2 . . PUNCT aji-51 2000 1 chen chen PROPN aji-51 2000 2 m m PROPN aji-51 2000 3 , , PUNCT aji-51 2000 4 lu lu PROPN aji-51 2000 5 j j PROPN aji-51 2000 6 , , PUNCT aji-51 2000 7 wei wei PROPN aji-51 2000 8 w w PROPN aji-51 2000 9 , , PUNCT aji-51 2000 10 lv lv PROPN aji-51 2000 11 y y PROPN aji-51 2000 12 , , PUNCT aji-51 2000 13 zhang zhang PROPN aji-51 2000 14 x x PROPN aji-51 2000 15 , , PUNCT aji-51 2000 16 yao yao PROPN aji-51 2000 17 y y PROPN aji-51 2000 18 , , PUNCT aji-51 2000 19 wang wang PROPN aji-51 2000 20 l l PROPN aji-51 2000 21 , , PUNCT aji-51 2000 22 ling ling PROPN aji-51 2000 23 t t PROPN aji-51 2000 24 , , PUNCT aji-51 2000 25 zou zou PROPN aji-51 2000 26 x. x. NOUN aji-51 2000 27 effects effect NOUN aji-51 2000 28 of of ADP aji-51 2000 29 proton proton NOUN aji-51 2000 30 pump pump NOUN aji-51 2000 31 inhibitors inhibitor NOUN aji-51 2000 32 on on ADP aji-51 2000 33 reversing reverse VERB aji-51 2000 34 multidrug multidrug NOUN aji-51 2000 35 resistance resistance NOUN aji-51 2000 36 via via ADP aji-51 2000 37 downregulating downregulating NOUN aji-51 2000 38 vatpases vatpase NOUN aji-51 2000 39 / / SYM aji-51 2000 40 pi3k pi3k NOUN aji-51 2000 41 / / SYM aji-51 2000 42 akt akt PROPN aji-51 2000 43 / / SYM aji-51 2000 44 mtor mtor PROPN aji-51 2000 45 / / SYM aji-51 2000 46 hif-1α hif-1α NOUN aji-51 2000 47 signaling signal VERB aji-51 2000 48 pathway pathway NOUN aji-51 2000 49 through through ADP aji-51 2000 50 tsc1/2 tsc1/2 PROPN aji-51 2000 51 complex complex ADJ aji-51 2000 52 and and CCONJ aji-51 2000 53 rheb rheb ADJ aji-51 2000 54 in in ADP aji-51 2000 55 human human ADJ aji-51 2000 56 gastric gastric ADJ aji-51 2000 57 adenocarcinoma adenocarcinoma NOUN aji-51 2000 58 cells cell NOUN aji-51 2000 59 in in ADP aji-51 2000 60 vitro vitro X aji-51 2000 61 and and CCONJ aji-51 2000 62 in in ADP aji-51 2000 63 vivo vivo NOUN aji-51 2000 64 . . PUNCT aji-51 2001 1 onco onco NOUN aji-51 2001 2 targets target NOUN aji-51 2001 3 ther ther ADV aji-51 2001 4 . . PUNCT aji-51 2002 1 2018 2018 NUM aji-51 2002 2 oct oct NOUN aji-51 2002 3 10;11:6705 10;11:6705 NUM aji-51 2002 4 - - PUNCT aji-51 2002 5 6722 6722 NUM aji-51 2002 6 . . PUNCT aji-51 2003 1 doi doi NOUN aji-51 2003 2 : : PUNCT aji-51 2003 3 10.2147 10.2147 NUM aji-51 2003 4 / / SYM aji-51 2003 5 ott.s161198 ott.s161198 PROPN aji-51 2003 6 pmid pmid NOUN aji-51 2003 7 : : PUNCT aji-51 2003 8 30349304 30349304 NUM aji-51 2003 9 ; ; PUNCT aji-51 2003 10 pmcid pmcid NOUN aji-51 2003 11 : : PUNCT aji-51 2003 12 pmc6188003 pmc6188003 NOUN aji-51 2003 13 . . PUNCT aji-51 2004 1 300 300 NUM aji-51 2004 2 . . PUNCT aji-51 2004 3 kienle kienle PROPN aji-51 2004 4 gs gs PROPN aji-51 2004 5 , , PUNCT aji-51 2004 6 kiene kiene PROPN aji-51 2004 7 h. h. PROPN aji-51 2004 8 review review PROPN aji-51 2004 9 article article NOUN aji-51 2004 10 : : PUNCT aji-51 2004 11 influence influence NOUN aji-51 2004 12 of of ADP aji-51 2004 13 viscum viscum ADJ aji-51 2004 14 album album NOUN aji-51 2004 15 l l NOUN aji-51 2004 16 ( ( PUNCT aji-51 2004 17 european european ADJ aji-51 2004 18 mistletoe mistletoe NOUN aji-51 2004 19 ) ) PUNCT aji-51 2004 20 extracts extract NOUN aji-51 2004 21 on on ADP aji-51 2004 22 quality quality NOUN aji-51 2004 23 of of ADP aji-51 2004 24 life life NOUN aji-51 2004 25 in in ADP aji-51 2004 26 cancer cancer NOUN aji-51 2004 27 patients patient NOUN aji-51 2004 28 : : PUNCT aji-51 2004 29 a a DET aji-51 2004 30 systematic systematic ADJ aji-51 2004 31 review review NOUN aji-51 2004 32 of of ADP aji-51 2004 33 controlled control VERB aji-51 2004 34 clinical clinical ADJ aji-51 2004 35 studies study NOUN aji-51 2004 36 . . PUNCT aji-51 2005 1 integr integr PROPN aji-51 2005 2 cancer cancer PROPN aji-51 2005 3 ther ther ADV aji-51 2005 4 . . PUNCT aji-51 2006 1 2010 2010 NUM aji-51 2006 2 jun;9(2):142 jun;9(2):142 PROPN aji-51 2006 3 - - PUNCT aji-51 2006 4 57 57 NUM aji-51 2006 5 . . PUNCT aji-51 2007 1 doi doi NOUN aji-51 2007 2 : : PUNCT aji-51 2007 3 10.1177/1534735410369673 10.1177/1534735410369673 NUM aji-51 2007 4 epub epub NOUN aji-51 2007 5 2010 2010 NUM aji-51 2007 6 may may PROPN aji-51 2007 7 18 18 NUM aji-51 2007 8 . . PUNCT aji-51 2008 1 pmid pmid NOUN aji-51 2008 2 : : PUNCT aji-51 2008 3 20483874 20483874 NUM aji-51 2008 4 . . PUNCT aji-51 2009 1 301 301 NUM aji-51 2009 2 . . PUNCT aji-51 2009 3 bar bar NOUN aji-51 2009 4 - - PUNCT aji-51 2009 5 sela sela NOUN aji-51 2009 6 g g NOUN aji-51 2009 7 , , PUNCT aji-51 2009 8 gershony gershony NOUN aji-51 2009 9 a a NOUN aji-51 2009 10 , , PUNCT aji-51 2009 11 haim haim PROPN aji-51 2009 12 n. n. PROPN aji-51 2010 1 [ [ X aji-51 2010 2 mistletoe mistletoe X aji-51 2010 3 ( ( PUNCT aji-51 2010 4 viscum viscum PROPN aji-51 2010 5 album album NOUN aji-51 2010 6 ) ) PUNCT aji-51 2010 7 preparations preparation NOUN aji-51 2010 8 : : PUNCT aji-51 2010 9 an an DET aji-51 2010 10 optional optional ADJ aji-51 2010 11 drug drug NOUN aji-51 2010 12 for for ADP aji-51 2010 13 cancer cancer NOUN aji-51 2010 14 patients patient NOUN aji-51 2010 15 ? ? PUNCT aji-51 2010 16 ] ] PUNCT aji-51 2010 17 . . PUNCT aji-51 2011 1 harefuah harefuah PROPN aji-51 2011 2 . . PUNCT aji-51 2012 1 2006 2006 NUM aji-51 2012 2 jan;145(1):42 jan;145(1):42 PROPN aji-51 2012 3 - - PUNCT aji-51 2012 4 6 6 NUM aji-51 2012 5 , , PUNCT aji-51 2012 6 77 77 NUM aji-51 2012 7 . . PUNCT aji-51 2013 1 hebrew hebrew ADJ aji-51 2013 2 . . PUNCT aji-51 2014 1 pmid pmid NOUN aji-51 2014 2 : : PUNCT aji-51 2014 3 16450726 16450726 NUM aji-51 2014 4 . . PUNCT aji-51 2015 1 302 302 NUM aji-51 2015 2 . . PUNCT aji-51 2015 3 ostermann ostermann PROPN aji-51 2015 4 t t PROPN aji-51 2015 5 , , PUNCT aji-51 2015 6 raak raak NOUN aji-51 2015 7 c c NOUN aji-51 2015 8 , , PUNCT aji-51 2015 9 büssing büsse VERB aji-51 2015 10 a. a. NOUN aji-51 2015 11 survival survival NOUN aji-51 2015 12 of of ADP aji-51 2015 13 cancer cancer NOUN aji-51 2015 14 patients patient NOUN aji-51 2015 15 treated treat VERB aji-51 2015 16 with with ADP aji-51 2015 17 mistletoe mistletoe NOUN aji-51 2015 18 extract extract NOUN aji-51 2015 19 ( ( PUNCT aji-51 2015 20 iscador iscador NOUN aji-51 2015 21 ): ): PUNCT aji-51 2015 22 a a DET aji-51 2015 23 systematic systematic ADJ aji-51 2015 24 literature literature NOUN aji-51 2015 25 review review NOUN aji-51 2015 26 . . PUNCT aji-51 2016 1 bmc bmc ADJ aji-51 2016 2 cancer cancer NOUN aji-51 2016 3 . . PUNCT aji-51 2017 1 2009 2009 NUM aji-51 2017 2 dec dec PROPN aji-51 2017 3 18;9:451 18;9:451 NUM aji-51 2017 4 . . PUNCT aji-51 2018 1 doi doi NOUN aji-51 2018 2 : : PUNCT aji-51 2018 3 10.1186/1471 10.1186/1471 NUM aji-51 2018 4 - - PUNCT aji-51 2018 5 2407 2407 NUM aji-51 2018 6 - - PUNCT aji-51 2018 7 9 9 NUM aji-51 2018 8 - - SYM aji-51 2018 9 451 451 NUM aji-51 2018 10 pmid pmid NOUN aji-51 2018 11 : : PUNCT aji-51 2018 12 20021637 20021637 NUM aji-51 2018 13 ; ; PUNCT aji-51 2018 14 pmcid pmcid NOUN aji-51 2018 15 : : PUNCT aji-51 2018 16 pmc2804713 pmc2804713 PROPN aji-51 2018 17 . . PUNCT aji-51 2019 1 303 303 NUM aji-51 2019 2 . . PUNCT aji-51 2020 1 gutsch gutsch PROPN aji-51 2020 2 j j PROPN aji-51 2020 3 , , PUNCT aji-51 2020 4 werthmann werthmann PROPN aji-51 2020 5 pg pg PROPN aji-51 2020 6 , , PUNCT aji-51 2020 7 rosenwald rosenwald NOUN aji-51 2020 8 a a PRON aji-51 2020 9 , , PUNCT aji-51 2020 10 kienle kienle PROPN aji-51 2020 11 gs gs PROPN aji-51 2020 12 . . PUNCT aji-51 2020 13 complete complete ADJ aji-51 2020 14 remission remission NOUN aji-51 2020 15 and and CCONJ aji-51 2020 16 longterm longterm ADJ aji-51 2020 17 survival survival NOUN aji-51 2020 18 of of ADP aji-51 2020 19 a a DET aji-51 2020 20 patient patient NOUN aji-51 2020 21 with with ADP aji-51 2020 22 a a DET aji-51 2020 23 diffuse diffuse ADJ aji-51 2020 24 large large ADJ aji-51 2020 25 b b NOUN aji-51 2020 26 - - PUNCT aji-51 2020 27 cell cell NOUN aji-51 2020 28 lymphoma lymphoma NOUN aji-51 2020 29 under under ADP aji-51 2020 30 viscum viscum ADJ aji-51 2020 31 album album NOUN aji-51 2020 32 extracts extract NOUN aji-51 2020 33 after after ADP aji-51 2020 34 resistance resistance NOUN aji-51 2020 35 to to ADP aji-51 2020 36 rchop rchop VERB aji-51 2020 37 : : PUNCT aji-51 2020 38 a a DET aji-51 2020 39 case case NOUN aji-51 2020 40 report report NOUN aji-51 2020 41 . . PUNCT aji-51 2021 1 anticancer anticancer NOUN aji-51 2021 2 res re NOUN aji-51 2021 3 . . PROPN aji-51 2021 4 2018 2018 NUM aji-51 2021 5 sep;38(9):5363 sep;38(9):5363 NOUN aji-51 2021 6 - - PUNCT aji-51 2021 7 5369 5369 NUM aji-51 2021 8 . . PUNCT aji-51 2022 1 doi doi NOUN aji-51 2022 2 : : PUNCT aji-51 2022 3 10.21873 10.21873 NUM aji-51 2022 4 / / SYM aji-51 2022 5 anticanres.12865 anticanres.12865 PROPN aji-51 2022 6 pmid pmid PROPN aji-51 2022 7 : : PUNCT aji-51 2022 8 30194190 30194190 NUM aji-51 2022 9 . . PUNCT aji-51 2023 1 304 304 NUM aji-51 2023 2 . . PUNCT aji-51 2024 1 siegle siegle PROPN aji-51 2024 2 i i PROPN aji-51 2024 3 , , PUNCT aji-51 2024 4 fritz fritz PROPN aji-51 2024 5 p p PROPN aji-51 2024 6 , , PUNCT aji-51 2024 7 mcclellan mcclellan PROPN aji-51 2024 8 m m PROPN aji-51 2024 9 , , PUNCT aji-51 2024 10 gutzeit gutzeit NOUN aji-51 2024 11 s s PROPN aji-51 2024 12 , , PUNCT aji-51 2024 13 mürdter mürdter NOUN aji-51 2024 14 te te PROPN aji-51 2024 15 . . PUNCT aji-51 2024 16 combined combine VERB aji-51 2024 17 cytotoxic cytotoxic ADJ aji-51 2024 18 action action NOUN aji-51 2024 19 of of ADP aji-51 2024 20 viscum viscum ADJ aji-51 2024 21 album album NOUN aji-51 2024 22 agglutinin-1 agglutinin-1 NUM aji-51 2024 23 and and CCONJ aji-51 2024 24 anticancer anticancer NOUN aji-51 2024 25 agents agent NOUN aji-51 2024 26 against against ADP aji-51 2024 27 human human NOUN aji-51 2024 28 a549 a549 PROPN aji-51 2024 29 lung lung NOUN aji-51 2024 30 cancer cancer NOUN aji-51 2024 31 cells cell NOUN aji-51 2024 32 . . PUNCT aji-51 2025 1 anticancer anticancer NOUN aji-51 2025 2 res re NOUN aji-51 2025 3 . . PUNCT aji-51 2025 4 2001 2001 NUM aji-51 2026 1 julaug;21(4a):2687 julaug;21(4a):2687 PROPN aji-51 2026 2 - - PUNCT aji-51 2026 3 91 91 NUM aji-51 2026 4 . . PUNCT aji-51 2027 1 pmid pmid NOUN aji-51 2027 2 : : PUNCT aji-51 2027 3 11724340 11724340 NUM aji-51 2027 4 . . PUNCT aji-51 2028 1 305 305 NUM aji-51 2028 2 . . X aji-51 2028 3 weissenstein weissenstein PROPN aji-51 2028 4 u u PROPN aji-51 2028 5 , , PUNCT aji-51 2028 6 kunz kunz PROPN aji-51 2028 7 m m PROPN aji-51 2028 8 , , PUNCT aji-51 2028 9 urech urech PROPN aji-51 2028 10 k k PROPN aji-51 2028 11 , , PUNCT aji-51 2028 12 baumgartner baumgartner PROPN aji-51 2028 13 s. s. PROPN aji-51 2028 14 interaction interaction NOUN aji-51 2028 15 of of ADP aji-51 2028 16 standardized standardized ADJ aji-51 2028 17 mistletoe mistletoe NOUN aji-51 2028 18 ( ( PUNCT aji-51 2028 19 viscum viscum ADJ aji-51 2028 20 album album NOUN aji-51 2028 21 ) ) PUNCT aji-51 2028 22 extracts extract NOUN aji-51 2028 23 with with ADP aji-51 2028 24 chemotherapeutic chemotherapeutic ADJ aji-51 2028 25 drugs drug NOUN aji-51 2028 26 regarding regard VERB aji-51 2028 27 cytostatic cytostatic ADJ aji-51 2028 28 and and CCONJ aji-51 2028 29 cytotoxic cytotoxic ADJ aji-51 2028 30 effects effect NOUN aji-51 2028 31 in in ADP aji-51 2028 32 vitro vitro X aji-51 2028 33 . . PUNCT aji-51 2029 1 bmc bmc PROPN aji-51 2029 2 complement complement PROPN aji-51 2029 3 altern altern NOUN aji-51 2029 4 med me VERB aji-51 2029 5 . . PUNCT aji-51 2029 6 2014 2014 NUM aji-51 2029 7 jan jan PROPN aji-51 2029 8 8;14:6 8;14:6 NUM aji-51 2029 9 . . PUNCT aji-51 2030 1 doi doi NOUN aji-51 2030 2 : : PUNCT aji-51 2030 3 10.1186/1472 10.1186/1472 NUM aji-51 2030 4 - - SYM aji-51 2030 5 6882 6882 NUM aji-51 2030 6 - - SYM aji-51 2030 7 14 14 NUM aji-51 2030 8 - - SYM aji-51 2030 9 6 6 NUM aji-51 2030 10 pmid pmid NOUN aji-51 2030 11 : : PUNCT aji-51 2030 12 24397864 24397864 NUM aji-51 2030 13 ; ; PUNCT aji-51 2030 14 pmcid pmcid ADJ aji-51 2030 15 : : PUNCT aji-51 2030 16 pmc3893555 pmc3893555 NOUN aji-51 2030 17 . . PUNCT aji-51 2031 1 306 306 NUM aji-51 2031 2 . . PUNCT aji-51 2032 1 melo melo PROPN aji-51 2032 2 mno mno PROPN aji-51 2032 3 , , PUNCT aji-51 2032 4 oliveira oliveira PROPN aji-51 2032 5 ap ap PROPN aji-51 2032 6 , , PUNCT aji-51 2032 7 wiecikowski wiecikowski ADJ aji-51 2032 8 af af PROPN aji-51 2032 9 , , PUNCT aji-51 2032 10 carvalho carvalho NOUN aji-51 2032 11 rs rs PROPN aji-51 2032 12 , , PUNCT aji-51 2032 13 castro castro PROPN aji-51 2032 14 jl jl PROPN aji-51 2032 15 , , PUNCT aji-51 2032 16 de de PROPN aji-51 2032 17 oliveira oliveira PROPN aji-51 2032 18 fag fag PROPN aji-51 2032 19 , , PUNCT aji-51 2032 20 pereira pereira PROPN aji-51 2032 21 hmg hmg PROPN aji-51 2032 22 , , PUNCT aji-51 2032 23 da da PROPN aji-51 2032 24 veiga veiga PROPN aji-51 2032 25 vf vf PROPN aji-51 2032 26 , , PUNCT aji-51 2032 27 capella capella PROPN aji-51 2032 28 mma mma PROPN aji-51 2032 29 , , PUNCT aji-51 2032 30 rocha rocha PROPN aji-51 2032 31 l l PROPN aji-51 2032 32 , , PUNCT aji-51 2032 33 holandino holandino PROPN aji-51 2032 34 c. c. PROPN aji-51 2032 35 phenolic phenolic PROPN aji-51 2032 36 compounds compound VERB aji-51 2032 37 from from ADP aji-51 2032 38 viscum viscum ADJ aji-51 2032 39 album album NOUN aji-51 2032 40 tinctures tincture NOUN aji-51 2032 41 enhanced enhance VERB aji-51 2032 42 antitumor antitumor PROPN aji-51 2032 43 activity activity NOUN aji-51 2032 44 in in ADP aji-51 2032 45 melanoma melanoma ADJ aji-51 2032 46 murine murine ADJ aji-51 2032 47 cancer cancer NOUN aji-51 2032 48 cells cell NOUN aji-51 2032 49 . . PUNCT aji-51 2033 1 saudi saudi ADJ aji-51 2033 2 pharm pharm PROPN aji-51 2033 3 j. j. PROPN aji-51 2033 4 2018 2018 NUM aji-51 2033 5 mar;26(3):311 mar;26(3):311 PROPN aji-51 2033 6 - - PUNCT aji-51 2033 7 322 322 NUM aji-51 2033 8 . . PUNCT aji-51 2033 9 doi doi NOUN aji-51 2033 10 : : PUNCT aji-51 2033 11 10.1016 10.1016 NUM aji-51 2033 12 / / SYM aji-51 2033 13 j.jsps.2018.01.011 j.jsps.2018.01.011 PROPN aji-51 2033 14 epub epub PROPN aji-51 2033 15 2018 2018 NUM aji-51 2033 16 jan jan PROPN aji-51 2033 17 31 31 NUM aji-51 2033 18 . . PUNCT aji-51 2034 1 pmid pmid NOUN aji-51 2034 2 : : PUNCT aji-51 2034 3 29556122 29556122 NUM aji-51 2034 4 ; ; PUNCT aji-51 2034 5 pmcid pmcid NOUN aji-51 2034 6 : : PUNCT aji-51 2034 7 pmc5856955 pmc5856955 NOUN aji-51 2034 8 . . PUNCT aji-51 2035 1 307 307 NUM aji-51 2035 2 . . PUNCT aji-51 2036 1 menke menke PROPN aji-51 2036 2 k k PROPN aji-51 2036 3 , , PUNCT aji-51 2036 4 schwermer schwermer PROPN aji-51 2036 5 m m PROPN aji-51 2036 6 , , PUNCT aji-51 2036 7 schramm schramm PROPN aji-51 2036 8 a a PRON aji-51 2036 9 , , PUNCT aji-51 2036 10 zuzak zuzak PROPN aji-51 2036 11 tj tj PROPN aji-51 2036 12 . . PROPN aji-51 2036 13 preclinical preclinical ADJ aji-51 2036 14 evaluation evaluation NOUN aji-51 2036 15 of of ADP aji-51 2036 16 antitumoral antitumoral ADJ aji-51 2036 17 and and CCONJ aji-51 2036 18 cytotoxic cytotoxic ADJ aji-51 2036 19 properties property NOUN aji-51 2036 20 of of ADP aji-51 2036 21 viscum viscum ADJ aji-51 2036 22 album album NOUN aji-51 2036 23 fraxini fraxini NOUN aji-51 2036 24 extract extract NOUN aji-51 2036 25 on on ADP aji-51 2036 26 pediatric pediatric ADJ aji-51 2036 27 tumor tumor NOUN aji-51 2036 28 cells cell NOUN aji-51 2036 29 . . PUNCT aji-51 2037 1 planta planta PROPN aji-51 2037 2 med med PROPN aji-51 2037 3 . . PUNCT aji-51 2037 4 2019 2019 NUM aji-51 2037 5 oct;85(1415):1150 oct;85(1415):1150 NOUN aji-51 2037 6 - - PUNCT aji-51 2037 7 1159 1159 NUM aji-51 2037 8 . . PUNCT aji-51 2038 1 doi doi NOUN aji-51 2038 2 : : PUNCT aji-51 2038 3 10.1055 10.1055 NUM aji-51 2038 4 / / SYM aji-51 2038 5 a-1013 a-1013 PROPN aji-51 2038 6 - - PUNCT aji-51 2038 7 0382 0382 NUM aji-51 2038 8 epub epub PROPN aji-51 2038 9 2019 2019 NUM aji-51 2038 10 oct oct PROPN aji-51 2038 11 7 7 NUM aji-51 2038 12 . . PUNCT aji-51 2039 1 pmid pmid NOUN aji-51 2039 2 : : PUNCT aji-51 2039 3 31590196 31590196 NUM aji-51 2039 4 . . PUNCT aji-51 2040 1 308 308 NUM aji-51 2040 2 . . PUNCT aji-51 2041 1 klingbeil klingbeil PROPN aji-51 2041 2 mf mf PROPN aji-51 2041 3 , , PUNCT aji-51 2041 4 xavier xavier PROPN aji-51 2041 5 fc fc PROPN aji-51 2041 6 , , PUNCT aji-51 2041 7 sardinha sardinha VERB aji-51 2041 8 lr lr NOUN aji-51 2041 9 , , PUNCT aji-51 2041 10 severino severino NOUN aji-51 2041 11 p p NOUN aji-51 2041 12 , , PUNCT aji-51 2041 13 mathor mathor NOUN aji-51 2041 14 mb mb NOUN aji-51 2041 15 , , PUNCT aji-51 2041 16 rodrigues rodrigues PROPN aji-51 2041 17 rv rv PROPN aji-51 2041 18 , , PUNCT aji-51 2041 19 pinto pinto NOUN aji-51 2041 20 ds ds PROPN aji-51 2041 21 jr jr PROPN aji-51 2041 22 . . PUNCT aji-51 2042 1 cytotoxic cytotoxic ADJ aji-51 2042 2 effects effect NOUN aji-51 2042 3 of of ADP aji-51 2042 4 mistletoe mistletoe NOUN aji-51 2042 5 ( ( PUNCT aji-51 2042 6 viscum viscum PROPN aji-51 2042 7 album album NOUN aji-51 2042 8 l. l. PROPN aji-51 2042 9 ) ) PUNCT aji-51 2042 10 in in ADP aji-51 2042 11 head head NOUN aji-51 2042 12 and and CCONJ aji-51 2042 13 neck neck VERB aji-51 2042 14 squamous squamous ADJ aji-51 2042 15 cell cell NOUN aji-51 2042 16 carcinoma carcinoma NOUN aji-51 2042 17 cell cell NOUN aji-51 2042 18 lines line NOUN aji-51 2042 19 . . PUNCT aji-51 2043 1 oncol oncol PROPN aji-51 2043 2 rep rep PROPN aji-51 2043 3 . . PROPN aji-51 2043 4 2013 2013 NUM aji-51 2043 5 nov;30(5):2316 nov;30(5):2316 PROPN aji-51 2043 6 - - PUNCT aji-51 2043 7 22 22 NUM aji-51 2043 8 . . PUNCT aji-51 2044 1 doi doi NOUN aji-51 2044 2 : : PUNCT aji-51 2044 3 10.3892 10.3892 NUM aji-51 2044 4 / / SYM aji-51 2044 5 or.2013.2732 or.2013.2732 NOUN aji-51 2044 6 epub epub PROPN aji-51 2044 7 2013 2013 NUM aji-51 2044 8 sep sep PROPN aji-51 2044 9 10 10 NUM aji-51 2044 10 . . PUNCT aji-51 2045 1 pmid pmid NOUN aji-51 2045 2 : : PUNCT aji-51 2045 3 24026291 24026291 NUM aji-51 2045 4 . . PUNCT aji-51 2046 1 309 309 NUM aji-51 2046 2 . . PUNCT aji-51 2047 1 chen chen PROPN aji-51 2047 2 yy yy PROPN aji-51 2047 3 , , PUNCT aji-51 2047 4 hou hou PROPN aji-51 2047 5 jp jp PROPN aji-51 2047 6 , , PUNCT aji-51 2047 7 huang huang PROPN aji-51 2047 8 l l PROPN aji-51 2047 9 , , PUNCT aji-51 2047 10 khan khan PROPN aji-51 2047 11 a a PRON aji-51 2047 12 , , PUNCT aji-51 2047 13 xing xing PROPN aji-51 2047 14 ff ff NUM aji-51 2047 15 , , PUNCT aji-51 2047 16 zhang zhang PROPN aji-51 2047 17 xh xh PROPN aji-51 2047 18 , , PUNCT aji-51 2047 19 han han PROPN aji-51 2047 20 df df PROPN aji-51 2047 21 , , PUNCT aji-51 2047 22 yan yan PROPN aji-51 2047 23 sl sl PROPN aji-51 2047 24 , , PUNCT aji-51 2047 25 cao cao PROPN aji-51 2047 26 gd gd PROPN aji-51 2047 27 , , PUNCT aji-51 2047 28 jiao jiao PROPN aji-51 2047 29 qy qy PROPN aji-51 2047 30 , , PUNCT aji-51 2047 31 liu liu PROPN aji-51 2047 32 d d PROPN aji-51 2047 33 , , PUNCT aji-51 2047 34 zhu zhu PROPN aji-51 2047 35 x x PROPN aji-51 2047 36 , , PUNCT aji-51 2047 37 hu hu PROPN aji-51 2048 1 q q PROPN aji-51 2048 2 , , PUNCT aji-51 2048 3 lou lou PROPN aji-51 2048 4 hx hx PROPN aji-51 2048 5 . . PUNCT aji-51 2049 1 chemical chemical ADJ aji-51 2049 2 constituents constituent NOUN aji-51 2049 3 of of ADP aji-51 2049 4 viscum viscum PROPN aji-51 2049 5 coloratum coloratum NOUN aji-51 2049 6 ( ( PUNCT aji-51 2049 7 kom kom NOUN aji-51 2049 8 . . PUNCT aji-51 2049 9 ) ) PUNCT aji-51 2050 1 nakai nakai PROPN aji-51 2050 2 and and CCONJ aji-51 2050 3 their their PRON aji-51 2050 4 cytotoxic cytotoxic ADJ aji-51 2050 5 activities activity NOUN aji-51 2050 6 . . PUNCT aji-51 2051 1 nat nat PROPN aji-51 2051 2 prod prod PROPN aji-51 2051 3 res re NOUN aji-51 2051 4 . . PROPN aji-51 2051 5 2020 2020 NUM aji-51 2051 6 oct oct NOUN aji-51 2051 7 27:1 27:1 NUM aji-51 2051 8 - - SYM aji-51 2051 9 7 7 NUM aji-51 2051 10 . . PUNCT aji-51 2051 11 doi doi NOUN aji-51 2051 12 : : PUNCT aji-51 2051 13 10.1080/14786419.2020.1837816 10.1080/14786419.2020.1837816 NUM aji-51 2051 14 epub epub NOUN aji-51 2051 15 ahead ahead ADV aji-51 2051 16 of of ADP aji-51 2051 17 print print NOUN aji-51 2051 18 . . PUNCT aji-51 2052 1 pmid pmid NOUN aji-51 2052 2 : : PUNCT aji-51 2052 3 33107346 33107346 NUM aji-51 2052 4 . . PUNCT aji-51 2053 1 310 310 NUM aji-51 2053 2 . . PUNCT aji-51 2053 3 sabová sabová PROPN aji-51 2053 4 l l PROPN aji-51 2053 5 , , PUNCT aji-51 2053 6 pilátová pilátová PROPN aji-51 2053 7 m m PROPN aji-51 2053 8 , , PUNCT aji-51 2053 9 szilagyi szilagyi PROPN aji-51 2053 10 k k PROPN aji-51 2053 11 , , PUNCT aji-51 2053 12 sabo sabo NOUN aji-51 2053 13 r r NOUN aji-51 2053 14 , , PUNCT aji-51 2053 15 mojzis mojzi VERB aji-51 2053 16 j. j. PROPN aji-51 2053 17 cytotoxic cytotoxic ADJ aji-51 2053 18 effect effect NOUN aji-51 2053 19 of of ADP aji-51 2053 20 mistletoe mistletoe PROPN aji-51 2053 21 ( ( PUNCT aji-51 2053 22 viscum viscum PROPN aji-51 2053 23 album album NOUN aji-51 2053 24 l. l. PROPN aji-51 2053 25 ) ) PUNCT aji-51 2053 26 extract extract VERB aji-51 2053 27 on on ADP aji-51 2053 28 jurkat jurkat PROPN aji-51 2053 29 cells cell NOUN aji-51 2053 30 and and CCONJ aji-51 2053 31 its its PRON aji-51 2053 32 interaction interaction NOUN aji-51 2053 33 with with ADP aji-51 2053 34 doxorubicin doxorubicin PROPN aji-51 2053 35 . . PUNCT aji-51 2054 1 phytother phytother PROPN aji-51 2054 2 res re NOUN aji-51 2054 3 . . PUNCT aji-51 2055 1 2010 2010 NUM aji-51 2055 2 mar;24(3 mar;24(3 NOUN aji-51 2055 3 ): ): PUNCT aji-51 2055 4 365 365 NUM aji-51 2055 5 - - SYM aji-51 2055 6 8 8 NUM aji-51 2055 7 . . PUNCT aji-51 2056 1 doi doi NOUN aji-51 2056 2 : : PUNCT aji-51 2056 3 10.1002 10.1002 NUM aji-51 2056 4 / / SYM aji-51 2056 5 ptr.2947 ptr.2947 NUM aji-51 2056 6 pmid pmid PROPN aji-51 2056 7 : : PUNCT aji-51 2056 8 19610041 19610041 NUM aji-51 2056 9 . . PUNCT aji-51 2057 1 311 311 NUM aji-51 2057 2 . . PUNCT aji-51 2058 1 wu wu PROPN aji-51 2058 2 f f PROPN aji-51 2058 3 , , PUNCT aji-51 2058 4 li li PROPN aji-51 2058 5 j j PROPN aji-51 2058 6 , , PUNCT aji-51 2058 7 jang jang PROPN aji-51 2058 8 c c PROPN aji-51 2058 9 , , PUNCT aji-51 2058 10 wang wang PROPN aji-51 2058 11 j j PROPN aji-51 2058 12 , , PUNCT aji-51 2058 13 xiong xiong PROPN aji-51 2058 14 j. j. PROPN aji-51 2059 1 the the DET aji-51 2059 2 role role NOUN aji-51 2059 3 of of ADP aji-51 2059 4 axl axl PROPN aji-51 2059 5 in in ADP aji-51 2059 6 drug drug NOUN aji-51 2059 7 resistance resistance NOUN aji-51 2059 8 and and CCONJ aji-51 2059 9 epithelialto epithelialto PROPN aji-51 2059 10 - - PUNCT aji-51 2059 11 mesenchymal mesenchymal NOUN aji-51 2059 12 transition transition NOUN aji-51 2059 13 of of ADP aji-51 2059 14 non non ADJ aji-51 2059 15 - - ADJ aji-51 2059 16 small small ADJ aji-51 2059 17 stoff stoff NOUN aji-51 2059 18 ; ; PUNCT aji-51 2059 19 aji aji PROPN aji-51 2059 20 , , PUNCT aji-51 2059 21 5(1 5(1 NUM aji-51 2059 22 ): ): PUNCT aji-51 2059 23 1 1 NUM aji-51 2059 24 - - SYM aji-51 2059 25 39 39 NUM aji-51 2059 26 , , PUNCT aji-51 2059 27 2022 2022 NUM aji-51 2059 28 ; ; PUNCT aji-51 2059 29 article article NOUN aji-51 2059 30 no.aji.77967 no.aji.77967 VERB aji-51 2059 31 38 38 NUM aji-51 2059 32 cell cell NOUN aji-51 2059 33 lung lung NOUN aji-51 2059 34 carcinoma carcinoma NOUN aji-51 2059 35 . . PUNCT aji-51 2060 1 int int PROPN aji-51 2061 1 j j PROPN aji-51 2061 2 clin clin PROPN aji-51 2061 3 exp exp NOUN aji-51 2061 4 pathol pathol NOUN aji-51 2061 5 . . PUNCT aji-51 2062 1 2014 2014 NUM aji-51 2062 2 sep sep NOUN aji-51 2062 3 15;7(10):6653 15;7(10):6653 NUM aji-51 2062 4 - - SYM aji-51 2062 5 61 61 NUM aji-51 2062 6 . . PUNCT aji-51 2063 1 pmid pmid NOUN aji-51 2063 2 : : PUNCT aji-51 2063 3 25400744 25400744 NUM aji-51 2063 4 ; ; PUNCT aji-51 2063 5 pmcid pmcid NOUN aji-51 2063 6 : : PUNCT aji-51 2063 7 pmc4230140 pmc4230140 NOUN aji-51 2063 8 . . PUNCT aji-51 2064 1 312 312 NUM aji-51 2064 2 . . PUNCT aji-51 2065 1 kim kim PROPN aji-51 2065 2 s s PROPN aji-51 2065 3 , , PUNCT aji-51 2065 4 kim kim PROPN aji-51 2065 5 kc kc PROPN aji-51 2065 6 , , PUNCT aji-51 2065 7 lee lee PROPN aji-51 2065 8 c. c. PROPN aji-51 2065 9 mistletoe mistletoe PROPN aji-51 2065 10 ( ( PUNCT aji-51 2065 11 viscum viscum PROPN aji-51 2065 12 album album NOUN aji-51 2065 13 ) ) PUNCT aji-51 2065 14 extract extract VERB aji-51 2065 15 targets target NOUN aji-51 2065 16 axl axl VERB aji-51 2065 17 to to PART aji-51 2065 18 suppress suppress VERB aji-51 2065 19 cell cell NOUN aji-51 2065 20 proliferation proliferation NOUN aji-51 2065 21 and and CCONJ aji-51 2065 22 overcome overcome VERB aji-51 2065 23 cisplatinand cisplatinand ADP aji-51 2065 24 erlotinib erlotinib NOUN aji-51 2065 25 - - PUNCT aji-51 2065 26 resistance resistance NOUN aji-51 2065 27 in in ADP aji-51 2065 28 non non ADJ aji-51 2065 29 - - ADJ aji-51 2065 30 small small ADJ aji-51 2065 31 cell cell NOUN aji-51 2065 32 lung lung NOUN aji-51 2065 33 cancer cancer NOUN aji-51 2065 34 cells cell NOUN aji-51 2065 35 . . PUNCT aji-51 2066 1 phytomedicine phytomedicine NOUN aji-51 2066 2 . . PUNCT aji-51 2067 1 2017 2017 NUM aji-51 2067 2 dec dec PROPN aji-51 2067 3 1;36:183 1;36:183 NUM aji-51 2067 4 - - SYM aji-51 2067 5 193 193 NUM aji-51 2067 6 . . PUNCT aji-51 2068 1 doi doi NOUN aji-51 2068 2 : : PUNCT aji-51 2068 3 10.1016 10.1016 NUM aji-51 2068 4 / / SYM aji-51 2068 5 j.phymed.2017.09.017 j.phymed.2017.09.017 PROPN aji-51 2068 6 epub epub VERB aji-51 2068 7 2017 2017 NUM aji-51 2068 8 sep sep PROPN aji-51 2068 9 29 29 NUM aji-51 2068 10 . . PUNCT aji-51 2069 1 pmid pmid NOUN aji-51 2069 2 : : PUNCT aji-51 2069 3 29157814 29157814 NUM aji-51 2069 4 . . PUNCT aji-51 2070 1 313 313 NUM aji-51 2070 2 . . PUNCT aji-51 2071 1 emmings emming NOUN aji-51 2071 2 e e NOUN aji-51 2071 3 , , PUNCT aji-51 2071 4 mullany mullany NOUN aji-51 2071 5 s s PROPN aji-51 2071 6 , , PUNCT aji-51 2071 7 chang chang PROPN aji-51 2071 8 z z PROPN aji-51 2071 9 , , PUNCT aji-51 2071 10 landen landen PROPN aji-51 2071 11 cn cn PROPN aji-51 2071 12 jr jr PROPN aji-51 2071 13 , , PUNCT aji-51 2071 14 linder linder PROPN aji-51 2071 15 s s PROPN aji-51 2071 16 , , PUNCT aji-51 2071 17 bazzaro bazzaro NOUN aji-51 2071 18 m. m. NOUN aji-51 2071 19 targeting target VERB aji-51 2071 20 mitochondria mitochondria NOUN aji-51 2071 21 for for ADP aji-51 2071 22 treatment treatment NOUN aji-51 2071 23 of of ADP aji-51 2071 24 chemoresistant chemoresistant ADJ aji-51 2071 25 ovarian ovarian ADJ aji-51 2071 26 cancer cancer NOUN aji-51 2071 27 . . PUNCT aji-51 2072 1 int int PROPN aji-51 2072 2 j j PROPN aji-51 2072 3 mol mol ADP aji-51 2072 4 sci sci PROPN aji-51 2072 5 . . PROPN aji-51 2072 6 2019 2019 NUM aji-51 2072 7 jan jan PROPN aji-51 2072 8 8;20(1):229 8;20(1):229 NUM aji-51 2072 9 . . PUNCT aji-51 2073 1 doi doi NOUN aji-51 2073 2 : : PUNCT aji-51 2073 3 10.3390 10.3390 NUM aji-51 2073 4 / / SYM aji-51 2073 5 ijms20010229 ijms20010229 PROPN aji-51 2073 6 pmid pmid PROPN aji-51 2073 7 : : PUNCT aji-51 2073 8 30626133 30626133 NUM aji-51 2073 9 ; ; PUNCT aji-51 2073 10 pmcid pmcid ADJ aji-51 2073 11 : : PUNCT aji-51 2073 12 pmc6337358 pmc6337358 NOUN aji-51 2073 13 . . PUNCT aji-51 2074 1 314 314 X aji-51 2074 2 . . PUNCT aji-51 2075 1 lamb lamb PROPN aji-51 2075 2 r r PROPN aji-51 2075 3 , , PUNCT aji-51 2075 4 fiorillo fiorillo NOUN aji-51 2075 5 m m PROPN aji-51 2075 6 , , PUNCT aji-51 2075 7 chadwick chadwick PROPN aji-51 2075 8 a a PRON aji-51 2075 9 , , PUNCT aji-51 2075 10 ozsvari ozsvari ADJ aji-51 2075 11 b b NUM aji-51 2075 12 , , PUNCT aji-51 2075 13 reeves reeves PROPN aji-51 2075 14 kj kj PROPN aji-51 2075 15 , , PUNCT aji-51 2075 16 smith smith PROPN aji-51 2075 17 dl dl PROPN aji-51 2075 18 , , PUNCT aji-51 2075 19 clarke clarke PROPN aji-51 2075 20 rb rb PROPN aji-51 2075 21 , , PUNCT aji-51 2075 22 howell howell PROPN aji-51 2075 23 sj sj PROPN aji-51 2075 24 , , PUNCT aji-51 2075 25 cappello cappello PROPN aji-51 2075 26 ar ar PROPN aji-51 2075 27 , , PUNCT aji-51 2075 28 martinez martinez PROPN aji-51 2075 29 - - PUNCT aji-51 2075 30 outschoorn outschoorn VERB aji-51 2075 31 ue ue ADJ aji-51 2075 32 , , PUNCT aji-51 2075 33 peiris peiris NOUN aji-51 2075 34 - - PUNCT aji-51 2075 35 pagès pagès NOUN aji-51 2075 36 m m PROPN aji-51 2075 37 , , PUNCT aji-51 2075 38 sotgia sotgia PROPN aji-51 2075 39 f f PROPN aji-51 2075 40 , , PUNCT aji-51 2075 41 lisanti lisanti PROPN aji-51 2075 42 mp mp PROPN aji-51 2075 43 . . PROPN aji-51 2075 44 doxycycline doxycycline PROPN aji-51 2075 45 down down ADP aji-51 2075 46 - - PUNCT aji-51 2075 47 regulates regulate VERB aji-51 2075 48 dna dna PROPN aji-51 2075 49 - - PUNCT aji-51 2075 50 pk pk NOUN aji-51 2075 51 and and CCONJ aji-51 2075 52 radiosensitizes radiosensitize VERB aji-51 2075 53 tumor tumor NOUN aji-51 2075 54 initiating initiate VERB aji-51 2075 55 cells cell NOUN aji-51 2075 56 : : PUNCT aji-51 2075 57 implications implication NOUN aji-51 2075 58 for for ADP aji-51 2075 59 more more ADV aji-51 2075 60 effective effective ADJ aji-51 2075 61 radiation radiation NOUN aji-51 2075 62 therapy therapy NOUN aji-51 2075 63 . . PUNCT aji-51 2076 1 oncotarget oncotarget NOUN aji-51 2076 2 . . PUNCT aji-51 2077 1 2015 2015 NUM aji-51 2077 2 jun jun PROPN aji-51 2077 3 10;6(16):14005 10;6(16):14005 NUM aji-51 2077 4 - - SYM aji-51 2077 5 25 25 NUM aji-51 2077 6 . . PUNCT aji-51 2078 1 doi doi NOUN aji-51 2078 2 : : PUNCT aji-51 2078 3 10.18632 10.18632 NUM aji-51 2078 4 / / SYM aji-51 2078 5 oncotarget.4159 oncotarget.4159 PROPN aji-51 2078 6 pmid pmid PROPN aji-51 2078 7 : : PUNCT aji-51 2078 8 26087309 26087309 NUM aji-51 2078 9 ; ; PUNCT aji-51 2078 10 pmcid pmcid ADJ aji-51 2078 11 : : PUNCT aji-51 2078 12 pmc4546447 pmc4546447 NOUN aji-51 2078 13 . . PUNCT aji-51 2079 1 315 315 NUM aji-51 2079 2 . . PUNCT aji-51 2080 1 huang huang PROPN aji-51 2080 2 t t PROPN aji-51 2080 3 , , PUNCT aji-51 2080 4 song song NOUN aji-51 2080 5 x x NOUN aji-51 2080 6 , , PUNCT aji-51 2080 7 xu xu PROPN aji-51 2081 1 d d PROPN aji-51 2081 2 , , PUNCT aji-51 2081 3 tiek tiek PROPN aji-51 2081 4 d d NOUN aji-51 2081 5 , , PUNCT aji-51 2081 6 goenka goenka PROPN aji-51 2081 7 a a PROPN aji-51 2081 8 , , PUNCT aji-51 2081 9 wu wu PROPN aji-51 2081 10 b b PROPN aji-51 2081 11 , , PUNCT aji-51 2081 12 sastry sastry PROPN aji-51 2081 13 n n PROPN aji-51 2081 14 , , PUNCT aji-51 2081 15 hu hu PROPN aji-51 2081 16 b b PROPN aji-51 2081 17 , , PUNCT aji-51 2081 18 cheng cheng PROPN aji-51 2081 19 sy sy PROPN aji-51 2081 20 . . PUNCT aji-51 2081 21 stem stem NOUN aji-51 2081 22 cell cell NOUN aji-51 2081 23 programs program NOUN aji-51 2081 24 in in ADP aji-51 2081 25 cancer cancer NOUN aji-51 2081 26 initiation initiation NOUN aji-51 2081 27 , , PUNCT aji-51 2081 28 progression progression NOUN aji-51 2081 29 , , PUNCT aji-51 2081 30 and and CCONJ aji-51 2081 31 therapy therapy NOUN aji-51 2081 32 resistance resistance NOUN aji-51 2081 33 . . PUNCT aji-51 2082 1 theranostics theranostic NOUN aji-51 2082 2 . . PUNCT aji-51 2083 1 2020 2020 NUM aji-51 2083 2 jul jul PROPN aji-51 2083 3 9;10(19):87218743 9;10(19):87218743 NUM aji-51 2083 4 . . PUNCT aji-51 2084 1 doi doi NOUN aji-51 2084 2 : : PUNCT aji-51 2084 3 10.7150 10.7150 NUM aji-51 2084 4 / / SYM aji-51 2084 5 thno.41648 thno.41648 PROPN aji-51 2084 6 pmid pmid PROPN aji-51 2084 7 : : PUNCT aji-51 2084 8 32754274 32754274 NUM aji-51 2084 9 ; ; PUNCT aji-51 2084 10 pmcid pmcid ADJ aji-51 2084 11 : : PUNCT aji-51 2084 12 pmc7392012 pmc7392012 NOUN aji-51 2084 13 . . PUNCT aji-51 2085 1 316 316 NUM aji-51 2085 2 . . PUNCT aji-51 2085 3 alisi alisi PROPN aji-51 2085 4 a a PROPN aji-51 2085 5 , , PUNCT aji-51 2085 6 cho cho PROPN aji-51 2085 7 wc wc PROPN aji-51 2085 8 , , PUNCT aji-51 2085 9 locatelli locatelli NOUN aji-51 2085 10 f f PROPN aji-51 2085 11 , , PUNCT aji-51 2085 12 fruci fruci PROPN aji-51 2085 13 d. d. PROPN aji-51 2085 14 multidrug multidrug VERB aji-51 2085 15 resistance resistance NOUN aji-51 2085 16 and and CCONJ aji-51 2085 17 cancer cancer NOUN aji-51 2085 18 stem stem NOUN aji-51 2085 19 cells cell NOUN aji-51 2085 20 in in ADP aji-51 2085 21 neuroblastoma neuroblastoma NOUN aji-51 2085 22 and and CCONJ aji-51 2085 23 hepatoblastoma hepatoblastoma ADJ aji-51 2085 24 . . PUNCT aji-51 2086 1 int int PROPN aji-51 2086 2 j j PROPN aji-51 2086 3 mol mol ADP aji-51 2086 4 sci sci PROPN aji-51 2086 5 . . PROPN aji-51 2087 1 2013 2013 NUM aji-51 2087 2 dec dec PROPN aji-51 2087 3 18;14(12):24706 18;14(12):24706 PROPN aji-51 2087 4 - - SYM aji-51 2087 5 25 25 NUM aji-51 2087 6 . . PUNCT aji-51 2088 1 doi doi NOUN aji-51 2088 2 : : PUNCT aji-51 2088 3 10.3390 10.3390 NUM aji-51 2088 4 / / SYM aji-51 2088 5 ijms141224706 ijms141224706 PROPN aji-51 2088 6 pmid pmid PROPN aji-51 2088 7 : : PUNCT aji-51 2088 8 24351843 24351843 NUM aji-51 2088 9 ; ; PUNCT aji-51 2088 10 pmcid pmcid NOUN aji-51 2088 11 : : PUNCT aji-51 2088 12 pmc3876137 pmc3876137 NOUN aji-51 2088 13 . . PUNCT aji-51 2089 1 317 317 NUM aji-51 2089 2 . . PUNCT aji-51 2090 1 mcintosh mcintosh PROPN aji-51 2090 2 k k PROPN aji-51 2090 3 , , PUNCT aji-51 2090 4 balch balch PROPN aji-51 2090 5 c c PROPN aji-51 2090 6 , , PUNCT aji-51 2090 7 tiwari tiwari PROPN aji-51 2090 8 ak ak PROPN aji-51 2090 9 . . PROPN aji-51 2090 10 tackling tackle VERB aji-51 2090 11 multidrug multidrug NOUN aji-51 2090 12 resistance resistance NOUN aji-51 2090 13 mediated mediate VERB aji-51 2090 14 by by ADP aji-51 2090 15 efflux efflux NOUN aji-51 2090 16 transporters transporter NOUN aji-51 2090 17 in in ADP aji-51 2090 18 tumor tumor NOUN aji-51 2090 19 - - PUNCT aji-51 2090 20 initiating initiate VERB aji-51 2090 21 cells cell NOUN aji-51 2090 22 . . PUNCT aji-51 2091 1 expert expert NOUN aji-51 2091 2 opin opin NOUN aji-51 2091 3 drug drug NOUN aji-51 2091 4 metab metab NOUN aji-51 2091 5 toxicol toxicol NOUN aji-51 2091 6 . . PUNCT aji-51 2091 7 2016 2016 NUM aji-51 2091 8 jun;12(6):633 jun;12(6):633 ADV aji-51 2091 9 - - PUNCT aji-51 2091 10 44 44 NUM aji-51 2091 11 . . PUNCT aji-51 2091 12 doi doi NOUN aji-51 2091 13 : : PUNCT aji-51 2091 14 10.1080/17425255.2016.1179280 10.1080/17425255.2016.1179280 NUM aji-51 2091 15 epub epub NOUN aji-51 2091 16 2016 2016 NUM aji-51 2091 17 may may AUX aji-51 2091 18 4 4 NUM aji-51 2091 19 . . PUNCT aji-51 2092 1 pmid pmid NOUN aji-51 2092 2 : : PUNCT aji-51 2092 3 27116192 27116192 NUM aji-51 2092 4 . . PUNCT aji-51 2093 1 318 318 NUM aji-51 2093 2 . . PUNCT aji-51 2094 1 garcia garcia PROPN aji-51 2094 2 - - PUNCT aji-51 2094 3 mayea mayea VERB aji-51 2094 4 y y PROPN aji-51 2094 5 , , PUNCT aji-51 2094 6 mir mir PROPN aji-51 2094 7 c c PROPN aji-51 2094 8 , , PUNCT aji-51 2094 9 masson masson PROPN aji-51 2094 10 f f PROPN aji-51 2094 11 , , PUNCT aji-51 2094 12 paciucci paciucci PROPN aji-51 2094 13 r r NOUN aji-51 2094 14 , , PUNCT aji-51 2094 15 lleonart lleonart VERB aji-51 2094 16 me i PRON aji-51 2094 17 . . PUNCT aji-51 2095 1 insights insight NOUN aji-51 2095 2 into into ADP aji-51 2095 3 new new ADJ aji-51 2095 4 mechanisms mechanism NOUN aji-51 2095 5 and and CCONJ aji-51 2095 6 models model NOUN aji-51 2095 7 of of ADP aji-51 2095 8 cancer cancer NOUN aji-51 2095 9 stem stem NOUN aji-51 2095 10 cell cell NOUN aji-51 2095 11 multidrug multidrug NOUN aji-51 2095 12 resistance resistance NOUN aji-51 2095 13 . . PUNCT aji-51 2096 1 semin semin PROPN aji-51 2096 2 cancer cancer PROPN aji-51 2096 3 biol biol PROPN aji-51 2096 4 . . PUNCT aji-51 2097 1 2020 2020 NUM aji-51 2097 2 feb;60:166 feb;60:166 NOUN aji-51 2097 3 - - PUNCT aji-51 2097 4 180 180 NUM aji-51 2097 5 . . PUNCT aji-51 2098 1 doi doi NOUN aji-51 2098 2 : : PUNCT aji-51 2098 3 10.1016 10.1016 NUM aji-51 2098 4 / / SYM aji-51 2098 5 j.semcancer.2019.07.022 j.semcancer.2019.07.022 PROPN aji-51 2098 6 epub epub PROPN aji-51 2098 7 2019 2019 NUM aji-51 2098 8 jul jul PROPN aji-51 2098 9 29 29 NUM aji-51 2098 10 . . PUNCT aji-51 2099 1 pmid pmid NOUN aji-51 2099 2 : : PUNCT aji-51 2099 3 31369817 31369817 NUM aji-51 2099 4 . . PUNCT aji-51 2100 1 319 319 NUM aji-51 2100 2 . . PUNCT aji-51 2101 1 zhang zhang PROPN aji-51 2101 2 q q PROPN aji-51 2101 3 , , PUNCT aji-51 2101 4 feng feng PROPN aji-51 2101 5 y y PROPN aji-51 2101 6 , , PUNCT aji-51 2101 7 kennedy kennedy PROPN aji-51 2101 8 d. d. PROPN aji-51 2101 9 multidrugresistant multidrugresistant PROPN aji-51 2101 10 cancer cancer NOUN aji-51 2101 11 cells cell NOUN aji-51 2101 12 and and CCONJ aji-51 2101 13 cancer cancer NOUN aji-51 2101 14 stem stem NOUN aji-51 2101 15 cells cell NOUN aji-51 2101 16 hijack hijack VERB aji-51 2101 17 cellular cellular ADJ aji-51 2101 18 systems system NOUN aji-51 2101 19 to to PART aji-51 2101 20 circumvent circumvent VERB aji-51 2101 21 systemic systemic ADJ aji-51 2101 22 therapies therapy NOUN aji-51 2101 23 , , PUNCT aji-51 2101 24 can can AUX aji-51 2101 25 natural natural ADJ aji-51 2101 26 products product NOUN aji-51 2101 27 reverse reverse VERB aji-51 2101 28 this this PRON aji-51 2101 29 ? ? PUNCT aji-51 2102 1 cell cell NOUN aji-51 2102 2 mol mol ADP aji-51 2102 3 life life PROPN aji-51 2102 4 sci sci PROPN aji-51 2102 5 . . PROPN aji-51 2102 6 2017 2017 NUM aji-51 2103 1 mar;74(5):777 mar;74(5):777 NOUN aji-51 2103 2 - - PUNCT aji-51 2103 3 801 801 NUM aji-51 2103 4 . . PUNCT aji-51 2104 1 doi doi NOUN aji-51 2104 2 : : PUNCT aji-51 2104 3 10.1007 10.1007 NUM aji-51 2104 4 / / SYM aji-51 2104 5 s00018 s00018 NOUN aji-51 2104 6 - - PUNCT aji-51 2104 7 016 016 NUM aji-51 2104 8 - - PUNCT aji-51 2104 9 2362 2362 NUM aji-51 2104 10 - - SYM aji-51 2104 11 3 3 NUM aji-51 2104 12 epub epub NOUN aji-51 2104 13 2016 2016 NUM aji-51 2104 14 sep sep NOUN aji-51 2104 15 12 12 NUM aji-51 2104 16 . . PUNCT aji-51 2105 1 pmid pmid NOUN aji-51 2105 2 : : PUNCT aji-51 2105 3 27622244 27622244 NUM aji-51 2105 4 . . PUNCT aji-51 2106 1 320 320 NUM aji-51 2106 2 . . PUNCT aji-51 2107 1 gilloteaux gilloteaux PROPN aji-51 2107 2 j j PROPN aji-51 2107 3 , , PUNCT aji-51 2107 4 jamison jamison PROPN aji-51 2107 5 jm jm PROPN aji-51 2107 6 , , PUNCT aji-51 2107 7 lorimer lorimer PROPN aji-51 2107 8 he he PRON aji-51 2107 9 , , PUNCT aji-51 2107 10 jarjoura jarjoura PROPN aji-51 2107 11 d d PROPN aji-51 2107 12 , , PUNCT aji-51 2107 13 taper taper NOUN aji-51 2107 14 hs hs PROPN aji-51 2107 15 , , PUNCT aji-51 2107 16 calderon calderon PROPN aji-51 2107 17 pb pb PROPN aji-51 2107 18 , , PUNCT aji-51 2107 19 neal neal PROPN aji-51 2107 20 dr dr PROPN aji-51 2107 21 , , PUNCT aji-51 2107 22 summers summers PROPN aji-51 2107 23 jl jl PROPN aji-51 2107 24 . . PUNCT aji-51 2107 25 autoschizis autoschizis PROPN aji-51 2107 26 : : PUNCT aji-51 2107 27 a a DET aji-51 2107 28 new new ADJ aji-51 2107 29 form form NOUN aji-51 2107 30 of of ADP aji-51 2107 31 cell cell NOUN aji-51 2107 32 death death NOUN aji-51 2107 33 for for ADP aji-51 2107 34 human human ADJ aji-51 2107 35 ovarian ovarian ADJ aji-51 2107 36 carcinoma carcinoma NOUN aji-51 2107 37 cells cell NOUN aji-51 2107 38 following follow VERB aji-51 2107 39 ascorbate ascorbate NOUN aji-51 2107 40 : : PUNCT aji-51 2107 41 menadione menadione NOUN aji-51 2107 42 treatment treatment NOUN aji-51 2107 43 . . PUNCT aji-51 2108 1 nuclear nuclear ADJ aji-51 2108 2 and and CCONJ aji-51 2108 3 dna dna PROPN aji-51 2108 4 degradation degradation NOUN aji-51 2108 5 . . PUNCT aji-51 2109 1 tissue tissue NOUN aji-51 2109 2 cell cell NOUN aji-51 2109 3 . . PUNCT aji-51 2110 1 2004 2004 NUM aji-51 2110 2 jun;36(3):197 jun;36(3):197 PROPN aji-51 2110 3 - - PUNCT aji-51 2110 4 209 209 NUM aji-51 2110 5 . . PUNCT aji-51 2111 1 doi doi NOUN aji-51 2111 2 : : PUNCT aji-51 2111 3 10.1016 10.1016 NUM aji-51 2111 4 / / SYM aji-51 2111 5 j.tice.2004.01.006 j.tice.2004.01.006 PROPN aji-51 2111 6 pmid pmid PROPN aji-51 2111 7 : : PUNCT aji-51 2111 8 15140597 15140597 NUM aji-51 2111 9 . . PUNCT aji-51 2112 1 321 321 NUM aji-51 2112 2 . . PUNCT aji-51 2113 1 jamison jamison PROPN aji-51 2113 2 jm jm PROPN aji-51 2113 3 , , PUNCT aji-51 2113 4 gilloteaux gilloteaux PROPN aji-51 2113 5 j j PROPN aji-51 2113 6 , , PUNCT aji-51 2113 7 taper taper VERB aji-51 2113 8 hs hs PROPN aji-51 2113 9 , , PUNCT aji-51 2113 10 calderon calderon NOUN aji-51 2113 11 pb pb PROPN aji-51 2113 12 , , PUNCT aji-51 2113 13 summers summers PROPN aji-51 2113 14 jl jl PROPN aji-51 2113 15 . . PUNCT aji-51 2113 16 autoschizis autoschizis PROPN aji-51 2113 17 : : PUNCT aji-51 2113 18 a a DET aji-51 2113 19 novel novel ADJ aji-51 2113 20 cell cell NOUN aji-51 2113 21 death death NOUN aji-51 2113 22 . . PUNCT aji-51 2114 1 biochem biochem PROPN aji-51 2114 2 pharmacol pharmacol PROPN aji-51 2114 3 . . PUNCT aji-51 2115 1 2002 2002 NUM aji-51 2115 2 may may AUX aji-51 2115 3 15;63(10):1773 15;63(10):1773 NUM aji-51 2115 4 - - PUNCT aji-51 2115 5 83 83 NUM aji-51 2115 6 . . PUNCT aji-51 2116 1 doi doi NOUN aji-51 2116 2 : : PUNCT aji-51 2116 3 10.1016 10.1016 NUM aji-51 2116 4 / / SYM aji-51 2116 5 s0006 s0006 NOUN aji-51 2116 6 - - PUNCT aji-51 2116 7 2952(02)00904 2952(02)00904 NUM aji-51 2116 8 - - SYM aji-51 2116 9 8 8 NUM aji-51 2116 10 pmid pmid NOUN aji-51 2116 11 : : PUNCT aji-51 2116 12 12034362 12034362 NUM aji-51 2116 13 . . PUNCT aji-51 2117 1 322 322 NUM aji-51 2117 2 . . PUNCT aji-51 2117 3 verrax verrax PROPN aji-51 2117 4 j j PROPN aji-51 2117 5 , , PUNCT aji-51 2117 6 cadrobbi cadrobbi PROPN aji-51 2117 7 j j PROPN aji-51 2117 8 , , PUNCT aji-51 2117 9 delvaux delvaux PROPN aji-51 2117 10 m m PROPN aji-51 2117 11 , , PUNCT aji-51 2117 12 jamison jamison PROPN aji-51 2117 13 jm jm PROPN aji-51 2117 14 , , PUNCT aji-51 2117 15 gilloteaux gilloteaux PROPN aji-51 2117 16 j j PROPN aji-51 2117 17 , , PUNCT aji-51 2117 18 summers summers PROPN aji-51 2117 19 jl jl PROPN aji-51 2117 20 , , PUNCT aji-51 2117 21 taper taper NOUN aji-51 2117 22 hs hs PROPN aji-51 2117 23 , , PUNCT aji-51 2117 24 buc buc PROPN aji-51 2117 25 calderon calderon PROPN aji-51 2118 1 p. p. PROPN aji-51 2118 2 the the DET aji-51 2118 3 association association NOUN aji-51 2118 4 of of ADP aji-51 2118 5 vitamins vitamin NOUN aji-51 2118 6 c c NOUN aji-51 2118 7 and and CCONJ aji-51 2118 8 k3 k3 PROPN aji-51 2118 9 kills kill VERB aji-51 2118 10 cancer cancer NOUN aji-51 2118 11 cells cell NOUN aji-51 2118 12 mainly mainly ADV aji-51 2118 13 by by ADP aji-51 2118 14 autoschizis autoschizi NOUN aji-51 2118 15 , , PUNCT aji-51 2118 16 a a DET aji-51 2118 17 novel novel ADJ aji-51 2118 18 form form NOUN aji-51 2118 19 of of ADP aji-51 2118 20 cell cell NOUN aji-51 2118 21 death death NOUN aji-51 2118 22 . . PUNCT aji-51 2119 1 basis basis NOUN aji-51 2119 2 for for ADP aji-51 2119 3 their their PRON aji-51 2119 4 potential potential ADJ aji-51 2119 5 use use NOUN aji-51 2119 6 as as ADP aji-51 2119 7 coadjuvants coadjuvant NOUN aji-51 2119 8 in in ADP aji-51 2119 9 anticancer anticancer NOUN aji-51 2119 10 therapy therapy NOUN aji-51 2119 11 . . PUNCT aji-51 2120 1 eur eur PROPN aji-51 2120 2 j j PROPN aji-51 2120 3 med med PROPN aji-51 2120 4 chem chem NOUN aji-51 2120 5 . . PUNCT aji-51 2121 1 2003 2003 NUM aji-51 2121 2 may;38(5 may;38(5 NOUN aji-51 2121 3 ): ): PUNCT aji-51 2121 4 451 451 NUM aji-51 2121 5 - - SYM aji-51 2121 6 7 7 NUM aji-51 2121 7 . . PUNCT aji-51 2121 8 doi doi NOUN aji-51 2121 9 : : PUNCT aji-51 2121 10 10.1016 10.1016 NUM aji-51 2121 11 / / SYM aji-51 2121 12 s0223 s0223 PROPN aji-51 2121 13 - - PUNCT aji-51 2121 14 5234(03)00082 5234(03)00082 NUM aji-51 2121 15 - - SYM aji-51 2121 16 5 5 NUM aji-51 2121 17 pmid pmid NOUN aji-51 2121 18 : : PUNCT aji-51 2121 19 12767595 12767595 NUM aji-51 2121 20 . . PUNCT aji-51 2122 1 323 323 NUM aji-51 2122 2 . . PUNCT aji-51 2123 1 fu fu PROPN aji-51 2123 2 j j PROPN aji-51 2123 3 , , PUNCT aji-51 2123 4 wu wu PROPN aji-51 2123 5 z z PROPN aji-51 2123 6 , , PUNCT aji-51 2123 7 liu liu PROPN aji-51 2123 8 j j PROPN aji-51 2123 9 , , PUNCT aji-51 2123 10 wu wu PROPN aji-51 2123 11 t. t. PROPN aji-51 2123 12 vitamin vitamin NOUN aji-51 2123 13 c c NOUN aji-51 2123 14 : : PUNCT aji-51 2123 15 a a DET aji-51 2123 16 stem stem NOUN aji-51 2123 17 cell cell NOUN aji-51 2123 18 promoter promoter NOUN aji-51 2123 19 in in ADP aji-51 2123 20 cancer cancer NOUN aji-51 2123 21 metastasis metastasis NOUN aji-51 2123 22 and and CCONJ aji-51 2123 23 immunotherapy immunotherapy NOUN aji-51 2123 24 . . PUNCT aji-51 2123 25 biomed biome VERB aji-51 2123 26 pharmacother pharmacother ADJ aji-51 2123 27 . . PUNCT aji-51 2124 1 2020 2020 NUM aji-51 2125 1 nov;131:110588 nov;131:110588 PROPN aji-51 2125 2 . . PUNCT aji-51 2126 1 doi doi NOUN aji-51 2126 2 : : PUNCT aji-51 2126 3 10.1016 10.1016 NUM aji-51 2126 4 / / SYM aji-51 2126 5 j.biopha.2020.110588 j.biopha.2020.110588 PROPN aji-51 2126 6 epub epub PROPN aji-51 2126 7 2020 2020 NUM aji-51 2126 8 aug aug PROPN aji-51 2126 9 21 21 NUM aji-51 2126 10 . . PUNCT aji-51 2127 1 pmid pmid NOUN aji-51 2127 2 : : PUNCT aji-51 2127 3 32836076 32836076 NUM aji-51 2127 4 . . PUNCT aji-51 2128 1 324 324 NUM aji-51 2128 2 . . PUNCT aji-51 2129 1 satheesh satheesh PROPN aji-51 2129 2 nj nj PROPN aji-51 2129 3 , , PUNCT aji-51 2129 4 samuel samuel PROPN aji-51 2129 5 sm sm PROPN aji-51 2129 6 , , PUNCT aji-51 2129 7 büsselberg büsselberg PROPN aji-51 2129 8 d. d. PROPN aji-51 2129 9 combination combination NOUN aji-51 2129 10 therapy therapy NOUN aji-51 2129 11 with with ADP aji-51 2129 12 vitamin vitamin NOUN aji-51 2129 13 c c NOUN aji-51 2129 14 could could AUX aji-51 2129 15 eradicate eradicate VERB aji-51 2129 16 cancer cancer NOUN aji-51 2129 17 stem stem NOUN aji-51 2129 18 cells cell NOUN aji-51 2129 19 . . PUNCT aji-51 2130 1 biomolecules biomolecule NOUN aji-51 2130 2 . . PUNCT aji-51 2131 1 2020 2020 NUM aji-51 2131 2 jan jan PROPN aji-51 2131 3 3;10(1):79 3;10(1):79 PROPN aji-51 2131 4 . . PUNCT aji-51 2132 1 doi doi NOUN aji-51 2132 2 : : PUNCT aji-51 2132 3 10.3390 10.3390 NUM aji-51 2132 4 / / SYM aji-51 2132 5 biom10010079 biom10010079 PROPN aji-51 2132 6 pmid pmid PROPN aji-51 2132 7 : : PUNCT aji-51 2132 8 31947879 31947879 NUM aji-51 2132 9 ; ; PUNCT aji-51 2132 10 pmcid pmcid ADJ aji-51 2132 11 : : PUNCT aji-51 2132 12 pmc7022456 pmc7022456 NOUN aji-51 2132 13 . . PUNCT aji-51 2133 1 stoff stoff PROPN aji-51 2133 2 ; ; PUNCT aji-51 2133 3 aji aji PROPN aji-51 2133 4 , , PUNCT aji-51 2133 5 5(1 5(1 NUM aji-51 2133 6 ): ): PUNCT aji-51 2133 7 1 1 NUM aji-51 2133 8 - - SYM aji-51 2133 9 39 39 NUM aji-51 2133 10 , , PUNCT aji-51 2133 11 2022 2022 NUM aji-51 2133 12 ; ; PUNCT aji-51 2133 13 article article NOUN aji-51 2133 14 no.aji.77967 no.aji.77967 VERB aji-51 2133 15 39 39 NUM aji-51 2133 16 325 325 NUM aji-51 2133 17 . . PUNCT aji-51 2134 1 cimmino cimmino PROPN aji-51 2134 2 l l PROPN aji-51 2134 3 , , PUNCT aji-51 2134 4 neel neel PROPN aji-51 2134 5 bg bg PROPN aji-51 2134 6 , , PUNCT aji-51 2134 7 aifantis aifantis PROPN aji-51 2134 8 i. i. PROPN aji-51 2134 9 vitamin vitamin PROPN aji-51 2134 10 c c PROPN aji-51 2134 11 in in ADP aji-51 2134 12 stem stem NOUN aji-51 2134 13 cell cell NOUN aji-51 2134 14 reprogramming reprogramming NOUN aji-51 2134 15 and and CCONJ aji-51 2134 16 cancer cancer NOUN aji-51 2134 17 . . PUNCT aji-51 2135 1 trends trend NOUN aji-51 2135 2 cell cell NOUN aji-51 2135 3 biol biol NOUN aji-51 2135 4 . . PUNCT aji-51 2136 1 2018 2018 NUM aji-51 2136 2 sep;28(9):698 sep;28(9):698 NUM aji-51 2136 3 - - PUNCT aji-51 2136 4 708 708 NUM aji-51 2136 5 . . PUNCT aji-51 2137 1 doi doi NOUN aji-51 2137 2 : : PUNCT aji-51 2137 3 10.1016 10.1016 NUM aji-51 2137 4 / / SYM aji-51 2137 5 j.tcb.2018.04.001 j.tcb.2018.04.001 PROPN aji-51 2137 6 epub epub NOUN aji-51 2137 7 2018 2018 NUM aji-51 2137 8 apr apr NOUN aji-51 2137 9 30 30 NUM aji-51 2137 10 . . PUNCT aji-51 2138 1 pmid pmid NOUN aji-51 2138 2 : : PUNCT aji-51 2138 3 29724526 29724526 NUM aji-51 2138 4 ; ; PUNCT aji-51 2138 5 pmcid pmcid ADJ aji-51 2138 6 : : PUNCT aji-51 2138 7 pmc6102081 pmc6102081 NOUN aji-51 2138 8 . . PUNCT aji-51 2139 1 326 326 NUM aji-51 2139 2 . . PUNCT aji-51 2140 1 lv lv PROPN aji-51 2140 2 h h PROPN aji-51 2140 3 , , PUNCT aji-51 2140 4 wang wang PROPN aji-51 2140 5 c c PROPN aji-51 2140 6 , , PUNCT aji-51 2140 7 fang fang PROPN aji-51 2140 8 t t PROPN aji-51 2140 9 , , PUNCT aji-51 2140 10 li li PROPN aji-51 2140 11 t t PROPN aji-51 2140 12 , , PUNCT aji-51 2140 13 lv lv PROPN aji-51 2140 14 g g PROPN aji-51 2140 15 , , PUNCT aji-51 2140 16 han han PROPN aji-51 2140 17 q q PROPN aji-51 2140 18 , , PUNCT aji-51 2140 19 yang yang PROPN aji-51 2140 20 w w PROPN aji-51 2140 21 , , PUNCT aji-51 2140 22 wang wang PROPN aji-51 2140 23 h. h. PROPN aji-51 2140 24 vitamin vitamin PROPN aji-51 2140 25 c c PROPN aji-51 2140 26 preferentially preferentially ADV aji-51 2140 27 kills kill VERB aji-51 2140 28 cancer cancer NOUN aji-51 2140 29 stem stem NOUN aji-51 2140 30 cells cell NOUN aji-51 2140 31 in in ADP aji-51 2140 32 hepatocellular hepatocellular ADJ aji-51 2140 33 carcinoma carcinoma NOUN aji-51 2140 34 via via ADP aji-51 2140 35 svct-2 svct-2 PROPN aji-51 2140 36 . . PROPN aji-51 2140 37 npj npj PROPN aji-51 2140 38 precis precis PROPN aji-51 2140 39 oncol oncol ADJ aji-51 2140 40 . . PUNCT aji-51 2141 1 2018 2018 NUM aji-51 2141 2 jan jan PROPN aji-51 2141 3 8;2(1):1 8;2(1):1 PROPN aji-51 2141 4 . . PUNCT aji-51 2141 5 doi doi NOUN aji-51 2141 6 : : PUNCT aji-51 2141 7 10.1038 10.1038 NUM aji-51 2141 8 / / SYM aji-51 2141 9 s41698 s41698 NOUN aji-51 2141 10 - - PUNCT aji-51 2141 11 017 017 NUM aji-51 2141 12 - - PUNCT aji-51 2141 13 0044 0044 NUM aji-51 2141 14 - - PUNCT aji-51 2141 15 8 8 NUM aji-51 2141 16 pmid pmid NOUN aji-51 2141 17 : : PUNCT aji-51 2141 18 29872720 29872720 NUM aji-51 2141 19 ; ; PUNCT aji-51 2141 20 pmcid pmcid NOUN aji-51 2141 21 : : PUNCT aji-51 2141 22 pmc5871898 pmc5871898 ADJ aji-51 2141 23 . . PUNCT aji-51 2142 1 327 327 NUM aji-51 2142 2 . . X aji-51 2142 3 de de PROPN aji-51 2142 4 francesco francesco PROPN aji-51 2142 5 em em PROPN aji-51 2142 6 , , PUNCT aji-51 2142 7 bonuccelli bonuccelli PROPN aji-51 2142 8 g g PROPN aji-51 2142 9 , , PUNCT aji-51 2142 10 maggiolini maggiolini PROPN aji-51 2142 11 m m PROPN aji-51 2142 12 , , PUNCT aji-51 2142 13 sotgia sotgia PROPN aji-51 2142 14 f f PROPN aji-51 2142 15 , , PUNCT aji-51 2142 16 lisanti lisanti PROPN aji-51 2142 17 mp mp PROPN aji-51 2142 18 . . PROPN aji-51 2142 19 vitamin vitamin PROPN aji-51 2142 20 c c PROPN aji-51 2142 21 and and CCONJ aji-51 2142 22 doxycycline doxycycline NOUN aji-51 2142 23 : : PUNCT aji-51 2142 24 a a DET aji-51 2142 25 synthetic synthetic ADJ aji-51 2142 26 lethal lethal ADJ aji-51 2142 27 combination combination NOUN aji-51 2142 28 therapy therapy NOUN aji-51 2142 29 targeting target VERB aji-51 2142 30 metabolic metabolic NOUN aji-51 2142 31 flexibility flexibility NOUN aji-51 2142 32 in in ADP aji-51 2142 33 cancer cancer NOUN aji-51 2142 34 stem stem NOUN aji-51 2142 35 cells cell NOUN aji-51 2142 36 ( ( PUNCT aji-51 2142 37 cscs cscs PROPN aji-51 2142 38 ) ) PUNCT aji-51 2142 39 . . PUNCT aji-51 2143 1 oncotarget oncotarget NOUN aji-51 2143 2 . . PUNCT aji-51 2144 1 2017 2017 NUM aji-51 2144 2 jun jun PROPN aji-51 2144 3 9;8(40):6726967286 9;8(40):6726967286 NUM aji-51 2144 4 . . PUNCT aji-51 2145 1 doi doi NOUN aji-51 2145 2 : : PUNCT aji-51 2145 3 10.18632 10.18632 NUM aji-51 2145 4 / / SYM aji-51 2145 5 oncotarget.18428 oncotarget.18428 PROPN aji-51 2145 6 pmid pmid NOUN aji-51 2145 7 : : PUNCT aji-51 2145 8 28978032 28978032 NUM aji-51 2145 9 ; ; PUNCT aji-51 2145 10 pmcid pmcid NOUN aji-51 2145 11 : : PUNCT aji-51 2145 12 pmc5620172 pmc5620172 ADJ aji-51 2145 13 . . PUNCT aji-51 2146 1 328 328 NUM aji-51 2146 2 . . PUNCT aji-51 2147 1 zhao zhao PROPN aji-51 2147 2 j. j. PROPN aji-51 2147 3 cancer cancer PROPN aji-51 2147 4 stem stem NOUN aji-51 2147 5 cells cell NOUN aji-51 2147 6 and and CCONJ aji-51 2147 7 chemoresistance chemoresistance NOUN aji-51 2147 8 : : PUNCT aji-51 2147 9 the the DET aji-51 2147 10 smartest smart ADJ aji-51 2147 11 survives survive VERB aji-51 2147 12 the the DET aji-51 2147 13 raid raid NOUN aji-51 2147 14 . . PUNCT aji-51 2148 1 pharmacol pharmacol VERB aji-51 2148 2 ther ther ADV aji-51 2148 3 . . PUNCT aji-51 2149 1 2016 2016 NUM aji-51 2149 2 apr;160:145 apr;160:145 NOUN aji-51 2149 3 - - PUNCT aji-51 2149 4 58 58 NUM aji-51 2149 5 . . PUNCT aji-51 2150 1 doi doi NOUN aji-51 2150 2 : : PUNCT aji-51 2150 3 10.1016 10.1016 NUM aji-51 2150 4 / / SYM aji-51 2150 5 j.pharmthera.2016.02.008 j.pharmthera.2016.02.008 PROPN aji-51 2150 6 epub epub PROPN aji-51 2150 7 2016 2016 NUM aji-51 2150 8 feb feb NOUN aji-51 2150 9 17 17 NUM aji-51 2150 10 . . PUNCT aji-51 2151 1 pmid pmid NOUN aji-51 2151 2 : : PUNCT aji-51 2151 3 26899500 26899500 NUM aji-51 2151 4 ; ; PUNCT aji-51 2151 5 pmcid pmcid ADJ aji-51 2151 6 : : PUNCT aji-51 2151 7 pmc4808328 pmc4808328 NOUN aji-51 2151 8 . . PUNCT aji-51 2152 1 329 329 NUM aji-51 2152 2 . . PUNCT aji-51 2152 3 akobeng akobeng PROPN aji-51 2152 4 ak ak PROPN aji-51 2152 5 . . PROPN aji-51 2153 1 principles principle NOUN aji-51 2153 2 of of ADP aji-51 2153 3 evidence evidence NOUN aji-51 2153 4 based base VERB aji-51 2153 5 medicine medicine NOUN aji-51 2153 6 . . PUNCT aji-51 2154 1 arch arch PROPN aji-51 2154 2 dis dis PROPN aji-51 2154 3 child child NOUN aji-51 2154 4 . . PUNCT aji-51 2155 1 2005 2005 NUM aji-51 2155 2 aug;90(8):837 aug;90(8):837 SYM aji-51 2155 3 - - PUNCT aji-51 2155 4 40 40 NUM aji-51 2155 5 . . PUNCT aji-51 2156 1 doi doi NOUN aji-51 2156 2 : : PUNCT aji-51 2156 3 10.1136 10.1136 NUM aji-51 2156 4 / / SYM aji-51 2156 5 adc.2005.071761 adc.2005.071761 NUM aji-51 2156 6 pmid pmid NOUN aji-51 2156 7 : : PUNCT aji-51 2156 8 16040884 16040884 NUM aji-51 2156 9 ; ; PUNCT aji-51 2156 10 pmcid pmcid PROPN aji-51 2156 11 : : PUNCT aji-51 2156 12 pmc1720507 pmc1720507 NOUN aji-51 2156 13 . . PROPN aji-51 2157 1 330 330 NUM aji-51 2157 2 . . PUNCT aji-51 2158 1 available available ADJ aji-51 2158 2 : : PUNCT aji-51 2158 3 https://search.ahrq.gov https://search.ahrq.gov ADJ aji-51 2158 4 / / SYM aji-51 2158 5 search?q search?q PROPN aji-51 2158 6 = = PUNCT aji-51 2158 7 " " PUNCT aji-51 2158 8 " " PUNCT aji-51 2158 9 + + ADJ aji-51 2158 10 the+right+care+at+the+right+time+to+t the+right+care+at+the+right+time+to+t ADJ aji-51 2158 11 he+right+patient he+right+patient NOUN aji-51 2158 12 " " PUNCT aji-51 2158 13 " " PUNCT aji-51 2158 14 accessed access VERB aji-51 2158 15 9/20/21 9/20/21 NUM aji-51 2158 16 331 331 NUM aji-51 2158 17 . . PUNCT aji-51 2159 1 available available ADJ aji-51 2159 2 : : PUNCT aji-51 2159 3 https://www.hopkinsmedicine.org https://www.hopkinsmedicine.org PUNCT aji-51 2159 4 /gim /gim PUNCT aji-51 2159 5 / / SYM aji-51 2159 6 research research NOUN aji-51 2159 7 / / SYM aji-51 2159 8 method method NOUN aji-51 2159 9 / / SYM aji-51 2159 10 ebm.html ebm.html NOUN aji-51 2159 11 accessed access VERB aji-51 2159 12 9/20/21 9/20/21 NUM aji-51 2159 13 332 332 NUM aji-51 2159 14 . . PUNCT aji-51 2160 1 stoff stoff PROPN aji-51 2160 2 ja ja PROPN aji-51 2160 3 . . PROPN aji-51 2160 4 selected select VERB aji-51 2160 5 office office NOUN aji-51 2160 6 based base VERB aji-51 2160 7 anticancer anticancer NOUN aji-51 2160 8 treatment treatment NOUN aji-51 2160 9 strategies strategy NOUN aji-51 2160 10 . . PUNCT aji-51 2161 1 j j PROPN aji-51 2161 2 oncol oncol ADJ aji-51 2161 3 . . PUNCT aji-51 2162 1 2019 2019 NUM aji-51 2162 2 jan jan PROPN aji-51 2162 3 15;2019:7462513 15;2019:7462513 PROPN aji-51 2162 4 . . PUNCT aji-51 2163 1 doi doi NOUN aji-51 2163 2 : : PUNCT aji-51 2163 3 10.1155/2019/7462513 10.1155/2019/7462513 NUM aji-51 2163 4 pmid pmid NOUN aji-51 2163 5 : : PUNCT aji-51 2163 6 30766601 30766601 NUM aji-51 2163 7 ; ; PUNCT aji-51 2163 8 pmcid pmcid NOUN aji-51 2163 9 : : PUNCT aji-51 2163 10 pmc6350558 pmc6350558 NOUN aji-51 2163 11 . . PUNCT aji-51 2164 1 333 333 NUM aji-51 2164 2 . . PUNCT aji-51 2165 1 leroi leroi NOUN aji-51 2165 2 r r PROPN aji-51 2165 3 , , PUNCT aji-51 2165 4 buehler buehler PROPN aji-51 2165 5 w. w. PROPN aji-51 2165 6 cancer cancer PROPN aji-51 2165 7 : : PUNCT aji-51 2165 8 disease disease NOUN aji-51 2165 9 of of ADP aji-51 2165 10 our our PRON aji-51 2165 11 times time NOUN aji-51 2165 12 . . PUNCT aji-51 2166 1 anthromedlibrary anthromedlibrary ADJ aji-51 2166 2 ; ; PUNCT aji-51 2166 3 2018 2018 NUM aji-51 2166 4 . . PUNCT aji-51 2167 1 available available ADJ aji-51 2167 2 : : PUNCT aji-51 2167 3 http://www.anthromed.org http://www.anthromed.org PROPN aji-51 2167 4 / / SYM aji-51 2167 5 article article NOUN aji-51 2167 6 .aspx?artpk=434 .aspx?artpk=434 PROPN aji-51 2167 7 . . PUNCT aji-51 2168 1 334 334 NUM aji-51 2168 2 . . PUNCT aji-51 2169 1 rosen rosen PROPN aji-51 2169 2 st st PROPN aji-51 2169 3 , , PUNCT aji-51 2169 4 dalgleish dalgleish PROPN aji-51 2169 5 ag ag PROPN aji-51 2169 6 , , PUNCT aji-51 2169 7 haefner haefner PROPN aji-51 2169 8 b. b. PROPN aji-51 2170 1 the the DET aji-51 2170 2 link link NOUN aji-51 2170 3 between between ADP aji-51 2170 4 inflammation inflammation NOUN aji-51 2170 5 and and CCONJ aji-51 2170 6 cancerwounds cancerwound NOUN aji-51 2170 7 that that PRON aji-51 2170 8 do do AUX aji-51 2170 9 not not PART aji-51 2170 10 heal heal VERB aji-51 2170 11 . . PUNCT aji-51 2171 1 springer springer NOUN aji-51 2171 2 ; ; PUNCT aji-51 2171 3 2006th 2006th ADJ aji-51 2171 4 edition edition NOUN aji-51 2171 5 . . PUNCT aji-51 2172 1 isbn isbn ADJ aji-51 2172 2 978 978 NUM aji-51 2172 3 - - SYM aji-51 2172 4 0 0 NUM aji-51 2172 5 - - PUNCT aji-51 2172 6 387 387 NUM aji-51 2172 7 - - NUM aji-51 2172 8 26283 26283 NUM aji-51 2172 9 335 335 NUM aji-51 2172 10 . . PUNCT aji-51 2173 1 best good ADJ aji-51 2173 2 answer answer VERB aji-51 2173 3 for for ADP aji-51 2173 4 cancer cancer NOUN aji-51 2173 5 foundation foundation PROPN aji-51 2173 6 . . PUNCT aji-51 2174 1 available available ADJ aji-51 2174 2 : : PUNCT aji-51 2174 3 https://bestanswerforcancer.org/ https://bestanswerforcancer.org/ PRON aji-51 2174 4 accessed access VERB aji-51 2174 5 august august PROPN aji-51 2174 6 10 10 NUM aji-51 2174 7 , , PUNCT aji-51 2174 8 2018 2018 NUM aji-51 2174 9 . . PUNCT aji-51 2175 1 336 336 NUM aji-51 2175 2 . . PUNCT aji-51 2176 1 the the DET aji-51 2176 2 institute institute NOUN aji-51 2176 3 for for ADP aji-51 2176 4 functional functional ADJ aji-51 2176 5 medicine medicine NOUN aji-51 2176 6 , , PUNCT aji-51 2176 7 the the DET aji-51 2176 8 functional functional ADJ aji-51 2176 9 medicine medicine NOUN aji-51 2176 10 approach approach NOUN aji-51 2176 11 . . PUNCT aji-51 2177 1 available available ADJ aji-51 2177 2 : : PUNCT aji-51 2177 3 https://www.ifm.org https://www.ifm.org ADJ aji-51 2177 4 / / SYM aji-51 2177 5 functionalmedicine functionalmedicine NOUN aji-51 2177 6 / / SYM aji-51 2177 7 what what PRON aji-51 2177 8 - - PUNCT aji-51 2177 9 is be AUX aji-51 2177 10 - - PUNCT aji-51 2177 11 functional functional ADJ aji-51 2177 12 - - PUNCT aji-51 2177 13 medicine/ medicine/ NUM aji-51 2177 14 accessed access VERB aji-51 2177 15 august august PROPN aji-51 2177 16 10 10 NUM aji-51 2177 17 , , PUNCT aji-51 2177 18 2018 2018 NUM aji-51 2177 19 . . PUNCT aji-51 2178 1 _ _ PUNCT aji-51 2179 1 _ _ PUNCT aji-51 2180 1 _ _ PUNCT aji-51 2181 1 _ _ PUNCT aji-51 2182 1 _ _ PUNCT aji-51 2183 1 _ _ PUNCT aji-51 2184 1 _ _ PUNCT aji-51 2185 1 _ _ PUNCT aji-51 2186 1 _ _ PUNCT aji-51 2187 1 _ _ PUNCT aji-51 2188 1 _ _ PUNCT aji-51 2189 1 _ _ PUNCT aji-51 2190 1 _ _ PUNCT aji-51 2191 1 _ _ PUNCT aji-51 2192 1 _ _ PUNCT aji-51 2193 1 _ _ PUNCT aji-51 2194 1 _ _ PUNCT aji-51 2195 1 _ _ PUNCT aji-51 2196 1 _ _ PUNCT aji-51 2197 1 _ _ PUNCT aji-51 2198 1 _ _ PUNCT aji-51 2199 1 _ _ PUNCT aji-51 2200 1 _ _ PUNCT aji-51 2201 1 _ _ PUNCT aji-51 2202 1 _ _ PUNCT aji-51 2203 1 _ _ PUNCT aji-51 2204 1 _ _ PUNCT aji-51 2205 1 _ _ PUNCT aji-51 2206 1 _ _ PUNCT aji-51 2207 1 _ _ PUNCT aji-51 2208 1 _ _ PUNCT aji-51 2209 1 _ _ PUNCT aji-51 2210 1 _ _ PUNCT aji-51 2211 1 _ _ PUNCT aji-51 2212 1 _ _ PUNCT aji-51 2213 1 _ _ PUNCT aji-51 2214 1 _ _ PUNCT aji-51 2215 1 _ _ PUNCT aji-51 2216 1 _ _ PUNCT aji-51 2217 1 _ _ PUNCT aji-51 2218 1 _ _ PUNCT aji-51 2219 1 _ _ PUNCT aji-51 2220 1 _ _ PUNCT aji-51 2221 1 _ _ PUNCT aji-51 2222 1 _ _ PUNCT aji-51 2223 1 _ _ PUNCT aji-51 2224 1 _ _ PUNCT aji-51 2225 1 _ _ PUNCT aji-51 2226 1 _ _ PUNCT aji-51 2227 1 _ _ PUNCT aji-51 2228 1 _ _ PUNCT aji-51 2229 1 _ _ PUNCT aji-51 2230 1 _ _ PUNCT aji-51 2231 1 _ _ PUNCT aji-51 2232 1 _ _ PUNCT aji-51 2233 1 _ _ PUNCT aji-51 2234 1 _ _ PUNCT aji-51 2235 1 _ _ PUNCT aji-51 2236 1 _ _ PUNCT aji-51 2237 1 _ _ PUNCT aji-51 2238 1 _ _ PUNCT aji-51 2239 1 _ _ PUNCT aji-51 2240 1 _ _ PUNCT aji-51 2241 1 _ _ PUNCT aji-51 2242 1 _ _ PUNCT aji-51 2243 1 _ _ PUNCT aji-51 2244 1 _ _ PUNCT aji-51 2245 1 _ _ PUNCT aji-51 2246 1 _ _ PUNCT aji-51 2247 1 _ _ PUNCT aji-51 2248 1 _ _ PUNCT aji-51 2249 1 _ _ PUNCT aji-51 2250 1 _ _ PUNCT aji-51 2251 1 _ _ PUNCT aji-51 2252 1 _ _ PUNCT aji-51 2253 1 _ _ PUNCT aji-51 2254 1 _ _ PUNCT aji-51 2255 1 _ _ PUNCT aji-51 2256 1 _ _ PUNCT aji-51 2257 1 _ _ PUNCT aji-51 2258 1 _ _ PUNCT aji-51 2259 1 © © PROPN aji-51 2259 2 2022 2022 NUM aji-51 2259 3 stoff stoff NOUN aji-51 2259 4 ; ; PUNCT aji-51 2259 5 this this PRON aji-51 2259 6 is be AUX aji-51 2259 7 an an DET aji-51 2259 8 open open ADJ aji-51 2259 9 access access NOUN aji-51 2259 10 article article NOUN aji-51 2259 11 distributed distribute VERB aji-51 2259 12 under under ADP aji-51 2259 13 the the DET aji-51 2259 14 terms term NOUN aji-51 2259 15 of of ADP aji-51 2259 16 the the DET aji-51 2259 17 creative creative ADJ aji-51 2259 18 commons common NOUN aji-51 2259 19 attribution attribution NOUN aji-51 2259 20 license license NOUN aji-51 2259 21 ( ( PUNCT aji-51 2259 22 http://creativecommons.org/licenses/by/4.0 http://creativecommons.org/licenses/by/4.0 NOUN aji-51 2259 23 ) ) PUNCT aji-51 2259 24 , , PUNCT aji-51 2259 25 which which PRON aji-51 2259 26 permits permit VERB aji-51 2259 27 unrestricted unrestricted ADJ aji-51 2259 28 use use NOUN aji-51 2259 29 , , PUNCT aji-51 2259 30 distribution distribution NOUN aji-51 2259 31 , , PUNCT aji-51 2259 32 and and CCONJ aji-51 2259 33 reproduction reproduction NOUN aji-51 2259 34 in in ADP aji-51 2259 35 any any DET aji-51 2259 36 medium medium NOUN aji-51 2259 37 , , PUNCT aji-51 2259 38 provided provide VERB aji-51 2259 39 the the DET aji-51 2259 40 original original ADJ aji-51 2259 41 work work NOUN aji-51 2259 42 is be AUX aji-51 2259 43 properly properly ADV aji-51 2259 44 cited cite VERB aji-51 2259 45 . . PUNCT aji-51 2260 1 peer peer NOUN aji-51 2260 2 - - PUNCT aji-51 2260 3 review review NOUN aji-51 2260 4 history history NOUN aji-51 2260 5 : : PUNCT aji-51 2260 6 the the DET aji-51 2260 7 peer peer NOUN aji-51 2260 8 review review NOUN aji-51 2260 9 history history NOUN aji-51 2260 10 for for ADP aji-51 2260 11 this this DET aji-51 2260 12 paper paper NOUN aji-51 2260 13 can can AUX aji-51 2260 14 be be AUX aji-51 2260 15 accessed access VERB aji-51 2260 16 here here ADV aji-51 2260 17 : : PUNCT aji-51 2260 18 https://www.sdiarticle5.com/review-history/77967 https://www.sdiarticle5.com/review-history/77967 PROPN aji-51 2260 19 http://creativecommons.org/licenses/by/4.0 http://creativecommons.org/licenses/by/4.0 X